<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29295408</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>245</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Building Interoperable FHIR-Based Vocabulary Mapping Services: A Case Study of OHDSI Vocabularies and Mappings.</ArticleTitle><Pagination><StartPage>1327</StartPage><MedlinePgn>1327</MedlinePgn></Pagination><Abstract><AbstractText>The OHDSI Common Data Model (CDM) is a deep information model, in which its vocabulary component plays a critical role in enabling consistent coding and query of clinical data. The objective of the study is to create methods and tools to expose the OHDSI vocabularies and mappings as the vocabulary mapping services using two HL7 FHIR core terminology resources ConceptMap and ValueSet. We discuss the benefits and challenges in building the FHIR-based terminology services.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiefer</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>W3C/MIT, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prud'hommeaux</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>W3C/MIT, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solbrig</LastName><ForeName>Harold R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>W3C/MIT, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM105688</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA180940</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG009450</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="N">Vocabulary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Controlled</Keyword><Keyword MajorTopicYN="N">Observational Study</Keyword><Keyword MajorTopicYN="N">Reference Standards</Keyword><Keyword MajorTopicYN="N">Vocabulary</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29295408</ArticleId><ArticleId IdType="mid">NIHMS961862</ArticleId><ArticleId IdType="pmc">PMC5939959</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>HL7 FHIR.   http://hl7.org/fhir/2016Sep/index.html. Last visited at November 24, 2016.</Citation></Reference><Reference><Citation>OMOP CDM V5.0.1.   http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:single-page. Last visited at November 24, 2016.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29365340</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Towards Implementation of OMOP in a German University Hospital Consortium.</ArticleTitle><Pagination><StartPage>54</StartPage><EndPage>61</EndPage><MedlinePgn>54-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0037-1617452</ELocationID><Abstract><AbstractText Label="BACKGROUND">In 2015, the German Federal Ministry of Education and Research initiated a large data integration and data sharing research initiative to improve the reuse of data from patient care and translational research. The Observational Medical Outcomes Partnership (OMOP) common data model and the Observational Health Data Sciences and Informatics (OHDSI) tools could be used as a core element in this initiative for harmonizing the terminologies used as well as facilitating the federation of research analyses across institutions.</AbstractText><AbstractText Label="OBJECTIVE">To realize an OMOP/OHDSI-based pilot implementation within a consortium of eight German university hospitals, evaluate the applicability to support data harmonization and sharing among them, and identify potential enhancement requirements.</AbstractText><AbstractText Label="METHODS">The vocabularies and terminological mapping required for importing the fact data were prepared, and the process for importing the data from the source files was designed. For eight German university hospitals, a virtual machine preconfigured with the OMOP database and the OHDSI tools as well as the jobs to import the data and conduct the analysis was provided. Last, a federated/distributed query to test the approach was executed.</AbstractText><AbstractText Label="RESULTS">While the mapping of ICD-10 German Modification succeeded with a rate of 98.8% of all terms for diagnoses, the procedures could not be mapped and hence an extension to the OMOP standard terminologies had to be made.Overall, the data of 3 million inpatients with approximately 26 million conditions, 21 million procedures, and 23 million observations have been imported.A federated query to identify a cohort of colorectal cancer patients was successfully executed and yielded 16,701 patient cases visualized in a Sunburst plot.</AbstractText><AbstractText Label="CONCLUSION">OMOP/OHDSI is a viable open source solution for data integration in a German research consortium. Once the terminology problems can be solved, researchers can build on an active community for further development.</AbstractText><CopyrightInformation>Schattauer GmbH Stuttgart.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Storf</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Vormstein</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Bieber</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Bernarding</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Herrmann</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Haverkamp</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Horki</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Laufer</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>H&#xf6;ning</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Fritsch</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Sch&#xfc;ttler</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ganslandt</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>H U</ForeName><Initials>HU</Initials></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="Y">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006284" MajorTopicYN="Y">Health Plan Implementation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="Y">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="N">Vocabulary</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of Interest: None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29365340</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Safran C, Bloomrosen M, Hammond W E et al.Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. J Am Med Inform Assoc. 2007;14(01):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage J M, Ryan P B, Reich C G, Hartzema A G, Stang P E. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(01):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaye A, Marcon Y, Isaeva J et al.DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. 2014;43(06):1929&#x2013;1944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276062</ArticleId><ArticleId IdType="pubmed">25261970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H et al.Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI Homepage. Available at:https://www.ohdsi.org. Accessed October 14, 2017</Citation></Reference><Reference><Citation>Hripcsak G, Ryan P B, Duke J D et al.Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Ministry of Education and Research (BMBF).Medical Informatics Funding Scheme &#x2013; Networking data &#x2013; improving healthcare2015. Available at:https://www.gesundheitsforschung-bmbf.de/files/Medical_Informatics_Funding_Scheme.pdf. Accessed December 25, 2017</Citation></Reference><Reference><Citation>MIRACUM Homepage. Available at:https://www.miracum.org. Accessed July 25, 2017</Citation></Reference><Reference><Citation>Mahlke L, Lefering R, Siebert H, Windolf J, Roeder N, Franz D. Description of the severely injured in the DRG system: is treatment of the severely injured still affordable? [Article in German] Chirurg. 2013;84(11):978&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">23512224</ArticleId></ArticleIdList></Reference><Reference><Citation>Barufka S, Heller M, Prayon V, Fegert J M. Nonnative guidelines for allocating human resources in child and adolescent psychiatry using average values under convergence conditions instead of price determination - analysis of the data of university hospitals in Germany concerning the costs of calculating day and minute values according to Psych-PV and PEPP-System [Article in German] Z Kinder Jugendpsychiatr Psychother. 2015;43(06):397&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer C R, Ganslandt T, Baum B et al.Integrated Data Repository Toolkit (IDRT). A suite of programs to facilitate health analytics on heterogeneous medical data. Methods Inf Med. 2016;55(02):125&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">26534843</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann J G, Abend A, Raghavan V A, Mandl K D, Murphy S N. Data interchange using i2b2. J Am Med Inform Assoc. 2016;23(05):909&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E A, Ma Q, Ryan P B. The impact of standardizing the definition of visits on the consistency of multi-database observational health research. BMC Medical Research Methodology. BioMed Central. 2015;15:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4369827</ArticleId><ArticleId IdType="pubmed">25887092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Depraetere K, De Roo J et al.Semantic processing of EHR data for clinical research. J Biomed Inform. 2015;58:247&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">26515501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain S, Sun H, Sinaci A et al.A framework for evaluating and utilizing medical terminology mappings. Stud Health Technol Inform. 2014;205:594&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">25160255</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M J, Gini R, Coloma P M et al.Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases. Drug Saf. 2013;36 01:S159&#x2013;S169.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166232</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan P B. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Wash DC) 2014;2(01):1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37(11):945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitz Henry F, Resnic F S, Robbins S L et al.Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6(03):536&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn E K, Park M Y et al.Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22(01):54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gini R, Schuemie M, Brown J et al.Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE Strategies. EGEMS (Wash DC) 2016;4(01):1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4780748</ArticleId><ArticleId IdType="pubmed">27014709</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs B T et al.A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 2015;38(08):749&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel J C, Kreda D A, Mandl K D, Kohane I S, Ramoni R B. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc. 2016;23(05):899&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29389968</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Inferring pregnancy episodes and outcomes within a network of observational databases.</ArticleTitle><Pagination><StartPage>e0192033</StartPage><MedlinePgn>e0192033</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0192033</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0192033</ELocationID><Abstract><AbstractText>Administrative claims and electronic health records are valuable resources for evaluating pharmaceutical effects during pregnancy. However, direct measures of gestational age are generally not available. Establishing a reliable approach to infer the duration and outcome of a pregnancy could improve pharmacovigilance activities. We developed and applied an algorithm to define pregnancy episodes in four observational databases: three US-based claims databases: Truven MarketScan&#xae; Commercial Claims and Encounters (CCAE), Truven MarketScan&#xae; Multi-state Medicaid (MDCD), and the Optum ClinFormatics&#xae; (Optum) database and one non-US database, the United Kingdom (UK) based Clinical Practice Research Datalink (CPRD). Pregnancy outcomes were classified as live births, stillbirths, abortions and ectopic pregnancies. Start dates were estimated using a derived hierarchy of available pregnancy markers, including records such as last menstrual period and nuchal ultrasound dates. Validation included clinical adjudication of 700 electronic Optum and CPRD pregnancy episode profiles to assess the operating characteristics of the algorithm, and a comparison of the algorithm's Optum pregnancy start estimates to starts based on dates of assisted conception procedures. Distributions of pregnancy outcome types were similar across all four data sources and pregnancy episode lengths found were as expected for all outcomes, excepting term lengths in episodes that used amenorrhea and urine pregnancy tests for start estimation. Validation survey results found highest agreement between reviewer chosen and algorithm operating characteristics for questions assessing pregnancy status and accuracy of outcome category with 99-100% agreement for Optum and CPRD. Outcome date agreement within seven days in either direction ranged from 95-100%, while start date agreement within seven days in either direction ranged from 90-97%. In Optum validation sensitivity analysis, a total of 73% of algorithm estimated starts for live births were in agreement with fertility procedure estimated starts within two weeks in either direction; ectopic pregnancy 77%, stillbirth 47%, and abortion 36%. An algorithm to infer live birth and ectopic pregnancy episodes and outcomes can be applied to multiple observational databases with acceptable accuracy for further epidemiologic research. Less accuracy was found for start date estimations in stillbirth and abortion outcomes in our sensitivity analysis, which may be expected given the nature of the outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matcho</LastName><ForeName>Amy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1016-8793</Identifier><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, LLC, Raritan, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen Research and Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fife</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen Research and Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gifkins</LastName><ForeName>Dina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen Research and Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knoll</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, LLC, Raritan, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Global Labeling, Janssen Research and Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="Y">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: at the time of work the authors, AM, PR, DF, DG, CK and AF were full-time employees of Janssen Research and Development, LLC, 920 US Route 202, Raritan, NJ, 08869, USA and stockholders of Johnson &amp; Johnson. Janssen Research and Development is a unit of Johnson &amp; Johnson. Janssen Research and Development, LLC provided support in the form of salaries for authors (AM, PR, DF, DG, CK and AF) and access to pre-collected observational databases, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. PR is principal investigator at the Observational Health Data Sciences and Informatics collaboration, 622 W 168th Street, NY, NY 10032. The above do not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29389968</ArticleId><ArticleId IdType="pmc">PMC5794136</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0192033</ArticleId><ArticleId IdType="pii">PONE-D-16-43954</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hornbrook MC, Whitlock EP, Berg CJ, Callaghan WM, Bachman DJ, Gold R
et al.
Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health services research. 2007;42(2):908&#x2013;27. doi: 10.1111/j.1475-6773.2006.00635.x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-6773.2006.00635.x</ArticleId><ArticleId IdType="pmc">PMC1955367</ArticleId><ArticleId IdType="pubmed">17362224</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA
et al.
Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiology and drug safety. 2006;15(8):546&#x2013;54. doi: 10.1002/pds.1235
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1235</ArticleId><ArticleId IdType="pubmed">16586470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JR, Holford TR, Hall GC, Bracken MB. Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database. Pharmacoepidemiology and drug safety. 2004;13(11):749&#x2013;59. doi: 10.1002/pds.935
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.935</ArticleId><ArticleId IdType="pubmed">15386720</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine S, West S, Andrews E, Tennis P, Hammad TA, Eaton S
et al.
The identification of pregnancies within the general practice research database. Pharmacoepidemiology and drug safety. 2010;19(1):45&#x2013;50. doi: 10.1002/pds.1862
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1862</ArticleId><ArticleId IdType="pubmed">19823973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cea-Soriano L, Garcia Rodriguez LA, Fernandez Cantero O, Hernandez-Diaz S. Challenges of using primary care electronic medical records in the UK to study medications in pregnancy. Pharmacoepidemiology and drug safety. 2013;22(9):977&#x2013;85. doi: 10.1002/pds.3472
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3472</ArticleId><ArticleId IdType="pubmed">23813653</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA
et al.
Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiology and drug safety. 2013;22(5):524&#x2013;32. doi: 10.1002/pds.3407
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3407</ArticleId><ArticleId IdType="pmc">PMC3644383</ArticleId><ArticleId IdType="pubmed">23335117</ArticleId></ArticleIdList></Reference><Reference><Citation>Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernandez-Diaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiology and drug safety. 2013;22(1):16&#x2013;24. doi: 10.1002/pds.3284
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3284</ArticleId><ArticleId IdType="pmc">PMC3437228</ArticleId><ArticleId IdType="pubmed">22550030</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikolajczyk RT, Kraut AA, Garbe E. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD). Pharmacoepidemiology and drug safety. 2013;22(8):873&#x2013;80. doi: 10.1002/pds.3467
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3467</ArticleId><ArticleId IdType="pubmed">23733705</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor LG, Thelus Jean R, Gordon G, Fram D, Coster T. Development of a mother-child database for drug exposure and adverse event detection in the Military Health System. Pharmacoepidemiology and drug safety. 2015;24(5):510&#x2013;7. doi: 10.1002/pds.3759
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3759</ArticleId><ArticleId IdType="pubmed">25833769</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade SE, Reichman ME, Mott K, Pitts M, Kieswetter C, Dinatale M
et al.
Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration&#x2019;s Mini-Sentinel program. Archives of women&#x2019;s mental health. 2016. 
doi: 10.1007/s00737-016-0637-1
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00737-016-0637-1</ArticleId><ArticleId IdType="pubmed">27178125</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. OMOP Common Data Model. 2016. http://www.ohdsi.org/data-standardization/the-common-data-model/. Accessed July 2016.</Citation></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug safety. 2014. 
doi: 10.1007/s40264-014-0214-3
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M
et al.
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. Journal of the American Medical Informatics Association: JAMIA. 2015;22(3):553&#x2013;64. doi: 10.1093/jamia/ocu023
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan PB, Stang PE, Rocca M. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. Journal of biomedical informatics. 2012;45(4):689&#x2013;96. doi: 10.1016/j.jbi.2012.05.002
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.05.002</ArticleId><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholes D, Yu O, Raebel MA, Trabert B, Holt VL. Improving automated case finding for ectopic pregnancy using a classification algorithm. Human reproduction (Oxford, England). 2011;26(11):3163&#x2013;8. doi: 10.1093/humrep/der299
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/der299</ArticleId><ArticleId IdType="pmc">PMC3196880</ArticleId><ArticleId IdType="pubmed">21911435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. International journal of epidemiology. 2007;36(3):666&#x2013;76. doi: 10.1093/ije/dym018
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dym018</ArticleId><ArticleId IdType="pubmed">17470488</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamliyan T, Kane RL, Dickinson S. A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. Journal of clinical epidemiology. 2010;63(10):1061&#x2013;70. doi: 10.1016/j.jclinepi.2010.04.014
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.014</ArticleId><ArticleId IdType="pubmed">20728045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29495212</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0254-6450</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi</Title><ISOAbbreviation>Zhonghua Liu Xing Bing Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Data harmonization and sharing in study cohorts of respiratory diseases].</ArticleTitle><Pagination><StartPage>233</StartPage><EndPage>239</EndPage><MedlinePgn>233-239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0254-6450.2018.02.019</ELocationID><Abstract><AbstractText><b>Objective:</b> Chronic obstructive pulmonary disease, asthma, interstitial lung disease and pulmonary thromboembolism are the most common and severe respiratory diseases, which seriously jeopardizing the health of the Chinese citizens. Large-scale prospective cohort studies are needed to explore the relationships between potential risk factors and respiratory disease outcomes and to observe disease prognoses through long-term follow-ups. We aimed to develop a common data model (CDM) for cohort studies on respiratory diseases, in order to harmonize and facilitate the exchange, pooling, sharing, and storing of data from multiple sources to serve the purpose of reusing or uniforming those follow-up data appeared in the cohorts. <b>Methods:</b> The process of developing this CDM of respiratory diseases would follow the steps as: &#x2460;Reviewing the international standards, including the Clinical Data Interchange Standards Consortium (CDISC), Clinical Data Acquisition Standards Harmonization (CDASH) and the Observational Medical Outcomes Partnership (OMOP) CDM; &#x2461;Summarizing four cohort studies of respiratory diseases recruited in this research and assessing the data availability; &#x2462;Developing a CDM related to respiratory diseases. <b>Results:</b> Data on recruited cohorts shared a few similar domains but with various schema. The cohorts also shared homogeneous data collection purposes for future follow-up studies, making the harmonization of current and future data feasible. The derived CDM would include two parts: &#x2460;thirteen common domains for all the four cohorts and derived variables from disparate questions with a common schema, &#x2461;additional domains designed upon disease-specific research needs, as well as additional variables that were disease-specific but not initially included in the common domains. <b>Conclusion:</b> Data harmonization appeared essential for sharing, comparing and pooled analyses, both retrospectively and prospectively. CDM was needed to convert heterogeneous data from multiple studies into one harmonized dataset. The use of a CDM in multicenter respiratory cohort studies would make the constant collection of uniformed data possible, so to guarantee the data exchange and sharing in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Y X</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Z C</ForeName><Initials>ZC</Initials></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>S Y</ForeName><Initials>SY</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Liu Xing Bing Xue Za Zhi</MedlineTA><NlmUniqueID>8208604</NlmUniqueID><ISSNLinking>0254-6450</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x6162;&#x6027;&#x963b;&#x585e;&#x6027;&#x80ba;&#x75be;&#x75c5;&#x3001;&#x54ee;&#x5598;&#x3001;&#x95f4;&#x8d28;&#x6027;&#x80ba;&#x75be;&#x75c5;&#x548c;&#x80ba;&#x8840;&#x6813;&#x6813;&#x585e;&#x75c7;&#x662f;&#x91cd;&#x5927;&#x547c;&#x5438;&#x7cfb;&#x7edf;&#x75be;&#x75c5;&#xff0c;&#x4e25;&#x91cd;&#x5371;&#x5bb3;&#x6211;&#x56fd;&#x5c45;&#x6c11;&#x5065;&#x5eb7;&#xff0c;&#x6574;&#x5408;&#x5e76;&#x5f00;&#x5c55;&#x5927;&#x89c4;&#x6a21;&#x4eba;&#x7fa4;&#x961f;&#x5217;&#x7814;&#x7a76;&#x6709;&#x52a9;&#x4e8e;&#x89c2;&#x5bdf;&#x75be;&#x75c5;&#x7684;&#x66b4;&#x9732;&#x3001;&#x53d1;&#x75c5;&#x4e0e;&#x8f6c;&#x5f52;&#x60c5;&#x51b5;&#x3002;&#x672c;&#x7814;&#x7a76;&#x9488;&#x5bf9;&#x6211;&#x56fd;&#x793e;&#x533a;&#x4e0e;&#x4e34;&#x5e8a;&#x961f;&#x5217;&#x8d44;&#x6e90;&#x7684;&#x591a;&#x6e90;&#x5f02;&#x6784;&#x73b0;&#x72b6;&#xff0c;&#x5236;&#x5b9a;&#x547c;&#x5438;&#x7cfb;&#x7edf;&#x75be;&#x75c5;&#x4e13;&#x75c5;&#x961f;&#x5217;&#xff08;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#xff09;&#x6570;&#x636e;&#x6807;&#x51c6;&#xff0c;&#x4e3a;&#x89e3;&#x51b3;&#x591a;&#x6e90;&#x5f02;&#x6784;&#x6570;&#x636e;&#x6240;&#x81f4;&#x5171;&#x4eab;&#x969c;&#x788d;&#xff0c;&#x4ee5;&#x53ca;&#x9879;&#x76ee;&#x6700;&#x5927;&#x7a0b;&#x5ea6;&#x5f00;&#x5c55;&#x6570;&#x636e;&#x4ea4;&#x6362;&#x3001;&#x6574;&#x5408;&#x3001;&#x5171;&#x4eab;&#x3001;&#x50a8;&#x5b58;&#x4e0e;&#x5229;&#x7528;&#x63d0;&#x4f9b;&#x601d;&#x8def;&#x4e0e;&#x65b9;&#x6cd5;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x6570;&#x636e;&#x6807;&#x51c6;&#x5236;&#x5b9a;&#x601d;&#x8def;&#xff1a;&#x2460;&#x5b66;&#x4e60;&#x3001;&#x53c2;&#x8003;&#x56fd;&#x9645;&#x6807;&#x51c6;&#xff0c;&#x5305;&#x62ec;&#x4e34;&#x5e8a;&#x6570;&#x636e;&#x4ea4;&#x6362;&#x6807;&#x51c6;&#x534f;&#x4f1a;&#xff08;CDISC&#xff09;&#x7684;CDASH&#x6a21;&#x578b;&#xff0c;&#x89c2;&#x5bdf;&#x6027;&#x533b;&#x7597;&#x7ed3;&#x679c;&#x5408;&#x4f5c;&#x7ec4;&#x7ec7;&#xff08;OMOP&#xff09;&#x7684;CDM&#x901a;&#x7528;&#x6570;&#x636e;&#x6a21;&#x578b;&#xff1b;&#x2461;&#x6574;&#x7406;&#x3001;&#x5f52;&#x7eb3;&#x6240;&#x7eb3;&#x5165;&#x7684;4&#x4e2a;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x8d44;&#x6e90;&#xff0c;&#x8bc4;&#x4f30;&#x5404;&#x961f;&#x5217;&#x8d44;&#x6e90;&#x95f4;&#x7684;&#x540c;&#x8d28;&#x6027;&#x4e0e;&#x6574;&#x5408;&#x7684;&#x53ef;&#x80fd;&#x6027;&#xff1b;&#x2462;&#x4e13;&#x5bb6;&#x8ba8;&#x8bba;&#xff0c;&#x5efa;&#x7acb;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x6570;&#x636e;&#x6807;&#x51c6;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> &#x7814;&#x7a76;&#x7eb3;&#x5165;&#x7684;&#x73b0;&#x6709;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x53d8;&#x91cf;&#x6a21;&#x5757;&#x540c;&#x8d28;&#x6027;&#x8f83;&#x597d;&#xff0c;&#x57fa;&#x672c;&#x7ed3;&#x6784;&#x76f8;&#x4f3c;&#xff0c;&#x5177;&#x6709;&#x6570;&#x636e;&#x6574;&#x5408;&#x7684;&#x53ef;&#x884c;&#x6027;&#x3002;&#x53c2;&#x8003;&#x56fd;&#x9645;&#x6807;&#x51c6;&#xff0c;&#x7ecf;&#x4e13;&#x5bb6;&#x8ba8;&#x8bba;&#xff0c;&#x9879;&#x76ee;&#x7ec4;&#x6784;&#x5efa;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x7684;&#x6570;&#x636e;&#x6807;&#x51c6;&#x6982;&#x5ff5;&#x6846;&#x67b6;&#xff0c;&#x7531;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x901a;&#x7528;&#x6570;&#x636e;&#x6807;&#x51c6;&#x53ca;&#x75be;&#x75c5;&#x7279;&#x5f02;&#x6570;&#x636e;&#x6807;&#x51c6;&#x4e24;&#x90e8;&#x5206;&#x6784;&#x6210;&#xff0c;&#x5176;&#x4e2d;&#x901a;&#x7528;&#x6570;&#x636e;&#x6807;&#x51c6;&#x9488;&#x5bf9;&#x5404;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x4e2d;&#x5747;&#x6709;&#x6d89;&#x53ca;&#x3001;&#x80fd;&#x591f;&#x7edf;&#x4e00;&#x6807;&#x51c6;&#x7684;&#x95ee;&#x9898;&#x6216;&#x7814;&#x7a76;&#x53d8;&#x91cf;&#xff1b;&#x7279;&#x5f02;&#x6570;&#x636e;&#x6807;&#x51c6;&#x5219;&#x4e3a;&#x5404;&#x75be;&#x75c5;&#x7279;&#x6709;&#x7684;&#x95ee;&#x9898;&#x3002;&#x7ecf;&#x6620;&#x5c04;&#x5339;&#x914d;&#xff0c;&#x8ba4;&#x4e3a;&#x8be5;&#x6807;&#x51c6;&#x4e0e;&#x5404;&#x73b0;&#x6709;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x7684;&#x53d8;&#x91cf;&#x6a21;&#x5757;&#x5339;&#x914d;&#x826f;&#x597d;&#xff0c;&#x6807;&#x51c6;&#x53ef;&#x884c;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> &#x6570;&#x636e;&#x6807;&#x51c6;&#x5efa;&#x7acb;&#x540e;&#xff0c;&#x5728;&#x56de;&#x987e;&#x6027;&#x6574;&#x5408;&#x73b0;&#x6709;&#x961f;&#x5217;&#x8d44;&#x6e90;&#x7684;&#x540c;&#x65f6;&#xff0c;&#x4f7f;&#x4e0d;&#x540c;&#x9879;&#x76ee;&#x4ee5;&#x76f8;&#x540c;&#x7684;&#x5b9a;&#x4e49;&#x548c;&#x6807;&#x51c6;&#x5f00;&#x5c55;&#x957f;&#x671f;&#x968f;&#x8bbf;&#xff0c;&#x6536;&#x96c6;&#x6838;&#x5fc3;&#x6570;&#x636e;&#x96c6;&#xff0c;&#x4e3a;&#x672a;&#x6765;&#x5f00;&#x5c55;&#x591a;&#x4e2d;&#x5fc3;&#x7814;&#x7a76;&#x626b;&#x9664;&#x56e0;&#x6570;&#x636e;&#x6807;&#x51c6;&#x4e0d;&#x4e00;&#x5bfc;&#x81f4;&#x7684;&#x6570;&#x636e;&#x5171;&#x4eab;&#x969c;&#x788d;&#xff0c;&#x66f4;&#x6709;&#x5229;&#x4e8e;&#x591a;&#x6e90;&#x7684;&#x6574;&#x5408;&#x4e0e;&#x5171;&#x4eab;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cohort study of respiratory diseases</Keyword><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Data harmonization</Keyword><Keyword MajorTopicYN="N">Data sharing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29495212</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.0254-6450.2018.02.019</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29531023</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data.</ArticleTitle><Pagination><StartPage>2571</StartPage><EndPage>2577</EndPage><MedlinePgn>2571-2577</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1708282114</ELocationID><Abstract><AbstractText>Observational healthcare data, such as electronic health records and administrative claims, offer potential to estimate effects of medical products at scale. Observational studies have often been found to be nonreproducible, however, generating conflicting results even when using the same database to answer the same question. One source of discrepancies is error, both random caused by sampling variability and systematic (for example, because of confounding, selection bias, and measurement error). Only random error is typically quantified but converges to zero as databases become larger, whereas systematic error persists independent from sample size and therefore, increases in relative importance. Negative controls are exposure-outcome pairs, where one believes no causal effect exists; they can be used to detect multiple sources of systematic error, but interpreting their results is not always straightforward. Previously, we have shown that an empirical null distribution can be derived from a sample of negative controls and used to calibrate <i>P</i> values, accounting for both random and systematic error. Here, we extend this work to calibration of confidence intervals (CIs). CIs require positive controls, which we synthesize by modifying negative controls. We show that our CI calibration restores nominal characteristics, such as 95% coverage of the true effect size by the 95% CI. We furthermore show that CI calibration reduces disagreement in replications of two pairs of conflicting observational studies: one related to dabigatran, warfarin, and gastrointestinal bleeding and one related to selective serotonin reuptake inhibitors and upper gastrointestinal bleeding. We recommend CI calibration to improve reproducibility of observational studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032; schuemie@ohdsi.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ 08560.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ 08560.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="Y">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002138" MajorTopicYN="N">Calibration</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006302" MajorTopicYN="N">Health Services Research</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="Y">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">calibration</Keyword><Keyword MajorTopicYN="N">observational studies</Keyword><Keyword MajorTopicYN="N">systematic error</Keyword></KeywordList><CoiStatement>Conflict of interest statement: M.J.S. and P.B.R. are full-time employees and shareholders of Janssen Research &amp; Development.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>3</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29531023</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pii">1708282114</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Desideratum for evidence based epidemiology. Drug Saf. 2013;1(36 Suppl):S5&#x2013;S14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166219</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad V, Jena AB. Prespecified falsification end points: Can they validate true observational associations? JAMA. 2013;309:241&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">23321761</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusetzina SB, Brookhart MA, Maciejewski ML. Control outcomes and exposures for improving internal validity of nonrandomized studies. Health Serv Res. 2015;50:1432&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4600355</ArticleId><ArticleId IdType="pubmed">25598384</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A. Negative control outcomes: A tool to detect bias in randomized trials. JAMA. 2016;316:2597&#x2013;2598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428075</ArticleId><ArticleId IdType="pubmed">28027378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: A tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21:383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A, Benjamin-Chung J, Colford JM. Brief report: Negative controls to detect selection bias and measurement bias in epidemiologic studies. Epidemiology. 2016;27:637&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969055</ArticleId><ArticleId IdType="pubmed">27182642</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaadstra BM, Chorus AM, vanBuuren S, Kalsbeek H, vanNoort JM. Selective association of multiple sclerosis with infectious mononucleosis. Mult Scler. 2008;14:307&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">18208871</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchetgen Tchetgen E. The control outcome calibration approach for causal inference with unobserved confounding. Am J Epidemiol. 2014;179:633&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3927977</ArticleId><ArticleId IdType="pubmed">24363326</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanders WD, Strickland MJ, Klein M. A new method for partial correction of residual confounding in time-series and other observational studies. Am J Epidemiol. 2017;185:941&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">28430842</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: Why empirical calibration is needed to correct p-values. Stat Med. 2014;33:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35:3883&#x2013;3888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Southworth MR, Reichman ME, Unger EF. Dabigatran and postmarketing reports of bleeding. N Engl J Med. 2013;368:1272&#x2013;1274.</Citation><ArticleIdList><ArticleId IdType="pubmed">23484796</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham DJ, et al. Stroke, bleeding, and mortality risks in elderly medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation. JAMA Intern Med. 2016;176:1662&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">27695821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tata LJ, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther. 2005;22:175&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">16091054</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, et al. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2016;66:72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren GN, Caster O, Juhlin K, Lindquist M. Zoo or Savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. 2014;37:655&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">25005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Series B Stat Methodol. 1996;73:267&#x2013;288.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa TP, Parkinson J. Response to: Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research by Lewis et al. Pharmacoepidemiol Drug Saf. 2008;17:103&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">18092305</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E, et al. Data resource profile: Clinical practice research datalink (CPRD) Int J Epidemiol. 2015;44:827&#x2013;836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29718407</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data.</ArticleTitle><Pagination><StartPage>969</StartPage><EndPage>975</EndPage><MedlinePgn>969-975</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy032</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To develop a conceptual prediction model framework containing standardized steps and describe the corresponding open-source software developed to consistently implement the framework across computational environments and observational healthcare databases to enable model sharing and reproducibility.</AbstractText><AbstractText Label="METHODS">Based on existing best practices we propose a 5 step standardized framework for: (1) transparently defining the problem; (2) selecting suitable datasets; (3) constructing variables from the observational data; (4) learning the predictive model; and (5) validating the model performance. We implemented this framework as open-source software utilizing the Observational Medical Outcomes Partnership Common Data Model to enable convenient sharing of models and reproduction of model evaluation across multiple observational datasets. The software implementation contains default covariates and classifiers but the framework enables customization and extension.</AbstractText><AbstractText Label="RESULTS">As a proof-of-concept, demonstrating the transparency and ease of model dissemination using the software, we developed prediction models for 21 different outcomes within a target population of people suffering from depression across 4 observational databases. All 84 models are available in an accessible online repository to be implemented by anyone with access to an observational database in the Common Data Model format.</AbstractText><AbstractText Label="CONCLUSIONS">The proof-of-concept study illustrates the framework's ability to develop reproducible models that can be readily shared and offers the potential to perform extensive external validation of models, and improve their likelihood of clinical uptake. In future work the framework will be applied to perform an "all-by-all" prediction analysis to assess the observational data prediction domain across numerous target populations, outcomes and time, and risk settings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biomathematics, UCLA School of Medicine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam,The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006301" MajorTopicYN="N">Health Services Needs and Demand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019370" MajorTopicYN="Y">Observation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="Y">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29718407</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pii">4989437</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collins GS, Mallett S, Omar O et al. . Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 2011;9:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3180398</ArticleId><ArticleId IdType="pubmed">21902820</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Omar O, Shanyinde M et al. . A systematic review finds prediction models for chronic kidney were poorly reported and often developed using inappropriate methods. J Clin Epidemiol 2013;66:268&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">23116690</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, de Groot JA, Dutton S et al. . External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol 2014;141:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3999945</ArticleId><ArticleId IdType="pubmed">24645774</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein BA, Navar AM, Pencina MJ et al. . Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review. J Am Med Inform Assoc 2017;241:198&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5201180</ArticleId><ArticleId IdType="pubmed">27189013</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG et al. . Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med 2015;131:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284921</ArticleId><ArticleId IdType="pubmed">25563062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemingway H, Croft P, Perel P et al. . Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 2013;346:e5595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3565687</ArticleId><ArticleId IdType="pubmed">23386360</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Hayden JA, Steyerberg EW et al. . Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med 2013;102:e1001380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3564757</ArticleId><ArticleId IdType="pubmed">23393429</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW, Moons KG, van der Windt DA et al. . Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med 2013;102:e1001381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3564751</ArticleId><ArticleId IdType="pubmed">23393430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hingorani AD, van der Windt DA, Riley RD et al. . Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ 2013;346:e5793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3565686</ArticleId><ArticleId IdType="pubmed">23386361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH et al. . Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG et al. . Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012;191:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD et al. . Characterizing treatment pathways at scale using the OHDSI network. PNAS 2016;11327:7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>
Schuemie MJ, Suchard MA. 
SqlRender: Rendering Parameterized SQL and Translation to Dialects. R Package Version 1.2.0. 2017. 
https://CRAN.R-project.org/package=SqlRender. Accessed February 1, 2017.</Citation></Reference><Reference><Citation>
Schuemie MJ, Suchard MA DatabaseConnector: A Wrapper Around RJDBC Containing Drivers for Various DBMSs. R Package Version 1.10.0. 2017. 
https://github.com/OHDSI/DatabaseConnector. Accessed February 1, 2017.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I et al. . Massive parallelization of serial inference algorithms for complex generalized linear models. ACM Transact Model Comput Simulation 2013;231:10&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H, Bai Y, Shantsila A et al. . Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review. Clin Res Cardiol 2017;10610:813&#x2013;823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5613037</ArticleId><ArticleId IdType="pubmed">28560516</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnabel RB, Sullivan LM, Levy D et al. . Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009;373.9665:739&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2764235</ArticleId><ArticleId IdType="pubmed">19249635</ArticleId></ArticleIdList></Reference><Reference><Citation>Empana JP, Ducimeti&#xe8;re P, Arveiler D et al. . Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003;24.21:1903&#x2013;1911.</Citation><ArticleIdList><ArticleId IdType="pubmed">14585248</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Can machine-learning improve cardiovascular risk prediction using routine clinical data?. PLoS One 2017;12.4:e0174944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5380334</ArticleId><ArticleId IdType="pubmed">28376093</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A et al. . Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc 2015;223:553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29726424</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>248</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>A Clinical Data Warehouse Based on OMOP and i2b2 for Austrian Health Claims Data.</ArticleTitle><Pagination><StartPage>94</StartPage><EndPage>99</EndPage><MedlinePgn>94-99</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To develop simulation models for healthcare related questions clinical data can be reused.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Develop a clinical data warehouse to harmonize different data sources in a standardized manner and get a reproducible interface for clinical data reuse.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Kimball life cycle for the development of data warehouse was used. The development is split into the technical, the data and the business intelligence pathway.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sample data was persisted in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). The i2b2 clinical data warehouse tools were used to query the OMOP CDM by applying the new i2b2 multi-fact table feature.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A clinical data warehouse was set up and sample data, data dimensions and ontologies for Austrian health claims data were created. The ability of the standardized data access layer to create and apply simulation models will be evaluated next.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rinner</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gezgin</LastName><ForeName>Deniz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendl</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N">Austria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="Y">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Secondary use</Keyword><Keyword MajorTopicYN="N">clinical data warehousing</Keyword><Keyword MajorTopicYN="N">standardized health data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29726424</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29735409</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0887</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title><ISOAbbreviation>Radiother Oncol</ISOAbbreviation></Journal><ArticleTitle>Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression.</ArticleTitle><Pagination><StartPage>493</StartPage><EndPage>500</EndPage><MedlinePgn>493-500</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2018.04.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-8140(18)30213-5</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Clinical challenges arise in the oligoprogressive (OP) state with little evidence to support the use of ablative strategies. Our aim is to report on outcomes and prognostic variables following stereotactic body radiotherapy (SBRT) for OP and oligometastases (OM).</AbstractText><AbstractText Label="MATERIAL AND METHODS">Overall (OS) and progression-free survivals (PFS) were calculated for 163 patients for 209 lesions (106 OM and 57 OP) treated with SBRT over 9&#x202f;years. OS and PFS comparisons were calculated using the Kaplan-Meier actuarial survival and log rank methods. Uni, multi-variate analyses and cumulative incidences of local failure were performed using the Cox modelling and Gray's test respectively.</AbstractText><AbstractText Label="RESULTS">The median OS and PFS was 37 and 15&#x202f;months versus 21.7 and 6.4&#x202f;months in the OM and OP groups respectively (P&#x202f;=&#x202f;0.02 and P&#x202f;=&#x202f;0.01). Performance status (&#x2a7e;2 HR 2.95) and number of metastases (1/2 vs &#x2a7e;3 HR 1.88) were independent prognosticators for survival. The 1/2-year PFS were 55%/25% versus 22%/6% in the OM and OP cohorts. Patterns of first relapse were four times higher outside the irradiated field and OP status (p&#x202f;=&#x202f;0.03), &#x2a7e;3 metastasis (p&#x202f;=&#x202f;0.002) and concurrent systemic therapy (p&#x202f;=&#x202f;0.001) conferred a greater risk. Time to second-line treatment was 20 vs 11&#x202f;months in the OM and OP groups (P&#x202f;=&#x202f;0.001).</AbstractText><AbstractText Label="CONCLUSION">Survival and distant relapse following SBRT to OM/OP is determined by the extent of metastatic disease and performance status. Future research should address the benefit of integrating SBRT with systemic therapies to allow deferral or continuation of therapeutic agents.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2018. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pembroke</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Velindre Cancer Centre, Cardiff, United Kingdom. Electronic address: Catherine.a.pembroke@wales.nhs.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortin</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, H&#xf4;pital Maisonneuve-Rosemont, Montreal, Canada. Electronic address: bfortin.hmr@sss.gouv.qc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kopek</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada. Electronic address: neil.kopek@mcgill.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Radiother Oncol</MedlineTA><NlmUniqueID>8407192</NlmUniqueID><ISSNLinking>0167-8140</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016634" MajorTopicYN="N">Radiosurgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Oligometastases</Keyword><Keyword MajorTopicYN="N">Oligoprogression</Keyword><Keyword MajorTopicYN="N">SBRT</Keyword><Keyword MajorTopicYN="N">Stereotactic radiotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29735409</ArticleId><ArticleId IdType="doi">10.1016/j.radonc.2018.04.022</ArticleId><ArticleId IdType="pii">S0167-8140(18)30213-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29755826</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2154-817X</ISSN><JournalIssue CitedMedium="Print"><Volume>2017</Volume><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>KDD : proceedings. International Conference on Knowledge Discovery &amp; Data Mining</Title><ISOAbbreviation>KDD</ISOAbbreviation></Journal><ArticleTitle>Pharmacovigilance via Baseline Regularization with Large-Scale Longitudinal Observational Data.</ArticleTitle><Pagination><StartPage>1537</StartPage><EndPage>1546</EndPage><MedlinePgn>1537-1546</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1145/3097983.3097998</ELocationID><Abstract><AbstractText>Several prominent public health hazards [29] that occurred at the beginning of this century due to adverse drug events (ADEs) have raised international awareness of governments and industries about pharmacovigilance (PhV) [6,7], the science and activities to monitor and prevent adverse events caused by pharmaceutical products after they are introduced to the market. A major data source for PhV is large-scale longitudinal observational databases (LODs) [6] such as electronic health records (EHRs) and medical insurance claim databases. Inspired by the Self-Controlled Case Series (SCCS) model [27], arguably the leading method for ADE discovery from LODs, we propose baseline regularization, a regularized generalized linear model that leverages the diverse health profiles available in LODs across different <i>individuals</i> at different <i>times</i>. We apply the proposed method as well as SCCS to the Marshfield Clinic EHR. Experimental results suggest that the proposed method outperforms SCCS under various settings in identifying <i>benchmark</i> ADEs from the Observational Medical Outcomes Partnership ground truth [26].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuang</LastName><ForeName>Zhaobin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University of Wisconsin-Madison.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peissig</LastName><ForeName>Peggy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Marshfield Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>V&#xed;tor Santos</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Universidade do Porto.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maclin</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Minnesota-Duluth.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Page</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Wisconsin-Madison.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM097618</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI117924</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>KDD</MedlineTA><NlmUniqueID>101523327</NlmUniqueID><ISSNLinking>2154-817X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse Drug Event Discovery</Keyword><Keyword MajorTopicYN="N">Baseline Regularization</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Longitudinal Data</Keyword><Keyword MajorTopicYN="N">Pharmacovigilance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29755826</ArticleId><ArticleId IdType="mid">NIHMS879005</ArticleId><ArticleId IdType="pmc">PMC5945223</ArticleId><ArticleId IdType="doi">10.1145/3097983.3097998</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Laurent Condat. A direct algorithm for 1D total variation denoising. IEEE Signal Processing Letters. 2013;20(11):1054&#x2013;1057. 2013.</Citation></Reference><Reference><Citation>Davies P Laurie, Kovac Arne. Local extremes, runs, strings and multiresolution. Annals of Statistics. 2001;2001:1&#x2013;48.</Citation></Reference><Reference><Citation>Findlay Steven. Health policy briefs: The FDA&#x2019;s sentinel initiative. Health Affiaris. 2015 2015.</Citation></Reference><Reference><Citation>Friedman Jerome, Hastie Trevor, Tibshirani Rob. Regularization paths for generalized linear models via coordinate descent. Journal of statistical software. 2010;33(1):1. 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow Ian, Bengio Yoshua, Courville Aaron.  Deep learning. MIT Press; 2016.   http://www.deeplearningbook.org.</Citation></Reference><Reference><Citation>Harpaz Rave, DuMochel William, Shah Nigam H. Big data and adverse drug reaction detection. Clinical Pharmacology &amp; Therapeutics. 2015 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">26575203</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz Rave, DuMouchel William, Shah Nigam H, Madigan David, Ryan Patrick, Friedman Carol. Novel data-mining methodologies for adverse drug event discovery and analysis. Clinical Pharmacology &amp; Therapeutics. 2012;91(6):1010&#x2013;1021. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675775</ArticleId><ArticleId IdType="pubmed">22549283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie Trevor, Tibshirani Robert, Wainwright Martin. Statistical learning with sparsity: the lasso and generalizations. CRC Press; 2015.</Citation></Reference><Reference><Citation>Hripcsak George, Duke Jon D, Shah Nigam H, Reich Christian G, Huser Vojtech, Schuemie Martijn J, Suchard Marc A, Park Rae Woong, Wong Ian Chi Kei, Rijnbeek Peter R, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Studies in Health Technology and Informatics. 2015;216(2015):574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson Nicholas A. A dynamic programming algorithm for the fused lasso and 10-segmentation. Journal of Computational and Graphical Statistics. 2013;22(2):246&#x2013;260. 2013.</Citation></Reference><Reference><Citation>Kuang Zhaobin, Thomson James, Caldwell Michael, Peissig Peggy, Stewart Ron, Page David. Baseline regularization for computational drug repositioning with longitudinal observational data. Proceedings of the Twenty-Fifth International Joint Conference on Artificial Intelligence (IJCAI-16) 2016:2521&#x2013;2528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382966</ArticleId><ArticleId IdType="pubmed">28392671</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan David, Raghavan Nandini, Dumouchel William, Nason Martha, Posse Christian, Ridgeway Greg. Likelihood-based data squashing: A modeling approach to instance construction. Data Mining and Knowledge Discovery. 2002;6(2):173&#x2013;190. 2002.</Citation></Reference><Reference><Citation>Madigan David, Schuemie Martijn J, Ryan Patrick B. Empirical performance of the case-control method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):73&#x2013;82. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell Tom M. Machine learning. 1. MGH; 1997.</Citation></Reference><Reference><Citation>Murphy Kevin P. Machine learning: a probabilistic perspective. MIT press; 2012.</Citation></Reference><Reference><Citation>Nesterov Yu. Efficiency of coordinate descent methods on huge-scale optimization problems. SIAM Journal on Optimization. 2012;22(2):341&#x2013;362. 2012.</Citation></Reference><Reference><Citation>Nor&#xe9;n G Niklas, Bergvall Tomas, Ryan Patrick B, Juhlin Kristina, Schuemie Martijn J, Madigan David. Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):107&#x2013;121. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166228</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena Javier, Tibshirani Ryan. Lecture notes in machine learning 10-725/statistics 36-725-convex optimization (fall 2016) 2016 2016.</Citation></Reference><Reference><Citation>Powell Valerie, Din Franklin M, Acharya Amit, Torres-Urquidy Miguel Humberto. Integration of medical and dental care and patient data. Vol. 3. Springer Science &amp; Business Media; 2012.</Citation></Reference><Reference><Citation>Ramdas Aaditya, Tibshirani Ryan J. Fast and flexible admm algorithms for trend filtering. Journal of Computational and Graphical Statistics. 2015 just-accepted 2015.</Citation></Reference><Reference><Citation>Robb Melissa A, Racoosin Judith A, Sherman Rachel E, Gross Thomas P, Ball Robert, Reichman Marsha E, Midthun Karen, Woodcock Janet. The US Food and Drug Administration&#x2019;s sentinel initiative: expanding the horizons of medical product safety. Pharmacoepidemiology and Drug Safety. 2012;21(S1):9&#x2013;11. 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">22262587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan Patrick B, Madigan David, Stang Paul E, Overhage J Marc, Racoosin Judith A, Hartzema Abraham G. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Statistics in Medicine. 2012;31(30):4401&#x2013;4415. 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan Patrick B, Schuemie Martijn J, Gruber Susan, Zorych Ivan, Madigan David. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):59&#x2013;72. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan Patrick B, Schuemie Martijn J, Madigan David. Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):95&#x2013;106. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166227</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie Martijn J, Madigan David, Ryan Patrick B. Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):133&#x2013;142. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166230</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson Shawn E. Self-controlled methods for postmarketing drug safety surveillance in large-scale longitudinal data. Columbia University; 2011.</Citation></Reference><Reference><Citation>Simpson Shawn E, Madigan David, Zorych Ivan, Schuemie Martijn J, Ryan Patrick B, Suchard Marc A. Multiple self-controlled case series for largescale longitudinal observational databases. Biometrics. 2013;69(4):893&#x2013;902. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24117144</ArticleId></ArticleIdList></Reference><Reference><Citation>Sra Suvrit, Nowozin Sebastian, Wright Stephen J. Optimization for machine learning. Mit Press; 2012.</Citation></Reference><Reference><Citation>Suchard Marc A, Simpson Shawn E, Zorych Ivan, Ryan Patrick, Madigan David. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Transactions on Modeling and Computer Simulation (TOMACS) 2013;23(1):10. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard Marc A, Zorych Ivan, Simpson Shawn E, Schuemie Martijn J, Ryan Patrick B, Madigan David. Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):83&#x2013;93. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani Robert, Saunders Michael, Rosset Saharon, Zhu Ji, Knight Keith. Sparsity and smoothness via the fused lasso. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2005;67(1):91&#x2013;108. 2005.</Citation></Reference><Reference><Citation>Tseng Paul. Convergence of a block coordinate descent method for nondifferentiable minimization. Journal of optimization theory and applications. 2001;109(3):475&#x2013;494. 2001.</Citation></Reference><Reference><Citation>Wright Stephen J. Coordinate descent algorithms. Mathematical Programming. 2015;151(1):3&#x2013;34. 2015.</Citation></Reference><Reference><Citation>Xu Stanley, Zeng Chan, Newcomer Sophia, Nelson Jennifer, Glanz Jason. Use of fixed effects models to analyze self-controlled case series data in vaccine safety studies. Journal of Biometrics &amp; Biostatistics. 2012;2012:006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3976179</ArticleId><ArticleId IdType="pubmed">24707443</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Tuo, Yu Mo, Wang Yiming, Arora Raman, Liu Han. Accelerated mini-batch randomized block coordinate descent method. Advances in Neural Information Processing Systems. 2014:3329&#x2013;3337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4303186</ArticleId><ArticleId IdType="pubmed">25620860</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29760661</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>A Semantic Transformation Methodology for the Secondary Use of Observational Healthcare Data in Postmarketing Safety Studies.</ArticleTitle><Pagination><StartPage>435</StartPage><MedlinePgn>435</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">435</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2018.00435</ELocationID><Abstract><AbstractText><b>Background:</b> Utilization of the available observational healthcare datasets is key to complement and strengthen the postmarketing safety studies. Use of common data models (CDM) is the predominant approach in order to enable large scale systematic analyses on disparate data models and vocabularies. Current CDM transformation practices depend on proprietarily developed Extract-Transform-Load (ETL) procedures, which require knowledge both on the semantics and technical characteristics of the source datasets and target CDM. <b>Purpose:</b> In this study, our aim is to develop a modular but coordinated transformation approach in order to separate semantic and technical steps of transformation processes, which do not have a strict separation in traditional ETL approaches. Such an approach would discretize the operations to extract data from source electronic health record systems, alignment of the source, and target models on the semantic level and the operations to populate target common data repositories. <b>Approach:</b> In order to separate the activities that are required to transform heterogeneous data sources to a target CDM, we introduce a semantic transformation approach composed of three steps: (1) transformation of source datasets to Resource Description Framework (RDF) format, (2) application of semantic conversion rules to get the data as instances of ontological model of the target CDM, and (3) population of repositories, which comply with the specifications of the CDM, by processing the RDF instances from step 2. The proposed approach has been implemented on real healthcare settings where Observational Medical Outcomes Partnership (OMOP) CDM has been chosen as the common data model and a comprehensive comparative analysis between the native and transformed data has been conducted. <b>Results:</b> Health records of ~1 million patients have been successfully transformed to an OMOP CDM based database from the source database. Descriptive statistics obtained from the source and target databases present analogous and consistent results. <b>Discussion and Conclusion:</b> Our method goes beyond the traditional ETL approaches by being more declarative and rigorous. Declarative because the use of RDF based mapping rules makes each mapping more transparent and understandable to humans while retaining logic-based computability. Rigorous because the mappings would be based on computer readable semantics which are amenable to validation through logic-based inference methods.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pacaci</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>David R. Cheriton School of Computer Science, University of Waterloo, Waterloo, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonul</LastName><ForeName>Suat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Engineering, Middle East Technical University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinaci</LastName><ForeName>A Anil</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuksel</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laleci Erturkmen</LastName><ForeName>Gokce B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">healthcare datasets</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword><Keyword MajorTopicYN="N">postmarketing safety study</Keyword><Keyword MajorTopicYN="N">semantic transformation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29760661</ArticleId><ArticleId IdType="pmc">PMC5937227</ArticleId><ArticleId IdType="doi">10.3389/fphar.2018.00435</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Benson K., Hartz A. J. (2000). A comparison of observational studies and randomized, controlled trials. N. Engl. J. Med. 342, 1878&#x2013;1886. 10.1056/NEJM200006223422506</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200006223422506</ArticleId><ArticleId IdType="pubmed">10861324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizer C., Seaborne A. (2004). D2RQ-treating non-RDF databases as virtual RDF graphs, in Proceedings of the 3rd International Semantic Web Conference (ISWC2004) (Hiroshima: ).</Citation></Reference><Reference><Citation>Brewer T., Colditz G. A. (1999). Postmarketing surveillance and adverse drug reactions. JAMA 281, 824&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">10071004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bright R. A., Nelson R. C. (2002). Automated support for pharmacovigilance: a proposed system. Pharmacoepidemiol. Drug Saf. 11, 121&#x2013;125. 10.1002/pds.684</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.684</ArticleId><ArticleId IdType="pubmed">11998536</ArticleId></ArticleIdList></Reference><Reference><Citation>Coorevits P., Sundgren M., Klein G. O., Bahr A., Claerhout B., Kalra D., et al. . (2013). Electronic health records: new opportunities for clinical research. J. Intern. Med. 274, 547&#x2013;560. 10.1111/joim.12119</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12119</ArticleId><ArticleId IdType="pubmed">23952476</ArticleId></ArticleIdList></Reference><Reference><Citation>El Akkaoui Z. E., Zim&#xe1;nyi E., Maz&#xf3;n J.-N., Trujillo J. (2013). A BPMN-based design and maintenance framework for ETL processes. Int. J. Data Warehousing Mining 9, 46&#x2013;72. 10.4018/jdwm.2013070103</Citation><ArticleIdList><ArticleId IdType="doi">10.4018/jdwm.2013070103</ArticleId></ArticleIdList></Reference><Reference><Citation>Furberg C. D., Levin A. A., Gross P. A., Shapiro R. S., Strom B. L. (2006). The FDA and drug safety: a proposal for sweeping changes. Arch. Intern. Med. 166, 1938&#x2013;1942. 10.1001/archinte.166.18.1938</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.18.1938</ArticleId><ArticleId IdType="pubmed">17030825</ArticleId></ArticleIdList></Reference><Reference><Citation>Hert M., Reif G., Gall H. C. (2011). A comparison of RDB-to-RDF mapping languages, in Proceedings of the 7th International Conference on Semantic Systems (ACM) (Graz: ).</Citation></Reference><Reference><Citation>Jiang G., Hommeaux E. P., Xiao G., Solbrig H. R. (2017). Developing a semantic web-based framework for executing the clinical quality language using FHIR, in Proceedings of the 10th International Conference on Semantic Web Applications and Tools for the Life Sciences, Vol. 42 (Rome: ).</Citation></Reference><Reference><Citation>Kunz R., Oxman A. D. (1998). The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 317, 1185&#x2013;1190. 10.1136/bmj.317.7167.1185</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.317.7167.1185</ArticleId><ArticleId IdType="pmc">PMC28700</ArticleId><ArticleId IdType="pubmed">9794851</ArticleId></ArticleIdList></Reference><Reference><Citation>Laleci Erturkmen G. B., Dogac A., Yuksel M. (2012). SALUS: Scalable, Standard based Interoperability Framework for Sustainable Proactive Post Market Safety Studies. MIE.</Citation></Reference><Reference><Citation>Liao K. P., Cai T., Savova G. K., Murphy S. N., Karlson E. W., Ananthakrishnan A. N., et al. . (2015). Development of phenotype algorithms using electronic medical records and incorporating natural language processing. BMJ 350:h1885. 10.1136/bmj.h1885</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h1885</ArticleId><ArticleId IdType="pmc">PMC4707569</ArticleId><ArticleId IdType="pubmed">25911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A., Ryan P., Fife D., Reich C. (2014). Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 37, 945&#x2013;959. 10.1007/s40264-014-0214-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel F., Montagnat J., Faron-Zucker C. (2014). A Survey of RDB to RDF Translation Approaches and Tools. Diss. I3S.</Citation></Reference><Reference><Citation>Moses L. E. (1995). Measuring effects without randomized trials? Options, problems, challenges. Med. Care 33, AS8&#x2013;AS14.</Citation><ArticleIdList><ArticleId IdType="pubmed">7723464</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebeker J. R., Barach P., Samore M. H. (2004). Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann. Intern. Med. 140, 795&#x2013;801. 10.7326/0003-4819-140-10-200405180-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-140-10-200405180-00009</ArticleId><ArticleId IdType="pubmed">15148066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n G. N., Hopstadius J., Bate A. (2013). Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat. Methods Med. Res. 22, 57&#x2013;69. 10.1177/0962280211403604</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280211403604</ArticleId><ArticleId IdType="pmc">PMC6331976</ArticleId><ArticleId IdType="pubmed">21705438</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira B., Belo O. (2012). BPMN patterns for ETL conceptual modelling and validation, in International Symposium on Methodologies for Intelligent Systems (Berlin; Heidelberg: Springer; ).</Citation></Reference><Reference><Citation>OMOP CDM (2013). Specifications version 4.0 and OMOP Standard Vocabulary Specification version 4.4.</Citation></Reference><Reference><Citation>Overhage J. M., Ryan P. B., Reich C. G., Hartzema A. G., Stang P. E. (2012). Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 19, 54&#x2013;60. 10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacaci A. (2015). Semantic Transformation Framework to Enable Statistical Research On Medical Summaries. Master's thesis, Middle East Technical University. Available online at: http://etd.lib.metu.edu.tr/upload/12618833/index.pdf</Citation></Reference><Reference><Citation>Piazza-Hepp T., Kennedy D. (1995). Reporting of adverse events to MedWatch. Am. J. Heal. Syst. Pharm. 52, 1436&#x2013;1439.</Citation><ArticleIdList><ArticleId IdType="pubmed">7671043</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger S. J., Ryan P. B., O'Hara D. J., Powell G. E., Painter J. L., Pattishall E. N., et al. . (2010). Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J. Am. Med. Inform. Assoc. 17, 652&#x2013;662. 10.1136/jamia.2009.002477</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002477</ArticleId><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvadores M., Alexander P. R., Musen M. A., Noy N. F. (2013). BioPortal as a dataset of linked biomedical ontologies and terminologies in RDF. Semant. Web 4, 277&#x2013;284. 10.3233/SW-2012-0086</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SW-2012-0086</ArticleId><ArticleId IdType="pmc">PMC4159173</ArticleId><ArticleId IdType="pubmed">25214827</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos M. R., Bax M. P., Kalra D. (2010). Building a logical EHR architecture based on ISO 13606 standard and semantic web technologies. Stud. Health Technol. Inform. 160, 161&#x2013;165. 10.3233/978-1-60750-588-4-161</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-60750-588-4-161</ArticleId><ArticleId IdType="pubmed">20841670</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Singh K. (2010). A descriptive classification of causes of data quality problems in data warehousing. Int. J. Comput. Sci. Issues 7, 41&#x2013;50.</Citation></Reference><Reference><Citation>Solbrig H. R., Prud'hommeaux E., Grieve G., McKenzie L., Mandel J. C., Sharma D. K., et al. . (2017). Modeling and validating HL7 FHIR profiles using semantic web Shape Expressions (ShEx). J. Biomed. Inform. 67, 90&#x2013;100. 10.1016/j.jbi.2017.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.02.009</ArticleId><ArticleId IdType="pmc">PMC5502481</ArticleId><ArticleId IdType="pubmed">28213144</ArticleId></ArticleIdList></Reference><Reference><Citation>Suling M., Pigeot I. (2012). Signal detection and monitoring based on longitudinal healthcare data. Pharmaceutics 4, 607&#x2013;640. 10.3390/pharmaceutics4040607</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics4040607</ArticleId><ArticleId IdType="pmc">PMC3834930</ArticleId><ArticleId IdType="pubmed">24300373</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziovara V., Vassiliadis P., Simitsis A. (2007). Deciding the physical implementation of ETL workflows, in Proceedings of the ACM Tenth International Workshop on Data Warehousing and OLAP (ACM) (Lisbon: ).</Citation></Reference><Reference><Citation>World Health Organization. (2002). The Importance of Pharmacovigilance.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysowski D. K., Swartz L. (2005). Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch. Intern. Med. 165, 1363&#x2013;1369. 10.1001/archinte.165.12.1363</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.165.12.1363</ArticleId><ArticleId IdType="pubmed">15983284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yosemite Manifesto  (2016). Available online at: http://yosemitemanifesto.org/</Citation></Reference><Reference><Citation>Yuksel M., Gonul S., Laleci Erturkmen G. B., Sinaci A. A., Invernizzi P., Facchinetti S., et al. . (2016). An interoperability platform enabling reuse of electronic health records for signal verification studies. BioMed Res. Int. 2016:6741418. 10.1155/2016/6741418</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6741418</ArticleId><ArticleId IdType="pmc">PMC4830705</ArticleId><ArticleId IdType="pubmed">27123451</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Murugesan S., Bhullar H., Liu Q., Cai B., Wentworth C., et al. . (2013). An evaluation of the THIN database in the OMOP common data model for active drug safety surveillance. Drug Saf. 36, 119&#x2013;134. 10.1007/s40264-012-0009-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0009-3</ArticleId><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29779949</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>173</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Jun</Month><Day>14</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Disease Heritability Inferred from Familial Relationships Reported in Medical Records.</ArticleTitle><Pagination><StartPage>1692</StartPage><EndPage>1704.e11</EndPage><MedlinePgn>1692-1704.e11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2018.04.032</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(18)30525-7</ELocationID><Abstract><AbstractText>Heritability is essential for understanding the biological causes of disease but requires laborious patient recruitment and phenotype ascertainment. Electronic health records (EHRs) passively capture a wide range of clinically relevant data and provide a resource for studying the heritability of traits that are not typically accessible. EHRs contain next-of-kin information collected via patient emergency contact forms, but until now, these data have gone unused in research. We mined emergency contact data at three academic medical centers and identified 7.4 million familial relationships while maintaining patient privacy. Identified relationships were consistent with genetically derived relatedness. We used EHR data to compute heritability estimates for 500 disease phenotypes. Overall, estimates were consistent with the literature and between sites. Inconsistencies were indicative of limitations and opportunities unique to EHR research. These analyses provide a validation of the use of EHRs for genetics and disease research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Polubriaginof</LastName><ForeName>Fernanda C G</ForeName><Initials>FCG</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanguri</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinnies</LastName><ForeName>Kayla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Institute for Genomic Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belbin</LastName><ForeName>Gillian M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yahi</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmasian</LastName><ForeName>Hojjat</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Value Institute, NewYork-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorberbaum</LastName><ForeName>Tal</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Department of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwankwo</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shervey</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glowe</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ionita-Laza</LastName><ForeName>Iuliana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Mailman School of Public Health, Columbia University, New York, NY, USA; Department of Biostatistics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmerling</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA; Quality and Patient Safety, NewYork-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakken</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; School of Nursing, Columbia University, New York, NY, USA; Data Science Institute, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Genomic Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiryluk</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenny</LastName><ForeName>Eimear E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vawdrey</LastName><ForeName>David K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Value Institute, NewYork-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Institute for Genomic Medicine, Columbia University, New York, NY, USA; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA; Department of Medicine, Columbia University, New York, NY, USA; Department of Systems Biology, Columbia University, New York, NY, USA; Data Science Institute, Columbia University, New York, NY, USA. Electronic address: nick.tatonetti@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH106910</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK105124</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS022961</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS021816</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM107145</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH095797</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Genet. 2018 Jul;19(7):403. doi: 10.1038/s41576-018-0021-2</RefSource><PMID Version="1">29795126</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2018 Jun 14;173(7):1568-1570. doi: 10.1016/j.cell.2018.05.053</RefSource><PMID Version="1">29906443</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005195" MajorTopicYN="N">Family Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030342" MajorTopicYN="N">Genetic Diseases, Inborn</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019655" MajorTopicYN="N">Quantitative Trait, Heritable</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data mining</Keyword><Keyword MajorTopicYN="N">disease heritability</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">familial relationships</Keyword><Keyword MajorTopicYN="N">family history</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">observational databases</Keyword></KeywordList><CoiStatement><b>Declaration of Interests</b>. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29779949</ArticleId><ArticleId IdType="mid">NIHMS969055</ArticleId><ArticleId IdType="pmc">PMC6015747</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.04.032</ArticleId><ArticleId IdType="pii">S0092-8674(18)30525-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. American Journal of Human Genetics. 1998;62:1198&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1377101</ArticleId><ArticleId IdType="pubmed">9545414</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson SJ, Rehm HL. Building the foundation for genomics in precision medicine. Nature. 2015;526:336&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669797</ArticleId><ArticleId IdType="pubmed">26469044</ArticleId></ArticleIdList></Reference><Reference><Citation>Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC, Brott T, Hademenos G, Chyatte D, Rosenwasser R, Caroselli C. Recommendations for the management of patients with unruptured intracranial aneurysms - A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2000;102:2300&#x2013;2308.</Citation><ArticleIdList><ArticleId IdType="pubmed">11056108</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkhead GS, Klompas M, Shah NR. Uses of electronic health records for public health surveillance to advance public health. Annu Rev Public Health. 2015;36:345&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">25581157</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Shahn Z, Madigan D, Hripcsak G, Tatonetti NP. Birth month affects lifetime disease risk: a phenome-wide method. Journal of the American Medical Informatics Association : JAMIA. 2015;22:1042&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986668</ArticleId><ArticleId IdType="pubmed">26041386</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronfenbrenner U, Ceci SJ. Nature-nurture reconceptualized in developmental perspective: a bioecological model. Psychol Rev. 1994;101:568&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">7984707</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani C, Picci L, Tamanini A, Girardi P, Rizzotti P, Assael BM. Association between carrier screening and incidence of cystic fibrosis. Jama. 2009;302:2573&#x2013;2579.</Citation><ArticleIdList><ArticleId IdType="pubmed">20009057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee N, Shi J, Garc&#xed;a-Closas M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nature Reviews Genetics. 2016;17:392&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6021129</ArticleId><ArticleId IdType="pubmed">27140283</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis A, Hamilton D, Cole DEC, Corey M. Cystic Fibrosis Birth Rates in Canada: A Decreasing Trend since the Onset of Genetic Testing. The Journal of Pediatrics. 2005;147:312&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16182667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge T, Chen CY, Neale BM, Sabuncu MR, Smoller JW. Phenome-wide heritability analysis of the UK Biobank. PLoS Genet. 2017;13:e1006711&#x2013;e1006721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5400281</ArticleId><ArticleId IdType="pubmed">28388634</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttmacher AE, Collins FS, Carmona RH. The family history&#x2013;more important than ever. N Engl J Med. 2004;351:2333&#x2013;2336.</Citation><ArticleIdList><ArticleId IdType="pubmed">15564550</ArticleId></ArticleIdList></Reference><Reference><Citation>Harden KP, Turkheimer E, Loehlin JC. Genotype by environment interaction in adolescents&#x2019; cognitive aptitude. Behav Genet. 2007;37:273&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2903846</ArticleId><ArticleId IdType="pubmed">16977503</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. Journal of the American Medical Informatics Association : JAMIA. 2013;20:117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA. 2016;113:7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan RM, Chambers DA, Glasgow RE. Big Data and Large Sample Size: A Cautionary Note on the Potential for Bias. Clinical and Translational Science. 2014;7:342&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439816</ArticleId><ArticleId IdType="pubmed">25043853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorberbaum T, Sampson KJ, Woosley RL, Kass RS, Tatonetti NP. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval. Drug Saf. 2016;39:433&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835515</ArticleId><ArticleId IdType="pubmed">26860921</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J, Kitchner T, Ye Z, Zhou Z, He M, Schrodi SJ, Hebbring SJ. Use of an electronic medical record to create the marshfield clinic twin/multiple birth cohort. Genet Epidemiol. 2014;38:692&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384889</ArticleId><ArticleId IdType="pubmed">25250975</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, Graff RE, Holst K, M&#xf6;ller S, Unger RH, et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. Jama. 2016;315:68&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5498110</ArticleId><ArticleId IdType="pubmed">26746459</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietil&#xe4;inen KH, S&#xf6;derlund S, Rissanen A, Nakanishi S, Jauhiainen M, Taskinen MR, Kaprio J. HDL subspecies in young adult twins: heritability and impact of overweight. Obesity (Silver Spring) 2009;17:1208&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">19584879</ArticleId></ArticleIdList></Reference><Reference><Citation>Polderman TJC, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, Posthuma D. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nature Publishing Group. 2015;47:702&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">25985137</ArticleId></ArticleIdList></Reference><Reference><Citation>Polubriaginof F, Tatonetti NP, Vawdrey DK. An Assessment of Family History Information Captured in an Electronic Health Record. AMIA Annu Symp Proc. 2015;2015:2035&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765557</ArticleId><ArticleId IdType="pubmed">26958303</ArticleId></ArticleIdList></Reference><Reference><Citation>Pordes R, Petravick D, Kramer B, Olson D, Livny M, Roy A, Avery P, Blackburn K, Wenaus T, W&#xfc;rthwein F, et al. The open science grid. J Phys: Conf Ser. 2007;78:012057.</Citation></Reference><Reference><Citation>Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. The American Journal of Human Genetics. 2007;81:559&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie MD, de Andrade M, Kuivaniemi H. The foundation of precision medicine: integration of electronic health records with genomics through basic, clinical, and translational research. Front Genet. 2015;6:104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362332</ArticleId><ArticleId IdType="pubmed">25852745</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotet V, Dugu&#xe9;p&#xe9;roux I, Saliou P, Rault G, Roussey M, Audr&#xe9;zet MP, F&#xe9;rec C. Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France. Orphanet Journal of Rare Diseases. 2012;7:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3310838</ArticleId><ArticleId IdType="pubmed">22380742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfiligoi I, Bradley DC, Holzman B, Mhashilkar P, Padhi S, W&#xfc;rthwein F. The Pilot Way to Grid Resources Using glideinWMS (IEEE) 2009</Citation></Reference><Reference><Citation>Slieker MG, Uiterwaal CSPM, Sinaasappel M, Heijerman HGM, van der Laag J, van der Ent CK. Birth Prevalence and Survival in Cystic Fibrosis: A National Cohort Study in the Netherlands. Chest. 2005;128:2309&#x2013;2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16236889</ArticleId></ArticleIdList></Reference><Reference><Citation>Souren NY, Paulussen ADC, Loos RJF, Gielen M, Beunen G, Fagard R, Derom C, Vlietinck R, Zeegers MP. Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities. Diabetologia. 2007;50:2107&#x2013;2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2039867</ArticleId><ArticleId IdType="pubmed">17694296</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez R. Breaching Doctor-Patient Confidentiality: Confusion among Physicians about Involuntary Disclosure of Genetic Information. S Cal Interdisc LJ 2011</Citation></Reference><Reference><Citation>Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012;4:125ra31&#x2013;125ra31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3382018</ArticleId><ArticleId IdType="pubmed">22422992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenesa A, Haley CS. The heritability of human disease: estimation, uses and abuses. Nature Reviews Genetics. 2013;14:139&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329114</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkheimer E, Haley A, Waldron M, D&#x2019;Onofrio B, Gottesman II. Socioeconomic status modifies heritability of IQ in young children. Psychol Sci. 2003;14:623&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">14629696</ArticleId></ArticleIdList></Reference><Reference><Citation>United States. Health Insurance Portability and Accountability Act of 1996. Public Law. 1996:104&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">16477734</ArticleId></ArticleIdList></Reference><Reference><Citation>Visscher PM, Hill WG, Wray NR. Heritability in the genomics era&#x2013;concepts and misconceptions. Nature Reviews Genetics. 2008;9:255&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">18319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei WQ, Denny JC. Extracting research-quality phenotypes from electronic health records to support precision medicine. Genome Med. 2015;7:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4416392</ArticleId><ArticleId IdType="pubmed">25937834</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. Journal of the American Medical Informatics Association. 2013;20:144&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29854108</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2017</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Improving the 'Fitness for Purpose' of Common Data Models through Realism Based Ontology.</ArticleTitle><Pagination><StartPage>440</StartPage><EndPage>447</EndPage><MedlinePgn>440-447</MedlinePgn></Pagination><Abstract><AbstractText>Common data models are designed and built based on requirements that are aimed towards fitness for purpose. But when common data models are used as lenses through which reality is observed from the perspective according to which they are built, then they exhibit restrictions that distort such view. Realism-based ontology design, when done properly, does not have these limitations as its fitness for purpose is only determined by the degree to which reality is represented the way it is. Therefore, we can use the principles that realism-based ontologies adhere to, not only to design application ontologies serving some specific purpose, but also to assess whether and where common data models fall short in their representational adequacy and how they can be corrected. If a realism based ontological perspective on the portion of reality the some common data model is trying to represent is compared with the perspective of the common data model itself, it is possible to determine how the latter deviates from the former and to suggest solutions to correct the misrepresentations found. Applying this method to the common data model of the Observational Medical Outcomes Partnership, revealed two major categories of errors: one where relationships are restricted based on the constraints of the data model, and one where the representation of reality is oversimplified.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blaisure</LastName><ForeName>Jonathan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Institute for Healthcare Informatics, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceusters</LastName><ForeName>Werner M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Institute for Healthcare Informatics, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064229" MajorTopicYN="Y">Biological Ontologies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065709" MajorTopicYN="Y">Common Data Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29854108</ArticleId><ArticleId IdType="pmc">PMC5977618</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ceusters W, Chiun Yu Hsu, Smith B. Clinical Data Wrangling using Ontological Realism and Referent Tracking. CEUR Workshop Proceedings. 2014;1237:27&#x2013;32.</Citation></Reference><Reference><Citation>Smith B, Ceusters W. Ontological realism: A methodology for coordinated evolution of scientific ontologies. Appl Ontol. 2010;5(3-4):139&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3104413</ArticleId><ArticleId IdType="pubmed">21637730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohane IS, Churchill SE, Murphy SN. A translational engine at the national scale: Informatics for integrating biology and the bedside. Journal of the American Medical Informatics Association. 2012;19(2):181&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277623</ArticleId><ArticleId IdType="pubmed">22081225</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, Denton J, Nookala L, Meeker D, et al. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6(3):536&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Califf RM. The Patient-Centered Outcomes Research Network: a national infrastructure for comparative effectiveness research. N C Med J. 2014;75(3):204&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">24830497</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross TR, Ng D, Brown JS, Pardee R, Hornbrook MC, Hart G, et al. The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS (Washington DC) 2014;2(1):1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza T, Kush R, Evans JP. Global clinical data interchange standards are here! Drug Discov Today. 2007;12(3-4):174&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">17275739</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. Journal of Biomedical Informatics. 2016;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunyemi OI, Meeker D, Kim HE, Ashish N, Farzaneh S, Boxwala A. Identifying appropriate reference data models for comparative effectiveness research (CER) studies based on data from clinical information systems. Medical care. 2013;51(8) Suppl 3:S45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23774519</ArticleId></ArticleIdList></Reference><Reference><Citation>Arp R, Smith B, Spear AD. Cambridge, Massachusetts: The MIT Press; 2015. Building ontologies with basic formal ontology.</Citation></Reference><Reference><Citation>Ceusters W. An information artifact ontology perspective on data collections and associated representational artifacts. Studies in health technology and informatics. 2012;180:68.</Citation><ArticleIdList><ArticleId IdType="pubmed">22874154</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of disease and diagnosis. Summit on translational bioinformatics</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041577</ArticleId><ArticleId IdType="pubmed">21347182</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B, Ceusters W. Ontological realism: A methodology for coordinated evolution of scientific ontologies. Applied Ontology. 2010;5(3-4):139&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3104413</ArticleId><ArticleId IdType="pubmed">21637730</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of disease and diagnosis. Summit on translational bioinformatics. 2009;2009:116&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041577</ArticleId><ArticleId IdType="pubmed">21347182</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceusters W. An information artifact ontology perspective on data collections and associated representational artifacts. Stud Health Technol Inform. 2012;180:68&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">22874154</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B, Ceusters W. Aboutness: Towards Foundations for the Information Artifact Ontology. International Conference on Biomedical Ontology; 2015 July 27-30; Lisbon, Portugal2015. pp. 47&#x2013;51.</Citation></Reference><Reference><Citation>Hogan WR, Ceusters W. Diagnosis, misdiagnosis, lucky guess, hearsay, and more: an ontological analysis. J Biomed Semantics. 2016;7(1):54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5025551</ArticleId><ArticleId IdType="pubmed">27633888</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitharana P. NEW YORK: ACM; 2003. Risks and challenges of component-based software development; pp. 67&#x2013;72.</Citation></Reference><Reference><Citation>OMOP CDM - Design Principles 2015 [OMOP Common Data Model]  Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:design_principles.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Medical Outcomes Partnership. OMOP Common Data Model Specification - Version 5. 2014. Oct 14, p. 69.</Citation></Reference><Reference><Citation>cubarkthik. OMOP CDM - PERSON table 2017.  Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:person.</Citation></Reference><Reference><Citation>Smith B, Ceusters W. HL7 RIM: an incoherent standard. Stud Health Technol Inform. 2006;124:133&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17108516</ArticleId></ArticleIdList></Reference><Reference><Citation>cgreich. OMOP CDM - PROVIDER table 2014.  Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:provider.</Citation></Reference><Reference><Citation>Blaisure J, Ceusters W. Business Rules to Improve Secondary Data Use of Electronic Healthcare Systems. Stud Health Technol Inform; Informatics for Health 2017; April 24-26, 2017; Manchester Central, UK. 2017. pp. 303&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">28423803</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29881733</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2327-9214</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>EGEMS (Washington, DC)</Title><ISOAbbreviation>EGEMS (Wash DC)</ISOAbbreviation></Journal><ArticleTitle>A Comparison of Data Quality Assessment Checks in Six Data Sharing Networks.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/egems.223</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare rule-based data quality (DQ) assessment approaches across multiple national clinical data sharing organizations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Six organizations with established data quality assessment (DQA) programs provided documentation or source code describing current DQ checks. DQ checks were mapped to the categories within the data verification context of the harmonized DQA terminology. To ensure all DQ checks were consistently mapped, conventions were developed and four iterations of mapping performed. Difficult-to-map DQ checks were discussed with research team members until consensus was achieved.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Participating organizations provided 11,026 DQ checks, of which 99.97 percent were successfully mapped to a DQA category. Of the mapped DQ checks (N=11,023), 214 (1.94 percent) mapped to multiple DQA categories. The majority of DQ checks mapped to Atemporal Plausibility (49.60 percent), Value Conformance (17.84 percent), and Atemporal Completeness (12.98 percent) categories.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Using the common DQA terminology, near-complete (99.97 percent) coverage across a wide range of DQA programs and specifications was reached. Comparing the distributions of mapped DQ checks revealed important differences between participating organizations. This variation may be related to the organization's stakeholder requirements, primary analytical focus, or maturity of their DQA program. Not within scope, mapping checks within the data validation context of the terminology may provide additional insights into DQA practice differences.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A common DQA terminology provides a means to help organizations and researchers understand the coverage of their current DQA efforts as well as highlight potential areas for additional DQA development. Sharing DQ checks between organizations could help expand the scope of DQA across clinical data networks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Computational Bioscience Program, University of Colorado Denver Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauck</LastName><ForeName>Alan E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northwest.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertoch</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Children's Hospital Association.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Harvard Pilgrim Health Care Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khare</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staab</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northwest.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zozus</LastName><ForeName>Meredith N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado Denver Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EGEMS (Wash DC)</MedlineTA><NlmUniqueID>101629606</NlmUniqueID><ISSNLinking>2327-9214</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29881733</ArticleId><ArticleId IdType="pmc">PMC5982846</ArticleId><ArticleId IdType="doi">10.5334/egems.223</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wright A. Henkin S, Feblowitz J, McCoy AB, Bates DW, Sittig DF. Early results of the meaningful use program for electronic health records. N Engl J Med. 2013. February 21;368(8):779&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">23425186</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control. Introduction: Meaningful Use [Internet]. [cited 2016 Jul 8]. Available from: http://www.cdc.gov/ehrmeaningfuluse/introduction.html</Citation></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services. Data and Program Reports [Internet]. 2016.  [cited 2016 Jul 8]. Available from: https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/DataAndReports.html</Citation></Reference><Reference><Citation>Heisey-Grove D, Danehy L-N, Consolazio M, Lynch K, Mostashari F. A national study of challenges to electronic health record adoption and meaningful use. Med Care. 2014. February;52(2):144&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24309669</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Appelbaum P, Hripcsak G, Kronish I, Busacca L, Davidson KW, et al. Using EHRs to integrate research with patient care: promises and challenges. J Am Med Inform Assoc JAMIA. 2012. October;19(5):684&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422845</ArticleId><ArticleId IdType="pubmed">22542813</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, et al. Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. J Am Med Inform Assoc. 2007;14(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner MG, Embi PJ. Toward reuse of clinical data for research and quality improvement: the end of the beginning? Ann Intern Med. 2009;151(5):359&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19638404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc JAMIA. 2013. January 1;20(1):117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh WR, Weiner MG, Embi PJ, Logan JR, Payne PRO, Bernstam EV, et al. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care. 2013. August;51(8 Suppl 3):S30&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae MD, Griffith S, Fan Y, Dunphy RN, Thompson MS, Parchman MHA, et al. The Challenges of Data Quality Evaluation in an EHR-based Data Registry. 2014.  [cited 2016 Jul 8]; Available from: http://repository.edm-forum.org/symposia/june2014/panels/15/</Citation></Reference><Reference><Citation>Brown JS, Kahn M, Toh S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013. August;51(8 Suppl 3):S22&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KS, Fowles JB, Weiner JP. Review: electronic health records and the reliability and validity of quality measures: a review of the literature. Med Care Res Rev MCRR. 2010. October;67(5):503&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150441</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lei J. Use and abuse of computer-stored medical records. Methods Inf Med. 1991. April;30(2):79&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">1857252</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnum JF. The misinformation era: the fall of the medical record. Ann Intern Med. 1989. March 15;110(6):482&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2919852</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsis T, Hartvigsen G, Chen F, Weng C. Secondary Use of EHR: Data Quality Issues and Informatics Opportunities. AMIA Jt Summits Transl Sci Proc AMIA Summit Transl Sci. 2010;2010:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041534</ArticleId><ArticleId IdType="pubmed">21347133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012. July;50 Suppl:S21&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw ST, Rahimi A, Ray P, Taggart J, Dennis S, de Lusignan S, et al. Towards an ontology for data quality in integrated chronic disease management: a realist review of the literature. Int J Med Inf. 2013. January;82(1):10&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23122633</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Hripcsak G, Swaminathan S, Weng C. Defining and measuring completeness of electronic health records for secondary use. J Biomed Inform. 2013. October;46(5):830&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810243</ArticleId><ArticleId IdType="pubmed">23820016</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc JAMIA. 2013. January 1;20(1):144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SG, Speedie S, Simon G, Kumar V, Westra BL. A Data Quality Ontology for the Secondary Use of EHR Data. AMIA Annu Symp Proc AMIA Symp AMIA Symp. 2015;2015:1937&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765682</ArticleId><ArticleId IdType="pubmed">26958293</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Hailey D, Wang N, Yu P. A review of data quality assessment methods for public health information systems. Int J Environ Res Public Health. 2014. May;11(5):5170&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053886</ArticleId><ArticleId IdType="pubmed">24830450</ArticleId></ArticleIdList></Reference><Reference><Citation>Long J, Richards J, Seko C.
The Canadian Institute for Health Information (CIHI) Data Quality Framework, Version 1: A Meta-Evaluation and Future Directions. In: Proceedings of the Sixth International Conference on Information Quality [Internet]
2001.  [cited 2016 Jul 8]. p. 370&#x2013;83. Available from: http://ssm-vm030.mit.edu/ICIQ/Documents/IQ%20Conference%202001/Papers/TheCanadianInstitute4HealthInfoDQFrame.pdf</Citation></Reference><Reference><Citation>Bauck A, Bachman D, Riedlinger K, Walker K, Luke S, Donovan J, et al. C-A1-02: Developing a Structure for Programmatic Quality Assurance Checks on the Virtual Data Warehouse. Clin Med Res. 2011;9(3-4):184&#x2013;184.</Citation></Reference><Reference><Citation>Hartzema AG, Reich CG, Ryan PB, Stang PE, Madigan D, Welebob E, et al. Managing data quality for a drug safety surveillance system. Drug Saf. 2013. October;36 Suppl 1:S49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M, Callahan T, Barnard J, Bauck A, Brown J, Davidson B, et al. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. EGEMs Gener Evid Methods Improve Patient Outcomes [Internet]. 2016. 
September
11;4(1). Available from: http://repository.edm-forum.org/egems/vol4/iss1/18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RY, Strong DM. Beyond accuracy: What data quality means to data consumers. J Manag Inf Syst. 1996;12(4):5&#x2013;33.</Citation></Reference><Reference><Citation>Center for Effectiveness &amp; Safety Research [Internet]. [cited 2016 Aug 24]. Available from: http://cesr.kp.org/en/</Citation></Reference><Reference><Citation>Ball R, Robb M, Anderson S, Dal Pan G. The FDA&#x2019;s sentinel initiative&#x2014;A comprehensive approach to medical product surveillance. Clin Pharmacol Ther. 2016. March 1;99(3):265&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R. Developing the Sentinel System &#x2014; A National Resource for Evidence Development. N Engl J Med. 2011. February 10;364(6):498&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Utidjian LH, Khare R, Burrows E, Schulte G.
Identifying and Understanding Data Quality Issues in a Pediatric Distributed Research Network. In: 2015 AAP National Conference and Exhibition [Internet]
American Academy of Pediatrics; 2015 [cited 2016 Aug 24]. Available from: https://aap.confex.com/aap/2015/webprogrampress/Paper30131.html</Citation></Reference><Reference><Citation>PHIS [Internet]. [cited 2016 Aug 24]. Available from: https://www.childrenshospitals.org/programs-and-services/data-analytics-and-research/pediatric-analytic-solutions/pediatric-health-information-system</Citation></Reference><Reference><Citation>Bhattacharya S, Dunham AA, Cornish MA, Christian VA, Ginsburg GS, Tenenbaum JD, et al. The Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study Community Registry and Biorepository. Am J Transl Res. 2012;4(4):458&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493022</ArticleId><ArticleId IdType="pubmed">23145214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc JAMIA. 2012;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskarada S, Gao J, Koronios A.
Agile Maturity Model Approach to Assessing and Enhancing the Quality of Asset Information in Engineering Asset Management Information Systems [Internet]
Rochester, NY: Social Science Research Network; 2005. 
May [cited 2016 Aug 22]. Report No.: ID 2149356. Available from: http://papers.ssrn.com/abstract=2149356</Citation></Reference><Reference><Citation>Paulk M.
Capability maturity model for software. Encycl Softw Eng [Internet]. 1993.  [cited 2016 Jul 20]; Available from: http://onlinelibrarywiley.com/doi/10.1002/0471028959.sof589/full</Citation></Reference><Reference><Citation>Paulk M, Weber C, Garcia-Miller S, Chrissis MB, Bush M.
Key Practices of the Capability Maturity Model Version 1.1 [Internet]. Software Engineering Institute; 1993.  Available from: http://resources.sei.cmu.edu/library/asset-view.cfm?assetid=11965</Citation></Reference><Reference><Citation>Assessments of Health Outcomes Among Individuals Exposed to Medical Products | Mini-Sentinel [Internet]. [cited 2016 Aug 24]. Available from: http://mini-sentinel.org/assessments/medical_events/default.aspx</Citation></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc JAMIA. 2014. August;21(4):578&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29888090</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2153-4063</ISSN><JournalIssue CitedMedium="Print"><Volume>2017</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science</Title><ISOAbbreviation>AMIA Jt Summits Transl Sci Proc</ISOAbbreviation></Journal><ArticleTitle>The Data Gap in the EHR for Clinical Research Eligibility Screening.</ArticleTitle><Pagination><StartPage>320</StartPage><EndPage>329</EndPage><MedlinePgn>320-329</MedlinePgn></Pagination><Abstract><AbstractText>Much effort has been devoted to leverage EHR data for matching patients into clinical trials. However, EHRs may not contain all important data elements for clinical research eligibility screening. To better design research-friendly EHRs, an important step is to identify data elements frequently used for eligibility screening but not yet available in EHRs. This study fills this knowledge gap. Using the Alzheimer's disease domain as an example, we performed text mining on the eligibility criteria text in Clinicaltrials.gov to identify frequently used eligibility criteria concepts. We compared them to the EHR data elements of a cohort of Alzheimer's Disease patients to assess the data gap by usingthe OMOP Common Data Model to standardize the representations for both criteria concepts and EHR data elements. We identified the most common SNOMED CT concepts used in Alzheimer 's Disease trials, andfound 40% of common eligibility criteria concepts were not even defined in the concept space in the EHR dataset for a cohort of Alzheimer 'sDisease patients, indicating a significant data gap may impede EHR-based eligibility screening. The results of this study can be useful for designing targeted research data collection forms to help fill the data gap in the EHR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Yuqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The University of Texas Health Science Center at Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T35 HL007616</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Jt Summits Transl Sci Proc</MedlineTA><NlmUniqueID>101539486</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29888090</ArticleId><ArticleId IdType="pmc">PMC5961795</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gul RB, Ali PA. Clinical trials: the challenge of recruitment and retention of participants. Journal of Clinical Nursing. 2010;19(1-2):227&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">20500260</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy LT, Dahman BA, Petkov VI, DeShazo JP. Effort Required in Eligibility Screening for Clinical Trials. Journal of Oncology Practice. 2012;8(6):365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3500483</ArticleId><ArticleId IdType="pubmed">23598846</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph RR. Viewpoints and concerns of a clinical trial participant. Cancer. 1994;74(S9):2692&#x2013;2693.</Citation><ArticleIdList><ArticleId IdType="pubmed">7954288</ArticleId></ArticleIdList></Reference><Reference><Citation>Campillo-Gimenez B, Buscail C, Zekri O, et al. Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials. Trials. 2015;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301877</ArticleId><ArticleId IdType="pubmed">25592642</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph G, Dohan D. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital. Contemp Clin Trials. 2009;30(6):552&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">19580887</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, Dahman B. Automated matching software for clinical trials eligibility: Measuring efficiency and flexibility. Contemporary Clinical Trials. 2010;31(3):207&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni Y, Wright J, Perentesis J, et al. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients. BMC Medical Informatics and Decision Making. 2015;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407835</ArticleId><ArticleId IdType="pubmed">25881112</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;pcke F, Lubgan D, Fietkau R, et al. Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data. BMC Medical Informatics and Decision Making. 2013;13(1):134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4029400</ArticleId><ArticleId IdType="pubmed">24321610</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadani SR WC, Bigger JT, Ennever JF, Wajngurt D. Electronic screening improves efficiency in clinical trial recruitment. J Am Med Inform Assoc. 2009;16(6):869&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Batres C, Borda T, et al. A Real-Time Screening Alert Improves Patient Recruitment Efficiency. AMIA Annual Symposium Proceedings. 2011;2011:1489&#x2013;1498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243166</ArticleId><ArticleId IdType="pubmed">22195213</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson ML, Weng C. Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials. AMIA Annu Symp Proc. 2015;2015:2025&#x2013;2034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765677</ArticleId><ArticleId IdType="pubmed">26958302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, et al. EliIE: An open-source information extraction system for clinical trial eligibility criteria. Journal of the American Medical Informatics Association: JAMIA. 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Weng C. An OMOP CDM-based Relational Database of Clinical Research Eligibility Criteria. Medinfo 2017. 2017 Hangzhou, China.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893219</ArticleId><ArticleId IdType="pubmed">29295240</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM RP, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2011;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G DJ, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, Van Der Lei J. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA CR, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R, Masys DR, Ritchie MD, Roden DM, Struewing JP. The eMERGE network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011;4(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Stearns MQ PC, Spackman KA, Wang AY. SNOMED clinical terms: overview of the development process and project status. Proceedings of the AMIA Symposium. 2001</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243297</ArticleId><ArticleId IdType="pubmed">11825268</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Tu SW, Sim I, Richesson R. Formal representation of eligibility criteria: A literature review. Journal of biomedical informatics. 2010;43(3):451&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2878905</ArticleId><ArticleId IdType="pubmed">20034594</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J, Dugas M. Frequency analysis of medical concepts in clinical trials and their coverage in MeSH and SNOMED-CT. Methods of information in medicine. 2015;54(1):83&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25346408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32(suppl_1):D267&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR. Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program. Proceedings of the AMIA Symposium. 2001:17&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243666</ArticleId><ArticleId IdType="pubmed">11825149</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson A, Lang F. An overview of MetaMap: historical perspective and recent advances. J Am Med Inform Assoc. 2010;17(3):229&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995713</ArticleId><ArticleId IdType="pubmed">20442139</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CA TT, Mosley-Williams AD. Usability of a computer-assisted interview system for the unaided self-entry of patient data in an urban rheumatology clinic. J Am Med Inform Assoc. 2004;11(4):249&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC436071</ArticleId><ArticleId IdType="pubmed">15064286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves RS, Tu SW, Nyulas CI, Tierney MJ, Musen MA. An ontology-driven tool for structured data acquisition using Web forms. Journal of Biomedical Semantics. 2017;8(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5540339</ArticleId><ArticleId IdType="pubmed">28764813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuerdeman L VL, Pizziferri L, Tsurikova R, Harris C, Feygin R, Epstein M, Meyers K, Wald JS, Lansky D, Bates DW. How accurate is information that patients contribute to their electronic health record? AMIA Annual Symposium Proceedings. 2005 Washington, DC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560697</ArticleId><ArticleId IdType="pubmed">16779157</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer N, Fevrier-Thomas U, Lokker C, McKibbon KA, Straus SE. Personal health records: a scoping review. Journal of the American Medical Informatics Association: JAMIA. 2011;18(4):515&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128401</ArticleId><ArticleId IdType="pubmed">21672914</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu LS, Shih PC, Hayes GR. Barriers to the adoption and use of personal health record systems. Proceedings of the 2011 iConference; 2011; Seattle, Washington, USA.</Citation></Reference><Reference><Citation>Sheehan J, Hirschfeld S, Foster E, et al. Improving the value of clinical research through the use of Common Data Elements. Clinical Trials. 2016;13(6):671&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5133155</ArticleId><ArticleId IdType="pubmed">27311638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Denny JC, Rosenbloom ST, Miller RA, Giuse DA, Xu H. A comparative study of current clinical natural language processing systems on handling abbreviations in discharge summaries. AMIA Annual Symposium Proceedings. 2012;2012:997&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540461</ArticleId><ArticleId IdType="pubmed">23304375</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30010902</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications.</ArticleTitle><Pagination><StartPage>1339</StartPage><EndPage>1350</EndPage><MedlinePgn>1339-1350</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy077</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aim of this work is to leverage relational information extracted from biomedical literature using a novel synthesis of unsupervised pretraining, representational composition, and supervised machine learning for drug safety monitoring.</AbstractText><AbstractText Label="METHODS">Using&#x2009;&#x2248;80 million concept-relationship-concept triples extracted from the literature using the SemRep Natural Language Processing system, distributed vector representations (embeddings) were generated for concepts as functions of their relationships utilizing two unsupervised representational approaches. Embeddings for drugs and side effects of interest from two widely used reference standards were then composed to generate embeddings of drug/side-effect pairs, which were used as input for supervised machine learning. This methodology was developed and evaluated using cross-validation strategies and compared to contemporary approaches. To qualitatively assess generalization, models trained on the Observational Medical Outcomes Partnership (OMOP) drug/side-effect reference set were evaluated against a list of&#x2009;&#x2248;1100 drugs from an online database.</AbstractText><AbstractText Label="RESULTS">The employed method improved performance over previous approaches. Cross-validation results advance the state of the art (AUC 0.96; F1 0.90 and AUC 0.95; F1 0.84 across the two sets), outperforming methods utilizing literature and/or spontaneous reporting system data. Examination of predictions for unseen drug/side-effect pairs indicates the ability of these methods to generalize, with over tenfold label support enrichment in the top 100 predictions versus the bottom 100 predictions.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION">Our methods can assist the pharmacovigilance process using information from the biomedical literature. Unsupervised pretraining generates a rich relationship-based representational foundation for machine learning techniques to classify drugs in the context of a putative side effect, given known examples.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mower</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Quantitative and Computational Biosciences, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Devika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Rice University, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Trevor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, University of Texas Health Science Center Houston, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM011563</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007093</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016206" MajorTopicYN="Y">Databases, Bibliographic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011358" MajorTopicYN="N">Product Surveillance, Postmarketing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="Y">Supervised Machine Learning</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30010902</ArticleId><ArticleId IdType="pmc">PMC6454491</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy077</ArticleId><ArticleId IdType="pii">5052182</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, et al. Defining a reference set to support methodological research in drug safety. Drug Saf 2013; 36 (S1): 33&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyboom RH, Hekster YA, Egberts AC, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 176: 374&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">9429837</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Callahan A, Tamang S, et al. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf 2014; 3710: 777&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4217510</ArticleId><ArticleId IdType="pubmed">25151493</ArticleId></ArticleIdList></Reference><Reference><Citation>
Swanson DR, Smalheiser NR. Undiscovered public knowledge: a ten-year update. In: KDD. 1996: 295&#x2013;8. https://ocs.aaai.org/Papers/KDD/1996/KDD96-051.pdf. Accessed July 13, 2017.</Citation></Reference><Reference><Citation>Cohen AM, Hersh WR.. A survey of current work in biomedical text mining. Brief Bioinform 2005; 61: 57&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">15826357</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-term Trends in Health. Hyattsville, MD; 2017. 
https://www.cdc.gov/nchs/data/hus/hus16.pdf. Accessed July 10, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28910066</ArticleId></ArticleIdList></Reference><Reference><Citation>
Hing E, Rui P, Palso K. National Ambulatory Medical Care Survey: 2013 State and National Summary Tables. 2014. 
http://www.cdc.gov/nchs/ahcd/ahcd_products.htm. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>
Center for Disease Control and Prevention. National Hospital Ambulatory Medical Care Survey: 2011 Outpatient Department Summary Tables. 2012. 
https://www.cdc.gov/nchs/data/ahcd/nhamcs_outpatient/2011_opd_web_tables.pdf. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>
Rui P, Kang K, Albert M.. 
National Hospital Ambulatory Medical Care Survey: 2013 Emergency Department Summary Tables
2014. 
http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2013_ed_web_tables.pdf. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>Watanabe JH, McInnis T, Hirsch JD.. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother 2018; 1060028018765159.</Citation><ArticleIdList><ArticleId IdType="pubmed">29577766</ArticleId></ArticleIdList></Reference><Reference><Citation>Stausberg J. International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA. BMC Health Serv Res 2014; 141: 125..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984698</ArticleId><ArticleId IdType="pubmed">24620750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeois FT, Shannon MW, Valim C, et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 2010; 199: 901&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2932855</ArticleId><ArticleId IdType="pubmed">20623513</ArticleId></ArticleIdList></Reference><Reference><Citation>Coloma PM, Trifir&#xf2; G, Patadia V, et al. Postmarketing safety surveillance: where does signal detection using electronic healthcare records fit into the big picture? Drug Saf 2013; 36: 183&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">23377696</ArticleId></ArticleIdList></Reference><Reference><Citation>
FDA. Postmarket Drug Safety Information for Patients and Providers&#x2014;Information for Healthcare Professionals: Valdecoxib (Marketed as Bextra). https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124649.htm Accessed July 11, 2017.</Citation></Reference><Reference><Citation>Ray WA, Griffin MR, Stein CM.. Cardiovascular toxicity of Valdecoxib. N Engl J Med 2004; 35126: 2767.</Citation><ArticleIdList><ArticleId IdType="pubmed">15608086</ArticleId></ArticleIdList></Reference><Reference><Citation>Downing NS, Shah ND, Aminawung JA, et al. Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010. JAMA 2017; 31718: 1854&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5815036</ArticleId><ArticleId IdType="pubmed">28492899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultana J, Cutroneo P, Trifir&#xf2; G.. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother 2013; 45: 73&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3853675</ArticleId><ArticleId IdType="pubmed">24347988</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. The Importance of Pharmacovigilance. 2002. 
http://apps.who.int/iris/bitstream/10665/42493/1/a75646.pdf. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>
Center for Drug Evaluation and Research. Questions and Answers on FDA&#x2019;s Adverse Event Reporting System (FAERS). 2016. https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/adversedrugeffects/ Accessed July 19, 2017.</Citation></Reference><Reference><Citation>
Center for Drug Evaluation and Research. FDA Adverse Events Reporting System (FAERS)&#x2014;Reports Received and Reports Entered into FAERS by Year. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070434.htm Accessed July 16, 2017.</Citation></Reference><Reference><Citation>Hazell L, Shakir SAW.. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 295: 385&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">16689555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez E, Herdeiro MT, Figueiras A.. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 321: 19&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">19132802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaeda T, Tamon A, Kadoyama K, et al. Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 2013; 107: 796&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3689877</ArticleId><ArticleId IdType="pubmed">23794943</ArticleId></ArticleIdList></Reference><Reference><Citation>Pariente A, Gregoire F, Fourrier-Reglat A, et al. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf 2007; 3010: 891&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17867726</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu RP. Causality assessment: a brief insight into practices in pharmaceutical industry. Perspect Clin Res 2013; 44: 233&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835968</ArticleId><ArticleId IdType="pubmed">24312892</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, LePendu P, et al. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther 2013; 936: 539&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857139</ArticleId><ArticleId IdType="pubmed">23571771</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ryan PB, Wei Y, et al. A method to combine signals from spontaneous reporting systems and observational healthcare data to detect adverse drug reactions. Drug Saf 2015; 3810: 895&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579260</ArticleId><ArticleId IdType="pubmed">26153397</ArticleId></ArticleIdList></Reference><Reference><Citation>Natsiavas P, Koutkias V, Maglaveras N. Exploring the capacity of open, linked data sources to assess adverse drug reaction signals. In: Semantic Web applications and tools for life sciences (SWAT4LS) International Conference, held at Cambridge, England Dec. 7-10th 2015. 2015: 224&#x2013;6.</Citation></Reference><Reference><Citation>Koutkias VG, Jaulent M-C.. Computational approaches for pharmacovigilance signal detection: toward integrated and semantically enriched frameworks. Drug Saf 2015; 383: 219&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374117</ArticleId><ArticleId IdType="pubmed">25749722</ArticleId></ArticleIdList></Reference><Reference><Citation>Food and Drug Administration. Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment. Rockville, MD: Food and Drug Administration; 2005.</Citation></Reference><Reference><Citation>
European Medicines Agency. Good Pharmacovigilance Practices. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000345.jsp Accessed July 20, 2017.</Citation></Reference><Reference><Citation>Zweigenbaum P, Demner-Fushman D, Yu H, et al. Frontiers of biomedical text mining: current progress. Brief Bioinform 2007; 85: 358&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2516302</ArticleId><ArticleId IdType="pubmed">17977867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebholz-Schuhmann D, Oellrich A, Hoehndorf R.. Text-mining solutions for biomedical research: enabling integrative biology. Nat Rev Genet 2012; 1312: 829&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">23150036</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Schvaneveldt R, Widdows D.. Reflective random indexing and indirect inference: a scalable method for discovery of implicit connections. J Biomed Inform 2010; 432: 240&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">19761870</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson DR, Smalheiser NR.. An interactive system for finding complementary literatures: a stimulus to scientific discovery. Artif Intell 1997; 912: 183&#x2013;203.</Citation></Reference><Reference><Citation>Henry S, McInnes BT.. Literature based discovery: models, methods, and trends. J Biomed Inform 2017; 74: 20&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">28838802</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, et al. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform 2017; 66: 72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Winnenburg R, Shah NH.. Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature. BMC Bioinformatics 2016; 171: 250..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918084</ArticleId><ArticleId IdType="pubmed">27333889</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson DR. Fish oil, Raynaud&#x2019;s syndrome, and undiscovered public knowledge. Perspect Biol Med 1986; 301: 7&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">3797213</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson DR. Migraine and magnesium: eleven neglected connections. Perspect Biol Med 1988; 314: 526&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">3075738</ArticleId></ArticleIdList></Reference><Reference><Citation>DiGiacomo RA, Kremer JM, Shah DM.. Fish-oil dietary supplementation in patients with Raynaud&#x2019;s phenomenon: a double-blind, controlled, prospective study. Am J Med 1989; 862: 158&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">2536517</ArticleId></ArticleIdList></Reference><Reference><Citation>
Hristovski D, Burgun-Parenthoine A, Avillach P,
et al. Towards using literature-based discovery to explain drug adverse effects. In: 24th International Conference of the European Federation for Medical Informatics Quality of Life through Quality of Information MIE. 2012. 
http://person.hst.aau.dk/ska/mie2012/AllPresentations/422.pdf. Accessed July 18, 2017.</Citation></Reference><Reference><Citation>Rindflesch TC, Fiszman M.. The interaction of domain knowledge and linguistic structure in natural language processing: interpreting hypernymic propositions in biomedical text. J Biomed Inform 2003; 366: 462&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">14759819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristovski D, Friedman C, Rindflesch TC, et al.. Exploiting semantic relations for literature-based discovery. In: AMIA Annual Symposium Proceedings, 2006, held in Washington, DC, USA Nov. 11&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839258</ArticleId><ArticleId IdType="pubmed">17238361</ArticleId></ArticleIdList></Reference><Reference><Citation>
Song D, Bruza P, Cole R. Concept Learning and Information Inferencing on a High-Dimensional Semantic Space. 2004. 
http://oro.open.ac.uk/35506/. Accessed October12, 2017.</Citation></Reference><Reference><Citation>
Gordon MD, Dumais S. Using Latent Semantic Indexing for Literature Based Discovery. 1998. 
https://deepblue.lib.umich.edu/handle/2027.42/34255. Accessed October12, 2017.</Citation></Reference><Reference><Citation>Cohen T, Widdows D, Schvaneveldt RW, et al. Discovering discovery patterns with predication-based semantic indexing. J Biomed Inform 2012; 456: 1049&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590916</ArticleId><ArticleId IdType="pubmed">22841748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lever J, Gakkhar S, Gottlieb M, et al. A collaborative filtering based approach to biomedical knowledge discovery. Bioinformatics. doi:10.1093/bioinformatics/btx613.</Citation><ArticleIdList><ArticleId IdType="pubmed">29028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlers CB, Hristovski D, Kilicoglu H, et al. Using the literature-based discovery paradigm to investigate drug mechanisms. AMIA Annu Symp Proc 2007; 2007: 6&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2655783</ArticleId><ArticleId IdType="pubmed">18693787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Adam TJ, Simon G, et al. Mining biomedical literature to explore interactions between cancer drugs and dietary supplements. AMIA Jt Summits Transl Sci Proc 2015; 2015: 69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525230</ArticleId><ArticleId IdType="pubmed">26306241</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Widdows D, De Vine L, et al. Many paths lead to discovery: analogical retrieval of cancer therapies In: 6th International Symposium, QI 2012, Paris, France, June 27-29, 2012, Revised Selected Papers. Paris, France: Springer; 2012: 90&#x2013;101.</Citation></Reference><Reference><Citation>
Cohen T, Widdows D, Schvaneveldt RW,
et al. Discovery at a distance: farther journeys in predication space. In: Bioinformatics and Biomedicine Workshops (BIBMW), 2012 IEEE International Conference on IEEE. 2012: 218&#x2013;25. http://ieeexplore.ieee.org/abstract/document/6470307/. Accessed July 18, 2017.</Citation></Reference><Reference><Citation>Shang N, Xu H, Rindflesch TC, et al. Identifying plausible adverse drug reactions using knowledge extracted from the literature. J Biomed Inform 2014; 52: 293&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4261011</ArticleId><ArticleId IdType="pubmed">25046831</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Wu Y, Chen Y, et al. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J Am Med Inform Assoc 2012; 19 (e1): e28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392844</ArticleId><ArticleId IdType="pubmed">22718037</ArticleId></ArticleIdList></Reference><Reference><Citation>Caster O, Sandberg L, Bergvall T, et al. vigiRank for statistical signal detection in pharmacovigilance: first results from prospective real-world use. Pharmacoepidemiol Drug Saf 2017; 268: 1006&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575476</ArticleId><ArticleId IdType="pubmed">28653790</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L-C, Wu X, Chen JY.. Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures. Proteomics 2013; 132: 313&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23184540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S, Goyal S, Shanker A, et al. Predicting neurological adverse drug reactions based on biological, chemical and phenotypic properties of drugs using machine learning models. Sci Rep 2017; 71: 872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5429831</ArticleId><ArticleId IdType="pubmed">28408735</ArticleId></ArticleIdList></Reference><Reference><Citation>
Bengio Y, Courville AC, Vincent P. Unsupervised feature learning and deep learning: a review and new perspectives. CoRR Abs120655382012; 1. https://pdfs.semanticscholar.org/f8c8/619ea7d68e604e40b814b40c72888a755e95.pdf. Accessed October 12, 2017.</Citation></Reference><Reference><Citation>Erhan D, Bengio Y, Courville A, et al. Why does unsupervised pre-training help deep learning? J Mach Learn Res 2010; 11: 625&#x2013;60.</Citation></Reference><Reference><Citation>Bengio Y, Courville A, Vincent P.. Representation learning: a review and new perspectives. IEEE Trans Pattern Anal Mach Intell 2013; 358: 1798&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">23787338</ArticleId></ArticleIdList></Reference><Reference><Citation>
Sun C, Shrivastava A, Singh S,
et al. Revisiting unreasonable effectiveness of data in deep learning era. ArXiv170702968 Cs.2017. 
http://arxiv.org/abs/1707.02968. Accessed July 19, 2017.</Citation></Reference><Reference><Citation>
Khodak M, Risteski A, Fellbaum C,
et al. Extending and improving wordnet via unsupervised word embeddings. ArXiv170500217 Cs
2017. 
http://arxiv.org/abs/1705.00217.</Citation></Reference><Reference><Citation>Mower J, Subramanian D, Shang N, et al. Classification-by-analogy: using vector representations of implicit relationships to identify plausibly causal drug/side-effect relationships. AMIA Annu Symp Proc 2016; 2016: 1940&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333205</ArticleId><ArticleId IdType="pubmed">28269953</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Widdows D.. Embedding of semantic predications. J Biomed Inform 2017; 68: 150&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441848</ArticleId><ArticleId IdType="pubmed">28284761</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Schvaneveldt RW, Rindflesch TC. Predication-based semantic indexing: permutations as a means to encode predications in semantic space. In: AMIA San Francisco, US: AMIA Annual Symposium Proceedings; 2009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815384</ArticleId><ArticleId IdType="pubmed">20351833</ArticleId></ArticleIdList></Reference><Reference><Citation>Widdows D, Cohen T.. Reasoning with vectors: a continuous model for fast robust inference. Log J IGPL Interest Group Pure Appl Log 2015; 232: 141&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646228</ArticleId><ArticleId IdType="pubmed">26582967</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Widdows D, Schvaneveldt R, et al. Finding Schizophrenia&#x2019;s prozac emergent relational similarity in predication space In: Quantum Interaction. Berlin, Heidelberg: Springer; 2011: 48&#x2013;59. doi:10.1007/978-3-642-24971-6_6.</Citation></Reference><Reference><Citation>Kilicoglu H, Shin D, Fiszman M, et al. SemMedDB: a PubMed-scale repository of biomedical semantic predications. Bioinforma Oxf Engl 2012; 2823: 3158&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3509487</ArticleId><ArticleId IdType="pubmed">23044550</ArticleId></ArticleIdList></Reference><Reference><Citation>Widdows D, Ferraro K.. Semantic vectors: a scalable open source package and online technology management application. In: Proceedings of the International Conference on Language Resources and Evaluation, LREC 2008, 26 May - 1 June 2008, Marrakech, Morocco.</Citation></Reference><Reference><Citation>Kanerva P. Binary spatter-coding of ordered K-tuples. Artif Neural Networks&#x2014;ICANN 96, Bochum, Germany: Artificial Neural Networks - ICANN 96 (Springer). 1996: 869&#x2013;73.</Citation></Reference><Reference><Citation>
Gayler RW, Wales R. Connections, Binding, Unification and Analogical Promiscuity. 1998. http://cogprints.org/500. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>Plate TA. Holographic Reduced Representation: Distributed Representation for cognitive structures, Chicago, IL: University of Chicago Press. 2003.</Citation></Reference><Reference><Citation>Rachkovskij DA, Kussul EM.. Binding and normalization of binary sparse distributed representations by context-dependent thinning. Neural Comput 2001; 132: 411&#x2013;52.</Citation></Reference><Reference><Citation>Coloma PM, Avillach P, Salvo F, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf 2013; 361: 13&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">23315292</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in python. Front Neuroinform 2014; 8: 2825&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3930868</ArticleId><ArticleId IdType="pubmed">24600388</ArticleId></ArticleIdList></Reference><Reference><Citation>
Continuum Analytics. Anaconda Python Distribution. https://www.anaconda.com/. Accessed October 12, 2017.</Citation></Reference><Reference><Citation>van der Maaten L, Hinton G.. Visualizing data using t-SNE. J Mach Learn Res 2008; 9: 2579&#x2013;605.</Citation></Reference><Reference><Citation>Kuhn M, Campillos M, Letunic I, et al. A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 2010; 6: 343..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824526</ArticleId><ArticleId IdType="pubmed">20087340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M, Letunic I, Jensen LJ, et al. The SIDER database of drugs and side effects. Nucleic Acids Res 2016; 44 (D1): D1075&#x2013;79. Accessed October 12, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702794</ArticleId><ArticleId IdType="pubmed">26481350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W-Q, Cronin RM, Xu H, et al. Development and evaluation of an ensemble resource linking medications to their indications. J Am Med Inform Assoc 2013; 205: 954&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756263</ArticleId><ArticleId IdType="pubmed">23576672</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;hm R, Hehn L, von Herdegen T, et al. OpenVigil FDA&#x2014;Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications. PLoS One 2016; 116: e0157753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4915658</ArticleId><ArticleId IdType="pubmed">27326858</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans SJ, Waller PC, Davis S.. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 106: 483&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11828828</ArticleId></ArticleIdList></Reference><Reference><Citation>Porro GB, Pace F.. 5 Ulcerogenic drugs and upper gastrointestinal bleeding. Bailli&#xe8;res Clin Gastroenterol 1988; 22: 309&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">3044465</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggirala HJ, Tonning JM, Smith E, et al. Use of data mining at the food and drug administration. J Am Med Inform Assoc 2016; 232: 428&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">26209436</ArticleId></ArticleIdList></Reference><Reference><Citation>Wattenberg M, Vi&#xe9;gas F, Johnson I.. How to use t-SNE effectively. Distill 2016; 1: e2.</Citation></Reference><Reference><Citation>Harpaz R, Odgers D, Gaskin G, et al. A time-indexed reference standard of adverse drug reactions. Sci Data 2014; 1: 140043..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306188</ArticleId><ArticleId IdType="pubmed">25632348</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Caster O, Juhlin K, et al. Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf 2014; 379: 655&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, Shah NH.. Comment on: &#x201c;Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance&#x201d;. Drug Saf 2015; 381: 113&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4706737</ArticleId><ArticleId IdType="pubmed">25432779</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, Schuemie M, et al. Toward multimodal signal detection of adverse drug reactions. J Biomed Inform 2017; doi:10.1016/j.jbi.2017.10.013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8502488</ArticleId><ArticleId IdType="pubmed">29081385</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30016814</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2511-705X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>S 01</Issue><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Methods of information in medicine</Title><ISOAbbreviation>Methods Inf Med</ISOAbbreviation></Journal><ArticleTitle>MIRACUM: Medical Informatics in Research and Care in University Medicine.</ArticleTitle><Pagination><StartPage>e82</StartPage><EndPage>e91</EndPage><MedlinePgn>e82-e91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3414/ME17-02-0025</ELocationID><Abstract><AbstractText Label="INTRODUCTION">This article is part of the Focus Theme of Methods of Information in Medicine on the German Medical Informatics Initiative. Similar to other large international data sharing networks (e.g. OHDSI, PCORnet, eMerge, RD-Connect) MIRACUM is a consortium of academic and hospital partners as well as one industrial partner in eight German cities which have joined forces to create interoperable data integration centres (DIC) and make data within those DIC available for innovative new IT solutions in patient care and medical research.</AbstractText><AbstractText Label="OBJECTIVES">Sharing data shall be supported by common interoperable tools and services, in order to leverage the power of such data for biomedical discovery and moving towards a learning health system. This paper aims at illustrating the major building blocks and concepts which MIRACUM will apply to achieve this goal.</AbstractText><AbstractText Label="GOVERNANCE AND POLICIES">Besides establishing an efficient governance structure within the MIRACUM consortium (based on the steering board, a central administrative office, the general MIRACUM assembly, six working groups and the international scientific advisory board), defining DIC governance rules and data sharing policies, as well as establishing (at each MIRACUM DIC site, but also for MIRACUM in total) use and access committees are major building blocks for the success of such an endeavor.</AbstractText><AbstractText Label="ARCHITECTURAL FRAMEWORK AND METHODOLOGY">The MIRACUM DIC architecture builds on a comprehensive ecosystem of reusable open source tools (MIRACOLIX), which are linkable and interoperable amongst each other, but also with the existing software environment of the MIRACUM hospitals. Efficient data protection measures, considering patient consent, data harmonization and a MIRACUM metadata repository as well as a common data model are major pillars of this framework. The methodological approach for shared data usage relies on a federated querying and analysis concept.</AbstractText><AbstractText Label="USE CASES">MIRACUM aims at proving the value of their DIC with three use cases: IT support for patient recruitment into clinical trials, the development and routine care implementation of a clinico-molecular predictive knowledge tool, and molecular-guided therapy recommendations in molecular tumor boards.</AbstractText><AbstractText Label="RESULTS">Based on the MIRACUM DIC release in the nine months conceptual phase first large scale analysis for stroke and colorectal cancer cohorts have been pursued.</AbstractText><AbstractText Label="DISCUSSION">Beyond all technological challenges successfully applying the MIRACUM tools for the enrichment of our knowledge about diagnostic and therapeutic concepts, thus supporting the concept of a Learning Health System will be crucial for the acceptance and sustainability in the medical community and the MIRACUM university hospitals.</AbstractText><CopyrightInformation>Schattauer GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials></Author><Author ValidYN="Y"><LastName>Acker</LastName><ForeName>Till</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bernarding</LastName><ForeName>Johannes</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Binder</LastName><ForeName>Harald</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Boeker</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Boerries</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Daumke</LastName><ForeName>Philipp</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ganslandt</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hesser</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>H&#xf6;ning</LastName><ForeName>Gunther</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Neumaier</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Marquardt</LastName><ForeName>Kurt</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Renz</LastName><ForeName>Harald</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Rothk&#xf6;tter</LastName><ForeName>Hermann-Josef</ForeName><Initials>HJ</Initials></Author><Author ValidYN="Y"><LastName>Schade-Brittinger</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Schm&#xfc;cker</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Sch&#xfc;ttler</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Serve</LastName><ForeName>Hubert</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Sohrabi</LastName><ForeName>Keywan</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Storf</LastName><ForeName>Holger</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>German Federal Ministry of Education and Research (BMBF)</GrantID><Agency>FKZ 01ZZ1606A-H</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Methods Inf Med</MedlineTA><NlmUniqueID>0210453</NlmUniqueID><ISSNLinking>0026-1270</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054976" MajorTopicYN="N">Clinical Governance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="Y">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="Y">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057766" MajorTopicYN="N">Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057386" MajorTopicYN="N">Search Engine</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30016814</ArticleId><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="doi">10.3414/ME17-02-0025</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meystre SM, Lovis C, B&#xfc;rkle T, Tognola G, Budrionis A, Lehmann CU. Clinical Data Reuse or Secondary Use: Current Status and Potential Future Progress. Yearb Med Inform. 2017;26(01):38&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239225</ArticleId><ArticleId IdType="pubmed">28480475</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, Banda JM, Reich CG, Schilling LM, Matheny ME, Meeker D, Pratt N, Madigan D. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li YC, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins FS, Hudson KL, Briggs JP, Lauer MS. PCORnet: turning a dream into reality. J Am Med Inform Assoc. 2014;21(04):576&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078299</ArticleId><ArticleId IdType="pubmed">24821744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(04):578&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>beMERGE Network . Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, B&#xf6;ttinger EP, Williams MS. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013;15(10):761&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Gainotti S, Torreri P, Wang CM, Reihs R, Mueller H, Heslop E, Roos M, Badowska DM, de Paulis F, Kodra Y, Carta C, Mart&#xec;n EL, Miller VR, Filocamo M, Mora M, Thompson M, Rubinstein Y, Posada de la Paz M, Monaco L, Lochm&#xfc;ller H, Taruscio D.The RD-Connect Registry &amp; Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers. Eur J Hum Genet 2018. Forthcoming. doi:10.1038/s41431&#x2013;017&#x2013;0085-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5945774</ArticleId><ArticleId IdType="pubmed">29396563</ArticleId></ArticleIdList></Reference><Reference><Citation>Biobanking and Biomolecular Resources Infrastructure &#x2013;European Research Infrastructure Consortium[cited 2018 Mar 28]. Available from:http://www.bbmri-eric.eu/</Citation></Reference><Reference><Citation>ELIXIR: A distributed infrastructure for lifescience information[cited 2018 Mar 28]. Available from:https://www.elixir-europe.org/</Citation></Reference><Reference><Citation>other founding members of DTL Data (see Acknowledgements) . Eijssen L, Evelo C, Kok R, Mons B, Hooft R. The Dutch Techcentre for Life Sciences: Enabling data-intensive life science research in the Netherlands. Version 2. F1000Res. 2015;04:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4743138</ArticleId><ArticleId IdType="pubmed">26913186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, Blomberg N, Boiten JW, da Silva Santos LB, Bourne PE, Bouwman J, Brookes AJ, Clark T, Crosas M, Dillo I, Dumon O, Edmunds S, Evelo CT, Finkers R, Gonzalez-Beltran A, Gray AJ, Groth P, Goble C, Grethe JS, Heringa J, tHoen PA, Hooft R, Kuhn T, Kok R, Kok J, Lusher SJ, Martone ME, Mons A, Packer AL, Persson B, Rocca-Serra P, Roos M, van Schaik R, Sansone SA, Schultes E, Sengstag T, Slater T, Strawn G, Swertz MA, Thompson M, van der Lei J, van Mulligen E, Velterop J, Waagmeester A, Wittenburg P, Wolstencroft K, Zhao J, Mons B. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;03:160018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler SC, Wissing F, Heyder R.German Medical Informatics Initiative: A national approach to integrating health data from patient care and medical research Methods Inf Med 201857(Open):e50&#x2013;e56..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>MIRACUM (Medical Informatics for Research and Care in University Medicine)[cited 2018 Mar 28]. Available from:http://www.miracum.org/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="pubmed">30016814</ArticleId></ArticleIdList></Reference><Reference><Citation>Pommerening K, Drepper J, Helbing K, Ganslandt T. Berlin: Medizinische Wissenschaftliche Verlagsgesellschaft; 2014. Leitfaden zum Datenschutz in medizinischen Forschungsprojekten. TMF Schriftenreihe.</Citation></Reference><Reference><Citation>Christoph J, Griebel L, Leb I, Engel I, K&#xf6;pcke F, Toddenroth D, Prokosch HU, Laufer J, Marquardt K, Sedlmayr M. Secure Secondary Use of Clinical Data with Cloud-based NLP Services. Towards a Highly Scalable Research Infrastructure. Methods Inf Med. 2015;54(03):276&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">25377309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialke M, Bahls T, Havemann C, Piegsa J, Weitmann K, Wegner T, Hoffmann W. MOSAIC &#x2013; A Modular Approach to Data Management in Epidemiological Studies. Methods Inf Med. 2015;54(04):364&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">26196494</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010;17(02):124&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohane IS, Churchill SE, Murphy SN. A translational engine at the national scale: informatics for integrating biology and the bedside. J Am Med Inform Assoc. 2012;19(02):181&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277623</ArticleId><ArticleId IdType="pubmed">22081225</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheufele E, Aronzon D, Coopersmith R, McDuffie MT, Kapoor M, Uhrich CA, Avitabile JE, Liu J, Housman D, Palchuk MB. tranSMART: An Open Source Knowledge Management and High Content Data Analytics Platform. AMIA Jt Summits Transl Sci Proc. 2014;2014:96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333702</ArticleId><ArticleId IdType="pubmed">25717408</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoph J, Knell C, Naschberger E, St&#xfc;rzl M, Maier C, Prokosch HU, Sedlmayr M. Two years of tranSMART in a university hospital for translational research and education. Stud Health Technol Inform. 2017;236:70&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">28508781</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoph J, Knell C, Bosserhoff A, Naschberger E, St&#xfc;rzl M, R&#xfc;bner M, Seuss H, Ruh M, Prokosch HU, Sedlmayr B. Usability and Suitability of the Omics-Integrating Analysis Platform tranSMART for Translational Research and Education. ACI. 2017;08(04):1173&#x2013;1183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5802312</ArticleId><ArticleId IdType="pubmed">29270954</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus DS, Archie KA, Olsen TR, Ramaratnam M. The open-source neuroimaging research enterprise. J Digit Imaging. 2007;20 01:130&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2039786</ArticleId><ArticleId IdType="pubmed">17710494</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrick R, Horton W, Olsen T, McKay M, Archie KA, Marcus DS.XNAT Central: Open sourcing imaging research data NeuroImage 2016124Part B:1093&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4965359</ArticleId><ArticleId IdType="pubmed">26143202</ArticleId></ArticleIdList></Reference><Reference><Citation>He S, Yong M, Matthews PM, Guo Y. tranSMARTXNAT Connector tranSMART-XNAT connector &#x2013; image selection based on clinical phenotypes and genetic profiles. Bioinformatics. 2016. p. btw714..</Citation><ArticleIdList><ArticleId IdType="pubmed">28025201</ArticleId></ArticleIdList></Reference><Reference><Citation>Doiron D, Burton P, Marcon Y, Gaye A, Wolffenbuttel BH, Perola M, Stolk RP, Foco L, Minelli C, Waldenberger M, Holle R, Kval&#xf8;y K, Hillege HL, Tass&#xe9; AM, Ferretti V, Fortier I. Data harmonization and federated analysis of population-based studies: the BioSHaRE project. Emerg Themes Epidemiol. 2013;10(01):12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4175511</ArticleId><ArticleId IdType="pubmed">24257327</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L&#x2019;Heureux F, Deschenes M, Knoppers BM, Doiron D, Keers JC, Linksted P, Harris JR, Lachance G, Boileau C, Pedersen NL, Hamilton CM, Hveem K, Borugian MJ, Gallagher RP, McLaughlin J, Parker L, Potter JD, Gallacher J, Kaaks R, Liu B, Sprosen T, Vilain A, Atkinson SA, Rengifo A, Morton R, Metspalu A, Wichmann HE, Tremblay M, Chisholm RL, Garcia-Montero A, Hillege H, Litton JE, Palmer LJ, Perola M, Wolffenbuttel BH, Peltonen L, Hudson TJ. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol. 2010;39(05):1383&#x2013;1393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2972444</ArticleId><ArticleId IdType="pubmed">20813861</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe D, Costanzo M, Fey P, Gojobori T, Hannick L, Hide W, Hill DP, Kania R, Schaeffer M, St Pierre S.Big data: the future of biocuration Nature 2008455(7209):47&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819144</ArticleId><ArticleId IdType="pubmed">18769432</ArticleId></ArticleIdList></Reference><Reference><Citation>Spjuth O, Krestyaninova M, Hastings J, Shen HY, Heikkinen J, Waldenberger M, Langhammer A, Ladenvall C, Esko T, Persson M&#xc5;, Heggland J, Dietrich J, Ose S, Gieger C, Ried JS, Peters A, Fortier I, de Geus EJ, Klovins J, Zaharenko L, Willemsen G, Hottenga JJ, Litton JE, Karvanen J, Boomsma DI, Groop L, Rung J, Palmgren J, Pedersen NL, McCarthy MI, van Duijn CM, Hveem K, Metspalu A, Ripatti S, Prokopenko I, Harris JR. Harmonising and linking biomedical and clinical data across disparate data archives to enable integrative cross-biobank research. Eur J Hum Genet. 2016;24(04):521&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929882</ArticleId><ArticleId IdType="pubmed">26306643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadioglu D, Weingardt P, &#xdc;ckert F, Wagner T.Samply.MDR &#x2013; Ein Open-Source-Metadaten-Repository. HEC 2016: Health &#x2013; Exploring Complexity Joint Conference of GMDS, DGEpi, IEA-EEF, EFMI; M&#xfc;nchen: 28.08.-02.09.2016. D&#xfc;sseldorf: German Medical Science GMS Publishing House;2016. DocAbstr. 425.</Citation></Reference><Reference><Citation>Lablans M, Kadioglu D, Muscholl M, &#xdc;ckert F. Exploiting Distributed, Heterogeneous and Sensitive Data Stocks while Maintaining the Owner&#x2019;s Data Sovereignty. Methods Inf Med. 2015;54(04):346&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">26196653</ArticleId></ArticleIdList></Reference><Reference><Citation>Storf H, Schaaf J, Kadioglu D, G&#xf6;bel J, Wagner TOF, &#xdc;ckert F.[Registries for rare diseases: OSSE &#x2013; An open-source framework for technical implementation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2017. Mar 13. doi: 10.1007/s00103&#x2013;017&#x2013;2536&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28289778</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>MIRACUM Metadata Repository. M-MDR[cited 2018 Mar 28]. Available from:http://mdr.miracum.de/</Citation></Reference><Reference><Citation>Mate S, Kadioglu D, Majeed RW, St&#xf6;hr MR, Folz M, Vormstein P, Storf H, Brucker DP, Keune D, Zerbe N, Hummel M, Senghas K, Prokosch HU, Lablans M. Proof-of-Concept Integration of Heterogeneous Biobank IT Infrastructures into a Hybrid Biobanking Network. Stud Health Technol Inform. 2017;243:100&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">28883179</ArticleId></ArticleIdList></Reference><Reference><Citation>Mate S, Vormstein P, Kadioglu D, Majeed RW, Lablans M, Prokosch HU, Storf H. On-The-Fly Query Translation Between i2b2 and Samply in the German Biobank Node (GBN) Prototypes. Stud Health Technol Inform. 2017;243:42&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">28883167</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, Minion J, Boyd AW, Newby CJ, Nuotio ML, Wilson R, Butters O, Murtagh B, Demir I, Doiron D, Giepmans L, Wallace SE, Budin-Lj&#xf8;sne I, Oliver Schmidt C, Boffetta P, Boniol M, Bota M, Carter KW, deKlerk N, Dibben C, Francis RW, Hiekkalinna T, Hveem K, Kval&#xf8;y K, Millar S, Perry IJ, Peters A, Phillips CM, Popham F, Raab G, Reischl E, Sheehan N, Waldenberger M, Perola M, van den Heuvel E, Macleod J, Knoppers BM, Stolk RP, Fortier I, Harris JR, Woffenbuttel BH, Murtagh MJ, Ferretti V, Burton PR. DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. 2014;43(06):1929&#x2013;1944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276062</ArticleId><ArticleId IdType="pubmed">25261970</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuggia M, Besana P, Glasspool D. Comparing semi-automatic systems for recruitment of patients to clinical trials. Int J Med Inform. 2011;80(06):371&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">21459664</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilts DM, Sandler AB. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol. 2006;24:4545&#x2013;4552.</Citation><ArticleIdList><ArticleId IdType="pubmed">17008693</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell MK, Snowdon C, Francis Det al.Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study Health Technol Assess 200711iii,ix&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">17999843</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinczek B, K&#xf6;pcke F, Leusch T, Majeed RW, Schreiweis B, Wenk J, Bergh B, Ohmann C, R&#xf6;hrig R, Prokosch HU, Dugas M. Design and multicentric implementation of a generic software architecture for patient recruitment systems re-using existing HIS tools and routine patient data. Appl Clin Inform. 2014;05(01):264&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3974260</ArticleId><ArticleId IdType="pubmed">24734138</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiweis B, Trinczek B, K&#xf6;pcke F, Leusch T, Majeed RW, Wenk J, Bergh B, Ohmann C, R&#xf6;hrig R, Dugas M, Prokosch HU. Comparison of electronic health record system functionalities to support the patient recruitment process in clinical trials. Int J Med Inform. 2014;83(11):860&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pubmed">25189709</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;pcke F, Trinczek B, Majeed RW, Schreiweis B, Wenk J, Leusch T, Ganslandt T, Ohmann C, Bergh B, R&#xf6;hrig R, Dugas M, Prokosch HU. Evaluation of data completeness in the electronic health record for the purpose of patient recruitment into clinical trials: a retrospective analysis of element presence. BMC Med Inform Decis Mak. 2013;13:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3606452</ArticleId><ArticleId IdType="pubmed">23514203</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moor G, Sundgren M, Kalra D, Schmidt A, Dugas M, Claerhout B, Karakoyun T, Ohmann C, Lastic PY, Ammour N, Kush R, Dupont D, Cuggia M, Daniel C, Thienpont G, Coorevits P. Using electronic health records for clinical research: the case of the EHR4CR project. J Biomed Inform. 2015;53:162&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">25463966</ArticleId></ArticleIdList></Reference><Reference><Citation>Doods J, Lafitte C, Ulliac-Sagnes N, Proeve J, Botteri F, Walls R, Sykes A, Dugas M, Fritz F. A European inventory of data elements for patient recruitment. Stud Health Technol Inform. 2015;210:506&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">25991199</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalilia M, Choi M, Henderson A, Iyengar S, Braunstein M, Sun J. Clinical Predictive Modeling Development and Deployment through FHIR Web Services. AMIA Annu Symp Proc. 2015;2015:717&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765683</ArticleId><ArticleId IdType="pubmed">26958207</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinderer M, Boeker M, Wagner SA, Binder H, &#xdc;ckert F, H&#xfc;lsemann JL, Neumaier M, Schade-Brittinger C, Acker T, Prokosch HU, Sedlmayr B. The experience of physicians in pharmacogenomic clinical decision support within eight German University Hospitals. Pharmacogenomics. 2017;18(08):773&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pubmed">28593816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinderer M, B&#xf6;rries M, Haller F, Wagner S, Sollfrank S, Acker T, Prokosch HU, Christoph J. Supporting Molecular Tumor Boards in Molecularguided Decision-making &#x2013; the Current Status of Five German University Hospitals. Stud Health Technol Inform. 2017;236:48&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">28508778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinderer M, Boeker M, Wagner SA, Lablans M, Newe S, H&#xfc;lsemann JL, Neumaier M, Binder H, Renz H, Acker T, Prokosch HU, Sedlmayr M. Integrating clinical decision support systems for pharmacogenomic testing into clinical routine &#x2013; a scoping review of designs of user-system interactions in recent system development. BMC Med Inform Decis Mak. 2017;17(01):81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5461630</ArticleId><ArticleId IdType="pubmed">28587608</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016;23(05):909&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Haverkamp C, Gansland T, Horki P, Boeker M, D&#xf6;rfler A, Schwab S, Berkefeld J, Pfeilschifter W, Niesen W-D, Egger K, Kaps M, Brockmann MA, Neumaier-Probst E, Szabo K, Skalej M, Bien S, Best C, Prokosch U, Urbach H. Regional differences in thrombectomy rates: secondary use of billing codes in the MIRACUM (Medical Informatics for Research and Care in University Medicine) Consortium. Clin Neuroradiol. 2018;28(02):225&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">29313057</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, Herrmann T, Haverkamp C, Horki P, Laufer J, Berger F, H&#xf6;ning G, Fritsch HW, Sch&#xfc;ttler J, Ganslandt T, Prokosch HU, Sedlmayr M. Towards implementation of OMOP in a German university hospital consortium. Appl Clin Inform. 2018;09(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Available from:http://www.medizininformatikinitiative.de/de/konsortien/hd4cr-konzeptphase[cited 2018 Mar 22].</Citation></Reference><Reference><Citation>Prasser F, Kohlmayer F, Lautenschl&#xe4;ger R, Kuhn KA. ARX &#x2013; A Comprehensive Tool for Anonymizing Biomedical Data. AMIA Annu Symp Proc. 2014;2014:984&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419984</ArticleId><ArticleId IdType="pubmed">25954407</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasser F, Kohlmayer F, Kuhn KA. Efficient and effective pruning strategies for health data de-identification. BMC Medical Informatics and Decision Making. 2016;16:49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4851781</ArticleId><ArticleId IdType="pubmed">27130179</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C, Rubin J, Brown J, Buntin M, Corn M, Etheredge L, Gunter C, Musen M, Platt R, Stead W, Sullivan K, Van Houweling D. Toward a science of learning systems: a research agenda for the highfunctioning Learning Health System. J Am Med Inform Assoc. 2015;22(01):43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433378</ArticleId><ArticleId IdType="pubmed">25342177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30082302</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-2962</ISSN><JournalIssue CitedMedium="Internet"><Volume>376</Volume><Issue>2128</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Philosophical transactions. Series A, Mathematical, physical, and engineering sciences</Title><ISOAbbreviation>Philos Trans A Math Phys Eng Sci</ISOAbbreviation></Journal><ArticleTitle>Improving reproducibility by using high-throughput observational studies with empirical calibration.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">20170356</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1098/rsta.2017.0356</ELocationID><Abstract><AbstractText>Concerns over reproducibility in science extend to research using existing healthcare data; many observational studies investigating the same topic produce conflicting results, even when using the same data. To address this problem, we propose a paradigm shift. The current paradigm centres on generating one estimate at a time using a unique study design with unknown reliability and publishing (or not) one estimate at a time. The new paradigm advocates for high-throughput observational studies using consistent and standardized methods, allowing evaluation, calibration and unbiased dissemination to generate a more reliable and complete evidence base. We demonstrate this new paradigm by comparing all depression treatments for a set of outcomes, producing 17&#x2009;718 hazard ratios, each using methodology on par with current best practice. We furthermore include control hypotheses to evaluate and calibrate our evidence generation process. Results show good transitivity and consistency between databases, and agree with four out of the five findings from clinical trials. The distribution of effect size estimates reported in the literature reveals an absence of small or null effects, with a sharp cut-off at <i>p</i>&#x2009;=&#x2009;0.05. No such phenomena were observed in our results, suggesting more complete and more reliable evidence.This article is part of a discussion meeting issue 'The growing ubiquity of algorithms in society: implications, impacts and innovations'.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA schuemie@ohdsi.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, NY 10027, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los&#xa0;Angeles, CA 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los&#xa0;Angeles, CA 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los&#xa0;Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Philos Trans A Math Phys Eng Sci</MedlineTA><NlmUniqueID>101133385</NlmUniqueID><ISSNLinking>1364-503X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">medicine</Keyword><Keyword MajorTopicYN="N">observational research</Keyword><Keyword MajorTopicYN="N">publication bias</Keyword><Keyword MajorTopicYN="N">reproducibility</Keyword></KeywordList><CoiStatement>We declare we have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30082302</ArticleId><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="doi">10.1098/rsta.2017.0356</ArticleId><ArticleId IdType="pii">rsta.2017.0356</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baker M. 2016. 1,500 scientists lift the lid on reproducibility. Nature 533, 452&#x2013;454. (10.1038/533452a)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/533452a</ArticleId><ArticleId IdType="pubmed">27225100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JP. 2005. Why most published research findings are false. PLoS Med. 2, e124 (10.1371/journal.pmed.0020124)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020124</ArticleId><ArticleId IdType="pmc">PMC1182327</ArticleId><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Munaf&#xf2; MR, et al. 2017. A manifesto for reproducible science. Nat. Hum. Behav. 1, 0021 (10.1038/s41562-016-0021)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-016-0021</ArticleId><ArticleId IdType="pmc">PMC7610724</ArticleId><ArticleId IdType="pubmed">33954258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal-R&#xe9; R, Ioannidis JP, Bracken MB, Buffler PA, Chan A-W, Franco EL, La Vecchia C, Weiderpass E. 2014. Making prospective registration of observational research a reality. Sci. Transl. Med. 6, 224cm1 (10.1126/scitranslmed.3007513)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007513</ArticleId><ArticleId IdType="pubmed">24553383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, et al. 2016. Characterizing treatment pathways at scale using the OHDSI network. Proc. Natl Acad. Sci. USA 113, 7329&#x2013;7336. (10.1073/pnas.1510502113)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. et al. 2018. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc. Natl Acad. Sci. USA 9, 201708282 (10.1073/pnas.1708282114)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. 2017. WHO fact sheet: depression.</Citation></Reference><Reference><Citation>Hernan MA, Robins JM. 2016. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758&#x2013;764. (10.1093/aje/kwv254)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv254</ArticleId><ArticleId IdType="pmc">PMC4832051</ArticleId><ArticleId IdType="pubmed">26994063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. 1983. The central role of the propensity score in observational studies for causal effects. Biometrika 70, 41&#x2013;55. (10.1093/biomet/70.1.41)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. 2013. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans. Model. Comput. Simul. 23, 1&#x2013;17. (10.1145/2414416.2414791)</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. 2016. Accuracy of an automated knowledge base for identifying drug adverse reactions. J. Biomed. Inform. 66, 72&#x2013;81. (10.1016/j.jbi.2016.12.005)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.12.005</ArticleId><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Avillach P, et al. 2013. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project. J. Am. Med. Inform. Assoc. 20, 446&#x2013;452. (10.1136/amiajnl-2012-001083)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-001083</ArticleId><ArticleId IdType="pmc">PMC3628051</ArticleId><ArticleId IdType="pubmed">23195749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilicoglu H, Rosemblat G, Fiszman M, Rindflesch TC. 2011. Constructing a semantic predication gold standard from the biomedical literature. BMC Bioinformatics 12, 486 (10.1186/1471-2105-12-486)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-486</ArticleId><ArticleId IdType="pmc">PMC3281188</ArticleId><ArticleId IdType="pubmed">22185221</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food &amp; Drug Administration. 2016. 
FDA adverse event reporting system (FAERS). cited 2016; See http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/</Citation></Reference><Reference><Citation>Duke J, Friedlin J, Li X. 2013. Consistency in the safety labeling of bioequivalent medications. Pharmacoepidemiol. Drug Saf. 22, 294&#x2013;301. (10.1002/pds.3351)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3351</ArticleId><ArticleId IdType="pubmed">23042584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski AF, et al. 2016. Good signal detection practices: evidence from IMI PROTECT. Drug Saf. 39, 469&#x2013;490. (10.1007/s40264-016-0405-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-016-0405-1</ArticleId><ArticleId IdType="pmc">PMC4871909</ArticleId><ArticleId IdType="pubmed">26951233</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren GN, Caster O, Juhlin K, Lindquist M. 2014. Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. 37, 655&#x2013;659. (10.1007/s40264-014-0198-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0198-z</ArticleId><ArticleId IdType="pubmed">25005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YC, Lin C-H, Lin M-S, Lu Y, Chang C-H, Lin J-W. 2016. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events. J. Clin. Psychiatry 77, e1&#x2013;e7. (10.4088/JCP.14m09394)</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.14m09394</ArticleId><ArticleId IdType="pubmed">26845272</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, et al. 2017. Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia 58, e101&#x2013;e106. (10.1111/epi.13828)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13828</ArticleId><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramcharran D, Qiu H, Schuemie MJ, Ryan PB. 2017. Atypical antipsychotics and the risk of falls and fractures among older adults: an emulation analysis and an evaluation of additional confounding control strategies. J. Clin. Psychopharmacol. 37, 162&#x2013;168. (10.1097/JCP.0000000000000647)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0000000000000647</ArticleId><ArticleId IdType="pubmed">28225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Desai M, Ryan PB, Defalco FJ, Schuemie MJ, Stang PE, Berlin JA, Yuan Z. 2017. Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents. Diabetes Res. Clin. Pract. 128, 83&#x2013;90. (10.1016/j.diabres.2017.04.004)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2017.04.004</ArticleId><ArticleId IdType="pubmed">28448895</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, Dumouchel W, Berlin JA. 2013. Evaluating the impact of database heterogeneity on observational study results. Am. J. Epidemiol. 178, 645&#x2013;651. (10.1093/aje/kwt010)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt010</ArticleId><ArticleId IdType="pmc">PMC3736754</ArticleId><ArticleId IdType="pubmed">23648805</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ 327, 557&#x2013;560. (10.1136/bmj.327.7414.557)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gartlehner G, et al. 2008. Drug class review: second generation antidepressants. Final report update 4. Portland, OR: Oregon Health &amp; Science University.</Citation></Reference><Reference><Citation>Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C. 2010. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst. Rev. 4, CD006117 (10.1002/14651858.CD006117)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006117</ArticleId><ArticleId IdType="pmc">PMC4163971</ArticleId><ArticleId IdType="pubmed">20393946</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelenberg AJ, et al. 2010. Practice guideline for the treatment of patients with major depressive disorder third edition. Am. J. Psychiatry 167, 1 (10.1176/appi.ajp.2009.09111601)</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2009.09111601</ArticleId><ArticleId IdType="pubmed">10767867</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG. 1993. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J. Clin. Psychiatry 54, 459&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">8276736</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Dumouchel W, Suchard MA, Madigan D. 2014. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat. Med. 33, 209&#x2013;218. (10.1002/sim.5925)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardwell CR, Abnet CC, Cantwell MM, Murray LJ. 2010. Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA 304, 657&#x2013;663. (10.1001/jama.2010.1098)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1098</ArticleId><ArticleId IdType="pmc">PMC3513370</ArticleId><ArticleId IdType="pubmed">20699457</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries F, De Vries C, Cooper C, Leufkens B, Van Staa T-P. 2006. Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the general practice research database. Int. J. Epidemiol. 35, 1301&#x2013;1308. (10.1093/ije/dyl147)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyl147</ArticleId><ArticleId IdType="pubmed">17053011</ArticleId></ArticleIdList></Reference><Reference><Citation>Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. 2010. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ 341, c4444 (10.1136/bmj.c4444)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c4444</ArticleId><ArticleId IdType="pmc">PMC2933354</ArticleId><ArticleId IdType="pubmed">20813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Grodstein F, Stampfer MJ, Manson JAE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. 1996. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl. J. Med. 335, 453&#x2013;461. (10.1056/NEJM199608153350701)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199608153350701</ArticleId><ArticleId IdType="pubmed">8672166</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JE, et al. 2003. Estrogen plus progestin and the risk of coronary heart disease. N Engl. J. Med. 349, 523&#x2013;534. (10.1056/NEJMoa030808)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa030808</ArticleId><ArticleId IdType="pubmed">12904517</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayes LC, Horwitz RI, Feinstein AR. 1988. A collection of 56 topics with contradictory results in case-control research. Int. J. Epidemiol. 17, 680&#x2013;685. (10.1093/ije/17.3.680)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/17.3.680</ArticleId><ArticleId IdType="pubmed">3272133</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. 2000. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283, 3205&#x2013;3210. (10.1001/jama.283.24.3205)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.24.3205</ArticleId><ArticleId IdType="pubmed">10866867</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa TP, Wegman S, de Vries F, Leufkens B, Cooper C. 2001. Use of statins and risk of fractures. JAMA 285, 1850&#x2013;1855. (10.1001/jama.285.14.1850)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.14.1850</ArticleId><ArticleId IdType="pubmed">11308398</ArticleId></ArticleIdList></Reference><Reference><Citation>Varas-Lorenzo C, Garc&#xed;a-Rodr&#xed;guez LA, Perez-Gutthann S, Duque-Oliart A. 2000. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation 101, 2572&#x2013;2578. (10.1161/01.CIR.101.22.2572)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.22.2572</ArticleId><ArticleId IdType="pubmed">10840007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson PW, Garrison RJ, Castelli WP. 1986. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham study. N Engl. J. Med. 313, 1038&#x2013;1043. (10.1056/NEJM198510243131702)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198510243131702</ArticleId><ArticleId IdType="pubmed">2995808</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A, Benjamin-Chung J, Colford JM.. 2016. Brief report: negative controls to detect selection bias and measurement bias in epidemiologic studies. Epidemiology 27, 637&#x2013;641. (10.1097/EDE.0000000000000504)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000504</ArticleId><ArticleId IdType="pmc">PMC4969055</ArticleId><ArticleId IdType="pubmed">27182642</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai JR, Hyde CL, Kabadi S, St Louis M, Bonato V, Katrina Loomis A, Galaznik A, Berger ML. 2017. Utilization of positive and negative controls to examine comorbid associations in observational database studies. Med. Care 55, 244&#x2013;251. (10.1097/MLR.0000000000000640)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000640</ArticleId><ArticleId IdType="pmc">PMC5318155</ArticleId><ArticleId IdType="pubmed">27787351</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrington CP. 1995. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 51, 228&#x2013;235. (10.2307/2533328)</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2533328</ArticleId><ArticleId IdType="pubmed">7766778</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30085008</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Web services for data warehouses: OMOP and PCORnet on i2b2.</ArticleTitle><Pagination><StartPage>1331</StartPage><EndPage>1338</EndPage><MedlinePgn>1331-1338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy093</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Healthcare organizations use research data models supported by projects and tools that interest them, which often means organizations must support the same data in multiple models. The healthcare research ecosystem would benefit if tools and projects could be adopted independently from the underlying data model. Here, we introduce the concept of a reusable application programming interface (API) for healthcare and show that the i2b2 API can be adapted to support diverse patient-centric data models.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We develop methodology for extending i2b2's pre-existing API to query additional data models, using i2b2's recent "multi-fact-table querying" feature. Our method involves developing data-model-specific i2b2 ontologies and mapping these to query non-standard table structure.</AbstractText><AbstractText Label="RESULTS">We implement this methodology to query OMOP and PCORnet models, which we validate with the i2b2 query tool. We implement the entire PCORnet data model and a five-domain subset of the OMOP model. We also demonstrate that additional, ancillary data model columns can be modeled and queried as i2b2 "modifiers."</AbstractText><AbstractText Label="DISCUSSION">i2b2's REST API can be used to query multiple healthcare data models, enabling shared tooling to have a choice of backend data stores. This enables separation between data model and software tooling for some of the more popular open analytic data models in healthcare.</AbstractText><AbstractText Label="CONCLUSION">This methodology immediately allows querying OMOP and PCORnet using the i2b2 API. It is released as an open-source set of Docker images, and also on the i2b2 community wiki.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Lori C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrick</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joss</LastName><ForeName>Matthew A H</ForeName><Initials>MAH</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagholikar</LastName><ForeName>Kavishwar B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 LM011575</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG007963</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009174</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="Y">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="N">Data Warehousing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="N">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30085008</ArticleId><ArticleId IdType="pmc">PMC6188504</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy093</ArticleId><ArticleId IdType="pii">5061849</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>OHDSI | Observational Health Data Sciences and Informatics. http://www.ohdsi.org/ Accessed July 29, 2015.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI. resources: data_network. Observational Health Data Sciences and Informatics. http://www.ohdsi.org/web/wiki/doku.php?id=resources: data_network Accessed April 18, 2018.</Citation></Reference><Reference><Citation>
All of Us Research Program. National Institutes of Health (NIH). https://allofus.nih.gov/ Accessed March 6, 2017.</Citation></Reference><Reference><Citation>Collins FS, Hudson KL, Briggs JP, et al. PCORnet: turning a dream into reality. J Am Med Inform Assoc 2014; 214: 576&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078299</ArticleId><ArticleId IdType="pubmed">24821744</ArticleId></ArticleIdList></Reference><Reference><Citation>PCORnet Common Data Model (CDM). PCORnet. http://www.pcornet.org/pcornet-common-data-model/ Accessed March 6, 2017.</Citation></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, et al. Serving the enterprise and beyond with Informatics for Integrating Biology and the Bedside (i2b2). J Am Med Inform Assoc 2010; 172: 124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurry AJ, Murphy SN, MacFadden D, et al. SHRINE: enabling nationally scalable multi-site disease studies. PLoS One 2013; 83: e55811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591385</ArticleId><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>CTSA Consortium Tackling Clinical Trial Recruitment Roadblocks. National Center for Advancing Translational Sciences. 2015. https://ncats.nih.gov/pubs/features/ctsa-act Accessed September 21, 2016.</Citation></Reference><Reference><Citation>i2b2 Community Plugins. GitHub. https://github.com/i2b2plugins Accessed January 6, 2018.</Citation></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, et al. Data interchange using i2b2. J Am Med Inform Assoc 2016; 235: 909&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Mendis M, Hackett K, et al. Architecture of the Open-source Clinical Research Chart from Informatics for Integrating Biology and the Bedside. AMIA Annu Symp Proc 2007; 2007: 548&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2655844</ArticleId><ArticleId IdType="pubmed">18693896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagholikar KB, Mandel JC, Klann JG, et al. SMART-on-FHIR implemented over i2b2. J Am Med Inform Assoc 2017; 242: 398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391721</ArticleId><ArticleId IdType="pubmed">27274012</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Murphy SN.. Computing health quality measures using Informatics for Integrating Biology and the Bedside. J Med Internet Res 2013; 154: e75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3636801</ArticleId><ArticleId IdType="pubmed">23603227</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Mendis M, Phillips LC, et al. Taking advantage of continuity of care documents to populate a research repository. J Am Med Inform Assoc 2014; 22 (2): 370&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080729</ArticleId><ArticleId IdType="pubmed">25352566</ArticleId></ArticleIdList></Reference><Reference><Citation>Wattanasin N, Porter A, Ubaha S, et al. Apps to display patient data, making SMART available in the i2b2 platform. AMIA Annu Symp Proc 2012; 2012: 960&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540423</ArticleId><ArticleId IdType="pubmed">23304371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenneth Fisher. UNPIVOT a table using CROSS APPLY. SQL Studies. 2013. 
https://sqlstudies.com/2013/04/01/unpivot-a-table-using-cross-apply/ Accessed April 23, 2018.</Citation></Reference><Reference><Citation>unpivot and PostgreSQL - Stack Overflow. https://stackoverflow.com/questions/1128737/unpivot-and-postgresql Accessed April 23, 2018.</Citation></Reference><Reference><Citation>Accessible Research Commons for Health Github. GitHub. https://github.com/ARCH-commons Accessed March 6, 2017.</Citation></Reference><Reference><Citation>
Phillips L. NCBO Extraction Tool Version 2.0. NCBO Ontology Tools for i2b2. https://community.i2b2.org/wiki/display/NCBO/NCBO+Extraction+Tool+version+2.0 Accessed December 4, 2014.</Citation></Reference><Reference><Citation>CommonDataModel: Definition and DDLs for the OMOP Common Data Model (CDM). Observational Health Data Sciences and Informatics 2017. https://github.com/OHDSI/CommonDataModel Accessed December 22, 2017.</Citation></Reference><Reference><Citation>i2b2 on OMOP - Release 1.7.09. https://community.i2b2.org/wiki/display/OMOP/Release+1.7.09 Accessed November 15, 2017.</Citation></Reference><Reference><Citation>
Klann JG, Joss M. i2b2-on-PCORnet: Scripts and Documentation for Implementing. Accessible Research Commons for Health 2017. 
https://github.com/ARCH-commons/arch-utils/tree/master/i2b2_on_PCORnet Accessed January 4, 2018.</Citation></Reference><Reference><Citation>ETL-CMS: Workproducts to ETL CMS datasets into OMOP Common Data Model. Observational Health Data Sciences and Informatics 2017. 
https://github.com/OHDSI/ETL-CMS Accessed January 7, 2018.</Citation></Reference><Reference><Citation>
pcori/omop i2b2 demo. https://github.com/waghsk/i2b2-quickstart/wiki/pcori-demo Accessed November 15, 2017.</Citation></Reference><Reference><Citation>
Install dockerized i2b2 on PCORnet/OMOP. https://github.com/ARCH-commons/arch-utils/wiki/Install-dockerized-i2b2-on-PCORnet Accessed November 15, 2017.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30100761</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1349</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Clinical epidemiology</Title><ISOAbbreviation>Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges.</ArticleTitle><Pagination><StartPage>875</StartPage><EndPage>885</EndPage><MedlinePgn>875-885</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/CLEP.S149961</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The goal of the Asian Pharmacoepidemiology Network is to study the effectiveness and safety of medications commonly used in Asia using databases from individual Asian countries. An efficient infrastructure to support multinational pharmacoepidemiologic studies is critical to this effort.</AbstractText><AbstractText Label="STUDY DESIGN AND SETTING" NlmCategory="METHODS">We converted data from the Japan Medical Data Center database, Taiwan's National Health Insurance Research Database, Hong Kong's Clinical Data Analysis and Reporting System, South Korea's Ajou University School of Medicine database, and the US Medicare 5% sample to the Observational Medical Outcome Partnership common data model (CDM).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We completed and documented the process for the CDM conversion. The coordinating center and participating sites reviewed the documents and refined the conversions based on the comments. The time required to convert data to the CDM varied widely across sites and included conversion to standard terminology codes and refinements of the conversion based on reviews. We mapped 97.2%, 86.7%, 92.6%, and 80.1% of domestic drug codes from the USA, Taiwan, Hong Kong, and Korea to RxNorm, respectively. The mapping rate from Japanese domestic drug codes to RxNorm (70.7%) was lower than from other countries, and we mapped remaining unmapped drugs to Anatomical Therapeutic Chemical Classification System codes. Because the native databases used international procedure coding systems for which mapping tables have been established, we were able to map &gt;90% of diagnosis and procedure codes to standard terminology codes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The CDM established the foundation and reinforced collaboration for multinational pharmacoepidemiologic studies in Asia. Mapping of terminology codes was the greatest challenge, because of differences in health systems, cultures, and coding systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Edward Chia-Cheng</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Outcome Research Center, National Cheng-Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yinghong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>N Chantelle</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamijima</LastName><ForeName>Yukari</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>NPO Drug Safety Research Unit Japan, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Japan Medical Data Center Co.,Ltd, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubota</LastName><ForeName>Kiyoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NPO Drug Safety Research Unit Japan, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth Kc</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Soo Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, School of Medicine, Ajou University, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, School of Medicine, Ajou University, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stang</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Chien-Chou</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Outcome Research Center, National Cheng-Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ian Ck</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Yea-Huei Yang</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Outcome Research Center, National Cheng-Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Setoguchi</LastName><ForeName>Soko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Health, Rutgers University and Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Clin Epidemiol</MedlineTA><NlmUniqueID>101531700</NlmUniqueID><ISSNLinking>1179-1349</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical coding</Keyword><Keyword MajorTopicYN="N">computer communication networks</Keyword><Keyword MajorTopicYN="N">feasibility studies</Keyword><Keyword MajorTopicYN="N">pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword></KeywordList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30100761</ArticleId><ArticleId IdType="pmc">PMC6067778</ArticleId><ArticleId IdType="doi">10.2147/CLEP.S149961</ArticleId><ArticleId IdType="pii">clep-10-875</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lai E, Stang P, Kao Yang Y, Kubota K, Wong IC, Setoguchi S. International multi-database pharmacoepidemiology: potentials and pitfalls. Curr Epidemiol Rep. 2015;2(4):229&#x2013;238.</Citation></Reference><Reference><Citation>Lai EC, Man KK, Chaiyakunapruk N, et al. Databases in the Asia-Pacific Region: the potential for a distributed network approach. Epidemiology. 2015;26(6):815&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">26133022</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen M, Bergman U, Choi NK, et al. The Asian Pharmacoepidemiology Network (AsPEN): promoting multinational collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf. 2013;22(7):700&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">23653370</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt N, Andersen M, Bergman U, et al. Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiol Drug Saf. 2013;22(9):915&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">23696036</ArticleId></ArticleIdList></Reference><Reference><Citation>Roughead EE, Chan EW, Choi NK, et al. Variation in association between thiazolidinediones and heart failure across ethnic groups: retrospective analysis of large healthcare claims databases in six countries. Drug Saf. 2015;38(9):823&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561996</ArticleId><ArticleId IdType="pubmed">26216600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt N, Chan EW, Choi NK, et al. Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pharmacoepidemiol Drug Saf. 2015;24(8):858&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690514</ArticleId><ArticleId IdType="pubmed">25907076</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI [homepage on the Internet]  The Observational Health Data Sciences and Informatics. 2017.  [Accessed September 23, 2017].  Available from:  https://www.ohdsi.org/</Citation></Reference><Reference><Citation>homepage on the Internet Tawian National Health Insurance Administration. 2017.  [Accessed September 23, 2017].  Available from:  http://www.nhi.gov.tw/</Citation></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153(9):600&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, et al. A comparative assessment of Observational Medical Outcomes Partnership and Mini-Sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 2015;38(8):749&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, et al. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013;36(2):119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>National Library of Medicine [homepage on the Internet]  National Institutes of Health.  [Accessed September 23, 2017].  Available from:  http://www.nlm.nih.gov/</Citation></Reference><Reference><Citation>SNOMED [homepage on the Internet]  NOMED International.  [Accessed September 23, 2017].  Available from:  https://www.snomed.org/</Citation></Reference><Reference><Citation>WHO Collaborating Center for Drug Statistics Methodology [homepage on the Internet]  Anatomical Therapeutic Chemical (ATC) Classification System.  [Accessed August 11, 2016].  Available from:  http://www.whocc.no.</Citation></Reference><Reference><Citation>Hsieh SC, Lai JN, Lee CF, Hu FC, Tseng WL, Wang JD. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiol Drug Saf. 2008;17(6):609&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">18481335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012;31(30):4401&#x2013;4415.</Citation><ArticleIdList><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30172760</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Methodological variations in lagged regression for detecting physiologic drug effects in EHR data.</ArticleTitle><Pagination><StartPage>149</StartPage><EndPage>159</EndPage><MedlinePgn>149-159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2018.08.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(18)30173-4</ELocationID><Abstract><AbstractText>We studied how lagged linear regression can be used to detect the physiologic effects of drugs from data in the electronic health record (EHR). We systematically examined the effect of methodological variations ((i) time series construction, (ii) temporal parameterization, (iii) intra-subject normalization, (iv) differencing (lagged rates of change achieved by taking differences between consecutive measurements), (v) explanatory variables, and (vi) regression models) on performance of lagged linear methods in this context. We generated two gold standards (one knowledge-base derived, one expert-curated) for expected pairwise relationships between 7 drugs and 4 labs, and evaluated how the 64 unique combinations of methodological perturbations reproduce the gold standards. Our 28 cohorts included patients in the Columbia University Medical Center/NewYork-Presbyterian Hospital clinical database, and ranged from 2820 to 79,514 patients with between 8 and 209 average time points per patient. The most accurate methods achieved AUROC of 0.794 for knowledge-base derived gold standard (95%CI [0.741, 0.847]) and 0.705 for expert-curated gold standard (95% CI [0.629, 0.781]). We observed a mean AUROC of 0.633 (95%CI [0.610, 0.657], expert-curated gold standard) across all methods that re-parameterize time according to sequence and use either a joint autoregressive model with time-series differencing or an independent lag model without differencing. The complement of this set of methods achieved a mean AUROC close to 0.5, indicating the importance of these choices. We conclude that time-series analysis of EHR data will likely rely on some of the beneficial pre-processing and modeling methodologies identified, and will certainly benefit from continued careful analysis of methodological perturbations. This study found that methodological variations, such as pre-processing and representations, have a large effect on results, exposing the importance of thoroughly evaluating these components when comparing machine-learning methods.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, 622 W. 168th Street, Presbyterian Building 20th Floor, New York, NY 10032, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States. Electronic address: mel2193@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, 622 W. 168th Street, Presbyterian Building 20th Floor, New York, NY 10032, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, 622 W. 168th Street, Presbyterian Building 20th Floor, New York, NY 10032, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States; NewYork-Presbyterian Hospital, 622 W. 168th Street, New York, NY 10032, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004358" MajorTopicYN="N">Drug Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009519" MajorTopicYN="N" Type="Geographic">New York City</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30172760</ArticleId><ArticleId IdType="mid">NIHMS1507969</ArticleId><ArticleId IdType="pmc">PMC6207533</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2018.08.014</ArticleId><ArticleId IdType="pii">S1532-0464(18)30173-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G and Albers DJ, &#x201c;Next-generation phenotyping of electronic health records,&#x201d; Journal of the American Medical Informatics Association, vol. 20, no. 1, pp. 117&#x2013;121, Jan. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G et al., &#x201c;Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers,&#x201d; Stud Health Technol Inform, vol. 216, pp. 574&#x2013;578, 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates DW, Evans RS, Murff H, Stetson PD, Pizziferri L, and Hripcsak G, &#x201c;Detecting Adverse Events Using Information Technology,&#x201d; J Am Med Inform Assoc, vol. 10, no. 2, pp. 115&#x2013;128, Mar. 2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC150365</ArticleId><ArticleId IdType="pubmed">12595401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho T-B, Le L, Thai DT, and Taewijit S, &#x201c;Data-driven Approach to Detect and Predict Adverse Drug Reactions,&#x201d; Current Pharmaceutical Design, vol. 22, no. 23, pp. 3498&#x2013;3526, Jun. 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27157416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn S, Kocher J-PA, Chute CG, and Savova GK, &#x201c;Drug side effect extraction from clinical narratives of psychiatry and psychology patients,&#x201d; J Am Med Inform Assoc, vol. 18, no. Suppl 1, pp. i144&#x2013;i149, Dec. 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241172</ArticleId><ArticleId IdType="pubmed">21946242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn S et al., &#x201c;Comprehensive temporal information detection from clinical text: medical events, time, and TLINK identification,&#x201d; J Am Med Inform Assoc, vol. 20, no. 5, pp. 836&#x2013;842, Sep. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756269</ArticleId><ArticleId IdType="pubmed">23558168</ArticleId></ArticleIdList></Reference><Reference><Citation>Golder S, Norman G, and Loke YK, &#x201c;Systematic review on the prevalence, frequency and comparative value of adverse events data in social media,&#x201d; Br J Clin Pharmacol, vol. 80, no. 4, pp. 878&#x2013;888, Oct. 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4594731</ArticleId><ArticleId IdType="pubmed">26271492</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G et al., &#x201c;Characterizing treatment pathways at scale using the OHDSI network,&#x201d; PNAS, vol. 113, no. 27, pp. 7329&#x2013;7336, May 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Hripcsak G, Madigan D, and Suchard MA, &#x201c;A systematic approach to improving the reliability and scale of evidence from health care data,&#x201d; arXiv:1803 10791 [stat], Mar. 2018.</Citation></Reference><Reference><Citation>Lasko TA, Denny JC, and Levy MA, &#x201c;Computational Phenotype Discovery Using Unsupervised Feature Learning over Noisy, Sparse, and Irregular Clinical Data,&#x201d; PLoS ONE, vol. 8, no. 6, p. e66341, Jun. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3691199</ArticleId><ArticleId IdType="pubmed">23826094</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z and Hauskrecht M, &#x201c;Learning Linear Dynamical Systems from Multivariate Time Series: A Matrix Factorization Based Framework,&#x201d; Proc SIAM Int Conf Data Min, vol. 2016, pp. 810&#x2013;818, May 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5098501</ArticleId><ArticleId IdType="pubmed">27830108</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z and Hauskrecht M, &#x201c;Learning Adaptive Forecasting Models from Irregularly Sampled Multivariate Clinical Data,&#x201d; Proc Conf AAAI Artif Intell, vol. 2016, pp. 1273&#x2013;1279, Feb. 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4980099</ArticleId><ArticleId IdType="pubmed">27525189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Lee N, Hu J, Sun J, and Ebadollahi S, &#x201c;Towards heterogeneous temporal clinical event pattern discovery: a convolutional approach,&#x201d; in Proceedings of the 18th ACM SIGKDD international conference on Knowledge discovery and data mining, 2012, pp. 453&#x2013;461.</Citation></Reference><Reference><Citation>Batal I, Valizadegan H, Cooper GF, and Hauskrecht M, &#x201c;A Pattern Mining Approach for Classifying Multivariate Temporal Data,&#x201d; Proceedings (IEEE Int Conf Bioinformatics Biomed), vol. 2011, pp. 358&#x2013;365, Nov. 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3261774</ArticleId><ArticleId IdType="pubmed">22267987</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Hopstadius J, Bate A, Star K, and Edwards IR, &#x201c;Temporal pattern discovery in longitudinal electronic patient records,&#x201d; Data Mining and Knowledge Discovery, vol. 20, no. 3, pp. 361&#x2013;387, May 2010.</Citation></Reference><Reference><Citation>Moskovitch R and Shahar Y, &#x201c;Medical temporal-knowledge discovery via temporal abstraction.,&#x201d; in AMIA, 2009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815492</ArticleId><ArticleId IdType="pubmed">20351898</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitch R and Shahar Y, &#x201c;Classification of multivariate time series via temporal abstraction and time intervals mining,&#x201d; Knowledge and Information Systems, vol. 45, no. 1, pp. 35&#x2013;74, Oct. 2015.</Citation></Reference><Reference><Citation>Ramati M and Shahar Y, &#x201c;Irregular-time Bayesian Networks,&#x201d; in Proceedings of the Twenty-Sixth Conference on Uncertainty in Artificial Intelligence, Arlington, Virginia, United States, 2010, pp. 484&#x2013;491.</Citation></Reference><Reference><Citation>Albers DJ and Hripcsak G, &#x201c;Using time-delayed mutual information to discover and interpret temporal correlation structure in complex populations,&#x201d; Chaos: An Interdisciplinary Journal of Nonlinear Science, vol. 22, no. 1, p. 013111, 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277606</ArticleId><ArticleId IdType="pubmed">22462987</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ and Hripcsak G, &#x201c;Estimation of time-delayed mutual information and bias for irregularly and sparsely sampled time-series,&#x201d; Chaos, Solitons &amp; Fractals, vol. 45, no. 6, pp. 853&#x2013;860, Jun. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3332129</ArticleId><ArticleId IdType="pubmed">22536009</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ, Elhadad N, Tabak E, Perotte A, and Hripcsak G, &#x201c;Dynamical Phenotyping: Using Temporal Analysis of Clinically Collected Physiologic Data to Stratify Populations,&#x201d; PLOS ONE, vol. 9, no. 6, p. e96443, Jun. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4059642</ArticleId><ArticleId IdType="pubmed">24933368</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ, Hripcsak G, and Schmidt M, &#x201c;Population Physiology: Leveraging Electronic Health Record Data to Understand Human Endocrine Dynamics,&#x201d; PLoS ONE, vol. 7, no. 12, p. e48058, Dec. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522687</ArticleId><ArticleId IdType="pubmed">23272040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G and Albers DJ, &#x201c;High-fidelity phenotyping: richness and freedom from bias,&#x201d; J Am Med Inform Assoc</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282504</ArticleId><ArticleId IdType="pubmed">29040596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ, and Perotte A, &#x201c;Parameterizing time in electronic health record studies,&#x201d; Journal of the American Medical Informatics Association, vol. 22, no. 4, pp. 794&#x2013;804, Jul. 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6169471</ArticleId><ArticleId IdType="pubmed">25725004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ, and Perotte A, &#x201c;Exploiting time in electronic health record correlations,&#x201d; Journal of the American Medical Informatics Association, vol. 18, no. Supplement 1, pp. i109&#x2013;i115, Dec. 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241180</ArticleId><ArticleId IdType="pubmed">22116643</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine ME, Albers DJ, and Hripcsak G, &#x201c;Comparing lagged linear correlation, lagged regression, Granger causality, and vector autoregression for uncovering associations in EHR data,&#x201d; AMIA Annu Symp Proc, vol. 2016, pp. 779&#x2013;788, Feb. 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333294</ArticleId><ArticleId IdType="pubmed">28269874</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G and Albers DJ, &#x201c;Correlating electronic health record concepts with healthcare process events,&#x201d; Journal of the American Medical Informatics Association, vol. 20, no. e2, pp. e311&#x2013;e318, Dec. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861922</ArticleId><ArticleId IdType="pubmed">23975625</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R, Albers DJ, Sepulveda JL, and Elhadad N, &#x201c;Identifying and mitigating biases in EHR laboratory tests,&#x201d; Journal of Biomedical Informatics, vol. 51, no. Supplement C, pp. 24&#x2013;34, Oct. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194228</ArticleId><ArticleId IdType="pubmed">24727481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R, Albers DJ, Hripcsak G, Sepulveda JL, and Elhadad N, &#x201c;Temporal trends of hemoglobin A1c testing,&#x201d; J Am Med Inform Assoc, vol. 21, no. 6, pp. 1038&#x2013;1044, Dec. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215045</ArticleId><ArticleId IdType="pubmed">24928176</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ and Hripcsak G, &#x201c;A statistical dynamics approach to the study of human health data: Resolving population scale diurnal variation in laboratory data,&#x201d; Physics Letters A, vol. 374, no. 9, pp. 1159&#x2013;1164, Feb. 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2882798</ArticleId><ArticleId IdType="pubmed">20544004</ArticleId></ArticleIdList></Reference><Reference><Citation>Little RJA and Rubin DB, Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data Hoboken, NJ, USA: John Wiley &amp; Sons, Inc., 2002.</Citation></Reference><Reference><Citation>Enders CK, Applied missing data analysis New York: Guilford Press, 2010.</Citation></Reference><Reference><Citation>Shannon CE, &#x201c;Communication in the presence of noise,&#x201d; Proceedings of the IEEE, vol. 72, no. 9, pp. 1192&#x2013;1201, Sep. 1984.</Citation></Reference><Reference><Citation>Shannon CE, &#x201c;A Mathematical Theory of Communication,&#x201d; SIGMOBILE Mob. Comput. Commun. Rev, vol. 5, no. 1, pp. 3&#x2013;55, Jan. 2001.</Citation></Reference><Reference><Citation>Lyons RG, Understanding digital signal processing, 3rd ed. Upper Saddle River, NJ: Prentice Hall, 2011.</Citation></Reference><Reference><Citation>Harris FJ, &#x201c;On the use of windows for harmonic analysis with the discrete Fourier transform,&#x201d; Proceedings of the IEEE, vol. 66, no. 1, pp. 51&#x2013;83, Jan. 1978.</Citation></Reference><Reference><Citation>Hamilton JD, Time series analysis, vol. 2 Princeton university press; Princeton, 1994.</Citation></Reference><Reference><Citation>Dickey DA and Fuller WA, &#x201c;Distribution of the Estimators for Autoregressive Time Series With a Unit Root,&#x201d; Journal of the American Statistical Association, vol. 74, no. 366, pp. 427&#x2013;431, 1979.</Citation></Reference><Reference><Citation>Box GEP, Jenkins GM, Reinsel GC, and Ljung GM, Time Series Analysis: Forecasting and Control John Wiley &amp; Sons, 2015.</Citation></Reference><Reference><Citation>Granger CWJ and Newbold P, &#x201c;Spurious regressions in econometrics,&#x201d; Journal of Econometrics, vol. 2, no. 2, pp. 111&#x2013;120, Jul. 1974.</Citation></Reference><Reference><Citation>Box GEP and Cox DR, &#x201c;An Analysis of Transformations,&#x201d; Journal of the Royal Statistical Society. Series B (Methodological), vol. 26, no. 2, pp. 211&#x2013;252, 1964.</Citation></Reference><Reference><Citation>Trees HLV, Detection, Estimation, and Modulation Theory: Radar-Sonar Signal Processing and Gaussian Signals in Noise Melbourne, FL, USA: Krieger Publishing Co., Inc., 1992.</Citation></Reference><Reference><Citation>Boyce RD et al., &#x201c;Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest,&#x201d; Drug Saf, vol. 37, no. 8, pp. 557&#x2013;567, Aug. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4134480</ArticleId><ArticleId IdType="pubmed">24985530</ArticleId></ArticleIdList></Reference><Reference><Citation>Efron B, &#x201c;Bootstrap Methods: Another Look at the Jackknife,&#x201d; Ann. Statist, vol. 7, no. 1, pp. 1&#x2013;26, Jan. 1979.</Citation></Reference><Reference><Citation>Granger CWJ, &#x201c;Investigating Causal Relations by Econometric Models and Cross-spectral Methods,&#x201d; Econometrica, vol. 37, no. 3, pp. 424&#x2013;438, 1969.</Citation></Reference><Reference><Citation>Kay SM, &#x201c;Statistical signal processing,&#x201d; Estimation Theory, vol. 1, 1993.</Citation></Reference><Reference><Citation>Hayashi F, Econometrics Princeton University Press, 2011.</Citation></Reference><Reference><Citation>Rusanov A, Weiskopf NG, Wang S, and Weng C, &#x201c;Hidden in plain sight: bias towards sick patients when sampling patients with sufficient electronic health record data for research,&#x201d; BMC medical informatics and decision making, vol. 14, no. 1, p. 1, 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4062889</ArticleId><ArticleId IdType="pubmed">24916006</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ, Elhadad N, Claassen J, Perotte R, Goldstein A, and Hripcsak G, &#x201c;Estimating summary statistics for electronic health record laboratory data for use in high-throughput phenotyping algorithms,&#x201d; J Biomed Inform, vol. 78, pp. 87&#x2013;101, Feb. 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856130</ArticleId><ArticleId IdType="pubmed">29369797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30306907</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>255</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMs.</ArticleTitle><Pagination><StartPage>60</StartPage><EndPage>64</EndPage><MedlinePgn>60-64</MedlinePgn></Pagination><Abstract><AbstractText>Common data models (CDM) have enabled the simultaneous analysis of disparate and large data sources. A literature review identified three relevant CDMs: The Observational Medical Outcomes Partnership (OMOP) was the most cited; next the Sentinel; and then the Patient Centered Outcomes Research Institute (PCORI). We tested these three CDMs with fifteen pre-defined criteria for a diabetes cohort study use case, assessing the benefit (good diabetes control), risk (hypoglycaemia) and cost effectiveness of recently licenced medications. We found all three CDMs have a useful role in planning collaborative research and enhance analysis of data cross jurisdiction. However, the number of pre-defined criteria achieved by these three CDMs varied. OMOP met 14/15, Sentinel 13/15, and PCORI 10/15. None met the privacy level we specified, and most of the other gaps were clinical and cost outcome related data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liyanage</LastName><ForeName>Harshana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical &amp; Experimental Medicine, University of Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Siaw-Teng</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>School of Public Health &amp; Community Medicine, UNSW Medicine Australia, Ingham Institute of Applied Medical Research, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Public Health &amp; Community Medicine, UNSW Medicine Australia, Ingham Institute of Applied Medical Research, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinton</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Clinical &amp; Experimental Medicine, University of Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lusignan</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical &amp; Experimental Medicine, University of Surrey, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="Y">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common data models</Keyword><Keyword MajorTopicYN="N">Costs and cost analysis</Keyword><Keyword MajorTopicYN="N">Diabetes Mellitus</Keyword><Keyword MajorTopicYN="N">Medical record systems</Keyword><Keyword MajorTopicYN="N">Organization and administration</Keyword><Keyword MajorTopicYN="N">computerized</Keyword><Keyword MajorTopicYN="N">data harmonisation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30306907</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30306935</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>255</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Biomedical Informatics Investigator.</ArticleTitle><Pagination><StartPage>195</StartPage><EndPage>199</EndPage><MedlinePgn>195-199</MedlinePgn></Pagination><Abstract><AbstractText>The BMI Investigator is a computer human interface built in .Net which allows simultaneous query of structured data such as demographics, administrative codes, medications (coded in RxNorm), laboratory test results (coded in LOINC) and formerly unstructured data in clinical notes (coded in SNOMED CT). The ontology terms identified using SNOMED are all coded as either positive, negative or uncertain assertions. They are then where applicable built into compositional expressions and stored in both a graph database and a triple store. The SNOMED CT codes are stored in a NOSQL database, Berkley DB, and the structured data is stored in SQL using the OMOP/OHDSI format. The BMI investigator also lets you develop models for cohort selection (data driven recruitment to clinical trials) and automated retrospective research using genomic criteria and we are adding image feature data currently to the system. We performed a usability experiment and the users identified some usability flaws which were used to improve the software. Overall, the BMI Investigator was felt to be usable by subject matter experts. Next steps for the software are to integrate genomic criteria and image features into the query engine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elkin</LastName><ForeName>Peter L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mullin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakilay</LastName><ForeName>Sylvester</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM012595</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AA026954</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM012495</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062245" MajorTopicYN="Y">RxNorm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="N">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Automated retrospective research</Keyword><Keyword MajorTopicYN="N">Clinical Research Informatics</Keyword><Keyword MajorTopicYN="N">Ontology</Keyword><Keyword MajorTopicYN="N">Recruitment to clinical trials</Keyword><Keyword MajorTopicYN="N">clinical genomic trial recruitment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30306935</ArticleId><ArticleId IdType="mid">NIHMS1655784</ArticleId><ArticleId IdType="pmc">PMC7847179</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Elkin PL, Bailey KR, Chute CG. A randomized controlled trial of automated term composition. Proc AMIA Symp. 1998:765&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2232145</ArticleId><ArticleId IdType="pubmed">9929322</ArticleId></ArticleIdList></Reference><Reference><Citation>PLElkin, Froehling D, Bauer BA, Wahner-Roedler D, Rosenbloom ST, Bailey K, Brown S. Aequus communis sententia:defining levels of interoperability Stud Health Technol Inform 2007;129(1):725&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17911812</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Brown SH, Chute CG. Guideline for health informatics: controlled health vocabularies--vocabulary structure and high-level indicators. Stud Health Technol Inform. 2001;84(Pt 1):191&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11604731</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Ruggieri AP, Brown SH, Buntrock J, Bauer BA, Wahner-Roedler D, Litin S, Beinborn J, Bailey K, Bergstrom L, A randomized controlled trial of the accuracy of clinical record retrieval using SNOMED-RT as compared with ICD9- CM. Proc AMIA Symp. 2001:159&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243271</ArticleId><ArticleId IdType="pubmed">11825173</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Brown SH, Lincoln MJ, Hogarth M, Rector A. A formal representation for messages containing compositional expressions. Int J Med Inform. 2003;71(2&#x2013;3):89&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">14519402</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Brown SH, Carter J, Bauer BA, Wahner-Roedler D, Bergstrom L, Pittelkow M, Rosse C,. Guideline and quality indicators for development, purchase and use of controlled health vocabularies. Int J Med Inform. 2002;68(1&#x2013;3):175&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">12467801</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Trusko BE, Koppel R, Speroff T, Mohrer D, Sakji S, Gurewitz I, Tuttle M, Brown S. Secondary use of clinical data. Stud Health Technol Inform. 2010;155:14&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">20543306</ArticleId></ArticleIdList></Reference><Reference><Citation>Murff HJ, FitzHenry F, Matheny ME, Gentry N, Kotter KL, Crimin K, Dittus R, Rosen A, Ekin PL, Brown SH, Speroff T. Automated identification of postoperative complications within an electronic medical record using natural language processing. JAMA. 2011;306(8):848&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">21862746</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Froehling DA, Wahner-Roedler DL, Brown SH, Bailey KR. Comparison of natural language processing biosurveillance methods for identifying influenza from encounter notes. Ann Intern Med. 2012;156(1 Pt 1):11&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22213490</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Miller RA, Johnson KB, Elkin PL, Brown SH. Interface terminologies: facilitating direct entry of clinical data into electronic health record systems. J Am Med Inform Assoc. 2006;13(3):277&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1513664</ArticleId><ArticleId IdType="pubmed">16501181</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SH, Husser CS, Wahner-Roedler D, Bailey S, Nugent L, Porter K, Bauer B, Elkin PL. Using SNOMED CT as a reference terminology to cross map two highly pre-coordinated classification systems. Stud Health Technol Inform. 2007;129(Pt 1):636&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17911794</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheny ME, Fitzhenry F, Speroff T, Green JK, Griffith ML, Vasilevskis EE, Fielstein E, Elkin PL, Brown SH. Detection of infectious symptoms from VA emergency department and primary care clinical documentation. Int J Med Inform. 2012;81(3):143&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">22244191</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Brown SH, Froehling D, Bauer BA, Wahner-Roedler DL, Gregg WM, Elkin PL Using SNOMED CT to represent two interface terminologies. J Am Med Inform Assoc. 2009;16(1):81&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605600</ArticleId><ArticleId IdType="pubmed">18952944</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Carter JS, Nabar M, Tuttle M, Lincoln M, Brown SH. Drug knowledge expressed as computable semantic triples. Stud Health Technol Inform. 2011;166:38&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">21685609</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Jensen M, Mullin S, Elkin PL. Safe Opioid Prescription: A SMART on FHIR Approach to Clinical Decision Support. Online J Public Health Inform. 2017;9(2):e193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5630280</ArticleId><ArticleId IdType="pubmed">29026458</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel DR, Crowner C, Lehoullier F, Elkin PL. HTP-NLP: A New NLP System for High Throughput Phenotyping. Stud Health Technol Inform. 2017;235:276&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7767581</ArticleId><ArticleId IdType="pubmed">28423797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceusters W, Elkin P, Smith B. Negative findings in electronic health records and biomedical ontologies: a realist approach. Int J Med Inform. 2007;76 Suppl 3:S326&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2211452</ArticleId><ArticleId IdType="pubmed">17369081</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuscart-Zephir MC, Elkin P, Pelayo S. Human factors engineering for clinical applications. Stud Health Technol Inform. 2006;124:685&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">17108595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammenwerth E, Talmon J, Ash JS, Bates DW, Beuscart-Zephir MC, Duhamel A, Elkin PL, Gardner R, Geissbuhler A. Impact of CPOE on mortality rates--contradictory findings, important messages. Methods Inf Med. 2006;45(6):586&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">17149499</ArticleId></ArticleIdList></Reference><Reference><Citation>Husser CS, Buchhalter JR, Raffo OS, Shabo A, Brown SH, Lee KE, Elkin PL. Standardization of microarray and pharmacogenomics data. Methods Mol Biol. 2006;316:111&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">16671403</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelayo S, Anceaux F, Rogalski J, Elkin P, Beuscart-Zephir MC. A comparison of the impact of CPOE implementation and organizational determinants on doctor-nurse communications and cooperation. Int J Med Inform. 2013;82(12):e321&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">22999779</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL. Human Factors Engineering in HI: So What? Who Cares? and What&#x2019;s in It for You? Healthc Inform Res. 2012;18(4):237&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3548152</ArticleId><ArticleId IdType="pubmed">23346473</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuscart-Zephir MC, Elkin P, Pelayo S, Beuscart R. The human factors engineering approach to biomedical informatics projects: state of the art, results, benefits and challenges. Yearb Med Inform. 2007:109&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">17700914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra G, Kaushik S, Elkin PL, Samudrala R. Combating Ebola with Repurposed Therapeutics Using the CANDO Platform. Molecules. 2016;21(12).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958544</ArticleId><ArticleId IdType="pubmed">27898018</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30395248</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>12</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Effect of vocabulary mapping for conditions on phenotype cohorts.</ArticleTitle><Pagination><StartPage>1618</StartPage><EndPage>1625</EndPage><MedlinePgn>1618-1625</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy124</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To study the effect on patient cohorts of mapping condition (diagnosis) codes from source billing vocabularies to a clinical vocabulary.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Nine International Classification of Diseases, Ninth Revision, Clinical Modification (ICD9-CM) concept sets were extracted from eMERGE network phenotypes, translated to Systematized Nomenclature of Medicine - Clinical Terms concept sets, and applied to patient data that were mapped from source ICD9-CM and ICD10-CM codes to Systematized Nomenclature of Medicine - Clinical Terms codes using Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) vocabulary mappings. The original ICD9-CM concept set and a concept set extended to ICD10-CM were used to create patient cohorts that served as gold standards.</AbstractText><AbstractText Label="RESULTS">Four phenotype concept sets were able to be translated to Systematized Nomenclature of Medicine - Clinical Terms without ambiguities and were able to perform perfectly with respect to the gold standards. The other 5 lost performance when 2 or more ICD9-CM or ICD10-CM codes mapped to the same Systematized Nomenclature of Medicine - Clinical Terms code. The patient cohorts had a total error (false positive and false negative) of up to 0.15% compared to querying ICD9-CM source data and up to 0.26% compared to querying ICD9-CM and ICD10-CM data. Knowledge engineering was required to produce that performance; simple automated methods to generate concept sets had errors up to 10% (one outlier at 250%).</AbstractText><AbstractText Label="DISCUSSION">The translation of data from source vocabularies to Systematized Nomenclature of Medicine - Clinical Terms (SNOMED CT) resulted in very small error rates that were an order of magnitude smaller than other error sources.</AbstractText><AbstractText Label="CONCLUSION">It appears possible to map diagnoses from disparate vocabularies to a single clinical vocabulary and carry out research using a single set of definitions, thus improving efficiency and transportability of research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, NewYork-Presbyterian Hospital, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="Y">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="N">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30395248</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pii">5159502</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), National Center for Health Statistics. http://www.cdc.gov/nchs/icd/icd9cm.htm Accessed April 24, 2018.</Citation></Reference><Reference><Citation>International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), National Center for Health Statistics. http://www.cdc.gov/nchs/icd/icd10cm.htm Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
SNOMED CT. http://www.snomed.org/snomed-ct Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
MedDRA. Medical dictionary for regulatory activities. http://www.meddra.org/ Accessed April 24, 2018.</Citation></Reference><Reference><Citation>RCD (Read Codes) &#x2013; Synopsis. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/RCD/ Accessed April 24, 2018.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers MEDINFO&#x2019;15; August 19&#x2013;23, 2015; S&#xe3;o Paulo, Brazil.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA 2016; 113 (27): 7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE.. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012; 19 (1): 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Unified Medical Language System (UMLS) Metathesaurus - Mapping Projects. https://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/mapping_projects/index.html Accessed June 15, 2018.</Citation></Reference><Reference><Citation>Reich C, Ryan PB, Stang PE, Rocca M.. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. J Biomed Inform 2012; 45 (4): 689&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, et al. Validation of electronic medical record&#x2013;based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013; 20 (e1): e147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>
The eMERGE Network. Type 2 diabetes mellitus. https://phekb.org/phenotype/type-2-diabetes-mellitus Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. Appendicitis. https://phekb.org/phenotype/appendicitis Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. ADHD phenotype algorithm. https://phekb.org/phenotype/adhd-phenotype-algorithm Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. Cataracts. https://phekb.org/phenotype/cataracts Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. Crohn&#x2019;s disease&#x2014;demonstration project. https://phekb.org/phenotype/crohns-disease-demonstration-project Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. Rheumatoid arthritis (RA). https://phekb.org/phenotype/rheumatoid-arthritis-ra Accessed April 24, 2018.</Citation></Reference><Reference><Citation>eMERGE Network. Heart failure (HF) with differentiation between preserved and reduced ejection fraction. https://phekb.org/phenotype/heart-failure-hf-differentiation-between-preserved-and-reduced-ejection-fraction Accessed April 24, 2018.</Citation></Reference><Reference><Citation>Hogan WR, Wagner MM.. Accuracy of data in computer-based patient records. J Am Med Inform Assoc 1997; 4 (5): 342&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61252</ArticleId><ArticleId IdType="pubmed">9292840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox AB, Chen YH, Hripcsak G.. Minimizing electronic health record patient-note mismatches. J Am Med Inform Assoc 2011; 18 (4): 511&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128397</ArticleId><ArticleId IdType="pubmed">21486875</ArticleId></ArticleIdList></Reference><Reference><Citation>Defalco FJ, Ryan PB, Soledad Cepeda M.. Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure. Health Serv Outcomes Res Methodol 2013; 13 (1): 58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3566397</ArticleId><ArticleId IdType="pubmed">23396660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartagena FP, Schaeffer M, Rifai D, Doroshenko V, Goldberg HS.. Leveraging the NLM map from SNOMED CT to ICD-10-CM to facilitate adoption of ICD-10-CM. J Am Med Inform Assoc 2015; 22 (3): 659&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25769685</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004; 32 (90001): 267D&#x2013;D270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Richesson R, Smerek M, et al. Preparing for the ICD-10-CM transition: automated methods for translating ICD codes in clinical phenotype definitions. eGEMs 2016; 4 (1): 4&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4862764</ArticleId><ArticleId IdType="pubmed">27195309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. Using SNOMED CT in combination with MedDRA for reporting signal detection and adverse drug reactions reporting. AMIA Annu Symp Proc 2009; 2009: 45&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815504</ArticleId><ArticleId IdType="pubmed">20351820</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Ruggieri AP, Brown SH, et al. A randomized controlled trial of the accuracy of clinical record retrieval using SNOMED-RT as compared with ICD9-CM. Proc AMIA Symp 2001; 159&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243271</ArticleId><ArticleId IdType="pubmed">11825173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30421323</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>12</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of medical systems</Title><ISOAbbreviation>J Med Syst</ISOAbbreviation></Journal><ArticleTitle>Analysis of treatment pathways for three chronic diseases using OMOP CDM.</ArticleTitle><Pagination><StartPage>260</StartPage><MedlinePgn>260</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">260</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10916-018-1076-5</ELocationID><Abstract><AbstractText>The present study examined treatment pathways (the ordered sequence of medications that a patient is prescribed) for three chronic diseases (hypertension, type 2 diabetes, and depression), compared the pathways with recommendations from guidelines, discussed differences and standardization of medications in different medical institutions, explored population diversification and changes of clinical treatment, and provided clinical big data analysis-based data support for the development and study of drugs in China. In order to run the "Treatment Pathways in Chronic Disease" protocol in Chinese data sources,we have built a large data research and analysis platform for Chinese clinical medical data. Data sourced from the Clinical Data Repository (CDR) of the First Affiliated Hospital of Nanjing Medical University was extracted, transformed, and loaded into an observational medical outcomes partnership common data model (OMOP CDM) Ver. 5.0. Diagnosis and medication information for patients with hypertension, type 2 diabetes, and depression from 2005 to 2015 were extracted for observational research to obtain treatment pathways for the three diseases. The most common medications used to treat diabetes and hypertension were metformin and acarbose, respectively, at 28.5 and 20.9% as first-line medication. New drugs were emerging for depression; therefore, the favorite medication changed accordingly. Most patients with these three diseases had different treatment pathways from other patients with the same diseases. The proportions of monotherapy increased for the three diseases, especially in recent years. The recommendations presented in guidelines show some predominance. High-quality, effective guidelines incorporating domestic facts should be established to further guide medication and improve therapy at local hospitals. Medical institutions at all levels could improve the quality of medical services, and further standardize medications in the future. This research is the first application of the CDM model and OHDSI software in China, which were used to study, treatment pathways for three chronic diseases (hypertension, type 2 diabetes and depression), compare the pathways with recommendations from guidelines, discuss differences and standardization of medications in different medical institutions, demonstrate the urgent need for quality national guidelines, explores population diversification and changes of clinical treatment, and provide clinical big data analysis-based data support for the development and study of drugs in China.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering and Informatics, Nanjing Medical University, 101Longmian Avenue, Nanjing, 211166, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Medical School, Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Shumei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Yuechuchu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yueshi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Zuolei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Shenqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoliang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhongqiu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhongmin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jianjun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China. liuyun@njmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China. liuyun@njmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering and Informatics, Nanjing Medical University, 101Longmian Avenue, Nanjing, 211166, Jiangsu, China. liuyun@njmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018YFC1314900</GrantID><Agency>the National key Research &amp; Development plan of Ministry of Science and Technology of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>2018YFC1314901</GrantID><Agency>the National key Research &amp; Development plan of Ministry of Science and Technology of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>2018YFC0116900</GrantID><Agency>the National key Research &amp; Development plan of Ministry of Science and Technology of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>BE2016002-4</GrantID><Agency>the 2016 industry prospecting and common key technology key projects of Jiangsu Province Science and Technology Department</Agency><Country/></Grant><Grant><GrantID>X201401</GrantID><Agency>the 2014 information projects of Jiangsu Province Health and Life Committee</Agency><Country/></Grant><Grant><GrantID>201608003</GrantID><Agency>The 2016 projects of Nanjing Science Bureau</Agency><Country/></Grant><Grant><GrantID>2018YFC0116902</GrantID><Agency>the National key Research &amp; Development plan of Ministry of Science and Technology of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>81873915</GrantID><Agency>the national science foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Syst</MedlineTA><NlmUniqueID>7806056</NlmUniqueID><ISSNLinking>0148-5598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019091" MajorTopicYN="Y">Critical Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019370" MajorTopicYN="N">Observation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic diseases</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP Common Data Model (CDM)</Keyword><Keyword MajorTopicYN="N">Treatment pathways</Keyword></KeywordList><CoiStatement>The authors have no conflict of interests regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30421323</ArticleId><ArticleId IdType="pmc">PMC6244882</ArticleId><ArticleId IdType="doi">10.1007/s10916-018-1076-5</ArticleId><ArticleId IdType="pii">10.1007/s10916-018-1076-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO, Global status report on noncommunicable diseases 2014, WHO Press, Geneva, Switzerland</Citation></Reference><Reference><Citation>Brenner R, Rimoldi SF. Arterial Hypertension-when are which combination therapies useful [J] Ther Lmsch. 2012;69(5):305&#x2013;313. doi: 10.1024/0040-5930/a000290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0040-5930/a000290</ArticleId><ArticleId IdType="pubmed">22547363</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee of Exports on Rational Drug Use, National Health and Family Planning Commission of the P.R. CHINA. Chinese Medical Doctor Association Hypertension Specialized Committee Guidelines for rational use of hypertension. Chinese Journal of Frontier medicine (electronic version). 2015;7(6):22&#x2013;64.</Citation></Reference><Reference><Citation>National Center for Cardiovascular Disease, China Report on Cardiovascular Diseases in China [M]. Beijing: EnEcyclopedia of China Publishing House, 2015: 11-15, 2014.</Citation></Reference><Reference><Citation>International Diabetes Federation.IDF Diabetes Atlas 7th edition. [EB/OL]. [2017-08-15]. http://www.diabetesatlas.org/</Citation></Reference><Reference><Citation>WHO. Global report on diabetes. [EB/OL]. [2017-08-16]. www.who.int/diabetes/global-report</Citation></Reference><Reference><Citation>Chinese Diabetes Society China Guideline for Type 2 Diabetes (2010) Chinese Journal of Diabetes. 2012;20(1):81&#x2013;117.</Citation></Reference><Reference><Citation>Grimaccia F, Kanavos P. Cost, outcomes, treatment pathways and challenges for diabetes care in Italy. Grimaccia and Kanavos Globalization and Health. 2014;10:58. doi: 10.1186/1744-8603-10-58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1744-8603-10-58</ArticleId><ArticleId IdType="pmc">PMC4110929</ArticleId><ArticleId IdType="pubmed">25024101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Yufang B, Weiqing W. Prevalence and control of diabetes in Chinese adults-the interpretation of a 2010 China Noncommunicable Disease Surveillance report. Chinese Journal of Endocrinology and Metabolism. 2014;30(3):184&#x2013;186.</Citation></Reference><Reference><Citation>WHO. Preventing suicide: A global imperative, WHO Press, Geneva, Switzerland, 2014</Citation></Reference><Reference><Citation>Hripcsak G, Ryanc PB, Dukec JD, et al. Characterizing treatment pathways at scale using the OHDSI network[J] PNAS. 2016;113(27):7329&#x2013;7336. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman SL. From randomized controlled trials to observational studies [J] Am J Med. 2009;122(2):114&#x2013;120. doi: 10.1016/j.amjmed.2008.09.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.09.030</ArticleId><ArticleId IdType="pubmed">19185083</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia-shuang HE, Xiao-dan XIAO. Thinking about the Application of OMOP CDM in the Clinical Research. China Digital Medicine. 2016;11(3):72&#x2013;74.</Citation></Reference><Reference><Citation>OMOP Common Data Model. Available at https://www.ohdsi.org/data-standardization/the-common-data-model/ (Accessed January 10, 2018).</Citation></Reference><Reference><Citation>Population-level estimation of comparative risks of Celecoxib versus non-selective NSAIDs. Available at http://www.ohdsi.org/web/wiki/doku.php?id=research:celecoxib_vs_nsnsaids (Accessed January 16, 2018).</Citation></Reference><Reference><Citation>Drug Utilization in Children. Available at http://www.ohdsi.org/web/wiki/doku.php?id=research:drugs_in_peds (Accessed January 16, 2018).</Citation></Reference><Reference><Citation>Data Quality Study. Available at http://www.ohdsi.org/web/wiki/doku.php?id=research:dqstudy (Accessed January 16, 2018).</Citation></Reference><Reference><Citation>Chinese Diabetes Society. Guidelines for the prevention and treatment of type 2 diabetes mellitus in China (2013 Edition). Chin J Diabetes, 8, 22(8):2-42, 2014</Citation></Reference><Reference><Citation>American Diabetes Association Standards of medical care in diabetes&#x2014;2014[J] Diabetes Care. 2014;37(Suppl 1):S14&#x2013;S80. doi: 10.2337/dc14-S014.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-S014</ArticleId><ArticleId IdType="pubmed">24357209</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee of Exports on Rational Drug Use, National Health and Familiy Planning Commission of the P.R. China. Chinese Medical Doctor Association Hypertension Specialized Committee. Guidelines for rational use of hypertension. Beijing: People's Medical Publishing House. 978-7-117-21142-0, 2015</Citation></Reference><Reference><Citation>Michael A. Weber,Ernesto L. Schiffrin,William B. et.al. Clinical Practice Guidelines for the Management of Hypertension in the Community[J]. J Clin Hypertens. (1), 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8031779</ArticleId><ArticleId IdType="pubmed">24341872</ArticleId></ArticleIdList></Reference><Reference><Citation>James Paul A., Oparil Suzanne, Carter Barry L., Cushman William C., Dennison-Himmelfarb Cheryl, Handler Joel, Lackland Daniel T., LeFevre Michael L., MacKenzie Thomas D., Ogedegbe Olugbenga, Smith Sidney C., Svetkey Laura P., Taler Sandra J., Townsend Raymond R., Wright Jackson T., Narva Andrew S., Ortiz Eduardo. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. JAMA. 2014;311(5):507. doi: 10.1001/jama.2013.284427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.284427</ArticleId><ArticleId IdType="pubmed">24352797</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Collaborating Centre for Drug Statistics Methodology ATC: Structure and principles. Available at www.whocc.no/atc/structure_and_principles/. Accessed August 23, 2017.</Citation></Reference><Reference><Citation>Alan J G, Marlene P F, John C M, et al. Practice Guideline for the treatment of Patients With Major Depressive Disorder[M]. The American Psychiatric Association (APA). 2010.</Citation></Reference><Reference><Citation>Lingjiang Li, Xin Ma. Guidelines for the prevention and treatment of depressive disorders in China (Second Edition) [M]. China medical electronic audio-visual press. June, 2015.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI). Treatment Pathways in Chronic Disease. Available at www.ohdsi.org/web/wiki/doku.php?id=research:treatment_pathways_in_chronic_disease. (Accessed August 23, 2017).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30480666</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4463</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2018</Year><Month>Nov</Month><Day>27</Day></PubDate></JournalIssue><Title>Scientific data</Title><ISOAbbreviation>Sci Data</ISOAbbreviation></Journal><ArticleTitle>Columbia Open Health Data, clinical concept prevalence and co-occurrence from electronic health records.</ArticleTitle><Pagination><StartPage>180273</StartPage><MedlinePgn>180273</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">180273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/sdata.2018.273</ELocationID><Abstract><AbstractText>Columbia Open Health Data (COHD) is a publicly accessible database of electronic health record (EHR) prevalence and co-occurrence frequencies between conditions, drugs, procedures, and demographics. COHD was derived from Columbia University Irving Medical Center's Observational Health Data Sciences and Informatics (OHDSI) database. The lifetime dataset, derived from all records, contains 36,578 single concepts (11,952 conditions, 12,334 drugs, and 10,816 procedures) and 32,788,901 concept pairs from 5,364,781 patients. The 5-year dataset, derived from records from 2013-2017, contains 29,964 single concepts (10,159 conditions, 10,264 drugs, and 8,270 procedures) and 15,927,195 concept pairs from 1,790,431 patients. Exclusion of rare concepts (count&#x2009;&#x2264;&#x2009;10) and Poisson randomization enable data sharing by eliminating risks to patient privacy. EHR prevalences are informative of healthcare consumption rates. Analysis of co-occurrence frequencies via relative frequency analysis and observed-expected frequency ratio are informative of associations between clinical concepts, useful for biomedical research tasks such as drug repurposing and pharmacovigilance. COHD is publicly accessible through a web application-programming interface (API) and downloadable from the Figshare repository. The code is available on GitHub.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumontier</LastName><ForeName>Michel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4727-9435</Identifier><AffiliationInfo><Affiliation>Institute of Data Science, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.c.4151252</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM107145</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D064886">Dataset</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Data</MedlineTA><NlmUniqueID>101640192</NlmUniqueID><ISSNLinking>2052-4463</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010361" MajorTopicYN="N">Patients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30480666</ArticleId><ArticleId IdType="pmc">PMC6257042</ArticleId><ArticleId IdType="doi">10.1038/sdata.2018.273</ArticleId><ArticleId IdType="pii">sdata2018273</ArticleId></ArticleIdList><ReferenceList><Title>Data Citations</Title><Reference><Citation>Ta C. N., Dumontier M., Hripcsak G., Tatonetti N. P., Weng C. 2018. figshare. https://doi.org/10.6084/m9.figshare.c.4151252</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.c.4151252</ArticleId><ArticleId IdType="pmc">PMC6257042</ArticleId><ArticleId IdType="pubmed">30480666</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Ross J. S., Lehman R. &amp; Gross C. P. The importance of clinical trial data sharing: toward more open science. Circ. Cardiovasc. Qual. Outcomes 5, 238&#x2013;240 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3318983</ArticleId><ArticleId IdType="pubmed">22438465</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson S. &amp; Downey A. S. Sharing Clinical Research Data: Workshop Summary. National Academies Press, (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23700647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo B. Sharing clinical trial data: maximizing benefits, minimizing risk. JAMA 313, 793&#x2013;794 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25594500</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez K. &amp; Malin B. Evaluating re-identification risks with respect to the HIPAA privacy rule. J. Am. Med. Inform. Assoc 17, 169&#x2013;177 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000773</ArticleId><ArticleId IdType="pubmed">20190059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward M. M. Estimating disease prevalence and incidence using administrative data: some assembly required. J. Rheumatol. 40, 1241&#x2013;1243 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159744</ArticleId><ArticleId IdType="pubmed">23908527</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldacre M., Kurina L., Yeates D., Seagroatt V. &amp; Gill L. Use of large medical databases to study associations between diseases. QJM Int. J. Med 93, 669&#x2013;675 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11029477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H, Markatou M, Melton G. B, Chiang M. F. &amp; Hripcsak G. Mining a clinical data warehouse to discover disease-finding associations using co-occurrence statistics. AMIA. Annu. Symp. Proc. 2005, 106&#x2013;110 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560759</ArticleId><ArticleId IdType="pubmed">16779011</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Hripcsak G., Markatou M. &amp; Friedman C. Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. J. Am. Med. Inform. Assoc 16, 328&#x2013;337 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732239</ArticleId><ArticleId IdType="pubmed">19261932</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant B. F., Stinson F. S., Dawson D. A., Chou S. P. &amp; Ruan W. J. Co-occurrence of DSM-IV personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Compr. Psychiatry 46, 1&#x2013;5 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15714187</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P. G., Cigolle C. &amp; Blaum C. The co&#x2010;occurrence of chronic diseases and geriatric syndromes: The Health and Retirement Study. J. Am. Geriatr. Soc 57, 511&#x2013;516 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19187416</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel R. L., Miller K. D. &amp; Jemal A. Cancer statistics, 2018. CA. Cancer J. Clin. 68, 7&#x2013;30 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29313949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wir&#xe9;hn A.-B. E., Karlsson H. M. &amp; Carstensen J. M. Estimating disease prevalence using a population-based administrative healthcare database. Scand. J. Public Health 35, 424&#x2013;431 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17786807</ArticleId></ArticleIdList></Reference><Reference><Citation>Naughton C., Bennett K. &amp; Feely J. Prevalence of chronic disease in the elderly based on a national pharmacy claims database. Age Ageing 35, 633&#x2013;636 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17047009</ArticleId></ArticleIdList></Reference><Reference><Citation>Viol&#xe1;n C. et al. Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity. BMC Public Health 13, 251 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659017</ArticleId><ArticleId IdType="pubmed">23517342</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornstein S. M., Nietert P. J., Jenkins R. G. &amp; Litvin C. B. The prevalence of chronic diseases and multimorbidity in primary care practice: a PPRNet report. J. Am. Board Fam. Med. 26, 518&#x2013;524 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24004703</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya M., Jurkovitz C. &amp; Shatkay H. Co-occurrence of medical conditions: exposing patterns through probabilistic topic modeling of SNOMED codes. J. Biomed. Inform. 82, 31&#x2013;40 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6510486</ArticleId><ArticleId IdType="pubmed">29655947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G. et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform. 216, 574&#x2013;578 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlayson S. G., LePendu P. &amp; Shah N. H. Building the graph of medicine from millions of clinical narratives. Sci. Data 1, 140032 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4322575</ArticleId><ArticleId IdType="pubmed">25977789</ArticleId></ArticleIdList></Reference><Reference><Citation>Census Bureau U. S.
American FactFinder
https://factfinder.census.gov/bkmk/table/1.0/en/DEC/10_DP/DPDP1/1600000US3651000?slice=GEO~1600000US3651000 (2018).</Citation></Reference><Reference><Citation>Bulmer M. G. Principles of Statistics. Dover Publications, (2012).</Citation></Reference><Reference><Citation>Wallentin L. et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. The Lancet 376, 975&#x2013;983 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20801496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales R. Uncomplicated acute bronchitis. Ann. Intern. Med. 133, 981&#x2013;991 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11119400</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo G. J. &amp; Castro-Rodriguez J. A. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 60, 740&#x2013;746 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1747524</ArticleId><ArticleId IdType="pubmed">16055613</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M., Fauconnet P., Villiger Y. &amp; Tschopp J.-M. Acute lung injury and outcomes after thoracic surgery. Curr. Opin. Anesthesiol 22, 61&#x2013;67 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19295294</ArticleId></ArticleIdList></Reference><Reference><Citation>Warrington K. J., Moder K. G. &amp; Brutinel W. M. The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin. Proc. 75, 467&#x2013;472 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10807075</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha A. K. Meaningful use of electronic health records: the road ahead. JAMA 304, 1709&#x2013;1710 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20959581</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwankwo T., Yoon S. S., Burt V. &amp; Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011&#x2013;2012. NCHS Data Brief 133, 1&#x2013;8 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24171916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuklina E, Shaw K. &amp; Hong Y. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol &#x2014; United States, 1999&#x2013;2002 and 2005&#x2013;2008. Morb. Mortal. Wkly. Rep. 60, 109&#x2013;114 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21293326</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Dental and Craniofacial Research. Dental Caries (Tooth Decay) in Adults (Age 20 to 64)
https://www.nidcr.nih.gov/research/data-statistics/dental-caries/adults (2018).</Citation></Reference><Reference><Citation>Scheurwegs E., Luyckx K., Luyten L. &amp; Daelemans W. &amp; Van den Bulcke. T. Data integration of structured and unstructured sources for assigning clinical codes to patient stays. J. Am. Med. Inform. Assoc. 23, e11&#x2013;e19 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954635</ArticleId><ArticleId IdType="pubmed">26316458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y. et al. Early detection of heart failure with varying prediction windows by structured and unstructured data in electronic health records. in Eng in Med and Biol Soc, 2015 Annual Conference IEEE 2530&#x2013;2533 10.1109/EMBC.2015.7318907. (2015)).</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/EMBC.2015.7318907</ArticleId><ArticleId IdType="pmc">PMC5233460</ArticleId><ArticleId IdType="pubmed">26736807</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J. T. &amp; Altman R. B. Extracting and characterizing gene&#x2013;drug relationships from the literature. Pharmacogenet. Genomics 14, 577&#x2013;586 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15475731</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen E. S., Hripcsak G., Xu H., Markatou M. &amp; Friedman C. Automated acquisition of disease&#x2013;drug knowledge from biomedical and clinical documents: an initial study. J. Am. Med. Inform. Assoc 15, 87&#x2013;98 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2274872</ArticleId><ArticleId IdType="pubmed">17947625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendon&#xe7;a E. A. &amp; Cimino J. J. Automated knowledge extraction from MEDLINE citations. Proc. AMIA Symp 575&#x2013;579 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244129</ArticleId><ArticleId IdType="pubmed">11079949</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy A. B. et al. Matching identifiers in electronic health records: implications for duplicate records and patient safety. BMJ Qual Saf 22, 219&#x2013;224 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23362505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Levine M. E., Shang N. &amp; Ryan P. B. Effect of vocabulary mapping for conditions on phenotype cohorts. J. Am. Med. Inform. Assoc, In press 10.1093/jamia/ocy124 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30526572</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>Suppl 5</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Preliminary exploration of survival analysis using the OHDSI common data model: a case study of intrahepatic cholangiocarcinoma.</ArticleTitle><Pagination><StartPage>116</StartPage><MedlinePgn>116</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">116</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-018-0686-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Data heterogeneity is a common phenomenon related to the secondary use of electronic health records (EHR) data from different sources. The Observational Health Data Sciences and Informatics (OHDSI) Common Data Model (CDM) organizes healthcare data into standard data structures using concepts that are explicitly and formally specified through standard vocabularies, thereby facilitating large-scale analysis. The objective of this study is to design, develop, and evaluate generic survival analysis routines built using the OHDSI CDM.</AbstractText><AbstractText Label="METHODS">We used intrahepatic cholangiocarcinoma (ICC) patient data to implement CDM-based survival analysis methods. Our methods comprise the following modules: 1) Mapping local terms to standard OHDSI concepts. The analytical expression of variables and values related to demographic characteristics, medical history, smoking status, laboratory results, and tumor feature data. These data were mapped to standard OHDSI concepts through a manual analysis; 2) Loading patient data into the CDM using the concept mappings; 3) Developing an R interface that supports the portable survival analysis on top of OHDSI CDM, and comparing the CDM-based analysis results with those using traditional statistical analysis methods.</AbstractText><AbstractText Label="RESULTS">Our dataset contained 346 patients diagnosed with ICC. The collected clinical data contains 115 variables, of which 75 variables were mapped to the OHDSI concepts. These concepts mainly belong to four domains: condition, observation, measurement, and procedure. The corresponding standard concepts are scattered in six vocabularies: ICD10CM, ICD10PCS, SNOMED, LOINC, NDFRT, and READ. We loaded a total of 25,950 patient data records into the OHDSI CDM database. However, 40 variables failed to map to the OHDSI CDM as they mostly belong to imaging data and pathological data.</AbstractText><AbstractText Label="CONCLUSIONS">Our study demonstrates that conducting survival analysis using the OHDSI CDM is feasible and can produce reusable analysis routines. However, challenges to be overcome include 1) semantic loss caused by inaccurate mapping and value normalization; 2) incomplete OHDSI vocabularies describing imaging data, pathological data, and modular data representation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Integrated TCM &amp; Western Medicine Department, 302 Military Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huawei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Chengdu Library and Information Center, University of Chinese Academy of Sciences, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Comprehensive Liver Cancer Center, 302 Military Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yinying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Comprehensive Liver Cancer Center, 302 Military Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. Jiang.guoqian@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HG009450</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="Y">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018281" MajorTopicYN="Y">Cholangiocarcinoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007256" MajorTopicYN="Y">Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="Y">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Intrahepatic cholangiocarcinoma</Keyword><Keyword MajorTopicYN="N">Multi-center analysis</Keyword><Keyword MajorTopicYN="N">OHDSI CDM</Keyword><Keyword MajorTopicYN="N">R</Keyword><Keyword MajorTopicYN="N">Survival analysis</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: This study was approval by ethics review committee at 302 Military Hospital. All patients were included based on their consent forms. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30526572</ArticleId><ArticleId IdType="pmc">PMC6284277</ArticleId><ArticleId IdType="doi">10.1186/s12911-018-0686-7</ArticleId><ArticleId IdType="pii">10.1186/s12911-018-0686-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu CL, Wang S, Ji Z, Wu Y, Xiong L, Jiang X, Ohno-Machado L. WebDISCO: a web service for distributed cox model learning without patient-level data sharing. J. Am. Med. Inform. Assoc. 2015;22(6):1212&#x2013;1219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009917</ArticleId><ArticleId IdType="pubmed">26159465</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, Gutierrez JM, Frogley SJ, Ibele AR, Brinton EA, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143&#x2013;1155. doi: 10.1056/NEJMoa1700459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1700459</ArticleId><ArticleId IdType="pmc">PMC5737957</ArticleId><ArticleId IdType="pubmed">28930514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzic M, Pellicano R, Fabri M, Luzza F, Boccuto L, Brkic S, Abenavoli L. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Med. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">29856183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Ledinghen V, Ouzan D, et al. Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs. Gastroenterology. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">30031138</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelmeier F, Dultz G, Peiffer KH, Kronenberger B, Krauss F, Zeuzem S, Sarrazin C, Vermehren J, Waidmann O. Risk of de novo hepatocellular carcinoma after HCV treatment with direct-acting antivirals. Liver Cancer. 2018;7(2):190&#x2013;204. doi: 10.1159/000486812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000486812</ArticleId><ArticleId IdType="pmc">PMC5985411</ArticleId><ArticleId IdType="pubmed">29888208</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvaruso V, Cabibbo G, Cacciola I, Petta S, Madonia S, Bellia A, Tine F, Distefano M, Licata A, Giannitrapani L, et al. Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents. Gastroenterology. 2018;155(2):411&#x2013;421. doi: 10.1053/j.gastro.2018.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2018.04.008</ArticleId><ArticleId IdType="pubmed">29655836</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen Y, Park JW, et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med. 2018;379(1):54&#x2013;63. doi: 10.1056/NEJMoa1717002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1717002</ArticleId><ArticleId IdType="pmc">PMC7523244</ArticleId><ArticleId IdType="pubmed">29972759</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Sanchez FJ, Aguiar-Pulido V, Lopez-Campos GH, Peek N, Sacchi L. Secondary use and analysis of big data collected for patient care. Yearbook of medical informatics. 2017;26(1):28&#x2013;37. doi: 10.15265/IY-2017-008.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2017-008</ArticleId><ArticleId IdType="pmc">PMC6239231</ArticleId><ArticleId IdType="pubmed">28480474</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Waitman LR, Aaronson LS, Nadkarni PM, Connolly DW, Campbell JR. The Greater Plains collaborative: a PCORnet clinical research data network. J. Am. Med. Inform. Assoc. 2014;21(4):637&#x2013;641. doi: 10.1136/amiajnl-2014-002756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002756</ArticleId><ArticleId IdType="pmc">PMC4078294</ArticleId><ArticleId IdType="pubmed">24778202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong N, Li Z, Kiefer RC, Robertson MS, Goode EL, Wang C, Jiang G. Building an i2b2-based integrated data repository for Cancer research: a case study of ovarian Cancer registry. In: VLDB workshop on data management and analytics for medicine and healthcare. Cham: Springer; 2016. p. 121&#x2013;35.</Citation></Reference><Reference><Citation>Vashisht R, Jung K, Shah N. Learning effective treatment pathways for Type-2 diabetes from a clinical data warehouse. AMIA Annu Symp Proc. 2016;2016:2036&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333256</ArticleId><ArticleId IdType="pubmed">28269963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;7336. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Buuren SV, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;451&#x2013;68.</Citation></Reference><Reference><Citation>Shah AD, Bartlett JW, Carpenter J, Nicholas O, Hemingway H. Comparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study. Am J Epidemiol. 2014;179(6):764&#x2013;774. doi: 10.1093/aje/kwt312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt312</ArticleId><ArticleId IdType="pmc">PMC3939843</ArticleId><ArticleId IdType="pubmed">24589914</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel MK, Khanna P, Kishore J. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010;1(4):274&#x2013;278. doi: 10.4103/0974-7788.76794.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-7788.76794</ArticleId><ArticleId IdType="pmc">PMC3059453</ArticleId><ArticleId IdType="pubmed">21455458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30540837</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study.</ArticleTitle><Pagination><StartPage>e0208796</StartPage><MedlinePgn>e0208796</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0208796</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0208796</ELocationID><Abstract><AbstractText Label="BACKGROUND">The number of patients with diabetes is increasing particularly in Asia-Pacific region. Many of them are treated with antidiabetics. As the basis of the studies on the benefit and harm of antidiabetic drugs in the region, the information on patterns of market penetration of new classes of antidiabetic medications is important in providing context for subsequent research and analyzing and interpreting results.</AbstractText><AbstractText Label="METHODS">We compared penetration patterns of dipeptidyl peptidase-4 (DPP-4) inhibitors in Taiwan, Hong Kong, Japan, and the United States. We used the Taiwan National Health Insurance Research Database, a random sample of the Hong Kong Clinical Data Analysis and Reporting System, the Japan Medical Data Center database, and a 5% random sample of the US Medicare database converted to the Observational Medical Outcomes Partnership's Common Data Model to identify new users of oral antidiabetic medications. We standardized prevalence and incidence rates of medication use by age and sex to those in the 2010 Taiwanese population. We compared age, sex, comorbid conditions, and concurrent medications between new users of DPP-4 inhibitors and biguanides.</AbstractText><AbstractText Label="RESULTS">Use of DPP-4 inhibitors 1 year after market entry was highest in Japan and lowest in Hong Kong. New users had more heart failure, hyperlipidemia, and renal failure than biguanide users in Taiwan, Hong Kong, and the United States while the proportions were similar in Japan. In a country with low penetration of DPP-4 inhibitors (eg, Hong Kong), users had diabetes with multiple comorbid conditions compared with biguanidine users. In a country with high penetration (eg, Japan), the proportion of users with comorbid conditions was similar to that of biguanide users.</AbstractText><AbstractText Label="CONCLUSIONS">We observed a marked difference of the penetration patterns of newly marketed antidiabetics in different countries in Asia. Those results will provide the basic information useful in the future studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kubota</LastName><ForeName>Kiyoshi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6092-8685</Identifier><AffiliationInfo><Affiliation>NPO Drug Safety Research Unit Japan, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamijima</LastName><ForeName>Yukari</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>NPO Drug Safety Research Unit Japan, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao Yang</LastName><ForeName>Yea-Huei</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Japan Medical Data Center, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia-Cheng Lai</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth K C</ForeName><Initials>KKC</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stang</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Chien-Chou</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ian C K</ForeName><Initials>ICK</Initials><Identifier Source="ORCID">0000-0001-8242-0014</Identifier><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yinghong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Setoguchi</LastName><ForeName>Soko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Rutgers School of Public Health, New Brunswick, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054873">Dipeptidyl-Peptidase IV Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054873" MajorTopicYN="N">Dipeptidyl-Peptidase IV Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005202" MajorTopicYN="N" Type="Geographic">Asia, Eastern</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>This work was supported by a research agreement between Duke University and Janssen Research &amp; Development, LLC. Among authors, P Ryan, M Schuemie, and P Stang are employees of Janssen, a company that developed canagliflozin for treatment of Type 2 diabetes. This does not alter our adherence to PLOS ONE policies on sharing data and material.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30540837</ArticleId><ArticleId IdType="pmc">PMC6291148</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0208796</ArticleId><ArticleId IdType="pii">PONE-D-18-06212</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>International Diabetes Federation. IDF Diabetes Atlas Eighth Edition 2017. Available from: http://www.idf.org/idf-diabetes-atlas-seventh-edition.</Citation></Reference><Reference><Citation>Ryd&#xe9;n L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N. et al.
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2013: 34, 3035&#x2013;3087. 10.1093/eurheartj/eht108
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht108</ArticleId><ArticleId IdType="pubmed">23996285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolffenbuttel BH, Landgraf R. A
1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Diabetes Care
1999: 22, 463&#x2013;467. 10.2337/diacare.22.3.463
</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.22.3.463</ArticleId><ArticleId IdType="pubmed">10097930</ArticleId></ArticleIdList></Reference><Reference><Citation>The DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P. et al.
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet
2006: 368,1096&#x2013;1105. 10.1016/S0140-6736(06)69420-8
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69420-8</ArticleId><ArticleId IdType="pubmed">16997664</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratley RE, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S. et al.
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet
2010: 375, 1447&#x2013;1456. 10.1016/S0140-6736(10)60307-8
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60307-8</ArticleId><ArticleId IdType="pubmed">20417856</ArticleId></ArticleIdList></Reference><Reference><Citation>Defronzo RA, Ranter RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (Exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care
2005: 28, 1092&#x2013;1100. 10.2337/diacare.28.5.1092
</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.28.5.1092</ArticleId><ArticleId IdType="pubmed">15855572</ArticleId></ArticleIdList></Reference><Reference><Citation>Cefalu WT, Leiter LA, Yoon KH, Arias P, Niskanen L, Xie J. et al.
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet
2013: 382, 941&#x2013;950. 10.1016/S0140-6736(13)60683-2
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60683-2</ArticleId><ArticleId IdType="pubmed">23850055</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah BR, Victor JC, Chiu M, Tu JV, Anand SS, Austin PC. et al.
Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care
2013: 36, 2670&#x2013;2676. 10.2337/dc12-2105
</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc12-2105</ArticleId><ArticleId IdType="pmc">PMC3747942</ArticleId><ArticleId IdType="pubmed">23637350</ArticleId></ArticleIdList></Reference><Reference><Citation>International Society for Pharmacoepidemiology. AsPEN, Asian Pharmacoepidemiology Network. Available from: https://www.pharmacoepi.org/communities/sigs/aspen/.</Citation></Reference><Reference><Citation>Asian Pharmacoepidemiology Network. Surveillance of Health Care in Asian Network (SCAN) Project. Available from: http://aspennet.asia/activities/activity6.html.</Citation></Reference><Reference><Citation>National Health Insurance Research Database. Available from: http://nhird.nhri.org.tw/.</Citation></Reference><Reference><Citation>Wong AY, Root A, Douglas IJ, Chui CS, Chan EW, Ghebremichael-Weldeselassie Y. et al.
Cardiovascular outcomes associated with use of clarithromycin: population based study. BMJ
2016: 352, h6926
10.1136/bmj.h6926
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h6926</ArticleId><ArticleId IdType="pubmed">26768836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Sato T., Ikeda S., Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010: 20, 413&#x2013;419. 10.2188/jea.JE20090066
</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20090066</ArticleId><ArticleId IdType="pmc">PMC3900837</ArticleId><ArticleId IdType="pubmed">20699602</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubberke ER, Olsen MA, Stwalley D, Kelly CP, Gerding DN, Young-Xu Y. et al.
Identification of Medicare recipients at highest risk for clostridium difficile infection in the US by population attributable risk analysis. PLoS ONE
2016: 11, e0146822
10.1371/journal.pone.0146822
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0146822</ArticleId><ArticleId IdType="pmc">PMC4747338</ArticleId><ArticleId IdType="pubmed">26859403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirikos TN. Medicare and the Social Security Disability Insurance program. Health Aff. (Millwood) 1995: 14, 244&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">8690350</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. OMOP Common Data Model. Available from: http://www.ohdsi.org/data-standardization/the-common-data-model/.</Citation></Reference><Reference><Citation>Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC. et al.
Reader&#x2019;s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ
2005: 330, 960&#x2013;962. 10.1136/bmj.330.7497.960
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.330.7497.960</ArticleId><ArticleId IdType="pmc">PMC556348</ArticleId><ArticleId IdType="pubmed">15845982</ArticleId></ArticleIdList></Reference><Reference><Citation>International Society for Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practice (GPP) (2015). Available from: https://www.pharmacoepi.org/resources/policies/guidelines-08027/.</Citation></Reference><Reference><Citation>The PLOS Medicine editors. Observational studies: getting clear about transparency. PLoS Med
2014: 11, e1001711
10.1371/journal.pmed.1001711
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001711</ArticleId><ArticleId IdType="pmc">PMC4144975</ArticleId><ArticleId IdType="pubmed">25158064</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CH, Jiang YD, Chung CH, Ho LT, Chuang LM. National trends in anti-diabetic treatment in Taiwan, 2000&#x2013;2009. J Formos Med Assoc. 2012: 111, 617&#x2013;624. 10.1016/j.jfma.2012.09.009
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2012.09.009</ArticleId><ArticleId IdType="pubmed">23217597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan SS, Clavarino AM, Mamun AA, Kairuz T. A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia. Australas Med J.2015: 8, 179&#x2013;188. 10.4066/AMJ.2015.2330
</Citation><ArticleIdList><ArticleId IdType="doi">10.4066/AMJ.2015.2330</ArticleId><ArticleId IdType="pmc">PMC4496718</ArticleId><ArticleId IdType="pubmed">26213581</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association. Approaches to glycemic treatment. Diabetes Care
2016: 39 (Suppl 1), S52&#x2013;S59. 10.2337/dc16-S010
</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-S010</ArticleId><ArticleId IdType="pubmed">26696682</ArticleId></ArticleIdList></Reference><Reference><Citation>Japan Diabetes Society. Treatment Guide for Diabetes 2012&#x2013;2013. Tokyo, Bunkodo, 2013. Available from: http://www.jds.or.jp/modules/publication/index.php?content_id = 1.</Citation></Reference><Reference><Citation>Noda M, Noto H. Standard treatment manual for diabetes (in Japanese). Available from: http://ncgm-dm.jp/center/manual.html.</Citation></Reference><Reference><Citation>Iizuka T. Experts' agency problems: evidence from the prescription drug market in Japan. Rand J Econ. 2007;38:844&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pubmed">18478669</ArticleId></ArticleIdList></Reference><Reference><Citation>Iizuka T. Physician Agency and Adoption of Generic Pharmaceuticals. Am Econ Rev. 2012;102:2826&#x2013;2858.</Citation><ArticleIdList><ArticleId IdType="pubmed">29522299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health Labour and Welfare. Survey of Medical Care Activities in Public Health Insurance 2010 (in Japanese). Available from: https://www.mhlw.go.jp/toukei/saikin/hw/sinryo/tyosa10/dl/ingai.pdf.</Citation></Reference><Reference><Citation>Marcum ZA, Driessen J, Thorpe CT, Donohue JM, Gellad WF. Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics. Ann Pharmacother. 2015. 
49:285&#x2013;292. 10.1177/1060028014563951
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1060028014563951</ArticleId><ArticleId IdType="pmc">PMC4876962</ArticleId><ArticleId IdType="pubmed">25515869</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30646124</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.</ArticleTitle><Pagination><StartPage>e181755</StartPage><MedlinePgn>e181755</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e181755</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2018.1755</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Consensus around an efficient second-line treatment option for type 2 diabetes (T2D) remains ambiguous. The availability of electronic medical records and insurance claims data, which capture routine medical practice, accessed via the Observational Health Data Sciences and Informatics network presents an opportunity to generate evidence for the effectiveness of second-line treatments.</AbstractText><AbstractText Label="OBJECTIVE">To identify which drug classes among sulfonylureas, dipeptidyl peptidase 4 (DPP-4) inhibitors, and thiazolidinediones are associated with reduced hemoglobin A1c (HbA1c) levels and lower risk of myocardial infarction, kidney disorders, and eye disorders in patients with T2D treated with metformin as a first-line therapy.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Three retrospective, propensity-matched, new-user cohort studies with replication across 8 sites were performed from 1975 to 2017. Medical data of 246&#x202f;558&#x202f;805 patients from multiple countries from the Observational Health Data Sciences and Informatics (OHDSI) initiative were included and medical data sets were transformed into a unified common data model, with analysis done using open-source analytical tools. Participants included patients with T2D receiving metformin with at least 1 prior HbA1c laboratory test who were then prescribed either sulfonylureas, DPP-4 inhibitors, or thiazolidinediones. Data analysis was conducted from 2015 to 2018.</AbstractText><AbstractText Label="EXPOSURES">Treatment with sulfonylureas, DPP-4 inhibitors, or thiazolidinediones starting at least 90 days after the initial prescription of metformin.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome is the first observation of the reduction of HbA1c level to 7% of total hemoglobin or less after prescription of a second-line drug. Secondary outcomes are myocardial infarction, kidney disorder, and eye disorder after prescription of a second-line drug.</AbstractText><AbstractText Label="RESULTS">A total of 246&#x202f;558&#x202f;805 patients (126&#x202f;977&#x202f;785 women [51.5%]) were analyzed. Effectiveness of sulfonylureas, DPP-4 inhibitors, and thiazolidinediones prescribed after metformin to lower HbA1c level to 7% or less of total hemoglobin remained indistinguishable in patients with T2D. Patients treated with sulfonylureas compared with DPP-4 inhibitors had a small increased consensus hazard ratio of myocardial infarction (1.12; 95% CI, 1.02-1.24) and eye disorders (1.15; 95% CI, 1.11-1.19) in the meta-analysis. Hazard of observing kidney disorders after treatment with sulfonylureas, DPP-4 inhibitors, or thiazolidinediones was equally likely.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The examined drug classes did not differ in lowering HbA1c and in hazards of kidney disorders in patients with T2D treated with metformin as a first-line therapy. Sulfonylureas had a small, higher observed hazard of myocardial infarction and eye disorders compared with DPP-4 inhibitors in the meta-analysis. The OHDSI collaborative network can be used to conduct a large international study examining the effectiveness of second-line treatment choices made in clinical management of T2D.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vashisht</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuler</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Sanghyung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Institute of Next Generation of Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Joel T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>The Institute of Next Generation of Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kipp W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>The Institute of Next Generation of Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shervey</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>The Institute of Next Generation of Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yonghui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Outcome and Policy, College of Medicine, University of Florida, Gainesville.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natrajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Zandt</LastName><ForeName>Mui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reckard</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM101430</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 CA180993</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK098242</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054873">Dipeptidyl-Peptidase IV Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013453">Sulfonylurea Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D045162">Thiazolidinediones</NameOfSubstance></Chemical><Chemical><RegistryNumber>9100L32L2N</RegistryNumber><NameOfSubstance UI="D008687">Metformin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054873" MajorTopicYN="N">Dipeptidyl-Peptidase IV Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013453" MajorTopicYN="N">Sulfonylurea Compounds</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045162" MajorTopicYN="N">Thiazolidinediones</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Dudley has received consulting fees or honoraria from Janssen Pharmaceuticals, GlaxoSmithKline, AstraZeneca, and Hoffman-La Roche; is a scientific advisor to LAM Therapeutics; and holds equity in NuMedii Inc, Ayasdi Inc, and Ontomics Inc. Dr Xu reported grants from the National Institutes of Health and the Cancer Prevention and Research Institute of Texas during the conduct of the study and personal fees from Hebta LLC, Melax Technologies Inc, and More Health Inc outside the submitted work. Dr Wu reported grants from the Cancer Prevention and Research Institute of Texas during the conduct of the study and grants from the National Institutes of Health outside the submitted work. Dr Schuemie reported personal fees and was a shareholder at Janssen Research and Development during the conduct of the study. Drs Callahan and Shah reported grants from National Institutes of Health during the conduct of the study. Dr Ryan and Mr Weaver are employees of Janssen Research and Development. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30646124</ArticleId><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.1755</ArticleId><ArticleId IdType="pii">2698083</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):-. doi:10.1001/jama.2015.10029</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.10029</ArticleId><ArticleId IdType="pubmed">26348752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. . IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50. doi:10.1016/j.diabres.2017.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2017.03.024</ArticleId><ArticleId IdType="pubmed">28437734</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P-J, Kent DM, Winn A, Cohen JT, Neumann PJ. Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care. 2015;21(1):e23-e34.</Citation><ArticleIdList><ArticleId IdType="pubmed">25880265</ArticleId></ArticleIdList></Reference><Reference><Citation>Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GAM. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006;6(1):84. doi:10.1186/1472-6963-6-84</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-6-84</ArticleId><ArticleId IdType="pmc">PMC1534031</ArticleId><ArticleId IdType="pubmed">16820048</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriaanse MC, Drewes HW, van der Heide I, Struijs JN, Baan CA. The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients. Qual Life Res. 2016;25(1):175-182. doi:10.1007/s11136-015-1061-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-015-1061-0</ArticleId><ArticleId IdType="pmc">PMC4706581</ArticleId><ArticleId IdType="pubmed">26267523</ArticleId></ArticleIdList></Reference><Reference><Citation>Marathe PH, Gao HX, Close KL. American Diabetes Association standards of medical care in diabetes 2017. J Diabetes. 2017;9(4):320-324. doi:10.1111/1753-0407.12524</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.12524</ArticleId><ArticleId IdType="pubmed">28070960</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber AJ, Abrahamson MJ, Barzilay JI, et al. . Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm&#x2014;2017 executive summary. Endocr Pract. 2017;23(2):207-238. doi:10.4158/EP161682.CS</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP161682.CS</ArticleId><ArticleId IdType="pubmed">28095040</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart WF, Shah NR, Selna MJ, Paulus RA, Walker JM. Bridging the inferential gap: the electronic health record and clinical evidence. Health Aff (Millwood). 2007;26(2):w181-w191. doi:10.1377/hlthaff.26.2.w181</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.26.2.w181</ArticleId><ArticleId IdType="pmc">PMC2670472</ArticleId><ArticleId IdType="pubmed">17259202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. . Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574-578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. . Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329-7336. doi:10.1073/pnas.1510502113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Standards of Medical Care in Diabetes&#x2014;2017. Danvers, MA: Diabetes Care; 2017. doi:10.2337/dc17-S001</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-S001</ArticleId></ArticleIdList></Reference><Reference><Citation>Reusch JEB, Manson JE. Management of type 2 diabetes in 2017: getting to goal. JAMA. 2017;317(10):1015-1016. doi:10.1001/jama.2017.0241</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.0241</ArticleId><ArticleId IdType="pmc">PMC5894353</ArticleId><ArticleId IdType="pubmed">28249081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett WL, Maruthur NM, Singh S, et al. . Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154(9):602-613. doi:10.7326/0003-4819-154-9-201105030-00336</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-154-9-201105030-00336</ArticleId><ArticleId IdType="pmc">PMC3733115</ArticleId><ArticleId IdType="pubmed">21403054</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, et al. . Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform. 2015;6(3):536-547. doi:10.4338/ACI-2014-12-CR-0121</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2014-12-CR-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics 
OHDSI Standardized Vocabularies. https://github.com/OHDSI/CommonDataModel/wiki/Standardized-Vocabularies. Accessed June 8, 2018.</Citation></Reference><Reference><Citation>Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25(1):1-21. doi:10.1214/09-STS313</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/09-STS313</ArticleId><ArticleId IdType="pmc">PMC2943670</ArticleId><ArticleId IdType="pubmed">20871802</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150-161. doi:10.1002/pst.433</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.433</ArticleId><ArticleId IdType="pmc">PMC3120982</ArticleId><ArticleId IdType="pubmed">20925139</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery JM, Nyhan B, Torres M. 
How conditioning on post-treatment variables can ruin your experiment and what to do about it In: Annual Meeting of the Midwest Political Science Association; 2016; Chicago, IL: 
http://www.dartmouth.edu/~nyhan/post-treatment-bias.pdf. Accessed May 25, 2018.</Citation></Reference><Reference><Citation>Abadie A, Imbens GW. Bias-corrected matching estimators for average treatment effects. J Bus Econ Stat. 2011;29(1):1-11. doi:10.1198/jbes.2009.07333</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/jbes.2009.07333</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Stang PE, Berlin JA, et al. . A systematic statistical approach to evaluating evidence from observational studies. Annu Rev Stat Appl. 2014;1(1):11-39. doi:10.1146/annurev-statistics-022513-115645</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-statistics-022513-115645</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383-388. doi:10.1097/EDE.0b013e3181d61eeb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181d61eeb</ArticleId><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33(2):209-218. doi:10.1002/sim.5925</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>R Development Core Team R: A Language and Environment for Statistical Computing. Vienna, Austria: The R Foundation for Statistical Computing; 2011.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. doi:10.1371/journal.pmed.0040296</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040296</ArticleId><ArticleId IdType="pmc">PMC2020495</ArticleId><ArticleId IdType="pubmed">17941714</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Standards of medical care in diabetes. Diabetes Care. 2005;28(suppl 1):S4-S36. doi:10.2337/diacare.28.suppl_1.S4</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.28.suppl_1.S4</ArticleId><ArticleId IdType="pubmed">15618112</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM. External validity of randomised controlled trials: &#x201c;to whom do the results of this trial apply?&#x201d; Lancet. 2005;365(9453):82-93. doi:10.1016/S0140-6736(04)17670-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)17670-8</ArticleId><ArticleId IdType="pubmed">15639683</ArticleId></ArticleIdList></Reference><Reference><Citation>Bothwell LE, Greene JA, Podolsky SH, Jones DS. Assessing the gold standard&#x2014;lessons from the history of RCTs. N Engl J Med. 2016;374(22):2175-2181. doi:10.1056/NEJMms1604593</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMms1604593</ArticleId><ArticleId IdType="pubmed">27248626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30680949</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1753-0407</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of diabetes</Title><ISOAbbreviation>J Diabetes</ISOAbbreviation></Journal><ArticleTitle>Real-world experience of metformin use in pregnancy: Observational data from the Northern Territory Diabetes in Pregnancy Clinical Register.</ArticleTitle><Pagination><StartPage>761</StartPage><EndPage>770</EndPage><MedlinePgn>761-770</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1753-0407.12905</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In Australia's Northern Territory, Indigenous mothers account for 33% of births and have high rates of hyperglycemia in pregnancy. The prevalence of type 2 diabetes (T2D) in pregnancy is up to 10-fold higher in Indigenous than non-Indigenous Australian mothers, and the use of metformin is common. We assessed birth outcomes in relation to metformin use during pregnancy from a clinical register.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study included women with gestational diabetes (GDM), newly diagnosed diabetes in pregnancy (DIP), or pre-existing T2D from 2012 to 2016. Data were analyzed for metformin use in the third trimester. Regression models were adjusted for maternal age, body mass index, parity, and insulin use.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1649 pregnancies, 814 (49.4%) were to Indigenous women, of whom 234 (28.7%) had T2D (vs 4.6% non-Indigenous women; P&#x2009;&lt;&#x2009;0.001). Metformin use was high in Indigenous women (84%-90% T2D, 42%-48% GDM/DIP) and increased over time in non-Indigenous women (43%-100% T2D, 14%-35% GDM/DIP). Among Indigenous women with GDM/DIP, there were no significant differences between groups with and without metformin in cesarean section (51% vs 39%; adjusted odds ratio [aOR] 1.25, 95% confidence interval [CI] 0.87-1.81), large for gestational age (24% vs 13%; aOR 1.5, 95% CI 0.9-2.5), or serious neonatal adverse events (9.4% vs 5.9%; aOR 1.32, 95% CI 0.68-2.57). Metformin use was independently associated with earlier gestational age (37.7 vs 38.5&#x2009;weeks), but the risk did not remain independently higher after exclusion of women managed with medical nutrition therapy alone, and the increase in births &lt;37&#x2009;weeks was not significant on multivariate analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found no clear evidence of any adverse outcomes related to the use of metformin for the treatment of hyperglycemia in pregnancy.</AbstractText><CopyrightInformation>&#xa9; 2019 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maple-Brown</LastName><ForeName>Louise J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindenmayer</LastName><ForeName>Greta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barzi</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitbread</LastName><ForeName>Cherie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connors</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Northern Territory Department of Health, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aboriginal Medical Services Alliance Northern Territory, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyle</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkwood</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>I-Lynn</ForeName><Initials>IL</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longmore</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Dokkum</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Research, Baker Heart and Diabetes Institute, Alice Springs, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wicks</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dowden</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>One Disease, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inglis</LastName><ForeName>Chrissie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Healthy Living NT, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotter</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aboriginal Medical Services Alliance Northern Territory, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkham</LastName><ForeName>Renae</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corpus</LastName><ForeName>Sumaria</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Danila Dilba Health Service, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chitturi</LastName><ForeName>Sridhar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Sujatha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Obstetrics and Gynaecology Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Dea</LastName><ForeName>Kerin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Population Health Research, University of South Australia, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmet</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oats</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Harold D</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Mater Medical Research Institute, University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Obstetrics and Gynaecology Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Jonathan E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Population Health Research, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Northern Territory Diabetes in Pregnancy Partnership</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1032116</GrantID><Agency>Australian National Health and Medical Research Council (NHMRC)</Agency><Country/></Grant><Grant><GrantID>631974</GrantID><Agency>Australian National Health and Medical Research Council (NHMRC)</Agency><Country/></Grant><Grant><GrantID>1092968</GrantID><Agency>Australian National Health and Medical Research Council (NHMRC)</Agency><Country/></Grant><Grant><GrantID>1078477</GrantID><Agency>Australian National Health and Medical Research Council (NHMRC)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Diabetes</MedlineTA><NlmUniqueID>101504326</NlmUniqueID><ISSNLinking>1753-0407</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9100L32L2N</RegistryNumber><NameOfSubstance UI="D008687">Metformin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001724" MajorTopicYN="N">Birth Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016640" MajorTopicYN="N">Diabetes, Gestational</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015876" MajorTopicYN="N" Type="Geographic">Northern Territory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044382" MajorTopicYN="N">Population Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011236" MajorTopicYN="N">Prediabetic State</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>&#x6458;&#x8981;: &#x80cc;&#x666f; &#x5728;&#x6fb3;&#x5927;&#x5229;&#x4e9a;&#x5317;&#x90e8;&#x5730;&#x533a;, &#x539f;&#x4f4f;&#x6c11;&#x6bcd;&#x4eb2;&#x7684;&#x5a74;&#x513f;&#x51fa;&#x751f;&#x7387;&#x5360;33%, &#x5979;&#x4eec;&#x598a;&#x5a20;&#x671f;&#x95f4;&#x51fa;&#x73b0;&#x9ad8;&#x8840;&#x7cd6;&#x7684;&#x98ce;&#x9669;&#x5f88;&#x9ad8;&#x3002;&#x539f;&#x4f4f;&#x6c11;&#x6bcd;&#x4eb2;&#x5728;&#x598a;&#x5a20;&#x671f;&#x95f4;&#x7684;2&#x578b;&#x7cd6;&#x5c3f;&#x75c5;(T2D)&#x60a3;&#x75c5;&#x7387;&#x4e0e;&#x975e;&#x539f;&#x4f4f;&#x6c11;&#x6fb3;&#x5927;&#x5229;&#x4e9a;&#x6bcd;&#x4eb2;&#x76f8;&#x6bd4;&#x8f83;&#x8981;&#x9ad8;10&#x500d;, &#x5e76;&#x4e14;&#x7ecf;&#x5e38;&#x4f7f;&#x7528;&#x4e8c;&#x7532;&#x53cc;&#x80cd;&#x6cbb;&#x7597;&#x3002;&#x6211;&#x4eec;&#x5229;&#x7528;&#x4e34;&#x5e8a;&#x767b;&#x8bb0;&#x8868;&#x6570;&#x636e;&#x8bc4;&#x4f30;&#x4e86;&#x598a;&#x5a20;&#x671f;&#x95f4;&#x4f7f;&#x7528;&#x4e8c;&#x7532;&#x53cc;&#x80cd;&#x6cbb;&#x7597;&#x4e0e;&#x51fa;&#x751f;&#x7ed3;&#x679c;&#x4e4b;&#x95f4;&#x7684;&#x5173;&#x7cfb;&#x3002; &#x65b9;&#x6cd5; &#x8fd9;&#x9879;&#x7814;&#x7a76;&#x4ece;2012&#x81f3;2016&#x5e74;&#x7eb3;&#x5165;&#x4e86;&#x598a;&#x5a20;&#x7cd6;&#x5c3f;&#x75c5;(gestational diabetes, GDM)&#x3001;&#x598a;&#x5a20;&#x671f;&#x65b0;&#x8bca;&#x65ad;&#x7cd6;&#x5c3f;&#x75c5;(newly diagnosed diabetes in pregnancy, DIP)&#x4ee5;&#x53ca;&#x65e2;&#x5f80;&#x5df2;&#x7ecf;&#x5b58;&#x5728;T2D&#x7684;&#x5987;&#x5973;&#x3002;&#x5bf9;&#x598a;&#x5a20;&#x665a;&#x671f;&#x4f7f;&#x7528;&#x4e8c;&#x7532;&#x53cc;&#x80cd;&#x7684;&#x6570;&#x636e;&#x8fdb;&#x884c;&#x4e86;&#x5206;&#x6790;&#x3002;&#x6839;&#x636e;&#x6bcd;&#x4eb2;&#x5e74;&#x9f84;&#x3001;&#x4f53;&#x91cd;&#x6307;&#x6570;&#x3001;&#x4ea7;&#x6b21;&#x4ee5;&#x53ca;&#x80f0;&#x5c9b;&#x7d20;&#x4f7f;&#x7528;&#x60c5;&#x51b5;&#x6821;&#x6b63;&#x4e86;&#x56de;&#x5f52;&#x6a21;&#x578b;&#x3002; &#x7ed3;&#x679c; &#x5728;1649&#x540d;&#x5b55;&#x5987;&#x4e2d;&#x6709;814&#x540d;(49.4%)&#x4e3a;&#x539f;&#x4f4f;&#x6c11;&#x5987;&#x5973;, &#x5176;&#x4e2d;234&#x540d;(28.7%)&#x4e3a;T2D(&#x975e;&#x539f;&#x4f4f;&#x6c11;&#x5987;&#x5973;T2D&#x6bd4;&#x4f8b;&#x4e3a;4.6%&#xff1b;P &lt;&#x2009;0.001)&#x3002;&#x539f;&#x4f4f;&#x6c11;&#x5987;&#x5973;&#x7684;&#x4e8c;&#x7532;&#x53cc;&#x80cd;&#x4f7f;&#x7528;&#x7387;&#x66f4;&#x9ad8;(&#x5728;T2D&#x4e2d;&#x4e3a;84%-90%, &#x5728;GDM/DIP&#x4e2d;&#x4e3a;42%-48%), &#x5e76;&#x4e14;&#x5728;&#x975e;&#x539f;&#x4f4f;&#x6c11;&#x5987;&#x5973;&#x4e2d;&#x968f;&#x7740;&#x65f6;&#x95f4;&#x7684;&#x63a8;&#x79fb;&#x4f7f;&#x7528;&#x7387;&#x5728;&#x4e0a;&#x5347;(&#x5728;T2D&#x4e2d;&#x4e3a;43%-100%, &#x5728;GDM/DIP&#x4e2d;&#x4e3a;14%-35%)&#x3002;&#x5728;&#x5408;&#x5e76;GDM/DIP&#x7684;&#x539f;&#x4f4f;&#x6c11;&#x5987;&#x5973;&#x4e2d;, &#x4f7f;&#x7528;&#x4e8c;&#x7532;&#x53cc;&#x80cd;&#x6cbb;&#x7597;&#x7ec4;&#x4e0e;&#x4e0d;&#x4f7f;&#x7528;&#x4e8c;&#x7532;&#x53cc;&#x80cd;&#x6cbb;&#x7597;&#x7ec4;&#x4e4b;&#x95f4;&#x7684;&#x5256;&#x5bab;&#x4ea7;&#x7387;(&#x5206;&#x522b;&#x4e3a;51%&#x4e0e;39%; &#x6821;&#x6b63;&#x540e;&#x7684;odds ratio [aOR]&#x4e3a;1.25, 95%&#x7f6e;&#x4fe1;&#x533a;&#x95f4;[CI]&#x4e3a;0.87-1.81)&#x3001;&#x51fa;&#x73b0;&#x5927;&#x80ce;&#x9f84;&#x7387;(&#x5206;&#x522b;&#x4e3a;24%&#x4e0e;13%&#xff1b;aOR&#x4e3a;1.5, 95% CI&#x4e3a;0.9-2.5)&#x3001;&#x65b0;&#x751f;&#x513f;&#x51fa;&#x73b0;&#x4e25;&#x91cd;&#x4e0d;&#x826f;&#x4e8b;&#x4ef6;&#x7387;(&#x5206;&#x522b;&#x4e3a;9.4%&#x4e0e;5.9%&#xff1b;aOR&#x4e3a;1.32, 95% CI&#x4e3a;0.68-2.57)&#x90fd;&#x6ca1;&#x6709;&#x663e;&#x8457;&#x6027;&#x5dee;&#x5f02;&#x3002;&#x4f7f;&#x7528;&#x4e8c;&#x7532;&#x53cc;&#x80cd;&#x6cbb;&#x7597;&#x4e0e;&#x80ce;&#x9f84;&#x66f4;&#x5c0f;(&#x5206;&#x522b;&#x4e3a;37.7&#x4e0e;38.5&#x5468;)&#x72ec;&#x7acb;&#x76f8;&#x5173;, &#x4f46;&#x662f;&#x5c06;&#x5355;&#x72ec;&#x63a5;&#x53d7;&#x836f;&#x7269;&#x8425;&#x517b;&#x6cbb;&#x7597;&#x7684;&#x5987;&#x5973;&#x6392;&#x9664;&#x4e4b;&#x540e;, &#x8fd9;&#x79cd;&#x98ce;&#x9669;&#x6ca1;&#x6709;&#x72ec;&#x7acb;&#x5730;&#x5904;&#x4e8e;&#x8f83;&#x9ad8;&#x7684;&#x6c34;&#x5e73;, &#x5e76;&#x4e14;&#x591a;&#x53d8;&#x91cf;&#x5206;&#x6790;&#x663e;&#x793a;&lt;37&#x5468;&#x7684;&#x51fa;&#x751f;&#x7387;&#x5e76;&#x6ca1;&#x6709;&#x663e;&#x8457;&#x5730;&#x5347;&#x9ad8;&#x3002; &#x7ed3;&#x8bba; &#x6211;&#x4eec;&#x6ca1;&#x6709;&#x53d1;&#x73b0;&#x4efb;&#x4f55;&#x4e0e;&#x598a;&#x5a20;&#x671f;&#x95f4;&#x9ad8;&#x8840;&#x7cd6;&#x5987;&#x5973;&#x4f7f;&#x7528;&#x4e8c;&#x7532;&#x53cc;&#x80cd;&#x6cbb;&#x7597;&#x51fa;&#x73b0;&#x4e0d;&#x826f;&#x7ed3;&#x679c;&#x76f8;&#x5173;&#x7684;&#x660e;&#x786e;&#x8bc1;&#x636e;&#x3002;.</AbstractText><CopyrightInformation>&#xa9; 2019 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">birth outcomes</Keyword><Keyword MajorTopicYN="N">diabetes in pregnancy</Keyword><Keyword MajorTopicYN="N">gestational diabetes</Keyword><Keyword MajorTopicYN="N">metformin</Keyword><Keyword MajorTopicYN="N">type 2 diabetes in pregnancy</Keyword><Keyword MajorTopicYN="N">&#x4e8c;&#x7532;&#x53cc;&#x80cd;</Keyword><Keyword MajorTopicYN="N">&#x51fa;&#x751f;&#x7ed3;&#x679c;</Keyword><Keyword MajorTopicYN="N">&#x598a;&#x5a20;&#x671f;2&#x578b;&#x7cd6;&#x5c3f;&#x75c5;</Keyword><Keyword MajorTopicYN="N">&#x598a;&#x5a20;&#x671f;&#x7cd6;&#x5c3f;&#x75c5;</Keyword><Keyword MajorTopicYN="N">&#x598a;&#x5a20;&#x7cd6;&#x5c3f;&#x75c5;</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30680949</ArticleId><ArticleId IdType="doi">10.1111/1753-0407.12905</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Minges KE, Zimmet P, Magliano DJ, Dunstan DW, Brown A, Shaw JE. Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review. Diabetes Res Clin Pract. 2011;93:139-149.</Citation></Reference><Reference><Citation>Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gyneacol Obstet. 2015;131(Suppl 3):S173-S211.</Citation></Reference><Reference><Citation>Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.</Citation></Reference><Reference><Citation>Manderson JG, Mullan B, Patterson CC, Hadden DR, Traub AI, McCance DR. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia. 2002;45:991-996.</Citation></Reference><Reference><Citation>Horvath K, Koch K, Jeitler K, et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ. 2010;340:c1395.</Citation></Reference><Reference><Citation>Hall J, O'Neil L. Mothers and Babies 2014. Darwin, Australia: Northern Territory Department of Health; 2016.</Citation></Reference><Reference><Citation>Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, Mi GTI. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358:2003-2015.</Citation></Reference><Reference><Citation>Ainuddin JA, Karim N, Zaheer S, Ali SS, Hasan AA. Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy. J Diabetes Res. 2015;2015:325851.</Citation></Reference><Reference><Citation>Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. Gestational diabetes mellitus - management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust. 1998;169:93-97.</Citation></Reference><Reference><Citation>Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676-682.</Citation></Reference><Reference><Citation>World Health Organization (WHO). Diagnostic Criteria and Classification Of Hyperglycaemia First Detected in Pregnancy. Geneva, Switzerland: WHO; 2013.</Citation></Reference><Reference><Citation>Kirkham R, Whitbread C, Connors C, et al. Implementation of a diabetes in pregnancy clinical register in a complex setting: findings from a process evaluation. PLoS One. 2017;12:e0179487.</Citation></Reference><Reference><Citation>Case A, Zhang X, Dempsey K. Mothers and Babies 2012. Darwin, Australia: Northern Territory Department of Health; 2015.</Citation></Reference><Reference><Citation>Hall J, Case A, O'Neil L. Mothers and Babies 2013. Darwin, Australia: Northern Territory Department of Health; 2015.</Citation></Reference><Reference><Citation>Dobbins TA, Sullivan EA, Roberts CL, Simpson JM. Australian national birthweight percentiles by sex and gestational age, 1998-2007. Med J Aust. 2012;197:291-294.</Citation></Reference><Reference><Citation>Guaran RL, Wein P, Sheedy M, Walstab J, Beischer NA. Update of growth percentiles for infants born in an Australian population. Aust N Z J Obstet Gynaecol. 1994;34:39-50.</Citation></Reference><Reference><Citation>Lee I, Purbrick B, Barzi F, et al. Cohort profile: The Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) study. Int J Epidemiol. 2018;47:1045-1046h.</Citation></Reference><Reference><Citation>Simmons D, Walters BN, Rowan JA, McIntyre HD. Metformin therapy and diabetes in pregnancy. Med J Aust. 2004;180:462-464.</Citation></Reference><Reference><Citation>Hyer S, Balani J, Shehata H. Metformin in pregnancy: mechanisms and clinical applications. Int J Mol Sci. 2018;19:7.</Citation></Reference><Reference><Citation>Priya G, Kalra S. Metformin in the management of diabetes during pregnancy and lactation. Drugs Context. 2018;7:212523.</Citation></Reference><Reference><Citation>Rowan JA, Rush EC, Plank LD, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018;6:e000456.</Citation></Reference><Reference><Citation>Simeonova-Krstevska S, Bogoev M, Bogoeva K, et al. Maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus treated with diet, metformin or insulin. Open Access Maced J Med Sci. 2018;6:803-807.</Citation></Reference><Reference><Citation>Alqudah A, McKinley MC, McNally R, et al. Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis. Diabet Med. 2018;35:160-172.</Citation></Reference><Reference><Citation>Nankervis A, Conn J. Gestational diabetes mellitus: negotiating the confusion. Aust Fam Physician. 2013;42:528-531.</Citation></Reference><Reference><Citation>National Institute for Heath and Care Excellence (NICE) Diabetes in pregnancy: management from preconception to the postnatal period. Published February 2015. https://www.nice.org.uk/guidance/ng3. Accessed April 1, 2018.</Citation></Reference><Reference><Citation>American Diabetes Association. Management of diabetes in pregnancy: standards of medical care in diabetes - 2018. Diabetes Care. 2018;41(Suppl 1):S137-S143.</Citation></Reference><Reference><Citation>Remote Primary Health Care Manuals. Minymaku Kutju Tjukurpa - Women's Business Manual. 5th ed. Alice Springs, Australia: Congress Alukura and Nganampa Health Council Inc; 2014.</Citation></Reference><Reference><Citation>Langer O. Pharmacological treatment of gestational diabetes mellitus: point/counterpoint. Am J Obstet Gynecol. 2018;218:490-499.</Citation></Reference><Reference><Citation>Butalia S, Gutierrez L, Lodha A, Aitken E, Zakariasen A, Donovan L. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med. 2017;34:27-36.</Citation></Reference><Reference><Citation>Corcoy R, Balsells M, Garcia-Patterson A, Shmueli A, Hadar E. Pharmacotherapy for hyperglycemia in pregnancy: do oral agents have a place? Diabetes Res Clin Pract. 2018;145:51-58.</Citation></Reference><Reference><Citation>Kirkham R, Boyle JA, Whitbread C, et al. Health service changes to address diabetes in pregnancy in a complex setting: perspectives of health professionals. BMC Health Serv Res. 2017;17:524.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30704256</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-6354</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Rural and remote health</Title><ISOAbbreviation>Rural Remote Health</ISOAbbreviation></Journal><ArticleTitle>Perspectives from the frontline of two North American community paramedicine programs: an observational, ethnographic study.</ArticleTitle><Pagination><StartPage>4888</StartPage><MedlinePgn>4888</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.22605/RRH4888</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Community paramedicine is one emerging model filling gaps in rural healthcare delivery. It can expand the reach of primary care and public health service provision in underserviced rural communities through proactive engagement of paramedics in preventative care and chronic disease management. This study addressed key research priorities identified at the National Agenda for Community Paramedicine Research conference in Atlanta, USA in 2012. The motivations, job satisfaction and challenges from the perspectives of community paramedics and their managers pioneering two independent programs in rural North America were identified.</AbstractText><AbstractText Label="METHODS">An observational ethnographic approach was used to acquire qualitative data from participants, through informal discussions, semi-structured interviews, focus groups and direct observation of practice. During field trips over two summers, researchers purposively recruited participants from Ontario, Canada and Colorado, USA. These sites were selected on the basis of uncomplicated facilitation of ethics and institutional approval, the diversity of the programs and willingness of service managers to welcome researchers. Thematic analysis techniques were adopted for transcribing, de-identifying and coding data that allowed identification of common themes.</AbstractText><AbstractText Label="RESULTS">This study highlighted that the innovative nature of the community paramedic role can leave practitioners feeling misunderstood and unsupported by their peers. Three themes emerged: the motivators driving participation, the transitional challenges facing practitioners and the characteristics of paramedics engaged in these roles. A major motivator is the growing use of ambulances for non-emergency calls and the associated need to develop strategies to combat this phenomenon. This has prompted paramedic service managers to engage stakeholders to explore ways they could be more proactive in health promotion and hospital avoidance. Community paramedicine programs are fostering collaborative partnerships between disciplines, while the positive outcomes for patients and health cost savings are tangible motivators for paramedic services and funders. Paramedics were motivated by a genuine desire to make a difference and attracted to the innovative nature of a role delivering preventative care options for patients. Transitional challenges included lack of self-regulation, navigating untraditional roles and managing role boundary tensions between disciplines. Community paramedics in this study were largely self-selected, genuinely interested in the concept and proactively engaged in the grassroots development of these programs. These paramedics were comfortable integrating and operating within multidisciplinary teams.</AbstractText><AbstractText Label="CONCLUSIONS">Improved education and communication from paramedic service management with staff and external stakeholders might improve transitional processes and better support a culture of inclusivity for community paramedicine programs. Experienced and highly motivated paramedics with excellent communication and interpersonal skills should be considered for community paramedic roles. Practitioners who are proactive about community paramedicine and self-nominate for positions transition more easily into the role: they tend to see the 'bigger picture', have broader insight into public health issues and the benefits of integrative health care. They are more likely to achieve higher job satisfaction, remain in the role longer, and contribute to better long-term program outcomes. Paramedic services and policymakers can use these findings to incentivize career pathways in community paramedicine and understand those changes that might better support this innovative model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Angela C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>LaTrobe Rural Health School, LaTrobe University, PO Box 199, Bendigo, Vic. 3552, Australia angela.martin@sa.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Meara</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Community Emergency health &amp; Paramedic Practice, Monash University, Frankston, Victoria peter.omeara@monash.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Rural Remote Health</MedlineTA><NlmUniqueID>101174860</NlmUniqueID><ISSNLinking>1445-6354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000488" MajorTopicYN="N">Allied Health Personnel</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003120" MajorTopicYN="N" Type="Geographic">Colorado</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="N">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="N">Emergency Medical Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004634" MajorTopicYN="N">Emergency Medical Technicians</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007400" MajorTopicYN="Y">Interprofessional Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019035" MajorTopicYN="N">Rural Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">North America</Keyword><Keyword MajorTopicYN="N">community paramedics</Keyword><Keyword MajorTopicYN="N">ethnography</Keyword><Keyword MajorTopicYN="N">implementation</Keyword><Keyword MajorTopicYN="N">inclusivity</Keyword><Keyword MajorTopicYN="N">innovation</Keyword><Keyword MajorTopicYN="N">integration</Keyword><Keyword MajorTopicYN="N">paramedicine</Keyword><Keyword MajorTopicYN="N">primary care</Keyword><Keyword MajorTopicYN="N">change</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30704256</ArticleId><ArticleId IdType="doi">10.22605/RRH4888</ArticleId><ArticleId IdType="pii">4888</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30738946</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model.</ArticleTitle><Pagination><StartPage>103119</StartPage><MedlinePgn>103119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103119</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30037-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Supplementing the Spontaneous Reporting System (SRS) with Electronic Health Record (EHR) data for adverse drug reaction detection could augment sample size, increase population heterogeneity and cross-validate results for pharmacovigilance research. The difference in the underlying data structures and terminologies between SRS and EHR data presents challenges when attempting to integrate the two into a single database. The Observational Health Data Sciences and Informatics (OHDSI) collaboration provides a Common Data Model (CDM) for organizing and standardizing EHR data to support large-scale observational studies. The objective of the study is to develop and evaluate an informatics platform known as ADEpedia-on-OHDSI, where spontaneous reporting data from FDA's Adverse Event Reporting System (FAERS) is converted into the OHDSI CDM format towards building a next generation pharmacovigilance signal detection platform.</AbstractText><AbstractText Label="METHODS">An extraction, transformation and loading (ETL) tool was designed, developed, and implemented to convert FAERS data into the OHDSI CDM format. A comprehensive evaluation, including overall ETL evaluation, mapping quality evaluation of drug names to RxNorm, and an evaluation of transformation and imputation quality, was then performed to assess the mapping accuracy and information loss using the FAERS data collected between 2012 and 2017. Previously published findings related to vascular safety profile of triptans were validated using ADEpedia-on-OHDSI in pharmacovigilance research. For the triptan-related vascular event detection, signals were detected by Reporting Odds Ratio (ROR) in high-level group terms (HLGT) level, high-level terms (HLT) level and preferred term (PT) level using the original FAERS data and CDM-based FAERS respectively. In addition, six standardized MedDRA queries (SMQs) related to vascular events were applied.</AbstractText><AbstractText Label="RESULTS">A total of 4,619,362 adverse event cases were loaded into 8 tables in the OHDSI CDM. For drug name mapping, 93.9% records and 47.0% unique names were matched with RxNorm codes. Mapping accuracy of drug names was 96% based on a manual verification of randomly sampled 500 unique mappings. Information loss evaluation showed that more than 93% of the data is loaded into the OHDSI CDM for most fields, with the exception of drug route data (66%). The replication study detected 5, 18, 47 and 6, 18, 50 triptan-related vascular event signals in MedDRA HLGT level, HLT level, and PT level for the original FAERS data and CDM-based FAERS respectively. The signal detection scores of six standardized MedDRA queries (SMQs) of vascular events in the raw data study were found to be lower than those scores in the CDM study.</AbstractText><AbstractText Label="CONCLUSION">The outcome of this work would facilitate seamless integration and combined analyses of both SRS and EHR data for pharmacovigilance in ADEpedia-on-OHDSI, our platform for next generation pharmacovigilance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruddy</LastName><ForeName>Kathryn J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Oncology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuji</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilay D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. Electronic address: Jiang.Guoqian@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HG009450</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data Standardization</Keyword><Keyword MajorTopicYN="N">ETL tool</Keyword><Keyword MajorTopicYN="N">FAERS</Keyword><Keyword MajorTopicYN="N">OHDSI Common Data Model</Keyword><Keyword MajorTopicYN="N">Pharmacovigilance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30738946</ArticleId><ArticleId IdType="mid">NIHMS1521934</ArticleId><ArticleId IdType="pmc">PMC6432939</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103119</ArticleId><ArticleId IdType="pii">S1532-0464(19)30037-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harpaz R, et al., Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis. Clinical Pharmacology &amp; Therapeutics, 2012. 91(6): p. 1010&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675775</ArticleId><ArticleId IdType="pubmed">22549283</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMochel W, and Shah NH, Big Data and Adverse Drug Reaction Detection. Clin Pharmacol Ther, 2016. 99(3): p. 268&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">26575203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, et al., An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf, 2013. 36(2): p. 119&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, et al., Evaluating common data models for use with a longitudinal community registry. Journal of Biomedical Informatics, 2016. 64: p. 333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, et al., Accuracy of an automated knowledge base for identifying drug adverse reactions. Journal of Biomedical Informatics, 2017. 66: p. 72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al., A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions. Drug Safety, 2015. 38(10): p. 895&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579260</ArticleId><ArticleId IdType="pubmed">26153397</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce RD, et al., Preparing Nursing Home Data from Multiple Sites for Clinical Research - A Case Study Using Observational Health Data Sciences and Informatics. EGEMS (Wash DC), 2016. 4(1): p. 1252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108634</ArticleId><ArticleId IdType="pubmed">27891528</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, et al., Representing Knowledge Consistently Across Health Systems. Yearb Med Inform, 2017. 26(1): p. 139&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, et al., Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform, 2015. 216: p. 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardoon SL, et al., Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: a longitudinal population-based study. J Epidemiol Community Health, 2011. 65(9): p. 770&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173802</ArticleId><ArticleId IdType="pubmed">20515898</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, et al., Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc, 2012. 19(1): p. 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, et al., Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf, 2014. 37(11): p. 945&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlienger RG, Jick H, and Meier CR, Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. British Journal of Clinical Pharmacology, 2002. 54(3): p. 327&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1874430</ArticleId><ArticleId IdType="pubmed">12236854</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Solbrig HR, and Chute CG, ADEpedia: a scalable and standardized knowledge base of Adverse Drug Events using semantic web technology. AMIA Annu Symp Proc, 2011. 2011: p. 607&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243176</ArticleId><ArticleId IdType="pubmed">22195116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, et al., ADEpedia 2.0: Integration of Normalized Adverse Drug Events (ADEs) Knowledge from the UMLS. AMIA Jt Summits Transl Sci Proc, 2013. 2013: p. 100&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845793</ArticleId><ArticleId IdType="pubmed">24303245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al., Standardizing adverse drug event reporting data. J Biomed Semantics, 2014. 5: p. 36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4142531</ArticleId><ArticleId IdType="pubmed">25157320</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, et al., A curated and standardized adverse drug event resource to accelerate drug safety research. Sci Data, 2016. 3: p. 160026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872271</ArticleId><ArticleId IdType="pubmed">27193236</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA. FAERS. Available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm.</Citation></Reference><Reference><Citation>Cohen J, A Coefficient of Agreement for Nominal Scales. Educational &amp; Psychological Measurement, 1960. 20(1): p. 37&#x2013;46.</Citation></Reference><Reference><Citation>Roberto G, et al., Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database. Cephalalgia, 2014. 34(1): p. 5&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">23921799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bate A, et al., A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol, 1998. 54(4): p. 315&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">9696956</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson RK, et al., Influence of the MedDRA hierarchy on pharmacovigilance data mining results. Int J Med Inform, 2009. 78(12): p. e97&#x2013;e103.</Citation><ArticleIdList><ArticleId IdType="pubmed">19230751</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis JR and Koch GG, The measurement of observer agreement for categorical data. Biometrics, 1977. 33(1): p. 159&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. ATLAS. Available from: www.ohdsi.org/web/atlas/.</Citation></Reference><Reference><Citation>OHDSI. Usagi. Available from: https://github.com/OHDSI/Usagi.</Citation></Reference><Reference><Citation>Bodenreider O, Using SNOMED CT in combination with MedDRA for reporting signal detection and adverse drug reactions reporting. AMIA Annu Symp Proc, 2009. 2009: p. 45&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815504</ArticleId><ArticleId IdType="pubmed">20351820</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, et al., Developing A Standards-based Signal Detection and Validation Framework of Immune-related Adverse Events Using the OHDSI Common Data Model, in AMIA Annu Symp Proc. 2018. (In press)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30753493</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Criteria2Query: a natural language interface to clinical databases for cohort definition.</ArticleTitle><Pagination><StartPage>294</StartPage><EndPage>305</EndPage><MedlinePgn>294-305</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy178</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Cohort definition is a bottleneck for conducting clinical research and depends on subjective decisions by domain experts. Data-driven cohort definition is appealing but requires substantial knowledge of terminologies and clinical data models. Criteria2Query is a natural language interface that facilitates human-computer collaboration for cohort definition and execution using clinical databases.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Criteria2Query uses a hybrid information extraction pipeline combining machine learning and rule-based methods to systematically parse eligibility criteria text, transforms it first into a structured criteria representation and next into sharable and executable clinical data queries represented as SQL queries conforming to the OMOP Common Data Model. Users can interactively review, refine, and execute queries in the ATLAS web application. To test effectiveness, we evaluated 125 criteria across different disease domains from ClinicalTrials.gov and 52 user-entered criteria. We evaluated F1 score and accuracy against 2 domain experts and calculated the average computation time for fully automated query formulation. We conducted an anonymous survey evaluating usability.</AbstractText><AbstractText Label="RESULTS">Criteria2Query achieved 0.795 and 0.805 F1 score for entity recognition and relation extraction, respectively. Accuracies for negation detection, logic detection, entity normalization, and attribute normalization were 0.984, 0.864, 0.514 and 0.793, respectively. Fully automatic query formulation took 1.22 seconds/criterion. More than 80% (11+ of 13) of users would use Criteria2Query in their future cohort definition tasks.</AbstractText><AbstractText Label="CONCLUSIONS">We contribute a novel natural language interface to clinical databases. It is open source and supports fully automated and interactive modes for autonomous data-driven cohort definition by researchers with minimal human effort. We demonstrate its promising user friendliness and usability.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Technology, Nanjing University of Science and Technology, Nanjing, Jiangsu Province, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yixuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ziran</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM131905</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019992" MajorTopicYN="Y">Databases as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004608" MajorTopicYN="N">Eligibility Determination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="Y">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cohort definition</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">natural language interfaces to database</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30753493</ArticleId><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy178</ArticleId><ArticleId IdType="pii">5308980</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>H&#xe4;yrinen K, Saranto K, Nyk&#xe4;nen P.. Definition, structure, content, use and impacts of electronic health records: a review of the research literature. Int J Med Inf 2008; 77: 291&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">17951106</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, et al. Automated matching software for clinical trials eligibility: measuring efficiency and flexibility. Contemp Clin Trials 2010; 31 (3): 207&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadani SR, Weng C, Bigger JT, et al. Electronic screening improves efficiency in clinical trial recruitment. J Am Med Inform Assoc 2009; 16 (6): 869&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy LT, Dahman BA, Petkov VI, et al. Effort required in eligibility screening for clinical trials. J Oncol Pract 2012; 8 (6): 365&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3500483</ArticleId><ArticleId IdType="pubmed">23598846</ArticleId></ArticleIdList></Reference><Reference><Citation>Musen MA, Rohn JA, Fagan LM, et al. Knowledge engineering for a clinical trial advice system: uncovering errors in protocol specification. Bull Cancer 1987; 74: 291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">3620734</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C. Optimizing clinical research participant selection with informatics. Trends Pharmacol Sci 2015; 36 (11): 706&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4686428</ArticleId><ArticleId IdType="pubmed">26549161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, et al. EliIE: an open-source information extraction system for clinical trial eligibility criteria. J Am Med Inform Assoc 2017; 24 (6): 1062&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman CP. A &#x201c;fundamental theorem&#x201d; of biomedical informatics. J Am Med Inform Assoc JAMIA 2009; 16 (2): 169&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2649317</ArticleId><ArticleId IdType="pubmed">19074294</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Tu SW, Sim I, et al. Formal representation of eligibility criteria: a literature review. J Biomed Inform 2010; 43 (3): 451&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2878905</ArticleId><ArticleId IdType="pubmed">20034594</ArticleId></ArticleIdList></Reference><Reference><Citation>ERGO: a template-based expression language for encoding eligibility criteria. http://rctbank.ucsf.edu/home/ergo. Accessed April 7, 2018.</Citation></Reference><Reference><Citation>Tu SW, Peleg M, Carini S, et al. A practical method for transforming free-text eligibility criteria into computable criteria. J Biomed Inform 2011; 44 (2): 239&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3129371</ArticleId><ArticleId IdType="pubmed">20851207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya S, Cantor MN.. Analysis of eligibility criteria representation in industry-standard clinical trial protocols. J Biomed Inform 2013; 46 (5): 805&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">23770150</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Wu X, Luo Z, et al. EliXR: an approach to eligibility criteria extraction and representation. J Am Med Inform Assoc 2011; 18 (Suppl 1): i116&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241167</ArticleId><ArticleId IdType="pubmed">21807647</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Tu SW, Carini S, et al. EliXR-TIME: a temporal knowledge representation for clinical research eligibility criteria. AMIA Summits Transl Sci Proc 2012; 2012: 71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392056</ArticleId><ArticleId IdType="pubmed">22779055</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao T, Liu H, Weng C.. Valx: a system for extracting and structuring numeric lab test comparison statements from text. Methods Inf Med 2016; 55 (3): 266&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573874</ArticleId><ArticleId IdType="pubmed">26940748</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker CG. Generating medical logic modules for clinical trial eligibility. PhD thesis, Brigham Young University; 2005.</Citation></Reference><Reference><Citation>OMOP Common Data Model &#x2013; OHDSI. https://www.ohdsi.org/data-standardization/the-common-data-model/. Accessed March 25, 2018.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS. http://www.ohdsi.org/web/atlas/#/home. Accessed March 25, 2018.</Citation></Reference><Reference><Citation>
Androutsopoulos I, Ritchie GD, Thanisch P.. 
Natural language interfaces to databases&#x2014;an introduction. Nat Lang Eng 1995; 1 (1): 29&#x2013;81. doi:10.1017/S135132490000005X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S135132490000005X</ArticleId></ArticleIdList></Reference><Reference><Citation>Copestake A, Jones KS.. Natural language interfaces to databases. Knowl Eng Rev 1990; 5 (4): 225&#x2013;49.</Citation></Reference><Reference><Citation>Woods WA. Progress in natural language understanding: an application to lunar geology. In: Proceedings of the June 4-8, 1973, National Computer Conference and Exposition. New York, NY: ACM; 1973:441&#x2013;50.</Citation></Reference><Reference><Citation>
Epstein MN, Walker DE.. 
Natural language access to a melanoma data base. Proc Annu Symp Comput Appl Med Care 1978; 1978: 320&#x2013;5. doi:10.1109/SCAMC.1978.679936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/SCAMC.1978.679936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra Y, Mihalcea R.. Natural language interfaces to databases. Master of Science thesis, University of North Texas, 2006.</Citation></Reference><Reference><Citation>Pazos RRA, Gonz&#xe1;lez BJJ, Aguirre LMA, et al. Natural language interfaces to databases: an analysis of the state of the art In: Castillo O, Melin P, Kacprzyk J, eds. Recent Advances in Hybrid Intelligence Systems. New York: Springer; 2013; 463&#x2013;80.</Citation></Reference><Reference><Citation>Woodyard M, Hamel B.. A natural language interface to a clinical data base management system. Comput Biomed Res 1981; 14 (1): 41&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">7237996</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts K, Demner-Fushman D.. Toward a natural language interface for EHR questions. AMIA Summits Transl Sci Proc 2015; 2015: 157&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525248</ArticleId><ArticleId IdType="pubmed">26306260</ArticleId></ArticleIdList></Reference><Reference><Citation>Loose coupling. Wikipedia. 2018. 
https://en.wikipedia.org/w/index.php?title=Loose_coupling&amp;oldid=840712645. Accessed May 14, 2018.</Citation></Reference><Reference><Citation>
Manning C, Surdeanu M, Bauer J,
et al. The Stanford CoreNLP natural language processing toolkit. In: Proceedings of 52nd Annual Meeting of the Association for Computational Linguistics: System Demonstrations. Baltimore, MD: Association for Computational Linguistics; 2014:55&#x2013;60. http://www.aclweb.org/anthology/P14-5010. Accessed July 18, 2018.</Citation></Reference><Reference><Citation>Chapman WW, Bridewell W, Hanbury P, et al. A simple algorithm for identifying negated findings and diseases in discharge summaries. J Biomed Inform 2001; 34 (5): 301&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12123149</ArticleId></ArticleIdList></Reference><Reference><Citation>
Schuster S, Manning CD. Enhanced English universal dependencies: an improved representation for natural language understanding tasks.  https://nlp.stanford.edu/pubs/schuster2016enhanced.pdf. Accessed March 26, 2018.</Citation></Reference><Reference><Citation>Dijkstra&#x2019;s algorithm. Wikipedia. 2018. 
https://en.wikipedia.org/w/index.php?title=Dijkstra%27s_algorithm&amp;oldid=832284506. Accessed March 26, 2018.</Citation></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004; 32 (90001): 267D&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Usagi. https://github.com/OHDSI/Usagi. Accessed April 7, 2018.</Citation></Reference><Reference><Citation>OHDSI WebAPI. http://webapidoc.ohdsi.org/job/WebAPI/WebAPI_Miredot_Documentation/index.html. Accessed April 7, 2018.</Citation></Reference><Reference><Citation>
Chang AX, Manning CD.. 
Sutime: a library for recognizing and normalizing time expressions In: Proceedings of the Eighth International Conference on Language Resources and Evaluation (LREC-2012). Istanbul, Turkey:
ELRA; 2012:3735&#x2013;740. https://pdfs.semanticscholar.org/fe80/746646f6ee819205ca9a8476292ea6b83e66.pdf. Accessed July 5, 2017.</Citation></Reference><Reference><Citation>Dogan RI, Lu Z. An inference method for disease name normalization. Paper presented at: AAAI Fall Symposium: Information Retrieval and Knowledge Discovery in Biomedical Text; November 2&#x2013;4, 2012; Arlington, VA.</Citation></Reference><Reference><Citation>Zhou L, Plasek JM, Mahoney LM, et al. Mapping partners master drug dictionary to RxNorm using an NLP-based approach. J Biomed Inform 2012; 45 (4): 626&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30762164</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches.</ArticleTitle><Pagination><StartPage>743</StartPage><EndPage>750</EndPage><MedlinePgn>743-750</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-018-00792-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION">It is important to monitor the safety profile of drugs, and mining for strong associations between drugs and adverse events is an effective and inexpensive method of post-marketing safety surveillance.</AbstractText><AbstractText Label="OBJECTIVE">The objective of our work was to compare the accuracy of both common and innovative methods of data mining for pharmacovigilance purposes.</AbstractText><AbstractText Label="METHODS">We used the reference standard provided by the Observational Medical Outcomes Partnership, which contains 398 drug-adverse event pairs (165 positive controls, 233 negative controls). Ten methods and algorithms were applied to the US FDA Adverse Event Reporting System data to investigate the 398 pairs. The ten methods include popular methods in the pharmacovigilance literature, newly developed pharmacovigilance methods as at 2018, and popular methods in the genome-wide association study literature. We compared their performance using the receiver operating characteristic (ROC) plot, area under the curve (AUC), and Youden's index.</AbstractText><AbstractText Label="RESULTS">The Bayesian confidence propagation neural network had the highest AUC overall. Monte Carlo expectation maximization, a method developed in 2018, had the second highest AUC and the highest Youden's index, and performed very well in terms of high specificity. The regression-adjusted gamma Poisson shrinkage model performed best under high-sensitivity requirements.</AbstractText><AbstractText Label="CONCLUSION">Our results will be useful to help choose a method for a given desired level of specificity. Methods popular in the genome-wide association study literature did not perform well because of the sparsity of data and will need modification before their properties can be used in the drug-adverse event association problem.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Minh</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3981-0951</Identifier><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, University of South Florida, 4202 East Fowler Ave, CMC342, Tampa, FL, 33620, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, 12901 Bruce B. Downs Blvd, MDC 30, Tampa, FL, 33612, USA. fcheng1@health.usf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramachandran</LastName><ForeName>Kandethody</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, University of South Florida, 4202 East Fowler Ave, CMC342, Tampa, FL, 33620, USA. ram@usf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="N">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014486" MajorTopicYN="N">United States Food and Drug Administration</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30762164</ArticleId><ArticleId IdType="doi">10.1007/s40264-018-00792-0</ArticleId><ArticleId IdType="pii">10.1007/s40264-018-00792-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Pharmacol Ther. 2013 Jun;93(6):539-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23571771</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15317031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Jan 29;8(1):1806</Citation><ArticleIdList><ArticleId IdType="pubmed">29379048</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2005 Feb;28(2):157-70</Citation><ArticleIdList><ArticleId IdType="pubmed">15532037</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 1998 Jun;54(4):315-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9696956</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2012 Jun;99(6):323-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22546560</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2001;21 Suppl 1:S600-1</Citation><ArticleIdList><ArticleId IdType="pubmed">11793745</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):525-6; discussion 527-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15317032</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2005;:531-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15759657</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11828828</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Pharmacol. 1997 Aug;44(2):109-10</Citation><ArticleIdList><ArticleId IdType="pubmed">9278192</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2013 Oct;36 Suppl 1:S33-47</Citation><ArticleIdList><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>BioData Min. 2016 Apr 06;9:14</Citation><ArticleIdList><ArticleId IdType="pubmed">27053949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Clin Psychiatry. 2008 Jan-Mar;20(1):21-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18297583</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2002;25(6):381-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12071774</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30771218</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1826-6983</ISSN><JournalIssue CitedMedium="Internet"><Volume>124</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>La Radiologia medica</Title><ISOAbbreviation>Radiol Med</ISOAbbreviation></Journal><ArticleTitle>Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group.</ArticleTitle><Pagination><StartPage>662</StartPage><EndPage>670</EndPage><MedlinePgn>662-670</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11547-019-00999-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate the role of radiotherapy (RT) in the management of EGFR- or ALK-mutated metastatic non-small cell lung cancer (NSCLC) treated with TKI.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Clinical data of 106 patients (pts) from five Institutions treated with RT concomitant to TKI were retrospectively revised. Overall survival (OS) and toxicities were analyzed as endpoints of the study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median age of pts was 65&#xa0;years. TKIs were given for EGFR (81%)- or ALK (19%)-mutated metastatic NSCLC. Stereotactic RT (SRT) was delivered to 49 pts (46%). Patients with four or less metastasis were defined as oligometastatic/oligoprogressive (OM/OP); sites of RT were brain, bone, lung or others in 46%, 27%, 14% and 13%, respectively. Median OS was 23&#xa0;months. At univariate analysis SRT, ECOG PS 0-1, OM/OP disease, lung sites and a TKI duration longer than median favorably affected OS (all p&#x2009;&lt;&#x2009;0.001). Multivariate analysis confirmed SRT (HR 0.355, CI 95% 0.212-0.595; p&#x2009;&lt;&#x2009;0.001) and median duration of TKI&#x2009;&gt;&#x2009;14&#xa0;months (HR 0.17, 95% CI 0.10-0.30; p&#x2009;&lt;&#x2009;0.001) as independent factors related to better OS. Toxicities were rare.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SRT seems to positively affect OS with limited toxicity in selected patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borghetti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Istituto del Radio O. Alberti, Spedali Civili Hospital and Brescia University, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bon&#xf9;</LastName><ForeName>Marco Lorenzo</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Istituto del Radio O. Alberti, Spedali Civili Hospital and Brescia University, Brescia, Italy. marcolorenzo89.mlb@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giubbolini</LastName><ForeName>Rachele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Radiotherapy Unit, Oncology and Hematology Department, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levra</LastName><ForeName>Niccolo' Giaj</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sacro Cuore Hospital, Negrar, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzola</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sacro Cuore Hospital, Negrar, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perna</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meacci</LastName><ForeName>Fiammetta</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taraborrelli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Radiotherapy Unit, SS Annunziata Hospital - G. D'annunzio University, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triggiani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Istituto del Radio O. Alberti, Spedali Civili Hospital and Brescia University, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franceschini</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy and Radiosurgery, Humanitas Research Hospital and Cancer Center, Milan, Rozzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departement of Radiation Oncology, Campus Bio-Medico University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Radiotherapy Unit, Oncology and Hematology Department, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magrini</LastName><ForeName>Stefano Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Istituto del Radio O. Alberti, Spedali Civili Hospital and Brescia University, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotti</LastName><ForeName>Vieri</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Radiol Med</MedlineTA><NlmUniqueID>0177625</NlmUniqueID><ISSNLinking>0033-8362</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C000626173">ALK protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D000077548">Anaplastic Lymphoma Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C512478">EGFR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D066246">ErbB Receptors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077548" MajorTopicYN="N">Anaplastic Lymphoma Kinase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066246" MajorTopicYN="N">ErbB Receptors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALK mutated</Keyword><Keyword MajorTopicYN="N">EGFR mutated</Keyword><Keyword MajorTopicYN="N">Oligometastatic</Keyword><Keyword MajorTopicYN="N">Oligoprogressive</Keyword><Keyword MajorTopicYN="N">Radiotherapy</Keyword><Keyword MajorTopicYN="N">Stage IV NSCLC</Keyword><Keyword MajorTopicYN="N">Stereotactic radiotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30771218</ArticleId><ArticleId IdType="doi">10.1007/s11547-019-00999-w</ArticleId><ArticleId IdType="pii">10.1007/s11547-019-00999-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Oncol. 2004 Dec;25(6):1677-83</Citation><ArticleIdList><ArticleId IdType="pubmed">15547705</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2005 Apr 15;65(8):3328-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15833866</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Oncol. 2009;48(4):578-83</Citation><ArticleIdList><ArticleId IdType="pubmed">19373699</ArticleId></ArticleIdList></Reference><Reference><Citation>Jpn J Clin Oncol. 2010 Feb;40(2):107-11</Citation><ArticleIdList><ArticleId IdType="pubmed">20047860</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiat Oncol. 2011 Jun 30;6:80</Citation><ArticleIdList><ArticleId IdType="pubmed">21718501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2012 Mar;13(3):239-46</Citation><ArticleIdList><ArticleId IdType="pubmed">22285168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2012 Oct;7(10):1547-55</Citation><ArticleIdList><ArticleId IdType="pubmed">22982655</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2013 May 1;105(9):595-605</Citation><ArticleIdList><ArticleId IdType="pubmed">23594426</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 2013 Nov 15;133(10):2277-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23720067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2013 Oct;82(1):95-102</Citation><ArticleIdList><ArticleId IdType="pubmed">23973202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2013 Dec;82(3):431-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24113550</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):892-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24462383</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):880-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24867533</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2015 Apr;20(4):400-10</Citation><ArticleIdList><ArticleId IdType="pubmed">25795635</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2015 Oct 20;33(30):3488-515</Citation><ArticleIdList><ArticleId IdType="pubmed">26324367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2016 Sep;27(suppl 5):v1-v27</Citation><ArticleIdList><ArticleId IdType="pubmed">27664245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2016 Dec;17(12):1672-1682</Citation><ArticleIdList><ArticleId IdType="pubmed">27789196</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Treat Rev. 2017 Feb;53:25-37</Citation><ArticleIdList><ArticleId IdType="pubmed">28056412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2017 Feb 1;28(2):270-277</Citation><ArticleIdList><ArticleId IdType="pubmed">28426106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Jul 1;390(10089):29-39</Citation><ArticleIdList><ArticleId IdType="pubmed">28501140</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30779778</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Data model harmonization for the All Of Us Research Program: Transforming i2b2 data into the OMOP common data model.</ArticleTitle><Pagination><StartPage>e0212463</StartPage><MedlinePgn>e0212463</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0212463</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0212463</ELocationID><Abstract><AbstractText Label="BACKGROUND">The All Of Us Research Program (AOU) is building a nationwide cohort of one million patients' EHR and genomic data. Data interoperability is paramount to the program's success. AOU is standardizing its EHR data around the Observational Medical Outcomes Partnership (OMOP) data model. OMOP is one of several standard data models presently used in national-scale initiatives. Each model is unique enough to make interoperability difficult. The i2b2 data warehousing and analytics platform is used at over 200 sites worldwide, which uses a flexible ontology-driven approach for data storage. We previously demonstrated this ontology system can drive data reconfiguration, to transform data into new formats without site-specific programming. We previously implemented this on our 12-site Accessible Research Commons for Health (ARCH) network to transform i2b2 into the Patient Centered Outcomes Research Network model.</AbstractText><AbstractText Label="METHODS AND RESULTS">Here, we leverage our investment in i2b2 high-performance transformations to support the AOU OMOP data pipeline. Because the ARCH ontology has gained widespread national interest (through the Accrual to Clinical Trials network, other PCORnet networks, and the Nebraska Lexicon), we leveraged sites' existing investments into this standard ontology. We developed an i2b2-to-OMOP transformation, driven by the ARCH-OMOP ontology and the OMOP concept mapping dictionary. We demonstrated and validated our approach in the AOU New England HPO (NEHPO). First, we transformed into OMOP a fake patient dataset in i2b2 and verified through AOU tools that the data was structurally compliant with OMOP. We then transformed a subset of data in the Partners Healthcare data warehouse into OMOP. We developed a checklist of assessments to ensure the transformed data had self-integrity (e.g., the distributions have an expected shape and required fields are populated), using OMOP's visual Achilles data quality tool. This i2b2-to-OMOP transformation is being used to send NEHPO production data to AOU. It is open-source and ready for use by other research projects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0003-2043-1601</Identifier><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Computer Science, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joss</LastName><ForeName>Matthew A H</ForeName><Initials>MAH</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Embree</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Personalized Medicine, Partners Healthcare, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Computer Science, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 OD026553</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009174</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008685</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30779778</ArticleId><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0212463</ArticleId><ArticleId IdType="pii">PONE-D-18-34751</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sankar PL, Parker LS. The Precision Medicine Initiative&#x2019;s All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genet Med Off J Am Coll Med Genet. 2017;19: 743&#x2013;750. 10.1038/gim.2016.183</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2016.183</ArticleId><ArticleId IdType="pubmed">27929525</ArticleId></ArticleIdList></Reference><Reference><Citation>All of Us Research Program. In: National Institutes of Health (NIH) [Internet]. [cited 6 Mar 2017]. Available: https://allofus.nih.gov/</Citation></Reference><Reference><Citation>Health Care Provider Organizations | All of Us [Internet]. [cited 3 Feb 2018]. Available: https://allofus.nih.gov/about/program-components/health-care-provider-organizations</Citation></Reference><Reference><Citation>Verily Life Sciences: Precision Medicine Initiative [Internet]. [cited 3 Feb 2018]. Available: https://verily.com/projects/precision-medicine/precision-medicine-initiative/</Citation></Reference><Reference><Citation>PCORnet Common Data Model (CDM). In: PCORnet [Internet]. [cited 6 Mar 2017]. Available: http://www.pcornet.org/pcornet-common-data-model/</Citation></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inf Assoc. 2010;17: 124&#x2013;130. 10.1136/jamia.2009.000893</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran S, Becich MJ, D&#x2019;Itri VS, Sendro ER, MacFadden D, Anderson NR, et al. Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network. JAMIA Open. 10.1093/jamiaopen/ooy033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooy033</ArticleId><ArticleId IdType="pmc">PMC6241502</ArticleId><ArticleId IdType="pubmed">30474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimball R, Ross M. The data warehouse toolkit: the complete guide to dimensional modeling [Internet]. John Wiley &amp; Sons; 2011.  Available: https://books.google.com/books?hl=en&amp;lr=&amp;id=XoS2oy1IcB4C&amp;oi=fnd&amp;pg=PA1&amp;dq=data+warehousing+kimball&amp;ots=1BJgqCeKaA&amp;sig=M6BhBzXKYwHZuXYFaq6NrepNnBY</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216: 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016;23: 909&#x2013;915. 10.1093/jamia/ocv188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv188</ArticleId><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurry AJ, Murphy SN, MacFadden D, Weber G, Simons WW, Orechia J, et al. SHRINE: Enabling Nationally Scalable Multi-Site Disease Studies. PLoS ONE. 2013;8: e55811 10.1371/journal.pone.0055811</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055811</ArticleId><ArticleId IdType="pmc">PMC3591385</ArticleId><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell W. Deploying ONC national Standards in Support of Metadata for Big Data Research Warehouse Management of Repurposed Laboratory, Pathology &amp; Patient Findings Data From the EHR. Available: http://grantome.com/grant/NIH/U01-HG009455-02</Citation></Reference><Reference><Citation>UNMC Terminology Development Center | Pathology and Microbiology | University of Nebraska Medical Center [Internet]. [cited 18 Oct 2018]. Available: https://www.unmc.edu/pathology/informatics/tdc.html</Citation></Reference><Reference><Citation>Natarajan K, Velez M. pmi_sprint_reporter: Data Sprints for the All of Us Research Program [Internet]. Department of Biomedical Informatics; 2017. Available: https://github.com/cumc-dbmi/pmi_sprint_reporter</Citation></Reference><Reference><Citation>Phillips L. NCBO Extraction Tool version 2.0. In: NCBO Ontology Tools for i2b2 [Internet]. [cited 4 Dec 2014]. Available: https://community.i2b2.org/wiki/display/NCBO/NCBO+Extraction+Tool+version+2.0</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics: Standardized Vocabulary Principles [Internet]. [cited 2 Feb 2018]. Available: http://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:principles</Citation></Reference><Reference><Citation>Precision Medicine Initiative Data Sprints [Internet]. [cited 3 Feb 2018]. Available: https://cumc-dbmi.github.io/pmi_sprint_reporter/</Citation></Reference><Reference><Citation>Klann JG, Joss M, Abend A, Embree K. i2o-transform: PCORnet Ontology to OMOP (beta version) [Internet]. Accessible Research Commons for Health; 2018. Available: https://github.com/i2b2-omop/i2o-transform</Citation></Reference><Reference><Citation>Klann JG, Phillips LC, Joss M. arch-ontology: ARCH i2b2 PCORnet Ontology [Internet]. Accessible Research Commons for Health; 2018. Available: https://github.com/ARCH-commons/arch-ontology</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30815088</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Clinical Concept Value Sets and Interoperability in Health Data Analytics.</ArticleTitle><Pagination><StartPage>480</StartPage><EndPage>489</EndPage><MedlinePgn>480-489</MedlinePgn></Pagination><Abstract><AbstractText>This paper focuses on <i>value sets</i> as an essential component in the health analytics ecosystem. We discuss shared repositories of reusable value sets and offer recommendations for their further development and adoption. In order to motivate these contributions, we explain how value sets fit into specific analytic tasks and the health analytics landscape more broadly; their growing importance and ubiquity with the advent of Common Data Models, Distributed Research Networks, and the availability of higher order, reusable analytic resources like electronic phenotypes and electronic clinical quality measures; the formidable barriers to value set reuse; and our introduction of a concept-agnostic orientation to vocabulary collections. The costs of ad hoc value set management and the benefits of value set reuse are described or implied throughout. Our standards, infrastructure, and design recommendations are not systematic or comprehensive but invite further work to support value set reuse for health analytics. <i>The views represented in the paper do not necessarily represent the views of the institutions or of all the co-authors</i>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>Sigfried</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Maryland, College Park.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batch</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Maryland, College Park.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClure</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>MD Partners, Lafayette, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharrazi</LastName><ForeName>Hadi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saripalle</LastName><ForeName>Rishi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Illinois State University; Normal, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>National Library of Medicine, Bethesda, MD.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roderer</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Maryland, College Park.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szarfman</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elmqvist</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Maryland, College Park.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gotz</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073892" MajorTopicYN="Y">Health Information Interoperability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075403" MajorTopicYN="N">Semantic Web</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30815088</ArticleId><ArticleId IdType="pmc">PMC6371254</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jiang G, Solbrig HR, Chute CG. Quality evaluation of cancer study Common Data Elements using the UMLS Semantic Network. J Biomed Inform. 2011 Dec;44(Suppl 1):S78&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">21840422</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Solbrig HR, Chute CG. Quality evaluation of value sets from cancer study common data elements using the UMLS semantic groups. J Am Med Inform Assoc. 2012 Jun;19(e1):e129&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392855</ArticleId><ArticleId IdType="pubmed">22511016</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson KJ, Jiang G, Brue SM, Liu H. Leveraging Terminology Services for Extract-Transform-Load Processes: A User-Centered Approach. AMIA Annu Symp Proc. 2016;2016:1010&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333225</ArticleId><ArticleId IdType="pubmed">28269898</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O, Nguyen D, Chiang P, Chuang P, Madden M, Winnenburg R. The NLM value set authority center. Stud Health Technol Inform. 2013;192:1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300102</ArticleId><ArticleId IdType="pubmed">23920998</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Kiefer R, Prud&#x2019;hommeaux E, Solbrig HR. Building Interoperable FHIR-Based Vocabulary Mapping Services: A Case Study of OHDSI Vocabularies and Mappings. Stud Health Technol Inform. 2017;245:1327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939959</ArticleId><ArticleId IdType="pubmed">29295408</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Sun J, Pathak J, Kho AN, Denny JC. Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods. Artif Intell Med. 2016 Jul;71:57&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480212</ArticleId><ArticleId IdType="pubmed">27506131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Jiang G, Pacheco JA, Kiefer R, Rasmussen LV, Pathak J. A Decompositional Approach to Executing Quality Data Model Algorithms on the i2b2 Platform. AMIA Jt Summits Transl Sci Proc. 2016 Jul 20;2016:167&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001760</ArticleId><ArticleId IdType="pubmed">27570665</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Kahn M, Toh S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013 Aug;51(8 Suppl 3):S22&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Carroll RJ, Warner JL, Matheny ME, Denny JC. Representing Knowledge Consistently Across Health Systems. Yearb Med Inform. 2017 Aug;26(1):139&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, Pacheco JA, Jiang G, Kiefer R. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc. 2015 Nov;22(6):1220&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016 Nov;23(6):1046&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>HL7 Standards Product Brief - HL7 Specification: Characteristics of a Formal Value Set Definition, Release 1 [Internet]  [cited 2018 Mar 8]. Available from:  http://www.hl7.org/implement/standards/product_brief.cfm?product_id=437.</Citation></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services, Office of the National Coordinator for Health Information Technology. Statin Therapy for the Prevention and Treatment of Cardiovascular Disease [Internet]. eCQI Resource Center. 2017.  [cited 2018 Mar 3]. Available from:  https://ecqi.healthit.gov/ecqm/measures/cms347v1.</Citation></Reference><Reference><Citation>Winnenburg R, Bodenreider O. Metrics for assessing the quality of value sets in clinical quality measures. AMIA Annu Symp Proc. 2013 Nov 16;2013:1497&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900160</ArticleId><ArticleId IdType="pubmed">24551422</ArticleId></ArticleIdList></Reference><Reference><Citation>Goss FR, Zhou L, Plasek JM, Broverman C, Robinson G, Middleton B. Evaluating standard terminologies for encoding allergy information. J Am Med Inform Assoc. 2013 Sep;20(5):969&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756252</ArticleId><ArticleId IdType="pubmed">23396542</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Nadkarni P. Data standards for clinical research data collection forms: current status and challenges. J Am Med Inform Assoc. 2011 May 1;18(3):341&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078665</ArticleId><ArticleId IdType="pubmed">21486890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rector AL, Qamar R, Marley T. Binding ontologies and coding systems to electronic health records and messages. Appl Ontol. 2009;4(1):51&#x2013;69.</Citation></Reference><Reference><Citation>Tu SW, Campbell JR, Glasgow J, Nyman MA, McClure R, McClay J. The SAGE Guideline Model: achievements and overview. J Am Med Inform Assoc. 2007;14(5):589&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1975799</ArticleId><ArticleId IdType="pubmed">17600098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rector AL. What&#x2019;s in a code? Towards a formal account of the relation of ontologies and coding systems. Stud Health Technol Inform. 2007;129(Pt 1):730&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">17911813</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O&#x2019;Hara DJ, Powell GE, Painter JL, Pattishall EN. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc. 2010 Nov;17(6):652&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012 Jan;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016 Dec;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG. 04-EHR data methodologies in clinical research: perspectives from the field. Session 1: Semantic harmonization: definition; content; ontologies. Common data models for sharing EHR data across settings. Health Sciences Library Photograph Collection and Special Collections, University of Colorado Anschutz Medical Campus, Health Sciences Library; Series V: School of Medicine Publications [Internet] 2007.  Available from:  https://dspace.library.colostate.edu/handle/10968/737.</Citation></Reference><Reference><Citation>Kuehn BM. FDA&#x2019;s Foray Into Big Data Still Maturing. JAMA. 2016 May 10;315(18):1934&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27097048</ArticleId></ArticleIdList></Reference><Reference><Citation>Velentgas P, Bohn RL, Brown JS, Chan KA, Gladowski P, Holick CN. A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study. Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1226&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">18956428</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1275&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">17955500</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss S. A basic study design for expedited safety signal evaluation based on electronic healthcare data. Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):858&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917262</ArticleId><ArticleId IdType="pubmed">20681003</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, Cimino JJ. Desiderata for healthcare integrated data repositories based on architectural comparison of three public repositories. AMIA Annu Symp Proc. 2013 Nov 16;2013:648&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900207</ArticleId><ArticleId IdType="pubmed">24551366</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010 Nov 2;153(9):600&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken S. An informatics infrastructure is essential for evidence-based practice. J Am Med Inform Assoc. 2001 May;8(3):199&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC131027</ArticleId><ArticleId IdType="pubmed">11320064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowker GC, Star SL. Springer: Community computing and support systems; 1998. Building information infrastructures for social worlds&#x2014;The role of classifications and standards; pp. 231&#x2013;48..</Citation></Reference><Reference><Citation>Becnel LB, Hastak S, Ver Hoef W, Milius RP, Slack M, Wold D. BRIDG: a domain information model for translational and clinical protocol-driven research. J Am Med Inform Assoc. 2017 Sep 1;24(5):882&#x2013;90..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259662</ArticleId><ArticleId IdType="pubmed">28339791</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFalco FJ, Ryan PB, Soledad Cepeda M. Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure. Health Serv Outcomes Res Methodol. 2013 Mar 1;13(1):58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3566397</ArticleId><ArticleId IdType="pubmed">23396660</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012 Jan;21(Suppl 1):23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">22262590</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFalco F. OHDSI Architecture Workgroup [Internet]. Observational Health Data Science and Informatics Wiki. [cited 2018 Mar 3]  Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=projects:workgroups:architecture_wg.</Citation></Reference><Reference><Citation>Cimino JJ. Desiderata for controlled medical vocabularies in the twenty-first century. Methods Inf Med. 1998;37(4-5):394&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3415631</ArticleId><ArticleId IdType="pubmed">9865037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimino JJ. In defense of the Desiderata. J Biomed Inform. 2006 Jun;39(3):299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185649</ArticleId><ArticleId IdType="pubmed">16386470</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanier J. 2014. Who Owns the Future? Simon and Schuster; p. 411.</Citation></Reference><Reference><Citation>Dean Beaulieu N, Epstein AM. National Committee on Quality Assurance health-plan accreditation: predictors, correlates of performance, and market impact. Med Care. 2002 Apr;40(4):325&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">12021688</ArticleId></ArticleIdList></Reference><Reference><Citation>National Drug Code Directory [Internet] U.S. Food &amp; Drug Administration. [cited 2018 Jun 27].  Available from:  https://www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm.</Citation></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc. 2010 Mar;17(2):124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH, Others. 2006. History of the development of the ICD. World Health Organization.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30815195</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Identifying Cases of Metastatic Prostate Cancer Using Machine Learning on Electronic Health Records.</ArticleTitle><Pagination><StartPage>1498</StartPage><EndPage>1504</EndPage><MedlinePgn>1498-1504</MedlinePgn></Pagination><Abstract><AbstractText>Cancer stage is rarely captured in structured form in the electronic health record (EHR). We evaluate the performance of a classifier, trained on structured EHR data, in identifying prostate cancer patients with metastatic disease. Using EHR data for a cohort of 5,861 prostate cancer patients mapped to the Observational Health Data Sciences and Informatics (OHDSI) data model, we constructed feature vectors containing frequency counts of conditions, procedures, medications, observations and laboratory values. Staging information from the California Cancer Registry was used as the ground-truth. For identifying patients with metastatic disease, a random forest model achieved precision and recall of 0.90, 0.40 using data within 12 months of diagnosis. This compared to precision 0.33, recall 0.54 for an ICD code-based query. High-precision classifiers using hundreds of structured data elements significantly outperform ICD queries, and may assist in identifying cohorts for observational research or clinical trial matching.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seneviratne</LastName><ForeName>Martin G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Urology, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez-Boussard</LastName><ForeName>Tina M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA183962</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="N">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075082" MajorTopicYN="N">Proof of Concept Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30815195</ArticleId><ArticleId IdType="pmc">PMC6371284</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Quality Forum. 2008. NQF 0386 Oncology: Cancer Stage Documented - Measure Submission and Evaluation Worksheet.</Citation></Reference><Reference><Citation>Evans TL, Gabriel PE, Shulman LN. Cancer Staging in Electronic Health Records: Strategies to Improve Documentation of These Critical Data. J Oncol Pract. 2016;12:137&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">26869653</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JL, Levy MA, Neuss MN, Warner JL, Levy MA, Neuss MN. ReCAP: Feasibility and Accuracy of Extracting Cancer Stage Information From Narrative Electronic Health Record Data. J Oncol Pract. 2016;12:157&#x2013;8. e169&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26306621</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss JA, Chao CR, Kwan ML, Ahmed SA, Schottinger JE, Quinn VP. Identifying primary and recurrent cancers using a SAS-based natural language processing algorithm. J Am Med Inform Assoc. 2013;20:349&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3638182</ArticleId><ArticleId IdType="pubmed">22822041</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen AN, Lawley MJ, Hansen DP, Bowman RV, Clarke BE, Duhig EE. Symbolic rule-based classification of lung cancer stages from free-text pathology reports. J Am Med Inform Assoc. 2010;17:440&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995652</ArticleId><ArticleId IdType="pubmed">20595312</ArticleId></ArticleIdList></Reference><Reference><Citation>Coden A, Savova G, Sominsky I, Tanenblatt M, Masanz J, Schuler K. Automatically extracting cancer disease characteristics from pathology reports into a Disease Knowledge Representation Model. J Biomed Inform. 2009;42:937&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">19135551</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim W-W, Yetisgen M, Harris WP, Kwan SW. Natural Language Processing in Oncology: A Review. JAMA Oncol. 2016;2:797&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">27124593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, Shah NH. AMIA Jt Summits Transl Sci Proc. 2017. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network; pp. 48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>APHRODITE. In: Observational Health Data Sciences and Informatics [Internet]  Available:  https://github.com/OHDSI/Aphrodite.</Citation></Reference><Reference><Citation>Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">29313949</ArticleId></ArticleIdList></Reference><Reference><Citation>Survival Rates for Prostate Cancer. In: American Cancer Society [Internet] 2017. Dec 18,  Available:  https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/survival-rates.html.</Citation></Reference><Reference><Citation>Seneviratne MG, Seto T, Blayney DW, Brooks JD, Hernandez-Boussard TM. Architecture and Implementation of a Clinical Research Data Warehouse for Prostate Cancer. eGEMS. 2018;6(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078122</ArticleId><ArticleId IdType="pubmed">30094285</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30912749</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.</ArticleTitle><Pagination><StartPage>e13249</StartPage><MedlinePgn>e13249</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13249</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/13249</ELocationID><Abstract><AbstractText Label="BACKGROUND">Clinical sequencing data should be shared in order to achieve the sufficient scale and diversity required to provide strong evidence for improving patient care. A distributed research network allows researchers to share this evidence rather than the patient-level data across centers, thereby avoiding privacy issues. The Observational Medical Outcomes Partnership (OMOP) common data model (CDM) used in distributed research networks has low coverage of sequencing data and does not reflect the latest trends of precision medicine.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study was to develop and evaluate the feasibility of a genomic CDM (G-CDM), as an extension of the OMOP-CDM, for application of genomic data in clinical practice.</AbstractText><AbstractText Label="METHODS">Existing genomic data models and sequencing reports were reviewed to extend the OMOP-CDM to cover genomic data. The Human Genome Organisation Gene Nomenclature Committee and Human Genome Variation Society nomenclature were adopted to standardize the terminology in the model. Sequencing data of 114 and 1060 patients with lung cancer were obtained from the Ajou University School of Medicine database of Ajou University Hospital and The Cancer Genome Atlas, respectively, which were transformed to a format appropriate for the G-CDM. The data were compared with respect to gene name, variant type, and actionable mutations.</AbstractText><AbstractText Label="RESULTS">The G-CDM was extended into four tables linked to tables of the OMOP-CDM. Upon comparison with The Cancer Genome Atlas data, a clinically actionable mutation, p.Leu858Arg, in the EGFR gene was 6.64 times more frequent in the Ajou University School of Medicine database, while the p.Gly12Xaa mutation in the KRAS gene was 2.02 times more frequent in The Cancer Genome Atlas dataset. The data-exploring tool GeneProfiler was further developed to conduct descriptive analyses automatically using the G-CDM, which provides the proportions of genes, variant types, and actionable mutations. GeneProfiler also allows for querying the specific gene name and Human Genome Variation Society nomenclature to calculate the proportion of patients with a given mutation.</AbstractText><AbstractText Label="CONCLUSIONS">We developed the G-CDM for effective integration of genomic data with standardized clinical data, allowing for data sharing across institutes. The feasibility of the G-CDM was validated by assessing the differences in data characteristics between two different genomic databases through the proposed data-exploring tool GeneProfiler. The G-CDM may facilitate analyses of interoperating clinical and genomic datasets across multiple institutions, minimizing privacy issues and enabling researchers to better understand the characteristics of patients and promote personalized medicine in clinical practice.</AbstractText><CopyrightInformation>&#xa9;Seo Jeong Shin, Seng Chan You, Yu Rang Park, Jin Roh, Jang-Hee Kim, Seokjin Haam, Christian G Reich, Clair Blacketer, Dae-Soon Son, Seungbin Oh, Rae Woong Park. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 26.03.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Shin</LastName><ForeName>Seo Jeong</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-0861-3576</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Park</LastName><ForeName>Yu Rang</ForeName><Initials>YR</Initials><Identifier Source="ORCID">0000-0002-4210-2094</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roh</LastName><ForeName>Jin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3995-355X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Ajou University Hospital, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jang-Hee</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5825-1361</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Ajou University Hospital, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haam</LastName><ForeName>Seokjin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0403-2216</Identifier><AffiliationInfo><Affiliation>Department of Thoracic &amp; Cardiovascular Surgery, Ajou University Hospital, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0002-3641-055X</Identifier><AffiliationInfo><Affiliation>IQVIA, Durham, NC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2570-2124</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Janssen Research and Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Dae-Soon</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-5164-4274</Identifier><AffiliationInfo><Affiliation>Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Seungbin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4183-3637</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, Kangwon University, Chuncheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data visualization</Keyword><Keyword MajorTopicYN="N">databases, genetic</Keyword><Keyword MajorTopicYN="N">high-throughput nucleotide sequencing</Keyword><Keyword MajorTopicYN="N">multicenter study</Keyword><Keyword MajorTopicYN="N">patient privacy</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30912749</ArticleId><ArticleId IdType="pmc">PMC6454347</ArticleId><ArticleId IdType="doi">10.2196/13249</ArticleId><ArticleId IdType="pii">v21i3e13249</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schwaederle M, Parker BA, Schwab RB, Daniels GA, Piccioni DE, Kesari S, Helsten TL, Bazhenova LA, Romero J, Fanta PT, Lippman SM, Kurzrock R. Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. Mol Cancer Ther. 2016 Dec;15(4):743&#x2013;52. doi: 10.1158/1535-7163.MCT-15-0795. 
 
1535-7163.MCT-15-0795</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-15-0795</ArticleId><ArticleId IdType="pubmed">26873727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kris MG, Johnson BE, Berry LD, Kwiatkowski DJ, Iafrate AJ, Wistuba II, Varella-Garcia M, Franklin WA, Aronson SL, Su P, Shyr Y, Camidge DR, Sequist LV, Glisson BS, Khuri FR, Garon EB, Pao W, Rudin C, Schiller J, Haura EB, Socinski M, Shirai K, Chen H, Giaccone G, Ladanyi M, Kugler K, Minna JD, Bunn PA. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014 May 21;311(19):1998&#x2013;2006. doi: 10.1001/jama.2014.3741. 
 
1872815</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.3741</ArticleId><ArticleId IdType="pmc">PMC4163053</ArticleId><ArticleId IdType="pubmed">24846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockley TL, Oza AM, Berman HK, Leighl NB, Knox JJ, Shepherd FA, Chen EX, Krzyzanowska MK, Dhani N, Joshua AM, Tsao M, Serra S, Clarke B, Roehrl MH, Zhang T, Sukhai MA, Califaretti N, Trinkaus M, Shaw P, van der Kwast T, Wang L, Virtanen C, Kim RH, Razak ARA, Hansen AR, Yu C, Pugh TJ, Kamel-Reid S, Siu LL, Bedard PL. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial. Genome Med. 2016 Dec 25;8(1):109. doi: 10.1186/s13073-016-0364-2. 
 
10.1186/s13073-016-0364-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-016-0364-2</ArticleId><ArticleId IdType="doi">10.1186/s13073-016-0364-2</ArticleId><ArticleId IdType="pmc">PMC5078968</ArticleId><ArticleId IdType="pubmed">27782854</ArticleId></ArticleIdList></Reference><Reference><Citation>AACR Project GENIE Consortium  AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017 Dec;7(8):818&#x2013;831. doi: 10.1158/2159-8290.CD-17-0151. 
 
2159-8290.CD-17-0151</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-17-0151</ArticleId><ArticleId IdType="pmc">PMC5611790</ArticleId><ArticleId IdType="pubmed">28572459</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyranoski D. China embraces precision medicine on a massive scale. Nature. 2016 Jan 07;529(7584):9&#x2013;10. doi: 10.1038/529009a.529009a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/529009a</ArticleId><ArticleId IdType="pubmed">26738574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Jiang X, Tang H, Wang X, Bu D, Carey K, Dyke SO, Fox D, Jiang C, Lauter K, Malin B, Sofia H, Telenti A, Wang L, Wang W, Ohno-Machado L. A community effort to protect genomic data sharing, collaboration and outsourcing. NPJ Genom Med. 2017;2:33. doi: 10.1038/s41525-017-0036-1. 
 
36</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-017-0036-1</ArticleId><ArticleId IdType="pmc">PMC5677972</ArticleId><ArticleId IdType="pubmed">29263842</ArticleId></ArticleIdList></Reference><Reference><Citation>Scollen S, Page A, Wilson J. From the data on many, precision medicine for &#x201c;one&#x201d;: The case for widespread genomic data sharing. Biomed Hub. 2017 Nov 21;2(1):21&#x2013;21. doi: 10.1159/000481682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481682</ArticleId><ArticleId IdType="pmc">PMC6945905</ArticleId><ArticleId IdType="pubmed">31988941</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015 Mar;12(3):e1001779. doi: 10.1371/journal.pmed.1001779. 
 
PMEDICINE-D-12-02351</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray MF. The path to routine genomic screening in health care. Ann Intern Med. 2018 Sep 18;169(6):407&#x2013;408. doi: 10.7326/M18-1722.2695042</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1722</ArticleId><ArticleId IdType="pubmed">30073309</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YR, Shin S. Status and direction of healthcare data in Korea for artificial intelligence. Hanyang Med Rev. 2017;37(2):86. doi: 10.7599/hmr.2017.37.2.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.7599/hmr.2017.37.2.86</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam DJ, Kwon HW, Lee H, Ahn EK. National healthcare service and its big data analytics. Healthc Inform Res. 2018 Jul;24(3):247&#x2013;249. doi: 10.4258/hir.2018.24.3.247. 
 
jpet.118.250076</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2018.24.3.247</ArticleId><ArticleId IdType="pmc">PMC6085206</ArticleId><ArticleId IdType="pubmed">30109158</ArticleId></ArticleIdList></Reference><Reference><Citation>Park RW. Sharing clinical big data while protecting confidentiality and security: Observational health data sciences and informatics. Healthc Inform Res. 2017 Jan;23(1):1&#x2013;3. doi: 10.4258/hir.2017.23.1.1. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2017.23.1.1</ArticleId><ArticleId IdType="pmc">PMC5334126</ArticleId><ArticleId IdType="pubmed">28261525</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Mendis ME, Berkowitz DA, Kohane I, Chueh HC. Integration of clinical and genetic data in the i2b2 architecture. AMIA Annu Symp Proc; 2006; Washington, DC. 2006. Nov 11, p. 1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839291</ArticleId><ArticleId IdType="pubmed">17238659</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016 Dec;23(5):909&#x2013;15. doi: 10.1093/jamia/ocv188. 
 
ocv188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv188</ArticleId><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KK, Browe DK, Logan HC, Holm R, Hack L, Ohno-Machado L. Data governance requirements for distributed clinical research networks: triangulating perspectives of diverse stakeholders. J Am Med Inform Assoc. 2014;21(4):714&#x2013;9. doi: 10.1136/amiajnl-2013-002308. 
 
amiajnl-2013-002308</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-002308</ArticleId><ArticleId IdType="pmc">PMC4078279</ArticleId><ArticleId IdType="pubmed">24302285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Green R, Rehm H, Kohane I. In: Clinical genome sequencing. Ginsburg H, Willard H, editors. San Diego: Genomic and personalized medicine; 2013.</Citation></Reference><Reference><Citation>Ibrahim MM, Lacadie SA, Ohler U. JAMM: a peak finder for joint analysis of NGS replicates. Bioinformatics. 2015 Jan 01;31(1):48&#x2013;55. doi: 10.1093/bioinformatics/btu568.btu568</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu568</ArticleId><ArticleId IdType="pubmed">25223640</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001 Dec;29(4):365&#x2013;71. doi: 10.1038/ng1201-365.ng1201-365</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1201-365</ArticleId><ArticleId IdType="pubmed">11726920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HW, Park YR, Sim J, Park RW, Kim WH, Kim JH. The tissue microarray object model: a data model for storage, analysis, and exchange of tissue microarray experimental data. Arch Pathol Lab Med. 2006 Jul;130(7):1004&#x2013;13. doi: 10.1043/1543-2165(2006)130[1004:TTMOMA]2.0.CO;2.OA5763</Citation><ArticleIdList><ArticleId IdType="doi">10.1043/1543-2165(2006)130[1004:TTMOMA]2.0.CO;2</ArticleId><ArticleId IdType="pubmed">16831026</ArticleId></ArticleIdList></Reference><Reference><Citation>Garwood K, McLaughlin T, Garwood C, Joens S, Morrison N, Taylor CF, Carroll K, Evans C, Whetton AD, Hart S, Stead D, Yin Z, Brown AJP, Hesketh A, Chater K, Hansson L, Mewissen M, Ghazal P, Howard J, Lilley KS, Gaskell SJ, Brass A, Hubbard SJ, Oliver SG, Paton NW. PEDRo: a database for storing, searching and disseminating experimental proteomics data. BMC Genomics. 2004 Sep 17;5:68. doi: 10.1186/1471-2164-5-68. 
 
1471-2164-5-68</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-5-68</ArticleId><ArticleId IdType="doi">10.1186/1471-2164-5-68</ArticleId><ArticleId IdType="pmc">PMC521486</ArticleId><ArticleId IdType="pubmed">15377392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahl G. The dictionary of genomics, transcriptomics and proteomics. Hoboken, NJ: Wiley-Blackwell; 2015. Minimum information about a high-throughput nucleotide sequencing experiment (MINSEQE)</Citation></Reference><Reference><Citation>Pavlopoulou A, Spandidos DA, Michalopoulos I. Human cancer databases (review) Oncol Rep. 2015 Jan;33(1):3&#x2013;18. doi: 10.3892/or.2014.3579. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2014.3579</ArticleId><ArticleId IdType="pmc">PMC4254674</ArticleId><ArticleId IdType="pubmed">25369839</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomczak K, Czerwi&#x144;ska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn) 2015;19(1A):A68&#x2013;77. doi: 10.5114/wo.2014.47136. 
 
24047</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/wo.2014.47136</ArticleId><ArticleId IdType="pmc">PMC4322527</ArticleId><ArticleId IdType="pubmed">25691825</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E, Fish P, Harsha B, Hathaway C, Jupe SC, Kok CY, Noble K, Ponting L, Ramshaw CC, Rye CE, Speedy HE, Stefancsik R, Thompson SL, Wang S, Ward S, Campbell PJ, Forbes SA. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019 Jan 08;47(D1):D941&#x2013;D947. doi: 10.1093/nar/gky1015. 
 
5146192</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1015</ArticleId><ArticleId IdType="pmc">PMC6323903</ArticleId><ArticleId IdType="pubmed">30371878</ArticleId></ArticleIdList></Reference><Reference><Citation>International Cancer Genome Consortium. Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernab&#xe9; RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, Kerr D, Klatt P, Kolar P, Kusada J, Lane DP, Laplace F, Youyong L, Nettekoven G, Ozenberger B, Peterson J, Rao TS, Remacle J, Schafer AJ, Shibata T, Stratton MR, Vockley JG, Watanabe K, Yang H, Yuen MMF, Knoppers BM, Bobrow M, Cambon-Thomsen A, Dressler LG, Dyke SOM, Joly Y, Kato K, Kennedy KL, Nicol&#xe1;s P, Parker MJ, Rial-Sebbag E, Romeo-Casabona CM, Shaw KM, Wallace S, Wiesner GL, Zeps N, Lichter P, Biankin AV, Chabannon C, Chin L, Cl&#xe9;ment B, de Alava E, Degos F, Ferguson ML, Geary P, Hayes DN, Hudson TJ, Johns AL, Kasprzyk A, Nakagawa H, Penny R, Piris MA, Sarin R, Scarpa A, Shibata T, van de Vijver M, Futreal PA, Aburatani H, Bay&#xe9;s M, Botwell DDL, Campbell PJ, Estivill X, Gerhard DS, Grimmond SM, Gut I, Hirst M, L&#xf3;pez-Ot&#xed;n C, Majumder P, Marra M, McPherson JD, Nakagawa H, Ning Z, Puente XS, Ruan Y, Shibata T, Stratton MR, Stunnenberg HG, Swerdlow H, Velculescu VE, Wilson RK, Xue HH, Yang L, Spellman PT, Bader GD, Boutros PC, Campbell PJ, Flicek P, Getz G, Guig&#xf3; R, Guo G, Haussler D, Heath S, Hubbard TJ, Jiang T, Jones SM, Li Q, L&#xf3;pez-Bigas N, Luo R, Muthuswamy L, Ouellette BFF, Pearson JV, Puente XS, Quesada V, Raphael BJ, Sander C, Shibata T, Speed TP, Stein LD, Stuart JM, Teague JW, Totoki Y, Tsunoda T, Valencia A, Wheeler DA, Wu H, Zhao S, Zhou G, Stein LD, Guig&#xf3; R, Hubbard TJ, Joly Y, Jones SM, Kasprzyk A, Lathrop M, L&#xf3;pez-Bigas N, Ouellette BFF, Spellman PT, Teague JW, Thomas G, Valencia A, Yoshida T, Kennedy KL, Axton M, Dyke SOM, Futreal PA, Gerhard DS, Gunter C, Guyer M, Hudson TJ, McPherson JD, Miller LJ, Ozenberger B, Shaw KM, Kasprzyk A, Stein LD, Zhang J, Haider SA, Wang J, Yung CK, Cros A, Cross A, Liang Y, Gnaneshan S, Guberman J, Hsu J, Bobrow M, Chalmers DRC, Hasel KW, Joly Y, Kaan TSH, Kennedy KL, Knoppers BM, Lowrance WW, Masui T, Nicol&#xe1;s P, Rial-Sebbag E, Rodriguez LL, Vergely C, Yoshida T, Grimmond SM, Biankin AV, Bowtell DDL, Cloonan N, deFazio A, Eshleman JR, Etemadmoghadam D, Gardiner BB, Gardiner BA, Kench JG, Scarpa A, Sutherland RL, Tempero MA, Waddell NJ, Wilson PJ, McPherson JD, Gallinger S, Tsao M, Shaw PA, Petersen GM, Mukhopadhyay D, Chin L, DePinho RA, Thayer S, Muthuswamy L, Shazand K, Beck T, Sam M, Timms L, Ballin V, Lu Y, Ji J, Zhang X, Chen F, Hu X, Zhou G, Yang Q, Tian G, Zhang L, Xing X, Li X, Zhu Z, Yu Y, Yu J, Yang H, Lathrop M, Tost J, Brennan P, Holcatova I, Zaridze D, Brazma A, Egevard L, Prokhortchouk E, Banks RE, Uhl&#xe9;n M, Cambon-Thomsen A, Viksna J, Ponten F, Skryabin K, Stratton MR, Futreal PA, Birney E, Borg A, B&#xf8;rresen-Dale A, Caldas C, Foekens JA, Martin S, Reis-Filho JS, Richardson AL, Sotiriou C, Stunnenberg HG, Thoms G, van de Vijver M, van't Veer L, Calvo F, Birnbaum D, Blanche H, Boucher P, Boyault S, Chabannon C, Gut I, Masson-Jacquemier JD, Lathrop M, Pauport&#xe9; I, Pivot X, Vincent-Salomon A, Tabone E, Theillet C, Thomas G, Tost J, Treilleux I, Calvo F, Bioulac-Sage P, Cl&#xe9;ment B, Decaens T, Degos F, Franco D, Gut I, Gut M, Heath S, Lathrop M, Samuel D, Thomas G, Zucman-Rossi J, Lichter P, Eils R, Brors B, Korbel JO, Korshunov A, Landgraf P, Lehrach H, Pfister S, Radlwimmer B, Reifenberger G, Taylor MD, von Kalle C, Majumder PP, Sarin R, Rao TS, Bhan MK, Scarpa A, Pederzoli P, Lawlor RA, Delledonne M, Bardelli A, Biankin AV, Grimmond SM, Gress T, Klimstra D, Zamboni G, Shibata T, Nakamura Y, Nakagawa H, Kusada J, Tsunoda T, Miyano S, Aburatani H, Kato K, Fujimoto A, Yoshida T, Campo E, L&#xf3;pez-Ot&#xed;n C, Estivill X, Guig&#xf3; R, de Sanjos&#xe9; S, Piris MA, Montserrat E, Gonz&#xe1;lez-D&#xed;az M, Puente XS, Jares P, Valencia A, Himmelbauer H, Himmelbaue H, Quesada V, Bea S, Stratton MR, Futreal PA, Campbell PJ, Vincent-Salomon A, Richardson AL, Reis-Filho JS, van de Vijver M, Thomas G, Masson-Jacquemier JD, Aparicio S, Borg A, B&#xf8;rresen-Dale A, Caldas C, Foekens JA, Stunnenberg HG, van't Veer L, Easton DF, Spellman PT, Martin S, Barker AD, Chin L, Collins FS, Compton CC, Ferguson ML, Gerhard DS, Getz G, Gunter C, Guttmacher A, Guyer M, Hayes DN, Lander ES, Ozenberger B, Penny R, Peterson J, Sander C, Shaw KM, Speed TP, Spellman PT, Vockley JG, Wheeler DA, Wilson RK, Hudson TJ, Chin L, Knoppers BM, Lander ES, Lichter P, Stein LD, Stratton MR, Anderson W, Barker AD, Bell C, Bobrow M, Burke W, Collins FS, Compton CC, DePinho RA, Easton DF, Futreal PA, Gerhard DS, Green AR, Guyer M, Hamilton SR, Hubbard TJ, Kallioniemi OP, Kennedy KL, Ley TJ, Liu ET, Lu Y, Majumder P, Marra M, Ozenberger B, Peterson J, Schafer AJ, Spellman PT, Stunnenberg HG, Wainwright BJ, Wilson RK, Yang H. International network of cancer genome projects. Nature. 2010 Apr 15;464(7291):993&#x2013;8. doi: 10.1038/nature08987. 
 
nature08987</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08987</ArticleId><ArticleId IdType="pmc">PMC2902243</ArticleId><ArticleId IdType="pubmed">20393554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewing AD, Houlahan KE, Hu Y, Ellrott K, Caloian C, Yamaguchi TN, Bare JC, P'ng C, Waggott D, Sabelnykova VY, ICGC-TCGA DREAM Somatic Mutation Calling Challenge participants. Kellen MR, Norman TC, Haussler D, Friend SH, Stolovitzky G, Margolin AA, Stuart JM, Boutros PC. Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection. Nat Methods. 2015 Jul;12(7):623&#x2013;30. doi: 10.1038/nmeth.3407. 
 
nmeth.3407</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3407</ArticleId><ArticleId IdType="pmc">PMC4856034</ArticleId><ArticleId IdType="pubmed">25984700</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaronke I, Gambo I, Soriyan A, Olaleke J. Interoperability in healthcare: benefits, challenges and resolutions. Int J Innov Appl Stud. 2013;38(1):64&#x2013;73.</Citation></Reference><Reference><Citation>Bicer V, Laleci GB, Dogac A, Kabak Y. Artemis message exchange framework: semantic interoperability of exchanged messages in the healthcare domain. SIGMOD Rec. 2005 Sep 01;34(3):71. doi: 10.1145/1084805.1084819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/1084805.1084819</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, Imielinski M, Hu X, Ling S, Akbani R, Rosenberg M, Cibulskis C, Ramachandran A, Collisson EA, Kwiatkowski DJ, Lawrence MS, Weinstein JN, Verhaak RGW, Wu CJ, Hammerman PS, Cherniack AD, Getz G, Cancer Genome Atlas Research Network. Artyomov MN, Schreiber R, Govindan R, Meyerson M. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Dec;48(6):607&#x2013;16. doi: 10.1038/ng.3564.ng.3564</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3564</ArticleId><ArticleId IdType="pmc">PMC4884143</ArticleId><ArticleId IdType="pubmed">27158780</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401&#x2013;4. doi: 10.1158/2159-8290.CD-12-0095. 
 
2/5/401</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-12-0095</ArticleId><ArticleId IdType="pmc">PMC3956037</ArticleId><ArticleId IdType="pubmed">22588877</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Liu J, Shao D, Deng Q, Tang H, Liu Z, Chen X, Guo F, Lin Y, Mao M, Kristiansen K, Ye M, He J. Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients. Cancer Sci. 2017 Dec;108(12):2487&#x2013;2494. doi: 10.1111/cas.13410. doi: 10.1111/cas.13410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.13410</ArticleId><ArticleId IdType="doi">10.1111/cas.13410</ArticleId><ArticleId IdType="pmc">PMC5715245</ArticleId><ArticleId IdType="pubmed">28949084</ArticleId></ArticleIdList></Reference><Reference><Citation>National Comprehensive Cancer Network. 2019.  [2019-02-08].  NCCN Guidelines
 https://www.nccn.org/professionals/physician_gls/default.aspx
.</Citation></Reference><Reference><Citation>Shin SJ, You SC, Kim JH. GitHub. 2019.  [2019-02-08].  GeneProfiler
 https://github.com/ABMI/GeneProfiler
.</Citation></Reference><Reference><Citation>Skidmore ZL, Wagner AH, Lesurf R, Campbell KM, Kunisaki J, Griffith OL, Griffith M. GenVisR: Genomic visualizations in R. Bioinformatics. 2016 Dec 01;32(19):3012&#x2013;4. doi: 10.1093/bioinformatics/btw325. 
 
btw325</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw325</ArticleId><ArticleId IdType="pmc">PMC5039916</ArticleId><ArticleId IdType="pubmed">27288499</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr TH, McEwen R, Dougherty B, Johnson JH, Dry JR, Lai Z, Ghazoui Z, Laing NM, Hodgson DR, Cruzalegui F, Hollingsworth SJ, Barrett JC. Defining actionable mutations for oncology therapeutic development. Nat Rev Cancer. 2016 Dec 26;16(5):319&#x2013;29. doi: 10.1038/nrc.2016.35.nrc.2016.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2016.35</ArticleId><ArticleId IdType="pubmed">27112209</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrieta O, Cardona AF, Mart&#xed;n C, M&#xe1;s-L&#xf3;pez L, Corrales-Rodr&#xed;guez L, Bramuglia G, Castillo-Fernandez O, Meyerson M, Amieva-Rivera E, Campos-Parra AD, Carranza H, G&#xf3;mez de la Torre JC, Powazniak Y, Aldaco-Sarvide F, Vargas C, Trigo M, Magallanes-Maciel M, Otero J, S&#xe1;nchez-Reyes R, Cuello M. Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: The Latin-American consortium for the investigation of lung cancer (CLICaP) J Thorac Oncol. 2015 May;10(5):838&#x2013;43. doi: 10.1097/JTO.0000000000000481. 
 
S1556-0864(15)32398-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTO.0000000000000481</ArticleId><ArticleId IdType="pubmed">25634006</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Plasek JM, Bates DW. Rethinking data sharing at the dawn of a health data economy: A viewpoint. J Med Internet Res. 2018 Nov 22;20(11):e11519. doi: 10.2196/11519. 
 
v20i11e11519</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/11519</ArticleId><ArticleId IdType="pmc">PMC6284141</ArticleId><ArticleId IdType="pubmed">30467103</ArticleId></ArticleIdList></Reference><Reference><Citation>Schadow G, Mead CN, Walker DM. The HL7 reference information model under scrutiny. Stud Health Technol Inform. 2006;124:151&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17108519</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeler GW. HL7 version 3--an object-oriented methodology for collaborative standards development. Int J Med Inform. 1998 Feb;48(1-3):151&#x2013;61.S1386-5056(97)00121-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9600415</ArticleId></ArticleIdList></Reference><Reference><Citation>Shringarpure SS, Bustamante CD. Privacy risks from genomic data-sharing beacons. Am J Hum Genet. 2015 Nov 05;97(5):631&#x2013;46. doi: 10.1016/j.ajhg.2015.09.010. 
 
S0002-9297(15)00374-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2015.09.010</ArticleId><ArticleId IdType="pmc">PMC4667107</ArticleId><ArticleId IdType="pubmed">26522470</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisaro JL, Tram&#xe8;r F, Ji Z, Bu D, Zhao Y, Carey K, Lloyd D, Sofia H, Baker D, Flicek P, Shringarpure S, Bustamante C, Wang S, Jiang X, Ohno-Machado L, Tang H, Wang X, Hubaux J. Addressing Beacon re-identification attacks: quantification and mitigation of privacy risks. J Am Med Inform Assoc. 2017 Jul 01;24(4):799&#x2013;805. doi: 10.1093/jamia/ocw167. 
 
3038412</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw167</ArticleId><ArticleId IdType="pmc">PMC5881894</ArticleId><ArticleId IdType="pubmed">28339683</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30937326</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2327-9214</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>EGEMS (Washington, DC)</Title><ISOAbbreviation>EGEMS (Wash DC)</ISOAbbreviation></Journal><ArticleTitle>Learning to Share Health Care Data: A Brief Timeline of Influential Common Data Models and Distributed Health Data Networks in U.S. Health Care Research.</ArticleTitle><Pagination><StartPage>4</StartPage><MedlinePgn>4</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/egems.279</ELocationID><Abstract><AbstractText>The last twenty years of health care research has seen a steady stream of common health care data models implemented for multi-organization research. Each model offers a uniform interface on data from the diverse organizations that implement them, enabling the sharing of research tools and data. While the groups designing the models have had various needs and aims, and the data available has changed significantly in this time, there are nevertheless striking similarities between them. This paper traces the evolution of common data models, describing their similarities and points of departure. We believe the history of this work should be understood and preserved. The work has empowered collaborative research across competing organizations and brought together researchers from clinical practice, universities and research institutes around the planet. Understanding the eco-system of data models designed for collaborative research allows readers to evaluate where we have been, where we are going as a field, and to evaluate the utility of different models to their own work.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weeks</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardee</LastName><ForeName>Roy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, US.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EGEMS (Wash DC)</MedlineTA><NlmUniqueID>101629606</NlmUniqueID><ISSNLinking>2327-9214</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CDM</Keyword><Keyword MajorTopicYN="N">HCSRN</Keyword><Keyword MajorTopicYN="N">HMORN</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">PCORI</Keyword><Keyword MajorTopicYN="N">PCORnet</Keyword><Keyword MajorTopicYN="N">SHRINE</Keyword><Keyword MajorTopicYN="N">VDW</Keyword><Keyword MajorTopicYN="N">VSD</Keyword><Keyword MajorTopicYN="N">i2b2</Keyword></KeywordList><CoiStatement>RP has no competing financial interests, but is a long time implementer and user of the HCSRN VDW and has participated in its design process since at least 2009. He also supports KPWHRI&#x2019;s implementations of the PCORnet and Sentinel data models and has been an end user of the PCORnet model and infrastructure. JW has no competing financial interests, but as an employee of KP Washington Health Research Institute has supported their use of CESR, OMOP, VDW, PCORnet, VSD, and Sentinel common data models. JW previously was an employee of CHI Institute of Research and Innovation (CIRI) and implemented the HCSRN VDW and OHDSI OMOP data models for the purpose of engaging in collaborative research with other hospital research institutes.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30937326</ArticleId><ArticleId IdType="pmc">PMC6437693</ArticleId><ArticleId IdType="doi">10.5334/egems.279</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PCORNet System. PCORnet Common Data Model. [06//2018]. Available from: https://pcornet.org/pcornet-common-data-model/.</Citation></Reference><Reference><Citation>Distributed Health Data Networks: A Practical and Preferred Approach to Multi-Institutional Evaluations of Comparative Effectiveness, Safety, and Quality of Care. Brown, JS, Holmes, JH, Shah, K, Hall, K, Lazarus, R and Platt, R (eds.), Medical Care; 2010. 
https://journals.lww.com/lww-medicalcare/Fulltext/2010/06001/Distributed_Health_Data_Networks__A_Practical_and.9.aspx.</Citation><ArticleIdList><ArticleId IdType="pubmed">20473204</ArticleId></ArticleIdList></Reference><Reference><Citation>DeStefano, F. The Vaccine Safety Datalink project. Pharmacoepidemiology and drug safety. Aug-Sep
2001; 10(5): 403&#x2013;6. https://www.ncbi.nlm.nih.gov/pubmed/11802585.</Citation><ArticleIdList><ArticleId IdType="pubmed">11802585</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Coordinating Council for Comparative Effectiveness Research. In: Federal Coordinating Council for Comparative Effectiveness Research. Report to the President and Congress, Services UDoHaH (ed.); 2009. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371424/#b5-egems1049.</Citation></Reference><Reference><Citation>Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States. In: Chen, RT, Glasser, JW, Rhodes, PH, Davis, RL, Barlow, WE, Thompson, RS, Mullooly, JP, Black, SB, Shinefield, HR, Vadheim, CM, Michael Marcy, S, Ward, JI, Wise, RP, Wassilak, SG, Hadler, SC and the Vaccine Safety Datalink Team (eds.), Pediatrics. June
1997; 99(6): 765&#x2013;773. https://pediatrics.aappublications.org/content/pediatrics/99/6/765.full.pdf DOI: 10.1542/peds.99.6.765</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.99.6.765</ArticleId><ArticleId IdType="pubmed">9164767</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt, TM, Lafata, JE, Tolsma, DD and Greene, SM. The Role of Research in Integrated Health Care Systems: The HMO Research Network. The Permanente Journal. 2004; 8(4): 10&#x2013;17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690686/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690686</ArticleId><ArticleId IdType="pubmed">26705313</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Research Network. CRN fact sheet. [June/16/2018]. Available from: https://crn.cancer.gov/about/CRN_fact_sheet.pdf.</Citation></Reference><Reference><Citation>Ross, TR, Ng, D, Brown, JS, Pardee, R, Hornbrook, MC, Hart, G and Steiner, JF. The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS. 2014; 2(1): 1049
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371424/ DOI: 10.13063/2327-9214.1049</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1049</ArticleId><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Care System Research Network. The VDW and How to Use It. [October/19/2018]. Available from: https://www.hcsrn.org/en/Tools%20&amp;%20Materials/VDW/VDWScientists/The+VDW+and+How+to+Use+It.pdf.</Citation></Reference><Reference><Citation>Murphy, S and Wilcox, A. Mission and Sustainability of Informatics for Integrating Biology and the Bedside (i2b2). eGEMs. 2014; 2(2): 1074 DOI: 10.13063/2327-9214.1074</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1074</ArticleId><ArticleId IdType="pmc">PMC4371505</ArticleId><ArticleId IdType="pubmed">25848608</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Biomedical Computing. Informatics for Integrating Biology &amp; the Bedside: Overview. [June/26/2018]. Available from: https://www.i2b2.org/about/index.html.</Citation></Reference><Reference><Citation>Prakash, M, Nadkarni, LM, Roland Chen, ES and Gordon Shepherd, PM. Organization of Heterogeneous Scientific Data Using the EAV/CR Representation. Journal of the American Medical Informatics Association. 1 November 1999; 6(6): 478&#x2013;493. DOI: 10.1136/jamia.1999.0060478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.1999.0060478</ArticleId><ArticleId IdType="pmc">PMC61391</ArticleId><ArticleId IdType="pubmed">10579606</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber, GM, Murphy, SN, McMurry, AJ, MacFadden, D, Nigrin, DJ, Churchill, S and Kohane, IS. The Shared Health Research Information Network (SHRINE): A Prototype Federated Query Tool for Clinical Data Repositories. Journal of the American Medical Informatics Association: JAMIA. 2009; 16(5): 624&#x2013;630. DOI: 10.1197/jamia.M3191</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3191</ArticleId><ArticleId IdType="pmc">PMC2744712</ArticleId><ArticleId IdType="pubmed">19567788</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak, G, Duke, JD, Shah, NH, Reich, CG, Huser, V, Schuemie, MJ, Ryan, PB, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Studies in Health Technology and Informatics. 2015; 216: 574&#x2013;578. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815923/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Foundation for the National Institutes of Health (FNIH). Observational Medical Outcomes Partnership (OMOP). [October/12/2018]. Available from: https://fnih.org/what-we-do/major-completed-programs/omop.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. OMOP Common Data Model. [June/16/2018]. Available from: https://www.ohdsi.org/data-standardization/the-common-data-model/.</Citation></Reference><Reference><Citation>Sentinel. Distributed Database Common Data Model. [June/16/2018]. Available from: https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model.</Citation></Reference><Reference><Citation>Ball, R, Robb, M, Anderson, S and Dal Pan, G. The FDA&#x2019;s sentinel initiative&#x2014;A comprehensive approach to medical product surveillance. Clin. Pharmacol. Ther. 2016; 99: 265&#x2013;268. DOI: 10.1002/cpt.320</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.320</ArticleId><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Effectiveness &amp; Safety Research. About Us. [June/16/2018]. Available from: https://cesr.kp.org/about.</Citation></Reference><Reference><Citation>Center for Effectiveness &amp; Safety Research. Externally-Funded Studies Led by the Center for Effectiveness &amp; Safety Research. [June/16/2018]. Available from: https://cesr.kp.org/research/studies.</Citation></Reference><Reference><Citation>PCORNet System. PCORnet Common Data Model. [June/16/2018]. Available from: https://pcornet.org/pcornet-common-data-model/.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30942734</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>258</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Standardizing Austrians Claims Data Using the OMOP Common Data Model: A Feasibility Study.</ArticleTitle><Pagination><StartPage>151</StartPage><EndPage>152</EndPage><MedlinePgn>151-152</MedlinePgn></Pagination><Abstract><AbstractText>The suitability of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) for Austrian pseudonymized claims data from social security institutions and information about hospital stays is evaluated. 1,023 (99.7%) of ATC codes and 3,695 (98.6%) of ICD10 codes coincide with the OMOP vocabulary. Mappings for the local vocabularies like the Austrian pharmaceutical registration numbers, the Socio-Economic Index and professional groups, to the OMOP vocabulary do not exist. A standardization with the OMOP CDM is possible, however an initial, not negligible effort is required to adapt and incorporate the vocabulary.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haberson</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinner</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="Y">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="Y">Insurance Claim Review</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">claims data</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">drug safety</Keyword><Keyword MajorTopicYN="N">secondary use</Keyword><Keyword MajorTopicYN="N">standardized health data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30942734</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30943974</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>Suppl 3</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Developing a portable natural language processing based phenotyping system.</ArticleTitle><Pagination><StartPage>78</StartPage><MedlinePgn>78</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">78</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-019-0786-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">This paper presents a portable phenotyping system that is capable of integrating both rule-based and statistical machine learning based approaches.</AbstractText><AbstractText Label="METHODS">Our system utilizes UMLS to extract clinically relevant features from the unstructured text and then facilitates portability across different institutions and data systems by incorporating OHDSI's OMOP Common Data Model (CDM) to standardize necessary data elements. Our system can also store the key components of rule-based systems (e.g., regular expression matches) in the format of OMOP CDM, thus enabling the reuse, adaptation and extension of many existing rule-based clinical NLP systems. We experimented with our system on the corpus from i2b2's Obesity Challenge as a pilot study.</AbstractText><AbstractText Label="RESULTS">Our system facilitates portable phenotyping of obesity and its 15 comorbidities based on the unstructured patient discharge summaries, while achieving a performance that often ranked among the top 10 of the challenge participants.</AbstractText><AbstractText Label="CONCLUSION">Our system of standardization enables a consistent application of numerous rule-based and machine learning based classification techniques downstream across disparate datasets which may originate across different institutions and data systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Himanshu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cyberinfrastructure, University of Illinois at Chicago, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Chengsheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yizhen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vatani</LastName><ForeName>Haleh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cyberinfrastructure, University of Illinois at Chicago, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yizhen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biomedical Informatics, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pathak</LastName><ForeName>Jyotishman</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Informatics, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA. yuan.luo@northwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM105688</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 LM012618</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 LM008748</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not Applicable. This work used i2b2 Obesity Shared-Task Challenge Data, which is a de-identified and retrospective dataset shared with researchers. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30943974</ArticleId><ArticleId IdType="pmc">PMC6448187</ArticleId><ArticleId IdType="doi">10.1186/s12911-019-0786-z</ArticleId><ArticleId IdType="pii">10.1186/s12911-019-0786-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harpaz R, Callahan A, Tamang S, Low Y, Odgers D, Finlayson S, Jung K, LePendu P, Shah NH. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf. 2014;37(10):777&#x2013;790. doi: 10.1007/s40264-014-0218-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0218-z</ArticleId><ArticleId IdType="pmc">PMC4217510</ArticleId><ArticleId IdType="pubmed">25151493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmiento RF, Dernoncourt F. Improving patient cohort identification using natural language processing. In: Secondary analysis of electronic health records: Springer; 2016. p. 405&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">31314253</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Thompson W, Herr T, Zeng Z, Berendsen M, Jonnalagadda S, Carson M, Starren J. Natural language processing for EHR-based pharmacovigilance: a structured review. Drug Saf. 2017. 10.1007/s40264-017-0558-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28643174</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, Embi PJ, Elhadad N, Johnson SB, Lai AM. A review of approaches to identifying patient phenotype cohorts using electronic health records. J Am Med Inform Assn. 2014;21(2):221&#x2013;230. doi: 10.1136/amiajnl-2013-001935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001935</ArticleId><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Shickel B, Tighe PJ, Bihorac A, Rashidi P. Deep EHR: a survey of recent advances in deep learning techniques for electronic health record (EHR) analysis. Ieee J Biomed Health. 2018;22(5):1589&#x2013;1604. doi: 10.1109/JBHI.2017.2767063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2017.2767063</ArticleId><ArticleId IdType="pmc">PMC6043423</ArticleId><ArticleId IdType="pubmed">29989977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z, Deng Y, Li X, Naumann T, Luo Y. Natural language processing for EHR-based computational phenotyping. IEEE/ACM Trans Comput Biol Bioinform. 2018; [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6388621</ArticleId><ArticleId IdType="pubmed">29994486</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Hripcsak G, Shen YF, Chung WK, Weng CH. Defining a comprehensive verotype using electronic health records for personalized medicine. J Am Med Inform Assn. 2013;20(E2):E232&#x2013;E238. doi: 10.1136/amiajnl-2013-001932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001932</ArticleId><ArticleId IdType="pmc">PMC3861934</ArticleId><ArticleId IdType="pubmed">24001516</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh W, Price S, Donohoe L. Assessing thesaurus-based query expansion using the UMLS metathesaurus. J Am Med Inform Assn. 2000:344&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244120</ArticleId><ArticleId IdType="pubmed">11079902</ArticleId></ArticleIdList></Reference><Reference><Citation>Passos A, Wainer J. International workshop on web and text intelligence (WTI-2009): 2009. 2009. Wordnet-based metrics do not seem to help document clustering.</Citation></Reference><Reference><Citation>Ferrajolo C, Coloma PM, Verhamme KM, Schuemie MJ, de Bie S, Gini R, Herings R, Mazzaglia G, Picelli G, Giaquinto C, et al. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. Drug Saf. 2014;37(2):99&#x2013;108. doi: 10.1007/s40264-013-0132-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0132-9</ArticleId><ArticleId IdType="pubmed">24446276</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Szolovits P. Efficient queries of stand-off annotations for natural language processing on electronic medical records. Biomedical Informatics Insights. 2016;8:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954589</ArticleId><ArticleId IdType="pubmed">27478379</ArticleId></ArticleIdList></Reference><Reference><Citation>Solt I, Tikk D, Gal V, Kardkovacs ZT. Semantic classification of diseases in discharge summaries using a context-aware rule-based classifier. J Am Med Inform Assn. 2009;16(4):580&#x2013;584. doi: 10.1197/jamia.M3087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3087</ArticleId><ArticleId IdType="pmc">PMC2705263</ArticleId><ArticleId IdType="pubmed">19390101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu HF, Huang FL, Lin CJ. Dual coordinate descent methods for logistic regression and maximum entropy models. Mach Learn. 2011;85(1&#x2013;2):41&#x2013;75. doi: 10.1007/s10994-010-5221-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10994-010-5221-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan RE, Chang KW, Hsieh CJ, Wang XR, Lin CJ. LIBLINEAR: a library for large linear classification. J Mach Learn Res. 2008;9:1871&#x2013;1874.</Citation></Reference><Reference><Citation>Breiman L. Classification and regression trees: Routledge; 2017.</Citation></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. The elements of statistical learning, vol. 1. New York, NY: Springer series in statistics; 2001.</Citation></Reference><Reference><Citation>Breiman L. Random forests. Mach Learn. 2001;45(1):5&#x2013;32. doi: 10.1023/A:1010933404324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chicco D. Ten quick tips for machine learning in computational biology. BioData mining. 2017;10(1):35. doi: 10.1186/s13040-017-0155-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13040-017-0155-3</ArticleId><ArticleId IdType="pmc">PMC5721660</ArticleId><ArticleId IdType="pubmed">29234465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C-W, Chang C-C, Lin C-J: A practical guide to support vector classification.</Citation></Reference><Reference><Citation>Uzuner O. Recognizing obesity and comorbidities in sparse data. J Am Med Inform Assn. 2009;16(4):561&#x2013;570. doi: 10.1197/jamia.M3115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3115</ArticleId><ArticleId IdType="pmc">PMC2705260</ArticleId><ArticleId IdType="pubmed">19390096</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng WH, Wagholikar KB, McCray AT, Szolovits P, Chueh HC. Medical subdomain classification of clinical notes using a machine learning-based natural language processing approach. Bmc Med Inform Decis. 2017;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5709846</ArticleId><ArticleId IdType="pubmed">29191207</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Szolovits P: Implementing a portable clinical NLP system with a common data model &#x2013; a LISP perspective. In: Bioinformatics and Biomedicine (BIBM), 2016 IEEE International Conference on: 2018: IEEE; 2018: 461&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769694</ArticleId><ArticleId IdType="pubmed">33376623</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li RL, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, et al. The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med. 2013;15(10):761&#x2013;771. doi: 10.1038/gim.2013.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2013.72</ArticleId><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LV, Kiefer RC, Mo H, Speltz P, Thompson WK, Jiang G, Pacheco JA, Xu J, Zhu Q, Denny JC. A modular architecture for electronic health record-driven phenotyping. AMIA Summits on Translational Science Proceedings. 2015;2015:147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525215</ArticleId><ArticleId IdType="pubmed">26306258</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31054141</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims Data.</ArticleTitle><Pagination><StartPage>1377</StartPage><EndPage>1386</EndPage><MedlinePgn>1377-1386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-019-00827-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION">US claims data contain medical data on large heterogeneous populations and are excellent sources for medical research. Some claims data do not contain complete death records, limiting their use for mortality or mortality-related studies. A model to predict whether a patient died at the end of the follow-up time (referred to as the end of observation) is needed to enable mortality-related studies.</AbstractText><AbstractText Label="OBJECTIVE">The objective of this study was to develop a patient-level model to predict whether the end of observation was due to death in US claims data.</AbstractText><AbstractText Label="METHODS">We used a claims dataset with full death records, Optum<sup>&#xa9;</sup> De-Identified Clinformatics<sup>&#xae;</sup> Data-Mart-Database-Date of Death mapped to the Observational Medical Outcome Partnership common data model, to develop a model that classifies the end of observations into death or non-death. A regularized logistic regression was trained using 88,514 predictors (recorded within the prior 365 or 30&#xa0;days) and externally validated by applying the model to three US claims datasets.</AbstractText><AbstractText Label="RESULTS">Approximately 25 in 1000 end of observations in Optum are due to death. The Discriminating End of observation into Alive and Dead (DEAD) model obtained an area under the receiver operating characteristic curve of 0.986. When defining death as a predicted risk of&#x2009;&gt;&#x2009;0.5, only 2% of the end of observations were predicted to be due to death and the model obtained a sensitivity of 62% and a positive predictive value of 74.8%. The external validation showed the model was transportable, with area under the receiver operating characteristic curves ranging between 0.951 and 0.995 across the US claims databases.</AbstractText><AbstractText Label="CONCLUSIONS">US claims data often lack complete death records. The DEAD model can be used to impute death at various sensitivity, specificity, or positive predictive values depending on the use of the model. The DEAD model can be readily applied to any observational healthcare database mapped to the Observational Medical Outcome Partnership common data model and is available from https://github.com/OHDSI/StudyProtocolSandbox/tree/master/DeadModel .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2970-0778</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. jreps@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="Y">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Jenna Reps is an employee of Janssen Research &amp; Development and a shareholder of Johnson &amp; Johnson. Patrick Ryan is an employee of Janssen Research &amp; Development and a shareholder of Johnson &amp; Johnson. Peter Rijnbeek works for a research group who received unconditional research grants from Boehringer-Ingelheim, GSK, Janssen Research &amp; Development, Novartis, Pfizer, Yamanouchi, and Servier. None of these grants result in a conflict of interest with the content of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31054141</ArticleId><ArticleId IdType="pmc">PMC6834730</ArticleId><ArticleId IdType="doi">10.1007/s40264-019-00827-0</ArticleId><ArticleId IdType="pii">10.1007/s40264-019-00827-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mariani AW, Pego-Fernandes PM. Observational studies: why are they so important? Sao Paulo Med J. 2014;132(1):1&#x2013;2. doi: 10.1590/1516-3180.2014.1321784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-3180.2014.1321784</ArticleId><ArticleId IdType="pubmed">24474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312(7040):1215&#x2013;1218. doi: 10.1136/bmj.312.7040.1215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.312.7040.1215</ArticleId><ArticleId IdType="pmc">PMC2350940</ArticleId><ArticleId IdType="pubmed">8634569</ArticleId></ArticleIdList></Reference><Reference><Citation>Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887&#x2013;1892. doi: 10.1056/NEJM200006223422507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200006223422507</ArticleId><ArticleId IdType="pmc">PMC1557642</ArticleId><ArticleId IdType="pubmed">10861325</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KA, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris R, Coffey R. Comorbidity measures for use with administrative data. Med Care. 1998;36:8&#x2013;27. doi: 10.1097/00005650-199801000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199801000-00004</ArticleId><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharabiani M, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50:1109&#x2013;1118. doi: 10.1097/MLR.0b013e31825f64d0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31825f64d0</ArticleId><ArticleId IdType="pubmed">22929993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutacker N, Bloor K, Cookson R. Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions. Eur J Public Health. 2015;25:15&#x2013;20. doi: 10.1093/eurpub/cku221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/cku221</ArticleId><ArticleId IdType="pubmed">25690125</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inf Assoc. 2018;25(8):969&#x2013;975. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, et al. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013 doi: 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubbo B, Fitzpatrick NK, Denaxas S, Daskalopoulou M, Yu N, Patel RS, et al. Use of electronic health records to ascertain, validate and phenotype acute myocardial infarction: a systematic review and recommendations. Int J Cardiol. 2015;187:705&#x2013;711. doi: 10.1016/j.ijcard.2015.03.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.03.075</ArticleId><ArticleId IdType="pubmed">25966015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumamaru H, Judd SE, Curtis JR, Ramachandran R, Hardy NC, Rhodes JD, et al. Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with Medicare claims. Circ Cardiovasc Qual Outcomes. 2014;7:611&#x2013;619. doi: 10.1161/CIRCOUTCOMES.113.000743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.113.000743</ArticleId><ArticleId IdType="pmc">PMC4109622</ArticleId><ArticleId IdType="pubmed">24963021</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31065558</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2327-9214</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>EGEMS (Washington, DC)</Title><ISOAbbreviation>EGEMS (Wash DC)</ISOAbbreviation></Journal><ArticleTitle>A Data Element-Function Conceptual Model for Data Quality Checks.</ArticleTitle><Pagination><StartPage>17</StartPage><MedlinePgn>17</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/egems.289</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In aggregate, existing data quality (DQ) checks are currently represented in heterogeneous formats, making it difficult to compare, categorize, and index checks. This study contributes a data element-function conceptual model to facilitate the categorization and indexing of DQ checks and explores the feasibility of leveraging natural language processing (NLP) for scalable acquisition of knowledge of common data elements and functions from DQ checks narratives.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The model defines a "data element", the primary focus of the check, and a "function", the qualitative or quantitative measure over a data element. We applied NLP techniques to extract both from 172 checks for Observational Health Data Sciences and Informatics (OHDSI) and 3,434 checks for Kaiser Permanente's Center for Effectiveness and Safety Research (CESR).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The model was able to classify all checks. A total of 751 unique data elements and 24 unique functions were extracted. The top five frequent data element-function pairings for OHDSI were Person-Count (55 checks), Insurance-Distribution (17), Medication-Count (16), Condition-Count (14), and Observations-Count (13); for CESR, they were Medication-Variable Type (175), Medication-Missing (172), Medication-Existence (152), Medication-Count (127), and Socioeconomic Factors-Variable Type (114).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows the efficacy of the data element-function conceptual model for classifying DQ checks, demonstrates early promise of NLP-assisted knowledge acquisition, and reveals the great heterogeneity in the focus in DQ checks, confirming variation in intrinsic checks and use-case specific "fitness-for-use" checks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>James R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0001-7329-3535</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>University of Colorado Denver Anschutz Medical Campus, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauck</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northwest Center for Health Research, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khare</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>University of Colorado Denver Anschutz Medical Campus, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, US.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM009451</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EGEMS (Wash DC)</MedlineTA><NlmUniqueID>101629606</NlmUniqueID><ISSNLinking>2327-9214</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical data research networks</Keyword><Keyword MajorTopicYN="N">data quality</Keyword><Keyword MajorTopicYN="N">electronic healthcare records</Keyword><Keyword MajorTopicYN="N">knowledge acquisition</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31065558</ArticleId><ArticleId IdType="pmc">PMC6484368</ArticleId><ArticleId IdType="doi">10.5334/egems.289</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raghupathi, W and Raghupathi, V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst. 2014; 2 DOI: 10.1186/2047-2501-2-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2047-2501-2-3</ArticleId><ArticleId IdType="pmc">PMC4341817</ArticleId><ArticleId IdType="pubmed">25825667</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss, S. Learning from Big Health Care Data. N Engl J Med. 2014; 370: 2161&#x2013;2163. DOI: 10.1056/NEJMp1401111</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1401111</ArticleId><ArticleId IdType="pubmed">24897079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, M and Lipsitz, SR. Comparative effectiveness research methodology using secondary data: A starting user&#x2019;s guide. Urol Oncol Semin Orig Investig; 2017. DOI: 10.1016/j.urolonc.2017.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2017.10.011</ArticleId><ArticleId IdType="pubmed">29146037</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentz, RJ, Hernandez, AF, Berdan, LG, et al. Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds. Circulation. 2016; 133: 872&#x2013;880. DOI: 10.1161/CIRCULATIONAHA.115.019902</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019902</ArticleId><ArticleId IdType="pmc">PMC4777975</ArticleId><ArticleId IdType="pubmed">26927005</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss, S, Eichler, H-G, Garcia-Altes, A, et al. Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making. Clin Pharmacol Ther. 2016; 100: 633&#x2013;646. DOI: 10.1002/cpt.512</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.512</ArticleId><ArticleId IdType="pubmed">27627027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazlehurst, BL, Kurtz, SE, Masica, A, et al. CER Hub: An informatics platform for conducting comparative effectiveness research using multi-institutional, heterogeneous, electronic clinical data. Int J Med Inf. 2015; 84: 763&#x2013;773. DOI: 10.1016/j.ijmedinf.2015.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2015.06.002</ArticleId><ArticleId IdType="pubmed">26138036</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa, T-P, Dyson, L, McCann, G, et al. The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials. Health Technol Assess Winch Engl. 2014; 18: 1&#x2013;146. DOI: 10.3310/hta18430</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta18430</ArticleId><ArticleId IdType="pmc">PMC4781625</ArticleId><ArticleId IdType="pubmed">25011568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosis, G, Vlug, AE, Mosseveld, M, et al. A Technical Infrastructure to Conduct Randomized Database Studies Facilitated by a General Practice Research Database. J Am Med Inform Assoc JAMIA. 2005; 12: 602&#x2013;607. DOI: 10.1197/jamia.M1803</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M1803</ArticleId><ArticleId IdType="pmc">PMC1294030</ArticleId><ArticleId IdType="pubmed">16049228</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes, JH, Elliott, TE, Brown, JS, et al. Clinical research data warehouse governance for distributed research networks in the USA: a systematic review of the literature. J Am Med Inform Assoc JAMIA. 2014; 21: 730&#x2013;736. DOI: 10.1136/amiajnl-2013-002370</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-002370</ArticleId><ArticleId IdType="pmc">PMC4078282</ArticleId><ArticleId IdType="pubmed">24682495</ArticleId></ArticleIdList></Reference><Reference><Citation>Maro, JC, Platt, R, Holmes, JH, et al. Design of a national distributed health data network. Ann Intern Med. 2009; 151: 341&#x2013;344. DOI: 10.7326/0003-4819-151-5-200909010-00139</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-5-200909010-00139</ArticleId><ArticleId IdType="pubmed">19638403</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Effectiveness &amp; Safety Research &#x2013; Center for Effectiveness &amp; Safety Research. Available at: https://cesr.kp.org/. Accessed October 30, 2017.</Citation></Reference><Reference><Citation>McGlynn, EA, Lieu, TA, Durham, ML, et al. Developing a data infrastructure for a learning health system: the PORTAL network. J Am Med Inform Assoc JAMIA. 2014; 21: 596&#x2013;601. DOI: 10.1136/amiajnl-2014-002746</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002746</ArticleId><ArticleId IdType="pmc">PMC4078291</ArticleId><ArticleId IdType="pubmed">24821738</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest, CB, Margolis, PA, Bailey, LC, et al. PEDSnet: a National Pediatric Learning Health System. J Am Med Inform Assoc JAMIA. 2014; 21: 602&#x2013;606. DOI: 10.1136/amiajnl-2014-002743</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002743</ArticleId><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrow, S, Campion, DM, Herrinton, LJ, et al. The organizational structure and governing principles of the Food and Drug Administration&#x2019;s Mini-Sentinel pilot program. Pharmacoepidemiol Drug Saf. 2012; 21: 12&#x2013;17. DOI: 10.1002/pds.2242</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2242</ArticleId><ArticleId IdType="pubmed">22262588</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman, RE, Benner, JS, Brown, JS, McClellan, M, Woodcock, J and Platt, R. Developing the Sentinel System &#x2014; A National Resource for Evidence Development. N Engl J Med. 2011; 364: 498&#x2013;499. DOI: 10.1056/NEJMp1014427</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1014427</ArticleId><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence, RL, Curtis, LH, Califf, RM, Platt, R, Selby, JV and Brown, JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc JAMIA. 2014; 21: 578&#x2013;582. DOI: 10.1136/amiajnl-2014-002747</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls, LG, Phillips, TA, Hammill, BG, et al. Evaluating Foundational Data Quality in the National Patient-Centered Clinical Research Network (PCORnet&#xae;). eGEMs. 2018; 6 DOI: 10.5334/egems.199</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/egems.199</ArticleId><ArticleId IdType="pmc">PMC5983028</ArticleId><ArticleId IdType="pubmed">29881761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak, G, Duke, JD, Shah, NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015; 216: 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayley, KB, Belnap, T, Savitz, L, Masica, AL, Shah, N and Fleming, NS. Challenges in Using Electronic Health Record Data for CER: Experience of 4 Learning Organizations and Solutions Applied. Med Care. 2013; 51: S80 DOI: 10.1097/MLR.0b013e31829b1d48</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1d48</ArticleId><ArticleId IdType="pubmed">23774512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh, WR, Weiner, MG, Embi, PJ, et al. Caveats for the Use of Operational Electronic Health Record Data in Comparative Effectiveness Research. Med Care. 2013; 51: S30&#x2013;S37. DOI: 10.1097/MLR.0b013e31829b1dbd</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1dbd</ArticleId><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha, KS and Eikermann, M. Codifying healthcare &#x2013; big data and the issue of misclassification. BMC Anesthesiol. 2015; 15 DOI: 10.1186/s12871-015-0165-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-015-0165-y</ArticleId><ArticleId IdType="pmc">PMC4678724</ArticleId><ArticleId IdType="pubmed">26667619</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf, NG, Bakken, S, Hripcsak, G and Weng, C. A Data Quality Assessment Guideline for Electronic Health Record Data Reuse. EGEMs Gener Evid Methods Improve Patient Outcomes. 2017; 5 DOI: 10.13063/egems.1280</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/egems.1280</ArticleId><ArticleId IdType="pmc">PMC5983018</ArticleId><ArticleId IdType="pubmed">29881734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn, MG, Callahan, TJ, Barnard, J, et al. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. eGEMs. 2016; 4 DOI: 10.13063/2327-9214.1244</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn, MG, Brown, JS, Chun, AT, et al. Transparent Reporting of Data Quality in Distributed Data Networks. eGEMs. 2015; 3 DOI: 10.13063/2327-9214.1052</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1052</ArticleId><ArticleId IdType="pmc">PMC4434997</ArticleId><ArticleId IdType="pubmed">25992385</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf, NG and Weng, C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc JAMIA. 2013; 20: 144&#x2013;151. DOI: 10.1136/amiajnl-2011-000681</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000681</ArticleId><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, J, Kahn, M and Toh, S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013; 51: S22&#x2013;S29. DOI: 10.1097/MLR.0b013e31829b1e2c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1e2c</ArticleId><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, RY and Strong, DM. Beyond Accuracy: What Data Quality Means to Data Consumers. J Manag Inf Syst. 1996; 12: 5&#x2013;33. DOI: 10.1080/07421222.1996.11518099</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07421222.1996.11518099</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri, H, Stephens, KA, Klann, JG and Murphy, SN. Exploring completeness in clinical data research networks with DQe-c. J Am Med Inform Assoc. 2018; 25: 17&#x2013;24. DOI: 10.1093/jamia/ocx109</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx109</ArticleId><ArticleId IdType="pmc">PMC6481389</ArticleId><ArticleId IdType="pubmed">29069394</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan, TJ, Bauck, AE, Bertoch, D, et al. A Comparison of Data Quality Assessment Checks in Six Data Sharing Networks. EGEMs Gener Evid Methods Improve Patient Outcomes. 2017; 5 DOI: 10.13063/egems.1287</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/egems.1287</ArticleId><ArticleId IdType="pmc">PMC5982846</ArticleId><ArticleId IdType="pubmed">29881733</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare, R, Utidjian, L, Ruth, BJ, et al. A longitudinal analysis of data quality in a large pediatric data research network. J Am Med Inform Assoc JAMIA. 2017; 24: 1072&#x2013;1079. DOI: 10.1093/jamia/ocx033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx033</ArticleId><ArticleId IdType="pmc">PMC6259665</ArticleId><ArticleId IdType="pubmed">28398525</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser, V, DeFalco, FJ, Schuemie, M, et al. Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Data Sets. eGEMs. 2016; 4 DOI: 10.13063/2327-9214.1239</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1239</ArticleId><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Raebel, MA, Haynes, K, Woodworth, TS, et al. Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2014; 23: 609&#x2013;618. DOI: 10.1002/pds.3580</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3580</ArticleId><ArticleId IdType="pubmed">24677577</ArticleId></ArticleIdList></Reference><Reference><Citation>Quasthoff, U and Wolff, C. Text-based Knowledge Acquisition for Ontology Engineering. In: Proceedings of Konvens &#x2013; 6 2002; 147&#x2013;154. Saarbr&#xfc;cken, Germany.</Citation></Reference><Reference><Citation>Achilles: Automated Characterization of Health Information at Large-scale Longitudinal Evidence Systems (ACHILLES) &#x2013; descriptive statistics about a OMOP CDM database. Observational Health Data Sciences and Informatics; 2018.  Available at: https://github.com/OHDSI/Achilles. Accessed December 8, 2017.</Citation></Reference><Reference><Citation>Nadkarni, PM, Marenco, L, Chen, R, Skoufos, E, Shepherd, G and Miller, P. Organization of Heterogeneous Scientific Data Using the EAV/CR Representation. J Am Med Inform Assoc. 1999; 6: 478&#x2013;493. DOI: 10.1136/jamia.1999.0060478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.1999.0060478</ArticleId><ArticleId IdType="pmc">PMC61391</ArticleId><ArticleId IdType="pubmed">10579606</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, T, Zhang, S, Tang, Y, et al. EliIE: An open-source information extraction system for clinical trial eligibility criteria. J Am Med Inform Assoc. 2017; 24: 1062&#x2013;1071. DOI: 10.1093/jamia/ocx019</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx019</ArticleId><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss, EA, Makadia, R, Matcho, A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015; 22: 553&#x2013;564. DOI: 10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Domain. Available at: https://github.com/OHDSI/CommonDataModel/wiki/DOMAIN. Accessed January 5, 2018.</Citation></Reference><Reference><Citation>Kahn, MG, Raebel, MA, Glanz, JM, Riedlinger, K and Steiner, JF. A Pragmatic Framework for Single-site and Multisite Data Quality Assessment in Electronic Health Record-based Clinical Research. Med Care. 2012; 50 DOI: 10.1097/MLR.0b013e318257dd67</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318257dd67</ArticleId><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>CommonDataModel: Definition and DDLs for the OMOP Common Data Model (CDM). Observational Health Data Sciences and Informatics, 2018.  Available at: https://github.com/OHDSI/CommonDataModel. Accessed January 5, 2018.</Citation></Reference><Reference><Citation>QDM|eCQI Resource Center. Available at: https://ecqi.healthit.gov/qdm. Accessed February 20, 2018.</Citation></Reference><Reference><Citation>HL7 Standards Product Brief &#x2013; HL7 Cross-Paradigm Specification: Clinical Quality Language, Release 1. Health Level Seven Int
2018.  Available at: http://www.hl7.org/implement/standards/product_brief.cfm?product_id=400. Accessed February 20, 2018.</Citation></Reference><Reference><Citation>SNOMED CT Starter Guide. Available at: https://confluence.ihtsdotools.org/display/DOCSTART/SNOMED+CT+Starter+Guide. Accessed February 19, 2018.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31066478</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Comment on "How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias".</ArticleTitle><Pagination><StartPage>1032</StartPage><EndPage>1033</EndPage><MedlinePgn>1032-1033</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.4798</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Real World Analytics Solutions, IQVIA, Cambridge, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berlin</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Pharmacoepidemiol Drug Saf. 2019 Jan 15. doi: 10.1002/pds.4722</RefSource><PMID Version="1">30648307</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="Y">Pharmacoepidemiology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31066478</ArticleId><ArticleId IdType="doi">10.1002/pds.4798</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31214700</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1367-4811</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>21</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Bioinformatics (Oxford, England)</Title><ISOAbbreviation>Bioinformatics</ISOAbbreviation></Journal><ArticleTitle>PatientExploreR: an extensible application for dynamic visualization of patient clinical history from electronic health records in the OMOP common data model.</ArticleTitle><Pagination><StartPage>4515</StartPage><EndPage>4518</EndPage><MedlinePgn>4515-4518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/btz409</ELocationID><Abstract><AbstractText Label="MOTIVATION">Electronic health records (EHRs) are quickly becoming omnipresent in healthcare, but interoperability issues and technical demands limit their use for biomedical and clinical research. Interactive and flexible software that interfaces directly with EHR data structured around a common data model (CDM) could accelerate more EHR-based research by making the data more accessible to researchers who lack computational expertise and/or domain knowledge.</AbstractText><AbstractText Label="RESULTS">We present PatientExploreR, an extensible application built on the R/Shiny framework that interfaces with a relational database of EHR data in the Observational Medical Outcomes Partnership CDM format. PatientExploreR produces patient-level interactive and dynamic reports and facilitates visualization of clinical data without any programming required. It allows researchers to easily construct and export patient cohorts from the EHR for analysis with other software. This application could enable easier exploration of patient-level data for physicians and researchers. PatientExploreR can incorporate EHR data from any institution that employs the CDM for users with approved access. The software code is free and open source under the MIT license, enabling institutions to install and users to expand and modify the application for their own purposes.</AbstractText><AbstractText Label="AVAILABILITY AND IMPLEMENTATION">PatientExploreR can be freely obtained from GitHub: https://github.com/BenGlicksberg/PatientExploreR. We provide instructions for how researchers with approved access to their institutional EHR can use this package. We also release an open sandbox server of synthesized patient data for users without EHR access to explore: http://patientexplorer.ucsf.edu.</AbstractText><AbstractText Label="SUPPLEMENTARY INFORMATION">Supplementary data are available at Bioinformatics online.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glicksberg</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oskotsky</LastName><ForeName>Boris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangaraj</LastName><ForeName>Phyllis M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giangreco</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badgeley</LastName><ForeName>Marcus A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kipp W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Debajyoti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudrapatna</LastName><ForeName>Vivek A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rappoport</LastName><ForeName>Nadav</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shervey</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miotto</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Theodore C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutenberg</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frazier</LastName><ForeName>Remi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Enterprise Information and Analytics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Enterprise Information and Analytics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israni</LastName><ForeName>Sharat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Enterprise Information and Analytics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Percha</LastName><ForeName>Bethany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Joel T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butte</LastName><ForeName>Atul J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Data-Driven Insights and Innovation, University of California Health, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 HL140946</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM131905</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DK007007</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioinformatics</MedlineTA><NlmUniqueID>9808944</NlmUniqueID><ISSNLinking>1367-4803</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003201" MajorTopicYN="N">Computers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31214700</ArticleId><ArticleId IdType="pmc">PMC6821222</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btz409</ArticleId><ArticleId IdType="pii">5520433</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Attali D., Almende B.V. (2016) timevis: create interactive timeline visualizations in R. R package version 0.4.</Citation></Reference><Reference><Citation>Badgeley M.A. et al. (2016) EHDViz: clinical dashboard development using open-source technologies. BMJ Open, 6, e010579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4809078</ArticleId><ArticleId IdType="pubmed">27013597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W. et al. (2015) Shiny: web application framework for R. R Package Version 0.11, 1, 106.</Citation></Reference><Reference><Citation>Duke J.D. et al. (2017) Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia, 58, e101&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H., Stephens K. (2017) DQe-v: a database-agnostic framework for exploring variability in electronic health record data across time and site location. EGEMS, 5, 3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994933</ArticleId><ArticleId IdType="pubmed">29930954</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankovich J. et al. (2011) Evidence-based medicine in the EMR era. N. Engl. J. Med., 365, 1758&#x2013;1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">22047518</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicksberg B.S. et al. (2019) ROMOP: a light-weight R package for interfacing with OMOP-formatted electronic health record data. JAMIA Open. 2, 10&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800657</ArticleId><ArticleId IdType="pubmed">31633087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch J.S. et al. (2015) HARVEST, a longitudinal patient record summarizer. J. Am. Med. Inform. Assoc., 22, 263&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394965</ArticleId><ArticleId IdType="pubmed">25352564</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G. et al. (2015) Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform., 216, 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G. et al. (2016) Characterizing treatment pathways at scale using the OHDSI network. Proc. Natl. Acad. Sci. USA, 113, 7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V. et al. (2016) Multisite evaluation of a data quality tool for patient-level clinical data sets. EGEMS, 4, 1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen P.B. et al. (2012) Mining electronic health records: towards better research applications and clinical care. Nat. Rev. Genet., 13, 395&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause J. et al. (2016) Supporting iterative Cohort construction with visual temporal queries. IEEE Trans. Vis Comput. Graph, 22, 91&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">26529690</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine M.E. et al. (2018) Methodological variations in lagged regression for detecting physiologic drug effects in EHR data. J. Biomed. Inform., 86, 149&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6207533</ArticleId><ArticleId IdType="pubmed">30172760</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik S. et al. (2015) Cohort comparison of event sequences with balanced integration of visual analytics and statistics In: Proceedings of the 20th International Conference on Intelligent User Interfaces, Atlanta, Georgia, USA, March 29 &#x2013; April 1, 2015. ACM, pp. 38&#x2013;49.</Citation></Reference><Reference><Citation>Mandel J.C. et al. (2016) SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J. Am. Med. Inform. Assoc., 23, 899&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference><Reference><Citation>Perer A. et al. (2015) Mining and exploring care pathways from electronic medical records with visual analytics. J. Biomed. Inform., 56, 369&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">26146159</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R., Elhadad N. (2015) Automated methods for the summarization of electronic health records. J. Am. Med. Inform. Assoc., 22, 938&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986665</ArticleId><ArticleId IdType="pubmed">25882031</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A. et al. (2018) Scalable and accurate deep learning with electronic health records. Npj Digital Med., 1, 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Rind A. et al. (2013) Interactive information visualization to explore and query electronic health records. Found. Trends Hum. Comput. Interact., 5, 207&#x2013;298.</Citation></Reference><Reference><Citation>Schuemie M.J. et al. (2018) Improving reproducibility by using high-throughput observational studies with empirical calibration. Philos Trans. A Math. Phys. Eng. Sci., 376, 1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaddox T.R. et al. (2016) Hierarchical models for multiple, rare outcomes using massive observational healthcare databases. Stat. Anal. Data Min., 9, 260&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423675</ArticleId><ArticleId IdType="pubmed">28503249</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievert C. et al. (2017) plotly: create interactive web graphics via &#x2018;plotly. js&#x2019;. R package version 4.7. 1.</Citation></Reference><Reference><Citation>Soulakis N.D. et al. (2015) Visualizing collaborative electronic health record usage for hospitalized patients with heart failure. J. Am. Med. Inform. Assoc., 22, 299&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394967</ArticleId><ArticleId IdType="pubmed">25710558</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R. et al. (2018) Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Network Open, 1, e181755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>West V.L. et al. (2015) Innovative information visualization of electronic health record data: a systematic review. J. Am. Med. Inform. Assoc., 22, 330&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394966</ArticleId><ArticleId IdType="pubmed">25336597</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. et al. (2015) Paving the COWpath: learning and visualizing clinical pathways from electronic health record data. J. Biomed. Inform., 58, 186&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">26419864</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31238109</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data model.</ArticleTitle><Pagination><StartPage>103239</StartPage><MedlinePgn>103239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103239</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30158-3</ELocationID><Abstract><AbstractText>Systematic application of observational data to the understanding of impacts of cancer treatments requires detailed information models allowing meaningful comparisons between treatment regimens. Unfortunately, details of systemic therapies are scarce in registries and data warehouses, primarily due to the complex nature of the protocols and a lack of standardization. Since 2011, we have been creating a curated and semi-structured website of chemotherapy regimens, HemOnc.org. In coordination with the Observational Health Data Sciences and Informatics (OHDSI) Oncology Subgroup, we have transformed a substantial subset of this content into the OMOP common data model, with bindings to multiple external vocabularies, e.g., RxNorm and the National Cancer Institute Thesaurus. Currently, there are &gt;73,000 concepts and &gt;177,000 relationships in the full vocabulary. Content related to the definition and composition of chemotherapy regimens has been released within the ATHENA tool (athena.ohdsi.org) for widespread utilization by the OHDSI membership. Here, we describe the rationale, data model, and initial contents of the HemOnc vocabulary along with several use cases for which it may be valuable.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>Jeremy L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, TN, United States; HemOnc.org, LLC, Lexington, MA, United States. Electronic address: jeremy.warner@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymshyts</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Inc., Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurley</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hochheiser</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moldwin</LastName><ForeName>Zachary H</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>University of Illinois at Chicago College of Pharmacy, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belenkaya</LastName><ForeName>Rimma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Tufts University, Medford, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>HemOnc.org, LLC, Lexington, MA, United States; Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA231840</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA184407</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA194215</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006405" MajorTopicYN="N">Hematology</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008495" MajorTopicYN="N">Medical Oncology</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054547" MajorTopicYN="N">National Cancer Institute (U.S.)</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009626" MajorTopicYN="N">Terminology as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="N">Vocabulary</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Knowledge engineering</Keyword><Keyword MajorTopicYN="N">Neoplasms</Keyword><Keyword MajorTopicYN="N">Ontologies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31238109</ArticleId><ArticleId IdType="mid">NIHMS1534326</ArticleId><ArticleId IdType="pmc">PMC6697579</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103239</ArticleId><ArticleId IdType="pii">S1532-0464(19)30158-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Miller KD, Jemal A, Cancer statistics, 2019, CA Cancer J Clin. 69 (2019) 7&#x2013;34. doi:10.3322/caac.21551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21551</ArticleId><ArticleId IdType="pubmed">30620402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehl KL, Arora NK, Schrag D, Ayanian JZ, Clauser SB, Klabunde CN, Kahn KL, Fletcher RH, Keating NL, Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer, J Natl Cancer Inst. 106 (2014). doi:10.1093/jnci/dju216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/dju216</ArticleId><ArticleId IdType="pmc">PMC4168309</ArticleId><ArticleId IdType="pubmed">25217775</ArticleId></ArticleIdList></Reference><Reference><Citation>Khozin S, Blumenthal GM, Pazdur R, Real-world Data for Clinical Evidence Generation in Oncology, J Natl Cancer Inst. 109 (2017). doi:10.1093/jnci/djx187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djx187</ArticleId><ArticleId IdType="pubmed">29059439</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Carroll RJ, Warner JL, Matheny ME, Denny JC, Representing Knowledge Consistently Across Health Systems, Yearb Med Inform. 26 (2017) 139&#x2013;147. doi:10.15265/IY-2017-018.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2017-018</ArticleId><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JL, Cowan AJ, Hall AC, Yang PC, HemOnc.org: A Collaborative Online Knowledge Platform for Oncology Professionals, J Oncol Pract. 11 (2015) e336&#x2013;50. doi:10.1200/JOP.2014.001511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JOP.2014.001511</ArticleId><ArticleId IdType="pmc">PMC5706141</ArticleId><ArticleId IdType="pubmed">25736385</ArticleId></ArticleIdList></Reference><Reference><Citation>Malty AM, Jain SK, Yang PC, Harvey K, Warner JL, Computerized Approach to Creating a Systematic Ontology of Hematology/Oncology Regimens, JCO Clinical Cancer Informatics. (2018) 1&#x2013;11. doi:10.1200/CCI.17.00142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.17.00142</ArticleId><ArticleId IdType="pmc">PMC6141041</ArticleId><ArticleId IdType="pubmed">30238070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y-C, Stang PE, Madigan D, Ryan PB, Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers, Stud Health Technol Inform. 216 (2015) 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss J, Collaborative thesaurus tagging the Wikipedia way, ArXiv:Cs/0604036. (2006). http://arxiv.org/abs/cs/0604036 (accessed
March 17, 2019).</Citation></Reference><Reference><Citation>R: The R Project for Statistical Computing, (n.d.). https://www.r-project.org/ (accessed
February 25, 2019).</Citation></Reference><Reference><Citation>APIs, (n.d.). https://rxnav.nlm.nih.gov/APIsOverview.html (accessed
February 25, 2019).</Citation></Reference><Reference><Citation>Sch&#xf6;fl G, reutils: Talk to the NCBI EUtils, 2016. 
https://CRAN.R-project.org/package=reutils (accessed
February 25, 2019).</Citation></Reference><Reference><Citation>Porschen R, Arkenau H-T, Kubicka S, Greil R, Seufferlein T, Freier W, Kretzschmar A, Graeven U, Grothey A, Hinke A, Schmiegel W, Schmoll H-J, AIO Colorectal Study Group, Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group, J. Clin. Oncol 25 (2007) 4217&#x2013;4223. doi:10.1200/JCO.2006.09.2684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2006.09.2684</ArticleId><ArticleId IdType="pubmed">17548840</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Tseytlin E, Finan S, Castine M, Miller T, Medvedeva O, Harris D, Hochheiser H, Lin C, Chavan G, Jacobson RS, DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records, Cancer Res. 77 (2017) e115&#x2013;e118. doi:10.1158/0008-5472.CAN-17-0615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-0615</ArticleId><ArticleId IdType="pmc">PMC5690492</ArticleId><ArticleId IdType="pubmed">29092954</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll NM, Burniece KM, Holzman J, McQuillan DB, Plata A, Ritzwoller DP, Algorithm to Identify Systemic Cancer Therapy Treatment Using Structured Electronic Data, JCO Clin Cancer Inform. 1 (2017) 1&#x2013;9. doi:10.1200/CCI.17.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.17.00002</ArticleId><ArticleId IdType="pmc">PMC7006900</ArticleId><ArticleId IdType="pubmed">30657379</ArticleId></ArticleIdList></Reference><Reference><Citation>Styler WF, Bethard S, Finan S, Palmer M, Pradhan S, de Groen PC, Erickson B, Miller T, Lin C, Savova G, Pustejovsky J, Temporal Annotation in the Clinical Domain, Transactions of the Association for Computational Linguistics. 2 (2014) 143&#x2013;154. doi:10.1162/tacl_a_00172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/tacl_a_00172</ArticleId><ArticleId IdType="pmc">PMC5657277</ArticleId><ArticleId IdType="pubmed">29082229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ontology | HemOnc.org - A Hematology Oncology Wiki, (n.d.). https://hemonc.org/wiki/Ontology (accessed
May 22, 2019).</Citation></Reference><Reference><Citation>Abrams TA, Brightly R, Mao J, Kirkner G, Meyerhardt JA, Schrag D, Fuchs CS, Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer, J Clin Oncol. 29 (2011) 3255&#x2013;62. doi:10.1200/JCO.2011.35.0058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2011.35.0058</ArticleId><ArticleId IdType="pubmed">21768462</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining N-ary Relations on the Semantic Web, (n.d.). https://www.w3.org/TR/swbp-naryRelations/ (accessed
February 23, 2019).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31307128</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1598-866X</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Genomics &amp; informatics</Title><ISOAbbreviation>Genomics Inform</ISOAbbreviation></Journal><ArticleTitle>Fully connecting the Observational Health Data Science and Informatics (OHDSI) initiative with the world of linked open data.</ArticleTitle><Pagination><StartPage>e13</StartPage><MedlinePgn>e13</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5808/GI.2019.17.2.e13</ELocationID><Abstract><AbstractText>The usage of controlled biomedical vocabularies is the cornerstone that enables seamless interoperability when using a common data model across multiple data sites. The Observational Health Data Science and Informatics (OHDSI) initiative combines over 100 controlled vocabularies into its own. However, the OHDSI vocabulary is limited in the sense that it combines multiple terminologies and does not provide a direct way to link them outside of their own self-contained scope. This issue makes the tasks of enriching feature sets by using external resources extremely difficult. In order to address these shortcomings, we have created a linked data version of the OHDSI vocabulary, connecting it with already established linked resources like bioportal, bio2rdf, etc. with the ultimate purpose of enabling the interoperability of resources previously foreign to the OHDSI universe.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Panacea Laboratory, Department of Computer Science, Georgia State University, Atlanta, GA 30303, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Genomics Inform</MedlineTA><NlmUniqueID>101223836</NlmUniqueID><ISSNLinking>1598-866X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RDF</Keyword><Keyword MajorTopicYN="N">clinical informatics</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">controlled vocabularies</Keyword><Keyword MajorTopicYN="N">linked open data</Keyword><Keyword MajorTopicYN="N">semantic web</Keyword></KeywordList><CoiStatement><b>Conflicts of Interest</b>. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31307128</ArticleId><ArticleId IdType="pmc">PMC6808628</ArticleId><ArticleId IdType="doi">10.5808/GI.2019.17.2.e13</ArticleId><ArticleId IdType="pii">GI.2019.17.2.e13</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>San Franciso: GitHub; 2019. Atlas. Accessed 2019 Apr 2. Available from:  https://github.com/OHDSI/Atlas.</Citation></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25:969&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, Shah NH. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Jt Summits Transl Sci Proc. 2017;2017:48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113:7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, Hripcsak G, Jin P, Reich C, et al. Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia. 2017;58:e101&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S, et al. Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Netw Open. 2018;1:e181755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32:D267&#x2013;D270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan A, Cruz-Toledo J, Ansell P, Dumontier M. Bio2RDF release 2: improved coverage, interoperability and provenance of life science linked data. In: Cimiano P, Corcho O, Presutti V, Hollink L, Rodolph S, editors. The Semantic Web: Semantics and Big Data; 2013 May 26-30; Montpellier, France. Berlin. 2013. pp. 200&#x2013;212.</Citation></Reference><Reference><Citation>Salvadores M, Alexander PR, Musen MA, Noy NF. BioPortal as a Dataset of Linked Biomedical Ontologies and Terminologies in RDF. Semant Web. 2013;4:277&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159173</ArticleId><ArticleId IdType="pubmed">25214827</ArticleId></ArticleIdList></Reference><Reference><Citation>San Franciso: GitHub; 2019. OHDSIananke. Accessed 2019 Apr 2. Available from:  https://github.com/thepanacealab/OHDSIananke.</Citation></Reference><Reference><Citation>Leroux H, Lefort L. Semantic enrichment of longitudinal clinical study data using the CDISC standards and the semantic statistics vocabularies. J Biomed Semantics. 2015;6:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4429421</ArticleId><ArticleId IdType="pubmed">25973166</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair DR, Wang K, Nestorov S, Evans JA, Rzhetsky A. Quantifying the impact and extent of undocumented biomedical synonymy. PLoS Comput Biol. 2014;10:e1003799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4177665</ArticleId><ArticleId IdType="pubmed">25255227</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson PN, K&#xf6;hler S, Bauer S, Seelow D, Horn D, Mundlos S. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008;83:610&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668030</ArticleId><ArticleId IdType="pubmed">18950739</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson J, Bridges R, Ho JC, Wallace BC, Ghosh J. PheKnow-Cloud: A Tool for Evaluating High-Throughput Phenotype Candidates using Online Medical Literature. AMIA Jt Summits Transl Sci Proc. 2017;2017:149&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543339</ArticleId><ArticleId IdType="pubmed">28815124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y, An Y, Liu M, Hasan SA, Fan Y, Hu X. Integrating extra knowledge into word embedding models for biomedical NLP tasks. 2017 International Joint Conference on Neural Networks (IJCNN); 2017 May 14-19; Anchorage, AK, USA. Hoffman Estates. 2017. pp. 968&#x2013;975.</Citation></Reference><Reference><Citation>Dubois S, Romano N, Kale DC, Shah N, Jung K.  Ithaca: arXiv, Cornell University; 2017. Effective representations of clinical notes. Accessed 2019 Apr 2. Available from:  http://arxiv.org/abs/1705.07025.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31325501</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Facilitating phenotype transfer using a common data model.</ArticleTitle><Pagination><StartPage>103253</StartPage><MedlinePgn>103253</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103253</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30172-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Implementing clinical phenotypes across a network is labor intensive and potentially error prone. Use of a common data model may facilitate the process.</AbstractText><AbstractText Label="METHODS">Electronic Medical Records and Genomics (eMERGE) sites implemented the Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) Common Data Model across their electronic health record (EHR)-linked DNA biobanks. Two previously implemented eMERGE phenotypes were converted to OMOP and implemented across the network.</AbstractText><AbstractText Label="RESULTS">It was feasible to implement the common data model across sites, with laboratory data producing the greatest challenge due to local encoding. Sites were then able to execute the OMOP phenotype in less than one day, as opposed to weeks of effort to manually implement an eMERGE phenotype in their bespoke research EHR databases. Of the sites that could compare the current OMOP phenotype implementation with the original eMERGE phenotype implementation, specific agreement ranged from 100% to 43%, with disagreements due to the original phenotype, the OMOP phenotype, changes in data, and issues in the databases. Using the OMOP query as a standard comparison revealed differences in the original implementations despite starting from the same definitions, code lists, flowcharts, and pseudocode.</AbstractText><AbstractText Label="CONCLUSION">Using a common data model can dramatically speed phenotype implementation at the cost of having to populate that data model, though this will produce a net benefit as the number of phenotype implementations increases. Inconsistencies among the implementations of the original queries point to a potential benefit of using a common data model so that actual phenotype code and logic can be shared, mitigating human error in reinterpretation of a narrative phenotype definition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY, United States. Electronic address: hripcsak@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peissig</LastName><ForeName>Peggy L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Luke V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoit</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrell</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dikilitas</LastName><ForeName>Ozan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainer</LastName><ForeName>Vivian S</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howell</LastName><ForeName>Kayla Marie</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kullo</LastName><ForeName>Iftikhar J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lingren</LastName><ForeName>Todd</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentch</LastName><ForeName>Frank D</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Qi</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute, NIH, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>S10 RR025141</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008672</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008684</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008679</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026553</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 MD007593</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG006379</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008664</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008701</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008676</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009174</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008657</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008666</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL133786</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008673</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008685</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054560" MajorTopicYN="N">National Human Genome Research Institute (U.S.)</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Phenotyping</Keyword></KeywordList><CoiStatement>Conflicts of interest: None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31325501</ArticleId><ArticleId IdType="mid">NIHMS1535478</ArticleId><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103253</ArticleId><ArticleId IdType="pii">S1532-0464(19)30172-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Newton KM, Peissig PL, Kho AN, Bielinski SJ, Berg RL, Choudhary V, Basford M, Chute CG, Kullo IJ, Li R, Pacheco JA, Rasmussen LV, Spangler L, Denny JC. J Am Med Inform Assoc. 2013 Jun;20(e1):e147&#x2013;54. Validation of electronic medical record&#x2013;based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013;20(e1):e147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, Pacheco JA, Jiang G, Kiefer R, Zhu Q, Xu J, Montague E, Carrell DS, Lingren T, Mentch FD, Ni Y, Wehbe FH, Peissig PL, Tromp G, Larson EB, Chute CG, Pathak J, Denny JC, Speltz P, Kho AN, Jarvik GP, Bejan CA, Williams MS, Borthwick K, Kitchner TE, Roden DM, Harris PA. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc. 2015. November;22(6):1220&#x2013;30. doi: 10.1093/jamia/ocv112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv112</ArticleId><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway M, Berg RL, Carrell D, Denny JC, Kho AN, Kullo IJ, Linneman JG, Pacheco JA, Peissig P, Rasmussen L, Weston N, Chute CG, Pathak J. Analyzing the heterogeneity and complexity of Electronic Health Record oriented phenotyping algorithms. AMIA Annu Symp Proc. 2011;2011:274&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243189</ArticleId><ArticleId IdType="pubmed">22195079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. High-fidelity phenotyping: richness and freedom from bias. J Am Med Inform Assoc 2017. doi: 10.1093/jamia/ocx110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx110</ArticleId><ArticleId IdType="pmc">PMC7282504</ArticleId><ArticleId IdType="pubmed">29040596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc 2013;20:117&#x2013;21. doi:10.1136/amiajnl-2012-001145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-001145</ArticleId><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R, Masys DR, Ritchie MD, Roden DM, Struewing JP, Wolf WA; eMERGE Team. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011. January 26;4:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, B&#xf6;ttinger EP, Williams MS; eMERGE Network. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013. October;15(10):761&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J, Wang J, Kashyap S, Basford M, Li R, Masys DR, Chute CG. Mapping clinical phenotype data elements to standardized metadata repositories and controlled terminologies: the eMERGE Network experience. J Am Med Inform Assoc. 2011. Jul-Aug;18(4):376&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128396</ArticleId><ArticleId IdType="pubmed">21597104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, Ryan PB. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc. 2018. December 1;25(12):1618&#x2013;1625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J, Pan H, Wang J, Kashyap S, Schad PA, Hamilton CM, Masys DR, Chute CG. Evaluating Phenotypic Data Elements for Genetics and Epidemiological Research: Experiences from the eMERGE and PhenX Network Projects. AMIA Jt Summits Transl Sci Proc. 2011;2011:41&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248754</ArticleId><ArticleId IdType="pubmed">22211178</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LV, Thompson WK, Pacheco JA, Kho AN, Carrell DS, Pathak J, Peissig PL, Tromp G, Denny JC, Starren JB. Design patterns for the development of electronic health record-driven phenotype extraction algorithms. J Biomed Inform. 2014. October;51:280&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194216</ArticleId><ArticleId IdType="pubmed">24960203</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson WK, Rasmussen LV, Pacheco JA, Peissig PL, Denny JC, Kho AN, Miller A, Pathak J. An evaluation of the NQF Quality Data Model for representing Electronic Health Record driven phenotyping algorithms. AMIA Annu Symp Proc. 2012;2012:911&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540514</ArticleId><ArticleId IdType="pubmed">23304366</ArticleId></ArticleIdList></Reference><Reference><Citation>Peissig PL, Rasmussen LV, Berg RL, Linneman JG, McCarty CA, Waudby C, Chen L, Denny JC, Wilke RA, Pathak J, Carrell D, Kho AN, Starren JB. Importance of multimodal approaches to effectively identify cataract cases from electronic health records. J Am Med Inform Assoc. 2012. Mar-Apr;19(2):225&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277618</ArticleId><ArticleId IdType="pubmed">22319176</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro VM, Dligach D, Finan S, Yu S, Can A, Abd-El-Barr M, Gainer V, Shadick NA, Murphy S, Cai T, Savova G, Weiss ST, Du R. Large-scale identification of patients with cerebral aneurysms using natural language processing. Neurology 2017. January 10; 88(2):164&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5224711</ArticleId><ArticleId IdType="pubmed">27927935</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao KP, Ananthakrishnan AN, Kumar V, Xia Z, Cagan A, Gainer VS, Goryachev S, Chen P, Savova GK, Agniel D, Churchill S, Lee J, Murphy SN, Plenge RM, Szolovits P, Kohane I, Shaw SY, Karlson EW, Cai T. Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts. PLoS One 2015; 10(8):e0136651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547801</ArticleId><ArticleId IdType="pubmed">26301417</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Ma Y, Gronsbell J, Cai T, Ananthakrishnan AN, Gainer VS, Churchill SE, Szolovits P, Murphy SN, Kohane IS, Liao KP, Cai T. Enabling phenotypic big data with PheNorm. J Am Med Inform Assoc 2018. 01 01; 25(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251688</ArticleId><ArticleId IdType="pubmed">29126253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco JA, Rasmussen LV, Kiefer RC, Campion TR, Speltz P, Carroll RJ, Stallings SC, Mo H, Ahuja M, Jiang G, LaRose ER, Peissig PL, Shang N, Benoit B, Gainer VS, Borthwick K, Jackson KL, Sharma A, Wu AY, Kho AN, Roden DM, Pathak J, Denny JC, Thompson WK. A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments. J Am Med Inform Assoc. 2018. November 1;25(11):1540&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6213083</ArticleId><ArticleId IdType="pubmed">30124903</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, Banda JM, Reich CG, Schilling LM, Matheny ME, Meeker D, Pratt N, Madigan D. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A 2016;113:7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012. Jan-Feb;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>SNOMED CT. http://www.snomed.org/snomed-ct (accessed 2019 March 14).</Citation></Reference><Reference><Citation>U.S. National Library of Medicine. Unified Medical Language System (UMLS) RxNorm. https://www.nlm.nih.gov/research/umls/rxnorm/ (accessed 2019 March 14).</Citation></Reference><Reference><Citation>Regenstrief Institute. LOINC. https://loinc.org/ (accessed 2019 March 14).</Citation></Reference><Reference><Citation>Wagner EH, Greene SM, Hart G, et al. Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr. 2005(35):3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">16287880</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Food and Drug Administration. Sentinel Distributed Database and Common Data Model. 2017; https://www.sentinelinitiative.org/sentinel/data/distributed-database-commondata-model.
Accessed 2017 Jul 21.</Citation></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL, Pacheco JA, Tromp G, Pathak J, Carrell DS, Ellis SB, Lingren T, Thompson WK, Savova G, Haines J, Roden DM, Harris PA, Denny JC. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc 2016;23:1046&#x2013;1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), National Center for Health Statistics; 
http://www.cdc.gov/nchs/icd/icd9cm.htm (accessed 2019 March 14).</Citation></Reference><Reference><Citation>International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), National Center for Health Statistics; 
http://www.cdc.gov/nchs/icd/icd10cm.htm (accessed 2019 March 14).</Citation></Reference><Reference><Citation>ODHSI. ATLAS. https://github.com/OHDSI/Atlas (assessed 2019 March 14).</Citation></Reference><Reference><Citation>PheKB. Type 2 Diabetes Mellitus. https://phekb.org/phenotype/type-2-diabetes-mellitus (accessed 2019 March 7).</Citation></Reference><Reference><Citation>PheKB. ADHD phenotype algorithm. https://phekb.org/phenotype/adhd-phenotype-algorithm (accessed 2019 March 7).</Citation></Reference><Reference><Citation>Hripcsak G, Rothschild AS. Agreement, the F-measure, and reliability in information retrieval. J Am Med Inform Assoc 2005;12:296&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1090460</ArticleId><ArticleId IdType="pubmed">15684123</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryor TA, Hripcsak G. Sharing MLM&#x2019;s: an experiment between Columbia-Presbyterian and LDS Hospital. Proc Annu Symp Comput Appl Med Care 1993:399&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2248539</ArticleId><ArticleId IdType="pubmed">8130503</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31369862</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>PheValuator: Development and evaluation of a phenotype algorithm evaluator.</ArticleTitle><Pagination><StartPage>103258</StartPage><MedlinePgn>103258</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103258</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30177-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">The primary approach for defining disease in observational healthcare databases is to construct phenotype algorithms (PAs), rule-based heuristics predicated on the presence, absence, and temporal logic of clinical observations. However, a complete evaluation of PAs, i.e., determining sensitivity, specificity, and positive predictive value (PPV), is rarely performed. In this study, we propose a tool (PheValuator) to efficiently estimate a complete PA evaluation.</AbstractText><AbstractText Label="METHODS">We used 4 administrative claims datasets: OptumInsight's de-identified Clinformatics&#x2122; Datamart (Eden Prairie,MN); IBM MarketScan Multi-State Medicaid); IBM MarketScan Medicare Supplemental Beneficiaries; and IBM MarketScan Commercial Claims and Encounters from 2000 to 2017. Using PheValuator involves (1) creating a diagnostic predictive model for the phenotype, (2) applying the model to a large set of randomly selected subjects, and (3) comparing each subject's predicted probability for the phenotype to inclusion/exclusion in PAs. We used the predictions as a 'probabilistic gold standard' measure to classify positive/negative cases. We examined 4 phenotypes: myocardial infarction, cerebral infarction, chronic kidney disease, and atrial fibrillation. We examined several PAs for each phenotype including 1-time (1X) occurrence of the diagnosis code in the subject's record and 1-time occurrence of the diagnosis in an inpatient setting with the diagnosis code as the primary reason for admission (1X-IP-1stPos).</AbstractText><AbstractText Label="RESULTS">Across phenotypes, the 1X PA showed the highest sensitivity/lowest PPV among all PAs. 1X-IP-1stPos yielded the highest PPV/lowest sensitivity. Specificity was very high across algorithms. We found similar results between algorithms across datasets.</AbstractText><AbstractText Label="CONCLUSION">PheValuator appears to show promise as a tool to estimate PA performance characteristics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, 920 Route 202, Raritan, NJ 08869, USA; OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY 10032, USA. Electronic address: jswerdel@its.jns.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY 10032, USA; Columbia University, 622 West 168th Street, PH20, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, 920 Route 202, Raritan, NJ 08869, USA; OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY 10032, USA; Columbia University, 622 West 168th Street, PH20, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002544" MajorTopicYN="N">Cerebral Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039702" MajorTopicYN="N">Current Procedural Terminology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="Y">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagnostic predictive modeling</Keyword><Keyword MajorTopicYN="N">Phenotype algorithms</Keyword><Keyword MajorTopicYN="N">Validation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31369862</ArticleId><ArticleId IdType="mid">NIHMS1651855</ArticleId><ArticleId IdType="pmc">PMC7736922</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103258</ArticleId><ArticleId IdType="pii">S1532-0464(19)30177-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rubbo B, Fitzpatrick NK, Denaxas S, Daskalopoulou M, Yu N, Patel RS and Hemingway H. Use of electronic health records to ascertain, validate and phenotype acute myocardial infarction: A systematic review and recommendations. Int J Cardiol. 2015;187:705&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">25966015</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick N, Bhole V, Lacaille D and Avina-Zubieta JA. Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review. PLoS One. 2015;10:e0135834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4546158</ArticleId><ArticleId IdType="pubmed">26292280</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick N, Lacaille D, Bhole V and Avina-Zubieta JA. Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review. PLoS One. 2014;9:e92286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969323</ArticleId><ArticleId IdType="pubmed">24682186</ArticleId></ArticleIdList></Reference><Reference><Citation>Widdifield J, Labrecque J, Lix L, Paterson JM, Bernatsky S, Tu K, Ivers N and Bombardier C. Systematic review and critical appraisal of validation studies to identify rheumatic diseases in health administrative databases. Arthritis Care Res (Hoboken). 2013;65:1490&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">23436765</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R and Dublin S. Identifying atrial fibrillation from electronic medical data: a systematic review. Pharmacoepidemiol Drug Saf. 2012;21:141&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674852</ArticleId><ArticleId IdType="pubmed">22262600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction: Oxford University Press; 2003.</Citation></Reference><Reference><Citation>Terris DD, Litaker DG and Koroukian SM. Health state information derived from secondary databases is affected by multiple sources of bias. J Clin Epidemiol. 2007;60:734&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1952240</ArticleId><ArticleId IdType="pubmed">17573990</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W and Berlin JA. Evaluating the Impact of Database Heterogeneity on Observational Study Results. Am J Epidemiol. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3736754</ArticleId><ArticleId IdType="pubmed">23648805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho ME, Duffett M, Willison DJ, Cook DJ and Brouwers MC. Written informed consent and selection bias in observational studies using medical records: systematic review. BMJ. 2009;338:b866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2769263</ArticleId><ArticleId IdType="pubmed">19282440</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG and Moons KM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (tripod): The tripod statement. Ann Intern Med. 2015;162:55&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">25560714</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia Carlson C.. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB and Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25:969&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B (Methodological). 1996;58:267&#x2013;288.</Citation></Reference><Reference><Citation>Agarwal V, Podchiyska T, Banda JM, Goel V, Leung TI, Minty EP, Sweeney TE, Gyang E and Shah NH. Learning statistical models of phenotypes using noisy labeled training data. J Am Med Inform Assoc. 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070523</ArticleId><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P and Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern EFO, Maney M, Miller DR, Tseng C-L, Tiwari A, Rajan M, Aron D and Pogach L. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res. 2006;41:564&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1702507</ArticleId><ArticleId IdType="pubmed">16584465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl PM, Rodgers K, Schneeweiss S, Gage BF, Butler J, Wilmer C, Nash M, Esper G, Gitlin N, Osborn N, Short LJ and Bohn RL. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf. 2010;19:596&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">20140892</ArticleId></ArticleIdList></Reference><Reference><Citation>Choma NN, Griffin MR, Huang RL, Mitchel EF Jr., Kaltenbach LA, Gideon P, Stratton SM and Roumie CL. An algorithm to identify incident myocardial infarction using Medicaid data. Pharmacoepidemiol Drug Saf. 2009;18:1064&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10401667</ArticleId><ArticleId IdType="pubmed">19718697</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutrona SL, Toh S, Iyer A, Foy S, Daniel GW, Nair VP, Ng D, Butler MG, Boudreau D, Forrow S, Goldberg R, Gore J, McManus D, Racoosin JA and Gurwitz JH. Validation of Acute Myocardial Infarction in the Food and Drug Administration&#x2019;s Mini-Sentinel program. Pharmacoepidemiol Drug Saf. 2013;22:40&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3601831</ArticleId><ArticleId IdType="pubmed">22745038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni GN, Gottesman O, Linneman JG, Chase H, Berg RL, Farouk S, Nadukuru R, Lotay V, Ellis S, Hripcsak G, Peissig P, Weng C and Bottinger EP. Development and validation of an electronic phenotyping algorithm for chronic kidney disease. AMIA Annual Symposium proceedings AMIA Symposium. 2014;2014:907&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419875</ArticleId><ArticleId IdType="pubmed">25954398</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco MA, Tamang S, Yazdany J and Schmajuk G. Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data. JAMA Intern Med. 2018;178:1544&#x2013;1547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347576</ArticleId><ArticleId IdType="pubmed">30128552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuot DS and Grubbs V. Chronic kidney disease care in the US safety net. Adv Chronic Kidney Dis. 2015;22:66&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4291537</ArticleId><ArticleId IdType="pubmed">25573515</ArticleId></ArticleIdList></Reference><Reference><Citation>Peabody JW, Luck J, Jain S, Bertenthal D and Glassman P. Assessing the accuracy of administrative data in health information systems. Med Care. 2004;42:1066&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">15586833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31386904</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Supplementing claims data analysis using self-reported data to develop a probabilistic phenotype model for current smoking status.</ArticleTitle><Pagination><StartPage>103264</StartPage><MedlinePgn>103264</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103264</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30183-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Smoking status is poorly record in US claims data. IBM MarketScan Commercial is a claims database that can be linked to an additional health risk assessment with self-reported smoking status for a subset of 1,966,174 patients. We investigate whether this subset could be used to learn a smoking status phenotype model generalizable to all US claims data that calculates the probability of being a current smoker.</AbstractText><AbstractText Label="METHODS">251,643 (12.8%) had self-reported their smoking status as 'current smoker'. A regularized logistic regression model, the Current Risk of Smoking Status (CROSS), was trained using the subset of patients with self-reported smoking status. CROSS considered 53,027 candidate covariates including demographics and conditions/drugs/measurements/procedures/observations recorded in the prior 365&#x202f;days, The CROSS phenotype model was validated across multiple other claims data.</AbstractText><AbstractText Label="RESULTS">The internal validation showed the CROSS model achieved an area under the receiver operating characteristic curve (AUC) of 0.76 and the calibration plots indicated it was well calibrated. The external validation across three US claims databases obtained AUCs ranging between 0.82 and 0.87 showing the model appears to be transportable across Claims data.</AbstractText><AbstractText Label="CONCLUSION">CROSS predicts current smoking status based on the claims records in the prior year. CROSS can be readily implemented to any US insurance claims mapped to the OMOP common data model and will be a useful way to impute smoking status when conducting epidemiology studies where smoking is a known confounder but smoking status is not recorded. CROSS is available from https://github.com/OHDSI/StudyProtocolSandbox/tree/master/SmokingModel.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA. Electronic address: jreps@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073865" MajorTopicYN="N">Cigarette Smoking</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="N">Insurance Claim Review</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Claims data</Keyword><Keyword MajorTopicYN="N">Imputation</Keyword><Keyword MajorTopicYN="N">Patient-level prediction</Keyword><Keyword MajorTopicYN="N">Probabilistic phenotype</Keyword><Keyword MajorTopicYN="N">Risk</Keyword><Keyword MajorTopicYN="N">Smoking</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31386904</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103264</ArticleId><ArticleId IdType="pii">S1532-0464(19)30183-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31419833</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2364-0502</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Yearbook of medical informatics</Title><ISOAbbreviation>Yearb Med Inform</ISOAbbreviation></Journal><ArticleTitle>Clinical Research Informatics: Contributions from 2018.</ArticleTitle><Pagination><StartPage>203</StartPage><EndPage>205</EndPage><MedlinePgn>203-205</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0039-1677921</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To summarize key contributions to current research in the field of Clinical Research Informatics (CRI) and to select best papers published in 2018.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A bibliographic search using a combination of MeSH descriptors and free-text terms on CRI was performed using PubMed, followed by a double-blind review in order to select a list of candidate best papers to be then peer-reviewed by external reviewers. After peer-review ranking, a consensus meeting of the editorial team was organized to conclude on the selection of best papers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 1,469 retrieved papers published in 2018 in the various areas of CRI, the full review process selected four best papers. The first best paper describes a simple algorithm detecting co-morbidities in Electronic Healthcare Records (EHRs) using a clinical data warehouse and a knowledge base. The authors of the second best paper present a federated algorithm for predicting heart failure hospital admissions based on patients' medical history described in their distributed EHRs. The third best paper reports the evaluation of an open source, interoperable, and scalable data quality assessment tool measuring completeness of data items, which can be run on different architectures (EHRs and Clinical Data Warehouses (CDWs) based on PCORnet or OMOP data models). The fourth best paper reports a data quality program conducted across 37 hospitals addressing data quality Issues through the whole data life cycle from patient to researcher.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Research efforts in the CRI field currently focus on consolidating promises of early Distributed Research Networks aimed at maximizing the potential of large-scale, harmonized data from diverse, quickly developing digital sources. Data quality assessment methods and tools as well as privacy-enhancing techniques are major concerns. It is also notable that, following examples in the US and Asia, ambitious regional or national plans in Europe are launched that aim at developing big data and new artificial intelligence technologies to contribute to the understanding of health and diseases in whole populations and whole health systems, and returning actionable feedback loops to improve existing models of research and care. The use of "real-world" data is continuously increasing but the ultimate role of this data in clinical research remains to be determined.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>Christel</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AP-HP Information Systems Direction, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne University, University Paris 13, Sorbonne Paris Cit&#xe9;, INSERM UMR_S 1142, LIMICS, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Dipak</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The University of Gent, Gent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Section Editors for the IMIA Yearbook Section on Clinical Research Informatics</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Yearb Med Inform</MedlineTA><NlmUniqueID>9312666</NlmUniqueID><ISSNLinking>0943-4747</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="Y">Data Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="N">Quality Improvement</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>8</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31419833</ArticleId><ArticleId IdType="pmc">PMC6697501</ArticleId><ArticleId IdType="doi">10.1055/s-0039-1677921</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hemingway H, Asselbergs F W, Danesh J, Dobson R, Maniadakis N, Maggioni A et al.Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. Eur Heart J. 2018;39(16):1481&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6019015</ArticleId><ArticleId IdType="pubmed">29370377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledieu T, Bouzille G, Thiessard F, Berquet K, Van Hille P, Renault E et al.Timeline representation of clinical data: usability and added value for pharmacovigilance. BMC Med Inform Decis Mak. 2018;18(01):86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6194681</ArticleId><ArticleId IdType="pubmed">30340483</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvestre E, Bouzille G, Chazard E, His-Mahier C, Riou C, Cuggia M. Combining information from a clinical data warehouse and a pharmaceutical database to generate a framework to detect comorbidities in electronic health records. BMC Med Inform Decis Mak 24. 2018;18(01):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784648</ArticleId><ArticleId IdType="pubmed">29368609</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcelon N, Neuraz A, Salomon R, Bahi-Buisson N, Amiel J, Picard C et al.Next generation phenotyping using narrative reports in a rare disease clinical data warehouse. Orphanet J Rare Di. 31. 2018;13(01):85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5984368</ArticleId><ArticleId IdType="pubmed">29855327</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich G, Krebs J, Fette G, Ertl M, Kaspar M, Stork S et al.Ad Hoc Information Extraction for Clinical Data Warehouses. Methods Inf Med. 2018;57(01):e22&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6193399</ArticleId><ArticleId IdType="pubmed">29801178</ArticleId></ArticleIdList></Reference><Reference><Citation>Brisimi T S, Chen R, Mela T, Olshevsky A, Paschalidis I C, Shi W. Federated learning of predictive models from federated Electronic Health Records. Int J Med Inf. 2018;112:59&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5836813</ArticleId><ArticleId IdType="pubmed">29500022</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris N, Mendis M, Daniel C, Murphy S, Tannier X, Zweigenbaum P. i2b2 implemented over SMART-on-FHIR. AMIA Jt Summits Transl Sci Proc AMIA Jt Summits Transl Sci. 2018;2017:369&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961782</ArticleId><ArticleId IdType="pubmed">29888095</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine E B, Van Eaton E, Zadworny M E, Symons R, Devlin A, Yanez D et al.Automating Electronic Clinical Data Capture for Quality Improvement and Research: The CERTAIN Validation Project of Real World Evidence. EGEMS Wash DC 22 mai. 2018;6(01):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983060</ArticleId><ArticleId IdType="pubmed">29881766</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls L G, Phillips T A, Hammill B G, Topping J, Louzao D M, Brown J S https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983028/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983028/</Citation></Reference><Reference><Citation>Looten V, Kong Win Chang L, Neuraz A, Landau-Loriot M A, Vedie B, Paul J L</Citation><ArticleIdList><ArticleId IdType="pubmed">30612785</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel C, Serre P, Orlova N, Br&#xe9;ant S, Paris N, Griffon N.Initializing a hospital-wide data quality program. The AP-HP experience. Comput Methods Programs Biomed. 2018 Nov 9</Citation><ArticleIdList><ArticleId IdType="pubmed">30497872</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H, Stephens K A, Klann J G, Murphy S N. Exploring completeness in clinical data research networks with DQe-c. J Am Med Inform Assoc. 2018;25(01):17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6481389</ArticleId><ArticleId IdType="pubmed">29069394</ArticleId></ArticleIdList></Reference><Reference><Citation>Veeningen M, Chatterjea S, Horvath A Z, Spindler G, Boersma E, van der Spek P et al.Enabling Analytics on Sensitive Medical Data with Secure Multi-Party Computation. Stud Health Technol Inform. 2018;247:76&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">29677926</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler S C, Wissing F, Heyder R.German Medical Informatics Initiative Methods Inf Med 201857(S01):e50&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuggia M, Combes S. The French Health Data Hub and the German Medical Informatics Initiative: Two National Projects to Promote Data Sharing in Healthcare. Yearb Med Inform. 2019:190&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697511</ArticleId><ArticleId IdType="pubmed">31419832</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31436848</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0258</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>22</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Statistics in medicine</Title><ISOAbbreviation>Stat Med</ISOAbbreviation></Journal><ArticleTitle>A plea to stop using the case-control design in retrospective database studies.</ArticleTitle><Pagination><StartPage>4199</StartPage><EndPage>4208</EndPage><MedlinePgn>4199-4208</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/sim.8215</ELocationID><Abstract><AbstractText>The case-control design is widely used in retrospective database studies, often leading to spectacular findings. However, results of these studies often cannot be replicated, and the advantage of this design over others is questionable. To demonstrate the shortcomings of applications of this design, we replicate two published case-control studies. The first investigates isotretinoin and ulcerative colitis using a simple case-control design. The second focuses on dipeptidyl peptidase-4 inhibitors and acute pancreatitis, using a nested case-control design. We include large sets of negative control exposures (where the true odds ratio is believed to be 1) in both studies. Both replication studies produce effect size estimates consistent with the original studies, but also generate estimates for the negative control exposures showing substantial residual bias. In contrast, applying a self-controlled design to answer the same questions using the same data reveals far less bias. Although the case-control design in general is not at fault, its application in retrospective database studies, where all exposure and covariate data for the entire cohort are available, is unnecessary, as other alternatives such as cohort and self-controlled designs are available. Moreover, by focusing on cases and controls it opens the door to inappropriate comparisons between exposure groups, leading to confounding for which the design has few options to adjust for. We argue that this design should no longer be used in these types of data. At the very least, negative control exposures should be used to prove that the concerns raised here do not apply.</AbstractText><CopyrightInformation>&#xa9; 2019 The Authors. Statistics&#xa0;in&#xa0;Medicine Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth K C</ForeName><Initials>KKC</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social Work and Social Administration, Faculty of Social Science, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ian C K</ForeName><Initials>ICK</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, NewYork-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM06910</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stat Med</MedlineTA><NlmUniqueID>8215016</NlmUniqueID><ISSNLinking>0277-6715</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Stat Med. 2019 Sep 30;38(22):4216-4217. doi: 10.1002/sim.8312</RefSource><PMID Version="1">31489682</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stat Med. 2019 Sep 30;38(22):4209-4212. doi: 10.1002/sim.8320</RefSource><PMID Version="1">31489683</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stat Med. 2019 Sep 30;38(22):4213-4215. doi: 10.1002/sim.8324</RefSource><PMID Version="1">31489684</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="Y">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="Y">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">case control</Keyword><Keyword MajorTopicYN="N">database studies</Keyword><Keyword MajorTopicYN="N">methods</Keyword><Keyword MajorTopicYN="N">retrospective studies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31436848</ArticleId><ArticleId IdType="pmc">PMC6771795</ArticleId><ArticleId IdType="doi">10.1002/sim.8215</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vandenbroucke JP, Pearce N. Case&#x2010;control studies: basic concepts. Int J Epidemiol. 2012;41(5):1480&#x2010;1489.</Citation><ArticleIdList><ArticleId IdType="pubmed">23045208</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950;2(4682):739&#x2010;748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2038856</ArticleId><ArticleId IdType="pubmed">14772469</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case&#x2010;control study. BMJ. 2018;361:k1315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5915701</ArticleId><ArticleId IdType="pubmed">29695481</ArticleId></ArticleIdList></Reference><Reference><Citation>Racette BA, Gross A, Vouri SM, Camacho&#x2010;Soto A, Willis AW, Nielsen SS. Immunosuppressants and risk of Parkinson disease. Ann Clin Transl Neurol. 2018;5:870&#x2010;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6043771</ArticleId><ArticleId IdType="pubmed">30009205</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams and Wilkins; 2008.</Citation></Reference><Reference><Citation>Schneeweiss S. A basic study design for expedited safety signal evaluation based on electronic healthcare data. Pharmacoepidemiol Drug Saf. 2010;19(8):858&#x2010;868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917262</ArticleId><ArticleId IdType="pubmed">20681003</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Schuemie MJ, Ryan PB. Empirical performance of the case&#x2010;control method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(Suppl 1):73&#x2010;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayes LC, Horwitz RI, Feinstein AR. A collection of 56 topics with contradictory results in case&#x2010;control research. Int J Epidemiol. 1988;17(3):680&#x2010;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">3272133</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD. Isotretinoin use and the risk of inflammatory bowel disease: a case&#x2010;control study. Am J Gastroenterol. 2010;105(9):1986&#x2010;1993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3073620</ArticleId><ArticleId IdType="pubmed">20354506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou HC, Chen WW, Hsiao FY. Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase&#x2010;4 inhibitors: a population&#x2010;based nested case&#x2010;control study. Drug Safety. 2014;37(7):521&#x2010;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">24859164</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population&#x2010;level effect estimation studies in observational healthcare data. Proc Natl Acad Sci USA. 2018;115(11):2571&#x2010;2577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p&#x2010;values. Statist Med. 2014;33(2):209&#x2010;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2017;66:72&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Avillach P, Dufour JC, Diallo G, et al. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU&#x2010;ADR project. J Am Med Inform Assoc. 2013;20(3):446&#x2010;452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628051</ArticleId><ArticleId IdType="pubmed">23195749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilicoglu H, Rosemblat G, Fiszman M, Rindflesch TC. Constructing a semantic predication gold standard from the biomedical literature. BMC Bioinformatics. 2011;12:486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281188</ArticleId><ArticleId IdType="pubmed">22185221</ArticleId></ArticleIdList></Reference><Reference><Citation>
Administration UFaD
. FDA adverse event reporting system (FAERS). 2016. 
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/
</Citation></Reference><Reference><Citation>Duke J, Friedlin J, Li X. Consistency in the safety labeling of bioequivalent medications. Pharmacoepidemiol Drug Saf. 2013;22(3):294&#x2010;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">23042584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski AF, Bate A, Bousquet C, et al. Good signal detection practices: evidence from IMI PROTECT. Drug Safety. 2016;39(6):469&#x2010;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871909</ArticleId><ArticleId IdType="pubmed">26951233</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self&#x2010;controlled case series method. Statist Med. 2006;25(10):1768&#x2010;1797.</Citation><ArticleIdList><ArticleId IdType="pubmed">16220518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population&#x2010;based case&#x2010;control study. Am J Gastroenterol. 2009;104(11):2774&#x2010;2778.</Citation><ArticleIdList><ArticleId IdType="pubmed">19623167</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1&#x2010;based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population&#x2010;based matched case&#x2010;control study. JAMA Intern Med. 2013;173(7):534&#x2010;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">23440284</ArticleId></ArticleIdList></Reference><Reference><Citation>Gault N, Casta&#xf1;eda&#x2010;Sanabria J, De Rycke Y, Guillo S, Foulon S, Tubach F. Self&#x2010;controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review. BMC Med Res Methodol. 2017;17(1):25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5299667</ArticleId><ArticleId IdType="pubmed">28178924</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh MC, Trentham&#x2010;Dietz A, Newcomb PA, Gangnon R, Palta M. Using propensity scores to reduce case&#x2010;control selection bias. Epidemiology. 2012;23(5):772&#x2010;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3433168</ArticleId><ArticleId IdType="pubmed">22872122</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbogast PG, Ray WA. Use of disease risk scores in pharmacoepidemiologic studies. Stat Methods Med Res. 2009;18(1):67&#x2010;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">18562398</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;nsson R, Joffe MM, Sun W, Hennessy S. On the estimation and use of propensity scores in case&#x2010;control and case&#x2010;cohort studies. Am J Epidemiol. 2007;166(3):332&#x2010;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">17504780</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31437920</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Transforming Two Decades of ePR Data to OMOP CDM for Clinical Research.</ArticleTitle><Pagination><StartPage>233</StartPage><EndPage>237</EndPage><MedlinePgn>233-237</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190218</ELocationID><Abstract><AbstractText>This paper presents the extract-transform-and-load (ETL) process from the Electronic Patient Records (ePR) at the Heart Institute (InCor) to the OMOP Common Data Model (CDM) format. We describe the initial database characterization, relational source mappings, selection filters, data transformations and patient de-identification using the open-source OHDSI tools and SQL scripts. We evaluate the resulting InCor-CDM database by recreating the same patient cohort from a previous reference study (over the original data source) and comparing the cohorts' descriptive statistics and inclusion reports. The results exhibit that up to 91% of the reference patients were retrieved by our method from the ePR through InCor-CDM, with AUC=0.938. The results indicate that the method that we employed was able to produce a new database that was both consistent with the original data and in accordance to the OMOP CDM standard.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Institute of Mathematical and Computer Sciences (ICMC), University of S&#xe3;o Paulo, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues-Jr</LastName><ForeName>Jose F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Institute of Mathematical and Computer Sciences (ICMC), University of S&#xe3;o Paulo, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traina</LastName><ForeName>Agma J M</ForeName><Initials>AJM</Initials><AffiliationInfo><Affiliation>Institute of Mathematical and Computer Sciences (ICMC), University of S&#xe3;o Paulo, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pires</LastName><ForeName>Fabio A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Institute of Mathematical and Computer Sciences (ICMC), University of S&#xe3;o Paulo, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez</LastName><ForeName>Marco A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Heart Institute (InCor), Clinics Hospital, Faculty of Medicine, University of S&#xe3;o Paulo, S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data Curation</Keyword><Keyword MajorTopicYN="N">Health Information Exchange</Keyword><Keyword MajorTopicYN="N">Medical Informatics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31437920</ArticleId><ArticleId IdType="doi">10.3233/SHTI190218</ArticleId><ArticleId IdType="pii">SHTI190218</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31437950</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Detecting Systemic Data Quality Issues in Electronic Health Records.</ArticleTitle><Pagination><StartPage>383</StartPage><EndPage>387</EndPage><MedlinePgn>383-387</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190248</ELocationID><Abstract><AbstractText>Secondary analysis of electronic health records for clinical research faces significant challenges due to known data quality issues in health data observationally collected for clinical care and the data biases caused by standard healthcare processes. In this manuscript, we contribute methodology for data quality assessment by plotting domain-level (conditions (diagnoses), drugs, and procedures) aggregate statistics and concept-level temporal frequencies (i.e., annual prevalence rates of clinical concepts). We detect common temporal patterns in concept frequencies by normalizing and clustering annual concept frequencies using K-means clustering. We apply these methods to the Columbia University Irving Medical Center Observational Medical Outcomes Partnership database. The resulting domain-aggregate and cluster plots show a variety of patterns. We review the patterns found in the condition domain and investigate the processes that shape them. We find that these patterns suggest data quality issues influenced by system-wide factors that affect individual concept frequencies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012895</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cluster Analysis</Keyword><Keyword MajorTopicYN="N">Data Accuracy</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31437950</ArticleId><ArticleId IdType="mid">NIHMS1058602</ArticleId><ArticleId IdType="pmc">PMC6857180</ArticleId><ArticleId IdType="doi">10.3233/SHTI190248</ArticleId><ArticleId IdType="pii">SHTI190248</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, and Albers DJ, Next-generation pheno-typing of electronic health records, J Am Med Inform Assoc 20 (2013), 117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R, and Lieu T, Data enclaves for sharing information derived from clinical and administrative data, JAMA (2018), E1&#x2013;E2.</Citation><ArticleIdList><ArticleId IdType="pubmed">30083726</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsis T, Hartvigsen G, Chen F, and Weng C, Secondary use of EHR: data quality issues and informatics opportunities, Summit on Translat Bioinforma 2010 (2010), 1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041534</ArticleId><ArticleId IdType="pubmed">21347133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharrazi H, Wang C, and Scharfstein D, Prospective EHR-based clinical trials: the challenge of missing data, J Gen Intern Med 29 (2014), 976&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4061350</ArticleId><ArticleId IdType="pubmed">24839057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharrazi H et al., Comparing population-based risk-stratification model performance using demographic, diagnosis and medication data extracted from outpatient electronic health records versus administrative claims, Med Care 55 (2017), 789&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">28598890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G et al., Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers, Stud Health Technol Inform 216 (2015), 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG et al., A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data, EGEMS (Wash DC) 4 (2016), 1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall GC et al., Guidelines for good database selection and use in pharmacoepidemiology research, Pharmacoepidemiology and Drug Safety 21 (2012), 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">22069180</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Kahn M, and Toh S, Data quality assessment for comparative effectiveness research in distributed data networks, Med Care 51 (2013), S22&#x2013;S29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharrazi H et al., A proposed national research and development agenda for population health informatics: summary recommendations from a national expert workshop, J Am Med Inform Assoc 24 (2017), 2&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5201177</ArticleId><ArticleId IdType="pubmed">27018264</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oostrom SH et al., Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys, PLoS One 11 (2016), e0160264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4970764</ArticleId><ArticleId IdType="pubmed">27482903</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartigan JA, and Wong MA, Algorithm AS 136: a K-means clustering algorithm, Journal of the Royal Statistical Society. Series C (Applied Statistics) 28 (1979), 100&#x2013;108.</Citation></Reference><Reference><Citation>Johnson SG, Speedie S, Simon G, Kumar V, and Westra BL, Application of an Ontology for Characterizing Data Quality for a Secondary Use of EHR Data, Appl Clin Inform 07 (2016), 69&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4817336</ArticleId><ArticleId IdType="pubmed">27081408</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R, Walther G, and Hastie T, Estimating the number of clusters in a data set via the gap statistic, Journal of the Royal Statistical Society: Series B (Statistical Methodology) 63 (2001), 411&#x2013;423.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31438202</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Augmenting Medical Device Evaluation Using a Reusable Unique Device Identifier Interoperability Solution Based on the OHDSI Common Data Model.</ArticleTitle><Pagination><StartPage>1502</StartPage><EndPage>1503</EndPage><MedlinePgn>1502-1503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190505</ELocationID><Abstract><AbstractText>The objective of the study is to augment safety and effectiveness evaluation of medical devices through building a reusable unique device identifier (UDI) interoperability solution. We propose a framework for building a UDI research database for medical device evaluation using the OHDSI common data model (CDM). As a pilot study, we design, develop and evaluate a UDI vocabulary, which would enable tackling challenges of data islands and standardization for medical device evaluation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kingsbury</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilay</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Controlled Vocabulary</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Equipment Safety</Keyword><Keyword MajorTopicYN="N">Reference Standards</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31438202</ArticleId><ArticleId IdType="doi">10.3233/SHTI190505</ArticleId><ArticleId IdType="pii">SHTI190505</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31438258</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Characterizing VA Users with the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>1614</StartPage><EndPage>1615</EndPage><MedlinePgn>1614-1615</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190561</ELocationID><Abstract><AbstractText>In 2015, the VA Informatics and Computing Infrastructure, a resource center of the Department of Veterans Affairs, began to transform parts of its Corporate Data Warehouse (CDW) into the Observational Medical Outcomes Partnership) Common Data Model for use by its research and operations communities. Using the hierarchical relationships within the clinical vocabularies in OMOP we found differences in visits, disease prevalence, and medications prescribed between male and female veterans seen between VA fiscal years 2000-17.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viernes</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>South</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coronado</LastName><ForeName>Gregorio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014493" MajorTopicYN="Y">United States Department of Veterans Affairs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014728" MajorTopicYN="Y">Veterans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic health ecords</Keyword><Keyword MajorTopicYN="N">systematized nomenclature of medicine</Keyword><Keyword MajorTopicYN="N">veterans</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31438258</ArticleId><ArticleId IdType="doi">10.3233/SHTI190561</ArticleId><ArticleId IdType="pii">SHTI190561</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31438365</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Standardized Observational Cancer Research Using the OMOP CDM Oncology Module.</ArticleTitle><Pagination><StartPage>1831</StartPage><EndPage>1832</EndPage><MedlinePgn>1831-1832</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190670</ELocationID><Abstract><AbstractText>Observational research in cancer requires substantially more detail than most other therapeutic areas. Cancer conditions are defined through histology, affected anatomical structures, staging and grading, and biomarkers, and are treated with complex therapies. Here, we show a new cancer module as part of the OMOP CDM, allowing manual and automated abstraction and standardized analytics. We tested the model in EHR and registry data against a number of typical use cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belenkaya</LastName><ForeName>Rimma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>OHDSI Oncology Workgroup, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurley</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical and Translational Sciences Institute, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymshyts</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odysseus Data Science Inc, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araujo</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Real World Analytics Solution, IQVIA, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maine Medical Center Research Institute, Center for Outcomes Research and Evaluation, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>RuiJun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Department, Columbia University Medical Center, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Analytics Solution, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="Y">Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Oncology</Keyword><Keyword MajorTopicYN="N">Research</Keyword><Keyword MajorTopicYN="N">Standardized</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31438365</ArticleId><ArticleId IdType="doi">10.3233/SHTI190670</ArticleId><ArticleId IdType="pii">SHTI190670</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31438371</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Genomic Common Data Model for Biomedical Data in Clinical Practice.</ArticleTitle><Pagination><StartPage>1843</StartPage><EndPage>1844</EndPage><MedlinePgn>1843-1844</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190676</ELocationID><Abstract><AbstractText>A common data model for clinical NGS panel data that is used in a distributed research network to achieve large scale to make evidence for improving patient care should be developed. This study developed OMOP-CDM extension for NGS panel data and confirmed the feasibility of the model by finding the differences between a database generated by research-purpose and clinical practice. We believe this data model can be used in distributed research model and will facilitate the usage of the clinical NGS data in patient care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Seo Jeong</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roh</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Ajou University Hospital, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yu Rang</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data Analysis</Keyword><Keyword MajorTopicYN="N">High-Throughput Nucleotide Sequencing</Keyword><Keyword MajorTopicYN="N">Observational Study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31438371</ArticleId><ArticleId IdType="doi">10.3233/SHTI190676</ArticleId><ArticleId IdType="pii">SHTI190676</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31445247</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>Automatic trial eligibility surveillance based on unstructured clinical data.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>19</EndPage><MedlinePgn>13-19</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2019.05.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(18)31052-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Insufficient patient enrollment in clinical trials remains a serious and costly problem and is often considered the most critical issue to solve for the clinical trials community. In this project, we assessed the feasibility of automatically detecting a patient's eligibility for a sample of breast cancer clinical trials by mapping coded clinical trial eligibility criteria to the corresponding clinical information automatically extracted from text in the EHR.</AbstractText><AbstractText Label="METHODS">Three open breast cancer clinical trials were selected by oncologists. Their eligibility criteria were manually abstracted from trial descriptions using the OHDSI ATLAS web application. Patients enrolled or screened for these trials were selected as 'positive' or 'possible' cases. Other patients diagnosed with breast cancer were selected as 'negative' cases. A selection of the clinical data and all clinical notes of these 229 selected patients was extracted from the MUSC clinical data warehouse and stored in a database implementing the OMOP common data model. Eligibility criteria were extracted from clinical notes using either manually crafted pattern matching (regular expressions) or a new natural language processing (NLP) application. These extracted criteria were then compared with reference criteria from trial descriptions. This comparison was realized with three different versions of a new application: rule-based, cosine similarity-based, and machine learning-based.</AbstractText><AbstractText Label="RESULTS">For eligibility criteria extraction from clinical notes, the machine learning-based NLP application allowed for the highest accuracy with a micro-averaged recall of 90.9% and precision of 89.7%. For trial eligibility determination, the highest accuracy was reached by the machine learning-based approach with a per-trial AUC between 75.5% and 89.8%.</AbstractText><AbstractText Label="CONCLUSION">NLP can be used to extract eligibility criteria from EHR clinical notes and automatically discover patients possibly eligible for a clinical trial with good accuracy, which could be leveraged to reduce the workload of humans screening patients for trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meystre</LastName><ForeName>St&#xe9;phane M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC, United States; Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, United States. Electronic address: meystre@musc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heider</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Youngjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aruch</LastName><ForeName>Daniel B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Britten</LastName><ForeName>Carolyn D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 CA210962</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG1 CA189848</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 CA210963</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA138313</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001331" MajorTopicYN="N">Automation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="N">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004608" MajorTopicYN="Y">Eligibility Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016526" MajorTopicYN="N">Workload</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">Eligibility criteria</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Natural language processing</Keyword></KeywordList><CoiStatement>COMPETING INTERESTS STATEMENT. The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31445247</ArticleId><ArticleId IdType="mid">NIHMS1530600</ArticleId><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.05.018</ArticleId><ArticleId IdType="pii">S1386-5056(18)31052-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung NS, Crowley WF, Genel M, Salber P, Sandy L, Sherwood LM, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003. March 12;289(10):1278&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pubmed">12633190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001. March 15;19(6):1728&#x2013;1733.</Citation><ArticleIdList><ArticleId IdType="pubmed">11251003</ArticleId></ArticleIdList></Reference><Reference><Citation>Somkin CP, Ackerson L, Husson G, Gomez V, Kolevska T, Goldstein D, et al. Effect of medical oncologists&#x2019; attitudes on accrual to clinical trials in a community setting. J Oncol Pract 2013. November;9(6):e275&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5706122</ArticleId><ArticleId IdType="pubmed">24151327</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, Dahman B. Automated matching software for clinical trials eligibility: measuring efficiency and flexibility. Contemp Clin Trials 2010. May;31(3):207&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadani SR, Weng C, Bigger JT, Ennever JF, Wajngurt D. Electronic screening improves efficiency in clinical trial recruitment. Journal of the American Medical Informatics Association Oxford University Press; 2009. November;16(6):869&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Embi PJ, Jain A, Clark J, Harris CM. Development of an electronic health record-based Clinical Trial Alert system to enhance recruitment at the point of care. AMIA Annu Symp Proc 2005;:231&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560758</ArticleId><ArticleId IdType="pubmed">16779036</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinemann S, Th&#xfc;ring S, Wedeken S, Sch&#xe4;fer T, Scheidt-Nave C, Ketterer M, et al. A clinical trial alert tool to recruit large patient samples and assess selection bias in general practice research. BMC Med Res Methodol BioMed Central; 2011. February 15;11(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3047292</ArticleId><ArticleId IdType="pubmed">21320358</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre SM, Savova GK, Kipper-Schuler KC, Hurdle JF. Extracting information from textual documents in the electronic health record: a review of recent research. Yearb Med Inform 2008:128&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">18660887</ArticleId></ArticleIdList></Reference><Reference><Citation>Demner-Fushman D, Elhadad N. Aspiring to Unintended Consequences of Natural Language Processing: A Review of Recent Developments in Clinical and Consumer-Generated Text Processing. Yearb Med Inform 2016:224&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5171557</ArticleId><ArticleId IdType="pubmed">27830255</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Sun J, Pathak J, Kho A. A survey of clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods. Artificial Intelligence in Medicine 2016;71:57&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480212</ArticleId><ArticleId IdType="pubmed">27506131</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Tseytlin E, Finan S, Castine M, Miller T, Medvedeva O, et al. DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. Cancer Res. 2017. November 1;77(21):e115&#x2013;e118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5690492</ArticleId><ArticleId IdType="pubmed">29092954</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern Y, Horng S, Choi Y, Sontag D. Electronic medical record phenotyping using the anchor and learn framework. J Am Med Inform Assoc 2016; 23(4):731&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926745</ArticleId><ArticleId IdType="pubmed">27107443</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Wu X, Luo Z, Boland MR, Theodoratos D, Johnson SB. EliXR: an approach to eligibility criteria extraction and representation. J Am Med Inform Assoc 2011;18 Suppl 1(Supplement 1):i116&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241167</ArticleId><ArticleId IdType="pubmed">21807647</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Tu SW, Carini S, Sim I, Weng C. EliXR-TIME: A Temporal Knowledge Representation for Clinical Research Eligibility Criteria. AMIA Summits Transl Sci Proc 2012;2012:71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392056</ArticleId><ArticleId IdType="pubmed">22779055</ArticleId></ArticleIdList></Reference><Reference><Citation>Duryea R, Danese MD. Human Readable Expression of Structured Algorithms for Describing and Storing Clinical Study Criteria and for Generating and Visualizing Queries. AMIA Summits Transl Sci Proc 2015:1&#x2013;5.</Citation></Reference><Reference><Citation>Levy-fix G, Yaman A, Weng C. Structuring Clinical Trial Eligibility Criteria with the Common Data Model. AMIA Summits Transl Sci Proc 2015.</Citation></Reference><Reference><Citation>Ni Y, Wright J, Perentesis J, Lingren T, Deleger L, Kaiser M, et al. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients. BMC Med Inform Decis Mak; 2015;15(1):28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407835</ArticleId><ArticleId IdType="pubmed">25881112</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Hebert C, Lopetegui M, de Marneffe M-C, Fosler-Lussier E, Lai AM. Textual inference for eligibility criteria resolution in clinical trials. J Biomed Inform 2015. December;58 Suppl:S211&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4978353</ArticleId><ArticleId IdType="pubmed">26376462</ArticleId></ArticleIdList></Reference><Reference><Citation>NLM. Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery. 2013. 
Available from: https://clinicaltrials.gov/ct2/show/NCT01872975</Citation></Reference><Reference><Citation>NLM. Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy. 2013. 
Available from: https://clinicaltrials.gov/ct2/show/NCT01901094</Citation></Reference><Reference><Citation>NLM. Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery. 2013. 
Available from: https://clinicaltrials.gov/ct2/show/NCT01953588</Citation></Reference><Reference><Citation>de Castilho RE, Mujdricza-Maydt E. A web-based tool for the integrated annotation of semantic and syntactic structures. Proceedings of the Workshop on Language Technology Resources and Tools for Digital Humanities; Osaka, Japan; 2016:76&#x2013;84.</Citation></Reference><Reference><Citation>Si Y, Weng C. An OMOP CDM-Based Relational Database of Clinical Research Eligibility Criteria. Stud Health Technol Inform 2017;245:950&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893219</ArticleId><ArticleId IdType="pubmed">29295240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI) - Opportunities for Observational Researchers. Stud Health Technol Inform 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>ClinicalTrials.gov. Available from: https://clinicaltrials.gov</Citation></Reference><Reference><Citation>Regenstrief Institute. Logical observation identifier names and codes (LOINC). Available from: http://loinc.org/</Citation></Reference><Reference><Citation>NLM. SNOMED Clinical Terms&#xae; (SNOMED-CT&#xae;). Available from: http://www.nlm.nih.gov/research/umls/Snomed/snomed_main.html</Citation></Reference><Reference><Citation>Apache. UIMA (Unstructured Information Management Architecture). Available from: http://uima.apache.org/</Citation></Reference><Reference><Citation>Kim Y, Riloff E, Hurdle JF. A Study of Concept Extraction Across Different Types of Clinical Notes. AMIA Annu Symp Proc 2015:737&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765588</ArticleId><ArticleId IdType="pubmed">26958209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafferty JD, McCallum A, Pereira F. Conditional random fields: Probabilistic models for segmenting and labeling sequence data. Proc. 18th International Conf. on Machine Learning 2001;:282&#x2013;289.</Citation></Reference><Reference><Citation>Fan R-E, Chang K-W, Hsieh C-J, Wang X-R, Lin C-J. LIBLINEAR: A Library for Large Linear Classification. JMLR 2008;9(Aug):1871&#x2013;1874.</Citation></Reference><Reference><Citation>van Rijsbergen CJ. Information Retrieval. Butterworth; 1979.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31494719</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of medical systems</Title><ISOAbbreviation>J Med Syst</ISOAbbreviation></Journal><ArticleTitle>Feasibility of Mapping Austrian Health Claims Data to the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>314</StartPage><MedlinePgn>314</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">314</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10916-019-1436-9</ELocationID><Abstract><AbstractText>The Main Association of Austrian Social Security Institutions collects pseudonymized claims data from Austrian social security institutions and information about hospital stays in a database for research purposes. For new studies the same data are repeatedly reprocessed and it is difficult to compare different study results even though the data is already preprocessed and prepared in a proprietary data model. Based on a study on adverse drug events in relation to inappropriate medication in geriatric patients the suitability of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) is analyzed and data is transformed into the OMOP CDM. 1,023 (99.7%) of drug codes and 3,812 (99.2%) of diagnoses codes coincide with the OMOP vocabularies. The biggest obstacles are missing mappings for the Local Vocabularies like the Austrian pharmaceutical registration numbers and the Socio-Economic Index to the OMOP vocabularies. OMOP CDM is a promising approach for the standardization of Austrian claims data. In the long run, the benefits of standardization and reproducibility of research should outweigh this initial drawback.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haberson</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2138-9732</Identifier><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria. a.haberson@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinner</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xf6;berl</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Syst</MedlineTA><NlmUniqueID>7806056</NlmUniqueID><ISSNLinking>0148-5598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005853" MajorTopicYN="N">Geriatrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="N">Insurance Claim Review</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063487" MajorTopicYN="N">Prescription Drug Misuse</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Claims data</Keyword><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Drug safety</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">Secondary use</Keyword><Keyword MajorTopicYN="N">Standardized health data</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31494719</ArticleId><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="doi">10.1007/s10916-019-1436-9</ArticleId><ArticleId IdType="pii">10.1007/s10916-019-1436-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ohlmeier C, Leverkus F, Kloss S, Basic E, Ble&#xdf; H-H. Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system. Z f Evidenz, Fortbild. und Qualitat Im Gesundheitswesen. 2018;139:46&#x2013;52. doi: 10.1016/j.zefq.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.zefq.2018.11.005</ArticleId><ArticleId IdType="pubmed">30477975</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, Detmer DE, Expert P. Toward a national framework for the secondary use of health data: An American medical informatics association white paper. J. Am. Med. Inform. Assoc. 2007;14:1):1&#x2013;1):9. doi: 10.1197/jamia.M2273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2273</ArticleId><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O'Hara DJ, Powell GE, Painter JL, Pattishall EN, Morris JA. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J. Am. Med. Inform. Assoc. 2010;17(6):652&#x2013;662. doi: 10.1136/jamia.2009.002477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002477</ArticleId><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A. A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: Implications for active drug safety surveillance. Drug Saf. 2015;38(8):749&#x2013;765. doi: 10.1007/s40264-015-0297-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-015-0297-5</ArticleId><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinner C, Gezgin D, Wendl C, Gall W. A clinical data warehouse based on OMOP and i2b2 for Austrian health claims data. Stud. Health Technol. Inform. 2018;248:94&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">29726424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Choi J, Jang I, Quach J, Ohno-Machado L. Feasibility of representing data from published nursing research using the OMOP common data model. AMIA Annu. Symp. Proc. 2016;2016:715&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333244</ArticleId><ArticleId IdType="pubmed">28269868</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, Herrmann T, Haverkamp C, Horki P, Laufer J, Berger F, Honing G, Fritsch HW, Schuttler J, Ganslandt T, Prokosch HU, Sedlmayr M. Towards implementation of OMOP in a German University hospital consortium. Appl. Clin. Inform. 2018;9(1):54&#x2013;61. doi: 10.1055/s-0037-1617452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31542521</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Making work visible for electronic phenotype implementation: Lessons learned from the eMERGE network.</ArticleTitle><Pagination><StartPage>103293</StartPage><MedlinePgn>103293</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103293</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30212-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Implementation of phenotype algorithms requires phenotype engineers to interpret human-readable algorithms and translate the description (text and flowcharts) into computable phenotypes - a process that can be labor intensive and error prone. To address the critical need for reducing the implementation efforts, it is important to develop portable algorithms.</AbstractText><AbstractText Label="METHODS">We conducted a retrospective analysis of phenotype algorithms developed in the Electronic Medical Records and Genomics (eMERGE) network and identified common customization tasks required for implementation. A novel scoring system was developed to quantify portability from three aspects: Knowledge conversion, clause Interpretation, and Programming (KIP). Tasks were grouped into twenty representative categories. Experienced phenotype engineers were asked to estimate the average time spent on each category and evaluate time saving enabled by a common data model (CDM), specifically the Observational Medical Outcomes Partnership (OMOP) model, for each category.</AbstractText><AbstractText Label="RESULTS">A total of 485 distinct clauses (phenotype criteria) were identified from 55 phenotype algorithms, corresponding to 1153 customization tasks. In addition to 25 non-phenotype-specific tasks, 46 tasks are related to interpretation, 613 tasks are related to knowledge conversion, and 469 tasks are related to programming. A score between 0 and 2 (0 for easy, 1 for moderate, and 2 for difficult portability) is assigned for each aspect, yielding a total KIP score range of 0 to 6. The average clause-wise KIP score to reflect portability is 1.37&#x202f;&#xb1;&#x202f;1.38. Specifically, the average knowledge (K) score is 0.64&#x202f;&#xb1;&#x202f;0.66, interpretation (I) score is 0.33&#x202f;&#xb1;&#x202f;0.55, and programming (P) score is 0.40&#x202f;&#xb1;&#x202f;0.64. 5% of the categories can be completed within one hour (median). 70% of the categories take from days to months to complete. The OMOP model can assist with vocabulary mapping tasks.</AbstractText><AbstractText Label="CONCLUSION">This study presents firsthand knowledge of the substantial implementation efforts in phenotyping and introduces a novel metric (KIP) to measure portability of phenotype algorithms for quantifying such efforts across the eMERGE Network. Phenotype developers are encouraged to analyze and optimize the portability in regards to knowledge, interpretation and programming. CDMs can be used to improve the portability for some 'knowledge-oriented' tasks.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Luke V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caroll</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoit</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lingren</LastName><ForeName>Todd</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dikilitas</LastName><ForeName>Ozan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentch</LastName><ForeName>Frank D</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrell</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Qi</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainer</LastName><ForeName>Vivian S</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kullo</LastName><ForeName>Iftikhar J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakonarson</LastName><ForeName>Hakon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walunas</LastName><ForeName>Theresa L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute, NIH, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY, United States. Electronic address: hripcsak@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States. Electronic address: chunhua@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HG008676</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008657</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008672</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008684</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008673</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008701</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008666</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL133786</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG006388</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG006379</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Phenotyping</Keyword><Keyword MajorTopicYN="N">Portability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31542521</ArticleId><ArticleId IdType="mid">NIHMS1544840</ArticleId><ArticleId IdType="pmc">PMC6894517</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103293</ArticleId><ArticleId IdType="pii">S1532-0464(19)30212-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liao KP, Cai T, Savova GK, et al. Development of phenotype algorithms using electronic medical records and incorporating natural language processing. BMJ 2015;350:h1885. doi:10.1136/bmj.h1885</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h1885</ArticleId><ArticleId IdType="pmc">PMC4707569</ArticleId><ArticleId IdType="pubmed">25911572</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, et al. The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011;4:13. doi:10.1186/1755-8794-4-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-4-13</ArticleId><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway M, Berg RL, Carrell D, et al. Analyzing the Heterogeneity and Complexity of Electronic Health Record Oriented Phenotyping Algorithms. AMIA Annu Symp Proc 2011;2011:274&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243189</ArticleId><ArticleId IdType="pubmed">22195079</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, et al. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013;20:e147&#x2013;54. doi:10.1136/amiajnl-2012-000896</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-000896</ArticleId><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W-Q, Denny JC. Extracting research-quality phenotypes from electronic health records to support precision medicine. Genome Med 2015;7:41. doi:10.1186/s13073-015-0166-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-015-0166-y</ArticleId><ArticleId IdType="pmc">PMC4416392</ArticleId><ArticleId IdType="pubmed">25937834</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Seneviratne M, Hernandez-Boussard T, et al. Advances in Electronic Phenotyping: From Rule-Based Definitions to Machine Learning Models. Annu Rev Biomed Data Sci 2018;1:53&#x2013;68. doi:10.1146/annurev-biodatasci-080917-013315</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biodatasci-080917-013315</ArticleId><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho AN, Hayes MG, Rasmussen-Torvik L, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc 2012;19:212&#x2013;8. doi:10.1136/amiajnl-2011-000439</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000439</ArticleId><ArticleId IdType="pmc">PMC3277617</ArticleId><ArticleId IdType="pubmed">22101970</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim U, Kim H-N, Sung Y-A, et al. Pathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) Cohorts. Genomics Inform 2014;12:195&#x2013;202. doi:10.5808/GI.2014.12.4.195</Citation><ArticleIdList><ArticleId IdType="doi">10.5808/GI.2014.12.4.195</ArticleId><ArticleId IdType="pmc">PMC4330254</ArticleId><ArticleId IdType="pubmed">25705158</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullo IJ, Ding K, Jouni H, et al. A genome-wide association study of red blood cell traits using the electronic medical record. PloS One 2010;5. doi:10.1371/journal.pone.0013011</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013011</ArticleId><ArticleId IdType="pmc">PMC2946914</ArticleId><ArticleId IdType="pubmed">20927387</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford DC, Crosslin DR, Tromp G, et al. eMERGEing progress in genomics&#x2014;the first seven years. Front Genet 2014;5. doi:10.3389/fgene.2014.00184</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2014.00184</ArticleId><ArticleId IdType="pmc">PMC4060012</ArticleId><ArticleId IdType="pubmed">24987407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc 2016;23:1046&#x2013;52. doi:10.1093/jamia/ocv202</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv202</ArticleId><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson O, Hurdle JF. Document Clustering of Clinical Narratives: a Systematic Study of Clinical Sublanguages. AMIA Annu Symp Proc 2011;2011:1099&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243234</ArticleId><ArticleId IdType="pubmed">22195171</ArticleId></ArticleIdList></Reference><Reference><Citation>Studer R, Benjamins VR, Fensel D. Knowledge engineering: Principles and methods. Data Knowl Eng 1998;25:161&#x2013;97. doi:10.1016/S0169-023X(97)00056-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-023X(97)00056-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Aylett RS, Doniat C. Supporting the Domain expert in planning domain construction. In: Proceedings of the AIPS&#x2019;02 Workshop on Knowledge Engineering Tools and Techniques for AI Planning. Citeseer 2002.</Citation></Reference><Reference><Citation>Alonso F, Mat&#xe9; JL, Pazos J. Knowledge engineering versus software engineering. Data Knowl Eng 1990;5:79&#x2013;91. doi:10.1016/0169-023X(90)90005-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0169-023X(90)90005-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. High-fidelity phenotyping: richness and freedom from bias. J Am Med Inform Assoc doi:10.1093/jamia/ocx110</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx110</ArticleId><ArticleId IdType="pmc">PMC7282504</ArticleId><ArticleId IdType="pubmed">29040596</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Sun J, Pathak J, et al. Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods. Artif Intell Med 2016;71:57&#x2013;61. doi:10.1016/j.artmed.2016.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2016.05.005</ArticleId><ArticleId IdType="pmc">PMC5480212</ArticleId><ArticleId IdType="pubmed">27506131</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RJ, Thompson WK, Eyler AE, et al. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc 2012;19:e162&#x2013;9. doi:10.1136/amiajnl-2011-000583</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000583</ArticleId><ArticleId IdType="pmc">PMC3392871</ArticleId><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Crawford DC, Ritchie MD, et al. Variants Near FOXE1 Are Associated with Hypothyroidism and Other Thyroid Conditions: Using Electronic Medical Records for Genome- and Phenome-wide Studies. Am J Hum Genet 2011;89:529&#x2013;42. doi:10.1016/j.ajhg.2011.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.09.008</ArticleId><ArticleId IdType="pmc">PMC3188836</ArticleId><ArticleId IdType="pubmed">21981779</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson WK, Rasmussen LV, Pacheco JA, et al.
An evaluation of the NQF Quality Data Model for representing Electronic Health Record driven phenotyping algorithms. In: AMIA. Citeseer
2012. 
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.453.993&amp;rep=rep1&amp;type=pdf (accessed 1 Mar 2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540514</ArticleId><ArticleId IdType="pubmed">23304366</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, et al. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc 2015;22:1220&#x2013;30. doi:10.1093/jamia/ocv112</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv112</ArticleId><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco JA, Rasmussen LV, Kiefer RC, et al. A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments. J Am Med Inform Assoc 2018;25:1540&#x2013;6. doi:10.1093/jamia/ocy101</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy101</ArticleId><ArticleId IdType="pmc">PMC6213083</ArticleId><ArticleId IdType="pubmed">30124903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LV, Thompson WK, Pacheco JA, et al. Design patterns for the development of electronic health record-driven phenotype extraction algorithms. J Biomed Inform 2014;51:280&#x2013;6. doi:10.1016/j.jbi.2014.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2014.06.007</ArticleId><ArticleId IdType="pmc">PMC4194216</ArticleId><ArticleId IdType="pubmed">24960203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, et al. Facilitating phenotype transfer using a common data model. J Biomed Inform Accepted.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang N, Weng C, Hripcsak G. A Method for Enhancing the Portability of Electronic Phenotyping Algorithms: An eMERGE Pilot Study. 2016.</Citation></Reference><Reference><Citation>Hripcsak G, Ludemann P, Pryor TA, et al. Rationale for the Arden Syntax. Comput Biomed Res 1994;27:291&#x2013;324. doi:10.1006/cbmr.1994.1023</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cbmr.1994.1023</ArticleId><ArticleId IdType="pubmed">7956129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G Writing Arden Syntax medical logic modules. Comput Biol Med 1994;24:331&#x2013;63. doi:10.1016/0010-4825(94)90002-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0010-4825(94)90002-7</ArticleId><ArticleId IdType="pubmed">7705066</ArticleId></ArticleIdList></Reference><Reference><Citation>Samwald M, Fehre K, de Bruin J, et al. The Arden Syntax standard for clinical decision support: Experiences and directions. J Biomed Inform 2012;45:711&#x2013;8. doi:10.1016/j.jbi.2012.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.02.001</ArticleId><ArticleId IdType="pubmed">22342733</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. ATLAS. http://www.ohdsi.org/web/atlas (accessed 28 May 2019).</Citation></Reference><Reference><Citation>Yuan C, Ryan PB, Ta C, et al. Criteria2Query: a natural language interface to clinical databases for cohort definition. J Am Med Inform Assoc 2019;26:294&#x2013;305. doi:10.1093/jamia/ocy178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy178</ArticleId><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Spickard A, Johnson KB, et al. Evaluation of a method to identify and categorize section headers in clinical documents. J Am Med Inform Assoc JAMIA 2009;16:806&#x2013;15. doi:10.1197/jamia.M3037</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3037</ArticleId><ArticleId IdType="pmc">PMC3002123</ArticleId><ArticleId IdType="pubmed">19717800</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Stenner SP, Doan S, et al. MedEx: a medication information extraction system for clinical narratives. J Am Med Inform Assoc 2010;17:19&#x2013;24. doi:10.1197/jamia.M3378</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3378</ArticleId><ArticleId IdType="pmc">PMC2995636</ArticleId><ArticleId IdType="pubmed">20064797</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Smithers JD, Miller RA, et al. &#x201c;Understanding&#x201d; medical school curriculum content using KnowledgeMap. J Am Med Inform Assoc JAMIA 2003;10:351&#x2013;62. doi:10.1197/jamia.M1176</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M1176</ArticleId><ArticleId IdType="pmc">PMC181986</ArticleId><ArticleId IdType="pubmed">12668688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci D, Lally A. UIMA: an architectural approach to unstructured information processing in the corporate research environment. Nat Lang Eng 2004;10:327&#x2013;48. doi:10.1017/S1351324904003523</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1351324904003523</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc 2010;17:507&#x2013;13. doi:10.1136/jamia.2009.001560</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001560</ArticleId><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullo IJ, Fan J, Pathak J, et al. Leveraging informatics for genetic studies: use of the electronic medical record to enable a genome-wide association study of peripheral arterial disease. J Am Med Inform Assoc 2010;17:568&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995686</ArticleId><ArticleId IdType="pubmed">20819866</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Bielinski SJ, Sohn S, et al. An Information Extraction Framework for Cohort Identification Using Electronic Health Records. AMIA Summits Transl Sci Proc 2013;2013:149&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845757</ArticleId><ArticleId IdType="pubmed">24303255</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Pacheco JA, Rasmussen LV, et al. A Prototype for Executable and Portable Electronic Clinical Quality Measures Using the KNIME Analytics Platform. AMIA Summits Transl Sci Proc 2015;2015:127&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525225</ArticleId><ArticleId IdType="pubmed">26306254</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C, Alderson PO, Austin JH, et al. A general natural-language text processor for clinical radiology. J Am Med Inform Assoc JAMIA 1994;1:161&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC116194</ArticleId><ArticleId IdType="pubmed">7719797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31545380</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Comparison of the cohort selection performance of Australian Medicines Terminology to Anatomical Therapeutic Chemical mappings.</ArticleTitle><Pagination><StartPage>1237</StartPage><EndPage>1246</EndPage><MedlinePgn>1237-1246</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocz143</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Electronic health records are increasingly utilized for observational and clinical research. Identification of cohorts using electronic health records is an important step in this process. Previous studies largely focused on the methods of cohort selection, but there is little evidence on the impact of underlying vocabularies and mappings between vocabularies used for cohort selection. We aim to compare the cohort selection performance using Australian Medicines Terminology to Anatomical Therapeutic Chemical (ATC) mappings from 2 different sources. These mappings were taken from the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) and the Pharmaceutical Benefits Scheme (PBS) schedule.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We retrieved patients from the electronic Practice Based Research Network data repository using 3 ATC classification groups (A10, N02A, N06A). The retrieved patients were further verified manually and pooled to form a reference standard which was used to assess the accuracy of mappings using precision, recall, and F measure metrics.</AbstractText><AbstractText Label="RESULTS">The OMOP-CDM mappings identified 2.6%, 15.2%, and 24.4% more drugs than the PBS mappings in the A10, N02A and N06A groups respectively. Despite this, the PBS mappings generally performed the same in cohort selection as OMOP-CDM mappings except for the N02A Opioids group, where a significantly greater number of patients were retrieved. Both mappings exhibited variable recall, but perfect precision, with all drugs found to be correctly identified.</AbstractText><AbstractText Label="CONCLUSION">We found that 1 of the 3 ATC groups had a significant difference and this affected cohort selection performance. Our findings highlighted that underlying terminology mappings can greatly impact cohort selection accuracy. Clinical researchers should carefully evaluate vocabulary mapping sources including methodologies used to develop those mappings.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Guan N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Centre for eHealth, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Centre for eHealth, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farshid</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Lister Hill National Centre for Biomedical Communications, National Library of Medicine National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Siaw-Teng</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Centre for eHealth, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="N">Pharmaceutical Preparations</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="N">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009626" MajorTopicYN="Y">Terminology as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Australian Medicines Terminology</Keyword><Keyword MajorTopicYN="N">anatomical therapeutic chemical classification</Keyword><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">cohort selection</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31545380</ArticleId><ArticleId IdType="pmc">PMC7647230</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocz143</ArticleId><ArticleId IdType="pii">5572827</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Charles D, Gabriel M, Furukawa MF.. Adoption of electronic health record systems among US non-federal acute care hospitals: 2008&#x2013;2012. ONC Data Brief 2013; 9: 1&#x2013;9.</Citation></Reference><Reference><Citation>Safran C. Using routinely collected data for clinical research. Stat Med 1991; 104: 559&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">1905417</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lusignan S, van Weel C.. The use of routinely collected computer data for research in primary care: opportunities and challenges. Fam Pract 2006; 232: 253&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">16368704</ArticleId></ArticleIdList></Reference><Reference><Citation>Concato J, Shah N, Horwitz RI.. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 34225: 1887&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1557642</ArticleId><ArticleId IdType="pubmed">10861325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence&#x2014;what is it and what can it tell us. N Engl J Med 2016; 37523: 2293&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, et al. The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med 2013; 1510: 761..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, et al. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Joint Summits on Translational Science proceedings. AMIA Jt Summits Transl Sci 2017; 2017: 48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, et al. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc 2015; 226: 1220&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W-Q, Teixeira PL, Mo H, et al. Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance. J Am Med Inform Assoc 2016; 23 (e1): e20&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954637</ArticleId><ArticleId IdType="pubmed">26338219</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PB, Jensen LJ, Brunak S.. Mining electronic health records: towards better research applications and clinical care. Nat Rev Genet 2012; 136: 395..</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, et al. A review of approaches to identifying patient phenotype cohorts using electronic health records. J Am Med Inform Assoc 2014; 212: 221&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao KP, Cai T, Gainer V, et al. Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res 2010; 628: 1120&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3121049</ArticleId><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, et al. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc 2018; 25 (12): 1618&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan PB, Stang PE, et al. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. J Biomed Inform 2012; 454: 689&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonnagaddala J, Dai H-J, Ray P, et al. Mining electronic health records to guide and support clinical decision support systems In: Siaw-Teng Liaw, Andrew Nunn, Tony Sahama, eds. Improving Health Management through Clinical Decision Support Systems. Pennsylvania, USA: IGI Global; 2016: 252&#x2013;69.</Citation></Reference><Reference><Citation>WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo: WHO; 2005.</Citation></Reference><Reference><Citation>Natsch S, Hekster YA, Jong R, et al. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998; 171: 20&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9512177</ArticleId></ArticleIdList></Reference><Reference><Citation>Basger BJ, Chen TF, Moles RJ.. Application of a prescribing indicators tool to assist in identifying drug-related problems in a cohort of older Australians. Int J Pharm Pract 2012; 203: 172&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">22554160</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrows RC Jr, Cimino JJ, Clayton PD. Mapping clinically useful terminology to a controlled medical vocabulary. In: Proceedings of the Annual Symposium on Computer Application in Medical Care. November 5&#x2013;9, 1994; Washington, DC. Pennsylvania: Hanley &amp; Belfus, Inc.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2247832</ArticleId><ArticleId IdType="pubmed">7949922</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys BL, Lindberg D.. The UMLS project: making the conceptual connection between users and the information they need. Bull Med Libr Assoc 1993; 812: 170..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC225759</ArticleId><ArticleId IdType="pubmed">8472002</ArticleId></ArticleIdList></Reference><Reference><Citation>Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 2010; 873: 385&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">19923032</ArticleId></ArticleIdList></Reference><Reference><Citation>Inacio MC, Hansen C, Pratt NL, et al. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open 2016; 64: e010664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4853994</ArticleId><ArticleId IdType="pubmed">27130165</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitry AI, Roughead EE, Preiss AK, et al. Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study. PLoS One 2010; 511: e14024..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2984440</ArticleId><ArticleId IdType="pubmed">21103337</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahor M, Chrischilles E, Guralnik J, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 104: 405&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">7843344</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber CA, Szucs TD, Rapold R, et al. Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health 2013; 131: 1030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3840632</ArticleId><ArticleId IdType="pubmed">24172142</ArticleId></ArticleIdList></Reference><Reference><Citation>Peissig PL, Costa VS, Caldwell MD, et al. Relational machine learning for electronic health record-driven phenotyping. J Biomed Inform 2014; 52: 260&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4261015</ArticleId><ArticleId IdType="pubmed">25048351</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Ma Y, Gronsbell J, et al. Enabling phenotypic big data with PheNorm. J Am Med Inform Assoc 2018; 251: 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251688</ArticleId><ArticleId IdType="pubmed">29126253</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitwal H, Qing D, Jones S, et al. Cross-terminology mapping challenges: a demonstration using medication terminological systems. J Biomed Inform 2012; 454: 613&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4398308</ArticleId><ArticleId IdType="pubmed">22750536</ArticleId></ArticleIdList></Reference><Reference><Citation>Defalco FJ, Ryan PB, Soledad Cepeda M.. Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure. Health Serv Outcomes Res Method 2013; 131: 58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3566397</ArticleId><ArticleId IdType="pubmed">23396660</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Jung C, Chae Y, et al. Comparison of validity of mapping between drug indications and ICD-10. Methods Inf Med 2014; 533: 195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">24727865</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H-T, Lu D.-F, Konicek D, et al. Nursing interventions classification in systematized nomenclature of medicine clinical terms: a cross-mapping validation. Comput Inform Nurs 2007; 254: 198&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">17625400</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Bodenreider O, Aronson AR, et al. Combining lexical and semantic methods of inter-terminology mapping using the UMLS. Stud Health Technol Inform 2007; 129 (Pt 1): 605..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2430093</ArticleId><ArticleId IdType="pubmed">17911788</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg DM, Fine J, Chappell R.. Sample size for positive and negative predictive value in diagnostic research using case-control designs. Biostatistics 2008; 101: 94&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3668447</ArticleId><ArticleId IdType="pubmed">18556677</ArticleId></ArticleIdList></Reference><Reference><Citation>Burt T, Button KS, Thom HHZ, et al. The burden of the &#x201c;false-negatives&#x201d; in clinical development: analyses of current and alternative scenarios and corrective measures. Clin Transl Sci 2017; 106: 470&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402187</ArticleId><ArticleId IdType="pubmed">28675646</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz S, Rodrigues JM, Rector A, et al. Interface terminologies, reference terminologies and aggregation terminologies: a strategy for better integration. Stud Health Technol Inform 2017; 245: 940&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chute CG. Clinical classification and terminology: some history and current observations. J Am Med Inform Assoc 2000; 73: 298&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61433</ArticleId><ArticleId IdType="pubmed">10833167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman SE. Coordination of SNOMED-CT and ICD-10: Getting the Most Out of Electronic Health Record Systems. J AHIMA 2005; 767: 60&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">16097126</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang MF, Hwang JC, Alexander CY, et al. Reliability of SNOMED-CT coding by three physicians using two terminology browsers. AMIA Annu Symp Proc 2006; 2006: 131&#x2013;5; Washington, DC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839418</ArticleId><ArticleId IdType="pubmed">17238317</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. Classification of diseases (ICD). 2018. 
https://www.who.int/classifications/icd/en/. Accessed December 23, 2018.</Citation></Reference><Reference><Citation>Jonnagaddala J, Hu F. Automatic coding of death certificates to ICD-10 terminology. In: Linda Cappellato, Nicola Ferro, Lorraine Goeuriot, Thomas Mandl, eds. CLEF (Working Notes) Dublin, Ireland: Sun SITE Central Europe; 2017.</Citation></Reference><Reference><Citation>
National Clinical Terminology Service. Australian medicines terminology fact sheet. 2016. 
https://www.digitalhealth.gov.au/using-the-my-health-record-system/digital-health-training-resources/guides/australian-medicines-terminology-amt-fact-sheet. Accessed November 14, 2018.</Citation></Reference><Reference><Citation>
International Health Terminology Standards Development Organisation. SNOMED CT July 2018 International Edition&#x2014;SNOMED International Release notes. 2018. 
https://confluence.ihtsdotools.org/display/RMT/SNOMED+CT+July+2018+International+Edition+-+SNOMED+International+Release+notes. Accessed December 11, 2018.</Citation></Reference><Reference><Citation>Bodenreider O, Rodriguez LM.. Analyzing U.S. prescription lists with RxNorm and the ATC/DDD Index. AMIA Annu Symp Proc 2014; 2014: 297&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419961</ArticleId><ArticleId IdType="pubmed">25954332</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Wilcox A.. Reference standards, judges, and comparison subjects: roles for experts in evaluating system performance. J Am Med Inform Assoc 2002; 91: 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC349383</ArticleId><ArticleId IdType="pubmed">11751799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Friedman C, Alderson PO, et al. Unlocking clinical data from narrative reports: a study of natural language processing. Ann Intern Med 1995; 1229: 681&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7702231</ArticleId></ArticleIdList></Reference><Reference><Citation>
ePBRN
. ePBRN/AMT-Study-JAMIA. 2019. 
https://github.com/ePBRN/AMT-Study-JAMIA. Accessed June 5, 2019.</Citation></Reference><Reference><Citation>
Pharmaceutical Benefits Scheme. PBS publications archive. 2018. 
http://www.pbs.gov.au/info/publication/schedule/archive. Accessed December 11, 2018.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>
US National Library of Medicine. RxNorm release notes. 2013. 
https://www.nlm.nih.gov/research/umls/rxnorm/docs/2013/rxnorm_releasenotes_full_08052013.html. Accessed December 11, 2018.</Citation></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics. Release notes 2017-09-06. 2017. 
https://github.com/OHDSI/OMOP-Standardized-Vocabularies/blob/master/Release%20Notes%202017-09-06.txt. Accessed November 10, 2018.</Citation></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics. Athena&#x2014;OHDSI Vocabularies Repository. 2015. 
http://athena.ohdsi.org/search-terms/terms/43351380. Accessed December 10, 2018.</Citation></Reference><Reference><Citation>Taggart J, Liaw ST, Yu H.. Structured data quality reports to improve EHR data quality. Int J Med Inform 2015; 8412: 1094&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26480872</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle D, Rafael N.. BioGrid Australia and GRHANITE&#x2122;: privacy-protecting subject matching. Stud Health Technol Inform 2011; 168: 24&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">21893908</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw S-T, Boyle D. Secure data linkage and information sharing with GRHANITE. In: Heather Grain, ed. HISA Health Informatics Conference (HIC) 2008. Melbourne: Health Informatics Society of Australia; August 31&#x2013;September 2 2008, pp. 159&#x2013;165.</Citation></Reference><Reference><Citation>
Farshid S, Jonnagaddala J, Guo GN, Wu M, Liaw, S.-T. Harmonising primary care data using international standard vocabularies for observational research; 2018. https://zenodo.org/record/1401691#.XUF9n-gzaUn. Accessed December 10, 2018.</Citation></Reference><Reference><Citation>Kohler F, Liaw S-T, Pennock R, et al. Integrated health care&#x2014;a population health approach in South Western Sydney. Int J Integr Care 2014; 149.</Citation></Reference><Reference><Citation>Royal Australian College of General Practitioners. RACGP Standards for General Practices 5th ed. East Melbourne, Australia: RACGP. 2017.</Citation></Reference><Reference><Citation>Meystre S, Haug PJ.. Natural language processing to extract medical problems from electronic clinical documents: performance evaluation. J Biomed Inform 2006; 396: 589&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">16359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Rothschild AS.. Agreement, the F-measure, and reliability in information retrieval. J Am Med Inform Assoc 2005; 123: 296&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1090460</ArticleId><ArticleId IdType="pubmed">15684123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: International Joint Conference on Artificial Intelligence, 1995.</Citation></Reference><Reference><Citation>Tilson L, Bennett K, Barry M.. Prescribing trends for nicotine replacement therapy in primary care. Irish Med J 2004; 979: 270&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15568584</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MV, Costello D, Yonkers KA.. Clinical correlates of prescription opioid analgesic use in pregnancy. Matern Child Health J 2015; 193: 548&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272915</ArticleId><ArticleId IdType="pubmed">24951127</ArticleId></ArticleIdList></Reference><Reference><Citation>Handal M, Engeland A, R&#xf8;nning M, et al. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. Eur J Clin Pharmacol 2011; 679: 953..</Citation><ArticleIdList><ArticleId IdType="pubmed">21484468</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale O, Borchgrevink PC, Fredheim OMS, et al. Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: impact of gender, age, exercise and prescription of opioids. BMC Public Health 2015; 151: 461..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428499</ArticleId><ArticleId IdType="pubmed">25934132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasselstr&#xf6;m J, Liu-Palmgren J, Rasj&#xf6;-Wr&#xe5;&#xe5;k G.. Prevalence of pain in general practice. Eur J Pain 2002; 65: 375&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">12160512</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Bureau of Statistics. 4364.0.55.001&#x2014;National Health Survey: First Results, 2014&#x2013;15 2015. Canberra, Australia: Australian Bureau of Statistics.</Citation></Reference><Reference><Citation>Dhombres F, Charlet J.. As ontologies reach maturity, artificial intelligence starts being fully efficient: findings from the section on knowledge representation and management for the yearbook 2018. Yearb Med Inform 2018; 2701: 140&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6115232</ArticleId><ArticleId IdType="pubmed">30157517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamunen K, Laitinen-Parkkonen P, Paakkari P, et al. What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 2008; 126: 705&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">18162422</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31553307</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>29</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation.</ArticleTitle><Pagination><StartPage>e14325</StartPage><MedlinePgn>e14325</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e14325</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/14325</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The phecode system was built upon the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) for phenome-wide association studies (PheWAS) using the electronic health record (EHR).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The goal of this paper was to develop and perform an initial evaluation of maps from the International Classification of Diseases, 10th Revision (ICD-10) and the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes to phecodes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We mapped ICD-10 and ICD-10-CM codes to phecodes using a number of methods and resources, such as concept relationships and explicit mappings from the Centers for Medicare &amp; Medicaid Services, the Unified Medical Language System, Observational Health Data Sciences and Informatics, Systematized Nomenclature of Medicine-Clinical Terms, and the National Library of Medicine. We assessed the coverage of the maps in two databases: Vanderbilt University Medical Center (VUMC) using ICD-10-CM and the UK Biobank (UKBB) using ICD-10. We assessed the fidelity of the ICD-10-CM map in comparison to the gold-standard ICD-9-CM phecode map by investigating phenotype reproducibility and conducting a PheWAS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We mapped &gt;75% of ICD-10 and ICD-10-CM codes to phecodes. Of the unique codes observed in the UKBB (ICD-10) and VUMC (ICD-10-CM) cohorts, &gt;90% were mapped to phecodes. We observed 70-75% reproducibility for chronic diseases and &lt;10% for an acute disease for phenotypes sourced from the ICD-10-CM phecode map. Using the ICD-9-CM and ICD-10-CM maps, we conducted a PheWAS with a Lipoprotein(a) genetic variant, rs10455872, which replicated two known genotype-phenotype associations with similar effect sizes: coronary atherosclerosis (ICD-9-CM: P&lt;.001; odds ratio (OR) 1.60 [95% CI 1.43-1.80] vs ICD-10-CM: P&lt;.001; OR 1.60 [95% CI 1.43-1.80]) and chronic ischemic heart disease (ICD-9-CM: P&lt;.001; OR 1.56 [95% CI 1.35-1.79] vs ICD-10-CM: P&lt;.001; OR 1.47 [95% CI 1.22-1.77]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study introduces the beta versions of ICD-10 and ICD-10-CM to phecode maps that enable researchers to leverage accumulated ICD-10 and ICD-10-CM data for PheWAS in the EHR.</AbstractText><CopyrightInformation>&#xa9;Patrick Wu, Aliya Gifford, Xiangrui Meng, Xue Li, Harry Campbell, Tim Varley, Juan Zhao, Robert Carroll, Lisa Bastarache, Joshua C Denny, Evropi Theodoratou, Wei-Qi Wei. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 29.11.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1437-6688</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gifford</LastName><ForeName>Aliya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8931-8362</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Meng</LastName><ForeName>Xiangrui</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-4889-4640</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xue</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-6880-2577</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Harry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6169-6262</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varley</LastName><ForeName>Tim</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6106-568X</Identifier><AffiliationInfo><Affiliation>Public Health and Intelligence Strategic Business Unit, National Services Scotland, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Juan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1429-0662</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3802-8183</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastarache</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3020-447X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-3049-7332</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodoratou</LastName><ForeName>Evropi</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5887-9132</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Qi</ForeName><Initials>WQ</Initials><Identifier Source="ORCID">0000-0003-4985-056X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T15 LM007450</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM010685</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL133786</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007347</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 GM115305</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>22804</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data science</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">genome-wide association study</Keyword><Keyword MajorTopicYN="N">medical informatics applications</Keyword><Keyword MajorTopicYN="N">phenome-wide association study</Keyword><Keyword MajorTopicYN="N">phenotyping</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31553307</ArticleId><ArticleId IdType="pmc">PMC6911227</ArticleId><ArticleId IdType="doi">10.2196/14325</ArticleId><ArticleId IdType="pii">v7i4e14325</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL, Pacheco JA, Tromp G, Pathak J, Carrell DS, Ellis SB, Lingren T, Thompson WK, Savova G, Haines J, Roden DM, Harris PA, Denny JC. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016 Nov;23(6):1046&#x2013;1052. doi: 10.1093/jamia/ocv202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv202</ArticleId><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamazon ER, Segr&#xe8; Ayellet V, van de Bunt M, Wen X, Xi HS, Hormozdiari F, Ongen H, Konkashbaev A, Derks EM, Aguet F, Quan J, GTEx Consortium. Nicolae DL, Eskin E, Kellis M, Getz G, McCarthy MI, Dermitzakis ET, Cox NJ, Ardlie KG. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat Genet. 2018 Jul;50(7):956&#x2013;967. doi: 10.1038/s41588-018-0154-4.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0154-4</ArticleId><ArticleId IdType="pmc">PMC6248311</ArticleId><ArticleId IdType="pubmed">29955180</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, Herron TJ, McCarthy S, Schmidt EM, Sveinbjornsson G, Surakka I, Mathis MR, Yamazaki M, Crawford RD, Gabrielsen ME, Skogholt AH, Holmen OL, Lin M, Wolford BN, Dey R, Dalen H, Sulem P, Chung JH, Backman JD, Arnar DO, Thorsteinsdottir U, Baras A, O'Dushlaine C, Holst AG, Wen X, Hornsby W, Dewey FE, Boehnke M, Kheterpal S, Mukherjee B, Lee S, Kang HM, Holm H, Kitzman J, Shavit JA, Jalife J, Brummett CM, Teslovich TM, Carey DJ, Gudbjartsson DF, Stefansson K, Abecasis GR, Hveem K, Willer CJ. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018 Sep;50(9):1234&#x2013;1239. doi: 10.1038/s41588-018-0171-3.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0171-3</ArticleId><ArticleId IdType="pmc">PMC6530775</ArticleId><ArticleId IdType="pubmed">30061737</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonti CN, Vernot B, Bastarache L, Bottinger E, Carrell DS, Chisholm RL, Crosslin DR, Hebbring SJ, Jarvik GP, Kullo IJ, Li R, Pathak J, Ritchie MD, Roden DM, Verma SS, Tromp G, Prato JD, Bush WS, Akey JM, Denny JC, Capra JA. The phenotypic legacy of admixture between modern humans and Neandertals. Science. 2016 Feb 12;351(6274):737&#x2013;41. doi: 10.1126/science.aad2149.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad2149</ArticleId><ArticleId IdType="pmc">PMC4849557</ArticleId><ArticleId IdType="pubmed">26912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Diogo D, Bastarache L, Liao KP, Graham RR, Fulton RS, Greenberg JD, Eyre S, Bowes J, Cui J, Lee A, Pappas DA, Kremer JM, Barton A, Coenen MJH, Franke B, Kiemeney LA, Mariette X, Richard-Miceli C, Canh&#xe3;o Helena, Fonseca JE, de Vries N, Tak PP, Crusius JBA, Nurmohamed MT, Kurreeman F, Mikuls TR, Okada Y, Stahl EA, Larson DE, Deluca TL, O'Laughlin M, Fronick CC, Fulton LL, Kosoy R, Ransom M, Bhangale TR, Ortmann W, Cagan A, Gainer V, Karlson EW, Kohane I, Murphy SN, Martin J, Zhernakova A, Klareskog L, Padyukov L, Worthington J, Mardis ER, Seldin MF, Gregersen PK, Behrens T, Raychaudhuri S, Denny JC, Plenge RM. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLoS One. 2015;10(4):e0122271. doi: 10.1371/journal.pone.0122271.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122271</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0122271</ArticleId><ArticleId IdType="pmc">PMC4388675</ArticleId><ArticleId IdType="pubmed">25849893</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastegar-Mojarad M, Ye Z, Kolesar JM, Hebbring SJ, Lin SM. Opportunities for drug repositioning from phenome-wide association studies. Nat Biotechnol. 2015 Apr;33(4):342&#x2013;5. doi: 10.1038/nbt.3183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3183</ArticleId><ArticleId IdType="pubmed">25850054</ArticleId></ArticleIdList></Reference><Reference><Citation>Millard LAC, Davies NM, Timpson NJ, Tilling K, Flach PA, Davey Smith G. MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization. Sci Rep. 2015 Nov 16;5:16645. doi: 10.1038/srep16645. doi: 10.1038/srep16645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16645</ArticleId><ArticleId IdType="doi">10.1038/srep16645</ArticleId><ArticleId IdType="pmc">PMC4644974</ArticleId><ArticleId IdType="pubmed">26568383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehm MG, Aponte JL, Chiano MN, Yerges-Armstrong LM, Johnson T, Barker JN, Cook SF, Gupta A, Hinds DA, Li L, Nelson MR, Simpson MA, Tian C, McCarthy LC, Rajpal DK, Waterworth DM. Phenome-wide association study using research participants' self-reported data provides insight into the Th17 and IL-17 pathway. PLoS One. 2017;12(11):e0186405. doi: 10.1371/journal.pone.0186405.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186405</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0186405</ArticleId><ArticleId IdType="pmc">PMC5665418</ArticleId><ArticleId IdType="pubmed">29091937</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Ye Z, Mayer JG, Hoch BA, Green C, Rolak L, Cold C, Khor S, Zheng X, Miyagawa T, Tokunaga K, Brilliant MH, Hebbring SJ. Phenome-wide association study maps new diseases to the human major histocompatibility complex region. J Med Genet. 2016 Oct;53(10):681&#x2013;9. doi: 10.1136/jmedgenet-2016-103867.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2016-103867</ArticleId><ArticleId IdType="pmc">PMC5035188</ArticleId><ArticleId IdType="pubmed">27287392</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuraz A, Chouchana L, Malamut G, Le Beller C, Roche D, Beaune P, Degoulet P, Burgun A, Loriot M, Avillach P. Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics. PLoS Comput Biol. 2013;9(12):e1003405. doi: 10.1371/journal.pcbi.1003405.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003405</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1003405</ArticleId><ArticleId IdType="pmc">PMC3873228</ArticleId><ArticleId IdType="pubmed">24385893</ArticleId></ArticleIdList></Reference><Reference><Citation>Doshi-Velez F, Ge Y, Kohane I. Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics. 2014 Jan;133(1):e54&#x2013;63. doi: 10.1542/peds.2013-0819.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2013-0819</ArticleId><ArticleId IdType="pmc">PMC3876178</ArticleId><ArticleId IdType="pubmed">24323995</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Meng X, Spiliopoulou A, Timofeeva M, Wei W, Gifford A, Shen X, He Y, Varley T, McKeigue P, Tzoulaki I, Wright AF, Joshi P, Denny JC, Campbell H, Theodoratou E. MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank. Ann Rheum Dis. 2018 Jul;77(7):1039&#x2013;1047. doi: 10.1136/annrheumdis-2017-212534.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-212534</ArticleId><ArticleId IdType="pmc">PMC6029646</ArticleId><ArticleId IdType="pubmed">29437585</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RJ, Bastarache L, Denny JC. R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment. Bioinformatics. 2014 Aug 15;30(16):2375&#x2013;6. doi: 10.1093/bioinformatics/btu197.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu197</ArticleId><ArticleId IdType="pmc">PMC4133579</ArticleId><ArticleId IdType="pubmed">24733291</ArticleId></ArticleIdList></Reference><Reference><Citation>PheWAS Catalog.  [2019-07-14].  Phecode Map 1.2 with ICD-9 Codes.  https://phewascatalog.org/phecodes.</Citation></Reference><Reference><Citation>Steindel SJ. International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets. J Am Med Inform Assoc. 2010;17(3):274&#x2013;82. doi: 10.1136/jamia.2009.001230.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001230</ArticleId><ArticleId IdType="pmc">PMC2995704</ArticleId><ArticleId IdType="pubmed">20442144</ArticleId></ArticleIdList></Reference><Reference><Citation>Topaz M, Shafran-Topaz L, Bowles KH. ICD-9 to ICD-10: evolution, revolution, and current debates in the United States. Perspect Health Inf Manag. 2013;10:1d.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC3692324</ArticleId><ArticleId IdType="pubmed">23805064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Richesson R, Smerek M, Pereira KC, Green BB, Patkar A, Clowse M, Bauck A, Bodenreider O. Preparing for the ICD-10-CM Transition: Automated Methods for Translating ICD Codes in Clinical Phenotype Definitions. EGEMS (Wash DC) 2016;4(1):1211. doi: 10.13063/2327-9214.1211.  </Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1211</ArticleId><ArticleId IdType="pmc">PMC4862764</ArticleId><ArticleId IdType="pubmed">27195309</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder V.  NLM Technical Bulletin. US National Library of Medicine; 2018. May,  [2019-07-16].  UMLS 2018AA Release Available.  https://www.nlm.nih.gov/pubs/techbull/mj18/mj18_umls_2018aa_release.html.</Citation></Reference><Reference><Citation>Denny JC, Bastarache L, Ritchie MD, Carroll RJ, Zink R, Mosley JD, Field JR, Pulley JM, Ramirez AH, Bowton E, Basford MA, Carrell DS, Peissig PL, Kho AN, Pacheco JA, Rasmussen LV, Crosslin DR, Crane PK, Pathak J, Bielinski SJ, Pendergrass SA, Xu H, Hindorff LA, Li R, Manolio TA, Chute CG, Chisholm RL, Larson EB, Jarvik GP, Brilliant MH, McCarty CA, Kullo IJ, Haines JL, Crawford DC, Masys DR, Roden DM. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol. 2013 Dec;31(12):1102&#x2013;10. doi: 10.1038/nbt.2749.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2749</ArticleId><ArticleId IdType="pmc">PMC3969265</ArticleId><ArticleId IdType="pubmed">24270849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Bastarache LA, Carroll RJ, Marlo JE, Osterman TJ, Gamazon ER, Cox NJ, Roden DM, Denny JC. Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record. PLoS One. 2017;12(7):e0175508. doi: 10.1371/journal.pone.0175508.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0175508</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0175508</ArticleId><ArticleId IdType="pmc">PMC5501393</ArticleId><ArticleId IdType="pubmed">28686612</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015 Mar;12(3):e1001779. doi: 10.1371/journal.pmed.1001779.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services  CMS.gov. 2017. Aug 11,  [2019-07-05].  2018 ICD-10-CM and GEMs.  https://www.cms.gov/Medicare/Coding/ICD10/2018-ICD-10-CM-and-GEMs.html.</Citation><ArticleIdList><ArticleId IdType="pubmed">26110197</ArticleId></ArticleIdList></Reference><Reference><Citation>US National Library of Medicine. 2018. Jan 26,  [2019-04-06].  SNOMED CT to ICD-9-CM Rule Based Mapping to Support Reimbursement.  https://www.nlm.nih.gov/research/umls/mapping_projects/snomedct_to_icd9cm_reimburse.html.</Citation></Reference><Reference><Citation>Fung KW, Bodenreider O. Utilizing the UMLS for semantic mapping between terminologies. AMIA Annu Symp Proc. 2005:266&#x2013;70.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560893</ArticleId><ArticleId IdType="pubmed">16779043</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. 2016. Jun 04,  [2019-07-17].  ICD9CM.  https://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:icd9cm.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei Johan, Pratt N, Nor&#xe9;n G Niklas, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuse DA. Supporting communication in an integrated patient record system. AMIA Annu Symp Proc. 2003:1065.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC1480157</ArticleId><ArticleId IdType="pubmed">14728568</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordestgaard BG, Chapman MJ, Ray K, Bor&#xe9;n Jan, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen M, Tokg&#xf6;zoglu Lale, Tybj&#xe6;rg-Hansen Anne, European Atherosclerosis Society Consensus Panel  Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010 Dec;31(23):2844&#x2013;53. doi: 10.1093/eurheartj/ehq386.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq386</ArticleId><ArticleId IdType="pmc">PMC3295201</ArticleId><ArticleId IdType="pubmed">20965889</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Feng Q, Wu P, Warner JL, Denny JC, Wei W. Using topic modeling via non-negative matrix factorization to identify relationships between genetic variants and disease phenotypes: A case study of Lipoprotein(a) (LPA) PLoS One. 2019;14(2):e0212112. doi: 10.1371/journal.pone.0212112.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212112</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0212112</ArticleId><ArticleId IdType="pmc">PMC6374022</ArticleId><ArticleId IdType="pubmed">30759150</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Li X, Feng Q, Kubo M, Kullo IJ, Peissig PL, Karlson EW, Jarvik GP, Lee MTM, Shang N, Larson EA, Edwards T, Shaffer CM, Mosley JD, Maeda S, Horikoshi M, Ritchie M, Williams MS, Larson EB, Crosslin DR, Bland ST, Pacheco JA, Rasmussen-Torvik LJ, Cronkite D, Hripcsak G, Cox NJ, Wilke RA, Stein CM, Rotter JI, Momozawa Y, Roden DM, Krauss RM, Denny JC. LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins. Circulation. 2018 Oct 23;138(17):1839&#x2013;1849. doi: 10.1161/CIRCULATIONAHA.117.031356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.031356</ArticleId><ArticleId IdType="pmc">PMC6202211</ArticleId><ArticleId IdType="pubmed">29703846</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, Masys DR. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther. 2008 Sep;84(3):362&#x2013;9. doi: 10.1038/clpt.2008.89.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/clpt.2008.89</ArticleId><ArticleId IdType="pmc">PMC3763939</ArticleId><ArticleId IdType="pubmed">18500243</ArticleId></ArticleIdList></Reference><Reference><Citation>PheWAS  GitHub.  [2019-10-04].  PheWAS R Package.  https://github.com/PheWAS/PheWAS.</Citation></Reference><Reference><Citation>Zhou W, Nielsen JB, Fritsche LG, Dey R, Gabrielsen ME, Wolford BN, LeFaive J, VandeHaar P, Gagliano SA, Gifford A, Bastarache LA, Wei W, Denny JC, Lin M, Hveem K, Kang HM, Abecasis GR, Willer CJ, Lee S. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018 Sep;50(9):1335&#x2013;1341. doi: 10.1038/s41588-018-0184-y.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0184-y</ArticleId><ArticleId IdType="pmc">PMC6119127</ArticleId><ArticleId IdType="pubmed">30104761</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaganti S, Mawn LA, Kang H, Egan J, Resnick SM, Beason-Held LL, Landman BA, Lasko T. Electronic Medical Record Context Signatures Improve Diagnostic Classification Using Medical Image Computing. IEEE J Biomed Health Inform. 2019 Sep;23(5):2052&#x2013;2062. doi: 10.1109/JBHI.2018.2890084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2018.2890084</ArticleId><ArticleId IdType="pmc">PMC6844192</ArticleId><ArticleId IdType="pubmed">30602428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Feng Q, Wu P, Lupu RA, Wilke RA, Wells QS, Denny JC, Wei W. Learning from Longitudinal Data in Electronic Health Record and Genetic Data to Improve Cardiovascular Event Prediction. Sci Rep. 2019 Jan 24;9(1):717. doi: 10.1038/s41598-018-36745-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36745-x</ArticleId><ArticleId IdType="pmc">PMC6345960</ArticleId><ArticleId IdType="pubmed">30679510</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M, ElTayeby O, Zolnoori M, Yao L. Public Opinions Toward Diseases: Infodemiological Study on News Media Data. J Med Internet Res. 2018 May 08;20(5):e10047. doi: 10.2196/10047.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10047</ArticleId><ArticleId IdType="pmc">PMC5964307</ArticleId><ArticleId IdType="pubmed">29739741</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Li X, Cai T. Spherical Regression under Mismatch Corruption with Application to Automated Knowledge Translation. arXiv preprint. 2019 Sep 04;  </Citation></Reference><Reference><Citation>Bastarache L, Hughey JJ, Hebbring S, Marlo J, Zhao W, Ho WT, Van Driest SL, McGregor TL, Mosley JD, Wells QS, Temple M, Ramirez AH, Carroll R, Osterman T, Edwards T, Ruderfer D, Velez Edwards DR, Hamid R, Cogan J, Glazer A, Wei W, Feng Q, Brilliant M, Zhao ZJ, Cox NJ, Roden DM, Denny JC. Phenotype risk scores identify patients with unrecognized Mendelian disease patterns. Science. 2018 Mar 16;359(6381):1233&#x2013;1239. doi: 10.1126/science.aal4043.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal4043</ArticleId><ArticleId IdType="pmc">PMC5959723</ArticleId><ArticleId IdType="pubmed">29590070</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency for Healthcare Research and Quality  Healthcare Cost and Utilization Project (HCUP) 2012. Jan,  [2019-07-15].  HCUP CCS Fact Sheet.  https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccsfactsheet.jsp.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413206</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatini AK, Kocher KE, Basu A, Hsia RY. In-Hospital Outcomes and Costs Among Patients Hospitalized During a Return Visit to the Emergency Department. JAMA. 2016 Feb 16;315(7):663&#x2013;71. doi: 10.1001/jama.2016.0649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0649</ArticleId><ArticleId IdType="pmc">PMC8366576</ArticleId><ArticleId IdType="pubmed">26881369</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Hao S, Jin B, Shin AY, Zhu C, Huang M, Wang Y, Zheng L, Dai D, Culver DS, Alfreds ST, Rogow T, Stearns F, Sylvester KG, Widen E, Ling X. Online Prediction of Health Care Utilization in the Next Six Months Based on Electronic Health Record Information: A Cohort and Validation Study. J Med Internet Res. 2015 Sep 22;17(9):e219. doi: 10.2196/jmir.4976.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.4976</ArticleId><ArticleId IdType="pmc">PMC4642374</ArticleId><ArticleId IdType="pubmed">26395541</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency for Healthcare Research and Quality  Healthcare Cost and Utilization Project (HCUP) 2019. Sep,  [2019-07-05].  Clinical Classifications Software (CCS) for ICD-10-PCS (beta version).  https://www.hcup-us.ahrq.gov/toolssoftware/ccs10/ccs10.jsp.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413206</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, Ryan PB. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc. 2018 Dec 01;25(12):1618&#x2013;1625. doi: 10.1093/jamia/ocy124.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31581246</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services.</ArticleTitle><Pagination><StartPage>e0223010</StartPage><MedlinePgn>e0223010</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0223010</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0223010</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE">To take full advantage of decision support, machine learning, and patient-level prediction models, it is important that models are not only created, but also deployed in a clinical setting. The KETOS platform demonstrated in this work implements a tool for researchers allowing them to perform statistical analyses and deploy resulting models in a secure environment.</AbstractText><AbstractText Label="METHODS">The proposed system uses Docker virtualization to provide researchers with reproducible data analysis and development environments, accessible via Jupyter Notebook, to perform statistical analysis and develop, train and deploy models based on standardized input data. The platform is built in a modular fashion and interfaces with web services using the Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) standard to access patient data. In our prototypical implementation we use an OMOP common data model (OMOP-CDM) database. The architecture supports the entire research lifecycle from creating a data analysis environment, retrieving data, and training to final deployment in a hospital setting.</AbstractText><AbstractText Label="RESULTS">We evaluated the platform by establishing and deploying an analysis and end user application for hemoglobin reference intervals within the University Hospital Erlangen. To demonstrate the potential of the system to deploy arbitrary models, we loaded a colorectal cancer dataset into an OMOP database and built machine learning models to predict patient outcomes and made them available via a web service. We demonstrated both the integration with FHIR as well as an example end user application. Finally, we integrated the platform with the open source DataSHIELD architecture to allow for distributed privacy preserving data analysis and training across networks of hospitals.</AbstractText><AbstractText Label="CONCLUSION">The KETOS platform takes a novel approach to data analysis, training and deploying decision support models in a hospital or healthcare setting. It does so in a secure and privacy-preserving manner, combining the flexibility of Docker virtualization with the advantages of standardized vocabularies, a widely applied database schema (OMOP-CDM), and a standardized way to exchange medical data (FHIR).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gruendner</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7204-5329</Identifier><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwachhofer</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sippl</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erpenbeck</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulden</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapsner</LastName><ForeName>Lorenz A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0003-1866-860X</Identifier><AffiliationInfo><Affiliation>Medical Centre for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zierk</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Centre for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Universit&#xe4;tsklinikumErlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mate</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1389-3384</Identifier><AffiliationInfo><Affiliation>Medical Centre for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xfc;rzl</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Molecular and Experimental Surgery, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croner</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, Vascular and Graft Surgery, University Hospital, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Centre for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toddenroth</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2019 Nov 13;14(11):e0225442. doi: 10.1371/journal.pone.0225442</RefSource><PMID Version="1">31721815</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073892" MajorTopicYN="Y">Health Information Interoperability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018907" MajorTopicYN="N">Privacy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="N">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31581246</ArticleId><ArticleId IdType="pmc">PMC6776354</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0223010</ArticleId><ArticleId IdType="pii">PONE-D-19-12555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wehling M. Translational medicine: science or wishful thinking? J Transl Med. 2008;6:31 Epub 2008/06/19. 10.1186/1479-5876-6-31</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-6-31</ArticleId><ArticleId IdType="pmc">PMC2442586</ArticleId><ArticleId IdType="pubmed">18559092</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasgow RE, Emmons KM. How can we increase translation of research into practice? Types of evidence needed. Annu Rev Public Health. 2007;28:413&#x2013;33. Epub 2006/12/08. 10.1146/annurev.publhealth.28.021406.144145 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.publhealth.28.021406.144145</ArticleId><ArticleId IdType="pubmed">17150029</ArticleId></ArticleIdList></Reference><Reference><Citation>Horig H, Marincola E, Marincola FM. Obstacles and opportunities in translational research. Nat Med. 2005;11(7):705&#x2013;8. Epub 2005/07/15. 10.1038/nm0705-705 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0705-705</ArticleId><ArticleId IdType="pubmed">16015353</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto GES J. A. EPOCH and ePRISM: A web-based translational framework for bridging outcomes research and clinical practice. Computers in Cardiology. 2007; 10.1109/CIC.2007.4745457:4</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/CIC.2007.4745457:4</ArticleId></ArticleIdList></Reference><Reference><Citation>Velickovski F, Ceccaroni L, Roca J, Burgos F, Galdiz JB, Marina N, et al. Clinical Decision Support Systems (CDSS) for preventive management of COPD patients. J Transl Med. 2014;12 Suppl 2:S9 Epub 2014/12/05. 10.1186/1479-5876-12-S2-S9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-12-S2-S9</ArticleId><ArticleId IdType="pmc">PMC4255917</ArticleId><ArticleId IdType="pubmed">25471545</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldow C, Salentin S, Schroeder M, Roeder I, Glauche I. MAGPIE: Simplifying access and execution of computational models in the life sciences. PLoS Comput Biol. 2017;13(12):e1005898 Epub 2017/12/16. 10.1371/journal.pcbi.1005898</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005898</ArticleId><ArticleId IdType="pmc">PMC5747461</ArticleId><ArticleId IdType="pubmed">29244826</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson E, Li W, Sudre C, Fidon L, Shakir DI, Wang G, et al. NiftyNet: a deep-learning platform for medical imaging. Comput Methods Programs Biomed. 2018;158:113&#x2013;22. Epub 2018/03/17. 10.1016/j.cmpb.2018.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2018.01.025</ArticleId><ArticleId IdType="pmc">PMC5869052</ArticleId><ArticleId IdType="pubmed">29544777</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalilia M, Choi M, Henderson A, Iyengar S, Braunstein M, Sun J. Clinical Predictive Modeling Development and Deployment through FHIR Web Services. AMIA Annu Symp Proc. 2015;2015:717&#x2013;26. Epub 2015/01/01.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765683</ArticleId><ArticleId IdType="pubmed">26958207</ArticleId></ArticleIdList></Reference><Reference><Citation>GT-FHIR: OMOP on FHIR Project [Internet]. 2018 [cited 2019 Sep 3]. Available from: https://github.com/gt-health/GT-FHIR.</Citation></Reference><Reference><Citation>HL7.org. HL7 FHIR [Internet]. [cited 2019 Sep 3]. Available from: https://www.hl7.org/fhir/.</Citation></Reference><Reference><Citation>Definition and DDLs for the OMOP Common Data Model (CDM) [Internet]. [cited 2019 Sep 3]. Available from: https://github.com/OHDSI/CommonDataModel.</Citation></Reference><Reference><Citation>Semler SC, Wissing F, Heyder R. German Medical Informatics Initiative. Methods Inf Med. 2018;57(S 01):e50&#x2013;e6. Epub 2018/07/18. 10.3414/ME18-03-0003</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-03-0003</ArticleId><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter A, Staubert S, Ammon D, Aiche S, Beyan O, Bischoff V, et al. Smart Medical Information Technology for Healthcare (SMITH). Methods Inf Med. 2018;57(S 01):e92&#x2013;e105. Epub 2018/07/18. 10.3414/ME18-02-0004</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-02-0004</ArticleId><ArticleId IdType="pmc">PMC6193398</ArticleId><ArticleId IdType="pubmed">30016815</ArticleId></ArticleIdList></Reference><Reference><Citation>Haarbrandt B, Schreiweis B, Rey S, Sax U, Scheithauer S, Rienhoff O, et al. HiGHmed&#x2014;An Open Platform Approach to Enhance Care and Research across Institutional Boundaries. Methods Inf Med. 2018;57(S 01):e66&#x2013;e81. Epub 2018/07/18. 10.3414/ME18-02-0002</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-02-0002</ArticleId><ArticleId IdType="pmc">PMC6193407</ArticleId><ArticleId IdType="pubmed">30016813</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasser F, Kohlbacher O, Mansmann U, Bauer B, Kuhn KA. Data Integration for Future Medicine (DIFUTURE). Methods Inf Med. 2018;57(S 01):e57&#x2013;e65. Epub 2018/07/18. 10.3414/ME17-02-0022</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME17-02-0022</ArticleId><ArticleId IdType="pmc">PMC6178202</ArticleId><ArticleId IdType="pubmed">30016812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. Epub 2015/08/12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes N, Rijnbeek P, Van Speybroeck M. The European Health Data and Evidence Network (EHDEN) [Internet]. Liberating Evidence via Harmonisation of EU Real world data. Rotterdam: European ODHSI Symposium;  [cited 2019 Sep 3]. Available from: http://www.ohdsi-europe.org/images/symposium-2018/posters/24-Nigel-Hughes.pdf.</Citation></Reference><Reference><Citation>Prokosch HU, Acker T, Bernarding J, Binder H, Boeker M, Boerries M, et al. MIRACUM: Medical Informatics in Research and Care in University Medicine. Methods Inf Med. 2018;57(S 01):e82&#x2013;e91. Epub 2018/07/18. 10.3414/ME17-02-0025</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME17-02-0025</ArticleId><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="pubmed">30016814</ArticleId></ArticleIdList></Reference><Reference><Citation>Project Jupyter. jupyter [Internet]. 2018 [cited 2019 Sep 3]. Available from: http://jupyter.org/.</Citation></Reference><Reference><Citation>Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, et al. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol. 2010;39(5):1383&#x2013;93. Epub 2010/09/04. 10.1093/ije/dyq139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyq139</ArticleId><ArticleId IdType="pmc">PMC2972444</ArticleId><ArticleId IdType="pubmed">20813861</ArticleId></ArticleIdList></Reference><Reference><Citation>Laursen SO. [SNOMED (Systematized Nomenclature of Medicine)&#x2014;multiaxial data registration]. Ugeskr Laeger. 1981;143(17):1081&#x2013;3. Epub 1981/04/20. .</Citation><ArticleIdList><ArticleId IdType="pubmed">7245387</ArticleId></ArticleIdList></Reference><Reference><Citation>Vreeman DJ, McDonald CJ, Huff SM. LOINC(R)&#x2014;A Universal Catalog of Individual Clinical Observations and Uniform Representation of Enumerated Collections. Int J Funct Inform Personal Med. 2010;3(4):273&#x2013;91. Epub 2010/01/01. 10.1504/IJFIPM.2010.040211</Citation><ArticleIdList><ArticleId IdType="doi">10.1504/IJFIPM.2010.040211</ArticleId><ArticleId IdType="pmc">PMC3418707</ArticleId><ArticleId IdType="pubmed">22899966</ArticleId></ArticleIdList></Reference><Reference><Citation>Rishi Kanth S. Fast Health Interoperability Resources (FHIR): Current Status in the Healthcare System. International Journal of E-Health and Medical Communications (IJEHMC). 2019;10(1):76&#x2013;93. 10.4018/IJEHMC.2019010105</Citation><ArticleIdList><ArticleId IdType="doi">10.4018/IJEHMC.2019010105</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS [Internet]. 2018 [cited 2019 Sep 3]. Available from: https://github.com/OHDSI/Atlas.</Citation></Reference><Reference><Citation>Grundner J, Prokosch HU, Sturzl M, Croner R, Christoph J, Toddenroth D. Predicting Clinical Outcomes in Colorectal Cancer Using Machine Learning. Stud Health Technol Inform. 2018;247:101&#x2013;5. Epub 2018/04/22. .</Citation><ArticleIdList><ArticleId IdType="pubmed">29677931</ArticleId></ArticleIdList></Reference><Reference><Citation>Logemann T. General Data Protection Regulation GDPR [Internet]. [cited 2019 14.01.2019]. Available from: https://gdpr-info.eu/.</Citation></Reference><Reference><Citation>Zierk J, Arzideh F, Haeckel R, Rauh M, Metzler M, Ganslandt T, et al. Indirect determination of hematology reference intervals in adult patients on Beckman Coulter UniCell DxH 800 and Abbott CELL-DYN Sapphire devices. Clin Chem Lab Med. 2018. Epub 2018/10/28. 10.1515/cclm-2018-0771 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2018-0771</ArticleId><ArticleId IdType="pubmed">30367783</ArticleId></ArticleIdList></Reference><Reference><Citation>Arzideh F. Reference Limit Estimator [Internet]. https://www.dgkl.de/fileadmin/Verbandsarbeit/Entscheidungsgrenzen/RLE49.zip2018 [cited 2019 Sep 3]. Available from: https://www.dgkl.de/fileadmin/Verbandsarbeit/Entscheidungsgrenzen/RLE49.zip.</Citation></Reference><Reference><Citation>Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H. The HUGO Gene Nomenclature Committee (HGNC). Hum Genet. 2001;109(6):678&#x2013;80. Epub 2002/01/26. 10.1007/s00439-001-0615-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-001-0615-0</ArticleId><ArticleId IdType="pubmed">11810281</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones BBaMLaLKaJSaJRaESaGCaZM. mlr: Machine Learning in R. Journal of Machine Learning Research. 2016;17(170):1&#x2013;5.</Citation></Reference><Reference><Citation>Kuhn M. The caret Package.</Citation></Reference><Reference><Citation>Gruendner J, Prokosch HU, Schindler S, Lenz S, Binder H. A Queue-Poll Extension and DataSHIELD: Standardised, Monitored, Indirect and Secure Access to Sensitive Data. Stud Health Technol Inform. 2019;258:115&#x2013;9. Epub 2019/04/04. .</Citation><ArticleIdList><ArticleId IdType="pubmed">30942726</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisch F, Dimitriadou E. mlbench: Machine Learning Benchmark Problems [Internet]. 2012.  [cited 2019 Aug 27]. Available from: https://cran.r-project.org/web/packages/mlbench/index.html.</Citation></Reference><Reference><Citation>Dua D, Graff C. Machine Learning Repository [Internet]. 2019.  [cited 2019 Aug 27]. Available from: http://archive.ics.uci.edu/ml.</Citation></Reference><Reference><Citation>HL7. HL7 FHIR&#x2014;Version History [Internet]. 2018 [cited 2019 Aug 13]. Available from: http://hl7.org/fhir/history.html.</Citation></Reference><Reference><Citation>Google. Cloud Healthcare API [Internet]. 2019 [cited 2019 Aug 14]. Available from: https://cloud.google.com/healthcare/.</Citation></Reference><Reference><Citation>Microsoft. Azure API for FHIR. [Internet]. 2019. Available from: https://azure.microsoft.com/en-us/services/azure-api-for-fhir/.</Citation></Reference><Reference><Citation>Apple. Accessing Health Records [Internet]. 2019 [cited 2019 Aug 14]. Available from: https://developer.apple.com/documentation/healthkit/samples/accessing_health_records.</Citation></Reference><Reference><Citation>Posnack S, Barker W. Heat Wave: The U.S. is Poised to Catch FHIR in 2019 [Internet]. 2018.  [cited 2019 Sep 3 ]. Available from: https://www.healthit.gov/buzz-blog/interoperability/heat-wave-the-u-s-is-poised-to-catch-fhir-in-2019.</Citation></Reference><Reference><Citation>Medizininformatik-Initiative. Medizininformatik-Initiative beschlie&#xdf;t Verwendung von FHIR. [Internet]. 2019 [cited 2019 Aug 17]. Available from: https://www.medizininformatik-initiative.de/de/medizininformatik-initiative-beschliesst-verwendung-von-fhir.</Citation></Reference><Reference><Citation>Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, et al. DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. 2014;43(6):1929&#x2013;44. Epub 2014/09/30. 10.1093/ije/dyu188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu188</ArticleId><ArticleId IdType="pmc">PMC4276062</ArticleId><ArticleId IdType="pubmed">25261970</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, et al. Towards Implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. 2018;9(1):54&#x2013;61. Epub 2018/01/25. 10.1055/s-0037-1617452</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel JC, Kreda DA, Mandl KD, Kohane IS, Ramoni RB. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc. 2016;23(5):899&#x2013;908. Epub 2016/02/26. 10.1093/jamia/ocv189</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv189</ArticleId><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31592524</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Leaf: an open-source, model-agnostic, data-driven web application for cohort discovery and translational biomedical research.</ArticleTitle><Pagination><StartPage>109</StartPage><EndPage>118</EndPage><MedlinePgn>109-118</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocz165</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Academic medical centers and health systems are increasingly challenged with supporting appropriate secondary use of clinical data. Enterprise data warehouses have emerged as central resources for these data, but often require an informatician to extract meaningful information, limiting direct access by end users. To overcome this challenge, we have developed Leaf, a lightweight self-service web application for querying clinical data from heterogeneous data models and sources.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Leaf utilizes a flexible biomedical concept system to define hierarchical concepts and ontologies. Each Leaf concept contains both textual representations and SQL query building blocks, exposed by a simple drag-and-drop user interface. Leaf generates abstract syntax trees which are compiled into dynamic SQL queries.</AbstractText><AbstractText Label="RESULTS">Leaf is a successful production-supported tool at the University of Washington, which hosts a central Leaf instance querying an enterprise data warehouse with over 300 active users. Through the support of UW Medicine (https://uwmedicine.org), the Institute of Translational Health Sciences (https://www.iths.org), and the National Center for Data to Health (https://ctsa.ncats.nih.gov/cd2h/), Leaf source code has been released into the public domain at https://github.com/uwrit/leaf.</AbstractText><AbstractText Label="DISCUSSION">Leaf allows the querying of single or multiple clinical databases simultaneously, even those of different data models. This enables fast installation without costly extraction or duplication.</AbstractText><AbstractText Label="CONCLUSIONS">Leaf differs from existing cohort discovery tools because it does not specify a required data model and is designed to seamlessly leverage existing user authentication systems and clinical databases in situ. We believe Leaf to be useful for health system analytics, clinical research data warehouses, precision medicine biobanks, and clinical studies involving large patient cohorts.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dobbins</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, UW Medicine Research IT, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spital</LastName><ForeName>Clifford H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>UW Medicine Research IT, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Population Health Analytics, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Jason M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Clinical Research Informatics, St. Jude's Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Veer</LastName><ForeName>Bas</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>UW Medicine Research IT, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampino</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UW Medicine Research IT, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Disease, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Britt</LastName><ForeName>Bethene D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>UW Medicine Analytics, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephens</LastName><ForeName>Kari A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilcox</LastName><ForeName>Adam B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarczy-Hornoch</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mooney</LastName><ForeName>Sean D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="Y">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019992" MajorTopicYN="N">Databases as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057170" MajorTopicYN="Y">Translational Research, Biomedical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017432" MajorTopicYN="N">Unified Medical Language System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="Y">User-Computer Interface</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biomedical informatics</Keyword><Keyword MajorTopicYN="N">cloud computing</Keyword><Keyword MajorTopicYN="N">cohort discovery</Keyword><Keyword MajorTopicYN="N">data integration</Keyword><Keyword MajorTopicYN="N">leaf</Keyword><Keyword MajorTopicYN="N">observational health data sciences and informatics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31592524</ArticleId><ArticleId IdType="pmc">PMC6913227</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocz165</ArticleId><ArticleId IdType="pii">5583724</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berner ES, Moss J.. Informatics challenges for the impending patient information explosion. J Am Med Inform Assoc 2005; 12 (6): 614&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1294032</ArticleId><ArticleId IdType="pubmed">16049224</ArticleId></ArticleIdList></Reference><Reference><Citation>Shameer K, Badgeley MA, Miotto R, et al. Translational bioinformatics in the era of real-time biomedical, health care and wellness data streams. Brief Bioinform 2017; 18 (1): 105&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5221424</ArticleId><ArticleId IdType="pubmed">26876889</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011; 4 (1): 13..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (2): 377&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>
Norman DA, Draper SW.. 
User Centered System Design|New Perspectives on Human-Computer Interaction. 
Abingdon, United Kingdom: 
Taylor &amp; Francis; 1986. 
https://www.taylorfrancis.com/books/e/9781482229639 Accessed April 6, 2019.</Citation></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc 2010; 17 (2): 124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferranti JM, Gilbert W, McCall J, et al. The design and implementation of an open-source, data-driven cohort recruitment system: the Duke integrated subject cohort and enrollment research network (DISCERN). J Am Med Inform Assoc 2012; 19 (e1): e68&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392865</ArticleId><ArticleId IdType="pubmed">21946237</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, Dahman B.. Automated matching software for clinical trials eligibility: measuring efficiency and flexibility. Contemp Clin Trials 2010; 31 (3): 207&#x2013;17 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson N, Abend A, Mandel A, et al. Implementation of a deidentified federated data network for population-based cohort discovery. J Am Med Inform Assoc 2012; 19 (e1): e60&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392860</ArticleId><ArticleId IdType="pubmed">21873473</ArticleId></ArticleIdList></Reference><Reference><Citation>TriNetX. https://www.trinetx.com/ Accessed April 30, 2019.</Citation></Reference><Reference><Citation>Dyb&#xe5; T, Dings&#xf8;yr T.. Empirical studies of agile software development: a systematic review. Inform Softw Technol 2008; 50 (9&#x2013;10): 833&#x2013;59.</Citation></Reference><Reference><Citation>Carine F, Parrent N.. Improving patient identification data on the patient master index. Health Inf Manage 1999; 29 (1): 14&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10977163</ArticleId></ArticleIdList></Reference><Reference><Citation>Pautasso C. RESTful web services: principles, patterns, emerging technologies In: Web Services Foundations. New York, NY: Springer; 2014: 31&#x2013;51.</Citation></Reference><Reference><Citation>Office for Civil Rights (OCR). Methods for de-identification of PHI. https://www.hhs.gov/hipaa/for-professionals/privacy/special-topics/de-identification/index.html Accessed April 29, 2019.</Citation></Reference><Reference><Citation>OMOP Common Data Model&#x2013;OHDSI. https://www.ohdsi.org/data-standardization/the-common-data-model/ Accessed April 6, 2019.</Citation></Reference><Reference><Citation>Epic. https://www.epic.com/ Accessed April 6, 2019.</Citation></Reference><Reference><Citation>Johnson AEW, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data 2016; 3 (1): 160035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878278</ArticleId><ArticleId IdType="pubmed">27219127</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004; 32 (Database issue): D267&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN.. Data interchange using i2b2. J Am Med Inform Assoc 2016; 23 (5): 909..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>
Klensin J, Saint-Andre P. Uniform Resource Names (URNs). https://tools.ietf.org/html/rfc8141 Accessed April 6, 2019.</Citation></Reference><Reference><Citation>Bender D, Sartipi K. HL7 FHIR: an agile and RESTful approach to healthcare information exchange; In: Proceedings of the 26th IEEE International Symposium on Computer-Based Medical Systems; 2013: 326&#x2013;31.</Citation></Reference><Reference><Citation>Morcos M, Lood C, Hughes G.. Demographic, clinical and immunologic correlates among a cohort of 50 cocaine users demonstrating anti-neutrophil cytoplasmic antibodies. J Rheumatol 2019; 46 (9): 1151&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">31092720</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomason J, Lood C, Hughes G.. The interferon gamma release assay is a novel predictor of disease activity in systemic Lupus erythematosus. Arthritis Rheumatol 2017; 69 (suppl 10).</Citation></Reference><Reference><Citation>Bartek MA, Kessler GL, Talbott JM, Nguyen J, Shalhub S.. Washington State abdominal aortic aneurysm mortality shows a steady decline between 1996 and 2016. J Vasc Surg 2019. Mar 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6728234</ArticleId><ArticleId IdType="pubmed">30850292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang C, Bartek MA, Shalhub S, et al. PC040. disease-based observational cohort study of patients with thoracoabdominal aortic aneurysm. J Vasc Surg 2018; 67 (6): e183&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7064148</ArticleId><ArticleId IdType="pubmed">31147133</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AP, Freeman RV, Bartek MA, Shalhub S.. Left ventricular hypertrophy is a possible biomarker for early mortality after type B aortic dissection. J Vasc Surg 2019; 69 (6): 1710&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548621</ArticleId><ArticleId IdType="pubmed">30552040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartek MA, Aldea G, Nguyen J, et al. IP003. Aortic dissection-related mortality in Washington State remains unchanged from 1996 to 2016. J Vasc Surg 2018; 67 (6): e89&#x2013;90.</Citation></Reference><Reference><Citation>Kang C, Bartek MA, Shalhub S, et al. Disease-based observation cohort study of patients with thoracoabdominal aortic aneurysm. J Vasc Surg 2018; 68 (3): e35&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7064148</ArticleId><ArticleId IdType="pubmed">31147133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartek MA, Talbot J, Nguyen J, et al. Trends in Washington state aortic-related deaths over a 21-year period, 1996-2016. J Vasc Surg 2017; 66 (3): e54.</Citation></Reference><Reference><Citation>Thornblade LW, Verdial FC, Bartek MA, et al. The safety of expectant management for adhesive small bowel obstruction: a systematic review. J Gastrointest Surg 2019; 23 (4): 846&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6988581</ArticleId><ArticleId IdType="pubmed">30788717</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang I, Liew J, Morcos B, Zuo S, Crawford C, Bays AM.. A pharmacist managed titration of urate-lowering therapy to streamline gout management. Arthritis Rheumatol 2019; 39 (9): 1637&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">31147732</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Veldtman G, Bouma B, et al. Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation. Are they safe? Open Heart2019; 6 (1): e000985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6560660</ArticleId><ArticleId IdType="pubmed">31245011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills B, Muller E, Feinstein B, et al. Differences in injury circumstances and outcomes between firearm injuries transported via EMS and private vehicle. In: proceedings from the Society for the Advancement of Violence and Injury Research Annual Meeting; April 1&#x2013;3, 2019; Cincinnati, OH.</Citation></Reference><Reference><Citation>Powelson L. Chronic pain after trauma. In: proceedings from the UW Medicine Anesthesiology and Pain Medicine Grand Rounds; June 27, 2018; Seattle, WA.</Citation></Reference><Reference><Citation>Amin TM, Schorn M, Krashin D, et al. Frequency of opioid use for migraines in the ED. In: proceedings from the World Congress on Pain; September 12&#x2013;16, 2018; Boston, MA.</Citation></Reference><Reference><Citation>INSIGHT Program Awarded Federal Research Education Grant. http://depts.washington.edu/hiprc/insight-program-awarded-federal-research-education-grant/ Accessed April 6, 2019.</Citation></Reference><Reference><Citation>HealthLink, UW Medicine. UW Medicine warns of danger to kids around a lawnmower. https://www.king5.com/article/news/health/uw-medicine-warns-of-danger-to-kids-around-a-lawnmower/281-576066862 Accessed April 6, 2019.</Citation></Reference><Reference><Citation>
Malcolm K, Hurst A. More bike sharing, fewer helmets. Are head injuries on the rise? https://kuow.org/stories/more-bike-sharing-fewer-helmets-are-head-injuries-on-the-rise/ Accessed April 6, 2019.</Citation></Reference><Reference><Citation>Sweeney L. K-anonymity: a model for protecting privacy. Int J Uncertain Fuzz Knowl Based Syst 2002; 10 (5): 557&#x2013;70.</Citation></Reference><Reference><Citation>El Elam K, Jonker E, Arbuckle L, Malin B.. A systematic review of re-identification attacks on health data. PLoS One 10 (4): e0126772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4400170</ArticleId><ArticleId IdType="pubmed">25880057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31596493</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence.</ArticleTitle><Pagination><StartPage>e1912869</StartPage><MedlinePgn>e1912869</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1912869</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.12869</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Although randomized clinical trials are considered to be the criterion standard for generating clinical evidence, the use of real-world evidence to evaluate the efficacy and safety of medical interventions is gaining interest. Whether observational data can be used to address the same clinical questions being answered by traditional clinical trials is still unclear.</AbstractText><AbstractText Label="OBJECTIVE">To identify the number of clinical trials published in high-impact journals in 2017 that could be feasibly replicated using observational data from insurance claims and/or electronic health records (EHRs).</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">In this cross-sectional analysis, PubMed was searched to identify all US-based clinical trials, regardless of randomization, published between January 1, 2017, and December 31, 2017, in the top 7 highest-impact general medical journals of 2017. Trials were excluded if they did not involve human participants, did not use end points that represented clinical outcomes among patients, were not characterized as clinical trials, and had no recruitment sites in the United States.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcomes were the number and percentage of trials for which the intervention, indication, trial inclusion and exclusion criteria, and primary end points could be ascertained from insurance claims and/or EHR data.</AbstractText><AbstractText Label="RESULTS">Of the 220 US-based trials analyzed, 33 (15.0%) could be replicated using observational data because their intervention, indication, inclusion and exclusion criteria, and primary end points could be routinely ascertained from insurance claims and/or EHR data. Of the 220 trials, 86 (39.1%) had an intervention that could be ascertained from insurance claims and/or EHR data. Among the 86 trials, 62 (72.1%) had an indication that could be ascertained. Forty-five (72.6%) of 62 trials had at least 80% of inclusion and exclusion criteria data that could be ascertained. Of these 45 studies, 33 (73.3%) had at least 1 primary end point that could be ascertained.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This study found that only 15% of the US-based clinical trials published in high-impact journals in 2017 could be feasibly replicated through analysis of administrative claims or EHR data. This finding suggests the potential for real-world evidence to complement clinical trials, both by examining the concordance between randomized experiments and observational studies and by comparing the generalizability of the trial population with the real-world population of interest.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Victoria L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhruva</LastName><ForeName>Sanket S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco School of Medicine, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Cardiology, San Francisco Veterans Affairs Health Care System, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilay D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Division of Health Care Policy &amp; Research, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Joseph S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Section of General Internal Medicine and the National Clinician Scholars Program, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T35 HL007649</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015706" MajorTopicYN="Y">Bibliometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007348" MajorTopicYN="N">Insurance, Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="Y">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Shah reported receiving grants from the US Food and Drug Administration (FDA), Agency for Healthcare Research and Quality (AHRQ), Center for Medicare and Medicaid Innovation (CMMI), National Heart, Lung and Blood Institute of the National Institutes of Health (NHLBI/NIH), National Science Foundation, and Patient Centered Outcomes Research Institute (PCORI) outside the submitted work and receiving research support through Mayo Clinic from the FDA to establish the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. Dr Ryan reported being an employee of Janssen Research and Development and a shareholder of Johnson &amp; Johnson. Dr Ross reported receiving grants from the FDA, the Centers for Medicare &amp; Medicaid Services, Medtronic Inc, Blue Cross Blue Shield Association, AHRQ, NHLBI/NIH, and Laura and John Arnold Foundation outside the submitted work and receiving research support through Yale University from Johnson &amp; Johnson. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31596493</ArticleId><ArticleId IdType="pmc">PMC6802419</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.12869</ArticleId><ArticleId IdType="pii">2752575</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, et al. . Real-world evidence&#x2014;what is it and what can it tell us? N Engl J Med. 2016;375(23):-. doi:10.1056/NEJMsb1609216</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb1609216</ArticleId><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine Forum on Drug Discovery, Development, and Translation Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary. Washington, DC:National Academies Press; 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">21210556</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhruva SS, Ross JS, Desai NR. Real-world evidence: promise and peril for medical product evaluation. P T. 2018;43(8):464-472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065494</ArticleId><ArticleId IdType="pubmed">30100687</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration  Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and Food and Drug Administration staff. https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm513027.pdf. Published August 2017. Accessed August 31, 2019.</Citation></Reference><Reference><Citation>National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Drug Discovery, Development, and Translation. Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings of a Workshop Washington, DC: National Academies Press; 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28211655</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv. 2008;1(3):211-217. doi:10.1016/j.jcin.2008.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2008.01.008</ArticleId><ArticleId IdType="pubmed">19463302</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578-582. doi:10.1136/amiajnl-2014-002747</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowie MR, Blomster JI, Curtis LH, et al. . Electronic health records to facilitate clinical research. Clin Res Cardiol. 2017;106(1):1-9. doi:10.1007/s00392-016-1025-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-016-1025-6</ArticleId><ArticleId IdType="pmc">PMC5226988</ArticleId><ArticleId IdType="pubmed">27557678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesselheim AS, Avorn J. New &#x201c;21st Century Cures&#x201d; legislation: speed and ease vs science. JAMA. 2017;317(6):581-582. doi:10.1001/jama.2016.20640</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.20640</ArticleId><ArticleId IdType="pubmed">28056124</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration  Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act. Accessed August 31, 2019.</Citation></Reference><Reference><Citation>Thomson Reuters. InCites Journal Citation Reports. https://jcr.clarivate.com. Accessed June 30, 2018.</Citation></Reference><Reference><Citation>Dhruva SS, Ross JS, Schulz WL, Krumholz HM. Fulfilling the promise of unique device identifiers. Ann Intern Med. 2018;169(3):183-185. doi:10.7326/M18-0526</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0526</ArticleId><ArticleId IdType="pubmed">29868760</ArticleId></ArticleIdList></Reference><Reference><Citation>US National Library of Medicine 
https://clinicaltrials.gov. Accessed October 8, 2018.</Citation></Reference><Reference><Citation>Resnic FS, Majithia A, Marinac-Dabic D, et al. . Registry-based prospective, active surveillance of medical-device safety. N Engl J Med. 2017;376(6):526-535. doi:10.1056/NEJMoa1516333</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1516333</ArticleId><ArticleId IdType="pmc">PMC6145132</ArticleId><ArticleId IdType="pubmed">28121489</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Thompson WK, Herr TM, et al. . Natural language processing for EHR-based pharmacovigilance: a structured review. Drug Saf. 2017;40(11):1075-1089. doi:10.1007/s40264-017-0558-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-017-0558-6</ArticleId><ArticleId IdType="pubmed">28643174</ArticleId></ArticleIdList></Reference><Reference><Citation>Moses H III, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174-189. doi:10.1001/jama.2014.15939</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.15939</ArticleId><ArticleId IdType="pubmed">25585329</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&amp;D costs. J Health Econ. 2016;47:20-33. doi:10.1016/j.jhealeco.2016.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhealeco.2016.01.012</ArticleId><ArticleId IdType="pubmed">26928437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pease AM, Krumholz HM, Downing NS, Aminawung JA, Shah ND, Ross JS. Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review. BMJ. 2017;357:j1680. doi:10.1136/bmj.j1680</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j1680</ArticleId><ArticleId IdType="pmc">PMC5421452</ArticleId><ArticleId IdType="pubmed">28468750</ArticleId></ArticleIdList></Reference><Reference><Citation>Downing NS, Shah ND, Aminawung JA, et al. . Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010. JAMA. 2017;317(18):1854-1863. doi:10.1001/jama.2017.5150</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.5150</ArticleId><ArticleId IdType="pmc">PMC5815036</ArticleId><ArticleId IdType="pubmed">28492899</ArticleId></ArticleIdList></Reference><Reference><Citation>Darrow JJ, Avorn J, Kesselheim AS. New FDA breakthrough-drug category&#x2013;implications for patients. N Engl J Med. 2014;370(13):1252-1258. doi:10.1056/NEJMhle1311493</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMhle1311493</ArticleId><ArticleId IdType="pubmed">24670173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mess&#xe9; SR, Kent DM. Still no closure on the question of PFO closure. N Engl J Med. 2013;368(12):1152-1153. doi:10.1056/NEJMe1301680</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe1301680</ArticleId><ArticleId IdType="pmc">PMC4420155</ArticleId><ArticleId IdType="pubmed">23514293</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb S. FDA budget matters: a cross-cutting data enterprise for real world evidence. FDA Voices.https://www.fda.gov/NewsEvents/Newsroom/FDAVoices/ucm614669.htm. Published June 10, 2018. Accessed November 11, 2018.</Citation></Reference><Reference><Citation>US Food and Drug Administration  Framework for FDA&#x2019;s real-world evidence program. https://www.fda.gov/media/120060/download. Published December 2018. Accessed August 31, 2019.</Citation></Reference><Reference><Citation>Guimar&#xe3;es PO, Krishnamoorthy A, Kaltenbach LA, et al. . Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary analysis of the TRANSLATE-ACS study. JAMA Cardiol. 2017;2(7):750-757. doi:10.1001/jamacardio.2017.1460</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2017.1460</ArticleId><ArticleId IdType="pmc">PMC5710613</ArticleId><ArticleId IdType="pubmed">28538984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148(1):99-104. doi:10.1016/j.ahj.2004.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2004.02.013</ArticleId><ArticleId IdType="pubmed">15215798</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">31633087</PMID><DateRevised><Year>2024</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>ROMOP: a light-weight R package for interfacing with OMOP-formatted electronic health record data.</ArticleTitle><Pagination><StartPage>10</StartPage><EndPage>14</EndPage><MedlinePgn>10-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooy059</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Electronic health record (EHR) data are increasingly used for biomedical discoveries. The nature of the data, however, requires expertise in both data science and EHR structure. The Observational Medical Out-comes Partnership (OMOP) common data model (CDM) standardizes the language and structure of EHR data to promote interoperability of EHR data for research. While the OMOP CDM is valuable and more attuned to research purposes, it still requires extensive domain knowledge to utilize effectively, potentially limiting more widespread adoption of EHR data for research and quality improvement.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We have created ROMOP: an R package for direct interfacing with EHR data in the OMOP CDM format.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ROMOP streamlines typical EHR-related data processes. Its functions include exploration of data types, extraction and summarization of patient clinical and demographic data, and patient searches using any CDM vocabulary concept.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ROMOP is freely available under the Massachusetts Institute of Technology (MIT) license and can be obtained from GitHub (http://github.com/BenGlicksberg/ROMOP). We detail instructions for setup and use in the Supplementary Materials. Additionally, we provide a public sandbox server containing synthesized clinical data for users to explore OMOP data and ROMOP (http://romop.ucsf.edu).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glicksberg</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oskotsky</LastName><ForeName>Boris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giangreco</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics, Systems Biology, and Medicine, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangaraj</LastName><ForeName>Phyllis M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics, Systems Biology, and Medicine, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudrapatna</LastName><ForeName>Vivek</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Debajyoti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frazier</LastName><ForeName>Remi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Academic Research Systems, Department of Enterprise Data Warehouse University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Academic Research Systems, Department of Enterprise Data Warehouse University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Academic Research Systems, Department of Enterprise Data Warehouse University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics, Systems Biology, and Medicine, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butte</LastName><ForeName>Atul J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 HL140946</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM131905</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest statement. None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31633087</ArticleId><ArticleId IdType="mid">NIHMS1052565</ArticleId><ArticleId IdType="pmc">PMC6800657</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooy059</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blumenthal D, Tavenner M.. The &#x201c;meaningful use&#x201d; regulation for electronic health records. N Engl J Med 2010; 3636: 501&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PB, Jensen LJ, Brunak S.. Mining electronic health records: towards better research applications and clinical care. Nat Rev Genet 2012; 136: 395&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004; 32: D267&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, DeFalco FJ, Schuemie M, et al. Multisite evaluation of a data quality tool for patient-level clinical data sets. EGEMS (Wash DC) 2016; 41: 1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaddox TR, Ryan PB, Schuemie MJ, Madigan D, Suchard MA.. Hierarchical models for multiple, rare outcomes using massive observational healthcare databases. Stat Anal Data Min 2016; 94: 260&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423675</ArticleId><ArticleId IdType="pubmed">28503249</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, et al. Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia 2017; 588: e101&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN.. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform 2016; 64: 333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, Oren E, Chen K, et al. Scalable and accurate deep learning with electronic health records. NPJ Digit Med 2018; 11: 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Shah N.. Learning effective treatment pathways for type-2 diabetes from a clinical data warehouse. AMIA Annu Symp Proc 2016; 2016: 2036&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333256</ArticleId><ArticleId IdType="pubmed">28269963</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wickham H, Danenberg P, Eugster M.. 
roxygen2: in-source documentation for R
https://cran.r-project.org/package=roxygen2 (version 6.0.1)2013; 3(0).</Citation></Reference><Reference><Citation>
Dowle M, Srinivasan A, Gorecki J,
et al.
Package &#x2018;data.table&#x2019;
2018. 
https://cran.r-project.org/web/packages/data.table/data.table.pdf (version 1.11.8)</Citation></Reference><Reference><Citation>
James D.
DBI: R database interface (2009); 2012. 
https://cran.r-project.org/web/packages/DBI/index.html (version 1.0.0).</Citation></Reference><Reference><Citation>
Wickham H, Francois R, Henry L, M&#xfc;ller K.. 
dplyr: A Grammar of Data Manipulation. R package version 0.5.0. Vienna: R Core Development Team; 2016. 
https://cran.r-project.org/web/packages/dplyr/dplyr.pdf (version 0.7.8)</Citation></Reference><Reference><Citation>
Hester J, Wickham H. odbc: connect to ODBC compatible databases (using the DBI interface). CRAN; 2018. 
https://cran.r-project.org/web/packages/odbc/odbc.pdf (version 1.1.5)</Citation></Reference><Reference><Citation>
Ooms J, James D, DebRoy S, Wickham H, Horner J.. 
RMySQL: Database Interface and MySQL Driver for R.
https://cran.r-project.org/web/packages/RMySQL/index.html (version 0.10.15); 3.</Citation></Reference><Reference><Citation>
Scheumie M, Suchard M.. 
DatabaseConnector: Connecting to Various Database Platforms
https://cran.r-project.org/web/packages/DatabaseConnector/index.html (version 2.2.0). 2018.</Citation></Reference><Reference><Citation>
Scheumie M, Suchard M.. 
DatabaseConnectorJars: JAR Dependencies for the &#x2018;DatabaseConnector&#x2019; Package
https://cran.r-project.org/web/packages/DatabaseConnectorJars/index.html (version 1.0.0). 2018.</Citation></Reference><Reference><Citation>
Scheumie M, Suchard M.. 
SqlRender: Rendering Parameterized SQL and Translation to Dialects
https://cran.r-project.org/web/packages/SqlRender/index.html (version 1.5.2). 2018.</Citation></Reference><Reference><Citation>
Wickham H, Chang W.. 
devtools: Tools to Make Developing R Packages Easier
https://cran.r-project.org/web/packages/devtools/index.html (version 1.13.6). 2016.</Citation></Reference><Reference><Citation>
Chang W, Cheng J, Allaire JJ, Xie Y, McPherson J.. 
Shiny: Web Application Framework for R.
https://cran.r-project.org/web/packages/shiny/index.html (version 1.1.0); 1 (4): 106.</Citation></Reference><Reference><Citation>
Schloerke B, Allaire J, Borges B.. 
learnr: Interactive Tutorials for R.
https://cran.rstudio.com/web/packages/learnr/index.html (version 0.9.2.1)
2018.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31645076</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Incrementally Transforming Electronic Medical Records into the Observational Medical Outcomes Partnership Common Data Model: A Multidimensional Quality Assurance Approach.</ArticleTitle><Pagination><StartPage>794</StartPage><EndPage>803</EndPage><MedlinePgn>794-803</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0039-1697598</ELocationID><Abstract><AbstractText Label="BACKGROUND">The development and adoption of health care common data models (CDMs) has addressed some of the logistical challenges of performing research on data generated from disparate health care systems by standardizing data representations and leveraging standardized terminology to express clinical information consistently. However, transforming a data system into a CDM is not a trivial task, and maintaining an operational, enterprise capable CDM that is incrementally updated within a data warehouse is challenging.</AbstractText><AbstractText Label="OBJECTIVES">To develop a quality assurance (QA) process and code base to accompany our incremental transformation of the Department of Veterans Affairs Corporate Data Warehouse health care database into the Observational Medical Outcomes Partnership (OMOP) CDM to prevent incremental load errors.</AbstractText><AbstractText Label="METHODS">We designed and implemented a multistage QA) approach centered on completeness, value conformance, and relational conformance data-quality elements. For each element we describe key incremental load challenges, our extract, transform, and load (ETL) solution of data to overcome those challenges, and potential impacts of incremental load failure.</AbstractText><AbstractText Label="RESULTS">Completeness and value conformance data-quality elements are most affected by incremental changes to the CDW, while updates to source identifiers impact relational conformance. ETL failures surrounding these elements lead to incomplete and inaccurate capture of clinical concepts as well as data fragmentation across patients, providers, and locations.</AbstractText><AbstractText Label="CONCLUSION">Development of robust QA processes supporting accurate transformation of OMOP and other CDMs from source data is still in evolution, and opportunities exist to extend the existing QA framework and tools used for incremental ETL QA processes.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>VA Salt Lake City Health Care System, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deppen</LastName><ForeName>Stephen A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>VA Salt Lake City Health Care System, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viernes</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VA Salt Lake City Health Care System, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Aize</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanchrow</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewa</LastName><ForeName>Kushan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greaves</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011785" MajorTopicYN="Y">Quality Assurance, Health Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31645076</ArticleId><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="doi">10.1055/s-0039-1697598</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Voss E A, Makadia R, Matcho A et al.Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(03):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf6;rg T, DeBloch S.Towards generating ETL processes for incremental loadingIn: ACM International Conference Proceeding Series; September 10&#x2013;12, 2008; Coimbra, Portugal. pp. 101&#x2013;110</Citation></Reference><Reference><Citation>Post A R, Ai M, Kalsanka Pai A, Overcash M, Stephens D S. Architecting the data loading process for an i2b2 research data warehouse: full reload versus incremental updating. AMIA Annu Symp Proc. 2018;2017:1411&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977612</ArticleId><ArticleId IdType="pubmed">29854210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M G, Brown J S, Chun A T et al.Transparent reporting of data quality in distributed data networks. EGEMS (Wash DC) 2015;3(01):1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4434997</ArticleId><ArticleId IdType="pubmed">25992385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M G, Callahan T J, Barnard J et al.A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016;4(01):1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh W R, Cimino J, Payne P R et al.Recommendations for the use of operational electronic health record data in comparative effectiveness research. EGEMS (Wash DC) 2013;1(01):1018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371471</ArticleId><ArticleId IdType="pubmed">25848563</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls L G, Phillips T A, Hammill B G et al.Evaluating foundational data quality in the National Patient-Centered Clinical Research Network (PCORnet&#xae;) EGEMS (Wash DC) 2018;6(01):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983028</ArticleId><ArticleId IdType="pubmed">29881761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. Available at:https://www.ohdsi.org. Accessed August 30, 2019</Citation></Reference><Reference><Citation>Makadia R, Ryan P B. Transforming the premier perspective hospital database into the Observational Medical Outcomes Partnership (OMOP) common data model. EGEMS (Wash DC) 2014;2(01):1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37(11):945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalm M, Raoul T, Chu D et al.PRM59 - Conversion of a French electronic medical record (EMR) database into the Observational Medical Outcomes Partnership common data model. Value Health. 2017;20(09):A741.</Citation></Reference><Reference><Citation>Maier C, Lang L, Storf H et al.Towards implementation of OMOP in a German university hospital consortium. Appl Clin Inform. 2018;9(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann J G, Joss M AH, Embree K, Murphy S N. Data model harmonization for the All Of Us Research Program: transforming i2b2 data into the OMOP common data model. PLoS One. 2019;14(02):e0212463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn E K, Park M Y et al.Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22(01):54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>You S C, Lee S, Cho S Y et al.Conversion of national health insurance service-national sample cohort (NHIS-NSC) database into Observational Medical Outcomes Partnership-common data model (OMOP-CDM) Stud Health Technol Inform. 2017;245:467&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic F S, Robbins S L et al.Creating a common data model for comparative effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6(03):536&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Veterans Affairs. National center for veterans analysis and statistics [11/13/2017]. Available at:https://www.va.gov/vetdata/Utilization.asp. Accessed August 30, 2019</Citation></Reference><Reference><Citation>Fihn S D, Francis J, Clancy C et al.Insights from advanced analytics at the Veterans Health Administration. Health Aff (Millwood) 2014;33(07):1203&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006147</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Singh S. A description of classification of causes of data quality problems in data warehousing. International Journal of Computer Science Issues. 2010;7(03):41&#x2013;49.</Citation></Reference><Reference><Citation>Rupali G, Singh J. A review of contemporary data quality issues in data warehouse ETL environment. Journal on Today's Ideas &#x2013; Tomorrow's Technologies. 2014;2(02):153&#x2013;160.</Citation></Reference><Reference><Citation>Weiskopf N G, Bakken S, Hripcsak G, Weng C. A data quality assessment guideline for electronic health record data reuse. EGEMS (Wash DC) 2017;5(01):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983018</ArticleId><ArticleId IdType="pubmed">29881734</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31721815</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Correction:&#xa0;KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services.</ArticleTitle><Pagination><StartPage>e0225442</StartPage><MedlinePgn>e0225442</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0225442</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0225442</ELocationID><Abstract><AbstractText>[This corrects the article DOI: 10.1371/journal.pone.0223010.].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gruendner</LastName><ForeName>Julian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Schwachhofer</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sippl</LastName><ForeName>Phillip</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Erpenbeck</LastName><ForeName>Marcel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gulden</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kapsner</LastName><ForeName>Lorenz A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Zierk</LastName><ForeName>Jakob</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mate</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>St&#xfc;rzl</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Croner</LastName><ForeName>Roland</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials></Author><Author ValidYN="Y"><LastName>Toddenroth</LastName><ForeName>Dennis</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>PLoS One. 2019 Oct 3;14(10):e0223010. doi: 10.1371/journal.pone.0223010</RefSource><PMID Version="1">31581246</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31721815</ArticleId><ArticleId IdType="pmc">PMC6853310</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0225442</ArticleId><ArticleId IdType="pii">PONE-D-19-30965</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gruendner J, Schwachhofer T, Sippl P, Wolf N, Erpenbeck M, Gulden C, et al. (2019) KETOS: Clinical decision support and machine learning as a service&#x2013;A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services. PLoS ONE 14(10): e0223010 10.1371/journal.pone.0223010</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0223010</ArticleId><ArticleId IdType="pmc">PMC6776354</ArticleId><ArticleId IdType="pubmed">31581246</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31797639</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2335-6936</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing</Title><ISOAbbreviation>Pac Symp Biocomput</ISOAbbreviation></Journal><ArticleTitle>Robust-ODAL: Learning from heterogeneous health systems without sharing patient-level data.</ArticleTitle><Pagination><StartPage>695</StartPage><EndPage>706</EndPage><MedlinePgn>695-706</MedlinePgn></Pagination><Abstract><AbstractText>Electronic Health Records (EHR) contain extensive patient data on various health outcomes and risk predictors, providing an efficient and wide-reaching source for health research. Integrated EHR data can provide a larger sample size of the population to improve estimation and prediction accuracy. To overcome the obstacle of sharing patient-level data, distributed algorithms were developed to conduct statistical analyses across multiple clinical sites through sharing only aggregated information. However, the heterogeneity of data across sites is often ignored by existing distributed algorithms, which leads to substantial bias when studying the association between the outcomes and exposures. In this study, we propose a privacy-preserving and communication-efficient distributed algorithm which accounts for the heterogeneity caused by a small number of the clinical sites. We evaluated our algorithm through a systematic simulation study motivated by real-world scenarios and applied our algorithm to multiple claims datasets from the Observational Health Data Sciences and Informatics (OHDSI) network. The results showed that the proposed method performed better than the existing distributed algorithm ODAL and a meta-analysis method.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Jiayi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology &amp; Informatics, University of Pennsylvania, Philadelphia, PA,19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Rui</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ruowang</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Scheuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Jason H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yong</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI130460</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012607</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pac Symp Biocomput</MedlineTA><NlmUniqueID>9711271</NlmUniqueID><ISSNLinking>2335-6928</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="Y">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31797639</ArticleId><ArticleId IdType="mid">NIHMS1061510</ArticleId><ArticleId IdType="pmc">PMC6905508</ArticleId><ArticleId IdType="pii">9789811215636_0061</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Center for Devices and Radiological Health. Real-World Evidence to Support Regulatory Decision-Making for Devices. FDA Med Bull. www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devices</Citation></Reference><Reference><Citation>Center for Drug Evaluation and Research. Submitting Documents Using Real-World Data and Real-World Evidence. FDA Med Bull. www.fda.gov/regulatory-information/search-fda-guidance-documents/submitting-documents-using-real-world-data-and-real-world-evidence-fda-drugs-andbiologics-guidance</Citation></Reference><Reference><Citation>Center for Drug Evaluation and Research. Use of Electronic Health Record Data in Clinical Investigations. FDA Med Bull. www.fda.gov/regulatory-information/search-fda-guidance-documents/use-electronic-health-record-data-clinical-investigations-guidance-industry</Citation></Reference><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-World Evidence - What Is It and What Can It Tell Us? N Engl J Med. 2016;375: 2293&#x2013;2297.</Citation><ArticleIdList><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowens FM, Frye PA, Jones WA. Health information technology: integration of clinical workflow into meaningful use of electronic health records. Perspect Health Inf Manag. 2010;7: 1d.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2966355</ArticleId><ArticleId IdType="pubmed">21063545</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman CP, Wong AK, Blumenthal D. Achieving a nationwide learning health system. Sci Transl Med. 2010;2: 57cm29.</Citation><ArticleIdList><ArticleId IdType="pubmed">21068440</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19: 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis PA, Bailey LC, Marsolo K, Del Beccaro MA, Finkelstein JA, et al. PEDSnet: a National Pediatric Learning Health System. J Am Med Inform Assoc. 2014;21: 602&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Jiang X, Kim J, Ohno-Machado L. Grid Binary LOgistic REgression (GLORE): building shared models without sharing data. J Am Med Inform Assoc. 2012;19: 758&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422844</ArticleId><ArticleId IdType="pubmed">22511014</ArticleId></ArticleIdList></Reference><Reference><Citation>Seol Kwangsoo, et al. Privacy-preserving attribute-based access control model for XML-based electronic health record system. IEEE Access 6 (2018): 9114&#x2013;9128.</Citation></Reference><Reference><Citation>Kho Abel N., et al. Design and implementation of a privacy preserving electronic health record linkage tool in Chicago. Journal of the American Medical Informatics Association 225 (2015): 1072&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009931</ArticleId><ArticleId IdType="pubmed">26104741</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Lu-Chou, et al. Privacy preservation and information security protection for patients&#x2019; portable electronic health records. Computers in Biology and Medicine 399 (2009): 743&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pubmed">19589509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahi Muneeb Ahmed, et al. Privacy preservation in e-healthcare environments: State of the art and future directions. IEEE Access 6 (2017): 464&#x2013;478.</Citation></Reference><Reference><Citation>Dubovitskaya Alevtina, et al. A cloud-based ehealth architecture for privacy preserving data integration. IFIP International Information Security and Privacy Conference Springer, Cham, 2015.</Citation></Reference><Reference><Citation>G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113: 7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Shahn Z, Madigan D, Hripcsak G, Tatonetti NP. Birth month affects lifetime disease risk: a phenome-wide method. J Am Med Inform Assoc. 2015;22: 1042&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986668</ArticleId><ArticleId IdType="pubmed">26041386</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzan IL, Rudick RA. Time to integrate clinical and research informatics. Sci Transl Med. 2012;4: 162fs41.</Citation><ArticleIdList><ArticleId IdType="pubmed">23197569</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DR. Regression Models and Life-Tables In: Kotz S, Johnson NL, editors. Breakthroughs in Statistics: Methodology and Distribution. New York, NY: Springer New York; 1992. pp. 527&#x2013;541.</Citation></Reference><Reference><Citation>Ohno-Machado L, Agha Z, Bell DS, Dahm L, Day ME, Doctor JN, et al. pSCANNER: Patient-centered scalable national network for effectiveness research. J Am Med Inform Assoc. BMJ Publishing Group; 2014;21: 621&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078293</ArticleId><ArticleId IdType="pubmed">24780722</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan R, Boland MR, Moore JH, Chen Y. ODAL: A one-shot distributed algorithm to perform logistic regressions on electronic health records data from multiple clinical sites. Pac Symp Biocomput. 2019;24: 30&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417819</ArticleId><ArticleId IdType="pubmed">30864308</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang KY. Extended Mantel-Haenszel estimating procedure for multivariate logistic regression models. Biometrics. 1987;43: 289&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">3607201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H-DI. Effect of Ignoring Heterogeneity in Hazards Regression In: Balakrishnan N, Nikulin MS, Mesbah M, Limnios N, editors. Parametric and Semiparametric Models with Applications to Reliability, Survival Analysis, and Quality of Life. Boston, MA: Birkh&#xe4;user Boston; 2004. pp. 239&#x2013;250.</Citation></Reference><Reference><Citation>Forrest CB, Crandall WV, Bailey LC, et al. Effectiveness of anti-TNF&#x3b1; for Crohn disease: research in a pediatric learning health system. Pediatrics 2014; 134(1): 37&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4531278</ArticleId><ArticleId IdType="pubmed">24935993</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes O, Filippi J, H&#xe9;buterne X, Peyrin-Biroulet L. Treatment algorithms in Crohn&#x2019;s&#x2013;Up, down or something else? Best Practice &amp; Research Clinical Gastroenterology 2014; 28(3): 473&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">24913386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YS, Baek SH, Kim MJ, Lee YM, Lee Y, Choe YH. Efficacy of early infliximab treatment for pediatric Crohn&#x2019;s disease: a three-year follow-up. Pediatric Gastroenterology, Hepatology &amp; Nutrition 2012; 15(4): 243&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746055</ArticleId><ArticleId IdType="pubmed">24010094</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29: 932&#x2013;940.</Citation><ArticleIdList><ArticleId IdType="pubmed">18334475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115: 1067&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pubmed">17339564</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31837755</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-9837</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Topics in companion animal medicine</Title><ISOAbbreviation>Top Companion Anim Med</ISOAbbreviation></Journal><ArticleTitle>Optimization of Electronic Medical Records for Data Mining Using a Common Data Model.</ArticleTitle><Pagination><StartPage>100364</StartPage><MedlinePgn>100364</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tcam.2019.100364</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1938-9736(19)30101-1</ELocationID><Abstract><AbstractText>The increasing use of electronic health records (EHRs) in veterinary medicine creates an opportunity to utilize the high volume of electronic patient data for mining and data-driven analytics with the goal of improving patient care and outcomes. A central focus of the Clinical and Translational Science Award One Health Alliance (COHA) is to integrate efforts across multiple disciplines to better understand shared diseases in animals and people. The ability to combine veterinary and human medical data provides a unique resource to study the interactions and relationships between animals, humans, and the environment. However, to effectively answer these questions, veterinary EHR data must first be prepared in the same way it is now commonly being done in human medicine to enable data mining and development of analytics to facilitate knowledge formation and solutions that advance our understanding of disease processes, with the ultimate goal of improving outcomes for veterinary patients and their owners. As a first step, COHA member institutions implemented a Common Data Model to standardize EHR data. Herein we present the approach executed within the COHA framework to prepare and optimize veterinary EHRs for data mining and knowledge formation based on the adoption of the Observational Health Data Sciences and Informatics' Observational Medical Outcomes Partnership Common Data Model.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwong</LastName><ForeName>Manlik</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tufts Medical Center, Boston, MA, USA. Electronic address: Mkwong@tuftsmedicalcenter.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardner</LastName><ForeName>Heather L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieterle</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cummings School of Veterinary Medicine, Tufts University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rentko</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cummings School of Veterinary Medicine, Tufts University, Boston, MA, USA; Animal Bioscience Inc., Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Top Companion Anim Med</MedlineTA><NlmUniqueID>101465592</NlmUniqueID><ISSNLinking>1946-9837</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="N">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014730" MajorTopicYN="N">Veterinary Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COHA</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">infrastructure</Keyword><Keyword MajorTopicYN="N">research</Keyword><Keyword MajorTopicYN="N">veterinary</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31837755</ArticleId><ArticleId IdType="mid">NIHMS1554946</ArticleId><ArticleId IdType="pmc">PMC7874511</ArticleId><ArticleId IdType="doi">10.1016/j.tcam.2019.100364</ArticleId><ArticleId IdType="pii">S1938-9736(19)30101-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc 20:117&#x2013;121, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinger C, Mohomed Jabbar MS, Zaiane O, Osornio-Vargas A. A systematic review of data mining and machine learning for air pollution epidemiology. BMC Public Health 17:907,2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5704396</ArticleId><ArticleId IdType="pubmed">29179711</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyfroidt G, Guiza F, Ramon J, Bruynooghe M. Machine learning techniques to examine large patient databases. BestPract Res Clin Anaesthesiol 23:127&#x2013;143,2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19449621</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Guo SL, Han LN, Li TL. Application and exploration of big data mining in clinical medicine. Chin Med J 129:731&#x2013;738, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4804421</ArticleId><ArticleId IdType="pubmed">26960378</ArticleId></ArticleIdList></Reference><Reference><Citation>Yala A, Lehman C, Schuster T, Portnoi T, Barzilay R. A deep learning mammography-based model for improved breast cancer risk prediction. Radiology :182716,2019</Citation><ArticleIdList><ArticleId IdType="pubmed">31063083</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty C, Camina S, White K, Orenstein G. The Path to Predictive Analytics and Machine Learning. 1 ed Sebastopol CA: O&#x2019;Reilly Media, Inc.; 2016</Citation></Reference><Reference><Citation>Law GC, Apfelbacher C, Posadzki PP, Kemp S, Tudor Car L. Choice of outcomes and measurement instruments in randomised trials on eLearning in medical education: a systematic mapping review protocol. SystRev 7:75,2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5960094</ArticleId><ArticleId IdType="pubmed">29776434</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonardi A, Clifford CJ, Hadar N. A Structured Approach Using the Systematic Review Data Repository (SRDR): building the evidence for oral health interventions in the population with intellectual and developmental disability. Eval Rev 41:111&#x2013;129,2017</Citation><ArticleIdList><ArticleId IdType="pubmed">27543432</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31866433</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Adapting electronic health records-derived phenotypes to claims data: Lessons learned in using limited clinical data for phenotyping.</ArticleTitle><Pagination><StartPage>103363</StartPage><MedlinePgn>103363</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103363</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30283-7</ELocationID><Abstract><AbstractText>Algorithms for identifying patients of interest from observational data must address missing and inaccurate data and are desired to achieve comparable performance on both administrative claims and electronic health records data. However, administrative claims data do not contain the necessary information to develop accurate algorithms for disorders that require laboratory results, and this omission can result in insensitive diagnostic code-based algorithms. In this paper, we tested our assertion that the performance of a diagnosis code-based algorithm for chronic kidney disorder (CKD) can be improved by adding other codes indirectly related to CKD (e.g., codes for dialysis, kidney transplant, suspicious kidney disorders). Following the best practices from Observational Health Data Sciences and Informatics (OHDSI), we adapted an electronic health record-based gold standard algorithm for CKD and then created algorithms that can be executed on administrative claims data and account for related data quality issues. We externally validated our algorithms on four electronic health record datasets in the OHDSI network. Compared to the algorithm that uses CKD diagnostic codes only, positive predictive value of the algorithms that use additional codes was slightly increased (47.4% vs. 47.9-48.5% respectively). The algorithms adapted from the gold standard algorithm can be used to infer chronic kidney disorder based on administrative claims data. We succeeded in improving the generalizability and consistency of the CKD phenotypes by using data and vocabulary standardized across the OHDSI network, although performance variability across datasets remains. We showed that identifying and addressing coding and data heterogeneity can improve the performance of the algorithms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Columbia University Medical Center, New York, NY, USA; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, USA; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Raritan, NJ, USA; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Columbia University Medical Center, New York, NY, USA; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Columbia University Medical Center, New York, NY, USA; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA. Electronic address: hripicsak@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Columbia University Medical Center, New York, NY, USA; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA. Electronic address: chunhua@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic kidney disorder</Keyword><Keyword MajorTopicYN="N">Data quality</Keyword><Keyword MajorTopicYN="N">Observational Health Data Sciences and Informatics (OHDSI)</Keyword><Keyword MajorTopicYN="N">Phenotyping</Keyword><Keyword MajorTopicYN="N">Portability</Keyword><Keyword MajorTopicYN="N">Reproducibility</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31866433</ArticleId><ArticleId IdType="mid">NIHMS1548044</ArticleId><ArticleId IdType="pmc">PMC7390483</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103363</ArticleId><ArticleId IdType="pii">S1532-0464(19)30283-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y-C, Stang PE, Madigan D, Ryan PB, Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers, Stud Health Technol Inform 216 (2015) 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI Data Network, (n.d.).
http://www.ohdsi.org/web/wiki/doku.php?id=resources:2018_data_network (accessed
May 21, 2019).</Citation></Reference><Reference><Citation>Page not found &#x2013; KDIGO, (n.d.).
https://kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf (accessed
July 11, 2019).</Citation></Reference><Reference><Citation>Levey AS, de Jong PE, Coresh J, M.E. l. Nahas, B.C. Astor, K. Matsushita, R.T. Gansevoort, B.L. Kasiske, K.-U. Eckardt, The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report, Kidney International. 80 (2011) 17&#x2013;28. 10.1038/ki.2010.483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.483</ArticleId><ArticleId IdType="pubmed">21150873</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease&#x2013;Mineral and Bone Disorder (CKD-MBD), Kidney International Supplements. 7 (2017) 1&#x2013;59. 10.1016/j.kisu.2017.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kisu.2017.04.001</ArticleId><ArticleId IdType="pmc">PMC6341011</ArticleId><ArticleId IdType="pubmed">30681074</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman N, Halas G, Peeler W, Casaclang N, Williamson T, Katz A, From patient care to research: a validation study examining the factors contributing to data quality in a primary care electronic medical record database, BMC Family Practice 16 (2015). 10.1186/s12875-015-0223-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-015-0223-z</ArticleId><ArticleId IdType="pmc">PMC4324413</ArticleId><ArticleId IdType="pubmed">25649201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadhim-Saleh A, Green M, Williamson T, Hunter D, Birtwhistle R, Validation of the diagnostic algorithms for 5 chronic conditions in the Canadian Primary Care Sentinel Surveillance Network (CPCSSN): a Kingston Practice-based Research Network (PBRN) report, J Am Board Fam Med. 26 (2013) 159&#x2013;167. 10.3122/jabfm.2013.02.120183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2013.02.120183</ArticleId><ArticleId IdType="pubmed">23471929</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleet JL, Dixon SN, Shariff SZ, Quinn RR, Nash DM, Harel Z, Garg AX, Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes, BMC Nephrology 14 (2013). 10.1186/1471-2369-14-81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-14-81</ArticleId><ArticleId IdType="pmc">PMC3637099</ArticleId><ArticleId IdType="pubmed">23560464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronksley PE, Tonelli M, Quan H, Manns BJ, James MT, Clement FM, Samuel S, Quinn RR, Ravani P, Brar SS, Hemmelgarn BR, For the Alberta Kidney Disease Network, Validating a case definition for chronic kidney disease using administrative data, Nephrology Dialysis Transplantation. 27 (2012) 1826&#x2013;1831. 10.1093/ndt/gfr598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfr598</ArticleId><ArticleId IdType="pubmed">22015442</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente F, Levey AS, Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease, J. Am. Soc. Nephrol 16 (2005) 2439&#x2013;2448. 10.1681/ASN.2005020192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2005020192</ArticleId><ArticleId IdType="pubmed">15930090</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH, Identification of Individuals With CKD From Medicare Claims Data: A Validation Study, American Journal of Kidney Diseases. 46 (2005) 225&#x2013;232. 10.1053/j.ajkd.2005.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2005.04.029</ArticleId><ArticleId IdType="pubmed">16112040</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO_2012_CKD_GL.pdf, (n.d.).
https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf (accessed
May 21, 2019).</Citation></Reference><Reference><Citation>KDIGO_2012_CKD_GL.pdf, (n.d.).
https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf (accessed
July 11, 2019).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31910437</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network.</ArticleTitle><Pagination><StartPage>e0226718</StartPage><MedlinePgn>e0226718</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0226718</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0226718</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Hemorrhagic transformation (HT) after cerebral infarction is a complex and multifactorial phenomenon in the acute stage of ischemic stroke, and often results in a poor prognosis. Thus, identifying risk factors and making an early prediction of HT in acute cerebral infarction contributes not only to the selections of therapeutic regimen but also, more importantly, to the improvement of prognosis of acute cerebral infarction. The purpose of this study was to develop and validate a model to predict a patient's risk of HT within 30 days of initial ischemic stroke.</AbstractText><AbstractText Label="METHODS">We utilized a retrospective multicenter observational cohort study design to develop a Lasso Logistic Regression prediction model with a large, US Electronic Health Record dataset which structured to the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). To examine clinical transportability, the model was externally validated across 10 additional real-world healthcare datasets include EHR records for patients from America, Europe and Asia.</AbstractText><AbstractText Label="RESULTS">In the database the model was developed, the target population cohort contained 621,178 patients with ischemic stroke, of which 5,624 patients had HT within 30 days following initial ischemic stroke. 612 risk predictors, including the distance a patient travels in an ambulance to get to care for a HT, were identified. An area under the receiver operating characteristic curve (AUC) of 0.75 was achieved in the internal validation of the risk model. External validation was performed across 10 databases totaling 5,515,508 patients with ischemic stroke, of which 86,401 patients had HT within 30 days following initial ischemic stroke. The mean external AUC was 0.71 and ranged between 0.60-0.78.</AbstractText><AbstractText Label="CONCLUSIONS">A HT prognostic predict model was developed with Lasso Logistic Regression based on routinely collected EMR data. This model can identify patients who have a higher risk of HT than the population average with an AUC of 0.78. It shows the OMOP CDM is an appropriate data standard for EMR secondary use in clinical multicenter research for prognostic prediction model development and validation. In the future, combining this model with clinical information systems will assist clinicians to make the right therapy decision for patients with acute ischemic stroke.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-7225-5235</Identifier><AffiliationInfo><Affiliation>Biomedical Engineering School, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin Feeney</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Yuhui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, General Hospital of Southern Theatre Command, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Erica A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>RuiJun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan Stewart</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tufts Medical Center, Institute for Clinical Research and Health Policy Studies, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ross D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Zandt</LastName><ForeName>Mui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Chas</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vashisht</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfohl</LastName><ForeName>Stephen R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasthurirathne</LastName><ForeName>Suranga N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Biomedical Engineering School, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 LM012409</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002543" MajorTopicYN="N">Cerebral Hemorrhage</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Reps, Dr. Ryan, Ms. Voss and Dr. Rao are employees of Janssen Research and Development. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31910437</ArticleId><ArticleId IdType="pmc">PMC6946584</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0226718</ArticleId><ArticleId IdType="pii">PONE-D-19-25005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Paciaroni M, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, et al.
Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes. J Am Heart Assoc [Internet]. 2018. 
November
20 [cited 2019 Apr 30];7(22). Available from: https://www.ahajournals.org/doi/10.1161/JAHA.118.010133</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.010133</ArticleId><ArticleId IdType="pmc">PMC6404429</ArticleId><ArticleId IdType="pubmed">30571487</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al.
Hemorrhagic Transformation in Acute Ischemic Stroke. Stroke [Internet]. 1999. 
July [cited 2019 Apr 30];30(7):1326&#x2013;32. Available from: https://www.ahajournals.org/doi/10.1161/01.STR.30.7.1326
</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.30.7.1326</ArticleId><ArticleId IdType="pubmed">10390303</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Zhao R, Feng X, Shi Y, Wu Y, reports XS-S, et al. Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model. nature.com [Internet]. [cited 2019 Apr 30]; https://www.nature.com/articles/s41598-018-25820-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5943582</ArticleId><ArticleId IdType="pubmed">29743683</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Y, Jiang X, Yang Y, Xi G. Hemorrhagic Transformation Induced by Acute Hyperglycemia in a Rat Model of Transient Focal Ischemia. In 2011.  [cited 2019 Apr 30]. p. 49&#x2013;54. http://www.springerlink.com/index/10.1007/978-3-7091-0693-8_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-7091-0693-8_9</ArticleId><ArticleId IdType="pubmed">21725731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Hong K, Lee J, Kim Y, &#x2026; TS-C neurology and, 2018 undefined. Prediction of hemorrhagic transformation in patients with mild atrial fibrillation-associated stroke treated with early anticoagulation: post hoc analysis of the Triple AXEL. Elsevier [Internet]. [cited 2019 Apr 30]; https://www.sciencedirect.com/science/article/pii/S0303846718303457</Citation><ArticleIdList><ArticleId IdType="pubmed">30243187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang N, Lin M, Wang B, &#x2026; WZ-ERM, 2016 undefined. Low level of low-density lipoprotein cholesterol is related with increased hemorrhagic transformation after acute ischemic cerebral infarction. europeanreview.org [Internet]. [cited 2019 May 1]; https://www.europeanreview.org/wp/wp-content/uploads/673-678.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">26957269</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardi K, Leys D, Eusebi P, &#x2026; CC-C, 2011 undefined. Influence of lipid profiles on the risk of hemorrhagic transformation after ischemic stroke: systematic review. karger.com [Internet]. [cited 2019 Apr 30]; https://www.karger.com/Article/Abstract/335014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3343754</ArticleId><ArticleId IdType="pubmed">22566990</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordenier A, Smedt A De, &#x2026; RB-AN, 2011 undefined. Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies. actaneurologica.be [Internet]. [cited 2019 Apr 30]; http://www.actaneurologica.be/pdfs/2011-4/02-Cordenier%20et%20al.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Montaner J, Bustamante A, S G-M, 2016.  undefined. Combination of thrombolysis and statins in acute stroke is safe: results of the STARS randomized trial (stroke treatment with acute reperfusion and simvastatin). Am Hear Assoc [Internet]. [cited 2019 Apr 30]; https://www.ahajournals.org/doi/abs/10.1161/strokeaha.116.014600</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.116.014600</ArticleId><ArticleId IdType="pubmed">27758944</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang O, Saver J, Liebeskind D, S S, 2007.  undefined. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. AAN Enterp [Internet]. [cited 2019 Apr 30]; https://n.neurology.org/content/68/10/737.short</Citation><ArticleIdList><ArticleId IdType="pubmed">17182976</ArticleId></ArticleIdList></Reference><Reference><Citation>Levent &#xd6;CEK, Derya G&#xdc;NER, &#x130;rem Fatma ULUDA&#x11e;, Bedile &#x130;rem T&#x130;FT&#x130;K&#xc7;&#x130;O&#x11e;LU and YZ. Risk Factors for Hemorrhagic transformation in patients with acute middle cerebral artery infarction. ncbi.nlm.nih.gov [Internet]. [cited 2019 Apr 30]; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353105/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353105</ArticleId><ArticleId IdType="pubmed">28360737</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Li C, Wan T, Gu X, Zhu W, Hao J, et al.
Risk factors for hemorrhagic transformation after intravenous thrombolysis in acute cerebral infarction: a retrospective single-center study. Elsevier;  [Internet]. [cited 2019 Apr 30]; https://www.sciencedirect.com/science/article/pii/S1878875017301146</Citation><ArticleIdList><ArticleId IdType="pubmed">28185970</ArticleId></ArticleIdList></Reference><Reference><Citation>Landolfi A, Selvetella G, Cugino D, &#x2026; G G journal of, 2016.  undefined. Hemorrhagic transformation of acute ischemic stroke is limited in hypertensive patients with cardiac hypertrophy. Elsevier;  [Internet]. [cited 2019 Apr 30]; https://www.sciencedirect.com/science/article/pii/S0167527316310671</Citation><ArticleIdList><ArticleId IdType="pubmed">27352208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160&#x2013;236. 10.1161/STR.0000000000000024</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000024</ArticleId><ArticleId IdType="pubmed">24788967</ArticleId></ArticleIdList></Reference><Reference><Citation>Paciaroni M, Agnelli G, Caso V, Tsivgoulis G, Furie KL, Tadi P, et al.
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema. Stroke [Internet]. 2017. 
March [cited 2019 Apr 30];48(3):726&#x2013;32. Available from: https://www.ahajournals.org/doi/10.1161/STROKEAHA.116.015770
</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.015770</ArticleId><ArticleId IdType="pubmed">28183856</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabay M. 21st century cures act. Hosp Pharm. 2017;52(4):264 10.1310/hpj5204-264</Citation><ArticleIdList><ArticleId IdType="doi">10.1310/hpj5204-264</ArticleId><ArticleId IdType="pmc">PMC5424829</ArticleId><ArticleId IdType="pubmed">28515504</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics,OMOP Common Data Model [Internet]. [cited 2019 Apr 17]. https://github.com/OHDSI/CommonDataModel/</Citation></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, Denton J, Nookala L, Meeker D, et al.
Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform [Internet]. 2015. 
December
19 [cited 2019 May 1];06(03):536&#x2013;47. Available from: http://www.thieme-connect.de/DOI/DOI?10.4338/ACI-2014-12-CR-0121</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>A H Jr, Bendixen B, Kappelle L, J B, 1993.  undefined. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Am Hear Assoc [Internet]. [cited 2019 May 1]; https://www.ahajournals.org/doi/pdf/10.1161/str.24.1.7678184</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/str.24.1.7678184</ArticleId><ArticleId IdType="pubmed">7678184</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M. WhiteRabbit [Internet]. github. [cited 2019 May 16]. https://github.com/OHDSI/WhiteRabbit</Citation></Reference><Reference><Citation>Clairblacketer. Definition and DDLs for the OMOP Common Data Model (CDM). 2019.</Citation></Reference><Reference><Citation>Reps J, Schuemie M, &#x2026; MS-J of the, 2018 undefined. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. academic.oup.com [Internet]. [cited 2019 May 1]; https://academic.oup.com/jamia/article-abstract/25/8/969/4989437</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Jie M, Collins G, Steyerberg E, &#x2026; V J of clinical, 2019 undefined. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. Elsevier;  [Internet]. [cited 2019 May 1]; https://www.sciencedirect.com/science/article/pii/S0895435618310813</Citation><ArticleIdList><ArticleId IdType="pubmed">30763612</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB RP. OHDSI Patient Level Prediction Package [Internet]. https://github.com/OHDSI/PatientLevelPrediction</Citation></Reference><Reference><Citation>Kassambara A. Machine Learning Essentials: Practical Guide in R [Internet]. 2018 [cited 2019 May 1]. https://books.google.com/books?hl=zh-CN&amp;lr=&amp;id=745QDwAAQBAJ&amp;oi=fnd&amp;pg=PP2&amp;dq=Machine+Learning+Essentials:+Practical+Guide+in+R&amp;ots=5DNtzSS2Pp&amp;sig=vTw7xrJZfcAhBK-B-4Y6I8Mc1yAl</Citation></Reference><Reference><Citation>Rathmann W, Bongaerts B, Carius H-J, Kruppert S, Kostev K. Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther. 2018;56(10):459&#x2013;66. 10.5414/CP203320&#x2029;</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CP203320&#x2029;</ArticleId><ArticleId IdType="pubmed">30168417</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Seto K, Kawakami K. Pharmacoepidemiology in Japan: medical databases and research achievements. J Pharm Heal care Sci. 2015;1(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4729130</ArticleId><ArticleId IdType="pubmed">26819727</ArticleId></ArticleIdList></Reference><Reference><Citation>Camm AJ, Fox KAA. Strengths and weaknesses of &#x2018;real-world&#x2019;studies involving non-vitamin K antagonist oral anticoagulants. Open Hear. 2018;5(1):e000788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5922572</ArticleId><ArticleId IdType="pubmed">29713485</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Kiefer RC, Sharma DK, Prud&#x2019;hommeaux E, Solbrig HR. A consensus-based approach for harmonizing the OHDSI common data model with HL7 FHIR. Stud Health Technol Inform. 2017;245:887</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939955</ArticleId><ArticleId IdType="pubmed">29295227</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31914471</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Transforming French Electronic Health Records into the Observational Medical Outcome Partnership's Common Data Model: A Feasibility Study.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>22</EndPage><MedlinePgn>13-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0039-3402754</ELocationID><Abstract><AbstractText Label="BACKGROUND">Common data models (CDMs) enable data to be standardized, and facilitate data exchange, sharing, and storage, particularly when the data have been collected via distinct, heterogeneous systems. Moreover, CDMs provide tools for data quality assessment, integration into models, visualization, and analysis. The observational medical outcome partnership (OMOP) provides a CDM for organizing and standardizing databases. Common data models not only facilitate data integration but also (and especially for the OMOP model) extends the range of available statistical analyses.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to evaluate the feasibility of implementing French national electronic health records in the OMOP CDM.</AbstractText><AbstractText Label="METHODS">The OMOP's specifications were used to audit the source data, specify the transformation into the OMOP CDM, implement an extract-transform-load process to feed data from the French health care system into the OMOP CDM, and evaluate the final database.</AbstractText><AbstractText Label="RESULTS">Seventeen vocabularies corresponding to the French context were added to the OMOP CDM's concepts. Three French terminologies were automatically mapped to standardized vocabularies. We loaded nine tables from the OMOP CDM's "standardized clinical data" section, and three tables from the "standardized health system data" section. Outpatient and inpatient data from 38,730 individuals were integrated. The median (interquartile range) number of outpatient and inpatient stays per patient was 160 (19-364).</AbstractText><AbstractText Label="CONCLUSION">Our results demonstrated that data from the French national health care system can be integrated into the OMOP CDM. One of the main challenges was the use of international OMOP concepts to annotate data recorded in a French context. The use of local terminologies was an obstacle to conceptual mapping; with the exception of an adaptation of the International Classification of Diseases 10th Revision, the French health care system does not use international terminologies. It would be interesting to extend our present findings to the 65 million people registered in the French health care system.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamer</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Depas</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doutreligne</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bureau Etat de Sant&#xe9; de la Population, Minist&#xe8;re des Affaires Sociales et de la Sant&#xe9;, Direction de la Recherche, des Etudes et des Statistiques - Observation de la Sant&#xe9; et de l'Assurance Maladie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrot</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Descartes, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Web INnovation Donn&#xe9;es-Direction des Syst&#xe8;mes d'Information, Assistance Publique - H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verloop</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service Etudes et Statistiques, ARS Hauts-de-France, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defebvre</LastName><ForeName>Marguerite-Marie</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Service Etudes et Statistiques, ARS Hauts-de-France, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ficheur</LastName><ForeName>Gr&#xe9;goire</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chazard</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beuscart</LastName><ForeName>Jean-Baptiste</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Appl Clin Inform. 2020 Jan;11(1):e1. doi: 10.1055/s-0040-1702166</RefSource><PMID Version="1">32162290</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D054869" MajorTopicYN="N">Clinical Audit</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010317" MajorTopicYN="Y">Partnership Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010343" MajorTopicYN="N">Patient Admission</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>G.F. reports grants from ARS Hauts-de-France, during the conduct of the study. E.C. reports grants from ARS Hauts-de-France, during the conduct of the study. A.L. reports grants from ARS Hauts-de-France, during the conduct of the study. M.M.D. reports grants from ARS Hauts-de-France, during the conduct of the study. J.B.B. reports grants from ARS Hauts-de-France, during the conduct of the study. M.D. reports personal fees from French Ministry of Health, (DREES), during the conduct of the study. N.D, reports grants from ARS Hauts-de-France, during the conduct of the study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31914471</ArticleId><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="doi">10.1055/s-0039-3402754</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sentinel Initiativetp. Available at:www.mini-sentinel.org/. Accessed April 4, 2019</Citation></Reference><Reference><Citation>National Patient-Centered Clinical Research Network. PCORnet. Available at:https://pcornet.org/pcornet-common-data-model/. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Chazard E, Merlin B, Ficheur G, Sarfati J-C, Beuscart R; PSIP Consortium.Detection of adverse drug events: proposal of a data model Stud Health Technol Inform 200914863&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">19745236</ArticleId></ArticleIdList></Reference><Reference><Citation>i2b2: Informatics for Integrating Biology &amp; the BedsideAvailable at:https://www.i2b2.org/. Accessed April 4, 2019</Citation></Reference><Reference><Citation>OHDSI&#x2014;Observational Health Data Sciences and Informatics. Available at:https://www.ohdsi.org/. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Weeks J, Pardee R. Learning to share health care data: a brief timeline of influential common data models and distributed health data networks in U.S. health care research. EGEMS Wash DC. 2019;7(01):4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6437693</ArticleId><ArticleId IdType="pubmed">30937326</ArticleId></ArticleIdList></Reference><Reference><Citation>Liyanage H, Liaw S-T, Jonnagaddala J, Hinton W, de Lusignan S. Common data models (CDMs) to enhance international big data analytics: a diabetes use case to compare three CDMs. Stud Health Technol Inform. 2018;255:60&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30306907</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus M N. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>CDISC.Study Data Tabulation Model (SDTM)Available at:https://www.cdisc.org/standards/foundational/sdtm. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Xu Y, Zhou X, Suehs B T et al.A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 2015;38(08):749&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H et al.Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan P B, Stang P E, Overhage J M et al.A comparison of the empirical performance of methods for a risk identification system. Drug Saf. 2013;36 01:S143&#x2013;S158.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166231</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M J, Gini R, Coloma P M et al.Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases. Drug Saf. 2013;36 01:S159&#x2013;S169.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166232</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H et al.Towards implementation of OMOP in a German university hospital consortium. Appl Clin Inform. 2018;9(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan P B. Transforming the premier perspective hospital database into the observational medical outcomes partnership (OMOP) common data model. EGEMS (Wash DC) 2014;2(01):1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>You S C, Lee S, Cho S-Y et al.Conversion of national health insurance service-national sample cohort (NHIS-NSC) database into observational medical outcomes partnership-common data model (OMOP-CDM) Stud Health Technol Inform. 2017;245:467&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn E K, Park M Y et al.Conversion and data quality assessment of electronic health record data at a korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22(01):54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Le dispositif Paerpa. Minist&#xe8;re des Solidarit&#xe9;s et de la Sant&#xe9;. Available at:https://solidarites-sante.gouv.fr/systeme-de-sante-et-medico-social/parcours-des-patients-et-des-usagers/le-parcours-sante-des-aines-paerpa/article/le-dispositif-paerpa. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merli&#xe8;re Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique. 2010;58(04):286&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">20598822</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc J-L, Sailler L. French health insurance databases: what interest for medical research? Rev Med Interne. 2015;36(06):411&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">25547954</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI/Common Data Model.Definition and DDLs for the OMOP Common Data Model (CDM)Available at:https://github.com/OHDSI/CommonDataModel. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics.ELT creation best practicesAvailable at:http://www.ohdsi.org/web/wiki/doku.php?id=documentation:etl_best_practices. Accessed April 4, 2019</Citation></Reference><Reference><Citation>OHDSI/Achilles.Automated Characterization of Health Information at Large-scale Longitudinal Evidence Systems (ACHILLES) - descriptive statistics about a OMOP CDM database; 2019Available at:https://github.com/OHDSI/Achilles. Accessed October 17, 2019</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics.WhiteRabbitAvailable at:http://www.ohdsi.org/web/wiki/doku.php?id=documentation:software:whiterabbit. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Open Source ETL&#x2014;Talend Open Studio for Data Integration.Talend real-time open source data integration softwareAvailable at:https://www.talend.com/products/data-integration/data-integration-open-studio/. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Postgre SQL.The world's most advanced open source databaseAvailable at:https://www.postgresql.org/. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Ubuntu.The leading operating system for PCs, IoT devices, servers and the cloudAvailable at:https://www.ubuntu.com/. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Athena. Available at:http://athena.ohdsi.org/search-terms/terms. Accessed April 4, 2019</Citation></Reference><Reference><Citation>Lima D M, Rodrigues-Jr J F, Traina A JM, Pires F A, Gutierrez M A. Transforming two decades of ePR data to OMOP CDM for clinical research. Stud Health Technol Inform. 2019;264:233&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">31437920</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic F S, Robbins S L et al.Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform. 2015;6(03):536&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang L, Miao S et al.Analysis of treatment pathways for three chronic diseases using OMOP CDM. J Med Syst. 2018;42(12):260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6244882</ArticleId><ArticleId IdType="pubmed">30421323</ArticleId></ArticleIdList></Reference><Reference><Citation>Viernes B, Lynch K E, South B, Coronado G, DuVall S L. Characterizing VA users with the OMOP common data model. Stud Health Technol Inform. 2019;264:1614&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pubmed">31438258</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H et al.An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013;36(02):119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>European Health Data Evidence Network Available at:https://www.ehden.eu/. Accessed October 9, 2019</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31923062</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-233X</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Obstetrics and gynecology</Title><ISOAbbreviation>Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.</ArticleTitle><Pagination><StartPage>319</StartPage><EndPage>327</EndPage><MedlinePgn>319-327</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/AOG.0000000000003656</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To evaluate the relative risk of cervical neoplasms among copper intrauterine device (Cu IUD) and levonorgestrel-releasing intrauterine system (LNG-IUS) users.</AbstractText><AbstractText Label="METHODS">We performed a retrospective cohort analysis of 10,674 patients who received IUDs at Columbia University Medical Center. Our data were transformed to a common data model and are part of the Observational Health Data Sciences and Informatics network. The cohort patients and outcomes were identified by a combination of procedure codes, condition codes, and medication exposures in billing and claims data. We adjusted for confounding with propensity score stratification and propensity score 1:1 matching.</AbstractText><AbstractText Label="RESULTS">Before propensity score adjustment, the Cu IUD cohort included 8,274 patients and the LNG-IUS cohort included 2,400 patients. The median age for both cohorts was 29 years at IUD placement. More than 95% of the LNG-IUS cohort used a device with 52 mg LNG. Before propensity score adjustment, we identified 114 cervical neoplasm outcomes. Seventy-seven (0.9%) cervical neoplasms were in the Cu IUD cohort and 37 (1.5%) were in the LNG-IUS cohort. The propensity score matching analysis identified 7,114 Cu IUD and 2,174 LNG-IUS users, with covariate balance achieved over 16,827 covariates. The diagnosis of high-grade cervical neoplasia was 0.7% in the Cu IUD cohort and 1.8% in the LNG-IUS cohort (2.4 [95% CI 1.5-4.0] cases/1,000 person-years and 5.2 [95% CI 3.7-7.1] cases/1,000 person-years, respectively). The relative risk of high-grade cervical neoplasms among Cu IUD users was 0.38 (95% CI 0.16-0.78, P&lt;.02) compared with LNG-IUS users. By inspection, the Kaplan-Meier curves for each cohort diverged over time.</AbstractText><AbstractText Label="CONCLUSION">Copper IUD users have a lower risk of high-grade cervical neoplasms compared with LNG-IUS users. The relative risk of cervical neoplasms of LNG-IUS users compared with the general population is unknown.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics and Obstetrics and Gynecology, Columbia University Medical Center, Observational Health Data Sciences and Informatics, and Medical Informatics Services, New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials></Author><Author ValidYN="Y"><LastName>Westhoff</LastName><ForeName>Carolyn L</ForeName><Initials>CL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obstet Gynecol</MedlineTA><NlmUniqueID>0401101</NlmUniqueID><ISSNLinking>0029-7844</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003271">Contraceptive Agents, Female</NameOfSubstance></Chemical><Chemical><RegistryNumber>5W7SIA7YZW</RegistryNumber><NameOfSubstance UI="D016912">Levonorgestrel</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Obstet Gynecol. 2020 Jun;135(6):1486-1487. doi: 10.1097/AOG.0000000000003911</RefSource><PMID Version="1">32443070</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Obstet Gynecol. 2020 Jun;135(6):1487. doi: 10.1097/AOG.0000000000003912</RefSource><PMID Version="1">32443071</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003271" MajorTopicYN="N">Contraceptive Agents, Female</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007435" MajorTopicYN="N">Intrauterine Devices, Copper</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007436" MajorTopicYN="N">Intrauterine Devices, Medicated</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016912" MajorTopicYN="N">Levonorgestrel</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009518" MajorTopicYN="N" Type="Geographic">New York</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31923062</ArticleId><ArticleId IdType="pmc">PMC7012337</ArticleId><ArticleId IdType="doi">10.1097/AOG.0000000000003656</ArticleId><ArticleId IdType="pii">00006250-202002000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cortessis VK, Barret M, Wade NQ, Enebish T, Perrigo JL, Tobin J, et al. Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis. Obstet Gynecol 2017;130:1226&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">29112647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lekovich JP, Amrane S, Pangasa M, Pereira N, Frey MK, Varrey A, et al. Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices. Obstet Gynecol 2015;125:1101&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25932838</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttinger A, Critchley HOD. Endometrial effects of intrauterine levonorgestrel. Contraception 2007;75:S93&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17531624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011;278:16&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">21087457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Batson D, Schilling LM. Data model considerations for clinical effectiveness researchers. Med Care 2012;50(Suppl):S60&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824370</ArticleId><ArticleId IdType="pubmed">22692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA 2016;113:7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational health data sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational health data sciences and Informatics (OHDSI) OMOP common data model V5.0. Available at: www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:single-page. Retrieved June 1, 2015.</Citation></Reference><Reference><Citation>Reich JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S, Mohan S, Husain SA, Natarajan K. Expanding transplant outcomes research opportunities through the use of a common data model. Am J Transplant 2018;18:1321&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6070138</ArticleId><ArticleId IdType="pubmed">29687963</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Scheumie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019; 394:1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med 2014;33:209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul 2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol 2018;47:2005&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration. Drug approval package: Mirena (levonorgestrel-releasing intrauterine system). Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-225_Mirena.cfm. Retrieved July 22, 2019.</Citation></Reference><Reference><Citation>Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">8137626</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011;103:368&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3046952</ArticleId><ArticleId IdType="pubmed">21282563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney ES, The intrauterine device and the intrauterine system. Best Pract Res Clin Obstet Gynaecol 2014;28:807&#x2013; 24.</Citation><ArticleIdList><ArticleId IdType="pubmed">24947600</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips SJ, Hofler LG, Modest AM, Harvey LFB, Wu LH, Hacker MR, et al. Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study. Am J Obstet Gynecol 2017;217:57.e1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5810132</ArticleId><ArticleId IdType="pubmed">28315664</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhling KH, Zite NB, Lotke P, Black K; INTRA Writing Group. Worldwide use of intrauterine contraception: a review. Contraception 2014;89:162&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">24369300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31926440</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8332</ISSN><JournalIssue CitedMedium="Internet"><Volume>141</Volume><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Lung cancer (Amsterdam, Netherlands)</Title><ISOAbbreviation>Lung Cancer</ISOAbbreviation></Journal><ArticleTitle>Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>8</EndPage><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lungcan.2019.12.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0169-5002(19)30791-3</ELocationID><Abstract><AbstractText Label="OBJECTIVES">stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) are a therapeutic option for Oligometastatic/Oligoprogressive (OM/OP) NSCLC. This retrospective multicentre analysis aims to analyse clinical outcomes and treatment related toxicity of patients treated to all sites of know disease with SRS and/or FSRT for OM/OP NSCLC in 8 Italian radiation oncology centres.</AbstractText><AbstractText Label="MATERIALS AND METHODS">From January 2016 to January 2017 198 OM/OP NSCLC patients (pts) were treated in 8 Centres. Inclusion criteria were as follows: 1-5 lesions at onset or after previous systemic treatment; Pts must have all metastatic lesions treated. Endpoints analysed were local progression free survival (LPFS); out-of-field recurrence free survival (OFPS); progression free survival (PFS); overall survival (OS). Time to New systemic Therapy free survival (TNT) and toxicity were also analysed.</AbstractText><AbstractText Label="RESULTS">At the time of radiotherapy, 119 pts (60 %) were treated for a single lesion, 49 (25 %) for 2 lesions, 30 (15 %) for 3-5 metastases. Total number of lesions treated was 333: 204 brain, 68 lung, 24 bone, 16 nodal, 12 adrenal, 8 liver and 1 soft tissue. 83/198 pts (41.8 %) had the primary tumour controlled at the time of the SRT. After a median follow-up of 18 months, median OS and PFS were 29.6 months and 10.6 months, respectively. One year LPFS and OPFS were 90 % and 47 %, respectively. Median TNT was 10 months. At univariate analysis factors associated with better OS were PS 0-1; controlled primary tumour, 1-2 lesions; extracranial metastasis. Multivariate analysis confirmed number of lesions &lt;3 and extracranial metastasis to be related with better survival (Relative Risk 0.4 and 0.41, respectively). Two cases of death possibly related to brain radionecrosis were observed.</AbstractText><AbstractText Label="CONCLUSION">OM/OP NSCLC pts treated with an ablative SRT to all metastatic sites have fair outcomes with acceptable toxicity. Better results might be achieved in case of low disease burden and extracranial possibly when primary tumour is controlled.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buglione</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University and Spedali Civili of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jereczek-Fossa</LastName><ForeName>Barbara Alicja</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology University of Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bon&#xf9;</LastName><ForeName>Marco Lorenzo</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University and Spedali Civili of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franceschini</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy and Radiosurgery, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fodor</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanetti</LastName><ForeName>Isa Bossi</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Cyberknife Unit, Centro Diagnostico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerardi</LastName><ForeName>Marianna Alessandra</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology IEO, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borghetti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University and Spedali Civili of Brescia, Brescia, Italy. Electronic address: paolobor82@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomasini</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University and Spedali Civili of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Muzio</LastName><ForeName>Nadia Gisella</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, San Raffaele Scientific Institute, Milan, Italy; Department of Radiotherapy, Universit&#xe0; Vita Salute S. Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oneta</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology University of Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scorsetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy and Radiosurgery, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franzese</LastName><ForeName>Ciro</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy and Radiosurgery, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romanelli</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology IEO, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catalano</LastName><ForeName>Giampiero</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, IRCCS MultiMedica, Sesto S. Giovanni, MI, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dell'Oca</LastName><ForeName>Italo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltramo</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cyberknife Unit, Centro Diagnostico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivaldi</LastName><ForeName>Giovanni Battista</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology ICS Maugeri, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laudati</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, ASST Lariana, Como, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magrini</LastName><ForeName>Stefano Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University and Spedali Civili of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antognoni</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, Ospedale di Circolo e Fondazione Macchi, ASST dei Sette Laghi, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Italian Society of Radiotherapy and Clinical Oncology &#x2013; Regional Group Lombardy (AIROL)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Lung Cancer</MedlineTA><NlmUniqueID>8800805</NlmUniqueID><ISSNLinking>0169-5002</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077192" MajorTopicYN="N">Adenocarcinoma of Lung</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019583" MajorTopicYN="Y">Dose Fractionation, Radiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016634" MajorTopicYN="N">Radiosurgery</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablative treatments</Keyword><Keyword MajorTopicYN="N">Non small cell lung cancer (NSCLC)</Keyword><Keyword MajorTopicYN="N">Oligometastasis</Keyword><Keyword MajorTopicYN="N">Stereotactic radiosurgery (SRS)</Keyword><Keyword MajorTopicYN="N">Stereotactic radiotherapy (SRT)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31926440</ArticleId><ArticleId IdType="doi">10.1016/j.lungcan.2019.12.019</ArticleId><ArticleId IdType="pii">S0169-5002(19)30791-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31937652</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>13</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Application of a Common Data Model (CDM) to rank the paediatric user and prescription prevalence of 15 different drug classes in South Korea, Hong Kong, Taiwan, Japan and Australia: an observational, descriptive study.</ArticleTitle><Pagination><StartPage>e032426</StartPage><MedlinePgn>e032426</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e032426</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2019-032426</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To measure the paediatric user and prescription prevalence in inpatient and ambulatory settings in South Korea, Hong Kong, Taiwan, Japan and Australia by age and gender. A further objective was to list the most commonly used drugs per drug class, per country.</AbstractText><AbstractText Label="DESIGN AND SETTING">Hospital inpatient and insurance paediatric healthcare data from the following databases were used to conduct this descriptive drug utilisation study: (i) the South Korean Ajou University School of Medicine database; (ii) the Hong Kong Clinical Data Analysis and Reporting System; (iii) the Japan Medical Data Center; (iv) Taiwan's National Health Insurance Research Database and (v) the Australian Pharmaceutical Benefits Scheme. Country-specific data were transformed into the Observational Medical Outcomes Partnership Common Data Model.</AbstractText><AbstractText Label="PATIENTS">Children (&#x2264;18 years) with at least 1 day of observation in any of the respective databases from January 2009 until December 2013 were included.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">For each drug class, we assessed the per-protocol overall user and prescription prevalence rates (per 1000 persons) per country and setting.</AbstractText><AbstractText Label="RESULTS">Our study population comprised 1 574 524 children (52.9% male). The highest proportion of dispensings was recorded in the youngest age category (&lt;2 years) for inpatients (45.1%) with a relatively high user prevalence of analgesics and antibiotics. Adrenergics, antihistamines, mucolytics and corticosteroids were used in 10%-15% of patients. For ambulatory patients, the highest proportion of dispensings was recorded in the middle age category (2-11 years, 67.1%) with antibiotics the most dispensed drug overall.</AbstractText><AbstractText Label="CONCLUSIONS">Country-specific paediatric drug utilisation patterns were described, ranked and compared between four East Asian countries and Australia. The widespread use of mucolytics in East Asia warrants further investigation.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brauer</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8934-347X</Identifier><AffiliationInfo><Affiliation>Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ian Chi Kei</ForeName><Initials>ICK</Initials><AffiliationInfo><Affiliation>Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK i.wong@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth Kc</ForeName><Initials>KK</Initials><Identifier Source="ORCID">0000-0001-8645-1942</Identifier><AffiliationInfo><Affiliation>Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Soo-Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yu-Chuan Jack</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taiwan Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The International Center for Health Information Technology (ICHIT), Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, Wan Fang Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Medical Informatics Association (IMIA), Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Usman</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>The International Center for Health Information Technology (ICHIT), Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masters &amp; PhD Program in Global Health Department, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health and Community Medicine, Shaikh Khalifa Bin Zayed Al-Nahyan Medical College, Shaikh Zayed Medical Complex, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Phung-Anh Alex</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>The International Center for Health Information Technology (ICHIT), Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="Y">Drug Utilization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006723" MajorTopicYN="N" Type="Geographic">Hong Kong</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="N">Pharmaceutical Preparations</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055656" MajorTopicYN="N">Prescriptions</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical pharmacology</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">paediatrics</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31937652</ArticleId><ArticleId IdType="pmc">PMC7044847</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2019-032426</ArticleId><ArticleId IdType="pii">bmjopen-2019-032426</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong ICK, Murray ML. The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol 2005;59:750&#x2013;5. 10.1111/j.1365-2125.2005.02450.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2005.02450.x</ArticleId><ArticleId IdType="pmc">PMC1884862</ArticleId><ArticleId IdType="pubmed">15948943</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashed AN, Wong ICK, Wilton L, et al. . Drug utilisation patterns in children admitted to a paediatric general medical ward in five countries. Drugs Real World Outcomes 2015;2:397&#x2013;410. 10.1007/s40801-015-0049-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40801-015-0049-y</ArticleId><ArticleId IdType="pmc">PMC4674526</ArticleId><ArticleId IdType="pubmed">26690854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturkenboom MCJM, Verhamme KMC, Nicolosi A, et al. . Drug use in children: cohort study in three European countries. BMJ 2008;337:a2245 10.1136/bmj.a2245</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.a2245</ArticleId><ArticleId IdType="pmc">PMC2593449</ArticleId><ArticleId IdType="pubmed">19029175</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua KL, Soh SE, Ma S, et al. . Pediatric asthma mortality and hospitalization trends across Asia Pacific: relationship with asthma drug utilization patterns. World Allergy Organ J 2009;2:77&#x2013;82. 10.1097/WOX.0b013e3181a7c288</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WOX.0b013e3181a7c288</ArticleId><ArticleId IdType="pmc">PMC3651014</ArticleId><ArticleId IdType="pubmed">23283014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon S-M, Park S, Rhie SJ, et al. . Prescribing patterns of polypharmacy in Korean pediatric patients. PLoS One 2019;14:e0222781 10.1371/journal.pone.0222781</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0222781</ArticleId><ArticleId IdType="pmc">PMC6773215</ArticleId><ArticleId IdType="pubmed">31574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C-L, Kao Yang Y-H, Liu C-C, et al. . A retrospective study on the usage of cough and cold medications in viral respiratory tract infections in Taiwanese children. Pharmacoepidemiol Drug Saf 2014;23:36&#x2013;42. 10.1002/pds.3460</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3460</ArticleId><ArticleId IdType="pubmed">23712880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai EC-C, Ryan P, Zhang Y, et al. . Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges. Clin Epidemiol 2018;10:875&#x2013;85. 10.2147/CLEP.S149961</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S149961</ArticleId><ArticleId IdType="pmc">PMC6067778</ArticleId><ArticleId IdType="pubmed">30100761</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen M, Bergman U, Choi N-K, et al. . The Asian pharmacoepidemiology network (aspen): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf 2013;22:700&#x2013;4. 10.1002/pds.3439</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3439</ArticleId><ArticleId IdType="pubmed">23653370</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan EW, Lau WCY, Leung WK, et al. . Prevention of Dabigatran-Related gastrointestinal bleeding with gastroprotective agents: a population-based study. Gastroenterology 2015;149:586&#x2013;95. 10.1053/j.gastro.2015.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2015.05.002</ArticleId><ArticleId IdType="pubmed">25960019</ArticleId></ArticleIdList></Reference><Reference><Citation>Chui CSL, Man KKC, Cheng C-L, et al. . An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study. J Antimicrob Chemother 2014;69:2563&#x2013;7. 10.1093/jac/dku145</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dku145</ArticleId><ArticleId IdType="pubmed">24833754</ArticleId></ArticleIdList></Reference><Reference><Citation>Man KKC, Chan EW, Coghill D, et al. . Methylphenidate and the risk of trauma. Pediatrics 2015;135:40&#x2013;8. 10.1542/peds.2014-1738</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2014-1738</ArticleId><ArticleId IdType="pubmed">25511122</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Seto K, Kawakami K. Pharmacoepidemiology in Japan: medical databases and research achievements. J Pharm Health Care Sci 2015;1 10.1186/s40780-015-0016-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40780-015-0016-5</ArticleId><ArticleId IdType="pmc">PMC4729130</ArticleId><ArticleId IdType="pubmed">26819727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai EC-C, Man KKC, Chaiyakunapruk N, et al. . Brief report: databases in the Asia-Pacific region: the potential for a distributed network approach. Epidemiology 2015;26:815&#x2013;20. 10.1097/EDE.0000000000000325</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000325</ArticleId><ArticleId IdType="pubmed">26133022</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose K, St&#xf6;tter H. ICH E 11: clinical investigation of medicinal products in the paediatric population : Rose K, Guide to paediatric clinical research. Basel: KArger, 2007: 33&#x2013;7.</Citation></Reference><Reference><Citation>Woo Y, Kim HE, Chung S, et al. . Pediatric medication error reports in Korea adverse event reporting system database, 1989-2012: comparing with adult reports. J Korean Med Sci 2015;30:371&#x2013;7. 10.3346/jkms.2015.30.4.371</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2015.30.4.371</ArticleId><ArticleId IdType="pmc">PMC4366956</ArticleId><ArticleId IdType="pubmed">25829803</ArticleId></ArticleIdList></Reference><Reference><Citation>
Taiwan Food and Drugs Administration 
Taiwan food and drug administration annual report, 2016.  Available: http://www.fda.gov.tw/upload/ebook/AnnuaReport/2016 [Accessed October 2016].</Citation></Reference><Reference><Citation>Sato J. Global pediatric development: we are making progress. PMDA Perspective.: Japanese Pharmaceuticals and Medical Devices Agency (PMDA), 2014.</Citation></Reference><Reference><Citation>Mallet P, Mourdi N, Dubus J-C, et al. . Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. PLoS One 2011;6:e22792 10.1371/journal.pone.0022792</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022792</ArticleId><ArticleId IdType="pmc">PMC3144941</ArticleId><ArticleId IdType="pubmed">21818391</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Medicines Agency (EMA) 
Revised assessment report: ambroxol and bromhexine containing medicinal products. Available: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Ambroxol_and_bromhexine_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500184106.pdf [Accessed 10 Sep 2015].</Citation></Reference><Reference><Citation>Schmiedl S, Fischer R, Ib&#xe1;&#xf1;ez L, et al. . Utilisation and off-label prescriptions of respiratory drugs in children. PLoS One 2014;9:e105110 10.1371/journal.pone.0105110</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105110</ArticleId><ArticleId IdType="pmc">PMC4152124</ArticleId><ArticleId IdType="pubmed">25180704</ArticleId></ArticleIdList></Reference><Reference><Citation>Arakawa H, Hamasaki Y, Kohno Y, et al. . Japanese guidelines for childhood asthma 2017. Allergol Int 2017;66:190&#x2013;204. 10.1016/j.alit.2016.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2016.11.003</ArticleId><ArticleId IdType="pubmed">28108245</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Medicines Agency (EMA) 
Opinion of the paediatric Committee on the refusal of a paediatric investigation plan and on the granting of a product-specific waiver. Available: http://www.ema.europa.eu/docs/en_GB/document_library/PIP_decision/WC500095327.pdf [Accessed 27 Feb 2017].</Citation></Reference><Reference><Citation>
European Medicines Agency (EMA) 
Assessment report: codeine containing medicinal products for the treatment of cough and/or cold in paediatric patients. Available: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Codeine_cough_or_cold_in_children/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500186522.pdf [Accessed 12 Mar 2015].</Citation></Reference><Reference><Citation>Ciszkowski C, Madadi P, Phillips MS, et al. . Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med 2009;361:827&#x2013;8. 10.1056/NEJMc0904266</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc0904266</ArticleId><ArticleId IdType="pubmed">19692698</ArticleId></ArticleIdList></Reference><Reference><Citation>
British National Formulary (BNF) 
Clarithromycin. Available: https://www.evidence.nhs.uk/formulary/bnf/current/5-infections/51-antibacterial-drugs/515-macrolides/clarithromycin [Accessed 30 Mar 2017].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31939079</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets.</ArticleTitle><Pagination><StartPage>447</StartPage><EndPage>455</EndPage><MedlinePgn>447-455</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-020-00906-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION">In observational studies with mortality endpoints, one needs to consider how to account for subjects whose interventions appear to be part of 'end-of-life' care.</AbstractText><AbstractText Label="OBJECTIVE">The objective of this study was to develop a diagnostic predictive model to identify those in end-of-life care at the time of a drug exposure.</AbstractText><AbstractText Label="METHODS">We used data from four administrative claims datasets from 2000 to 2017. The index date was the date of the first prescription for the last new drug subjects received during their observation period. The outcome of end-of-life care was determined by the presence of one or more codes indicating terminal or hospice care. Models were developed using regularized logistic regression. Internal validation was through examination of the area under the receiver operating characteristic curve (AUC) and through model calibration in a 25% subset of the data held back from model training. External validation was through examination of the AUC after applying the model learned on one dataset to the three other datasets.</AbstractText><AbstractText Label="RESULTS">The models showed excellent performance characteristics. Internal validation resulted in AUCs ranging from 0.918 (95% confidence interval [CI] 0.905-0.930) to 0.983 (95% CI 0.978-0.987) for the four different datasets. Calibration results were also very good, with slopes near unity. External validation also produced very good to excellent performance metrics, with AUCs ranging from 0.840 (95% CI 0.834-0.846) to 0.956 (95% CI 0.952-0.960).</AbstractText><AbstractText Label="CONCLUSION">These results show that developing diagnostic predictive models for determining subjects in end-of-life care at the time of a drug treatment is possible and may improve the validity of the risk profile for those treatments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel N</ForeName><Initials>JN</Initials><Identifier Source="ORCID">0000-0001-9491-2737</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 920 Route 202, Raritan, NJ, 08869, USA. jswerdel@its.jnj.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY, 10032, USA. jswerdel@its.jnj.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA. jswerdel@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 920 Route 202, Raritan, NJ, 08869, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fife</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 920 Route 202, Raritan, NJ, 08869, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 920 Route 202, Raritan, NJ, 08869, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY, 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University, 622 West 168th Street, PH20, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013727" MajorTopicYN="Y">Terminal Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Joel Swerdel, Jenna M. Reps, Daniel Fife, and Patrick Ryan were full-time employees of Janssen Research &amp; Development LLC at the time the study was conducted. They own stock, stock options, and pension rights from the company.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31939079</ArticleId><ArticleId IdType="pmc">PMC7165142</ArticleId><ArticleId IdType="doi">10.1007/s40264-020-00906-7</ArticleId><ArticleId IdType="pii">10.1007/s40264-020-00906-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Smith A, Murphy L, Bennett K, Barron TI. Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life. Support Care Cancer. 2017;25(5):1629&#x2013;1637. doi: 10.1007/s00520-017-3576-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-017-3576-0</ArticleId><ArticleId IdType="pmc">PMC5378743</ArticleId><ArticleId IdType="pubmed">28101676</ArticleId></ArticleIdList></Reference><Reference><Citation>Arana A, Johannes CB, McQuay LJ, Varas-Lorenzo C, Fife D, Rothman KJ. Risk of out-of-hospital sudden cardiac death in users of domperidone, proton pump inhibitors, or metoclopramide: a population-based nested case-control study. Drug Saf. 2015;38(12):1187&#x2013;1199. doi: 10.1007/s40264-015-0338-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-015-0338-0</ArticleId><ArticleId IdType="pmc">PMC4659849</ArticleId><ArticleId IdType="pubmed">26350642</ArticleId></ArticleIdList></Reference><Reference><Citation>Varas-Lorenzo C, Arana A, Johannes CB, McQuay LJ, Rothman KJ, Fife D. Improving the identification of out-of-hospital sudden cardiac deaths in a general practice research database. Drugs Real World Outcomes. 2016;3(3):353&#x2013;358. doi: 10.1007/s40801-016-0086-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40801-016-0086-1</ArticleId><ArticleId IdType="pmc">PMC5042942</ArticleId><ArticleId IdType="pubmed">27747831</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulshof TA, Zuidema SU, Ostelo RW, Luijendijk HJ. The mortality risk of conventional antipsychotics in elderly patients: a systematic review and meta-analysis of randomized placebo-controlled trials. J Am Med Dir Assoc. 2015;16(10):817&#x2013;824. doi: 10.1016/j.jamda.2015.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2015.03.015</ArticleId><ArticleId IdType="pubmed">25933724</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Podchiyska T, Banda JM, Goel V, Leung TI, Minty EP, et al. Learning statistical models of phenotypes using noisy labeled training data. J Am Med Inform Assoc. 2016;23(6):1166&#x2013;1173. doi: 10.1093/jamia/ocw028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw028</ArticleId><ArticleId IdType="pmc">PMC5070523</ArticleId><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern Y, Horng S, Choi Y, Sontag D. Electronic medical record phenotyping using the anchor and learn framework. J Am Med Inform Assoc. 2016;23(4):731&#x2013;740. doi: 10.1093/jamia/ocw011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw011</ArticleId><ArticleId IdType="pmc">PMC4926745</ArticleId><ArticleId IdType="pubmed">27107443</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirer E, Miller AC, Kunter E, Kartaloglu Z, Barnett SD, Elamin EM. Predictive models for tuberculous pleural effusions in a high tuberculosis prevalence region. Lung. 2012;190(2):239&#x2013;248. doi: 10.1007/s00408-011-9342-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-011-9342-z</ArticleId><ArticleId IdType="pubmed">22057296</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas-Fernandez I, Garcia-Gomez FJ, Garcia-Solis D, Benitez-Rivero S, Marin-Oyaga VA, Jesus S, et al. Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson&#x2019;s disease using [(123)I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging. 2015;42(1):112&#x2013;119. doi: 10.1007/s00259-014-2882-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-014-2882-8</ArticleId><ArticleId IdType="pubmed">25120041</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams BA, Ladapo JA, Merhige ME. External validation of models for estimating pretest probability of coronary artery disease among individuals undergoing myocardial perfusion imaging. Int J Cardiol. 2015;182:534&#x2013;540. doi: 10.1016/j.ijcard.2015.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.01.015</ArticleId><ArticleId IdType="pubmed">25665971</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153(9):600&#x2013;606. doi: 10.7326/0003-4819-153-9-201011020-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>National Hospice and Palliative Care Organization. NHPCO&#x2019;s facts and figures hospice care in America. 2017. https://legacy.nhpco.org/sites/default/files/public/Statistics_Research/2017_Facts_Figures.pdf.</Citation></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008;14(1):15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810070</ArticleId><ArticleId IdType="pubmed">18197741</ArticleId></ArticleIdList></Reference><Reference><Citation>Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among patients with coronary heart disease: data from the Heart and Soul Study. Am Heart J. 2011;162(3):555&#x2013;561. doi: 10.1016/j.ahj.2011.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2011.05.023</ArticleId><ArticleId IdType="pmc">PMC3199107</ArticleId><ArticleId IdType="pubmed">21884876</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25(8):969&#x2013;975. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B (Methodol) 1996;58(1):267&#x2013;288.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23(1):1&#x2013;23. doi: 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ME, Langefeld CD, Tierney WM, Hui SL, McDonald CJ. Validation of probabilistic predictions. Med Decis Mak. 1993;13(1):49&#x2013;58. doi: 10.1177/0272989X9301300107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989X9301300107</ArticleId><ArticleId IdType="pubmed">8433637</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Definition of Palliative Care. 2017. http://www.who.int/cancer/palliative/definition/en/.</Citation></Reference><Reference><Citation>Hughes MT, Smith TJ. The growth of palliative care in the United States. Annu Rev Public Health. 2014;35:459&#x2013;475. doi: 10.1146/annurev-publhealth-032013-182406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-032013-182406</ArticleId><ArticleId IdType="pubmed">24641562</ArticleId></ArticleIdList></Reference><Reference><Citation>Guadagnolo BA, Liao KP, Elting L, Giordano S, Buchholz TA, Shih YC. Use of radiation therapy in the last 30&#xa0;days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol. 2013;31(1):80&#x2013;87. doi: 10.1200/JCO.2012.45.0585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2012.45.0585</ArticleId><ArticleId IdType="pmc">PMC3530693</ArticleId><ArticleId IdType="pubmed">23169520</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo J, Du XL, Lairson DR, Chan W, Jiang J, Buchholz TA, et al. Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma. Am J Clin Oncol. 2015;38(3):235&#x2013;241. doi: 10.1097/COC.0b013e31829378f9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COC.0b013e31829378f9</ArticleId><ArticleId IdType="pmc">PMC3796177</ArticleId><ArticleId IdType="pubmed">23648436</ArticleId></ArticleIdList></Reference><Reference><Citation>Miesfeldt S, Murray K, Lucas L, Chang CH, Goodman D, Morden NE. Association of age, gender, and race with intensity of end-of-life care for Medicare beneficiaries with cancer. J Palliat Med. 2012;15(5):548&#x2013;554. doi: 10.1089/jpm.2011.0310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2011.0310</ArticleId><ArticleId IdType="pmc">PMC3353746</ArticleId><ArticleId IdType="pubmed">22468739</ArticleId></ArticleIdList></Reference><Reference><Citation>Virnig BA, Kind S, McBean M, Fisher E. Geographic variation in hospice use prior to death. J Am Geriatr Soc. 2000;48(9):1117&#x2013;1125. doi: 10.1111/j.1532-5415.2000.tb04789.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2000.tb04789.x</ArticleId><ArticleId IdType="pubmed">10983913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lackan NA, Ostir GV, Freeman JL, Mahnken JD, Goodwin JS. Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer. Med Care. 2004;42(2):116&#x2013;122. doi: 10.1097/01.mlr.0000108765.86294.1b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000108765.86294.1b</ArticleId><ArticleId IdType="pubmed">14734948</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeyer Z, Powers BW, Makar M, Keating NL, Cutler DM. Physician characteristics strongly predict patient enrollment in hospice. Health Aff (Millwood). 2015;34(6):993&#x2013;1000. doi: 10.1377/hlthaff.2014.1055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2014.1055</ArticleId><ArticleId IdType="pmc">PMC4852702</ArticleId><ArticleId IdType="pubmed">26056205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindley LC, Edwards SL. Geographic variation in california pediatric hospice care for children and adolescents: 2007&#x2013;2010. Am J Hosp Palliat Care. 2018;35(1):15&#x2013;20. doi: 10.1177/1049909116678380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049909116678380</ArticleId><ArticleId IdType="pmc">PMC5344704</ArticleId><ArticleId IdType="pubmed">27837156</ArticleId></ArticleIdList></Reference><Reference><Citation>Adsersen M, Thygesen LC, Jensen AB, Neergaard MA, Sjogren P, Groenvold M. Is admittance to specialised palliative care among cancer patients related to sex, age and cancer diagnosis? A nation-wide study from the Danish Palliative Care Database (DPD) BMC Palliat Care. 2017;16(1):21. doi: 10.1186/s12904-017-0194-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12904-017-0194-z</ArticleId><ArticleId IdType="pmc">PMC5363002</ArticleId><ArticleId IdType="pubmed">28330507</ArticleId></ArticleIdList></Reference><Reference><Citation>Avati A, Jung K, Harman S, Downing L, Ng A, Shah NH. Improving palliative care with deep learning. BMC Med Inform Decis Mak. 2018;18(Suppl 4):122. doi: 10.1186/s12911-018-0677-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-018-0677-8</ArticleId><ArticleId IdType="pmc">PMC6290509</ArticleId><ArticleId IdType="pubmed">30537977</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K, Sudat SEK, Kwon N, Stewart WF, Shah NH. Predicting need for advanced illness or palliative care in a primary care population using electronic health record data. J Biomed Inform. 2019;92:103115. doi: 10.1016/j.jbi.2019.103115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103115</ArticleId><ArticleId IdType="pmc">PMC6512802</ArticleId><ArticleId IdType="pubmed">30753951</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31943641</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5448</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pediatric diabetes</Title><ISOAbbreviation>Pediatr Diabetes</ISOAbbreviation></Journal><ArticleTitle>Diabetic ketoacidosis at diagnosis among youth with type 1 and type 2 diabetes: Results from SEARCH (United States) and YDR (India) registries.</ArticleTitle><Pagination><StartPage>40</StartPage><EndPage>46</EndPage><MedlinePgn>40-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pedi.12979</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is significant global variation in the prevalence of diabetic ketoacidosis (DKA) at diagnosis among youth with type 1 diabetes (T1D). However, data for youth with type 2 diabetes (T2D) are limited, even in developed countries. We compared the prevalence of DKA at diagnosis among individuals with T1D and T2D from the SEARCH for Diabetes in Youth (SEARCH) and the Registry of Youth Onset Diabetes in India (YDR) registries.</AbstractText><AbstractText Label="METHODS">We harmonized the SEARCH and YDR registries to the structure and terminology in the Observational Medical Outcome Partnership Common Data Model. Data used were from youth with T1D and T2D diagnosed before 20&#x2009;years and newly diagnosed between 2006 and 2012 in YDR and 2009 and 2012 in SEARCH.</AbstractText><AbstractText Label="RESULTS">There were 5366 US youth (4078 with T1D, 1288 with T2D) and 2335 Indian youth (2108 with T1D, 227 with T2D). More than one third of T1D youth enrolled in SEARCH had DKA at diagnosis which was significantly higher than in YDR (35.3% vs 28.7%, P&#x2009;&lt;&#x2009;.0001). The burden of DKA in youth with T1D was significantly higher among younger age groups; this relationship was similar across registries (P = .4). The prevalence of DKA among T2D in SEARCH and YDR were 5.5% and 6.6% respectively (P = .4).</AbstractText><AbstractText Label="CONCLUSIONS">There is significant burden of DKA at diagnosis with T1D among youth from United States and India, especially among the younger age groups. The reasons for this high prevalence are largely unknown but are critical to developing interventions to prevent DKA at diagnosis.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Praveen</LastName><ForeName>Pradeep A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hockett</LastName><ForeName>Christine W</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0002-1665-6763</Identifier><AffiliationInfo><Affiliation>Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Toan C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amutha</LastName><ForeName>Anandakumar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isom</LastName><ForeName>Scott P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Elizabeth T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Viswanathan</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5038-6210</Identifier><AffiliationInfo><Affiliation>Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabelea</LastName><ForeName>Dana A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0001-9514-8929</Identifier><AffiliationInfo><Affiliation>Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agostino</LastName><ForeName>Ralph B</ForeName><Initials>RB</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamman</LastName><ForeName>Richard F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer-Davis</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-3858-0517</Identifier><AffiliationInfo><Affiliation>Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Jean M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolan</LastName><ForeName>Lawrence M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madhu</LastName><ForeName>Sri Venkata</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>University College of Medical Science, GTB Hospital, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4604-1986</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK057516</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006139</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000247</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000154</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U48/CCU819241-3</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000244</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006134</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002709</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP002708</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21DK105869-02</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006138</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U48/CCU519239</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002710</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR00423</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP006138</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK57516</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U48/CCU919219</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006138</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002714</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006134</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 Tr001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000248</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>00097</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP002714</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U48/CCU419249</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1U18DP002709</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U58/CCU019235-4</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP002710-01</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006136</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006131</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP-10-001</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 DK105869</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006139</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>200-2010-35171</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006133</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000077</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP-05-069</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK127208</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1U18DP006131</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000423</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006136</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP000247-06A1</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000250</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000246</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000254</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006133</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002708</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pediatr Diabetes</MedlineTA><NlmUniqueID>100939345</NlmUniqueID><ISSNLinking>1399-543X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016883" MajorTopicYN="N">Diabetic Ketoacidosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SEARCH for Diabetes in Youth registry</Keyword><Keyword MajorTopicYN="N">YDR registry</Keyword><Keyword MajorTopicYN="N">diabetic ketoacidosis</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList><CoiStatement><b>Disclosures:</b> None of the authors have any potential conflicts of interest relevant to the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31943641</ArticleId><ArticleId IdType="mid">NIHMS1648755</ArticleId><ArticleId IdType="pmc">PMC7748377</ArticleId><ArticleId IdType="doi">10.1111/pedi.12979</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha N. Overview of the diagnosis and management of diabetic ketoacidosis. Am J Med Sci. 2006;331(5):243&#x2013;251. http://www.ncbi.nlm.nih.gov/pubmed/16702793. Accessed
May 19, 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">16702793</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P. Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association. Diabetes Care. 2018;41(12):2648&#x2013;2668. doi:10.2337/dci18-0052</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci18-0052</ArticleId><ArticleId IdType="pmc">PMC7732108</ArticleId><ArticleId IdType="pubmed">30425094</ArticleId></ArticleIdList></Reference><Reference><Citation>Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001;85(1):16&#x2013;22. http://www.ncbi.nlm.nih.gov/pubmed/11420189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1718828</ArticleId><ArticleId IdType="pubmed">11420189</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001;344(4):264&#x2013;269. doi:10.1056/NEJM200101253440404</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200101253440404</ArticleId><ArticleId IdType="pubmed">11172153</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146(5):688&#x2013;692. doi:10.1016/j.jpeds.2004.12.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2004.12.041</ArticleId><ArticleId IdType="pubmed">15870676</ArticleId></ArticleIdList></Reference><Reference><Citation>Duca LM, Wang B, Rewers M, Rewers A. Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control. Diabetes Care. 2017;40(9):1249&#x2013;1255. doi:10.2337/dc17-0558</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-0558</ArticleId><ArticleId IdType="pubmed">28667128</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalitin S, Fisher S, Yackbovitch-Gavan M, et al. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control. Pediatr Diabetes. 2018;19(2):320&#x2013;328. doi:10.1111/pedi.12546</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12546</ArticleId><ArticleId IdType="pubmed">28568379</ArticleId></ArticleIdList></Reference><Reference><Citation>Duca LM, Reboussin BA, Pihoker C, et al. Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study. Pediatr Diabetes. 2019;20(2):172&#x2013;179. doi:10.1111/pedi.12809</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12809</ArticleId><ArticleId IdType="pmc">PMC6361710</ArticleId><ArticleId IdType="pubmed">30556249</ArticleId></ArticleIdList></Reference><Reference><Citation>Usher-Smith JA, Thompson M, Ercole A, Walter FM. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia. 2012;55(11):2878&#x2013;2894. doi:10.1007/s00125-012-2690-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-012-2690-2</ArticleId><ArticleId IdType="pmc">PMC3464389</ArticleId><ArticleId IdType="pubmed">22933123</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabelea D, Rewers A, Stafford JM, et al. Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study. Pediatrics. 2014;133(4):e938&#x2013;e945. doi:10.1542/peds.2013-2795</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2013-2795</ArticleId><ArticleId IdType="pmc">PMC4074618</ArticleId><ArticleId IdType="pubmed">24685959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamman RF, Bell RA, Dabelea D, et al. The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care. 2014;37(12):3336&#x2013;3344. doi:10.2337/dc14-0574</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-0574</ArticleId><ArticleId IdType="pmc">PMC4237981</ArticleId><ArticleId IdType="pubmed">25414389</ArticleId></ArticleIdList></Reference><Reference><Citation>Praveen PA, Madhu SV, Mohan V, et al. Registry of Youth Onset Diabetes in India (YDR): Rationale, Recruitment, and Current Status. J Diabetes Sci Technol. May 2016. doi:10.1177/1932296816645121</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296816645121</ArticleId><ArticleId IdType="pmc">PMC5032954</ArticleId><ArticleId IdType="pubmed">27179010</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui TP, Werther GA, Cameron FJ. Trends in diabetic ketoacidosis in childhood and adolescence: a 15-yr experience. Pediatr Diabetes. 2002;3(2):82&#x2013;88. doi:10.1034/j.1399-5448.2002.30204.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-5448.2002.30204.x</ArticleId><ArticleId IdType="pubmed">15016161</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekkala A, Knip M, Veijola R. Ketoacidosis at Diagnosis of Type 1 Diabetes in Children in Northern Finland: Temporal changes over 20 years. Diabetes Care. 2007;30(4):861&#x2013;866. doi:10.2337/dc06-2281</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc06-2281</ArticleId><ArticleId IdType="pubmed">17392547</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;vy-Marchal C, Patterson CC, Green A, EURODIAB ACE Study Group. Europe and Diabetes. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes. Diabetologia. 2001;44
Suppl 3:B75&#x2013;80. http://www.ncbi.nlm.nih.gov/pubmed/11724421.</Citation><ArticleIdList><ArticleId IdType="pubmed">11724421</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele J, Pollack T, Oakes DJ, et al. Validation of data from electronic data warehouse in diabetic ketoacidosis: Caution is needed. J Diabetes Complications. 2018;32(7):650&#x2013;654. doi:10.1016/j.jdiacomp.2018.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2018.05.004</ArticleId><ArticleId IdType="pubmed">29903409</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadarajan P Risk factors for mortality in children with diabetic keto acidosis from developing countries. World J Diabetes. 2014;5(6):932. doi:10.4239/wjd.v5.i6.932</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v5.i6.932</ArticleId><ArticleId IdType="pmc">PMC4265883</ArticleId><ArticleId IdType="pubmed">25512799</ArticleId></ArticleIdList></Reference><Reference><Citation>The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci. 2008;1150(1):1&#x2013;13. doi:10.1196/annals.1447.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1447.062</ArticleId><ArticleId IdType="pmc">PMC2886800</ArticleId><ArticleId IdType="pubmed">19120261</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Rasoul M, Al-Mahdi M, Al-Qattan H, et al. Ketoacidosis at presentation of type 1 diabetes in children in Kuwait: frequency and clinical characteristics. Pediatr Diabetes. 2010;11(5):351&#x2013;356. doi:10.1111/j.1399-5448.2009.00600.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5448.2009.00600.x</ArticleId><ArticleId IdType="pubmed">19821943</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferies C, Cutfield SW, Derraik JGB, et al. 15-year incidence of diabetic ketoacidosis at onset of type 1 diabetes in children from a regional setting (Auckland, New Zealand). Sci Rep. 2015;5(1):10358. doi:10.1038/srep10358</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep10358</ArticleId><ArticleId IdType="pmc">PMC4650806</ArticleId><ArticleId IdType="pubmed">25989414</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31951272</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>03</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Assessment of a Machine Learning Model Applied to Harmonized Electronic Health Record Data for the Prediction of Incident Atrial Fibrillation.</ArticleTitle><Pagination><StartPage>e1919396</StartPage><MedlinePgn>e1919396</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1919396</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.19396</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and its early detection could lead to significant improvements in outcomes through the appropriate prescription of anticoagulation medication. Although a variety of methods exist for screening for AF, a targeted approach, which requires an efficient method for identifying patients at risk, would be preferred.</AbstractText><AbstractText Label="OBJECTIVE">To examine machine learning approaches applied to electronic health record data that have been harmonized to the Observational Medical Outcomes Partnership Common Data Model for identifying risk of AF.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This diagnostic study used data from 2&#x202f;252&#x202f;219 individuals cared for in the UCHealth hospital system, which comprises 3 large hospitals in Colorado, from January 1, 2011, to October 1, 2018. Initial analysis was performed in December 2018; follow-up analysis was performed in July 2019.</AbstractText><AbstractText Label="EXPOSURES">All Observational Medical Outcomes Partnership Common Data Model-harmonized electronic health record features, including diagnoses, procedures, medications, age, and sex.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Classification of incident AF in designated 6-month intervals, adjudicated retrospectively, based on area under the receiver operating characteristic curve and F1 statistic.</AbstractText><AbstractText Label="RESULTS">Of 2&#x202f;252&#x202f;219 individuals (1&#x202f;225&#x202f;533 [54.4%] women; mean [SD] age, 42.9 [22.3] years), 28&#x202f;036 (1.2%) developed incident AF during a designated 6-month interval. The machine learning model that used the 200 most common electronic health record features, including age and sex, and random oversampling with a single-layer, fully connected neural network provided the optimal prediction of 6-month incident AF, with an area under the receiver operating characteristic curve of 0.800 and an F1 score of 0.110. This model performed only slightly better than a more basic logistic regression model composed of known clinical risk factors for AF, which had an area under the receiver operating characteristic curve of 0.794 and an F1 score of 0.079.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Machine learning approaches to electronic health record data offer a promising method for improving risk prediction for incident AF, but more work is needed to show improvement beyond standard risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tiwari</LastName><ForeName>Premanand</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colborn</LastName><ForeName>Kathryn L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Colorado School of Public Health, Department of Biostatics and Informatics, University of Colorado Denver, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Derek E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Children's Hospital Colorado, Cancer Center Biostatistics Core, Department of Pediatrics, University of Colorado, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Fuyong</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Colorado School of Public Health, Department of Biostatics and Informatics, University of Colorado Denver, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Debashis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Colorado School of Public Health, Department of Biostatics and Informatics, University of Colorado Denver, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology and Cardiac Electrophysiology, University of Colorado School of Medicine, Aurora.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL127296</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31951272</ArticleId><ArticleId IdType="pmc">PMC6991266</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.19396</ArticleId><ArticleId IdType="pii">2758859</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart. 2001;86(3):-. doi:10.1136/heart.86.3.284</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heart.86.3.284</ArticleId><ArticleId IdType="pmc">PMC1729916</ArticleId><ArticleId IdType="pubmed">11514479</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin EJ, Blaha MJ, Chiuve SE, et al. ; American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics, 2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146-e603. doi:10.1161/CIR.0000000000000485</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000485</ArticleId><ArticleId IdType="pmc">PMC5408160</ArticleId><ArticleId IdType="pubmed">28122885</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin EJ, Wolf PA, D&#x2019;Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946-952. doi:10.1161/01.CIR.98.10.946</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.98.10.946</ArticleId><ArticleId IdType="pubmed">9737513</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin EJ, Levy D, Vaziri SM, D&#x2019;Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271(11):840-844. doi:10.1001/jama.1994.03510350050036</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1994.03510350050036</ArticleId><ArticleId IdType="pubmed">8114238</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer DE, Hughes RA, Gress DR, et al. ; Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators . The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323(22):1505-1511. doi:10.1056/NEJM199011293232201</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199011293232201</ArticleId><ArticleId IdType="pubmed">2233931</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke Prevention in Atrial Fibrillation Study: final results. Circulation. 1991;84(2):527-539. doi:10.1161/01.CIR.84.2.527</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.84.2.527</ArticleId><ArticleId IdType="pubmed">1860198</ArticleId></ArticleIdList></Reference><Reference><Citation>Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet. 1994;343(8899):687-691.</Citation><ArticleIdList><ArticleId IdType="pubmed">7907677</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet. 1989;1(8631):175-179. doi:10.1016/S0140-6736(89)91200-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(89)91200-2</ArticleId><ArticleId IdType="pubmed">2563096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezekowitz MD, Bridgers SL, James KE, et al. ; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators . Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992;327(20):1406-1412. doi:10.1056/NEJM199211123272002</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199211123272002</ArticleId><ArticleId IdType="pubmed">1406859</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991;18(2):349-355. doi:10.1016/0735-1097(91)90585-W</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(91)90585-W</ArticleId><ArticleId IdType="pubmed">1856403</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154(13):1449-1457. doi:10.1001/archinte.1994.00420130036007</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1994.00420130036007</ArticleId><ArticleId IdType="pubmed">8018000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857-867. doi:10.7326/0003-4819-146-12-200706190-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-146-12-200706190-00007</ArticleId><ArticleId IdType="pubmed">17577005</ArticleId></ArticleIdList></Reference><Reference><Citation>van Walraven C, Hart RG, Singer DE, et al. . Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA. 2002;288(19):2441-2448. doi:10.1001/jama.288.19.2441</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.288.19.2441</ArticleId><ArticleId IdType="pubmed">12435257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper NJ, Sutton AJ, Lu G, Khunti K. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med. 2006;166(12):1269-1275. doi:10.1001/archinte.166.12.1269</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.12.1269</ArticleId><ArticleId IdType="pubmed">16801509</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Ezekowitz MD, Yusuf S, et al. ; RE-LY Steering Committee and Investigators . Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139-1151. doi:10.1056/NEJMoa0905561</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0905561</ArticleId><ArticleId IdType="pubmed">19717844</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MR, Mahaffey KW, Garg J, et al. ; ROCKET AF Investigators . Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-891. doi:10.1056/NEJMoa1009638</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1009638</ArticleId><ArticleId IdType="pubmed">21830957</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Eikelboom J, Joyner C, et al. ; AVERROES Steering Committee and Investigators . Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364(9):806-817. doi:10.1056/NEJMoa1007432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1007432</ArticleId><ArticleId IdType="pubmed">21309657</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaakkola J, Mustonen P, Kiviniemi T, et al. . Stroke as the first manifestation of atrial fibrillation. PLoS One. 2016;11(12):e0168010. doi:10.1371/journal.pone.0168010</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168010</ArticleId><ArticleId IdType="pmc">PMC5148080</ArticleId><ArticleId IdType="pubmed">27936187</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry SJ, Krist AH, Owens DK, et al. ; US Preventive Services Task Force . Screening for atrial fibrillation with electrocardiography: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(5):478-484. doi:10.1001/jama.2018.10321</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.10321</ArticleId><ArticleId IdType="pubmed">30088016</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonas DE, Kahwati LC, Yun JDY, Middleton JC, Coker-Schwimmer M, Asher GN. Screening for atrial fibrillation with electrocardiography: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320(5):485-498. doi:10.1001/jama.2018.4190</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.4190</ArticleId><ArticleId IdType="pubmed">30088015</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman B, Camm J, Calkins H, et al. ; AF-Screen Collaborators . Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration. Circulation. 2017;135(19):1851-1867. doi:10.1161/CIRCULATIONAHA.116.026693</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.026693</ArticleId><ArticleId IdType="pubmed">28483832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocher R, Emanuel EJ, DeParle NA. The Affordable Care Act and the future of clinical medicine: the opportunities and challenges. Ann Intern Med. 2010;153(8):536-539. doi:10.7326/0003-4819-153-8-201010190-00274</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-8-201010190-00274</ArticleId><ArticleId IdType="pubmed">20733178</ArticleId></ArticleIdList></Reference><Reference><Citation>Dexheimer JW, Talbot TR, Sanders DL, Rosenbloom ST, Aronsky D. Prompting clinicians about preventive care measures: a systematic review of randomized controlled trials. J Am Med Inform Assoc. 2008;15(3):311-320. doi:10.1197/jamia.M2555</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2555</ArticleId><ArticleId IdType="pmc">PMC2410011</ArticleId><ArticleId IdType="pubmed">18308989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadoughi F, Erfannia L. Health information system in a cloud computing context. Stud Health Technol Inform. 2017;236:290-297.</Citation><ArticleIdList><ArticleId IdType="pubmed">28508809</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen RE, Rothrock NE, DeWitt EM, et al. . The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care. Med Care. 2015;53(2):153-159. doi:10.1097/MLR.0000000000000289</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000289</ArticleId><ArticleId IdType="pmc">PMC4801509</ArticleId><ArticleId IdType="pubmed">25588135</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey JA, Schwartz BS, Stewart WF, Adler NE. Using electronic health records for population health research: a review of methods and applications. Annu Rev Public Health. 2016;37:61-81. doi:10.1146/annurev-publhealth-032315-021353</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-032315-021353</ArticleId><ArticleId IdType="pmc">PMC6724703</ArticleId><ArticleId IdType="pubmed">26667605</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Lee J, Wang S, Sun J, Liu H, Jiang X. Privacy-preserving predictive modeling: harmonization of contextual embeddings from different sources. JMIR Med Inform. 2018;6(2):e33. doi:10.2196/medinform.9455</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/medinform.9455</ArticleId><ArticleId IdType="pmc">PMC5981054</ArticleId><ArticleId IdType="pubmed">29769172</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Kiefer RC, Sharma DK, Prud&#x2019;hommeaux E, Solbrig HR. A consensus-based approach for harmonizing the OHDSI Common Data Model with HL7 FHIR. Stud Health Technol Inform. 2017;245:887-891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939955</ArticleId><ArticleId IdType="pubmed">29295227</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Evans J, Oniki TA, et al. . Harmonization of detailed clinical models with clinical study data standards. Methods Inf Med. 2015;54(1):65-74. doi:10.3414/ME13-02-0019</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME13-02-0019</ArticleId><ArticleId IdType="pubmed">25426730</ArticleId></ArticleIdList></Reference><Reference><Citation>Oca&#xf1;a K, de Oliveira D. Parallel computing in genomic research: advances and applications. Adv Appl Bioinform Chem. 2015;8:23-35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655901</ArticleId><ArticleId IdType="pubmed">26604801</ArticleId></ArticleIdList></Reference><Reference><Citation>Korb O, Finn PW, Jones G. The cloud and other new computational methods to improve molecular modelling. Expert Opin Drug Discov. 2014;9(10):1121-1131. doi:10.1517/17460441.2014.941800</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17460441.2014.941800</ArticleId><ArticleId IdType="pubmed">25146114</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013;36(3):328-333. doi:10.1111/pace.12053</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.12053</ArticleId><ArticleId IdType="pmc">PMC3618372</ArticleId><ArticleId IdType="pubmed">23240827</ArticleId></ArticleIdList></Reference><Reference><Citation>Diederichsen SZ, Haugan KJ, K&#xf8;ber L, et al. . Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): rationale and design of a large randomized controlled trial. Am Heart J. 2017;187:122-132. doi:10.1016/j.ahj.2017.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2017.02.017</ArticleId><ArticleId IdType="pubmed">28454796</ArticleId></ArticleIdList></Reference><Reference><Citation>LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521(7553):436-444. doi:10.1038/nature14539</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14539</ArticleId><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallkamp J, Schlipsing M, Salmen J, Igel C. Man vs. computer: benchmarking machine learning algorithms for traffic sign recognition. Neural Netw. 2012;32:323-332.</Citation><ArticleIdList><ArticleId IdType="pubmed">22394690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooi T, Litjens G, van Ginneken B, et al. . Large scale deep learning for computer aided detection of mammographic lesions. Med Image Anal. 2017;35:303-312. doi:10.1016/j.media.2016.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.media.2016.07.007</ArticleId><ArticleId IdType="pubmed">27497072</ArticleId></ArticleIdList></Reference><Reference><Citation>Minarro-Gim&#xe9;nez JA, Mar&#xed;n-Alonso O, Samwald M. Exploring the application of deep learning techniques on medical text corpora. Stud Health Technol Inform. 2014;205:584-588.</Citation><ArticleIdList><ArticleId IdType="pubmed">25160253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Li X, Conesa A, Pereira C. GRAM-CNN: a deep learning approach with local context for named entity recognition in biomedical text. Bioinformatics. 2018;34(9):1547-1554. doi:10.1093/bioinformatics/btx815</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx815</ArticleId><ArticleId IdType="pmc">PMC5925775</ArticleId><ArticleId IdType="pubmed">29272325</ArticleId></ArticleIdList></Reference><Reference><Citation>Morav&#x10d;&#xed;k M, Schmid M, Burch N, et al. . DeepStack: expert-level artificial intelligence in heads-up no-limit poker. Science. 2017;356(6337):508-513. doi:10.1126/science.aam6960</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aam6960</ArticleId><ArticleId IdType="pubmed">28254783</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer J, Burch N, Bj&#xf6;rnsson Y, et al. . Checkers is solved. Science. 2007;317(5844):1518-1522. doi:10.1126/science.1144079</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1144079</ArticleId><ArticleId IdType="pubmed">17641166</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver D, Huang A, Maddison CJ, et al. . Mastering the game of Go with deep neural networks and tree search. Nature. 2016;529(7587):484-489. doi:10.1038/nature16961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16961</ArticleId><ArticleId IdType="pubmed">26819042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez J, Monasterio V, Minchol&#xe9; A, et al. . Automatic SVM classification of sudden cardiac death and pump failure death from autonomic and repolarization ECG markers. J Electrocardiol. 2015;48(4):551-557. doi:10.1016/j.jelectrocard.2015.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2015.04.002</ArticleId><ArticleId IdType="pubmed">25912974</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu-Jones BK, Greene CS; Pooled Resource Open-Access ALS Clinical Trials Consortium . Semi-supervised learning of the electronic health record for phenotype stratification. J Biomed Inform. 2016;64:168-178. doi:10.1016/j.jbi.2016.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.007</ArticleId><ArticleId IdType="pubmed">27744022</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Li Z, Guo H, et al. . Predicting congenital heart defects: a comparison of three data mining methods. PLoS One. 2017;12(5):e0177811. doi:10.1371/journal.pone.0177811</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177811</ArticleId><ArticleId IdType="pmc">PMC5443514</ArticleId><ArticleId IdType="pubmed">28542318</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini P, Ahmadinia H, Poorolajal J, Moqaddasi Amiri M. Evaluating the high risk groups for suicide: a comparison of logistic regression, support vector machine, decision tree and artificial neural network. Iran J Public Health. 2016;45(9):1179-1187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149472</ArticleId><ArticleId IdType="pubmed">27957463</ArticleId></ArticleIdList></Reference><Reference><Citation>Churpek MM, Yuen TC, Winslow C, Meltzer DO, Kattan MW, Edelson DP. Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Crit Care Med. 2016;44(2):368-374. doi:10.1097/CCM.0000000000001571</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001571</ArticleId><ArticleId IdType="pmc">PMC4736499</ArticleId><ArticleId IdType="pubmed">26771782</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KW, Torres Soto J, Glicksberg BS, et al. . Artificial intelligence in cardiology. J Am Coll Cardiol. 2018;71(23):2668-2679. doi:10.1016/j.jacc.2018.03.521</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.03.521</ArticleId><ArticleId IdType="pubmed">29880128</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594. doi:10.1136/bmj.g7594</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7594</ArticleId><ArticleId IdType="pubmed">25569120</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan PB. Transforming the Premier Perspective hospital database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Wash DC). 2014;2(1):1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321-357. doi:10.1613/jair.953</Citation><ArticleIdList><ArticleId IdType="doi">10.1613/jair.953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai KE, Anthony S, Coiera E, Magrabi F. Using statistical text classification to identify health information technology incidents. J Am Med Inform Assoc. 2013;20(5):980-985. doi:10.1136/amiajnl-2012-001409</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-001409</ArticleId><ArticleId IdType="pmc">PMC3756261</ArticleId><ArticleId IdType="pubmed">23666777</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis J, Goadrich M. The relationship between precision-recall and ROC curves. In: ICML &#x2019;06 Proceedings of the 23rd International Conference on Machine Learning. New York, NY: Association for Computing Machinery; 2006:233-240. doi:10.1145/1143844.1143874</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/1143844.1143874</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Rothschild AS. Agreement, the f-measure, and reliability in information retrieval. J Am Med Inform Assoc. 2005;12(3):296-298. doi:10.1197/jamia.M1733</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M1733</ArticleId><ArticleId IdType="pmc">PMC1090460</ArticleId><ArticleId IdType="pubmed">15684123</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261-5267. doi:10.1128/AEM.00062-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.00062-07</ArticleId><ArticleId IdType="pmc">PMC1950982</ArticleId><ArticleId IdType="pubmed">17586664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansoor H, Elgendy IY, Segal R, Bavry AA, Bian J. Risk prediction model for in-hospital mortality in women with ST-elevation myocardial infarction: A machine learning approach. Heart Lung. 2017;46(6):405-411.</Citation><ArticleIdList><ArticleId IdType="pubmed">28992993</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y, Adam BL, Yasui Y, et al. . Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem. 2002;48(10):1835-1843.</Citation><ArticleIdList><ArticleId IdType="pubmed">12324514</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny W, Frost D. Neural networks in clinical medicine. Med Decis Making. 1996;16(4):386-398. doi:10.1177/0272989X9601600409</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989X9601600409</ArticleId><ArticleId IdType="pubmed">8912300</ArticleId></ArticleIdList></Reference><Reference><Citation>Agresti A, Coull BA. 
Approximate is better than &#x201c;exact&#x201d; for interval estimation of binomial proportions. Am Stat. 1998;52(2):119-126. http://users.stat.ufl.edu/~aa/articles/agresti_coull_1998.pdf. Accessed December 2, 2019.</Citation></Reference><Reference><Citation>Lakhani P, Langlotz CP. Automated detection of radiology reports that document non-routine communication of critical or significant results. J Digit Imaging. 2010;23(6):647-657. doi:10.1007/s10278-009-9237-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10278-009-9237-1</ArticleId><ArticleId IdType="pmc">PMC2978900</ArticleId><ArticleId IdType="pubmed">19826871</ArticleId></ArticleIdList></Reference><Reference><Citation>Nattel S, Shiroshita-Takeshita A, Brundel BJ, Rivard L. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis. 2005;48(1):9-28. doi:10.1016/j.pcad.2005.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2005.06.002</ArticleId><ArticleId IdType="pubmed">16194689</ArticleId></ArticleIdList></Reference><Reference><Citation>Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63(22):2335-2345. doi:10.1016/j.jacc.2014.02.555</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.02.555</ArticleId><ArticleId IdType="pubmed">24613319</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg MA, Manning WJ. Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal. Circulation. 2012;126(19):2353-2362. doi:10.1161/CIRCULATIONAHA.112.113233</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.113233</ArticleId><ArticleId IdType="pubmed">23129702</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Krijthe BP, Aspelund T, et al. . Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2(2):e000102. doi:10.1161/JAHA.112.000102</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.112.000102</ArticleId><ArticleId IdType="pmc">PMC3647274</ArticleId><ArticleId IdType="pubmed">23537808</ArticleId></ArticleIdList></Reference><Reference><Citation>Li DC, Hu SC, Lin LS, Yeh CW. Detecting representative data and generating synthetic samples to improve learning accuracy with imbalanced data sets. PLoS One. 2017;12(8):e0181853. doi:10.1371/journal.pone.0181853</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0181853</ArticleId><ArticleId IdType="pmc">PMC5542532</ArticleId><ArticleId IdType="pubmed">28771522</ArticleId></ArticleIdList></Reference><Reference><Citation>Colborn KL, Bronsert M, Amioka E, Hammermeister K, Henderson WG, Meguid R. Identification of surgical site infections using electronic health record data. Am J Infect Control. 2018;46(11):1230-1235. doi:10.1016/j.ajic.2018.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2018.05.011</ArticleId><ArticleId IdType="pubmed">29907448</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagus R, Lusa L. SMOTE for high-dimensional class-imbalanced data. BMC Bioinformatics. 2013;14:106. doi:10.1186/1471-2105-14-106</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-106</ArticleId><ArticleId IdType="pmc">PMC3648438</ArticleId><ArticleId IdType="pubmed">23522326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JG, Jun S, Cho YW, et al. . Deep learning in medical imaging: general overview. Korean J Radiol. 2017;18(4):570-584. doi:10.3348/kjr.2017.18.4.570</Citation><ArticleIdList><ArticleId IdType="doi">10.3348/kjr.2017.18.4.570</ArticleId><ArticleId IdType="pmc">PMC5447633</ArticleId><ArticleId IdType="pubmed">28670152</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwalla S, Sarma KK. Machine learning based sample extraction for automatic speech recognition using dialectal Assamese speech. Neural Netw. 2016;78:97-111.</Citation><ArticleIdList><ArticleId IdType="pubmed">26783204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Ghosh J, Bejan CA, et al. . Building bridges across electronic health record systems through inferred phenotypic topics. J Biomed Inform. 2015;55:82-93. doi:10.1016/j.jbi.2015.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.03.011</ArticleId><ArticleId IdType="pmc">PMC4464930</ArticleId><ArticleId IdType="pubmed">25841328</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham T, Tran T, Phung D, Venkatesh S. Predicting healthcare trajectories from medical records: a deep learning approach. J Biomed Inform. 2017;69:218-229. doi:10.1016/j.jbi.2017.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.04.001</ArticleId><ArticleId IdType="pubmed">28410981</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Pan Z, Tao Q. Robust and adaptive online time series prediction with long short-term memory. Comput Intell Neurosci. 2017;2017:9478952. doi:10.1155/2017/9478952</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/9478952</ArticleId><ArticleId IdType="pmc">PMC5748146</ArticleId><ArticleId IdType="pubmed">29391864</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z. Parametric regression model for survival data: Weibull regression model as an example. Ann Transl Med. 2016;4(24):484. doi:10.21037/atm.2016.08.45</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2016.08.45</ArticleId><ArticleId IdType="pmc">PMC5233524</ArticleId><ArticleId IdType="pubmed">28149846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg MA, Maziarz M, Tan AY, et al. . Circulating fibrosis biomarkers and risk of atrial fibrillation: the Cardiovascular Health Study (CHS). Am Heart J. 2014;167(5):723-8.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4060155</ArticleId><ArticleId IdType="pubmed">24766983</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton KK, Ellinor PT, Heckbert SR, et al. . N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation. 2009;120(18):1768-1774. doi:10.1161/CIRCULATIONAHA.109.873265</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.873265</ArticleId><ArticleId IdType="pmc">PMC4132053</ArticleId><ArticleId IdType="pubmed">19841297</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ. Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J. 2012;33(7):904-912. doi:10.1093/eurheartj/ehr378</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr378</ArticleId><ArticleId IdType="pmc">PMC3345546</ArticleId><ArticleId IdType="pubmed">21990265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31953884</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5448</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pediatric diabetes</Title><ISOAbbreviation>Pediatr Diabetes</ISOAbbreviation></Journal><ArticleTitle>Clinical profile at diagnosis with youth-onset type 1 and type 2 diabetes in two pediatric diabetes registries: SEARCH (United States) and YDR (India).</ArticleTitle><Pagination><StartPage>22</StartPage><EndPage>30</EndPage><MedlinePgn>22-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pedi.12981</ELocationID><Abstract><AbstractText Label="BACKGROUND">Over the last decades, diabetes in youth has increased in both India and the United States, along with the burden of long-term complications and healthcare costs. However, there are limited standardized population-based data in contemporary youth cohorts for comparison of clinical and demographic characteristics of diabetes for both type 1 (T1D) and type 2 (T2D).</AbstractText><AbstractText Label="METHODS">In partnership, we harmonized demographic and clinical data from the SEARCH for Diabetes in Youth (SEARCH) registry in the United States and the Registry of People with Diabetes with Youth Age at Onset (YDR) in India to the structure and terminology of the Observational Medical Outcomes Partnership Common Data Model. Data were from youth with T1D and T2D, aged &lt;20&#x2009;years and newly diagnosed between 2006 and 2010. We compared key characteristics across registries using &#x3c7;<sup>2</sup> tests and t-tests.</AbstractText><AbstractText Label="RESULTS">In total, there were 9650 youth with T1D and 2406 youth with T2D from 2006 to 2012. SEARCH youth were diagnosed at younger ages than YDR youth for T1D and T2D (10.0 vs 10.5&#x2009;years, P&#x2009;&lt;&#x2009;.001 and 14.7 vs 16.1&#x2009;years, P&#x2009;&lt;&#x2009;.001, respectively). For T2D, SEARCH had a higher proportion of females and significantly lower proportion of youth of high socioeconomic status compared to YDR. For T1D and T2D, SEARCH youth had higher BMI, lower blood pressure, and lower A1c compared to YDR youth.</AbstractText><AbstractText Label="CONCLUSIONS">These data offer insights into the demographic and clinical characteristics of diabetes in youth across the two countries. Further research is needed to better understand why these differences exist.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hockett</LastName><ForeName>Christine W</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0002-1665-6763</Identifier><AffiliationInfo><Affiliation>Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Praveen</LastName><ForeName>Pradeep A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Endocrinology &amp; Metabolism, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Toan C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amutha</LastName><ForeName>Anandakumar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isom</LastName><ForeName>Scott P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Elizabeth T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agostino</LastName><ForeName>Ralph B</ForeName><Initials>RB</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamman</LastName><ForeName>Richard F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer-Davis</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-3858-0517</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Medicine, University of North Carolina, Chapel Hill, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Jean M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pihoker</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9074-7770</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Viswanathan</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5038-6210</Identifier><AffiliationInfo><Affiliation>Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4604-1986</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology &amp; Metabolism, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabelea</LastName><ForeName>Dana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9514-8929</Identifier><AffiliationInfo><Affiliation>Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U18DP006139</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000247</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002710</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP006138</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006138</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000154</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002714</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000248</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000244</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006134</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002709</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006131</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000077</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000423</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK057516</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HIR 10-001</GrantID><Acronym>HX</Acronym><Agency>HSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 DK105869</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006136</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000250</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000246</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000254</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006133</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002708</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21DK105869-02</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pediatr Diabetes</MedlineTA><NlmUniqueID>100939345</NlmUniqueID><ISSNLinking>1399-543X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">India</Keyword><Keyword MajorTopicYN="N">United States</Keyword><Keyword MajorTopicYN="N">data harmonization</Keyword><Keyword MajorTopicYN="N">early onset type 2 diabetes</Keyword><Keyword MajorTopicYN="N">registry</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList><CoiStatement><b>Disclosures:</b> None of the authors have any potential conflicts of interest relevant to the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31953884</ArticleId><ArticleId IdType="mid">NIHMS1648761</ArticleId><ArticleId IdType="pmc">PMC7785282</ArticleId><ArticleId IdType="doi">10.1111/pedi.12981</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hamman RF, Bell RA, Dabelea D, et al. The SEARCH for Diabetes in Youth Study: Rationale, Findings, and Future Directions. Diabetes Care. 2014;37(12):3336&#x2013;3344. doi:10.2337/dc14-0574</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-0574</ArticleId><ArticleId IdType="pmc">PMC4237981</ArticleId><ArticleId IdType="pubmed">25414389</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson C, Guariguata L, Dahlquist G, Solt&#xe9;sz G, Ogle G, Silink M. Diabetes in the young &#x2013; a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract. 2014;103(2):161&#x2013;175. doi:10.1016/j.diabres.2013.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2013.11.005</ArticleId><ArticleId IdType="pubmed">24331235</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer-Davis EJ, Dabelea D, Lawrence JM. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002&#x2013;2012. N Engl J Med. 2017;377(3):301. doi:10.1056/NEJMc1706291</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1706291</ArticleId><ArticleId IdType="pmc">PMC5639715</ArticleId><ArticleId IdType="pubmed">28723318</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettitt DJ, Talton J, Dabelea D, et al. Prevalence of Diabetes in U.S. Youth in 2009: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2014;37(2):402&#x2013;408. doi:10.2337/dc13-1838</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-1838</ArticleId><ArticleId IdType="pmc">PMC3898760</ArticleId><ArticleId IdType="pubmed">24041677</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradeepa R, Mohan V. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation. Eur J Clin Nutr. 2017;71(7):816&#x2013;824. doi:10.1038/ejcn.2017.40</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2017.40</ArticleId><ArticleId IdType="pubmed">28422124</ArticleId></ArticleIdList></Reference><Reference><Citation>Petitti DB, Klingensmith GJ, Bell RA, et al. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr. 2009;155(5):668&#x2013;672.e1-3. doi:10.1016/j.jpeds.2009.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2009.05.025</ArticleId><ArticleId IdType="pmc">PMC4689142</ArticleId><ArticleId IdType="pubmed">19643434</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabelea D, Stafford JM, Mayer-Davis EJ, et al. Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood. JAMA. 2017;317(8):825&#x2013;835. doi:10.1001/jama.2017.0686</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.0686</ArticleId><ArticleId IdType="pmc">PMC5483855</ArticleId><ArticleId IdType="pubmed">28245334</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltesz G, Patterson CC, Dahlquist G, EURODIAB Study Group. Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology? Pediatr Diabetes. 2007;8 Suppl 6:6&#x2013;14. doi:10.1111/j.1399-5448.2007.00280.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5448.2007.00280.x</ArticleId><ArticleId IdType="pubmed">17727380</ArticleId></ArticleIdList></Reference><Reference><Citation>Praveen PA, Madhu SV, Mohan V, et al. Registry of Youth Onset Diabetes in India (YDR). J Diabetes Sci Technol. 2016;10(5):1034&#x2013;1041. doi:10.1177/1932296816645121</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296816645121</ArticleId><ArticleId IdType="pmc">PMC5032954</ArticleId><ArticleId IdType="pubmed">27179010</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniar D, Chen L. Integrations of Data Warehousing, Data Mining and Database Technologies: Innovative Approaches. IGI Global; 2001. 
https://www.igi-global.com/book/integrations-data-warehousing-data-mining/45967.
Accessed March 5, 2019.</Citation></Reference><Reference><Citation>Definition and DDLs for the OMOP Common Data Model (CDM): OHDSI/CommonDataModel. Observational Health Data Sciences and Informatics; 2018. 
https://github.com/OHDSI/CommonDataModel.
Accessed December 6, 2018.</Citation></Reference><Reference><Citation>Kahn MG, Batson D, Schilling LM. Data model considerations for clinical effectiveness researchers. Med Care. 2012;50 Suppl:S60&#x2013;67. doi:10.1097/MLR.0b013e318259bff4</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318259bff4</ArticleId><ArticleId IdType="pmc">PMC3824370</ArticleId><ArticleId IdType="pubmed">22692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez BL, Dabelea D, Liese AD, et al. Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: the SEARCH for diabetes in youth study. J Pediatr. 2010;157(2):245&#x2013;251.e1. doi:10.1016/j.jpeds.2010.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2010.02.021</ArticleId><ArticleId IdType="pubmed">20394942</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO | The WHO Child Growth Standards. WHO; 
http://www.who.int/childgrowth/en/.
Accessed November 26, 2018.</Citation></Reference><Reference><Citation>de Onis M Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(09):660&#x2013;667. doi:10.2471/BLT.07.043497</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.07.043497</ArticleId><ArticleId IdType="pmc">PMC2636412</ArticleId><ArticleId IdType="pubmed">18026621</ArticleId></ArticleIdList></Reference><Reference><Citation>National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555&#x2013;576.</Citation><ArticleIdList><ArticleId IdType="pubmed">15286277</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes&#x2014;2019. Diabetes Care. 2019;42(Supplement 1):S61&#x2013;S70. doi:10.2337/dc19-S006</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc19-S006</ArticleId><ArticleId IdType="pubmed">30559232</ArticleId></ArticleIdList></Reference><Reference><Citation>Unnikrishnan AG, Bhatia E, Bhatia V, et al. Type 1 diabetes versus type 2 diabetes with onset in persons younger than 20 years of age. Ann N Y Acad Sci. 2008;1150:239&#x2013;244. doi:10.1196/annals.1447.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1447.056</ArticleId><ArticleId IdType="pubmed">19120303</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia V, Arya V, Dabadghao P, et al. Etiology and Outcome of Childhood and Adolescent Diabetes Mellitus in North India. J Pediatr Endocrinol Metab. 2011;17(7):993&#x2013;1000. doi:10.1515/JPEM.2004.17.7.993</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/JPEM.2004.17.7.993</ArticleId><ArticleId IdType="pubmed">15301047</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchers AT, Uibo R, Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun Rev. 2010;9(5):A355&#x2013;365. doi:10.1016/j.autrev.2009.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.12.003</ArticleId><ArticleId IdType="pubmed">19969107</ArticleId></ArticleIdList></Reference><Reference><Citation>Liese AD, Puett RC, Lamichhane AP, et al. Neighborhood level risk factors for type 1 diabetes in youth: the SEARCH case-control study. Int J Health Geogr. 2012;11:1. doi:10.1186/1476-072X-11-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-072X-11-1</ArticleId><ArticleId IdType="pmc">PMC3269381</ArticleId><ArticleId IdType="pubmed">22230476</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemiatycki J, Colle E, Campbell S, Dewar R, Aubert D, Belmonte MM. Incidence of IDDM in Montreal by ethnic group and by social class and comparisons with ethnic groups living elsewhere. Diabetes. 1988;37(8):1096&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pubmed">3391344</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health. 2000;54(3):173&#x2013;177. doi:10.1136/jech.54.3.173</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.54.3.173</ArticleId><ArticleId IdType="pmc">PMC1731634</ArticleId><ArticleId IdType="pubmed">10746110</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins JM, Vaccarino V, Zhang H, Kasl SV. Socioeconomic status and diagnosed diabetes incidence. Diabetes Res Clin Pract. 2005;68(3):230&#x2013;236. doi:10.1016/j.diabres.2004.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2004.09.007</ArticleId><ArticleId IdType="pubmed">15936465</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulgaron ER, Delamater AM. Obesity and Type 2 Diabetes in Children: Epidemiology and Treatment. Curr Diab Rep. 2014;14(8):508. doi:10.1007/s11892-014-0508-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-014-0508-y</ArticleId><ArticleId IdType="pmc">PMC4099943</ArticleId><ArticleId IdType="pubmed">24919749</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan V, Shanthirani S, Deepa R, et al. Intra-urban differences in the prevalence of the metabolic syndrome in southern India -- the Chennai Urban Population Study (CUPS No. 4). Diabet Med J Br Diabet Assoc. 2001;18(4):280&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">11437858</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbanya JC, Ngogang J, Salah JN, Minkoulou E, Balkau B. Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia. 1997;40(7):824&#x2013;829. doi:10.1007/s001250050755</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001250050755</ArticleId><ArticleId IdType="pubmed">9243104</ArticleId></ArticleIdList></Reference><Reference><Citation>abu Sayeed M, Ali L, Hussain MZ, Rumi MA, Banu A, Azad Khan AK. Effect of socioeconomic risk factors on the difference in prevalence of diabetes between rural and urban populations in Bangladesh. Diabetes Care. 1997;20(4):551&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">9096979</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen L, Williams J, Townsend N, et al. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. Lancet Glob Health. 2017;5(3):e277&#x2013;e289. doi:10.1016/S2214-109X(17)30058-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(17)30058-X</ArticleId><ArticleId IdType="pmc">PMC5673683</ArticleId><ArticleId IdType="pubmed">28193397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu WC, Araneta MRG, Kanaya AM, Chiang JL, Fujimoto W. BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening. Diabetes Care. 2015;38(1):150&#x2013;158. doi:10.2337/dc14-2391</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-2391</ArticleId><ArticleId IdType="pmc">PMC4392932</ArticleId><ArticleId IdType="pubmed">25538311</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JCN, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129&#x2013;2140. doi:10.1001/jama.2009.726</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.726</ArticleId><ArticleId IdType="pubmed">19470990</ArticleId></ArticleIdList></Reference><Reference><Citation>King GL, McNeely MJ, Thorpe LE, et al. Understanding and Addressing Unique Needs of Diabetes in Asian Americans, Native Hawaiians, and Pacific Islanders. Diabetes Care. 2012;35(5):1181&#x2013;1188. doi:10.2337/dc12-0210</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc12-0210</ArticleId><ArticleId IdType="pmc">PMC3329823</ArticleId><ArticleId IdType="pubmed">22517939</ArticleId></ArticleIdList></Reference><Reference><Citation>Flowers E, Lin F, Kandula NR, et al. Body Composition and Diabetes Risk in South Asians: Findings From the MASALA and MESA Studies. Diabetes Care. February 2019:dc181510. doi:10.2337/dc18-1510</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc18-1510</ArticleId><ArticleId IdType="pmc">PMC6489113</ArticleId><ArticleId IdType="pubmed">30796111</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977&#x2013;986. doi:10.1056/NEJM199309303291401</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199309303291401</ArticleId><ArticleId IdType="pubmed">8366922</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet Lond Engl. 1998;352(9131):837&#x2013;853.</Citation><ArticleIdList><ArticleId IdType="pubmed">9742976</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman WH, Dungan KM, Wolffenbuttel BHR, et al. Racial and Ethnic Differences in Mean Plasma Glucose, Hemoglobin A1c, and 1,5-Anhydroglucitol in Over 2000 Patients with Type 2 Diabetes. J Clin Endocrinol Metab. 2009;94(5):1689&#x2013;1694. doi:10.1210/jc.2008-1940</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2008-1940</ArticleId><ArticleId IdType="pubmed">19276235</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan CL, McFann K, Newnes L, Nadeau KJ, Zeitler PS, Kelsey M. Hemoglobin A1c Assay Variations and Implications for Diabetes Screening in Obese Youth. Pediatr Diabetes. 2014;15(8):557&#x2013;563. doi:10.1111/pedi.12132</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12132</ArticleId><ArticleId IdType="pmc">PMC4167160</ArticleId><ArticleId IdType="pubmed">24636682</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31956997</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-6535</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Clinical pharmacology and therapeutics</Title><ISOAbbreviation>Clin Pharmacol Ther</ISOAbbreviation></Journal><ArticleTitle>Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children.</ArticleTitle><Pagination><StartPage>915</StartPage><EndPage>925</EndPage><MedlinePgn>915-925</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cpt.1785</ELocationID><Abstract><AbstractText>Exploring and combining results from more than one real-world data (RWD) source might be necessary in order to explore variability and demonstrate generalizability of the results or for regulatory requirements. However, the heterogeneous nature of RWD poses challenges when working with more than one source, some of which can be solved by analyzing databases converted into a common data model (CDM). The main objective of the study was to evaluate the implementation of the Observational Medical Outcome Partnership (OMOP) CDM on IQVIA Medical Research Data (IMRD)-UK data. A drug utilization study describing the prescribing of codeine for pain in children was used as a case study to be replicated in IMRD-UK and its corresponding OMOP CDM transformation. Differences between IMRD-UK source and OMOP CDM were identified and investigated. In IMRD-UK updated to May 2017, results were similar between source and transformed data with few discrepancies. These were the result of different conventions applied during the transformation regarding the date of birth for children younger than 15&#xa0;years and the start of the observation period, and of a misclassification of two drug treatments. After the initial analysis and feedback provided, a rerun of the analysis in IMRD-UK updated to September 2018 showed almost identical results for all the measures analyzed. For this study, the conversion to OMOP CDM was adequate. Although some decisions and mapping could be improved, these impacted on the absolute results but not on the study inferences. This validation study supports six recommendations for good practice in transforming to CDMs.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Clinical Pharmacology &amp; Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Candore</LastName><ForeName>Gianmario</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Business Data Department, European Medicines Agency, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedenmalm</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Business Data Department, European Medicines Agency, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slattery</LastName><ForeName>Jim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cave</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arlett</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Pharmacol Ther</MedlineTA><NlmUniqueID>0372741</NlmUniqueID><ISSNLinking>0009-9236</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>UX6OWY2V7J</RegistryNumber><NameOfSubstance UI="D003061">Codeine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003061" MajorTopicYN="N">Codeine</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="N">Data Management</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>All authors declared no competing interests for this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31956997</ArticleId><ArticleId IdType="pmc">PMC7158210</ArticleId><ArticleId IdType="doi">10.1002/cpt.1785</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cave, A. , Kurz, X. &amp; Arlett, P. Real&#x2010;world data for regulatory decision making: challenges and possible solutions for Europe. Clin. Pharmacol. Ther. 106, 36&#x2013;39 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6617710</ArticleId><ArticleId IdType="pubmed">30970161</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
. Chapter 4: approaches to data collection In ENCePP Guide on Methodological Standards in Pharmacoepidemiology. European Medicines Agency;  &lt;http://www.encepp.eu/standards_and_guidances/methodologicalGuide4.shtml&gt; Accessed August 26, 2019.</Citation></Reference><Reference><Citation>
European Commission
. Guideline on the format and content of applications for designation as orphan medicinal products and on the transfer of designations from one sponsor to another, 27.03.2014. Belgium: European Commission Health and Consumers Directorate&#x2010;General;  &lt;https://ec.europa.eu/health//sites/health/files/files/orphanmp/2014-03_guideline_rev4_final.pdf&gt; (2014).</Citation></Reference><Reference><Citation>
European Medicines Agency
. Orphan designation: Overview &lt;https://www.ema.europa.eu/en/human-regulatory/overview/orphan-designation-overview&gt;.</Citation></Reference><Reference><Citation>Zhou, X. et al An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 36, 119&#x2013;134 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage, J.M. , Ryan, P.B. , Reich, C.G. , Hartzema, A.G. &amp; Stang, P.E. Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 19, 54&#x2013;60 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Y. et al A comparative assessment of observational medical outcomes partnership and mini&#x2010;sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 38, 749&#x2013;765 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt, R.W. , Platt, R. , Brown, J.S. , Henry, D.A. , Klungel, O.H. &amp; Suissa, S. How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiol. Drug Saf. 29, 3&#x2013;7 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30648307</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak, G. et al Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Studies Health Technol. Inform. 216, 574&#x2013;548 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI)
. Observational health data sciences and informatics &lt;https://www.ohdsi.org/&gt;.</Citation></Reference><Reference><Citation>Ball, R. , Robb, M. , Anderson, S.A. &amp; Dal Pan, G. The FDA's sentinel initiative&#x2013;a comprehensive approach to medical product surveillance. Clin. Pharmacol. Ther. 99, 265&#x2013;268 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss, S. , Brown, J.S. , Bate, A. , Trifiro, G. &amp; Bartels, D.B. Choosing among common data models for real&#x2010;world data analyses fit for making decisions about the effectiveness of medical products. Clin. Pharmacol. Ther. 107: 827&#x2013;833 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31330042</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho, A. , Ryan, P. , Fife, D. &amp; Reich, C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 37, 945&#x2013;959 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss, E.A. et al Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J. Am. Med. Inform. Assoc. 22, 553&#x2013;564 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberson, A. , Rinner, C. &amp; Gall, W. Standardizing Austrians claims data using the OMOP common data model: a feasibility study. Stud. Health Technol. Inform. 258, 151&#x2013;152 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30942734</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberson, A. , Rinner, C. , Schoberl, A. &amp; Gall, W. Feasibility of mapping Austrian health claims data to the OMOP common data model. J. Med. Syst. 43, 314 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="pubmed">31494719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima, D.M. , Rodrigues, J.F. Jr , Traina, A.J.M. , Pires, F.A. &amp; Gutierrez, M.A. Transforming two decades of ePR data to OMOP CDM for clinical research. Stud. Health Technol. Inform. 264, 233&#x2013;237 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31437920</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier, C. et al Towards implementation of OMOP in a German University Hospital Consortium. Appl. Clin. Inform. 9, 54&#x2013;61 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia, R. &amp; Ryan, P.B. Transforming the premier perspective hospital database into the Observational Medical Outcomes Partnership (OMOP) common data model. EGEMS 2, 1110 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon, D. et al Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthcare Inform. Res. 22, 54&#x2013;58 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>You, S.C. et al Conversion of National Health Insurance Service&#x2010;National Sample Cohort (NHIS&#x2010;NSC) Database into Observational Medical Outcomes Partnership&#x2010;Common Data Model (OMOP&#x2010;CDM). Stud. Health Technol. Inform. 245, 467&#x2013;470 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijnbeek, P.R. Converting to a common data model: what is lost in translation?: Commentary on "fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model". Drug Saf. 37, 893&#x2013;896 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25187018</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency (EMA)/350259/2013
. PRAC recommends restricting the use of codeine when used for pain relief in children London, United Kingdom &lt;http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Codeine_containing_medicinal_products/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500144445.pdf&gt; (2013).</Citation></Reference><Reference><Citation>
European Medicines Agency
. Restrictions on use of codeine for pain relief in children &#x2013; CMDh endorses PRAC recommendation London, United Kingdom &lt;http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/06/news_detail_001829.jsp%26mxml:id=WC0b01ac058004d5c1&gt; (2013).</Citation></Reference><Reference><Citation>European Medicines Agency (EMA)/H/A&#x2010;31/1342
. Assessment report for codeine&#x2010;containing medicinal products indicated in the management of pain in children 2013 [updated June 24, 2013. 1&#x2013;18] &lt;http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Codeine_containing_medicinal_products/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500147065.pdf&gt;.</Citation></Reference><Reference><Citation>Hedenmalm, K. et al A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiol. Drug Saf. 28, 1086&#x2013;1096 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771637</ArticleId><ArticleId IdType="pubmed">31219227</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher, H. , Kostev, K. &amp; Schroder&#x2010;Bernhardi, D. Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int. J. Clin. Pharmacol. Ther. 47, 617&#x2013;626 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19825325</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvador Rosa, A. , Moreno Perez, J.C. , Sonego, D. , Garcia Rodriguez, L.A. &amp; de Abajo Iglesias, F.J. The BIFAP project: database for pharmaco&#x2010;epidemiological research in primary care. Aten. Primaria 30, 655&#x2013;661 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7679749</ArticleId><ArticleId IdType="pubmed">12525343</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett, E. et al Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int. J. Epidemiol. 44, 827&#x2013;836 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference><Reference><Citation>Blak, B.T. , Thompson, M. , Dattani, H. &amp; Bourke, A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Informatics Primary Care 19, 251&#x2013;255 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22828580</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI/CommonDataModel
&lt;https://github.com/OHDSI/CommonDataModel/wiki&gt;.</Citation></Reference><Reference><Citation>IQVIA . THIN Research Format Data Guide. Version 1809 (IQVIA, London, UK, 2018).</Citation></Reference><Reference><Citation>Kim, H.J. , Fay, M.P. , Feuer, E.J. &amp; Midthune, D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19, 335&#x2013;351 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10649300</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Cancer Institute
. Joinpoint Regression Program, version 4.5.0.1 &#x2013; June 2017 &lt;https://surveillance.cancer.gov/joinpoint/&gt; (2017).</Citation></Reference><Reference><Citation>Fay, M.P. , Tiwari, R.C. , Feuer, E.J. &amp; Zou, Z. Estimating average annual percent change for disease rates without assuming constant change. Biometrics 62, 847&#x2013;854 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16984328</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales, D.R. , Slattery, J. , Pacurariu, A. , Pinheiro, L. , McGettigan, P. &amp; Kurz, X. Relative and absolute risk of tendon rupture with fluoroquinolone and concomitant fluoroquinolone/corticosteroid therapy: population&#x2010;based nested case&#x2010;control study. Clin. Drug Investig. 39, 205&#x2013;213 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6394638</ArticleId><ArticleId IdType="pubmed">30465300</ArticleId></ArticleIdList></Reference><Reference><Citation>

Tranchard, S
. Revised IDMP standards to improve description of medicinal products worldwide &lt;https://www.iso.org/news/ref2234.html&gt; (2017).</Citation></Reference><Reference><Citation>Schneeweiss, S. &amp; Glynn, R.J. Real&#x2010;world data analytics fit for regulatory decision&#x2010;making. Am. J. Law Med. 44, 197&#x2013;217 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30106649</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonari, D.M. et al Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN). Pharmacoepidemiol. Drug Saf. 24, 999&#x2013;1003 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26213344</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave, A. Opportunities for 'big data' in medicines development and regulatory science. 34th International Conference of Pharmacoepidemiology &amp; Therapeutic Risk Management, Prague, Czech Republic, August 24, 2018.</Citation></Reference><Reference><Citation>
European Medicines Agency (EMA)/614680/2018
. A common data model for Europe? Why? Which? How? &lt;https://www.ema.europa.eu/en/documents/report/common-data-model-europe-why-which-how-workshop-report_en.pdf&gt; (2018).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31970824</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-1746</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of gastroenterology and hepatology</Title><ISOAbbreviation>J Gastroenterol Hepatol</ISOAbbreviation></Journal><ArticleTitle>Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.</ArticleTitle><Pagination><StartPage>1325</StartPage><EndPage>1330</EndPage><MedlinePgn>1325-1330</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jgh.14983</ELocationID><Abstract><AbstractText Label="BACKGROUNDS AND AIM" NlmCategory="OBJECTIVE">There are potential concerns regarding infectious complications including Clostridium difficile infections (CDIs) among patients taking gastric acid suppressants. Furthermore, it is speculated that the stronger acid suppression by proton pump inhibitors (PPIs) potentially enhance infectious complications. This study aimed to compare the risk of CDI between PPIs and histamine-2 receptor antagonists (H2RAs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using the long-term database of the Kangdong Sacred Heart Hospital, converted to the Observational Medical Outcomes Partnership Common Data Model, we identified outpatients treated with PPIs and H2RAs for &#x2265;&#xa0;7&#xa0;days from January 1, 2004 through December 31, 2018. We conducted Cox regression analysis to examine the hazard ratio (HR) of CDI after propensity score matching.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During a median follow-up period of 1.2&#xa0;years (interquartile range, 0.2-3.2&#xa0;years), the initial CDI occurrence differed significantly between matched cohorts of patients taking PPIs and H2RAs [PPIs vs H2RAs, 88/31&#xa0;095 person years vs 47/32&#xa0;836 person years; HR, 2.22; 95% confidence interval (CI) 1.29-3.96; P&#xa0;=&#xa0;0.005]. Almost 50% of all events occurred within 1&#xa0;year of drug exposure. The risk of CDIs was significantly greater among groups receiving PPIs or H2RAs than in matched controls (PPIs vs control: HR, 2.65; 95% CI 1.28-5.79; P&#xa0;=&#xa0;0.011; and H2RAs vs control: HR 2.43; 95% CI 1.09-5.68; P&#xa0;=&#xa0;0.034].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In long-term hospital cohort, outpatient-based PPIs were associated with greater risk of CDI than H2RAs. It is necessary to be cautioned about complication of CDI in patients taking long-term PPI therapy.</AbstractText><CopyrightInformation>&#xa9; 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Seung In</ForeName><Initials>SI</Initials><Identifier Source="ORCID">0000-0003-4417-0135</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Chan Hyuk</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae Joon</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>You Sang</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yerim</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Jong Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jinseob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Woon Geon</ForeName><Initials>WG</Initials><Identifier Source="ORCID">0000-0002-9851-5576</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HI19C0143</GrantID><Agency>Ministry of Health &amp; Welfare, Republic of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Gastroenterol Hepatol</MedlineTA><NlmUniqueID>8607909</NlmUniqueID><ISSNLinking>0815-9319</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006635">Histamine H2 Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054328">Proton Pump Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003015" MajorTopicYN="N">Clostridium Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006635" MajorTopicYN="N">Histamine H2 Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054328" MajorTopicYN="N">Proton Pump Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clostridium difficile infections</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">histamine-2 receptor antagonists</Keyword><Keyword MajorTopicYN="N">hospital-based cohort</Keyword><Keyword MajorTopicYN="N">proton pump inhibitors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31970824</ArticleId><ArticleId IdType="doi">10.1111/jgh.14983</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Savarino V, Tosetti C, Benedetto E, Compare D, Nardone G. Appropriateness in prescribing PPIs: a position paper of the Italian Society of Gastroenterology (SIGE)-study section &#x201c;Digestive Diseases in Primary Care&#x201d;. Dig. Liver Dis. 2018; 50: 894-902.</Citation></Reference><Reference><Citation>Malfertheiner P, Kandulski A, Venerito M. Proton-pump inhibitors: understanding the complications and risks. Nat. Rev. Gastroenterol. Hepatol. 2017; 14: 697-710.</Citation></Reference><Reference><Citation>Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology 2017; 153: 35-48.</Citation></Reference><Reference><Citation>Lessa FC, Mu Y, Bamberg WM et al. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 2015; 372: 825-834.</Citation></Reference><Reference><Citation>Gerding DN, Lessa FC. The epidemiology of Clostridium difficile infection inside and outside health care institutions. Infect. Dis. Clin. North Am. 2015; 29: 37-50.</Citation></Reference><Reference><Citation>Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005; 353: 2442-2449.</Citation></Reference><Reference><Citation>Reveles KR, Lawson KA, Mortensen EM et al. National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014. PLoS ONE 2017; 12: e0189227.</Citation></Reference><Reference><Citation>Yang BK, Do BJ, Kim EJ et al. The simple predictors of pseudomembranous colitis in patients with hospital-acquired diarrhea: a prospective observational study. Gut Liver 2014; 8: 41-48.</Citation></Reference><Reference><Citation>Kim YG, Graham DY, Jang BI. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J. Clin. Gastroenterol. 2012; 46: 397-400.</Citation></Reference><Reference><Citation>Buendgens L, Bruensing J, Matthes M et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. J. Crit. Care 2014; 29 696.e11-5.</Citation></Reference><Reference><Citation>Faleck DM, Salmasian H, Furuya EY, Larson EL, Abrams JA, Freedberg DE. Proton pump inhibitors do not increase risk for Clostridium difficile infection in the intensive care unit. Am. J. Gastroenterol. 2016; 111: 1641-1648.</Citation></Reference><Reference><Citation>Savarino V, Dulbecco P, Savarino E. Are proton pump inhibitors really so dangerous? Dig. Liver Dis. 2016; 48: 851-859.</Citation></Reference><Reference><Citation>Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am. J. Gastroenterol. 2012; 107: 1001-1010.</Citation></Reference><Reference><Citation>Moayyedi P, Eikelboom JW, Bosch J et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology 2019; 157: 682-691.e2.</Citation></Reference><Reference><Citation>Gordon D, Young LR, Reddy S, Bergman C, Young JD. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor. J. Hosp. Infect. 2016; 92: 173-177.</Citation></Reference><Reference><Citation>Park YH, Seong JM, Cho S et al. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study. J. Gastroenterol. 2019.</Citation></Reference><Reference><Citation>Trifan A, Stanciu C, Girleanu I et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J. Gastroenterol. 2017; 23: 6500-6515.</Citation></Reference><Reference><Citation>Azab M, Doo L, Doo DH et al. Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis. Gut Lliver 2017; 11: 781-788.</Citation></Reference><Reference><Citation>Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am. J. Gastroenterol. 2012; 107: 1011-1019.</Citation></Reference><Reference><Citation>MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern. Med. 2014; 174: 564-574.</Citation></Reference><Reference><Citation>Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005; 294: 2989-2995.</Citation></Reference><Reference><Citation>Dubberke ER, Reske KA, Olsen MA et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch. Intern. Med. 2007; 167: 1092-1097.</Citation></Reference><Reference><Citation>Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment. Pharmacol. Ther. 2009; 29: 626-634.</Citation></Reference><Reference><Citation>Howell MD, Novack V, Grgurich P et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch. Intern. Med. 2010; 170: 784-790.</Citation></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY et al. Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016; 22: 54-58.</Citation></Reference><Reference><Citation>Makadia R, Ryan PB. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Washington, DC) 2014; 2: 1110.</Citation></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet (London, England) 2019; 394: 1816-1826.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform. 2015; 216: 574-578.</Citation></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A et al. Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Netw. Open 2018; 1: e181755.</Citation></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J. Am. Med. Inform. Assoc. 2015; 22: 553-564.</Citation></Reference><Reference><Citation>You SC, Lee S, Cho SY et al. Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM). Stud. Health Technol. Inform. 2017; 245: 467-470.</Citation></Reference><Reference><Citation>Imhann F, Bonder MJ, Vich Vila A et al. Proton pump inhibitors affect the gut microbiome. Gut 2016; 65: 740-748.</Citation></Reference><Reference><Citation>Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome. 2014; 2: 42.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32065600</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6114</ISSN><JournalIssue CitedMedium="Internet"><Volume>180</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA internal medicine</Title><ISOAbbreviation>JAMA Intern Med</ISOAbbreviation></Journal><ArticleTitle>Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension.</ArticleTitle><Pagination><StartPage>542</StartPage><EndPage>551</EndPage><MedlinePgn>542-551</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2019.7454</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Chlorthalidone is currently recommended as the preferred thiazide diuretic to treat hypertension, but no trials have directly compared risks and benefits.</AbstractText><AbstractText Label="OBJECTIVE">To compare the effectiveness and safety of chlorthalidone and hydrochlorothiazide as first-line therapies for hypertension in real-world practice.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This is a Large-Scale Evidence Generation and Evaluation in a Network of Databases (LEGEND) observational comparative cohort study with large-scale propensity score stratification and negative-control and synthetic positive-control calibration on databases spanning January 2001 through December 2018. Outpatient and inpatient care episodes of first-time users of antihypertensive monotherapy in the United States based on 2 administrative claims databases and 1 collection of electronic health records were analyzed. Analysis began June 2018.</AbstractText><AbstractText Label="EXPOSURES">Chlorthalidone and hydrochlorothiazide.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcomes were acute myocardial infarction, hospitalization for heart failure, ischemic or hemorrhagic stroke, and a composite cardiovascular disease outcome including the first 3 outcomes and sudden cardiac death. Fifty-one safety outcomes were measured.</AbstractText><AbstractText Label="RESULTS">Of 730&#x202f;225 individuals (mean [SD] age, 51.5 [13.3] years; 450&#x202f;100 women [61.6%]), 36&#x202f;918 were dispensed or prescribed chlorthalidone and had 149 composite outcome events, and 693&#x202f;337 were dispensed or prescribed hydrochlorothiazide and had 3089 composite outcome events. No significant difference was found in the associated risk of myocardial infarction, hospitalized heart failure, or stroke, with a calibrated hazard ratio for the composite cardiovascular outcome of 1.00 for chlorthalidone compared with hydrochlorothiazide (95% CI, 0.85-1.17). Chlorthalidone was associated with a significantly higher risk of hypokalemia (hazard ratio [HR], 2.72; 95% CI, 2.38-3.12), hyponatremia (HR, 1.31; 95% CI, 1.16-1.47), acute renal failure (HR, 1.37; 95% CI, 1.15-1.63), chronic kidney disease (HR, 1.24; 95% CI, 1.09-1.42), and type 2 diabetes mellitus (HR, 1.21; 95% CI, 1.12-1.30). Chlorthalidone was associated with a significantly lower risk of diagnosed abnormal weight gain (HR, 0.73; 95% CI, 0.61-0.86).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This study found that chlorthalidone use was not associated with significant cardiovascular benefits when compared with hydrochlorothiazide, while its use was associated with greater risk of renal and electrolyte abnormalities. These findings do not support current recommendations to prefer chlorthalidone vs hydrochlorothiazide for hypertension treatment in first-time users was found. We used advanced methods, sensitivity analyses, and diagnostics, but given the possibility of residual confounding and the limited length of observation periods, further study is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, NewYork-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fielding School of Public Health, Department of Biostatistics, University of California, Los Angeles, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>David Geffen School of Medicine, Department of Biomathematics, University of California, Los Angeles, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shea</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>RuiJun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medical College, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fielding School of Public Health, Department of Biostatistics, University of California, Los Angeles, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI135995</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Intern Med</MedlineTA><NlmUniqueID>101589534</NlmUniqueID><ISSNLinking>2168-6106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0J48LPH2TH</RegistryNumber><NameOfSubstance UI="D006852">Hydrochlorothiazide</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q0MQD1073Q</RegistryNumber><NameOfSubstance UI="D002752">Chlorthalidone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Intern Med. 2020 Aug 1;180(8):1133. doi: 10.1001/jamainternmed.2020.1742</RefSource><PMID Version="1">32568361</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Intern Med. 2020 Aug 1;180(8):1133-1134. doi: 10.1001/jamainternmed.2020.1736</RefSource><PMID Version="1">32568364</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Intern Med. 2020 Aug 1;180(8):1132-1133. doi: 10.1001/jamainternmed.2020.1739</RefSource><PMID Version="1">32568375</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002752" MajorTopicYN="N">Chlorthalidone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006852" MajorTopicYN="N">Hydrochlorothiazide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Hripcsak reports grants from the National Library of Medicine during the conduct of the study and grants from Janssen Research outside the submitted work. Dr Suchard reports grants from the National Science Foundation and the National Institutes of Health during the conduct of the study and grants from Janssen Research and Development outside the submitted work. Dr Shea reports grants from the National Heart, Lung, and Blood Institute and the US Health Resources and Services Administration not directly relevant to the published work. Dr Madigan reports personal fees from Simon Greenstone Panatier; Williams Hart; Lanier Law Firm; Kazan, McClain, Satterley &amp; Greenwood; Shire; and Bayer outside the submitted work. Dr Krumholz reports personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, Siegfried &amp; Jenson Law Firm, Arnold &amp; Porter Law Firm, Ben C. Martin Law Firm, and the National Center for Cardiovascular Diseases (Beijing); cofounder of Hugo Health and Refactor Health; contracts with US Centers for Medicare &amp; Medicaid Services; and grants from Medtronic/US Food and Drug Administration, Medtronic/Johnson &amp; Johnson, and Shenzhen Center for Health Information outside the submitted work. Dr Ryan is an employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson during the conduct of the study. Dr Schuemie is an employee and shareholder of Janssen Research and Development outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32065600</ArticleId><ArticleId IdType="pmc">PMC7042845</ArticleId><ArticleId IdType="doi">10.1001/jamainternmed.2019.7454</ArticleId><ArticleId IdType="pii">2760777</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whelton PK, Carey RM, Aronow WS, et al. . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task force on clinical practice guidelines. Hypertension. 2018;71(6):1269-1324. doi:10.1161/HYP.0000000000000066</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYP.0000000000000066</ArticleId><ArticleId IdType="pubmed">29133354</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederle FA, Cushman WC, Ferguson RE, Brophy MT, Fiore Md LD. Chlorthalidone Versus hydrochlorothiazide: a new kind of Veterans Affairs cooperative study. Ann Intern Med. 2016;165(9):663-664. doi:10.7326/M16-1208</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M16-1208</ArticleId><ArticleId IdType="pubmed">27538129</ArticleId></ArticleIdList></Reference><Reference><Citation>Olde Engberink RH, Frenkel WJ, van den Bogaard B, Brewster LM, Vogt L, van den Born BJ. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. Hypertension. 2015;65(5):1033-1040. doi:10.1161/HYPERTENSIONAHA.114.05122</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.114.05122</ArticleId><ArticleId IdType="pubmed">25733241</ArticleId></ArticleIdList></Reference><Reference><Citation>Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension. 2012;59(6):1110-1117. doi:10.1161/HYPERTENSIONAHA.112.191106</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.112.191106</ArticleId><ArticleId IdType="pubmed">22526259</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhalla IA, Gomes T, Yao Z, et al. . Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann Intern Med. 2013;158(6):447-455. doi:10.7326/0003-4819-158-6-201303190-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-6-201303190-00004</ArticleId><ArticleId IdType="pubmed">23552325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst ME, Carter BL, Goerdt CJ, et al. . Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47(3):352-358. doi:10.1161/01.HYP.0000203309.07140.d3</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000203309.07140.d3</ArticleId><ArticleId IdType="pubmed">16432050</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakris GL, Sica D, White WB, et al. . Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil. Am J Med. 2012;125(12):1229.e1-1229.e10. doi:10.1016/j.amjmed.2012.05.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2012.05.023</ArticleId><ArticleId IdType="pubmed">22939358</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018;47(6):2005-2014. doi:10.1093/ije/dyy120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc Natl Acad Sci USA. 2018;115(11):2571-2577. doi:10.1073/pnas.1708282114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383-388. doi:10.1097/EDE.0b013e3181d61eeb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181d61eeb</ArticleId><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Hripcsak G, Madigan D, Suchard MA. Improving reproducibility by using high-throughput observational studies with empirical calibration. Philos Trans A Math Phys Eng Sci. 2018;376(2128):20170356. doi:10.1098/rsta.2017.0356</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2017.0356</ArticleId><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. . Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574-578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al. . Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394(10211):1816-1826. doi:10.1016/S0140-6736(19)32317-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Gruber S, Zorych I, Madigan D. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(suppl 1):S59-S72. doi:10.1007/s40264-013-0099-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0099-6</ArticleId><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54-60. doi:10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758-764. doi:10.1093/aje/kwv254</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv254</ArticleId><ArticleId IdType="pmc">PMC4832051</ArticleId><ArticleId IdType="pubmed">26994063</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-1251. doi:10.1016/0895-4356(94)90129-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(94)90129-5</ArticleId><ArticleId IdType="pubmed">7722560</ArticleId></ArticleIdList></Reference><Reference><Citation>GitHub. OHDSI/CohortMethod: New-user cohort method with large scale propensity and outcome models. https://github.com/OHDSI/CohortMethod. Accessed January 13, 2020.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23(1):10. doi:10.1145/2414416.2414791</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55. doi:10.1093/biomet/70.1.41</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AM, Patrick AR, Lauer MS, et al. . A tool for assessing the feasibility of comparative effectiveness research. Comp Effectiveness Res. 2013;3:11-20. doi:10.2147/CER.S40357</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CER.S40357</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2017;66:72-81. doi:10.1016/j.jbi.2016.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.12.005</ArticleId><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4: effects of various classes of antihypertensive drugs&#x2013;overview and meta-analyses. J Hypertens. 2015;33(2):195-211. doi:10.1097/HJH.0000000000000447</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000000447</ArticleId><ArticleId IdType="pubmed">25485720</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B, Mancia G, Spiering W, et al. ; Task Force Members . 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. doi:10.1097/HJH.0000000000001940</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000001940</ArticleId><ArticleId IdType="pubmed">30234752</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. 2011;57(4):689-694. doi:10.1161/HYPERTENSIONAHA.110.161505</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.110.161505</ArticleId><ArticleId IdType="pubmed">21383313</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen JP, Fleurence R, Devine B, et al. . Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011;14(4):417-428. doi:10.1016/j.jval.2011.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2011.04.002</ArticleId><ArticleId IdType="pubmed">21669366</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43(1):4-9. doi:10.1161/01.HYP.0000103632.19915.0E</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000103632.19915.0E</ArticleId><ArticleId IdType="pubmed">14638621</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterzan MA, Hardy R, Chaturvedi N, Hughes AD. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension. 2012;59(6):1104-1109. doi:10.1161/HYPERTENSIONAHA.111.190637</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.111.190637</ArticleId><ArticleId IdType="pmc">PMC4930655</ArticleId><ArticleId IdType="pubmed">22547443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst ME, Carter BL, Zheng S, Grimm RH Jr. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens. 2010;23(4):440-446. doi:10.1038/ajh.2010.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2010.1</ArticleId><ArticleId IdType="pubmed">20111008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst ME, Neaton JD, Grimm RH Jr, et al. ; Multiple Risk Factor Intervention Trial Research Group . Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension. 2011;58(6):1001-1007. doi:10.1161/HYPERTENSIONAHA.111.181248</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.111.181248</ArticleId><ArticleId IdType="pmc">PMC3245686</ArticleId><ArticleId IdType="pubmed">22025372</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32133717</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project.</ArticleTitle><Pagination><StartPage>993</StartPage><EndPage>1000</EndPage><MedlinePgn>993-1000</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.4983</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To introduce the methodology of the ALCAPONE project.</AbstractText><AbstractText Label="BACKGROUND">The French National Healthcare System Database (SNDS), covering 99% of the French population, provides a potentially valuable opportunity for drug safety alert generation. ALCAPONE aimed to assess empirically in the SNDS case-based designs for alert generation related to four health outcomes of interest.</AbstractText><AbstractText Label="METHODS">ALCAPONE used a reference set adapted from observational medical outcomes partnership (OMOP) and Exploring and Understanding Adverse Drug Reactions (EU-ADR) project, with four outcomes-acute liver injury (ALI), myocardial infarction (MI), acute kidney injury (AKI), and upper gastrointestinal bleeding (UGIB)-and positive and negative drug controls. ALCAPONE consisted of four main phases: (1) data preparation to fit the OMOP Common Data Model and select the drug controls; (2) detection of the selected controls via three case-based designs: case-population, case-control, and self-controlled case series, including design variants (varying risk window, adjustment strategy, etc.); (3) comparison of design variant performance (area under the ROC curve, mean square error, etc.); and (4) selection of the optimal design variants and their calibration for each outcome.</AbstractText><AbstractText Label="RESULTS">Over 2009-2014, 5225 cases of ALI, 354&#x2009;109 MI, 12&#x2009;633 AKI, and 156&#x2009;057 UGIB were identified using specific definitions. The number of detectable drugs ranged from 61 for MI to 25 for ALI. Design variants generated more than 50&#x2009;000 points estimates. Results by outcome will be published in forthcoming papers.</AbstractText><AbstractText Label="CONCLUSIONS">ALCAPONE has shown the interest of the empirical assessment of pharmacoepidemiological approaches for drug safety alert generation and may encourage other researchers to do the same in other databases.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thurin</LastName><ForeName>Nicolas H</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0003-3589-0819</Identifier><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1219, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lassalle</LastName><ForeName>R&#xe9;gis</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;nichon</LastName><ForeName>Marine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagne</LastName><ForeName>Joshua J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rassen</LastName><ForeName>Jeremy A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Aetion, Inc., New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benichou</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1181, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weill</LastName><ForeName>Alain</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8687-9092</Identifier><AffiliationInfo><Affiliation>Caisse Nationale de l'Assurance Maladie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blin</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1212-2817</Identifier><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1219, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Droz-Perroteau</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="N">National Health Programs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="N">Pharmacoepidemiology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SNDS</Keyword><Keyword MajorTopicYN="N">calibration</Keyword><Keyword MajorTopicYN="N">case-population</Keyword><Keyword MajorTopicYN="N">claims database</Keyword><Keyword MajorTopicYN="N">method assessment</Keyword><Keyword MajorTopicYN="N">pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32133717</ArticleId><ArticleId IdType="doi">10.1002/pds.4983</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Moore N. The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist. Eur J Clin Pharmacol. 2013;69(Suppl 1):33-41.</Citation></Reference><Reference><Citation>Trifiro G, Pariente A, Coloma PM, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009;18:1176-1184.</Citation></Reference><Reference><Citation>Trifiro G, Fourrier-Reglat A, Sturkenboom MC, Diaz Acedo C, Van Der Lei J, Group E-A. The EU-ADR project: preliminary results and perspective. Stud Health Technol Inform. 2009;148:43-49.</Citation></Reference><Reference><Citation>Trifiro G, Patadia V, Schuemie MJ, et al. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. Stud Health Technol Inform. 2011;166:25-30.</Citation></Reference><Reference><Citation>DuMouchel W, Ryan PB, Schuemie MJ, Madigan D. Evaluation of disproportionality safety signaling applied to healthcare databases. Drug Saf. 2013;36(Suppl 1):S123-S132.</Citation></Reference><Reference><Citation>Madigan D, Schuemie MJ, Ryan PB. Empirical performance of the case-control method: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S73-S82.</Citation></Reference><Reference><Citation>Noren GN, Bergvall T, Ryan PB, Juhlin K, Schuemie MJ, Madigan D. Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S107-S121.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Gruber S, Zorych I, Madigan D. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S59-S72.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Madigan D. Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S95-S106.</Citation></Reference><Reference><Citation>Schuemie MJ, Madigan D, Ryan PB. Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S133-S142.</Citation></Reference><Reference><Citation>Suchard MA, Zorych I, Simpson SE, Schuemie MJ, Ryan PB, Madigan D. Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S83-S93.</Citation></Reference><Reference><Citation>Ryan P, Stang P, Overhage J, et al. A comparison of the empirical performance of methods for a risk identification system. Drug Saf. 2013;36(Suppl 1):S143-S158.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574-578.</Citation></Reference><Reference><Citation>Bezin J, Duong M, Lassalle R, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954-962.</Citation></Reference><Reference><Citation>Gulmez SE, Larrey D, Pageaux GP, et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf. 2013;36:135-144.</Citation></Reference><Reference><Citation>Moore N, Gulmez SE, Larrey D, et al. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiol Drug Saf. 2013;22:160-167.</Citation></Reference><Reference><Citation>Theophile H, Laporte JR, Moore N, Martin KL, Begaud B. The case-population study design: an analysis of its application in pharmacovigilance. Drug Saf. 2011;34:861-868.</Citation></Reference><Reference><Citation>Moore N, Gulmez SE, Blin P, et al. Relative risks from case-population data. Epidemiology. 2013;24:935-936.</Citation></Reference><Reference><Citation>Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016;14:10.</Citation></Reference><Reference><Citation>Abbing-Karahagopian V, Kurz X, de Vries F, et al. Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol. 2014;9:130-138.</Citation></Reference><Reference><Citation>Castellsague J, Riera-Guardia N, Calingaert B, et al. Safety of non-steroidal anti-inflammatory drugs P. individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35:1127-1146.</Citation></Reference><Reference><Citation>Gulmez SE, Larrey D, Pageaux GP, et al. Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the study of acute liver transplant (SALT). Eur J Clin Pharmacol. 2013;69:605-616.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36(Suppl 1):S33-S47.</Citation></Reference><Reference><Citation>Coloma PM, Avillach P, Salvo F, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf. 2013;36:13-23.</Citation></Reference><Reference><Citation>Reich C, Ryan P, Schuemie MJ. Alternative outcome definitions and their effect on the performance of methods for observational outcome studies. Drug Saf. 2013;36(Suppl 1):S181-S193.</Citation></Reference><Reference><Citation>Duong M, Salvo F, Pariente A, et al. Usage patterns of 'over-the-counter&#x2019; vs. prescription-strength nonsteroidal anti-inflammatory drugs in France. Br J Clin Pharmacol. 2014;77:887-895.</Citation></Reference><Reference><Citation>Bezin J, Pariente A, Lassalle R, et al. Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol. 2014;70(4):429-436.</Citation></Reference><Reference><Citation>Rapsomaniki E, Thuresson M, Yang E, et al. Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction. Eur Heart J Qual Care Clin Outcomes. 2016;2(3):172-183.</Citation></Reference><Reference><Citation>Blin P, Dureau-Pournin C, Lassalle R, Abouelfath A, Droz-Perroteau C, Moore N. A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC. Br J Clin Pharmacol. 2016;81:569-578.</Citation></Reference><Reference><Citation>Gulmez SE, Unal US, Lassalle R, Chartier A, Grolleau A, Moore N. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: preliminary results from the EPIHAM study. Pharmacoepidemiol Drug Saf. 2018;27:1174-1181.</Citation></Reference><Reference><Citation>Moore N, Duret S, Grolleau A, et al. Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French national healthcare data system. Drug Saf. 2019;42(4):559-572.</Citation></Reference><Reference><Citation>Armstrong B. A simple estimator of minimum detectable relative risk, sample size, or power in cohort studies. Am J Epidemiol. 1987;126:356-358.</Citation></Reference><Reference><Citation>Whitaker H, Farrington C, Spiessens B, Musonda P. Tutorail in biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768-1797.</Citation></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33:209-218.</Citation></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35:3883-3888.</Citation></Reference><Reference><Citation>Gruber S, Tchetgen Tchetgen E. Limitations of empirical calibration of p-values using observational data. Stat Med. 2016;35:3869-3882.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI; 2019.</Citation></Reference><Reference><Citation>Schuemie M, Soledad C, Suchard M, Tian Y, Schuler A, Ryan P, Hripcsak G. Empirical evaluation of the OHDSI methods library. OHDSI Symposium 2017. https://www.ohdsi.org/past-events/2017-ohdsi-symposium-materials/.</Citation></Reference><Reference><Citation>Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976;103:226-235.</Citation></Reference><Reference><Citation>Miettinen OS. Estimation of relative risk from individually matched series. Biometrics. 1970;26:75-86.</Citation></Reference><Reference><Citation>Schneeweiss S, Suissa S. Discussion of Schuemie et al: "a plea to stop using the case-control design in retrospective database studies". Stat Med. 2019;38:4209-4212.</Citation></Reference><Reference><Citation>Ibanez L, Ballarin E, Vidal X, Laporte JR. Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches. Eur J Clin Pharmacol. 2000;56:763-767.</Citation></Reference><Reference><Citation>Keisu M, Ekman E, Wiholm BE. Comparing risk estimates of sulphonamide-induced agranulocytosis from the Swedish drug monitoring system and a case-control study. Eur J Clin Pharmacol. 1992;43:211-214.</Citation></Reference><Reference><Citation>Laporte JR, Ibanez L, Ballarin E, Perez E, Vidal X. Fatal aplastic anaemia associated with nifedipine. Lancet. 1998;352:619-620.</Citation></Reference><Reference><Citation>Laporte JR, Vidal X, Ballarin E, Ibanez L. Possible association between ocular chloramphenicol and aplastic anaemia-the absolute risk is very low. Br J Clin Pharmacol. 1998;46:181-184.</Citation></Reference><Reference><Citation>Hauben M, Aronson JK, Ferner RE. Evidence of misclassification of drug-event associations classified as gold standard 'Negative controls&#x2019; by the observational medical outcomes partnership (OMOP). Drug Saf. 2016;39:421-432.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32134536</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5448</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pediatric diabetes</Title><ISOAbbreviation>Pediatr Diabetes</ISOAbbreviation></Journal><ArticleTitle>Treatment regimens and glycosylated hemoglobin levels in youth with Type 1 and Type 2 diabetes: Data from SEARCH (United States) and YDR (India) registries.</ArticleTitle><Pagination><StartPage>31</StartPage><EndPage>39</EndPage><MedlinePgn>31-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pedi.13004</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To compare treatment regimens and glycosylated hemoglobin (A1c) levels in Type 1 (T1D) and Type 2 diabetes (T2D) using diabetes registries from two countries-U.S. SEARCH for Diabetes in Youth (SEARCH) and Indian Registry of youth onset diabetes in India (YDR).</AbstractText><AbstractText Label="METHODS">The SEARCH and YDR data were harmonized to the structure and terminology in the Observational Medical Outcomes Partnership Common Data Model. Data used were from T1D and T2D youth diagnosed &lt;20&#x2009;years between 2006-2012 for YDR, and 2006, 2008, and 2012 for SEARCH. We compared treatment regimens and A1c levels across the two registries.</AbstractText><AbstractText Label="RESULTS">There were 4003 T1D (SEARCH = 1899; YDR = 2104) and 611 T2D (SEARCH = 384; YDR = 227) youth. The mean A1c was higher in YDR compared to SEARCH (T1D:11.0%&#x2009;&#xb1;&#x2009;2.9% vs 7.8% &#xb1;&#x2009;1.7%, P&#x2009;&lt;&#x2009;.001; T2D:9.9%&#x2009;&#xb1;&#x2009;2.8% vs 7.2%&#x2009;&#xb1;&#x2009;2.1%, P&#x2009;&lt;&#x2009;.001). Among T1D youth in SEARCH, 65.1% were on a basal/bolus regimen, whereas in YDR, 52.8% were on once/twice daily insulin regimen. Pumps were used by 16.2% of SEARCH and 1.5% of YDR youth with T1D. Among T2D youth, in SEARCH and YDR, a majority were on metformin only (43.0% vs 30.0%), followed by insulin&#x2009;+&#x2009;any oral hypoglycemic agents (26.3% vs 13.7%) and insulin only (12.8% vs 18.9%), respectively.</AbstractText><AbstractText Label="CONCLUSION">We found significant differences between SEARCH and YDR in treatment patterns in T1D and T2D. A1c levels were higher in YDR than SEARCH youth, for both T1D and T2D, irrespective of the regimens used. Efforts to achieve better glycemic control for youth are urgently needed to reduce the risk of long-term complications.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amutha</LastName><ForeName>Anandakumar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Madras Diabetes Research Foundation &amp; Dr. Mohan's Diabetes Specialties Centre, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Praveen</LastName><ForeName>Pradeep A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Endocrinology &amp; Metabolism, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hockett</LastName><ForeName>Christine W</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0002-1665-6763</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Toan C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Elizabeth T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isom</LastName><ForeName>Scott P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agostino</LastName><ForeName>Ralph B Jr</ForeName><Initials>RBJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamman</LastName><ForeName>Richard F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer-Davis</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-3858-0517</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadwa</LastName><ForeName>Raj Paul</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Jean M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pihoker</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9074-7770</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabelea</LastName><ForeName>Dana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9514-8929</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4604-1986</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology &amp; Metabolism, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Viswanathan</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5038-6210</Identifier><AffiliationInfo><Affiliation>Department of Diabetology, Madras Diabetes Research Foundation &amp; Dr. Mohan's Diabetes Specialties Centre, Chennai, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U18DP006139</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000247</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002710</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP006138</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006138</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000154</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002714</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000248</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000244</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006134</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002709</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006131</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000077</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000423</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK057516</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HIR 10-001</GrantID><Acronym>HX</Acronym><Agency>HSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 DK105869</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006136</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000250</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000246</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000254</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006133</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002708</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21DK105869-02</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pediatr Diabetes</MedlineTA><NlmUniqueID>100939345</NlmUniqueID><ISSNLinking>1399-543X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">A1c levels</Keyword><Keyword MajorTopicYN="N">Type 1 diabetes</Keyword><Keyword MajorTopicYN="N">diabetes registry</Keyword><Keyword MajorTopicYN="N">youth onset Type 2 diabetes</Keyword></KeywordList><CoiStatement><b>Disclosures:</b> None of the authors have any potential conflicts of interest relevant to the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32134536</ArticleId><ArticleId IdType="mid">NIHMS1648764</ArticleId><ArticleId IdType="pmc">PMC7744104</ArticleId><ArticleId IdType="doi">10.1111/pedi.13004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amutha A, Datta M, Unnikrishnan IR, Anjana RM, Rema M, Narayan KM, Mohan V. Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in south India. Prim Care Diabetes. 2011. December;5(4):223&#x2013;9. doi: 10.1016/j.pcd.2011.04.003. Epub 2011 May 23. PubMed PMID: 21601548</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2011.04.003</ArticleId><ArticleId IdType="pubmed">21601548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran A, Snehalatha C, Ma RC. Diabetes in South-East Asia: an update. Diabetes Res Clin Pract 2014;103(2):231&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">24300015</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabelea D, DeGroat J, Sorrelman C, Glass M, Percy CA, Avery C, Hu D, D&#x2019;Agostino RB Jr, Beyer J, Imperatore G, Testaverde L, Klingensmith G, Hamman RF; SEARCH for Diabetes in Youth Study Group. Diabetes in Navajo youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009. March;32 Suppl 2:S141&#x2013;7. doi: 10.2337/dc09-S206. PubMed PMID: 19246579; PubMed Central PMCID: PMC2647690.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-S206</ArticleId><ArticleId IdType="pmc">PMC2647690</ArticleId><ArticleId IdType="pubmed">19246579</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton J, Crume T, Liese AD, Merchant AT, Lawrence JM, Reynolds K, Dolan L, Liu LL, Hamman RF, for the SEARCH for Diabetes in Youth Study. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. Journal of the American Medical Association 2014;311(17):1778&#x2013;1786. PMID: 24794371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4368900</ArticleId><ArticleId IdType="pubmed">24794371</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence JM, Imperatore G, Dabelea D, Mayer-Davis EJ, Linder B, Saydah S, Klingensmith GJ, Dolan L, Standiford DA, Pihoker C, Pettitt DJ, Talton JW, Thomas J, Bell RA, D&#x2019;Agostino RB Jr; SEARCH for Diabetes in Youth Study Group. Trends in incidence of type 1 diabetes among non-Hispanic white youth in the U.S., 2002&#x2013;2009. Diabetes. 2014. November;63(11):3938&#x2013;45. doi: 10.2337/db13-1891. Epub 2014. Jun 4. PubMed PMID: 24898146; PubMed Central PMCID: PMC4207387.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-1891</ArticleId><ArticleId IdType="pmc">PMC4207387</ArticleId><ArticleId IdType="pubmed">24898146</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, Imperatore G, Linder B, Marcovina S, Pettitt DJ, Pihoker C, Saydah S, Wagenknecht L, SEARCH for Diabetes in Youth Study. Incidence Trends of Type 1 and Type 2 Diabetes Among Youths, 2002&#x2013;2012. The New England Journal of Medicine 2017; 376:1419&#x2013;1429. PMID: 28402773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592722</ArticleId><ArticleId IdType="pubmed">28402773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh K, Saligram PS, Hort K. What explains regulatory failure? Analysing the architecture of health care regulation in two Indian states. Health Policy Plan 2015; 30(1): 39&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">24342742</ArticleId></ArticleIdList></Reference><Reference><Citation>The U.S. Health Care System: An International Perspective - DPEAFLCIO". dpeajlcio.org.</Citation></Reference><Reference><Citation>Fast Facts on US Hospitals". Aha.org. Retrieved December
1, 2016</Citation></Reference><Reference><Citation>Pihoker C, Badaru A, Anderson A, Morgan T, Dolan L, Dabelea D, Imperatore G, Linder B, Marcovina S, Mayer-Davis E, Reynolds K, Klingensmith GJ; SEARCH for Diabetes in Youth Study Group. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the SEARCH for Diabetes in Youth study. Diabetes Care. 2013. January;36(1):27&#x2013;33. doi: 10.2337/dc12-0720. Epub 2012 Sep 6. PubMed PMID: 22961571; PubMed Central PMCID: PMC3526205.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc12-0720</ArticleId><ArticleId IdType="pmc">PMC3526205</ArticleId><ArticleId IdType="pubmed">22961571</ArticleId></ArticleIdList></Reference><Reference><Citation>Badaru A, Klingensmith GJ, Dabelea D, Mayer-Davis EJ, Dolan L, Lawrence JM, Marcovina S, Beavers D, Rodriguez BL, Imperatore G, Pihoker C. Correlates of treatment patterns among youth with type 2 diabetes. Diabetes Care. 2014;37(1):64&#x2013;72. doi: 10.2337/dc13-1124. Epub 2013 Sep 11. PubMed PMID: 24026554; PubMed Central PMCID: PMC3867996.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-1124</ArticleId><ArticleId IdType="pmc">PMC3867996</ArticleId><ArticleId IdType="pubmed">24026554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamman RF, Bell RA, Dabelea D, D'Agostino RB Jr, Dolan L, Imperatore G, Lawrence JM, Linder B, Marcovina SM, Mayer-Davis EJ, Pihoker C, Rodriguez BL, Saydah S; SEARCH for Diabetes in Youth Study Group. The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care. 2014. December;37(12):3336&#x2013;44. doi: 10.2337/dc14-0574. Review. PubMed PMID: 25414389; PubMed Central PMCID: PMC4237981.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-0574</ArticleId><ArticleId IdType="pmc">PMC4237981</ArticleId><ArticleId IdType="pubmed">25414389</ArticleId></ArticleIdList></Reference><Reference><Citation>Praveen PA, Madhu SV, Mohan V, Das S, Kakati S, Shah N, Chaddha M, Bhadada SK, Das AK, Shukla DK, Kaur T, Tandon N. Registry of Youth Onset Diabetes in India (YDR): Rationale, Recruitment, and Current Status. J Diabetes Sci Technol. 2016. August 22;10(5):1034&#x2013;41. doi: 10.1177/1932296816645121. Print 2016 Sep. PubMed PMID: 27179010; PubMed Central PMCID: PMC5032954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296816645121</ArticleId><ArticleId IdType="pmc">PMC5032954</ArticleId><ArticleId IdType="pubmed">27179010</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO &#x2223; The WHO Child Growth Standards. WHO; 
http://www.who.int/childgrowth/en/
Accessed November 26, 2018.</Citation></Reference><Reference><Citation>Rewers MJ, Pillay K, de Beaufort C, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2014;15(Suppl. 20):102&#x2013;114 pmid:25182311.</Citation><ArticleIdList><ArticleId IdType="pubmed">25182311</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanungo A, Jhingan A, Sahay RK, Muruganathan A, Das AK; Diabetes Consensus Group. Consensus evidence-based guidelines for insulin therapy in patients with type 1 diabetes mellitus as per Indian clinical practice. J Assoc Physicians India. 2014. July;62(7 Suppl):26&#x2013;33. Review. PubMed PMID: 25668934.</Citation><ArticleIdList><ArticleId IdType="pubmed">25668934</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013;36:S11&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3537269</ArticleId><ArticleId IdType="pubmed">23264422</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults, 2012. 
http://www.nice.org.uk/nicemedia/live/10944/29390/29390.pdf Last accessed on February 18, 2014.</Citation></Reference><Reference><Citation>Cheng AY, Lau DC. The Canadian diabetes association 2013 clinical practice guidelines raising the bar and setting higher standards. Can J Diabetes 2013;37:137&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">24070834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesavadev J, Das AK, Unnikrishnan R 1st, Joshi SR, Ramachandran A, Shamsudeen J, Krishnan G, Jothydev S, Mohan V. Use of insulin pumps in India: suggested guidelines based on experience and cultural differences. Diabetes Technol Ther. 2010. October;12(10):823&#x2013;31. doi: 10.1089/dia.2010.0027. PubMed PMID: 20807118; PubMed Central PMCID: PMC2956384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2010.0027</ArticleId><ArticleId IdType="pmc">PMC2956384</ArticleId><ArticleId IdType="pubmed">20807118</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudhakaran C, Anjana RM, Rao K, Unnikrishnan R 1st, Suresh T, Mohan V. Role of continuous subcutaneous insulin infusion in patients with recalcitrant diabetes in South India. Diabetes Technol Ther. 2009. November;11(11):733&#x2013;7. doi: 10.1089/dia.2009.0066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2009.0066</ArticleId><ArticleId IdType="pubmed">19905890</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris CA, Imperatore G, Klingensmith G, Petitti D, Rodriguez B, Anderson AM, Schwartz ID, Standiford DA, Pihoker C. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatr. 2009. August;155(2):183&#x2013;9.e1. doi: 10.1016/j.jpeds.2009.01.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2009.01.063</ArticleId><ArticleId IdType="pubmed">19394043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, Arslanian S, Cuttler L, Nathan DM, Tollefsen S, Wilfley D, Kaufman F. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012. June 14;366(24):2247&#x2013;56. doi: 10.1056/NEJMoa1109333. Epub 2012 Apr 29. PubMed PMID: 22540912; PubMed Central PMCID: PMC3478667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1109333</ArticleId><ArticleId IdType="pmc">PMC3478667</ArticleId><ArticleId IdType="pubmed">22540912</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen SG, Hoekstra JB, DeVries JH. Insulin therapy for type 2 diabetes. Diabetes Care. 2009. November;32 Suppl 2:S253&#x2013;9. doi: 10.2337/dc09-S318. Review. PubMed PMID: 19875560; PubMed Central PMCID: PMC2811456.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-S318</ArticleId><ArticleId IdType="pmc">PMC2811456</ArticleId><ArticleId IdType="pubmed">19875560</ArticleId></ArticleIdList></Reference><Reference><Citation>Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008. October 9;359(15):1577&#x2013;89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10. PubMed PMID: 18784090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0806470</ArticleId><ArticleId IdType="pubmed">18784090</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury S. Puberty and type 1 diabetes. Indian journal of endocrinology and metabolism, 2015. 19(Suppl 1), S51&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4413391</ArticleId><ArticleId IdType="pubmed">25941652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatric Diabetes 2009: 10 (Suppl. 12): 71&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">19754620</ArticleId></ArticleIdList></Reference><Reference><Citation>George MM, &amp; Copeland KC Current treatment options for type 2 diabetes mellitus in youth: today&#x2019;s realities and lessons from the TODAY study. Current diabetes reports, 2013. 13(1), 72&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3545061</ArticleId><ArticleId IdType="pubmed">23065368</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care. 2007. April;30(4):790&#x2013;4. PubMed PMID: 17392540.</Citation><ArticleIdList><ArticleId IdType="pubmed">17392540</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaidyanathan J, Choe S, Sahajwalla CG. Type 2 diabetes in pediatrics and adults: thoughts from a clinical pharmacology perspective. Journal of pharmaceutical sciences. 2012;101(5):1659&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">22383396</ArticleId></ArticleIdList></Reference><Reference><Citation>Unnikrishnan R, Anjana RM, Deepa M, et al. Glycemic control among individuals with self-reported diabetes in India--the ICMR-INDIAB Study. Diabetes Technol Ther. 2014;16(9):596&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4135327</ArticleId><ArticleId IdType="pubmed">25101698</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements MA, Foster NC, Maahs DM, Schatz DA, Olson BA, Tsalikian E, Lee JM, Burt-Solorzano CM, Tamborlane WV, Chen V, Miller KM, Beck RW; T1D Exchange Clinic Network. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes. 2016. August;17(5):327&#x2013;36. doi: 10.1m/pedi.12295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1m/pedi.12295</ArticleId><ArticleId IdType="pubmed">26153338</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV; T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015. June;38(6):971&#x2013;8. doi: 10.2337/dc15-0078. PubMed PMID: 25998289.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc15-0078</ArticleId><ArticleId IdType="pubmed">25998289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahkoska AR, Shay CM, Crandell J, et al. Association of Race and Ethnicity With Glycemic Control and Hemoglobin A1c Levels in Youth With Type 1 Diabetes. JAMA Netw Open. 2018;1(5):e181851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6203341</ArticleId><ArticleId IdType="pubmed">30370425</ArticleId></ArticleIdList></Reference><Reference><Citation>Copeland KC, Zeitler P, Geffner M, et al.; TODAY Study Group. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab 2011; 96:159&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038479</ArticleId><ArticleId IdType="pubmed">20962021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellers EAC, Yung G, Dean HJ. Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus. Pediatr Diabetes 2007; 8:384&#x2013;390</Citation><ArticleIdList><ArticleId IdType="pubmed">18036065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadeau KJ, Anderson BJ, Berg EG, Chiang JL, Chou H, Copeland KC, Hannon TS, Huang TT, Lynch JL, Powell J, Sellers E, Tamborlane WV, Zeitler P. Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities. Diabetes Care. 2016. September;39(9):1635&#x2013;42. doi: 10.2337/dc16-1066.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-1066</ArticleId><ArticleId IdType="pmc">PMC5314694</ArticleId><ArticleId IdType="pubmed">27486237</ArticleId></ArticleIdList></Reference><Reference><Citation>Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 2014; 37:436&#x2013;443</Citation><ArticleIdList><ArticleId IdType="pubmed">24130346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannon TS, Arslanian SA. The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes. Ann N Y Acad Sci 2015; 1353:113&#x2013;137 22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26448515</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabelea D, Stafford JM, Mayer-Davis EJ, D&#x2019;Agostino R Jr, Dolan L, Imperatore G, Linder B, Lawrence JM, Marcovina SM, Mottl AK, Black MH, Pop-Busui R, Saydah S, Hamman RF, Pihoker C, SEARCH for Diabetes in Youth Research Group. Association of Type 1 Diabetes Vs Type 2 Diabetes Diagnosed During Childhood and Adolescence with Complications During Teenage Years and Young Adulthood. JAMA 2017;317:825&#x2013;835. PMID: 28245334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5483855</ArticleId><ArticleId IdType="pubmed">28245334</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32134687</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2473-4276</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>JCO clinical cancer informatics</Title><ISOAbbreviation>JCO Clin Cancer Inform</ISOAbbreviation></Journal><ArticleTitle>Treatment Patterns for Chronic Comorbid Conditions in Patients With Cancer Using a Large-Scale Observational Data Network.</ArticleTitle><Pagination><StartPage>171</StartPage><EndPage>183</EndPage><MedlinePgn>171-183</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CCI.19.00107</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1200/CCI.19.00107</ELocationID><Abstract><AbstractText Label="PURPOSE">Patients with cancer are predisposed to developing chronic, comorbid conditions that affect prognosis, quality of life, and mortality. While treatment guidelines and care variations for these comorbidities have been described for the general noncancer population, less is known about real-world treatment patterns in patients with cancer. We sought to characterize the prevalence and distribution of initial treatment patterns across a large-scale data network for depression, hypertension, and type II diabetes mellitus (T2DM) among patients with cancer.</AbstractText><AbstractText Label="METHODS">We used the Observational Health Data Sciences and Informatics network, an international collaborative implementing the Observational Medical Outcomes Partnership Common Data Model to standardize more than 2 billion patient records. For this study, we used 8 databases across 3 countries-the United States, France, and Germany-with 295,529,655 patient records. We identified patients with cancer using SNOMED (Systematized Nomenclature of Medicine) codes validated via manual review. We then characterized the treatment patterns of these patients initiating treatment of depression, hypertension, or T2DM with persistent treatment and at least 365 days of observation.</AbstractText><AbstractText Label="RESULTS">Across databases, wide variations exist in treatment patterns for depression (n = 1,145,510), hypertension (n = 3,178,944), and T2DM (n = 886,766). When limited to 6-node (6-drug) sequences, we identified 61,052 unique sequences for depression, 346,067 sequences for hypertension, and 40,629 sequences for T2DM. These variations persisted across sites, databases, countries, and conditions, with the exception of metformin (73.8%) being the most common initial T2DM treatment. The most common initial medications were sertraline (17.5%) and escitalopram (17.5%) for depression and hydrochlorothiazide (20.5%) and lisinopril (19.6%) for hypertension.</AbstractText><AbstractText Label="CONCLUSION">We identified wide variations in the treatment of common comorbidities in patients with cancer, similar to the general population, and demonstrate the feasibility of conducting research on patients with cancer across a large-scale observational data network using a common data model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ruijun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medical College, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crew</LastName><ForeName>Katherine D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Medicine and the Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vashisht</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randhawa</LastName><ForeName>Gurvaneet</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Health Systems and Interventions Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCO Clin Cancer Inform</MedlineTA><NlmUniqueID>101708809</NlmUniqueID><ISSNLinking>2473-4276</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/cci/author-center. Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments). PATRICK RYAN: <b>Employment:</b> Janssen Research &amp; Development <b>Stock and Other Ownership Interests:</b> Johnson &amp; Johnson NIGAM H. SHAH: <b>Leadership:</b> Prealize Health <b>Stock and Other Ownership Interests:</b> Apixio <b>Consulting or Advisory Role:</b> Apixio <b>Research Funding:</b> Google (Inst) <b>Travel, Accommodations, Expenses:</b> Apixio GEORGE HRIPCSAK: <b>Research Funding:</b> Janssen Research &amp; Development No other potential conflicts of interest were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32134687</ArticleId><ArticleId IdType="pmc">PMC7113074</ArticleId><ArticleId IdType="doi">10.1200/CCI.19.00107</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Edwards BK, Noone A-M, Mariotto AB, et al. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3999205</ArticleId><ArticleId IdType="pubmed">24343171</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;gaard M, Thomsen RW, Bossen KS, et al. The impact of comorbidity on cancer survival: A review. Clin Epidemiol. 2013;5(suppl 1):3&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820483</ArticleId><ArticleId IdType="pubmed">24227920</ArticleId></ArticleIdList></Reference><Reference><Citation>Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">8256968</ArticleId></ArticleIdList></Reference><Reference><Citation>Albertsen PC, Moore DF, Shih W, et al. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol. 2011;29:1335&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3084001</ArticleId><ArticleId IdType="pubmed">21357791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003;103:792&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">12516101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the &#x201c;silver tsunami&#x201d;: Prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev. 2016;25:1029&#x2013;1036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933329</ArticleId><ArticleId IdType="pubmed">27371756</ArticleId></ArticleIdList></Reference><Reference><Citation>Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35:181&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">10960800</ArticleId></ArticleIdList></Reference><Reference><Citation>Chochinov HM. Depression in cancer patients. Lancet Oncol. 2001;2:499&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">11905726</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon L, Yin H, Suissa S, et al. Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control. 2014;25:329&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">24384808</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32:1605&#x2013;1619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090422</ArticleId><ArticleId IdType="pubmed">24733793</ArticleId></ArticleIdList></Reference><Reference><Citation>McDaniel JS, Musselman DL, Porter MR, et al. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995;52:89&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">7848055</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;2004:32&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">15263039</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman E, Messerli FH, Boyko V, et al. Is there an association between hypertension and cancer mortality? Am J Med. 2002;112:479&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">11959059</ArticleId></ArticleIdList></Reference><Reference><Citation>Scartozzi M, Galizia E, Chiorrini S, et al. Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab. Ann Oncol. 2009;20:227&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">18842611</ArticleId></ArticleIdList></Reference><Reference><Citation>Rini BI, Cohen DP, Lu DR, et al. Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst. 2011;103:763&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086879</ArticleId><ArticleId IdType="pubmed">21527770</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000;284:2907&#x2013;2911.</Citation><ArticleIdList><ArticleId IdType="pubmed">11147988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranpura V, Pulipati B, Chu D, et al. Increased risk of high-grade hypertension with bevacizumab in cancer patients: A meta-analysis. Am J Hypertens. 2010;23:460&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">20186127</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Chen JJ, Kudelka A, et al. Incidence and risk of hypertension with sorafenib in patients with cancer: A systematic review and meta-analysis. Lancet Oncol. 2008;9:117&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">18221915</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelton PK, Carey RM, Aronow WS, et al: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 71:1269-1324, 2018 [Errata: Hypertension 71:e136-e139, 2018; Hypertension 72:e33, 2018] PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">29133354</ArticleId></ArticleIdList></Reference><Reference><Citation> Work Group on Major Depressive Disorder.  https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf.</Citation></Reference><Reference><Citation>American Diabetes Association 8. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(suppl 1):S73&#x2013;S85.</Citation><ArticleIdList><ArticleId IdType="pubmed">29222379</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin SS, Calle EE, Teras LR, et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004;159:1160&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pubmed">15191933</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R, Lieu T. Data enclaves for sharing information derived from clinical and administrative data. JAMA. 2018;320:753&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">30083726</ArticleId></ArticleIdList></Reference><Reference><Citation>Randhawa GS, Slutsky JR. Building sustainable multi-functional prospective electronic clinical data systems. Med Care. 2012;50(suppl):S3&#x2013;S6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22692255</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics  Mission, vision &amp; values.  https://www.ohdsi.org/who-we-are/mission-vision-values/</Citation></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, et al. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA. 2016;113:7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan P, Belenkaya R, et al.  OMOP Common Data Model v5.3 Specifications.  https://github.com/OHDSI/CommonDataModel</Citation></Reference><Reference><Citation> Observational Health Data Sciences and Informatics: Treatment Pathways in Patients With Cancer.  https://www.ohdsi.org/web/wiki/doku.php?id=research:treatment_pathways_in_cancer_12mo.</Citation></Reference><Reference><Citation> Observational Health Data Sciences and Informatics: Common Data Model.  https://github.com/OHDSI/CommonDataModel/wiki.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320306</ArticleId><ArticleId IdType="pubmed">32530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">10088625</ArticleId></ArticleIdList></Reference><Reference><Citation>Barone BB, Yeh H-C, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA. 2008;300:2754&#x2013;2764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093051</ArticleId><ArticleId IdType="pubmed">19088353</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Poll-Franse LV, Houterman S, Janssen-Heijnen MLG, et al. Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis. Int J Cancer. 2007;120:1986&#x2013;1992.</Citation><ArticleIdList><ArticleId IdType="pubmed">17230509</ArticleId></ArticleIdList></Reference><Reference><Citation>Keating NL, O&#x2019;Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006;24:4448&#x2013;4456.</Citation><ArticleIdList><ArticleId IdType="pubmed">16983113</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: A consensus report. Diabetes Care. 2010;33:1674&#x2013;1685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2890380</ArticleId><ArticleId IdType="pubmed">20587728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32162290</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Erratum: Transforming French Electronic Health Records into the Observational Medical Outcome Partnership's Common Data Model: A Feasibility Study.</ArticleTitle><Pagination><StartPage>e1</StartPage><MedlinePgn>e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1702166</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamer</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Depas</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doutreligne</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bureau Etat de Sant&#xe9; de la Population, Minist&#xe8;re des Affaires Sociales et de la Sant&#xe9;, Direction de la Recherche, des Etudes et des Statistiques - Observation de la Sant&#xe9; et de l'Assurance Maladie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrot</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Descartes, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Web INnovation Donn&#xe9;es-Direction des Syst&#xe8;mes d'Information, Assistance Publique - H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verloop</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service Etudes et Statistiques, ARS Hauts-de-France, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defebvre</LastName><ForeName>Marguerite-Marie</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Service Etudes et Statistiques, ARS Hauts-de-France, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ficheur</LastName><ForeName>Gr&#xe9;goire</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chazard</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beuscart</LastName><ForeName>Jean-Baptiste</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694-METRICS: &#xc9;valuation des Technologies de Sant&#xe9; et des Pratiques M&#xe9;dicales, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Appl Clin Inform. 2020 Jan;11(1):13-22. doi: 10.1055/s-0039-3402754</RefSource><PMID Version="1">31914471</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32162290</ArticleId><ArticleId IdType="pmc">PMC7065979</ArticleId><ArticleId IdType="doi">10.1055/s-0040-1702166</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32196874</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5448</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pediatric diabetes</Title><ISOAbbreviation>Pediatr Diabetes</ISOAbbreviation></Journal><ArticleTitle>Comparison of the incidence of diabetes in United States and Indian youth: An international harmonization of youth diabetes registries.</ArticleTitle><Pagination><StartPage>8</StartPage><EndPage>14</EndPage><MedlinePgn>8-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pedi.13009</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Incidence of youth-onset diabetes in India has not been well described. Comparison of incidence, across diabetes registries, has the potential to inform hypotheses for risk factors. We sought to compare the incidence of diabetes in the U.S.-based registry of youth onset diabetes (SEARCH) to the Registry of Diabetes with Young Age at Onset (YDR-Chennai and New Delhi regions) in India.</AbstractText><AbstractText Label="METHODS">We harmonized data from both SEARCH and YDR to the Observational Medical Outcomes Partnership (OMOP) Common Data Model. Data were from youth registered with incident diabetes (2006-2012). Denominators were from census and membership data. We calculated diabetes incidence by averaging the total cases across the entire follow-up period and dividing this by the estimated census population corresponding to the source population for case ascertainment. Incidence was calculated for each of the registries and compared by type and within age and sex categories using a 2-sided, skew-corrected inverted score test.</AbstractText><AbstractText Label="RESULTS">Incidence of type 1 was higher in SEARCH (21.2 cases/100&#x2009;000 [95% CI: 19.9, 22.5]) than YDR (4.9 cases/100&#x2009;000 [95% CI: 4.3, 5.6]). Incidence of type 2 diabetes was also higher in SEARCH (5.9 cases/100&#x2009;000 [95% CI: 5.3, 6.6] in SEARCH vs 0.5/cases/100&#x2009;000 [95% CI: 0.3, 0.7] in YDR). The age distribution of incident type 1 diabetes cases was similar across registries, whereas type 2 diabetes incidence was higher at an earlier age in SEARCH. Sex differences existed in SEARCH only, with a higher rate of type 2 diabetes among females.</AbstractText><AbstractText Label="CONCLUSION">The incidence of youth-onset type 1 and 2 diabetes was significantly different between registries. Additional data are needed to elucidate whether the differences observed represent diagnostic delay, differences in genetic susceptibility, or differences in distribution of risk factors.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Elizabeth T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabelea</LastName><ForeName>Dana A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0001-9514-8929</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Praveen</LastName><ForeName>Pradeep A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Metabolism and Diabetes, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amutha</LastName><ForeName>Anandakumar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hockett</LastName><ForeName>Christine W</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0002-1665-6763</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isom</LastName><ForeName>Scott P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Toan C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Viswanathan</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-7939-6295</Identifier><AffiliationInfo><Affiliation>Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agostino</LastName><ForeName>Ralph</ForeName><Initials>R</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Biostatistics and Data Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamman</LastName><ForeName>Richard F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadwa</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolan</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Jean M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Research &amp; Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madhu</LastName><ForeName>S V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Centre for Diabetes, Endocrinology and Metabolism, University College of Medical Science, GTB Hospital, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chhokar</LastName><ForeName>Reshmi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Metabolism and Diabetes, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goel</LastName><ForeName>Komal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Metabolism and Diabetes, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4604-1986</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Metabolism and Diabetes, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer-Davis</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3858-0517</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK057516</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006139</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000247</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002710</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP006138</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006138</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000154</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002714</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000248</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000244</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006134</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002709</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006131</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000077</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK108173</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 DK105869</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK127208</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000423</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006136</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000250</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000246</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DP000254</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18DP006133</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 DP002708</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21DK105869-02</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pediatr Diabetes</MedlineTA><NlmUniqueID>100939345</NlmUniqueID><ISSNLinking>1399-543X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">India</Keyword><Keyword MajorTopicYN="N">United States</Keyword><Keyword MajorTopicYN="N">descriptive epidemiology of diabetes</Keyword><Keyword MajorTopicYN="N">diabetes in youth; incidence</Keyword></KeywordList><CoiStatement><b>Disclosures:</b> None of the authors have any potential conflicts of interest relevant to the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32196874</ArticleId><ArticleId IdType="mid">NIHMS1648766</ArticleId><ArticleId IdType="pmc">PMC7748376</ArticleId><ArticleId IdType="doi">10.1111/pedi.13009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amed S, Islam N, Sutherland J, Reimer K. Incidence and prevalence trends of youth-onset type 2 diabetes in a cohort of Canadian youth: 2002&#x2013;2013. Pediatric diabetes. 2018;19(4):630&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">29280255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox DA, Islam N, Sutherland J, Reimer K, Amed S. Type 1 diabetes incidence and prevalence trends in a cohort of Canadian children and youth. Pediatric diabetes. 2018;19(3):501&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">28857360</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer-Davis EJ, Dabelea D, Lamichhane AP, et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCh for diabetes in youth case-control study. Diabetes Care. 2008;31(3):470&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">18071004</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazeli Farsani S, Souverein PC, van der Vorst MM, et al. Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the Netherlands. Pediatric diabetes. 2016;17(1):44&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">25377748</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson CC, Harjutsalo V, Rosenbauer J, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989&#x2013;2013: a multicentre prospective registration study. Diabetologia. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">30483858</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss LD, Hosking J, Metcalf BS, Jeffery AN, Fremeaux AE, Wilkin TJ. Metabolic risk in contemporary children is unrelated to socio-economic status: longitudinal study of a UK urban population (EarlyBird 42). Pediatric diabetes. 2014;15(3):244&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">24827703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolahdooz F, Nader F, Daemi M, Jang SL, Johnston N, Sharma S. Prevalence of Known Risk Factors for Type 2 Diabetes Mellitus in Multiethnic Urban Youth in Edmonton: Findings From the WHY ACT NOW Project. Canadian journal of diabetes. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">30551935</ArticleId></ArticleIdList></Reference><Reference><Citation>Praveen PA, Madhu SV, Mohan V, et al. Registry of Youth Onset Diabetes in India (YDR): Rationale, Recruitment, and Current Status. Journal of diabetes science and technology. 2016;10(5):1034&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5032954</ArticleId><ArticleId IdType="pubmed">27179010</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamman RF, Bell RA, Dabelea D, et al. The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care. 2014;37(12):3336&#x2013;3344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237981</ArticleId><ArticleId IdType="pubmed">25414389</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002&#x2013;2012. N Engl J Med. 2017;376(15):1419&#x2013;1429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592722</ArticleId><ArticleId IdType="pubmed">28402773</ArticleId></ArticleIdList></Reference><Reference><Citation>Verlato G, Muggeo M. Capture-recapture method in the epidemiology of type 2 diabetes: a contribution from the Verona Diabetes Study. Diabetes Care. 2000;23(6):759&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pubmed">10840992</ArticleId></ArticleIdList></Reference><Reference><Citation>Commissioner OotRGaC. 2011; http://www.censusindia.gov.in/2011census/censusdata2k11.aspx. Accessed
9.1.2018, 2018.</Citation></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. Journal of the American Medical Informatics Association : JAMIA. 2015;22(3):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra A, Sattar N, Tandon N, et al. Clinical management of type 2 diabetes in south Asia. The lancet Diabetes &amp; endocrinology. 2018;6(12):979&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pubmed">30287103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980&#x2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2014;384(9945):766&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4624264</ArticleId><ArticleId IdType="pubmed">24880830</ArticleId></ArticleIdList></Reference><Reference><Citation>Somera LP, Lee HR, Badowski G, Cassel K. Health Information Seeking, Source Trust, and Culture: A Comparative Analysis of Health Information Trends and Needs Between Guam and the United States. Journal of health communication. 2016;21(4):469&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4905759</ArticleId><ArticleId IdType="pubmed">26983674</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N, Gill JMR. Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. The Lancet Diabetes &amp; Endocrinology. 2015;3(12):1004&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">26489808</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra A, Tandon N, Ebrahim S, et al. Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions. Bmj. 2017;357:j1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">28400361</ArticleId></ArticleIdList></Reference><Reference><Citation>Harron KL, Feltbower RG, McKinney PA, Bodansky HJ, Campbell FM, Parslow RC. Rising rates of all types of diabetes in south Asian and non-south Asian children and young people aged 0&#x2013;29 years in West Yorkshire, U.K., 1991&#x2013;2006. Diabetes Care. 2011;34(3):652&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041200</ArticleId><ArticleId IdType="pubmed">21278139</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayashree M, Singhi S. Diabetic ketoacidosis: predictors of outcome in a pediatric intensive care unit of a developing country. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2004;5(5):427&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">15329157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran A, Snehalatha C, Vijay V, King H. Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabet Med. 2002;19(2):130&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">11874429</ArticleId></ArticleIdList></Reference><Reference><Citation>Raskind IG, Patil SS, Haard&#xf6;rfer R, Cunningham SA. UNHEALTHY WEIGHT IN INDIAN FAMILIES: THE ROLE OF THE FAMILY ENVIRONMENT IN THE CONTEXT OF THE NUTRITION TRANSITION. Population research and policy review. 2018;37(2):157&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6023548</ArticleId><ArticleId IdType="pubmed">29962562</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32229499</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2632-1009</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>BMJ health &amp; care informatics</Title><ISOAbbreviation>BMJ Health Care Inform</ISOAbbreviation></Journal><ArticleTitle>Extending an open-source tool to measure data quality: case report on Observational Health Data Science and Informatics (OHDSI).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e100054</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjhci-2019-100054</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">As the health system seeks to leverage large-scale data to inform population outcomes, the informatics community is developing tools for analysing these data. To support data quality assessment within such a tool, we extended the open-source software Observational Health Data Sciences and Informatics (OHDSI) to incorporate new functions useful for population health.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed and tested methods to measure the completeness, timeliness and entropy of information. The new data quality methods were applied to over 100&#x2009;million clinical messages received from emergency department information systems for use in public health syndromic surveillance systems.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">While completeness and entropy methods were implemented by the OHDSI community, timeliness was not adopted as its context did not fit with the existing OHDSI domains. The case report examines the process and reasons for acceptance and rejection of ideas proposed to an open-source community like OHDSI.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dixon</LastName><ForeName>Brian E</ForeName><Initials>BE</Initials><Identifier Source="ORCID">0000-0002-1121-0607</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Indiana University Richard M Fairbanks School of Public Health, Indianapolis, Indiana, USA bedixon@regenstrief.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics, Regenstrief Institute Inc, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics, Regenstrief Institute Inc, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>French</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics, Regenstrief Institute Inc, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics, Regenstrief Institute Inc, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duke</LastName><ForeName>Jon D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Center for Health Analytics and Informatics, Georgia Tech Research Institute, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grannis</LastName><ForeName>Shaun J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics, Regenstrief Institute Inc, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 HS025502</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 LM012219</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Health Care Inform</MedlineTA><NlmUniqueID>101745500</NlmUniqueID><ISSNLinking>2632-1009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">information systems</Keyword><Keyword MajorTopicYN="N">medical informatics</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32229499</ArticleId><ArticleId IdType="mid">NIHMS1590928</ArticleId><ArticleId IdType="pmc">PMC7254131</ArticleId><ArticleId IdType="doi">10.1136/bmjhci-2019-100054</ArticleId><ArticleId IdType="pii">bmjhci-2019-100054</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dixon BE, Whipple EC, Lajiness JM, et al. . Utilizing an integrated infrastructure for outcomes research: a systematic review. Health Info Libr J 2016;33:7&#x2013;32.10.1111/hir.12127</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hir.12127</ArticleId><ArticleId IdType="pubmed">26639793</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine Digital infrastructure for the learning health system: the foundation for continuous improvement in health and health care: workshop series summary. Washington, DC: The National Academies Press, 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">22379651</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon BE, Rosenman M, Xia Y, et al. . A vision for the systematic monitoring and improvement of the quality of electronic health data. Stud Health Technol Inform 2013;192:884&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23920685</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Bakken S, Hripcsak G, et al. . A data quality assessment guideline for electronic health record data reuse. EGEMS 2017;5:14.10.5334/egems.218</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/egems.218</ArticleId><ArticleId IdType="pmc">PMC5983018</ArticleId><ArticleId IdType="pubmed">29881734</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw S-T, Chen H-Y, Maneze D, et al. . Health reform: is routinely collected electronic information fit for purpose? Emerg Med Australas 2012;24:57&#x2013;63.10.1111/j.1742-6723.2011.01486.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-6723.2011.01486.x</ArticleId><ArticleId IdType="pubmed">22313561</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon BE, Siegel JA, Oemig TV, et al. . Electronic health information quality challenges and interventions to improve public health surveillance data and practice. Public Health Rep 2013;128:546&#x2013;53.10.1177/003335491312800614</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/003335491312800614</ArticleId><ArticleId IdType="pmc">PMC3804098</ArticleId><ArticleId IdType="pubmed">24179266</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin EG, Law J, Ran W, et al. . Evaluating the quality and usability of open data for public health research: a systematic review of data Offerings on 3 open data platforms. J Public Health Manag Pract 2017;23:e5&#x2013;13.10.1097/PHH.0000000000000388</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHH.0000000000000388</ArticleId><ArticleId IdType="pubmed">26910872</ArticleId></ArticleIdList></Reference><Reference><Citation>Botts N, Bouhaddou O, Bennett J, et al. . Data quality and Interoperability challenges for eHealth exchange participants: observations from the Department of Veterans Affairs' virtual lifetime electronic record health pilot phase. AMIA Annu Symp Proc 2014;2014:307&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419918</ArticleId><ArticleId IdType="pubmed">25954333</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C, Rubin J, Brown J, et al. . Toward a science of learning systems: a research agenda for the high-functioning learning health system. J Am Med Inform Assoc 2015;22:43&#x2013;50.10.1136/amiajnl-2014-002977</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002977</ArticleId><ArticleId IdType="pmc">PMC4433378</ArticleId><ArticleId IdType="pubmed">25342177</ArticleId></ArticleIdList></Reference><Reference><Citation>A Learning Health System Activity; Roundtable on Value and Science-Driven Health Care; Institute of Medicine Observational studies in a learning health system: workshop summary. Washington (DC: National Academies Press (US), 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24830068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. . Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, et al. . Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012;19:54&#x2013;60.10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al. . Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann Intern Med 2010;153:600&#x2013;6.10.7326/0003-4819-153-9-201011020-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, et al. . Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia 2017;58:e101&#x2013;6.10.1111/epi.13828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13828</ArticleId><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Shahn Z, Madigan D, et al. . Birth month affects lifetime disease risk: a phenome-wide method. J Am Med Inform Assoc 2015;22:1042&#x2013;53.10.1093/jamia/ocv046</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv046</ArticleId><ArticleId IdType="pmc">PMC4986668</ArticleId><ArticleId IdType="pubmed">26041386</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, DeFalco FJ, Schuemie M, et al. . Multisite evaluation of a data quality tool for patient-level clinical data sets. EGEMS 2016;4:24.10.13063/2327-9214.1239</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1239</ArticleId><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, et al. . A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS 2016;4:18&#x2013;44.10.13063/2327-9214.1244</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon BE, Rahurkar S. Public Health Informatics : Hoyt RE, Hersh WR, Health informatics: practical guide. 7th edn Lulu, 2018.</Citation></Reference><Reference><Citation>Williams KS, Shah GH. Electronic health records and meaningful use in local health departments: updates from the 2015 NACCHO informatics assessment survey. J Public Health Manag Pract 2016;22 Suppl 6, Public Health Informatics:S27&#x2013;33.10.1097/PHH.0000000000000460</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHH.0000000000000460</ArticleId><ArticleId IdType="pmc">PMC5050007</ArticleId><ArticleId IdType="pubmed">27684614</ArticleId></ArticleIdList></Reference><Reference><Citation>Doroshenko A, Cooper D, Smith G, et al. . Evaluation of syndromic surveillance based on national health service direct derived data-England and Wales. MMWR Morb Mortal Wkly Rep 2005;54:117&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16177702</ArticleId></ArticleIdList></Reference><Reference><Citation>Buehler JW, Sonricker A, Paladini M, et al. . Syndromic surveillance practice in the United States: findings from a survey of state, territorial, and selected local health departments. Advances in Disease Surveillance 2008;6:1&#x2013;20.</Citation></Reference><Reference><Citation>Ong M-S, Magrabi F, Coiera E. Syndromic surveillance for health information system failures: a feasibility study. J Am Med Inform Assoc 2013;20:506&#x2013;12.10.1136/amiajnl-2012-001144</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-001144</ArticleId><ArticleId IdType="pmc">PMC3628054</ArticleId><ArticleId IdType="pubmed">23184193</ArticleId></ArticleIdList></Reference><Reference><Citation>Grannis S, Wade M, Gibson J, et al. . The Indiana public health emergency surveillance system: ongoing progress, early findings, and future directions. AMIA Annu Symp Proc 2006:304&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839268</ArticleId><ArticleId IdType="pubmed">17238352</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon BE, Lai PTS, Grannis SJ. Variation in information needs and quality: implications for public health surveillance and biomedical informatics. AMIA Annu Symp Proc 2013;2013:670&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900209</ArticleId><ArticleId IdType="pubmed">24551368</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI 
Welcome to OHDSI: observational health data sciences and informatics community, 2017.  Available: http://www.ohdsi.org/web/wiki/doku.php?id=welcome [Accessed 5 Dec 2017].</Citation></Reference><Reference><Citation>Wen C.
Add observation.row_created_db_time column: GitHub, 2017.  Available: https://github.com/OHDSI/CommonDataModel/issues/104 [Accessed 22 Dec 2017].</Citation></Reference><Reference><Citation>Wang RY, Strong DM. Beyond accuracy: what data quality means to data consumers. J Manag Inf Syst 1996;12:5&#x2013;33.10.1080/07421222.1996.11518099</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07421222.1996.11518099</ArticleId></ArticleIdList></Reference><Reference><Citation>Batini C, Cappiello C, Francalanci C, et al. . Methodologies for data quality assessment and improvement. ACM Comput Surv 2009;41:1&#x2013;52.10.1145/1541880.1541883</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/1541880.1541883</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden RJ, Voida S, Savoy A, et al. . Human Factors Engineering and Human&#x2013;Computer Interaction: Supporting User Performance and Experience : Finnell JT, Dixon BE, Clinical informatics study guide: text and review. Zurich: Springer International Publishing, 2016: 287&#x2013;307.</Citation></Reference><Reference><Citation>The Book of OHDSI Observational health data sciences and informatics, ED.: observational health data sciences and informatics 2019.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32293578</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study.</ArticleTitle><Pagination><StartPage>e15124</StartPage><MedlinePgn>e15124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e15124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/15124</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Observational Health Data Sciences and Informatics (OHDSI) network is an international collaboration established to apply open-source data analytics to a large network of health databases, including the Korean common data model (K-CDM) network.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study is to analyze the effect that age at diagnosis has on the prognosis of inflammatory bowel disease (IBD) in Korea using a CDM network database.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analyzed the K-CDM network database from 2005 to 2015. We transformed the electronic medical record into the CDM version 5.0 used in OHDSI. A worsened IBD prognosis was defined as the initiation of therapy with biologic agents, including infliximab and adalimumab. To evaluate the effect that age at diagnosis had on the prognosis of IBD, we divided the patients into an early-onset (EO) IBD group (age at diagnosis &lt;40 years) and a late-onset (LO) IBD group (age at diagnosis &#x2265;40 years) with the cutoff value of age at diagnosis as 40 years, which was calculated using the Youden index method. We then used the logrank test and Cox proportional hazards model to analyze the effect that age at diagnosis (EO group vs LO group) had on the prognosis in patients with IBD.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 3480 patients were enrolled. There was 2017 patients with ulcerative colitis (UC) and 1463 with Crohn's disease (CD). The median follow up period was 109.5 weeks. The EO UC group was statistically significant and showed less event-free survival (ie, experiences of biologic agents) than the LO UC group (P&lt;.001). In CD, the EO CD group showed less event-free survival (ie, experiences of biologic agents) than the LO CD group. In the Cox proportional hazard analysis, the odds ratio (OR) of the EO UC group on experiences of biologic agents compared with the LO UC group was 2.3 (95% CI 1.3-3.8, P=.002). The OR of the EO CD group on experiences of biologic agents compared with the LO CD group was 5.4 (95% CI 1.9-14.9, P=.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The EO IBD group showed a worse prognosis than the LO IBD group in Korean patients with IBD. In addition, this study successfully verified the CDM model in gastrointestinal research.</AbstractText><CopyrightInformation>&#xa9;Youn I Choi, Yoon Jae Kim, Jun-Won Chung, Kyoung Oh Kim, Hakki Kim, Rae Woong Park, Dong Kyun Park. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 15.04.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Youn I</ForeName><Initials>YI</Initials><Identifier Source="ORCID">0000-0001-6561-6752</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Gil Medical Center, Gachon University College of Internal Medicine, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName><ForeName>Yoon Jae</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0001-8477-6823</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Gil Medical Center, Gachon University College of Internal Medicine, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Jun-Won</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0002-0869-7661</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Gil Medical Center, Gachon University College of Internal Medicine, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyoung Oh</ForeName><Initials>KO</Initials><Identifier Source="ORCID">0000-0002-5365-2550</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Gil Medical Center, Gachon University College of Internal Medicine, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hakki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3361-8232</Identifier><AffiliationInfo><Affiliation>Health IT Research Center, Gil Medical Center, Gachon University, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Ajou Medical Center, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Dong Kyun</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0002-2862-6641</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Gil Medical Center, Gachon University College of Internal Medicine, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Crohn&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">early-onset</Keyword><Keyword MajorTopicYN="N">late-onset</Keyword><Keyword MajorTopicYN="N">ulcerative colitis</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32293578</ArticleId><ArticleId IdType="pmc">PMC7191339</ArticleId><ArticleId IdType="doi">10.2196/15124</ArticleId><ArticleId IdType="pii">v8i4e15124</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720&#x2013;7. doi: 10.1038/nrgastro.2015.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2015.150</ArticleId><ArticleId IdType="pubmed">26323879</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima Martins A, Volpato RA, Zago-Gomes MDP. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. BMC Gastroenterol. 2018 Jun 18;18(1):87. doi: 10.1186/s12876-018-0822-y.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-018-0822-y</ArticleId><ArticleId IdType="doi">10.1186/s12876-018-0822-y</ArticleId><ArticleId IdType="pmc">PMC6006948</ArticleId><ArticleId IdType="pubmed">29914399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018 Dec 23;390(10114):2769&#x2013;2778. doi: 10.1016/S0140-6736(17)32448-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32448-0</ArticleId><ArticleId IdType="pubmed">29050646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamm MA. Rapid changes in epidemiology of inflammatory bowel disease. Lancet. 2018 Dec 23;390(10114):2741&#x2013;2742. doi: 10.1016/S0140-6736(17)32669-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32669-7</ArticleId><ArticleId IdType="pubmed">29050647</ArticleId></ArticleIdList></Reference><Reference><Citation>Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012 Jan;142(1):46&#x2013;54.e42; quiz e30. doi: 10.1053/j.gastro.2011.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2011.10.001</ArticleId><ArticleId IdType="pubmed">22001864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O'Morain C, Moum B, Colombel J. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013 Apr;62(4):630&#x2013;49. doi: 10.1136/gutjnl-2012-303661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2012-303661</ArticleId><ArticleId IdType="pubmed">23335431</ArticleId></ArticleIdList></Reference><Reference><Citation>Salgado VCL, Luiz RR, Boechat N, Schorr BC, Le&#xe3;o IS, Nunes T, Zaltman C. Crohn's disease environmental factors in the developing world: a case-control study in a statewide catchment area in Brazil. World J Gastroenterol. 2017 Aug 14;23(30):5549&#x2013;5556. doi: 10.3748/wjg.v23.i30.5549.  </Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v23.i30.5549</ArticleId><ArticleId IdType="pmc">PMC5558118</ArticleId><ArticleId IdType="pubmed">28852314</ArticleId></ArticleIdList></Reference><Reference><Citation>Ol&#xe9;n O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, Ekbom A, Malmborg P, Ludvigsson JF. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014. BMJ. 2017 Sep 20;358:j3951. doi: 10.1136/bmj.j3951.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j3951</ArticleId><ArticleId IdType="pmc">PMC5605779</ArticleId><ArticleId IdType="pubmed">28931512</ArticleId></ArticleIdList></Reference><Reference><Citation>Klement E, Lysy J, Hoshen M, Avitan M, Goldin E, Israeli E. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2008 Jul;103(7):1775&#x2013;82. doi: 10.1111/j.1572-0241.2008.01905.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2008.01905.x</ArticleId><ArticleId IdType="pubmed">18557710</ArticleId></ArticleIdList></Reference><Reference><Citation>Everhov &#xc5;H, Halfvarson J, Myrelid P, Sachs MC, Nordenvall C, S&#xf6;derling J, Ekbom A, Neovius M, Ludvigsson JF, Askling J, Ol&#xe9;n O. Incidence and treatment of patients diagnosed with&#xa0;inflammatory bowel diseases at 60 years or older&#xa0;in&#xa0;Sweden. Gastroenterology. 2018 Feb;154(3):518&#x2013;528.e15. doi: 10.1053/j.gastro.2017.10.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.10.034</ArticleId><ArticleId IdType="pubmed">29102619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009 Feb;15(2):182&#x2013;9. doi: 10.1002/ibd.20628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.20628</ArticleId><ArticleId IdType="pubmed">18668678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulai PS, Boland BS, Singh S, Chaudrey K, Koliani-Pace JL, Kochhar G, Parikh MP, Shmidt E, Hartke J, Chilukuri P, Meserve J, Whitehead D, Hirten R, Winters AC, Katta LG, Peerani F, Narula N, Sultan K, Swaminath A, Bohm M, Lukin D, Hudesman D, Chang JT, Rivera-Nieves J, Jairath V, Zou GY, Feagan BG, Shen B, Siegel CA, Loftus EV, Kane S, Sands BE, Colombel J, Sandborn WJ, Lasch K, Cao C. Development and validation of a scoring system to predict outcomes of vedolizumab treatment in patients with Crohn's&#xa0;disease. Gastroenterology. 2018 Sep;155(3):687&#x2013;695.e10. doi: 10.1053/j.gastro.2018.05.039.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2018.05.039</ArticleId><ArticleId IdType="pmc">PMC6419724</ArticleId><ArticleId IdType="pubmed">29857091</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan NH, Almukhtar RM, Cole EB, Abbas AM. Early corticosteroids requirement after the diagnosis of ulcerative colitis diagnosis can predict a more severe long-term course of the disease - a nationwide study of 1035 patients. Aliment Pharmacol Ther. 2014 Aug;40(4):374&#x2013;81. doi: 10.1111/apt.12834. doi: 10.1111/apt.12834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.12834</ArticleId><ArticleId IdType="doi">10.1111/apt.12834</ArticleId><ArticleId IdType="pubmed">24961751</ArticleId></ArticleIdList></Reference><Reference><Citation>Baars JE, Kuipers EJ, van Haastert M, Nicola&#xef; JJ, Poen AC, van der Woude CJ. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. J Gastroenterol. 2012 Dec;47(12):1308&#x2013;22. doi: 10.1007/s00535-012-0603-2.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-012-0603-2</ArticleId><ArticleId IdType="pmc">PMC3523115</ArticleId><ArticleId IdType="pubmed">22627504</ArticleId></ArticleIdList></Reference><Reference><Citation>Israeli E, Ryan JD, Shafer L, Bernstein CN. Younger age at diagnosis is associated with panenteric, but not more aggressive, Crohn's disease. Clin Gastroenterol Hepatol. 2014 Jan;12(1):72&#x2013;79.e1. doi: 10.1016/j.cgh.2013.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2013.06.027</ArticleId><ArticleId IdType="pubmed">23880115</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen MZ, Thompson CB, Yates B, Zimmerman L, Pullen CH. Implementing common data elements across studies to advance research. Nurs Outlook. 2015;63(2):181&#x2013;8. doi: 10.1016/j.outlook.2014.11.006.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.outlook.2014.11.006</ArticleId><ArticleId IdType="pmc">PMC4361774</ArticleId><ArticleId IdType="pubmed">25771192</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan J, Hirschfeld S, Foster E, Ghitza U, Goetz K, Karpinski J, Lang L, Moser RP, Odenkirchen J, Reeves D, Rubinstein Y, Werner E, Huerta M. Improving the value of clinical research through the use of Common Data Elements. Clin Trials. 2016 Dec;13(6):671&#x2013;676. doi: 10.1177/1740774516653238.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1740774516653238</ArticleId><ArticleId IdType="pmc">PMC5133155</ArticleId><ArticleId IdType="pubmed">27311638</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, Banda JM, Reich CG, Schilling LM, Matheny ME, Meeker D, Pratt N, Madigan D. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016 Dec 05;113(27):7329&#x2013;36. doi: 10.1073/pnas.1510502113.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, Liu Q, Cai B, Wentworth C, Bate A. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013 Feb;36(2):119&#x2013;34. doi: 10.1007/s40264-012-0009-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0009-3</ArticleId><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Cheng C, Kaddi CD, Venugopalan J, Hoffman R, Wang MD. -Omic and Electronic Health Record Big Data Analytics for Precision Medicine. IEEE Trans Biomed Eng. 2017 Feb;64(2):263&#x2013;273. doi: 10.1109/TBME.2016.2573285.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TBME.2016.2573285</ArticleId><ArticleId IdType="pmc">PMC5859562</ArticleId><ArticleId IdType="pubmed">27740470</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R, Gurley M, Dymshyts D, Araujo S, Williams A, Chen R, Reich C. Standardized observational cancer research using the OMOP CDM oncology module. Stud Health Technol Inform. 2019 Aug 21;264:1831&#x2013;1832. doi: 10.3233/SHTI190670.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI190670</ArticleId><ArticleId IdType="pubmed">31438365</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung Y, Hwangbo Y, Yoon SM, Koo HS, Shin HD, Shin JE, Moon HS, Kang SB, Lee JR, Huh KC. Predictive factors for differentiating between Crohn's disease and intestinal tuberculosis in Koreans. Am J Gastroenterol. 2016 Aug;111(8):1156&#x2013;64. doi: 10.1038/ajg.2016.212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2016.212</ArticleId><ArticleId IdType="pubmed">27296940</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Liao W, Yu C, Tu Y, Pan X, Chen Y, Lv N, Zhu X. Differences in clinical features of Crohn's disease and intestinal tuberculosis. World J Gastroenterol. 2015 Mar 28;21(12):3650&#x2013;6. doi: 10.3748/wjg.v21.i12.3650.  </Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v21.i12.3650</ArticleId><ArticleId IdType="pmc">PMC4375590</ArticleId><ArticleId IdType="pubmed">25834333</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumla A, George A, Sharma V, Herbert RHN, Baroness Masham of Ilton. Oxley A, Oliver M. The WHO 2014 global tuberculosis report&#x2014;further to go. Lancet Glob Health. 2015 Jan;3(1):e10&#x2013;2. doi: 10.1016/S2214-109X(14)70361-4.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(14)70361-4</ArticleId><ArticleId IdType="pubmed">25539957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010 Mar;4(1):1&#x2013;14. doi: 10.5009/gnl.2010.4.1.1.  </Citation><ArticleIdList><ArticleId IdType="doi">10.5009/gnl.2010.4.1.1</ArticleId><ArticleId IdType="pmc">PMC2871616</ArticleId><ArticleId IdType="pubmed">20479907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Im JP, Han K, Kim J, Lee HJ, Chun J, Kim JS. Changes in direct healthcare costs before and after the diagnosis of inflammatory bowel disease: a nationwide population-based study. Gut Liver. 2020 Jan 15;14(1):89&#x2013;99. doi: 10.5009/gnl19023.  </Citation><ArticleIdList><ArticleId IdType="doi">10.5009/gnl19023</ArticleId><ArticleId IdType="pmc">PMC6974324</ArticleId><ArticleId IdType="pubmed">31158951</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek S, Lee KY, Song KH, Yu CS. Current status and trends in inflammatory bowel disease surgery in Korea: analysis of data in a nationwide registry. Ann Coloproctol. 2018 Dec;34(6):299&#x2013;305. doi: 10.3393/ac.2018.07.21.  </Citation><ArticleIdList><ArticleId IdType="doi">10.3393/ac.2018.07.21</ArticleId><ArticleId IdType="pmc">PMC6347339</ArticleId><ArticleId IdType="pubmed">30630303</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019 Dec;68(Suppl 3):s1&#x2013;s106. doi: 10.1136/gutjnl-2019-318484.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2019-318484</ArticleId><ArticleId IdType="pmc">PMC6872448</ArticleId><ArticleId IdType="pubmed">31562236</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019 Mar;114(3):384&#x2013;413. doi: 10.14309/ajg.0000000000000152.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000152</ArticleId><ArticleId IdType="pubmed">30840605</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018 Apr;113(4):481&#x2013;517. doi: 10.1038/ajg.2018.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2018.27</ArticleId><ArticleId IdType="pubmed">29610508</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JJ, Yang S, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H. Second Korean guidelines for the management of Crohn's disease. Intest Res. 2017 Jan;15(1):38&#x2013;67. doi: 10.5217/ir.2017.15.1.38.  </Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2017.15.1.38</ArticleId><ArticleId IdType="pmc">PMC5323307</ArticleId><ArticleId IdType="pubmed">28239314</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JW, Im JP, Cheon JH, Kim YS, Kim JS, Han DS. Inflammatory bowel disease cohort studies in Korea: present and future. Intest Res. 2015 Jul;13(3):213&#x2013;8. doi: 10.5217/ir.2015.13.3.213.  </Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2015.13.3.213</ArticleId><ArticleId IdType="pmc">PMC4479735</ArticleId><ArticleId IdType="pubmed">26130995</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi CH, Moon W, Kim YS, Kim ES, Lee B, Jung Y, Yoon YS, Lee H, Park DI, Han DS. Second Korean guidelines for the management of ulcerative colitis. Intest Res. 2017 Jan;15(1):7&#x2013;37. doi: 10.5217/ir.2017.15.1.7.  </Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2017.15.1.7</ArticleId><ArticleId IdType="pmc">PMC5323310</ArticleId><ArticleId IdType="pubmed">28239313</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SJ, Cho SM, Choe B, Jang HJ, Choi KH, Kang B, Kim JE, Hwang JH. Characteristics and incidence trends for pediatric inflammatory bowel disease in Daegu-Kyungpook province in Korea: a multi-center study. J Korean Med Sci. 2018 Apr 30;33(18):e132. doi: 10.3346/jkms.2018.33.e132.  </Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2018.33.e132</ArticleId><ArticleId IdType="pmc">PMC5920122</ArticleId><ArticleId IdType="pubmed">29713253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobore I, Li J, Yuhang L, Al-Handarish Y, Kandwal A, Nie Z, Wang L. Deep learning intervention for health care challenges: some biomedical domain considerations. JMIR Mhealth Uhealth. 2019 Aug 02;7(8):e11966. doi: 10.2196/11966.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/11966</ArticleId><ArticleId IdType="pmc">PMC6696854</ArticleId><ArticleId IdType="pubmed">31376272</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiske A, Prainsack B, Buyx A. Data work: meaning-making in the era of data-rich medicine. J Med Internet Res. 2019 Jul 09;21(7):e11672. doi: 10.2196/11672.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/11672</ArticleId><ArticleId IdType="pmc">PMC6647753</ArticleId><ArticleId IdType="pubmed">31290397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Sun S, Mukkamala RR, Vatrapu R, Ordieres-Mer&#xe9; J. Accelerating health data sharing: a solution based on the Internet of Things and distributed ledger technologies. J Med Internet Res. 2019 Jun 06;21(6):e13583. doi: 10.2196/13583.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13583</ArticleId><ArticleId IdType="pmc">PMC6592507</ArticleId><ArticleId IdType="pubmed">31172963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavragani A, Ochoa G. Google trends in infodemiology and infoveillance: methodology framework. JMIR Public Health Surveill. 2019 May 29;5(2):e13439. doi: 10.2196/13439.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13439</ArticleId><ArticleId IdType="pmc">PMC6660120</ArticleId><ArticleId IdType="pubmed">31144671</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonnel F, Ninot G. Identifying frameworks for validation and monitoring of consensual behavioral intervention technologies: narrative review. J Med Internet Res. 2019 Oct 16;21(10):e13606. doi: 10.2196/13606.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13606</ArticleId><ArticleId IdType="pmc">PMC6822061</ArticleId><ArticleId IdType="pubmed">31621638</ArticleId></ArticleIdList></Reference><Reference><Citation>Katapally TR. The SMART framework: integration of citizen science, community-based participatory research, and systems science for population health science in the digital age. JMIR Mhealth Uhealth. 2019 Aug 30;7(8):e14056. doi: 10.2196/14056.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/14056</ArticleId><ArticleId IdType="pmc">PMC6743262</ArticleId><ArticleId IdType="pubmed">31471963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HH, Kim B, Joo S, Shin S, Cha HS, Park YR. Why do data users say health care data are difficult to use? a cross-sectional survey study. J Med Internet Res. 2019 Aug 06;21(8):e14126. doi: 10.2196/14126.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/14126</ArticleId><ArticleId IdType="pmc">PMC6701164</ArticleId><ArticleId IdType="pubmed">31389335</ArticleId></ArticleIdList></Reference><Reference><Citation>McPadden J, Durant TJ, Bunch DR, Coppi A, Price N, Rodgerson K, Torre CJ, Byron W, Hsiao AL, Krumholz HM, Schulz WL. Health care and precision medicine research: analysis of a scalable data science platform. J Med Internet Res. 2019 Apr 09;21(4):e13043. doi: 10.2196/13043.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13043</ArticleId><ArticleId IdType="pmc">PMC6477571</ArticleId><ArticleId IdType="pubmed">30964441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavragani A, Ochoa G, Tsagarakis KP. Assessing the methods, tools, and statistical approaches in Google trends research: systematic review. J Med Internet Res. 2018 Nov 06;20(11):e270. doi: 10.2196/jmir.9366.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.9366</ArticleId><ArticleId IdType="pmc">PMC6246971</ArticleId><ArticleId IdType="pubmed">30401664</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Solbrig HR, Prud'hommeaux E, Tao C, Weng C, Chute CG. Quality assurance of cancer study Common Data Elements using a post-coordination approach. AMIA Annu Symp Proc. 2015;2015:659&#x2013;68.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765658</ArticleId><ArticleId IdType="pubmed">26958201</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DH, Hicks RR, Johnson VE, Bergstrom DA, Cummings DM, Noble LJ, Hovda D, Whalen M, Ahlers ST, LaPlaca M, Tortella FC, Duhaime A, Dixon CE. Pre-clinical traumatic brain injury Common Data Elements: toward a common language across laboratories. J Neurotrauma. 2015 Nov 15;32(22):1725&#x2013;35. doi: 10.1089/neu.2014.3861.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2014.3861</ArticleId><ArticleId IdType="pmc">PMC4651035</ArticleId><ArticleId IdType="pubmed">26058402</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell MJ, Kochanek PM. Pediatric traumatic brain injury in 2012: the year with new guidelines and common data elements. Crit Care Clin. 2013 Apr;29(2):223&#x2013;38. doi: 10.1016/j.ccc.2012.11.004.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2012.11.004</ArticleId><ArticleId IdType="pmc">PMC3632392</ArticleId><ArticleId IdType="pubmed">23537673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Shin S, Kang M, Yi B, Chang DK. Developing a standardization algorithm for categorical laboratory tests for clinical big data research: retrospective study. JMIR Med Inform. 2019 Aug 29;7(3):e14083. doi: 10.2196/14083.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/14083</ArticleId><ArticleId IdType="pmc">PMC6740165</ArticleId><ArticleId IdType="pubmed">31469075</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue JK, Vassar MJ, Lingsma HF, Cooper SR, Okonkwo DO, Valadka AB, Gordon WA, Maas AIR, Mukherjee P, Yuh EL, Puccio AM, Schnyer DM, Manley GT, TRACK-TBI Investigators  Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury. J Neurotrauma. 2013 Nov 15;30(22):1831&#x2013;44. doi: 10.1089/neu.2013.2970.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2013.2970</ArticleId><ArticleId IdType="pmc">PMC3814815</ArticleId><ArticleId IdType="pubmed">23815563</ArticleId></ArticleIdList></Reference><Reference><Citation>Amre DK, Lambrette P, Law L, Krupoves A, Chotard V, Costea F, Grimard G, Israel D, Mack D, Seidman EG. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol. 2006 May;101(5):1005&#x2013;11. doi: 10.1111/j.1572-0241.2006.00526.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2006.00526.x</ArticleId><ArticleId IdType="pubmed">16573775</ArticleId></ArticleIdList></Reference><Reference><Citation>Panaccio MP, Cummins G, Wentworth C, Lanes S, Reynolds SL, Reynolds MW, Miao R, Koren A. A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records. Clin Epidemiol. 2015;7:77&#x2013;90. doi: 10.2147/CLEP.S64936. doi: 10.2147/CLEP.S64936.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S64936</ArticleId><ArticleId IdType="doi">10.2147/CLEP.S64936</ArticleId><ArticleId IdType="pmc">PMC4296911</ArticleId><ArticleId IdType="pubmed">25624771</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaty HM, Sansgiry S, Artinyan A, Hou JK. Time trends, clinical characteristics, and risk factors of chronic anal fissure among a national cohort of patients with inflammatory bowel disease. Dig Dis Sci. 2016 Mar;61(3):861&#x2013;4. doi: 10.1007/s10620-015-3930-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-015-3930-3</ArticleId><ArticleId IdType="pubmed">26514675</ArticleId></ArticleIdList></Reference><Reference><Citation>Gower-Rousseau C, Dauchet L, Vernier-Massouille G, Tilloy E, Brazier F, Merle V, Dupas J, Savoye G, Bald&#xe9; M, Marti R, Lerebours E, Cortot A, Salomez J, Turck D, Colombel J. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009 Aug;104(8):2080&#x2013;8. doi: 10.1038/ajg.2009.177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2009.177</ArticleId><ArticleId IdType="pubmed">19436273</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32308871</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2019</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Considerations for Improving the Portability of Electronic Health Record-Based Phenotype Algorithms.</ArticleTitle><Pagination><StartPage>755</StartPage><EndPage>764</EndPage><MedlinePgn>755-764</MedlinePgn></Pagination><Abstract><AbstractText>With the increased adoption of electronic health records, data collected for routine clinical care is used for health outcomes and population sciences research, including the identification of phenotypes. In recent years, research networks, such as eMERGE, OHDSI and PCORnet, have been able to increase statistical power and population diversity by combining patient cohorts. These networks share phenotype algorithms that are executed at each participating site. Here we observe experiences with phenotype algorithm portability across seven research networks and propose a generalizable framework for phenotype algorithm portability. Several strategies exist to increase the portability of phenotype algorithms, reducing the implementation effort needed by each site. These include using a common data model, standardized representation of the phenotype algorithm logic, and technical solutions to facilitate federated execution of queries. Portability is achieved by tradeoffs across three domains: Data, Authoring and Implementation, and multiple approaches were observed in representing portable phenotype algorithms. Our proposed framework will help guide future research in operationalizing phenotype algorithm portability at scale.</AbstractText><CopyrightInformation>&#xa9;2019 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Luke V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandt</LastName><ForeName>Pascal S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiefer</LastName><ForeName>Richard C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adekkanattu</LastName><ForeName>Prakash</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ancker</LastName><ForeName>Jessica S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhenxing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pathak</LastName><ForeName>Jyotishman</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM105688</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008673</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065709" MajorTopicYN="N">Common Data Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003195" MajorTopicYN="N">Computer Communication Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32308871</ArticleId><ArticleId IdType="pmc">PMC7153055</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pathak J, Kho AN, Denny JC. Electronic health records-driven phenotyping: challenges, recent advances, and perspectives. Journal of the American Medical Informatics Association : JAMIA. 2013;20(e2):e206&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861925</ArticleId><ArticleId IdType="pubmed">24302669</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Seneviratne M, Hernandez-Boussard T, Shah NH. Advances in Electronic Phenotyping: From Rule-Based Definitions to Machine Learning Models. Annual Review of Biomedical Data Science. 2018;1(1):53&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt TM, Elston-Lafata J, Tolsma D, Greene SM. The role of research in integrated healthcare systems: the HMO Research Network. Am J Manag Care. 2004;10(9):643&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15515997</ArticleId></ArticleIdList></Reference><Reference><Citation>McGraw D, Rosati K, Evans B. A policy framework for public health uses of electronic health data. Pharmacoepidemiology and Drug Safety. 2012;21:18&#x2013;22. Suppl 1.</Citation><ArticleIdList><ArticleId IdType="pubmed">22262589</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013;15(10):761&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Califf RM. The Patient-Centered Outcomes Research Network: a national infrastructure for comparative effectiveness research. North Carolina Medical Journal. 2014;75(3):204&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">24830497</ArticleId></ArticleIdList></Reference><Reference><Citation>NCATS. Welcome to the ACT Network! 2019 [March 13, 2019].  Available from: http://www.actnetwork.us.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Studies in health technology and informatics. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moor G, Sundgren M, Kalra D, Schmidt A, Dugas M, Claerhout B, et al. Using electronic health records for clinical research: the case of the EHR4CR project. Journal of Biomedical Informatics. 2015;53:162&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">25463966</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Sun J, Pathak J, Kho AN, Denny JC. Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods. Artificial Intelligence in Medicine. 2016;71:57&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480212</ArticleId><ArticleId IdType="pubmed">27506131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. Journal of the American Medical Informatics Association : JAMIA. 2016;23(6):1046&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. National Library of Medicine. Home -ClinicalTrials.gov 2019 [March 13, 2019].  Available from: https://clinicaltrials.gov/</Citation></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, Bielinski SJ, Berg RL, Choudhary V, et al. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. Journal of the American Medical Informatics Association : JAMIA. 2013;20(e1):e147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, Embi PJ, Elhadad N, Johnson SB, et al. A review of approaches to identifying patient phenotype cohorts using electronic health records. Journal of the American Medical Informatics Association : JAMIA. 2014;21(2):221&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohane IS, Churchill SE, Murphy SN. A translational engine at the national scale: informatics for integrating biology and the bedside. Journal of the American Medical Informatics Association: JAMIA. 2012;19(2):181&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277623</ArticleId><ArticleId IdType="pubmed">22081225</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentinel Coordinating Center. Sentinel Common Data Model 2019 [March 13, 2019].  Available from:  https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model.</Citation></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, Denton J, Nookala L, Meeker D, et al. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Applied Clinical Informatics. 2015;6(3):536&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Data Interchange Standards Consortium. Study Data Tabulation Model 2018 [March 13, 2019].  Available from:  https://www.cdisc.org/standards/foundational/sdtm.</Citation></Reference><Reference><Citation>Platt R, Davis R, Finkelstein J, Go AS, Gurwitz JH, Roblin D, et al. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiology and Drug Safety. 2001;10(5):373&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11802579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross TR, Ng D, Brown JS, Pardee R, Hornbrook MC, Hart G, et al. EGEMS. 1. Vol. 2. Washington,DC: 2014. The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. p. 1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. Journal of Biomedical Informatics. 2016;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S.Department of Health and Human Services. Harmonization of Various Common Data Models and Open Standards for Evidence Generation 2017 [July 10, 2019]  Available from: https://aspe.hhs.gov/harmonization-various-common-data-models-and-open-standards-evidence-generation.</Citation></Reference><Reference><Citation>Clinical Data Interchange Standards Consortium.  BRIDG 2019. 2019 Jul 10; Available from:  https://www.cdisc.org/standards/domain-information-module/bridg.</Citation></Reference><Reference><Citation>Rasmussen LV, Kiefer RC, Mo H, Speltz P, Thompson WK, Jiang G, et al. A Modular Architecture for Electronic Health Record-Driven Phenotyping. AMIA Joint Summits on Translational Science proceedings AMIA Joint Summits on Translational Science. 2015;2015:147&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525215</ArticleId><ArticleId IdType="pubmed">26306258</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco JA, Rasmussen LV, Kiefer RC, Campion TR, Speltz P, Carroll RJ, et al. A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments. Journal of the American Medical Informatics Association : JAMIA. 2018;25(11):1540&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6213083</ArticleId><ArticleId IdType="pubmed">30124903</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Szolovits P, editors. Implementing a Portable Clinical NLP System with a Common Data Model -- a Lisp Perspective. 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2018 Dec 3-6; 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769694</ArticleId><ArticleId IdType="pubmed">33376623</ArticleId></ArticleIdList></Reference><Reference><Citation>Bache R, Miles S, Taweel A. An adaptable architecture for patient cohort identification from diverse data sources. Journal of the American Medical Informatics Association : JAMIA. 2013;20(e2):e327&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861920</ArticleId><ArticleId IdType="pubmed">24064442</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI.  OHDSI/PhenotypeLibrary: A repository to store validated phenotype cohort definitions, with all associated source code, documentation, and validation results. 2019. 2019 Mar 13; Available from: https://github.com/OHDSI/PhenotypeLibrary.</Citation></Reference><Reference><Citation>McMurry AJ, Murphy SN, MacFadden D, Weber G, Simons WW, Orechia J, et al. SHRINE: Enabling Nationally Scalable Multi-Site Disease Studies. PLOS ONE. 2013;8(3):e55811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591385</ArticleId><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Jiang G, Pacheco JA, Kiefer R, Rasmussen LV, Pathak J, et al. A Decompositional Approach to Executing Quality Data Model Algorithms on the i2b2 Platform. AMIA Joint Summits on Translational Science proceedings AMIA Joint Summits on Translational Science. 2016;2016:167&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001760</ArticleId><ArticleId IdType="pubmed">27570665</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson R. Project management: cost, time and quality, two best guesses and a phenomenon, its time to accept other success criteria. International Journal of Project Management. 1999;17(6):337&#x2013;42.</Citation></Reference><Reference><Citation>Jackson KL, Mbagwu M, Pacheco JA, Baldridge AS, Viox DJ, Linneman JG, et al. Performance of an electronic health record-based phenotype algorithm to identify community associated methicillin-resistant Staphylococcus aureus cases and controls for genetic association studies. BMC Infectious Diseases. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5114817</ArticleId><ArticleId IdType="pubmed">27855652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, Pacheco JA, Jiang G, Kiefer R, et al. Desiderata for computable representations of electronic health records-driven phenotype algorithms. Journal of the American Medical Informatics Association : JAMIA. 2015;22(6):1220&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Girardeau Y, Doods J, Zapletal E, Chatellier G, Daniel C, Burgun A, et al. Leveraging the EHR4CR platform to support patient inclusion in academic studies: challenges and lessons learned. BMC medical research methodology. 2017;17(1):36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5329914</ArticleId><ArticleId IdType="pubmed">28241798</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Kiefer RC, Sharma DK, Prud&#x2019;hommeaux E, Solbrig HR. A Consensus-based Approach for Harmonizing the OHDSI Common Data Model with HL7 FHIR. Studies in health technology and informatics. 2017;245:887&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939955</ArticleId><ArticleId IdType="pubmed">29295227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei WQ, Leibson CL, Ransom JE, Kho AN, Caraballo PJ, Chai HS, et al. Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus. Journal of the American Medical Informatics Association : JAMIA. 2012;19(2):219&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277630</ArticleId><ArticleId IdType="pubmed">22249968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Choi Keung SN, Zhao L, Tyler E, Taweel A, Delaney B, Peterson KA, et al. Cohort identification for clinical research: querying federated electronic healthcare records using controlled vocabularies and semantic types. AMIA Joint Summits on Translational Science proceedings AMIA Joint Summits on Translational Science. 2012;2012:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392063</ArticleId><ArticleId IdType="pubmed">22779039</ArticleId></ArticleIdList></Reference><Reference><Citation>National Patient-Centered Clinical Research Network (PCORnet). ADAPTABLETRIAL/PHENOTYPE: Eligibility phenotype for potential participant identification 2017. 2019 Mar 13; Available from:  https://github.com/ADAPTABLETRIAL/PHENOTYPE.</Citation></Reference><Reference><Citation>Liao KP, Cai T, Savova GK, Murphy SN, Karlson EW, Ananthakrishnan AN, et al. Development of phenotype algorithms using electronic medical records and incorporating natural language processing. BMJ : British Medical Journal. 2015;350:h1885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707569</ArticleId><ArticleId IdType="pubmed">25911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho JC, Ghosh J, Steinhubl SR, Stewart WF, Denny JC, Malin BA, et al. Limestone: High-throughput candidate phenotype generation via tensor factorization. Journal of Biomedical Informatics. 2014;52:199&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6563906</ArticleId><ArticleId IdType="pubmed">25038555</ArticleId></ArticleIdList></Reference><Reference><Citation>Farjah F, Halgrim S, Buist DS, Gould MK, Zeliadt SB, Loggers ET, et al. EGEMS 2016. 1. Washington,DC; 2016. An Automated Method for Identifying Individuals with a Lung Nodule Can Be Feasibly Implemented Across Health Systems. p. 1254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5013935</ArticleId><ArticleId IdType="pubmed">27668266</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RJ, Thompson WK, Eyler AE, Mandelin AM, Cai T, Zink RM, et al. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. Journal of the American Medical Informatics Association: JAMIA. 2012;19(e1):e162&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392871</ArticleId><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrell DS, Schoen RE, Leffler DA, Morris M, Rose S, Baer A, et al. Challenges in adapting existing clinical natural language processing systems to multiple, diverse health care settings. Journal of the American Medical Informatics Association : JAMIA. 2017;24(5):986&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080843</ArticleId><ArticleId IdType="pubmed">28419261</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan B, Ramage D. Google AI Blog. [Internet] 2017 Available from:  https://ai.googleblog.com/2017/04/federated-learning-collaborative.html.</Citation></Reference><Reference><Citation>Brisimi TS, Chen R, Mela T, Olshevsky A, Paschalidis IC, Shi W. Federated learning of predictive models from federated Electronic Health Records. International Journal of Medical Informatics. 2018;112:59&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5836813</ArticleId><ArticleId IdType="pubmed">29500022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32374408</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Development and validation of phenotype classifiers across multiple sites in the observational health data sciences and informatics network.</ArticleTitle><Pagination><StartPage>877</StartPage><EndPage>883</EndPage><MedlinePgn>877-883</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocaa032</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Accurate electronic phenotyping is essential to support collaborative observational research. Supervised machine learning methods can be used to train phenotype classifiers in a high-throughput manner using imperfectly labeled data. We developed 10 phenotype classifiers using this approach and evaluated performance across multiple sites within the Observational Health Data Sciences and Informatics (OHDSI) network.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We constructed classifiers using the Automated PHenotype Routine for Observational Definition, Identification, Training and Evaluation (APHRODITE) R-package, an open-source framework for learning phenotype classifiers using datasets in the Observational Medical Outcomes Partnership Common Data Model. We labeled training data based on the presence of multiple mentions of disease-specific codes. Performance was evaluated on cohorts derived using rule-based definitions and real-world disease prevalence. Classifiers were developed and evaluated across 3 medical centers, including 1 international site.</AbstractText><AbstractText Label="RESULTS">Compared to the multiple mentions labeling heuristic, classifiers showed a mean recall boost of 0.43 with a mean precision loss of 0.17. Performance decreased slightly when classifiers were shared across medical centers, with mean recall and precision decreasing by 0.08 and 0.01, respectively, at a site within the USA, and by 0.18 and 0.10, respectively, at an international site.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION">We demonstrate a high-throughput pipeline for constructing and sharing phenotype classifiers across sites within the OHDSI network using APHRODITE. Classifiers exhibit good portability between sites within the USA, however limited portability internationally, indicating that classifier generalizability may have geographic limitations, and, consequently, sharing the classifier-building recipe, rather than the pretrained classifiers, may be more useful for facilitating collaborative observational research.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kashyap</LastName><ForeName>Mehr</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seneviratne</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, Georgia State University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Borim</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Office of eHealth and Business, Seoul National University Bundang Hospital, Gyeonggi-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of eHealth and Business, Seoul National University Bundang Hospital, Gyeonggi-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG059307</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002965" MajorTopicYN="N">Classification</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="N">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="Y">Supervised Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cohort identification</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">electronic phenotyping</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">phenotype</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32374408</ArticleId><ArticleId IdType="pmc">PMC7309227</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocaa032</ArticleId><ArticleId IdType="pii">5831103</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Banda JM, Seneviratne M, Hernandez-Boussard T, et al. Advances in electronic phenotyping: from rule-based definitions to machine learning models. Annu Rev Biomed Data Sci. 2018; 1 (1): 53&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Hammond WE, Nahm M, et al. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. J Am Med Inform Assoc. 2013; 20 (e2): e226&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861929</ArticleId><ArticleId IdType="pubmed">23956018</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ.. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc. 2013; 20 (1): 117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J, Kho AN, Denny JC.. Electronic health records-driven phenotyping: challenges, recent advances, and perspectives. J Am Med Inform Assoc. 2013; 20 (e2): e206&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861925</ArticleId><ArticleId IdType="pubmed">24302669</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, et al. A review of approaches to identifying patient phenotype cohorts using electronic health records. J Am Med Inform Assoc. 2014; 21 (2): 221&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016; 23 (6): 1046&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco JA, Rasmussen LV, Kiefer RC, et al. A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments. J Am Med Inform Assoc. 2018; 25 (11): 1540&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6213083</ArticleId><ArticleId IdType="pubmed">30124903</ArticleId></ArticleIdList></Reference><Reference><Citation>Denaxas SC, George J, Herrett E, et al. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol. 2012; 41 (6): 1625&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3535749</ArticleId><ArticleId IdType="pubmed">23220717</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, et al. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc. 2013; 20 (e1): e147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Heal Technol Inform. 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohane IS, Churchill SE, Murphy SN.. A translational engine at the national scale: informatics for integrating biology and the bedside. J Am Med Inform Assoc. 2012; 19 (2): 181&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277623</ArticleId><ArticleId IdType="pubmed">22081225</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, et al. Facilitating phenotype transfer using a common data model. J Biomed Inform. 2019; 96: 103253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian TY, Zlateva I, Anderson DR.. Using electronic health records data to identify patients with chronic pain in a primary care setting. J Am Med Inform Assoc. 2013; 20 (e2): e275&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861913</ArticleId><ArticleId IdType="pubmed">23904323</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RJ, Eyler AE, Denny JC.. Na&#xef;ve Electronic Health Record phenotype identification for rheumatoid arthritis. AMIA Annu Symp Proc. 2011; 2011: 189&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243261</ArticleId><ArticleId IdType="pubmed">22195070</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RJ, Thompson WK, Eyler AE, et al. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc. 2012; 19 (e1): e162&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392871</ArticleId><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Carroll RJ, Hinz ERM, et al. Applying active learning to high-throughput phenotyping algorithms for electronic health records data. J Am Med Inform Assoc. 2013; 20 (e2): e253&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861916</ArticleId><ArticleId IdType="pubmed">23851443</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Podchiyska T, Banda JM, et al. Learning statistical models of phenotypes using noisy labeled training data. J Am Med Inform Assoc. 2016; 23 (6): 1166&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070523</ArticleId><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern Y, Choi Y, Horng S, et al. Using anchors to estimate clinical state without labeled data. AMIA Annu Symp Proc. 2014; 2014: 606&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419996</ArticleId><ArticleId IdType="pubmed">25954366</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern Y, Horng S, Choi Y, et al. Electronic medical record phenotyping using the anchor and learn framework. J Am Med Inform Assoc. 2016; 23 (4): 731&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926745</ArticleId><ArticleId IdType="pubmed">27107443</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu-Jones BK, Greene CS.. Consortium PRO-AALSCT. Semi-supervised learning of the electronic health record for phenotype stratification. J Biomed Inform. 2016; 64: 168&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">27744022</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Chakrabortty A, Liao KP, et al. Surrogate-assisted feature extraction for high-throughput phenotyping. J Am Med Inform Assoc. 2017; 24 (e1): e143&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080726</ArticleId><ArticleId IdType="pubmed">27632993</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray SG, Avati A, Schmajuk G, et al. Automated and flexible identification of complex disease: building a model for systemic lupus erythematosus using noisy labeling. J Am Med Informatics Assoc. 2019; 26 (1): 61&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6308013</ArticleId><ArticleId IdType="pubmed">30476175</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon HU. General bounds on the number of examples needed for learning probabilistic concepts. J Comput Syst Sci. 1996; 52 (2): 239&#x2013;54.</Citation></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, et al. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Jt Summits Transl Sci Proc. 2017; 2017: 48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Hripcsak G, Ryan PB.. PheValuator: development and evaluation of a phenotype algorithm evaluator. J Biomed Inform. 2019; 97: 103258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736922</ArticleId><ArticleId IdType="pubmed">31369862</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32375693</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>06</Day></PubDate></JournalIssue><Title>BMC medical research methodology</Title><ISOAbbreviation>BMC Med Res Methodol</ISOAbbreviation></Journal><ArticleTitle>Feasibility and evaluation of a large-scale external validation approach for patient-level prediction in an international data network: validation of models predicting stroke in female patients newly diagnosed with atrial fibrillation.</ArticleTitle><Pagination><StartPage>102</StartPage><MedlinePgn>102</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12874-020-00991-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">To demonstrate how the Observational Healthcare Data Science and Informatics (OHDSI) collaborative network and standardization can be utilized to scale-up external validation of patient-level prediction models by enabling validation across a large number of heterogeneous observational healthcare datasets.</AbstractText><AbstractText Label="METHODS">Five previously published prognostic models (ATRIA, CHADS<sub>2</sub>, CHADS<sub>2</sub>VASC, Q-Stroke and Framingham) that predict future risk of stroke in patients with atrial fibrillation were replicated using the OHDSI frameworks. A network study was run that enabled the five models to be externally validated across nine observational healthcare datasets spanning three countries and five independent sites.</AbstractText><AbstractText Label="RESULTS">The five existing models were able to be integrated into the OHDSI framework for patient-level prediction and they obtained mean c-statistics ranging between 0.57-0.63 across the 6 databases with sufficient data to predict stroke within 1&#x2009;year of initial atrial fibrillation diagnosis for females with atrial fibrillation. This was comparable with existing validation studies. The validation network study was run across nine datasets within 60&#x2009;days once the models were replicated. An R package for the study was published at https://github.com/OHDSI/StudyProtocolSandbox/tree/master/ExistingStrokeRiskExternalValidation.</AbstractText><AbstractText Label="CONCLUSION">This study demonstrates the ability to scale up external validation of patient-level prediction models using a collaboration of researchers and a data standardization that enable models to be readily shared across data sites. External validation is necessary to understand the transportability or reproducibility of a prediction model, but without collaborative approaches it can take three or more years for a model to be validated by one independent researcher. In this paper we show it is possible to both scale-up and speed-up external validation by showing how validation can be done across multiple databases in less than 2&#x2009;months. We recommend that researchers developing new prediction models use the OHDSI network to externally validate their models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2970-0778</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. jreps@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ross D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>O'Brien Institute for Public Health, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, School of Medicine, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Hong-Seok</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ajou University Medical Centre, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HI16C0992</GrantID><Agency>Health Promotion Administration, Ministry of Health and Welfare (TW)</Agency><Country>International</Country></Grant><Grant><GrantID>806968</GrantID><Agency>Innovative Medicines Initiative Joint Undertaking</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Res Methodol</MedlineTA><NlmUniqueID>100968545</NlmUniqueID><ISSNLinking>1471-2288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Collaborative network</Keyword><Keyword MajorTopicYN="N">External validation</Keyword><Keyword MajorTopicYN="N">Patient-level prediction</Keyword><Keyword MajorTopicYN="N">Prognostic model</Keyword><Keyword MajorTopicYN="N">Transportability</Keyword></KeywordList><CoiStatement>Jenna Reps is an employee of Janssen Research &amp; Development and shareholder of Johnson &amp; Johnson. Patrick Ryan is an employee of Janssen Research &amp; Development and shareholder of Johnson &amp; Johnson. Peter Rijnbeek works for a research group who received unconditional research grants from Boehringer-Ingelheim, GSK, Janssen Research &amp; Development, Novartis, Pfizer, Yamanouchi, Servier. None of these grants result in a conflict of interest to the content of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32375693</ArticleId><ArticleId IdType="pmc">PMC7201646</ArticleId><ArticleId IdType="doi">10.1186/s12874-020-00991-3</ArticleId><ArticleId IdType="pii">10.1186/s12874-020-00991-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siontis GC, Tzoulaki I, Castaldi PJ, et al. External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol. 2015;68(1):25&#x2013;34. doi: 10.1016/j.jclinepi.2014.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.09.007</ArticleId><ArticleId IdType="pubmed">25441703</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeyer Z, Emanuel EJ. Predicting the future&#x2014;big data, machine learning, and clinical medicine. N Engl J Med. 2016;375(13):1216. doi: 10.1056/NEJMp1606181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1606181</ArticleId><ArticleId IdType="pmc">PMC5070532</ArticleId><ArticleId IdType="pubmed">27682033</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5331469</ArticleId><ArticleId IdType="pubmed">28286646</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Calster B, Wynants L, Timmerman D, Steyerberg EW, Collins GS. Predictive analytics in health care: how can we know it works? J Am Med Inform Assoc. 2019;26(12):1651&#x2013;1654. doi: 10.1093/jamia/ocz130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz130</ArticleId><ArticleId IdType="pmc">PMC6857503</ArticleId><ArticleId IdType="pubmed">31373357</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Vergouwe Y, Royston P, et al. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605. doi: 10.1136/bmj.b605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b605</ArticleId><ArticleId IdType="pubmed">19477892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25(8):969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer DE, Chang Y, Borowsky LH, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013;2(3):e000250. doi: 10.1161/JAHA.113.000250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000250</ArticleId><ArticleId IdType="pmc">PMC3698792</ArticleId><ArticleId IdType="pubmed">23782923</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham heart study. JAMA. 2003;290(8):1049&#x2013;1056. doi: 10.1001/jama.290.8.1049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.290.8.1049</ArticleId><ArticleId IdType="pubmed">12941677</ArticleId></ArticleIdList></Reference><Reference><Citation>Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of atrial fibrillation. JAMA. 2001;285(22):2864&#x2013;2870. doi: 10.1001/jama.285.22.2864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.22.2864</ArticleId><ArticleId IdType="pubmed">11401607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263&#x2013;272. doi: 10.1378/chest.09-1584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-1584</ArticleId><ArticleId IdType="pubmed">19762550</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Coupland C, Brindle P. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. BMJ. 2013;346:f2573. doi: 10.1136/bmj.f2573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f2573</ArticleId><ArticleId IdType="pmc">PMC3641809</ArticleId><ArticleId IdType="pubmed">23641033</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Ham HA, Klungel OH, Singer DE, et al. Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a national primary care database. J Am Coll Cardiol. 2015;66(17):1851&#x2013;1859. doi: 10.1016/j.jacc.2015.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.08.033</ArticleId><ArticleId IdType="pubmed">26493655</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspberg S, Chang Y, Atterman A, et al. Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation. Eur Heart J. 2016;37(42):3203&#x2013;3210. doi: 10.1093/eurheartj/ehw077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw077</ArticleId><ArticleId IdType="pubmed">26941204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao TF, Liu CJ, Tuan TC, et al. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: which scoring system should be used for Asians? Heart Rhythm. 2016;13(1):46&#x2013;53. doi: 10.1016/j.hrthm.2015.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.08.017</ArticleId><ArticleId IdType="pubmed">26277496</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmar P, Krishnamurthi R, Ikram MA, et al. The stroke Riskometer&#x2122; app: validation of a data collection tool and stroke risk predictor. Int J Stroke. 2015;10(2):231&#x2013;244. doi: 10.1111/ijs.12411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijs.12411</ArticleId><ArticleId IdType="pmc">PMC4335600</ArticleId><ArticleId IdType="pubmed">25491651</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Staa TP, Setakis E, Di Tanna GL, et al. A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice. J Thromb Haemost. 2011;9(1):39&#x2013;48. doi: 10.1111/j.1538-7836.2010.04085.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2010.04085.x</ArticleId><ArticleId IdType="pubmed">21029359</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32399991</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases.</ArticleTitle><Pagination><StartPage>951</StartPage><EndPage>957</EndPage><MedlinePgn>951-957</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5022</ELocationID><Abstract><AbstractText Label="PURPOSE">Statistical screening of Vigibase, the global database of individual case safety reports, highlighted an association between the MedDRA Preferred Term (PT) "colitis" and nintedanib. Nintedanib is a protein kinase inhibitor authorized in accelerated regulatory procedures for the treatment of idiopathic pulmonary fibrosis (IPF). The aim of this report is to describe the integration of two types of real-world evidence, spontaneous reports of adverse drug reactions (ADR), and observational health data (OHD) in the assessment of a post-authorization safety signal of ischemic colitis.</AbstractText><AbstractText Label="METHODS">Assessment of the statistical signal of "nintedanib - colitis" was undertaken using data from VigiBase, OHD from the Observational Heath Data Sciences and Informatics (OHDSI) collaborative, published literature, and openly available regulatory documents. Evidence synthesis was performed to support Bradford Hill criteria in causality assessment.</AbstractText><AbstractText Label="RESULTS">Evidence for strength of association, specificity, consistency, and analogy was found upon review of the case series. OHD was used to calculate incidence rates of colitis in new users of nintedanib across multiple populations, supportive of consistency, and further evidence for strength of association. Literature review identified support for biological plausibility and analogy. Signal assessment was supplemented with characterization of real-world users and exploration of potential risk factors using OHD.</AbstractText><AbstractText Label="CONCLUSIONS">An integrated approach using two forms of real-world data, spontaneous reports of ADRs and data from observational databases allowed a comprehensive and efficient signal assessment of nintedanib and colitis. Further exploration of the complementary use of real-time OHD in signal assessment could inform more efficient approaches to current signal management practices.</AbstractText><CopyrightInformation>&#xa9; 2020 Uppsala Monitoring Centre. Pharmacoepidemiology and Drug Safety published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chandler</LastName><ForeName>Rebecca E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0002-9334-9046</Identifier><AffiliationInfo><Affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007211">Indoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>G6HRD2P839</RegistryNumber><NameOfSubstance UI="C530716">nintedanib</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017091" MajorTopicYN="N">Colitis, Ischemic</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="N">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword><Keyword MajorTopicYN="N">real-world evidence</Keyword><Keyword MajorTopicYN="N">signal detection</Keyword></KeywordList><CoiStatement>The opinions expressed in this piece are not necessarily those of the national pharmacovigilance centers of the WHO Program for International Drug Monitoring or of the WHO. The author has no conflicts of interest that are directly relevant to the content of this piece.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32399991</ArticleId><ArticleId IdType="pmc">PMC7496543</ArticleId><ArticleId IdType="doi">10.1002/pds.5022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
European Medicines Agency
. Ofev. Assessment report. Procedure No. EMEA/H/C/003821/0000. Available at: https://www.ema.europa.eu/en/documents/assessment-report/ofev-epar-public-assessment-report_en.pdf. Accessed January 16, 2020.</Citation></Reference><Reference><Citation>
FDA
. Highlights of Prescribing Information. Ofev. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205832s012lbl.pdf. Accessed January 16, 2020.</Citation></Reference><Reference><Citation>Trotter JM, Peter MB. Ischaemic colitis. BMJ. 2016;355:i6600.</Citation><ArticleIdList><ArticleId IdType="pubmed">28007701</ArticleId></ArticleIdList></Reference><Reference><Citation>Caster O, Juhlin K, Watson S, Nor&#xe9;n GN. Improved statistical signal detection in pharmacovigilance by combining multiple strength&#x2010;of&#x2010;evidence aspects in VigiRank. Drug Saf. 2014;37(8):617&#x2010;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4134478</ArticleId><ArticleId IdType="pubmed">25052742</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrio M, Voss S, Shakir SA. Application of the Bradford Hill criteria to assess the causality of cisapride&#x2010;induced arrhythmia: a model for assessing causal association in pharmacovigilance. Drug Saf. 2007;30(4):333&#x2010;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">17408310</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2010;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis LM, Hicklin DL. VEGF&#x2010;targeted therapy: mechanisms of anti&#x2010;tumour activity. Nat Rev Cancer. 2008;8:579&#x2010;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">18596824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamba T, Tam BY, Hashizume H, et al. VEGF&#x2010;dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol. 2006;290(2):H560&#x2010;H5766.</Citation><ArticleIdList><ArticleId IdType="pubmed">16172168</ArticleId></ArticleIdList></Reference><Reference><Citation>Saif MW, Elfiky A, Salem RR. Gastrointestinal perforation due to bevacizumab in colorectal cancer. Ann Surg Oncol. 2007;14:1860&#x2010;1869.</Citation><ArticleIdList><ArticleId IdType="pubmed">17356952</ArticleId></ArticleIdList></Reference><Reference><Citation>Batteux B, Gras V, Mahboud Y, et al. Ischemic colitis associated with intravitreal administration of aflibercept: a first case report. Br J Clin Pharmacol. 2019;4:845&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6422656</ArticleId><ArticleId IdType="pubmed">30610744</ArticleId></ArticleIdList></Reference><Reference><Citation>Onoda Y, Shiba T, Hori Y, Maeno T, Takahashi M. Two cases of acute abdomen after an intravitreal injection of bevacizumab. Case Rep Ophthalmol. 2015;6(1):110&#x2010;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410506</ArticleId><ArticleId IdType="pubmed">25960733</ArticleId></ArticleIdList></Reference><Reference><Citation>Patadia VK, Coloma P, Schuemie MJ, et al. Using real&#x2010;world healthcare data for pharmacovigilance signal detection &#x2010; the experience of the EU&#x2010;ADR project. Expert Rev Clin Pharmacol. 2015;8(1):95&#x2010;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">25487079</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Vilar S, Dumouchel W, et al. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J Am Med Inform Assoc. 2018;20:413&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628045</ArticleId><ArticleId IdType="pubmed">23118093</ArticleId></ArticleIdList></Reference><Reference><Citation>Star K, Watson S, Sandberg L, Johansson J, Edwards IR. Longitudinal medical records as a complement to routine drug safety signal analysis. Pharmacoepidemiol Drug Saf. 2015;24(5):486&#x2010;494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024044</ArticleId><ArticleId IdType="pubmed">25623045</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifir&#xf2; G, Sultana J, Bate A. From big data to smart data for pharmacovigilance: the role of healthcare databases and other emerging sources. Drug Saf. 2018;41(2):143&#x2010;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">28840504</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32458499</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making.</ArticleTitle><Pagination><StartPage>1303</StartPage><EndPage>1306</EndPage><MedlinePgn>1303-1306</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5025</ELocationID><Abstract><AbstractText Label="PURPOSE">To present the process of establishing a pharmacoepidemiological database in Saudi Arabia, challenges and models used.</AbstractText><AbstractText Label="METHODS">The database establishment has started in 2017 by piloting the conversion of electronic health records of one hospital to the Observational Health Data Sciences and Informatics (OHDSI), Observational Medical Outcomes Partnership's Common Data Model (OMOP).</AbstractText><AbstractText Label="RESULTS">During the pilot phase we have faced several challenges such as limited contribution in providing data by local medical institution due to uncertainty about data governance, diversity of systems used by hospitals, inconsistent coding of medical information, and limited awareness about data structure from participating hospital. The pilot phase was completed in 2019 containing information about patient attributes, medical care, therapies, and other additional services for around 130&#x2009;000 patients in Saudi Arabia. The majority of patients were below the age of 50&#x2009;years (89%), and acute respiratory infections were the most frequent diagnosis. The data quality was acceptable and no major anomalies were detected during the conversion.</AbstractText><AbstractText Label="CONCLUSIONS">We demonstrated a successful creation of a pilot database using OHDSI Common Data Model. Our experience with the pilot database could be extended to other institutions to create a national dataset that could be used to generate real-world evidence.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alnofal</LastName><ForeName>Fatemah A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Research Department, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alrwisan</LastName><ForeName>Adel A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-9422-7390</Identifier><AffiliationInfo><Affiliation>Research Department, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0002-5630-2468</Identifier><AffiliationInfo><Affiliation>Research Department, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="Y">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="N">Pharmacoepidemiology</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Saudi Arabia</Keyword><Keyword MajorTopicYN="N">database</Keyword><Keyword MajorTopicYN="N">pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">real-world data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32458499</ArticleId><ArticleId IdType="doi">10.1002/pds.5025</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Heikinheimo O, Bitzer J, Garcia RL. Real-world research and the role of observational data in the field of gynaecology-a practical review. Eur J Contracept Reprod Health Care. 2017;22(4):250-259.</Citation></Reference><Reference><Citation>OECD. New Health Technologies, Managing Access, Value and Sustainability [Internet]; 2017. https://www.oecd.org/publications/managing-new-technologies-in-health-care-9789264266438-en.htm.</Citation></Reference><Reference><Citation>OHDSI. OMOP Common Data Model - OHDSI [Internet]; 2019. https://www.ohdsi.org/data-standardization/the-common-data-model.</Citation></Reference><Reference><Citation>Si Y, Weng C. An OMOP CDM-based relational database of clinical research eligibility criteria. Stud Health Technol Inform. 2017;245:950-954.</Citation></Reference><Reference><Citation>Haberson A, Rinner C, Gall W. Standardizing Austrians claims data using the OMOP common data model: a feasibility study. Stud Health Technol Inform. 2019;258:151-152.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32470694</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Converting clinical document architecture documents to the common data model for incorporating health information exchange data in observational health studies: CDA to CDM.</ArticleTitle><Pagination><StartPage>103459</StartPage><MedlinePgn>103459</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2020.103459</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(20)30087-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Utilization of standard health information exchange (HIE) data is growing due to the high adoption rate and interoperability of electronic health record (EHR) systems. However, integration of HIE data into an EHR system is not yet fully adopted in clinical research. In addition, data quality should be verified for the secondary use of these data. Thus, the aims of this study were to convert referral documents in a Health Level 7 (HL7) clinical document architecture (CDA) to the common data model (CDM) to facilitate HIE data availability for longitudinal data analysis, and to identify data quality levels for application in future clinical studies.</AbstractText><AbstractText Label="METHODS">A total of 21,492 referral CDA documents accumulated for over 10&#xa0;years in a tertiary general hospital in South Korea were analyzed. To convert CDA documents to the Observational Medical Outcomes Partnership (OMOP) CDM, processes such as CDA parsing, data cleaning, standard vocabulary mapping, CDA-to-CDM mapping, and CDM conversion were performed. The quality of CDM data was then evaluated using the Achilles Heel and visualized with the Achilles tool.</AbstractText><AbstractText Label="RESULTS">Mapping five CDA elements (document header, problem, medication, laboratory, and procedure) into an OMOP CDM table resulted in population of 9 CDM tables (person, visit_occurrence, condition_occurrence, drug_exposure, measurement, observation, procedure_occurrence, care_site, and provider). Three CDM tables (drug_era, condition_era, and observation_period) were derived from the converted table. From vocabulary mapping codes in CDA documents according to domain, 98.6% of conditions, 68.8% of drugs, 35.7% of measurements, 100% of observation, and 56.4% of procedures were mapped as standard concepts. The conversion rates of the CDA to the OMOP CDM were 96.3% for conditions, 97.2% for drug exposure, 98.1% for procedure occurrence, 55.1% for measurements, and 100% for observation.</AbstractText><AbstractText Label="CONCLUSIONS">We examined the possibility of CDM conversion by defining mapping rules for CDA-to-CDM conversion using the referral CDA documents collected from clinics in actual medical practice. Although mapping standard vocabulary for CDM conversion requires further improvement, the conversion could facilitate further research on the usage patterns of medical resources and referral patterns.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Hyerim</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Soyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Hee</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea; Department of Pediatrics, Seoul National University Bundang Hospital, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jeong-Whun</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Seoul National University Bundang Hospital, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea. Electronic address: yoosoo0@snubh.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066275" MajorTopicYN="Y">Health Information Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical document architecture</Keyword><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership</Keyword><Keyword MajorTopicYN="N">Referral documents</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32470694</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2020.103459</ArticleId><ArticleId IdType="pii">S1532-0464(20)30087-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32477256</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Characterization of Anti-seizure Medication Treatment Pathways in Pediatric Epilepsy Using the Electronic Health Record-Based Common Data Model.</ArticleTitle><Pagination><StartPage>409</StartPage><MedlinePgn>409</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">409</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2020.00409</ELocationID><Abstract><AbstractText>The purpose of this pilot study was to analyze treatment pathways of pediatric epilepsy using the common data model (CDM) based on electronic health record (EHR) data. We also aimed to reveal whether CDM analysis was feasible and applicable to epilepsy research. We analyzed the treatment pathways of pediatric epilepsy patients from our institute who underwent antiseizure medication (ASM) treatment for at least 2 years, using the Observational Medical Outcomes Partnership (OMOP)-CDM. Subgroup analysis was performed for generalized or focal epilepsy, varying age of epilepsy onset, and specific epilepsy syndromes. Changes in annual prescription patterns were also analyzed to reveal the different trends. We also calculated the proportion of drug-resistant epilepsy by applying the definition of seizure persistence after application of two ASMs for a sufficient period of time (more than 6 months). We identified 1,192 patients who underwent treatment for more than 2 years (mean &#xb1; standard deviation: 6.5 &#xb1; 3.2 years). In our pediatric epilepsy cohort, we identified 313 different treatment pathways. Drug resistance, calculated as the application of more than three ASMs during the first 2 years of treatment, was 23.8%. Treatment pathways and ASM resistance differed between subgroups of generalized vs. focal epilepsy, different onset age of epilepsy, and specific epilepsy syndromes. The frequency of ASM prescription was similar between onset groups of different ages; however, phenobarbital was frequently used in children with epilepsy onset &lt; 4 years. Ninety-one of 344 cases of generalized epilepsy and 187 of 835 cases of focal epilepsy were classified as medically intractable epilepsy. The percentage of drug resistance was markedly different depending on the specific electro-clinical epilepsy syndrome [79.0% for Lennox-Gastaut syndrome (LGS), 7.1% for childhood absence epilepsy (CAE), and 9.0% for benign epilepsy with centrotemporal spikes (BECTS)]. We could visualize the annual trend and changes of ASM prescription for pediatric epilepsy in our institute from 2004 to 2017. We revealed that CDM analysis was feasible and applicable for epilepsy research. The strengths and limitations of CDM analysis should be carefully considered when planning the analysis, result extraction, and interpretation of results.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Kim, Yoo, Jeon, Yi, Kim, Choi, Hwang and Kim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hunmin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Yonghoon</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Soyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sun Ah</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Ewha Woman's University Medical Center, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Hee</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ki Joong</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Pediatric, Seoul National University Children's Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common Data Model (CDM)</Keyword><Keyword MajorTopicYN="N">antiseizure medications</Keyword><Keyword MajorTopicYN="N">drug-resistant epilepsy</Keyword><Keyword MajorTopicYN="N">epilepsy</Keyword><Keyword MajorTopicYN="N">treatment pathway</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32477256</ArticleId><ArticleId IdType="pmc">PMC7235379</ArticleId><ArticleId IdType="doi">10.3389/fneur.2020.00409</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. (2014) 348:g254. 10.1136/bmj.g254</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g254</ArticleId><ArticleId IdType="pubmed">24583319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejada J, Costa KM, Bertti P, Garcia-Cairasco N. The epilepsies: complex challenges needing complex solutions. Epilepsy Behav. (2013) 26:212&#x2013;28. 10.1016/j.yebeh.2012.09.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2012.09.029</ArticleId><ArticleId IdType="pubmed">23146364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirtz D, Berg A, Bettis D, Camfield C, Camfield P, Crumrine P, et al. . Practice parameter: treatment of the child with a first unprovoked seizure: report of the quality standards subcommittee of the American academy of neurology and the practice committee of the child neurology society. Neurology. (2003) 60:166&#x2013;75. 10.1212/01.WNL.0000033622.27961.B6</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000033622.27961.B6</ArticleId><ArticleId IdType="pubmed">12552027</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt D. Drug treatment of epilepsy: options and limitations. Epilepsy Behav. (2009) 15:56&#x2013;65. 10.1016/j.yebeh.2009.02.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2009.02.030</ArticleId><ArticleId IdType="pubmed">19236951</ArticleId></ArticleIdList></Reference><Reference><Citation>Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav. (2005) 7:1&#x2013;64. 10.1016/j.yebeh.2005.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2005.06.001</ArticleId><ArticleId IdType="pubmed">16102515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol. (2005) 20:S1&#x2013;S56. 10.1177/088307380502000101</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/088307380502000101</ArticleId><ArticleId IdType="pubmed">16615562</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolin K, Berggren F, Berling P, Morberg S, Gauffin H, Landtblom A. Patterns of antiepileptic drug prescription in Sweden: a register-based approach. Acta Neurol Scand. (2017) 136:521&#x2013;7. 10.1111/ane.12776</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12776</ArticleId><ArticleId IdType="pubmed">28585316</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. . Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. (2016) 113:7329&#x2013;36. 10.1073/pnas.1510502113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota K, Kamijima Y, Yang YHK, Kimura S, Lai ECC, Man KK, et al. . Penetration of new antidiabetic medications in east Asian countries and the United States: a cross-national comparative study. PloS One. (2018) 13:e0208796. 10.1371/journal.pone.0208796</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208796</ArticleId><ArticleId IdType="pmc">PMC6291148</ArticleId><ArticleId IdType="pubmed">30540837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. . Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. (2015) 216:574&#x2013;8. 10.3233/978-1-61499-564-7-574</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-564-7-574</ArticleId><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. . Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. (2010) 51:1069&#x2013;77. 10.1111/j.1528-1167.2009.02397.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2009.02397.x</ArticleId><ArticleId IdType="pubmed">19889013</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinnar S, Vining EP, Mellits ED, D'Souza BJ, Holden K, Baumgardner RA, et al. . Discontinuing antiepileptic medication in children with epilepsy after two years without seizures: a prospective study. N Engl J Med. (1985) 313:976&#x2013;80. 10.1056/NEJM198510173131603</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198510173131603</ArticleId><ArticleId IdType="pubmed">4047105</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulac O, Leppik I, Chadwick D, Specchio L. Starting stopping treatment In: Engel J, Pedley TA, Aicardi J, editors. Epilepsy: A Comprehensive Textbook, Vol. 2 Philadelphia, PA: Lippincott-Raven; (1997). p. 1301&#x2013;10.</Citation></Reference><Reference><Citation>Tomson T, Battino D. Teratogenicity of antiepileptic drugs: state of the art. Curr Opin Neurol. (2005) 18:135&#x2013;40. 10.1097/01.wco.0000162854.67767.06</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000162854.67767.06</ArticleId><ArticleId IdType="pubmed">15791143</ArticleId></ArticleIdList></Reference><Reference><Citation>Meo R, Bilo L. Polycystic ovary syndrome and epilepsy. Drugs. (2003) 63:1185&#x2013;227. 10.2165/00003495-200363120-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-200363120-00002</ArticleId><ArticleId IdType="pubmed">12790692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ijff DM, Aldenkamp AP. Cognitive side-effects of antiepileptic drugs in children. Handb Clin Neurol. (2013) 111:707&#x2013;18. 10.1016/B978-0-444-52891-9.00073-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-52891-9.00073-7</ArticleId><ArticleId IdType="pubmed">23622218</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts A, Arts WF, Stroink H, Peeters E, Brouwer O, Peters B, et al. . Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch study of epilepsy in childhood. Epilepsia. (2010) 51:1189&#x2013;97. 10.1111/j.1528-1167.2010.02546.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2010.02546.x</ArticleId><ArticleId IdType="pubmed">20557350</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg AT, Rychlik K, Levy SR, Testa FM. Complete remission of childhood-onset epilepsy: stability and prediction over two decades. Brain. (2014) 137:3213&#x2013;22. 10.1093/brain/awu294</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu294</ArticleId><ArticleId IdType="pmc">PMC4240301</ArticleId><ArticleId IdType="pubmed">25338950</ArticleId></ArticleIdList></Reference><Reference><Citation>Sillanp&#xe4;&#xe4; M, Schmidt D. Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain. (2009) 132:989&#x2013;98. 10.1093/brain/awn357</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn357</ArticleId><ArticleId IdType="pubmed">19153149</ArticleId></ArticleIdList></Reference><Reference><Citation>Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia. (1979) 20:729&#x2013;37. 10.1111/j.1528-1157.1979.tb04857.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1157.1979.tb04857.x</ArticleId><ArticleId IdType="pubmed">499118</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockerell OC, Sander J, Hart YM, Shorvon SD, Johnson A. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet. (1995) 346:140&#x2013;4. 10.1016/S0140-6736(95)91208-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(95)91208-8</ArticleId><ArticleId IdType="pubmed">7603228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. (2000) 342:314&#x2013;9. 10.1056/NEJM200002033420503</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200002033420503</ArticleId><ArticleId IdType="pubmed">10660394</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue-Ping W, Hai-Jiao W, Li-Na Z, Xu D, Ling L. Risk factors for drug-resistant epilepsy: a systematic review and meta-analysis. Medicine (Baltimore). (2019) 98:e16402. 10.1097/MD.0000000000016402</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000016402</ArticleId><ArticleId IdType="pmc">PMC6708813</ArticleId><ArticleId IdType="pubmed">31348240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Lizana J, Rodriguez-Lucenilla MI, Aguilera-L&#xf3;pez P, Aguirre-Rodr&#xed;guez J, Cassinello-Garc&#xed;a E. A study of drug-resistant childhood epilepsy testing the new ILAE criteria. Seizure. (2012) 21:266&#x2013;72. 10.1016/j.seizure.2012.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2012.01.009</ArticleId><ArticleId IdType="pubmed">22333178</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. . ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. (2017) 58:512&#x2013;21. 10.1111/epi.13709</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13709</ArticleId><ArticleId IdType="pmc">PMC5386840</ArticleId><ArticleId IdType="pubmed">28276062</ArticleId></ArticleIdList></Reference><Reference><Citation>Fejerman N, Caraballo R, Tenembaum SN. Atypical evolutions of benign localization-related epilepsies in children: are they predictable? Epilepsia. (2000) 41:380&#x2013;90. 10.1111/j.1528-1157.2000.tb00177.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1157.2000.tb00177.x</ArticleId><ArticleId IdType="pubmed">10756401</ArticleId></ArticleIdList></Reference><Reference><Citation>Willmore LJ. Valproate. In: Nordli DR, Pellock JM, Sankar R, Wheless JW, editors. Pellock's Pediatric Epilepsy: Diagnosis Therapy. 4th ed New York, NY: Demos Medical Publishing; (2016). p. 941&#x2013;56.</Citation></Reference><Reference><Citation>Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kalviainen R, et al. . Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. (2013) 54:551&#x2013;63. 10.1111/epi.12074</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.12074</ArticleId><ArticleId IdType="pubmed">23350722</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. (2007) 9:353&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">18077226</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson RH, Cramer JA, Collins JF, Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group . A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Eng J Med. (1992) 327:765&#x2013;71. 10.1056/NEJM199209103271104</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199209103271104</ArticleId><ArticleId IdType="pubmed">1298221</ArticleId></ArticleIdList></Reference><Reference><Citation>Willmore LJ, Shu V, Wallin B. Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. The M88-194 study group. Neurology. (1996) 46:49&#x2013;53. 10.1212/WNL.46.1.49</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.46.1.49</ArticleId><ArticleId IdType="pubmed">8559420</ArticleId></ArticleIdList></Reference><Reference><Citation>Verity CM, Hosking G, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The paediatric EPITEG collaborative group. Dev Med Child Neurol. (1995) 37:97&#x2013;108. 10.1111/j.1469-8749.1995.tb11978.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-8749.1995.tb11978.x</ArticleId><ArticleId IdType="pubmed">7851677</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, Hripcsak G, Jin P, Reich C, et al. . Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia. (2017) 58:e101&#x2013;6. 10.1111/epi.13828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13828</ArticleId><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32477631</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2153-4063</ISSN><JournalIssue CitedMedium="Print"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science</Title><ISOAbbreviation>AMIA Jt Summits Transl Sci Proc</ISOAbbreviation></Journal><ArticleTitle>Comparative Analysis and Evaluation of State-of-the-Art Medication Mapping Tools to Transform a Local Medication Terminology to RxNorm.</ArticleTitle><Pagination><StartPage>126</StartPage><EndPage>135</EndPage><MedlinePgn>126-135</MedlinePgn></Pagination><Abstract><AbstractText>Mapping local terminologies to standardized terminologies facilitates secondary use of electronic health records (EHR). Penn Medicine comprises multiple hospitals and facilities within the Philadelphia Metropolitan area providing services from primary to quaternary care. Our Penn Medicine (PennMed) data include medications collected during both inpatient and outpatient encounters at multiple facilities. Our goal was to map 941,198 unique medication terms to RxNorm, a standardized drug nomenclature from the National Library of Medicine (NLM). We chose three popular tools for mapping: NLM's RxMix and RxNav-in-a-Box, OHDSI's Usagi and Mayo Clinic's MedXN. We manually reviewed 400 mappings obtained from each tool and evaluated their performance for drug name, strength, form, and route. RxMix performed the best with an F1 score of 90% for drug name versus Usagi's 82% and MedXN's 74%. We discuss the strengths and limitations of each method and tips for other institutions seeking to map a local terminology to RxNorm.</AbstractText><CopyrightInformation>&#xa9;2020 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Biomedical Informatics, University of Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Excellence in Environmental Toxicology, University of Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boland</LastName><ForeName>Mary Regina</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Biomedical Informatics, University of Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Excellence in Environmental Toxicology, University of Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Jt Summits Transl Sci Proc</MedlineTA><NlmUniqueID>101539486</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32477631</ArticleId><ArticleId IdType="pmc">PMC7233099</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>U.S. National Library of Medicine. RxNorm overview [Internet]  Available from:  https://www.nlm.nih.gov/research/umls/rxnorm/overview.html.</Citation></Reference><Reference><Citation>Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc [Internet] 2011;18(4):441&#x2013;8. Available from:  http://www.ncbi.nlm.nih.gov/pubmed/21515544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128404</ArticleId><ArticleId IdType="pubmed">21515544</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitwal H, Qing D, Jones S, Bernstam E V., Chute CG, Johnson TR. Cross-terminology mapping challenges: A demonstration using medication terminological systems. J Biomed Inform [Internet] 2012 Aug 1;45(4):613&#x2013;25. Available from:  https://www.sciencedirect.com/science/article/pii/S1532046412000950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4398308</ArticleId><ArticleId IdType="pubmed">22750536</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O, Peters L. RxMix &#x2013; Use of NLM drug APIs by non-programmers. 2017:2291.</Citation></Reference><Reference><Citation>U.S. National Library of Medicine. Approximate matching in the RxNorm API [Internet] 2015 Available from:  https://rxnav.nlm.nih.gov/RxNormApproxMatch.html.</Citation></Reference><Reference><Citation>Peters L, Kapusnik-Uner JE, Bodenreider O. Methods for managing variation in clinical drug names. AMIA Annu Symp Proc [Internet] 2010;2010:637. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041346/pdf/amia-2010_sympproc_0637.pdf.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041346</ArticleId><ArticleId IdType="pubmed">21347056</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters L, Rice R, Bodenreider O. RxNav-in-a-Box &#x2013; A locally-installable version of RxNav and related APIs. 2018;2102</Citation></Reference><Reference><Citation>Sohn S, Clark C, Halgrim SR, Murphy SP, Chute CG, Liu H. MedXN: An open source medication extraction and normalization tool for clinical text. J Am Med Informatics Assoc. 2014;21(5):858&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4147619</ArticleId><ArticleId IdType="pubmed">24637954</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Informatics Assoc [Internet] 2012 Jan 1;19(1):54&#x2013;60. Available from:  https://academic.oup.com/jamia/article-lookup/doi/10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI/Usagi [Internet]  Available from:  https://github.com/OHDSI/Usagi.</Citation></Reference><Reference><Citation>Kopacka I. Basic regular expressions in R: Cheat sheet [Internet] 2016 Available from:  https://www.rstudio.com/wp-content/uploads/2016/09/RegExCheatsheet.pdf.</Citation></Reference><Reference><Citation>Common medical abbreviations [Internet] 2002 Available from:  http://dhss.alaska.gov/dph/Emergency/Documents/ems/assets/Downloads/Common_Med_Abbrev.pdf.</Citation></Reference><Reference><Citation>List of abbreviations used in medical prescriptions [Internet]  Available from:  https://en.wikipedia.org/wiki/List_of_abbreviations_used_in_medical_prescriptions.</Citation></Reference><Reference><Citation>American Speech-Language Hearing Association. Common medical abbreviations [Internet]  Available from:  https://www.asha.org/uploadedfiles/slp/healthcare/medicalabbreviations.pdf.</Citation></Reference><Reference><Citation>100 most popular american last names [Internet]  Available from:  https://www.rong-chang.com/namesdict/100_last_names.htm.</Citation></Reference><Reference><Citation>Butler R. Most common last names for blacks in the U.S. [Internet]  Available from:  https://names.mongabay.com/data/black.html.</Citation></Reference><Reference><Citation>Spitzer Y. Most common jewish names [Internet] 2012 Available from:  https://yannayspitzer.net/2012/07/24/most-common-jewish-names/</Citation></Reference><Reference><Citation>Pallmann P, Hothorn LA. Analysis of means: A generalized approach using R. J Appl Stat. 2016;43(8):1541&#x2013;60.</Citation></Reference><Reference><Citation>Boland MR, Alur-Gupta S, Levine L, Gabriel P, Gonzalez-Hernandez G. Disease associations depend on visit type: results from a visit-wide association study. BioData Min [Internet] 2019 Dec 11;12(1):15. Available from:  https://biodatamining.biomedcentral.com/articles/10.1186/s13040-019-0203-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13040-019-0203-2</ArticleId><ArticleId IdType="pmc">PMC6625053</ArticleId><ArticleId IdType="pubmed">31338127</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. National Library of Medicine. Abbreviations and acronyms in RxNorm normalization [Internet]  Available from:  https://rxnav.nlm.nih.gov/Abbreviations.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32477663</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2153-4063</ISSN><JournalIssue CitedMedium="Print"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science</Title><ISOAbbreviation>AMIA Jt Summits Transl Sci Proc</ISOAbbreviation></Journal><ArticleTitle>Mapping Local Biospecimen Records to the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>422</StartPage><EndPage>429</EndPage><MedlinePgn>422-429</MedlinePgn></Pagination><Abstract><AbstractText>Research to support precision medicine for leukemia patients requires integration of biospecimen and clinical data. The Observational Medical Outcomes Partnership common data model (OMOP CDM) and its Specimen table presents a potential solution. Although researchers have described progress and challenges in mapping electronic health record (EHR) data to populate the OMOP CDM, to our knowledge no studies have described populating the OMOP CDM with biospecimen data. Using biobank data from our institution, we mapped 26% of biospecimen records to the OMOP Specimen table. Records failed mapping due to local codes for time point that were incompatible with the OMOP reference terminology. We recommend expanding allowable codes to encompass research data, adding foreign keys to leverage additional OMOP tables with data from other sources or to store additional specimen details, and considering a new table to represent processed samples and inventory.</AbstractText><CopyrightInformation>&#xa9;2020 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Michael</LastName><ForeName>Chelsea L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Health Informatics, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Healthcare Policy &amp; Research, Weill Cornell Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sholle</LastName><ForeName>Evan T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Information Technologies &amp; Services Department, Weill Cornell Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wulff</LastName><ForeName>Regina T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medicine New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roboz</LastName><ForeName>Gail J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medicine New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campion</LastName><ForeName>Thomas R</ForeName><Initials>TR</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Healthcare Policy &amp; Research, Weill Cornell Medicine, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Information Technologies &amp; Services Department, Weill Cornell Medicine, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Science Center, Weill Cornell Medicine, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Weill Cornell Medicine, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Jt Summits Transl Sci Proc</MedlineTA><NlmUniqueID>101539486</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32477663</ArticleId><ArticleId IdType="pmc">PMC7233045</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Atlanta, GA: American Cancer Society; 2019. Key statistics for acute myeloid leukemia (AML) [Internet]. [cited 2019 Jul 20]. Available from:  https://www.cancer.org/cancer/acute-myeloid-leukemia/about/key-statistics.html.</Citation></Reference><Reference><Citation>Cancer stat facts: leukemia [Internet] National Cancer Institute. 2019.  [cited 2019 Apr 3]. Available from:  https://seer.cancer.gov/statfacts/html/leuks.html.</Citation></Reference><Reference><Citation>Myelodysplastic syndromes treatment (PDQ&#xae;)&#x2013;patient version [Internet] National Cancer Institute.  [updated 2019 Mar 28; cited 2019 Jul 29]. Available from:  https://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq.</Citation></Reference><Reference><Citation>Adult acute myeloid leukemia treatment (PDQ&#xae;)&#x2013;patient version [Internet]. National Cancer Institute.  [updated 2019 Jul 23; cited 2019 Jul 22]. Available from:  https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq#_1.</Citation></Reference><Reference><Citation>Paradiso AV, Daidone MG, Canzonieri V, Zito A. Biobanks and scientists: supply and demand. Journal of translational medicine. 2018;16(1):136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5963141</ArticleId><ArticleId IdType="pubmed">29783984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Studies in health technology and informatics. 2015;(216):574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O"Hara DJ, Powell GE, Painter JL, Pattishall EN, et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. Journal of the American Medical Informatics Association : JAMIA. 2010;17(6):652&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. Journal of the American Medical Informatics Association : JAMIA. 2012;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. Journal of the American Medical Informatics Association : JAMIA. 2015;22(3):553&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, et al. Towards implementation of OMOP in a German university hospital consortium. Applied clinical informatics. 2018;9(1):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinner C, Gezgin D, Wendl C, Gall W. A clinical data warehouse based on OMOP and i2b2 for Austrian health claims data. Studies in health technology and informatics. 2018;248:94&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29726424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, Ryan PB. Effect of vocabulary mapping for conditions on phenotype cohorts. Journal of the American Medical Informatics Association : JAMIA. 2018;25(12):1618&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Wulff RT, Sholle ET, Roboz GJ, Kraemer DA, Campion TR. Evaluating generalizability of a biospecimen informatics approach: support for local requirements and best practices. AMIA Joint Summits on Translational Science proceedings AMIA Joint Summits on Translational Science. 2018;2017:55&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961803</ArticleId><ArticleId IdType="pubmed">29888041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholle ET, Kabariti J, Johnson SB, Leonard JP, Pathak J, Varughese VI, et al. Secondary use of patients" electronic records (SUPER): an approach for meeting specific data needs of clinical and translational researchers. AMIA Annual Symposium proceedings AMIA Symposium. 2017;(2017):1581&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977622</ArticleId><ArticleId IdType="pubmed">29854228</ArticleId></ArticleIdList></Reference><Reference><Citation>Specimen [Internet]  Observational Health Data Sciences and Informatics; [updated 11 Oct 2018; cited 2019 Jul 29]. Available from:  https://github.com/OHDSI/CommonDataModel/wiki/SPECIMEN.</Citation></Reference><Reference><Citation>Peripheral blood specimen [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Jul 29]. Available from:  http://athena.ohdsi.org/search-terms/terms/4047495.</Citation></Reference><Reference><Citation>Blood specimen [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Jul 29]. Available from:  http://athena.ohdsi.org/search-terms/terms/4001225.</Citation></Reference><Reference><Citation>Blood specimen with EDTA [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Jul 29]. Available from:  http://athena.ohdsi.org/search-terms/terms/40482922.</Citation></Reference><Reference><Citation>Blood specimen submitted in heparinized collection tube [Internet]  Odysseus Data Services, Inc. ; [updated 2018 Dec 28; cited 2019 Jul 29]. Available from:  http://athena.ohdsi.org/search-terms/terms/40486989.</Citation></Reference><Reference><Citation>Bone marrow specimen [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Jul 29]. Available from:  http://athena.ohdsi.org/search-terms/terms/4000623.</Citation></Reference><Reference><Citation>Venous structure [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Jul 29]. Available from:  http://athena.ohdsi.org/search-terms/terms/4104340.</Citation></Reference><Reference><Citation>Bone marrow structure [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Aug 12]. Available from:  http://athena.ohdsi.org/search-terms/terms/4029619.</Citation></Reference><Reference><Citation>Normal [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Aug 14]. Available from:  http://athena.ohdsi.org/search-terms/terms/4069590.</Citation></Reference><Reference><Citation>Abnormal [Internet].  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Aug 14]. Available from:  http://athena.ohdsi.org/search-terms/terms/4135493.</Citation></Reference><Reference><Citation>Malignant [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Aug 14]. Available from:  http://athena.ohdsi.org/search-terms/terms/4066212.</Citation></Reference><Reference><Citation>Research administration [Internet]  Odysseus Data Services, Inc.; [updated 2018 Dec 28; cited 2019 Aug 14]. Available from:  http://athena.ohdsi.org/search-terms/terms/ext-link&gt;44803476.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>